{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 104,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Here I am using gensim for learning the word embeddings from the EUADR corpus\n",
    "# This is just a rough start to learn \n",
    "import gensim\n",
    "import logging\n",
    "import os\n",
    "import pandas as pd"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 105,
   "metadata": {},
   "outputs": [],
   "source": [
    "# start the log\n",
    "logging.basicConfig(\n",
    "    format='%(asctime)s : %(levelname)s : %(message)s',\n",
    "    level=logging.INFO)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 106,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'/home/santosh/Work/Unsupervised-Protein-Genes-Diseases-Extraction/Datasets/'"
      ]
     },
     "execution_count": 106,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "data_path"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 107,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2019-06-19 15:57:56,489 : INFO : Done reading data files\n"
     ]
    }
   ],
   "source": [
    "# get the current working directory\n",
    "data_path = os.path.abspath(os.path.join(os.path.dirname( '__file__' ), '..', 'Datasets'))+'/'\n",
    "\n",
    "# Although the dataset says csv, it is tab delimited. In addition to this, they have severe codels problems. \n",
    "# So best to parse throught codes first. \n",
    "# UnicodeDecodeError: 'utf-8' codec can't decode byte 0xfc in position 2: invalid start byte\n",
    "\n",
    "#open for reading with \"universal\" type set\n",
    "\n",
    "import codecs\n",
    "\n",
    "doc_d_t = codecs.open(data_path+'EUADR_Corpus_IBIgroup/'+'EUADR_drug_target'+'.csv','rU','UTF-8') \n",
    "EUADR_drug_target = pd.read_csv(doc_d_t, sep='\\t')\n",
    "\n",
    "\n",
    "doc_t_d = codecs.open(data_path+'EUADR_Corpus_IBIgroup/'+'EUADR_target_disease'+'.csv','rU','UTF-8',errors='ignore') \n",
    "EUADR_target_disease = pd.read_csv(doc_t_d, sep='\\t')\n",
    "       \n",
    "doc_d_d = codecs.open(data_path+'EUADR_Corpus_IBIgroup/'+'EUADR_drug_disease'+'.csv','rU','UTF-8')                       \n",
    "EUADR_drug_disease = pd.read_csv(doc_d_d, sep='\\t')\n",
    "\n",
    "logging.info(\"Done reading data files\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 108,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Index(['ASSOCIATION_TYPE', 'PMID', 'NUM_SENTENCE', 'ENTITY1_TEXT',\n",
       "       'ENTITY1_INI', 'ENTITY1_END', 'ENTITY1_TYPE', 'ENTITY2_TEXT',\n",
       "       'ENTITY2_INI', 'ENTITY2_END', 'ENTITY2_TYPE', 'SENTENCE'],\n",
       "      dtype='object')"
      ]
     },
     "execution_count": 108,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "EUADR_target_disease.columns"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 109,
   "metadata": {},
   "outputs": [],
   "source": [
    "sentences =  EUADR_drug_target['SENTENCE'].tolist() + EUADR_target_disease['SENTENCE'].tolist()+ EUADR_drug_disease['SENTENCE'].tolist()\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 113,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['Gefitinib inhibition of drug resistance to doxorubicin by inactivating ABCG2 in thyroid cancer cell lines.',\n",
       " 'Inactivation of EGFR kinase by gefitinib was analyzed by Western blot analysis and immunofluorescence.',\n",
       " 'Gefitinib inhibition of drug resistance to doxorubicin by inactivating ABCG2 in thyroid cancer cell lines.',\n",
       " 'Extrusion assays using flow cytometry analysis were used to determine the ability of thyroid cancer cells to extrude the chemotherapy drug, doxorubicin, via the ABCG2 drug transporter in the presence or absence of gefitinib.',\n",
       " 'Inactivation of the EGFR kinase by gefitinib potentiates the cytotoxic effect of doxorubicin in thyroid cancer, most likely by decreasing the ability of the cell to extrude doxorubicin.',\n",
       " 'Inhibition of EGFR kinase activity by gefitinib causes the translocation of the ABCG2 drug transporter away from the plasma membrane, resulting in a concomitant decrease in doxorubicin extrusion in thyroid cancer cell lines.',\n",
       " 'A terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick-end labeling assay was performed to demonstrate ABCG2-mediated apoptosis in the presence of doxorubicin.',\n",
       " 'Both ARO and WRO demonstrated differential ABCG2 expression, whereas both were sensitized to doxorubicin-induced apoptosis on ABCG2 knockdown with short interfering RNA.',\n",
       " 'Inactivation of the EGFR kinase by gefitinib potentiates the cytotoxic effect of doxorubicin in thyroid cancer, most likely by decreasing the ability of the cell to extrude doxorubicin.',\n",
       " 'Inhibition of EGFR kinase activity by gefitinib causes the translocation of the ABCG2 drug transporter away from the plasma membrane, resulting in a concomitant decrease in doxorubicin extrusion in thyroid cancer cell lines.',\n",
       " 'Inhibition of EGFR kinase activity by gefitinib causes the translocation of the ABCG2 drug transporter away from the plasma membrane, resulting in a concomitant decrease in doxorubicin extrusion in thyroid cancer cell lines.',\n",
       " 'The expression of ABCG2 may explain in part the ineffectiveness of doxorubicin as a single modality treatment for anaplastic thyroid cancer or for treatment of metastatic follicular thyroid cancer.',\n",
       " 'Inhibition of EGFR kinase activity by gefitinib causes the translocation of the ABCG2 drug transporter away from the plasma membrane, resulting in a concomitant decrease in doxorubicin extrusion in thyroid cancer cell lines.',\n",
       " 'GSK221149A had similar affinity (K(i) = 4.1 nM) and selectivity for native oxytocin receptors from rat and produced a functional, competitive block of oxytocin-induced contractions in isolated rat myometrial strips with a pA(2) value of 8.18.',\n",
       " 'Oral administration of GSK221149A (5 mg/kg) was effective in inhibiting oxytocin-induced uterine contractions after single and multiple (4-day) dosing.',\n",
       " 'Intravenous administration of GSK221149A produced a dose-dependent decrease in oxytocin-induced uterine contractions in anesthetized rats with an ID(50) = 0.27 +/- 0.60 mg/kg (corresponding plasma concentrations were 88 ng/ml).',\n",
       " 'PML/RARalpha is directly targeted by all-trans-retinoic acid (ATRA), which degrades the oncoprotein and induces complete remission of malignancies.',\n",
       " 'ATRA co-operated with MEK inhibitor to increase degradation of PML/RARalpha and exhibited a convergence point in caspase activation with MEK inhibitors.',\n",
       " 'Assessment of 1177 human immunodeficiency virus (HIV) resistance genotypes at an HIV/AIDS clinic showed a decrease in the incidence of the K65R mutation, from 15.2% of isolates during the period 2002-2004 to 2.7% of isolates during the period 2005-2006 (P < .001), despite elevated and stable rates of tenofovir use.',\n",
       " 'One among the 17 genes studied is ATP7B which is involved in the transport of copper ions across the cell membrane into the cell.',\n",
       " 'Topoisomerase IIbeta mediated DNA double-strand breaks: implications in doxorubicin cardiotoxicity and prevention by dexrazoxane.',\n",
       " 'Topoisomerase IIbeta mediated DNA double-strand breaks: implications in doxorubicin cardiotoxicity and prevention by dexrazoxane.',\n",
       " 'Furthermore, in addition to antagonizing Top2 cleavage complex formation, dexrazoxane also induced rapid degradation of Top2beta, which paralleled the reduction of doxorubicin-induced DNA damage.',\n",
       " 'Doxorubicin-induced DNA damage was also specifically abolished by the proteasome inhibitors bortezomib and MG132 and much reduced in top2beta(-/-) mouse embryonic fibroblasts (MEF) compared with TOP2beta(+/+) MEFs, suggesting the involvement of proteasome and DNA topoisomerase IIbeta (Top2beta).',\n",
       " 'Doxorubicin-induced DNA damage was also specifically abolished by the proteasome inhibitors bortezomib and MG132 and much reduced in top2beta(-/-) mouse embryonic fibroblasts (MEF) compared with TOP2beta(+/+) MEFs, suggesting the involvement of proteasome and DNA topoisomerase IIbeta (Top2beta).',\n",
       " 'Doxorubicin-induced DNA damage was also specifically abolished by the proteasome inhibitors bortezomib and MG132 and much reduced in top2beta(-/-) mouse embryonic fibroblasts (MEF) compared with TOP2beta(+/+) MEFs, suggesting the involvement of proteasome and DNA topoisomerase IIbeta (Top2beta).',\n",
       " 'Together, our results suggest that dexrazoxane antagonizes doxorubicin-induced DNA damage through its interference with Top2beta, which could implicate Top2beta in doxorubicin cardiotoxicity.',\n",
       " 'Furthermore, in addition to antagonizing Top2 cleavage complex formation, dexrazoxane also induced rapid degradation of Top2beta, which paralleled the reduction of doxorubicin-induced DNA damage.',\n",
       " 'Together, our results suggest that dexrazoxane antagonizes doxorubicin-induced DNA damage through its interference with Top2beta, which could implicate Top2beta in doxorubicin cardiotoxicity.',\n",
       " 'The specific involvement of proteasome and Top2beta in doxorubicin-induced DNA damage is consistent with a model in which proteasomal processing of doxorubicin-induced Top2beta-DNA covalent complexes exposes the Top2beta-concealed DNA double-strand breaks.',\n",
       " 'Doxorubicin-induced DNA damage was also specifically abolished by the proteasome inhibitors bortezomib and MG132 and much reduced in top2beta(-/-) mouse embryonic fibroblasts (MEF) compared with TOP2beta(+/+) MEFs, suggesting the involvement of proteasome and DNA topoisomerase IIbeta (Top2beta).',\n",
       " 'Doxorubicin-induced DNA damage was also specifically abolished by the proteasome inhibitors bortezomib and MG132 and much reduced in top2beta(-/-) mouse embryonic fibroblasts (MEF) compared with TOP2beta(+/+) MEFs, suggesting the involvement of proteasome and DNA topoisomerase IIbeta (Top2beta).',\n",
       " 'After feeding a diet containing FOS (100 g/kg diet) to rats for 2 d, we investigated gene transcripts of transient receptor potential vanilloid type 6 (TRPV6), calbindin-D9k, and plasma membrane calcium-ATPase 1b (PMCA1b).',\n",
       " 'After feeding a diet containing FOS (100 g/kg diet) to rats for 2 d, we investigated gene transcripts of transient receptor potential vanilloid type 6 (TRPV6), calbindin-D9k, and plasma membrane calcium-ATPase 1b (PMCA1b).',\n",
       " 'We found for the first time, to our knowledge, that regulation of TRPV6 gene expression by SCFA may be a molecular mechanism involved in the promotion of calcium absorption by FOS in rats.',\n",
       " 'The FOS diet increased expression of TRPV6 and calbindin-D9k but did not affect PMCA1b expression.',\n",
       " 'The FOS diet increased expression of TRPV6 and calbindin-D9k but did not affect PMCA1b expression.',\n",
       " 'The FOS diet increased expression of TRPV6 and calbindin-D9k but did not affect PMCA1b expression.',\n",
       " 'After feeding a diet containing FOS (100 g/kg diet) to rats for 2 d, we investigated gene transcripts of transient receptor potential vanilloid type 6 (TRPV6), calbindin-D9k, and plasma membrane calcium-ATPase 1b (PMCA1b).',\n",
       " 'After feeding a diet containing FOS (100 g/kg diet) to rats for 2 d, we investigated gene transcripts of transient receptor potential vanilloid type 6 (TRPV6), calbindin-D9k, and plasma membrane calcium-ATPase 1b (PMCA1b).',\n",
       " 'These results suggest that FOS increase calcium absorption by increasing mRNA expression of TRPV6 in rat colorectum, and cell culture analysis indicated that SCFA, as fermentation products of FOS, are involved in the increased mRNA expression of TRPV6.',\n",
       " 'Adalimumab is a subcutaneously administered, recombinant, human IgG1 monoclonal antibody specific for human tumor necrosis factor (TNF).',\n",
       " 'Adalimumab is a subcutaneously administered, recombinant, human IgG1 monoclonal antibody specific for human tumor necrosis factor (TNF).',\n",
       " '[3H]A-804598 ([3H]2-cyano-1-[(1S)-1-phenylethyl]-3-quinolin-5-ylguanidine) is a novel, potent, and selective antagonist radioligand for P2X7 receptors.',\n",
       " 'While several species selective P2X7 antagonists exist, A-804598 represents a structurally novel, competitive, and selective antagonist that has equivalent high affinity at rat (IC50 = 10 nM), mouse (IC50 = 9 nM) and human (IC50 = 11 nM) P2X7 receptors.',\n",
       " 'The pharmacological profile for P2X antagonists to inhibit [3H]A-804598 binding correlated with their ability to block functional activation of P2X7 receptors (r=0.95, P<0.05).',\n",
       " 'The pharmacological profile for P2X antagonists to inhibit [3H]A-804598 binding correlated with their ability to block functional activation of P2X7 receptors (r=0.95, P<0.05).',\n",
       " 'A-804598 also potently blocked agonist stimulated release of IL-1beta and Yo-Pro uptake from differentiated THP-1 cells that natively express human P2X7 receptors.',\n",
       " 'A-804598 also potently blocked agonist stimulated release of IL-1beta and Yo-Pro uptake from differentiated THP-1 cells that natively express human P2X7 receptors.',\n",
       " 'These data demonstrate that A-804598 is one of the most potent and selective antagonists for mammalian P2X7 receptors described to date and [3H]A-804598 is a high affinity antagonist radioligand that specifically labels rat P2X7 receptors.',\n",
       " 'MA and MD were reversible inhibitors of CYP3A with competitive Ki values of 2.7 and 0.2 microM, respectively.',\n",
       " 'MD did not inactivate CYP3A.',\n",
       " 'Sequential metabolism is responsible for diltiazem-induced time-dependent loss of CYP3A.',\n",
       " 'We previously reported that microsomal inactivation kinetic parameters of diltiazem underpredicted CYP3A inactivation in hepatocytes.',\n",
       " 'Inactivation of CYP3A by diltiazem was dependent on microsomal protein concentration (25, 36, and 41% decrease in CYP3A activity at 0.2, 0.4, and 0.8 mg/ml microsomal protein, respectively, incubated with 10 microM diltiazem over 20 min), whereas inactivation by MA did not seem to be protein concentration-dependent.',\n",
       " 'Inactivation of CYP3A by diltiazem was dependent on microsomal protein concentration (25, 36, and 41% decrease in CYP3A activity at 0.2, 0.4, and 0.8 mg/ml microsomal protein, respectively, incubated with 10 microM diltiazem over 20 min), whereas inactivation by MA did not seem to be protein concentration-dependent.',\n",
       " 'In summary, time-dependent CYP3A inactivation by MA seems to be the major contributor responsible for the loss of CYP3A in human liver microsomes and human hepatocytes incubated with diltiazem.',\n",
       " 'In cryopreserved hepatocytes incubated with diltiazem, time-dependent loss of CYP3A was accompanied by increased formation of MA and MD, with the MA level similar to its K(I) at higher diltiazem concentrations.',\n",
       " 'In cryopreserved hepatocytes incubated with diltiazem, time-dependent loss of CYP3A was accompanied by increased formation of MA and MD, with the MA level similar to its K(I) at higher diltiazem concentrations.',\n",
       " 'In human liver microsomes, MA was a more potent time-dependent inactivator of CYP3A than its parent drug, with apparent k(inact) approximately 4-fold higher than that of diltiazem at a microsomal protein concentration of 0.2 mg/ml.',\n",
       " 'In cryopreserved hepatocytes incubated with diltiazem, time-dependent loss of CYP3A was accompanied by increased formation of MA and MD, with the MA level similar to its K(I) at higher diltiazem concentrations.',\n",
       " 'In human liver microsomes, MA was a more potent time-dependent inactivator of CYP3A than its parent drug, with apparent k(inact) approximately 4-fold higher than that of diltiazem at a microsomal protein concentration of 0.2 mg/ml.',\n",
       " 'MA and MD were reversible inhibitors of CYP3A with competitive Ki values of 2.7 and 0.2 microM, respectively.',\n",
       " 'In Bcr-Abl-positive mouse bone marrow cells, nonphosphorylatable Hsp90beta expression conferred imatinib (Gleevec) resistance.',\n",
       " 'In Bcr-Abl-positive mouse bone marrow cells, nonphosphorylatable Hsp90beta expression conferred imatinib (Gleevec) resistance.',\n",
       " 'We then established that localized intra-abdominal desensitization of TRPV1 channels with intraperitoneal resiniferatoxin blocks the T(b) response to systemic AMG0347; the extent of desensitization was determined by using a comprehensive battery of functional tests.',\n",
       " 'We then found that this drug is the most potent TRPV1 antagonist known to increase T(b) of rats and mice and showed (by using knock-out mice) that the entire hyperthermic effect of AMG0347 is TRPV1 dependent.',\n",
       " 'The magnitude of the hyperthermic response depended on neither T(b) nor tail-skin temperature at the time of AMG0347 administration, thus indicating that AMG0347-induced hyperthermia results from blockade of tonic TRPV1 activation by nonthermal factors.',\n",
       " 'Paeonol suppresses intercellular adhesion molecule-1 expression in tumor necrosis factor-alpha-stimulated human umbilical vein endothelial cells by blocking p38, ERK and nuclear factor-kappaB signaling pathways.',\n",
       " 'Paeonol suppresses intercellular adhesion molecule-1 expression in tumor necrosis factor-alpha-stimulated human umbilical vein endothelial cells by blocking p38, ERK and nuclear factor-kappaB signaling pathways.',\n",
       " 'Paeonol suppresses intercellular adhesion molecule-1 expression in tumor necrosis factor-alpha-stimulated human umbilical vein endothelial cells by blocking p38, ERK and nuclear factor-kappaB signaling pathways.',\n",
       " 'The inhibitory effect of paeonol on ICAM-1 production might be mediated by inhibiting p38, ERK and NF-kappaB signaling pathways, which are involved in TNF-alpha-induced ICAM-1 production.',\n",
       " 'The inhibitory effect of paeonol on ICAM-1 production might be mediated by inhibiting p38, ERK and NF-kappaB signaling pathways, which are involved in TNF-alpha-induced ICAM-1 production.',\n",
       " 'Paeonol suppresses intercellular adhesion molecule-1 expression in tumor necrosis factor-alpha-stimulated human umbilical vein endothelial cells by blocking p38, ERK and nuclear factor-kappaB signaling pathways.',\n",
       " 'The inhibitory effect of paeonol on ICAM-1 production might be mediated by inhibiting p38, ERK and NF-kappaB signaling pathways, which are involved in TNF-alpha-induced ICAM-1 production.',\n",
       " 'The inhibitory effect of paeonol on ICAM-1 production might be mediated by inhibiting p38, ERK and NF-kappaB signaling pathways, which are involved in TNF-alpha-induced ICAM-1 production.',\n",
       " 'Paeonol concentration-dependently inhibited the production of ICAM-1; it inhibited nuclear factor-kappaB (NF-kappaB) p65 translocation into the nucleus and the phosphorylation of inhibitory factor kappaBalpha (IkappaBalpha).',\n",
       " 'Paeonol concentration-dependently inhibited the production of ICAM-1; it inhibited nuclear factor-kappaB (NF-kappaB) p65 translocation into the nucleus and the phosphorylation of inhibitory factor kappaBalpha (IkappaBalpha).',\n",
       " 'Paeonol concentration-dependently inhibited the production of ICAM-1; it inhibited nuclear factor-kappaB (NF-kappaB) p65 translocation into the nucleus and the phosphorylation of inhibitory factor kappaBalpha (IkappaBalpha).',\n",
       " 'Paeonol suppresses intercellular adhesion molecule-1 expression in tumor necrosis factor-alpha-stimulated human umbilical vein endothelial cells by blocking p38, ERK and nuclear factor-kappaB signaling pathways.',\n",
       " 'Paeonol inhibited U937 monocyte adhesion to HUVECs stimulated by TNF-alpha, suggesting that it may inhibit the binding of monocytes to endothelium by regulating the production of critical adhesion molecules by TNF-alpha.',\n",
       " 'We studied how the levels of intercellular adhesion molecule-1 (ICAM-1), one of the key molecules in the development of atherosclerosis, might be affected by paeonol in tumor necrosis factor-alpha (TNF-alpha)-activated human umbilical vein endothelial cells (HUVECs).',\n",
       " 'Paeonol concentration-dependently inhibited the production of ICAM-1; it inhibited nuclear factor-kappaB (NF-kappaB) p65 translocation into the nucleus and the phosphorylation of inhibitory factor kappaBalpha (IkappaBalpha).',\n",
       " 'Paeonol concentration-dependently inhibited the production of ICAM-1; it inhibited nuclear factor-kappaB (NF-kappaB) p65 translocation into the nucleus and the phosphorylation of inhibitory factor kappaBalpha (IkappaBalpha).',\n",
       " 'Paeonol concentration-dependently inhibited the production of ICAM-1; it inhibited nuclear factor-kappaB (NF-kappaB) p65 translocation into the nucleus and the phosphorylation of inhibitory factor kappaBalpha (IkappaBalpha).',\n",
       " 'The inhibitory effect of paeonol on ICAM-1 production might be mediated by inhibiting p38, ERK and NF-kappaB signaling pathways, which are involved in TNF-alpha-induced ICAM-1 production.',\n",
       " 'Here we report that osteoblastic cells express scavenger receptors of class B that are implicated in the uptake of cholesterol and estradiol from LDL and HDL3.',\n",
       " 'Scavenger receptor of class B expressed by osteoblastic cells are implicated in the uptake of cholesteryl ester and estradiol from LDL and HDL3.',\n",
       " 'Scavenger receptor of class B expressed by osteoblastic cells are implicated in the uptake of cholesteryl ester and estradiol from LDL and HDL3.',\n",
       " 'Here we report that osteoblastic cells express scavenger receptors of class B that are implicated in the uptake of cholesterol and estradiol from LDL and HDL3.',\n",
       " 'Scavenger receptor of class B expressed by osteoblastic cells are implicated in the uptake of cholesteryl ester and estradiol from LDL and HDL3.',\n",
       " 'Here we report that osteoblastic cells express scavenger receptors of class B that are implicated in the uptake of cholesterol and estradiol from LDL and HDL3.',\n",
       " 'Overall, our results suggest a novel mechanism for the routing of cholesterol and estradiol to osteoblasts involving the metabolism of LDL and HDL3 by SR-B receptors.',\n",
       " 'Overall, our results suggest a novel mechanism for the routing of cholesterol and estradiol to osteoblasts involving the metabolism of LDL and HDL3 by SR-B receptors.',\n",
       " 'Finally, estradiol carried by LDL and HDL3 was selectively transferred to the osteoblastic cells also through SR-B receptors.',\n",
       " 'Finally, estradiol carried by LDL and HDL3 was selectively transferred to the osteoblastic cells also through SR-B receptors.',\n",
       " 'Finally, estradiol carried by LDL and HDL3 was selectively transferred to the osteoblastic cells also through SR-B receptors.',\n",
       " 'Overall, our results suggest a novel mechanism for the routing of cholesterol and estradiol to osteoblasts involving the metabolism of LDL and HDL3 by SR-B receptors.',\n",
       " 'On the one hand, endocannabinoids have been implicated in the protective effects of IPC through cannabinoid CB1/CB2 receptor-dependent and -independent mechanisms.',\n",
       " 'On the one hand, endocannabinoids have been implicated in the protective effects of IPC through cannabinoid CB1/CB2 receptor-dependent and -independent mechanisms.',\n",
       " 'Previous studies using synthetic CB1 receptor agonists or knockout mice demonstrated CB1 receptor-dependent protection against cerebral I/R injury in various animal models.',\n",
       " 'This review is aimed to discuss the role of endocannabinoids and CB receptors in various forms of I/R injury (myocardial, cerebral, hepatic and circulatory shock) and preconditioning, and to delineate the evidence supporting the therapeutic utility of selective CB2 receptor agonists, which are devoid of psychoactive effects, as a promising new approach to limit I/R-induced tissue damage.',\n",
       " 'Excitedly, emerging studies using potent CB2 receptor agonists and/or knockout mice have provided compelling evidence that CB2 receptor activation is protective against myocardial, cerebral and hepatic I/R injuries by decreasing the endothelial cell activation/inflammatory response (for example, expression of adhesion molecules, secretion of chemokines, and so on), and by attenuating the leukocyte chemotaxis, rolling, adhesion to endothelium, activation and transendothelial migration, and interrelated oxidative/nitrosative damage.',\n",
       " 'We have developed a small-molecule inhibitor of all three vascular endothelial growth factor (VEGF) receptors (VEGFR), platelet-derived growth factor receptor, and c-Kit tyrosine kinases, pazopanib (GW786034), which selectively inhibits VEGF-induced endothelial cell proliferation.',\n",
       " 'We have developed a small-molecule inhibitor of all three vascular endothelial growth factor (VEGF) receptors (VEGFR), platelet-derived growth factor receptor, and c-Kit tyrosine kinases, pazopanib (GW786034), which selectively inhibits VEGF-induced endothelial cell proliferation.',\n",
       " 'We have developed a small-molecule inhibitor of all three vascular endothelial growth factor (VEGF) receptors (VEGFR), platelet-derived growth factor receptor, and c-Kit tyrosine kinases, pazopanib (GW786034), which selectively inhibits VEGF-induced endothelial cell proliferation.',\n",
       " 'We have developed a small-molecule inhibitor of all three vascular endothelial growth factor (VEGF) receptors (VEGFR), platelet-derived growth factor receptor, and c-Kit tyrosine kinases, pazopanib (GW786034), which selectively inhibits VEGF-induced endothelial cell proliferation.',\n",
       " 'We have developed a small-molecule inhibitor of all three vascular endothelial growth factor (VEGF) receptors (VEGFR), platelet-derived growth factor receptor, and c-Kit tyrosine kinases, pazopanib (GW786034), which selectively inhibits VEGF-induced endothelial cell proliferation.',\n",
       " 'We have developed a small-molecule inhibitor of all three vascular endothelial growth factor (VEGF) receptors (VEGFR), platelet-derived growth factor receptor, and c-Kit tyrosine kinases, pazopanib (GW786034), which selectively inhibits VEGF-induced endothelial cell proliferation.',\n",
       " 'We have developed a small-molecule inhibitor of all three vascular endothelial growth factor (VEGF) receptors (VEGFR), platelet-derived growth factor receptor, and c-Kit tyrosine kinases, pazopanib (GW786034), which selectively inhibits VEGF-induced endothelial cell proliferation.',\n",
       " 'We have developed a small-molecule inhibitor of all three vascular endothelial growth factor (VEGF) receptors (VEGFR), platelet-derived growth factor receptor, and c-Kit tyrosine kinases, pazopanib (GW786034), which selectively inhibits VEGF-induced endothelial cell proliferation.',\n",
       " 'We have developed a small-molecule inhibitor of all three vascular endothelial growth factor (VEGF) receptors (VEGFR), platelet-derived growth factor receptor, and c-Kit tyrosine kinases, pazopanib (GW786034), which selectively inhibits VEGF-induced endothelial cell proliferation.',\n",
       " 'We have developed a small-molecule inhibitor of all three vascular endothelial growth factor (VEGF) receptors (VEGFR), platelet-derived growth factor receptor, and c-Kit tyrosine kinases, pazopanib (GW786034), which selectively inhibits VEGF-induced endothelial cell proliferation.',\n",
       " 'The pharmacokinetics of the three 5HT3 antagonists investigated were dominated by CYP3A4 (and/or 2C9) compared with CYP1A2 in man, possibly determined by enzyme capacity rather than relative enzyme affinity.',\n",
       " 'The pharmacokinetics of the three 5HT3 antagonists investigated were dominated by CYP3A4 (and/or 2C9) compared with CYP1A2 in man, possibly determined by enzyme capacity rather than relative enzyme affinity.',\n",
       " 'Novel iminobenzoxathiolone compound inhibits nuclear factor-kappaB activation targeting inhibitory kappaB kinase beta and down-regulating interleukin-1beta expression in lipopolysaccharide-activated macrophages.',\n",
       " 'In this study, a novel iminobenzoxathiolone LYR-71 of 6-methyl-2-propylimino-6,7-dihydro-5H-benzo[1,3]oxathiol-4-one has been demonstrated to inhibit in vitro catalytic activity of inhibitory kappaB (IkappaB) kinase beta (IKKbeta), a key enzyme required for NF-kappaB activation, with an IC(50) value of 7 microM.',\n",
       " 'In this study, a novel iminobenzoxathiolone LYR-71 of 6-methyl-2-propylimino-6,7-dihydro-5H-benzo[1,3]oxathiol-4-one has been demonstrated to inhibit in vitro catalytic activity of inhibitory kappaB (IkappaB) kinase beta (IKKbeta), a key enzyme required for NF-kappaB activation, with an IC(50) value of 7 microM.',\n",
       " 'Novel iminobenzoxathiolone compound inhibits nuclear factor-kappaB activation targeting inhibitory kappaB kinase beta and down-regulating interleukin-1beta expression in lipopolysaccharide-activated macrophages.',\n",
       " 'Furthermore, LYR-71 down-regulated LPS-induced transcription of interleukin (IL)-1beta or other cytokines in the cells, and inhibited expression vector IKKbeta-elicited IL-1beta promoter activity.',\n",
       " 'Furthermore, LYR-71 down-regulated LPS-induced transcription of interleukin (IL)-1beta or other cytokines in the cells, and inhibited expression vector IKKbeta-elicited IL-1beta promoter activity.',\n",
       " 'In this study, a novel iminobenzoxathiolone LYR-71 of 6-methyl-2-propylimino-6,7-dihydro-5H-benzo[1,3]oxathiol-4-one has been demonstrated to inhibit in vitro catalytic activity of inhibitory kappaB (IkappaB) kinase beta (IKKbeta), a key enzyme required for NF-kappaB activation, with an IC(50) value of 7 microM.',\n",
       " 'LYR-71 inhibited IKKbeta-mediated phosphorylation of cytoplasmic IkappaBalpha in lipopolysaccharide (LPS)-activated macrophages, and sequentially preventing IkappaBalpha degradation as well as transcriptional activation of NF-kappaB.',\n",
       " 'Taken together, LYR-71 was an efficient inhibitor of IKKbeta, preventing NF-kappaB activation in macrophages, and this mechanism of action could contribute its down-regulatory effect on LPS-induced expression of inflammatory cytokines at the transcription level.',\n",
       " 'Taken together, LYR-71 was an efficient inhibitor of IKKbeta, preventing NF-kappaB activation in macrophages, and this mechanism of action could contribute its down-regulatory effect on LPS-induced expression of inflammatory cytokines at the transcription level.',\n",
       " 'LYR-71 inhibited IKKbeta-mediated phosphorylation of cytoplasmic IkappaBalpha in lipopolysaccharide (LPS)-activated macrophages, and sequentially preventing IkappaBalpha degradation as well as transcriptional activation of NF-kappaB.',\n",
       " 'LYR-71 inhibited IKKbeta-mediated phosphorylation of cytoplasmic IkappaBalpha in lipopolysaccharide (LPS)-activated macrophages, and sequentially preventing IkappaBalpha degradation as well as transcriptional activation of NF-kappaB.',\n",
       " 'Taken together, LYR-71 was an efficient inhibitor of IKKbeta, preventing NF-kappaB activation in macrophages, and this mechanism of action could contribute its down-regulatory effect on LPS-induced expression of inflammatory cytokines at the transcription level.',\n",
       " 'Novel iminobenzoxathiolone compound inhibits nuclear factor-kappaB activation targeting inhibitory kappaB kinase beta and down-regulating interleukin-1beta expression in lipopolysaccharide-activated macrophages.',\n",
       " 'To counter this, we have studied the pharmacokinetics in mice of two murine analogs of human TNF blockers, a murine p75-FC fusion protein (analogous to etanercept), and the rat MP6-XT22 anti-murine TNF mAb (analogous to infliximab).',\n",
       " 'Phosphorylation of EGFR and activated downstream signaling proteins, such as ERK1, JNK and P38, were found to be depressed after incubation with F90 for 48 hours in vitro.',\n",
       " 'Phosphorylation of EGFR and activated downstream signaling proteins, such as ERK1, JNK and P38, were found to be depressed after incubation with F90 for 48 hours in vitro.',\n",
       " 'Phosphorylation of EGFR and activated downstream signaling proteins, such as ERK1, JNK and P38, were found to be depressed after incubation with F90 for 48 hours in vitro.',\n",
       " 'Phosphorylation of EGFR and activated downstream signaling proteins, such as ERK1, JNK and P38, were found to be depressed after incubation with F90 for 48 hours in vitro.',\n",
       " 'Two monoclonal antibodies, cetuximab, which targets EGFR, and bevacizumab, which target the VEGF signaling pathway, are being evaluated as monotherapy and in combination with other agents and/or radiotherapy for the treatment of cervical cancer.',\n",
       " 'Two monoclonal antibodies, cetuximab, which targets EGFR, and bevacizumab, which target the VEGF signaling pathway, are being evaluated as monotherapy and in combination with other agents and/or radiotherapy for the treatment of cervical cancer.',\n",
       " 'Using these methods, we show that EGFR kinase inhibitors sensitize colorectal SW-480 tumor cells for 5-fluorouracil-induced apoptosis, indicating that EGFR-mediated survival signaling contributes to apoptosis resistance via its intrinsic kinase activity.',\n",
       " 'In cells grown under hypoxia for 6 h, BRCA1 was not decreased, but induction of CYP1A1 by TCDD was significantly decreased.',\n",
       " 'Treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) induces CYP1A1 protein and mRNA levels and also activates inhibitory AhR-ERalpha crosstalk associated with hormone-induced reporter gene expression.',\n",
       " 'Cotreatment of ZR-75 cells with TCDD plus the protein synthesis inhibitor cycloheximide for 6 h enhanced CYP1A1 expression in cells grown under hypoxia and normoxia.',\n",
       " 'Cotreatment of ZR-75 cells with TCDD plus the protein synthesis inhibitor cycloheximide for 6 h enhanced CYP1A1 expression in cells grown under hypoxia and normoxia.',\n",
       " 'Treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) induces CYP1A1 protein and mRNA levels and also activates inhibitory AhR-ERalpha crosstalk associated with hormone-induced reporter gene expression.',\n",
       " 'In ZR-75 cells grown under hypoxia, induction of these AhR-mediated responses by TCDD was significantly inhibited.',\n",
       " 'Here we show the reversal effects of an extensive panel of flavonoids upon BCRP-, P-gp-, and MRP1-mediated drug resistance.',\n",
       " 'Here we show the reversal effects of an extensive panel of flavonoids upon BCRP-, P-gp-, and MRP1-mediated drug resistance.',\n",
       " 'We previously reported that some flavonoids have BCRP-inhibitory activity.',\n",
       " \"Among these active compounds, 3',4',7-trimethoxyflavone showed the strongest anti-BCRP activity with RI(50) values of 0.012 microM for SN-38 and 0.044 muM for mitoxantrone.\",\n",
       " 'Flavonoids inhibit breast cancer resistance protein-mediated drug resistance: transporter specificity and structure-activity relationship.',\n",
       " 'Here we show the reversal effects of an extensive panel of flavonoids upon BCRP-, P-gp-, and MRP1-mediated drug resistance.',\n",
       " 'Reversal effects of flavonoids upon BCRP-, P-gp-, or MRP1-mediated drug resistance were examined in the BCRP- or MDR1-transduced human leukemia K562 cells or in the MRP1-transfected human epidermoid carcinoma KB-3-1 cells using cell growth inhibition assays.',\n",
       " 'None of the flavonoids that we tested inhibited MRP1.',\n",
       " \"Among these active compounds, 3',4',7-trimethoxyflavone showed the strongest anti-BCRP activity with RI(50) values of 0.012 microM for SN-38 and 0.044 muM for mitoxantrone.\",\n",
       " \"Two of the flavones, 3',4',7-trimethoxyflavone and acacetin, showed only low anti-P-gp activity, with the remainder displaying no suppressive effects against P-gp.\",\n",
       " 'The reversal of BCRP activity was tested by measuring the fluorescence of intracellular topotecan.',\n",
       " \"Two of the flavones, 3',4',7-trimethoxyflavone and acacetin, showed only low anti-P-gp activity, with the remainder displaying no suppressive effects against P-gp.\",\n",
       " 'Our present results thus indicate that many flavonoids selectively inhibit BCRP only.',\n",
       " 'Reversal effects of flavonoids upon BCRP-, P-gp-, or MRP1-mediated drug resistance were examined in the BCRP- or MDR1-transduced human leukemia K562 cells or in the MRP1-transfected human epidermoid carcinoma KB-3-1 cells using cell growth inhibition assays.',\n",
       " 'Reversal effects of flavonoids upon BCRP-, P-gp-, or MRP1-mediated drug resistance were examined in the BCRP- or MDR1-transduced human leukemia K562 cells or in the MRP1-transfected human epidermoid carcinoma KB-3-1 cells using cell growth inhibition assays.',\n",
       " \"Among these active compounds, 3',4',7-trimethoxyflavone showed the strongest anti-BCRP activity with RI(50) values of 0.012 microM for SN-38 and 0.044 muM for mitoxantrone.\",\n",
       " 'We report here the chemical synthesis and pharmacological characterization of SHA 66 (3-oxo-1,1-diphenyl-tetrahydro-oxazolo[3,4-a]pyrazine-7-carboxylic acid benzylamide) and SHA 68 (3-oxo-1,1-diphenyl-tetrahydro-oxazolo[3,4-a]pyrazine-7-carboxylic acid 4-fluoro-benzylamide), two closely related bicyclic piperazines with antagonistic properties at the NPS receptor (NPSR).',\n",
       " 'We report here the chemical synthesis and pharmacological characterization of SHA 66 (3-oxo-1,1-diphenyl-tetrahydro-oxazolo[3,4-a]pyrazine-7-carboxylic acid benzylamide) and SHA 68 (3-oxo-1,1-diphenyl-tetrahydro-oxazolo[3,4-a]pyrazine-7-carboxylic acid 4-fluoro-benzylamide), two closely related bicyclic piperazines with antagonistic properties at the NPS receptor (NPSR).',\n",
       " 'Furthermore, peripheral administration of SHA 68 in mice (50 mg/kg i.p.) is able to antagonize NPS-induced horizontal and vertical activity as well as stereotypic behavior.',\n",
       " 'Synthesis and pharmacological in vitro and in vivo profile of 3-oxo-1,1-diphenyl-tetrahydro-oxazolo[3,4-a]pyrazine-7-carboxylic acid 4-fluoro-benzylamide (SHA 68), a selective antagonist of the neuropeptide S receptor.',\n",
       " 'We report here the chemical synthesis and pharmacological characterization of SHA 66 (3-oxo-1,1-diphenyl-tetrahydro-oxazolo[3,4-a]pyrazine-7-carboxylic acid benzylamide) and SHA 68 (3-oxo-1,1-diphenyl-tetrahydro-oxazolo[3,4-a]pyrazine-7-carboxylic acid 4-fluoro-benzylamide), two closely related bicyclic piperazines with antagonistic properties at the NPS receptor (NPSR).',\n",
       " 'We report here the chemical synthesis and pharmacological characterization of SHA 66 (3-oxo-1,1-diphenyl-tetrahydro-oxazolo[3,4-a]pyrazine-7-carboxylic acid benzylamide) and SHA 68 (3-oxo-1,1-diphenyl-tetrahydro-oxazolo[3,4-a]pyrazine-7-carboxylic acid 4-fluoro-benzylamide), two closely related bicyclic piperazines with antagonistic properties at the NPS receptor (NPSR).',\n",
       " 'The compounds block NPS-induced Ca2+ mobilization, and SHA 68 shows displaceable binding to NPSR in the nanomolar range.',\n",
       " 'Therefore, SHA 68 could be a useful tool to characterize physiological functions and pharmacological parameters of the NPS system in vitro and in vivo.',\n",
       " 'In vitro studies using Western blot analysis and cell-based ELISA assays showed that P2281 inhibits mTOR activity in colon cancer cells.',\n",
       " 'In the dextran sulfate sodium (DSS) model of colitis, 1) macroscopic colon observations demonstrated that P2281 significantly inhibited DSS-induced weight loss, improved rectal bleeding index, decreased disease activity index, and reversed DSS-induced shortening of the colon; 2) histological analyses of colonic tissues revealed that P2281 distinctly attenuated DSS-induced edema, prominently diminished the leukocyte infiltration in the colonic mucosa, and resulted in protection against DSS-induced crypt damage; and 3) Western blot analysis showed that P2281 blocks DSS-induced activation of mTOR.',\n",
       " 'In vitro and in vivo assays of proinflammatory cytokine production revealed that P2281 diminishes induced IFN-gamma production but not TNF-alpha production, indicating preferential inhibitory effects of P2281 on T cell function.',\n",
       " 'In vitro and in vivo assays of proinflammatory cytokine production revealed that P2281 diminishes induced IFN-gamma production but not TNF-alpha production, indicating preferential inhibitory effects of P2281 on T cell function.',\n",
       " 'In the dextran sulfate sodium (DSS) model of colitis, 1) macroscopic colon observations demonstrated that P2281 significantly inhibited DSS-induced weight loss, improved rectal bleeding index, decreased disease activity index, and reversed DSS-induced shortening of the colon; 2) histological analyses of colonic tissues revealed that P2281 distinctly attenuated DSS-induced edema, prominently diminished the leukocyte infiltration in the colonic mucosa, and resulted in protection against DSS-induced crypt damage; and 3) Western blot analysis showed that P2281 blocks DSS-induced activation of mTOR.',\n",
       " 'In the dextran sulfate sodium (DSS) model of colitis, 1) macroscopic colon observations demonstrated that P2281 significantly inhibited DSS-induced weight loss, improved rectal bleeding index, decreased disease activity index, and reversed DSS-induced shortening of the colon; 2) histological analyses of colonic tissues revealed that P2281 distinctly attenuated DSS-induced edema, prominently diminished the leukocyte infiltration in the colonic mucosa, and resulted in protection against DSS-induced crypt damage; and 3) Western blot analysis showed that P2281 blocks DSS-induced activation of mTOR.',\n",
       " 'In the SH-SY5Y studies, treatment with L-165041 or GW501516 significantly and concentration-dependently attenuated cell death following thapsigargin, 1-methyl-4-phenylpyridinium, or staurosporine exposure, with the extent of damage correlated with the level of caspase-3 inhibition.',\n",
       " 'In the SH-SY5Y studies, treatment with L-165041 or GW501516 significantly and concentration-dependently attenuated cell death following thapsigargin, 1-methyl-4-phenylpyridinium, or staurosporine exposure, with the extent of damage correlated with the level of caspase-3 inhibition.',\n",
       " 'Acute myeloid leukaemia blast cells with a tyrosine kinase domain mutation of FLT3 are less sensitive to lestaurtinib than those with a FLT3 internal tandem duplication.',\n",
       " 'FLT3/TKD+ cells showed a similar response to lestaurtinib as FLT3/WT cells, whereas FLT3/ITD+ cells were more sensitive (P = 0.004).',\n",
       " 'Whilst FLT3/ITD+ cells are more susceptible to the cytotoxic effects of FLT3 inhibitors than wild type (WT) cells, the sensitivity of FLT3/TKD+ cells to therapeutic agents is unclear, as is the importance of the mutant level.',\n",
       " 'Acute myeloid leukaemia blast cells with a tyrosine kinase domain mutation of FLT3 are less sensitive to lestaurtinib than those with a FLT3 internal tandem duplication.',\n",
       " 'All three groups showed similar sensitivity to the cytotoxic effects of cytarabine but FLT3/ITD mutant level was inversely correlated with cytarabine cytotoxicity (P = 0.04) whereas FLT3/TKD mutant level had no impact.',\n",
       " 'Acute myeloid leukaemia blast cells with a tyrosine kinase domain mutation of FLT3 are less sensitive to lestaurtinib than those with a FLT3 internal tandem duplication.',\n",
       " 'These results suggest that FLT3/TKD+ and FLT3/WT cases should not be differentiated when considering patients for treatment with FLT3 inhibitors.',\n",
       " 'There was no correlation between mutant level and lestaurtinib sensitivity for either FLT3/ITD+ or FLT3/TKD+ cells.',\n",
       " 'FLT3/TKD+ cells showed a similar response to lestaurtinib as FLT3/WT cells, whereas FLT3/ITD+ cells were more sensitive (P = 0.004).',\n",
       " 'These results suggest that FLT3/TKD+ and FLT3/WT cases should not be differentiated when considering patients for treatment with FLT3 inhibitors.',\n",
       " 'All three groups showed similar sensitivity to the cytotoxic effects of cytarabine but FLT3/ITD mutant level was inversely correlated with cytarabine cytotoxicity (P = 0.04) whereas FLT3/TKD mutant level had no impact.',\n",
       " 'The treatment of adenocarcinoma cells with telomerase inhibitor, GRN163L, led to loss of telomerase activity, reduction in telomere length, and growth arrest through induction of both the senescence and apoptosis.',\n",
       " \"The fact that NSAIDs delay the onset of and reduce the risk of developing Alzheimer's disease (AD), while also binding to and activating PPARgamma, led to the hypothesis that one dimension of NSAID protection in AD is mediated by PPARgamma.\",\n",
       " \"The fact that NSAIDs delay the onset of and reduce the risk of developing Alzheimer's disease (AD), while also binding to and activating PPARgamma, led to the hypothesis that one dimension of NSAID protection in AD is mediated by PPARgamma.\",\n",
       " 'Decreased plasma soluble RAGE in patients with hypercholesterolemia: effects of statins.',\n",
       " 'In KBM5 and K562 cells, imatinib, INNO-406, or IFN-alpha increased CXCR4 expression and migration.',\n",
       " 'We proposed that tyrosine kinase inhibitors, imatinib or INNO-406, may restore CXCR4 expression and cause the migration of CML cells to bone marrow microenvironment niches, which in turn results in acquisition of stroma-mediated chemoresistance of CML progenitor cells.',\n",
       " 'This increase in CXCR4 levels on CML progenitor cells was likewise found in samples from CML patients treated with imatinib or IFN-alpha.',\n",
       " 'CXCR4 up-regulation by imatinib induces chronic myelogenous leukemia (CML) cell migration to bone marrow stroma and promotes survival of quiescent CML cells.',\n",
       " 'This increase in CXCR4 levels on CML progenitor cells was likewise found in samples from CML patients treated with imatinib or IFN-alpha.',\n",
       " 'In KBM5 and K562 cells, imatinib, INNO-406, or IFN-alpha increased CXCR4 expression and migration.',\n",
       " 'Altogether, these findings suggest that the up-regulation of CXCR4 by imatinib promotes migration of CML cells to bone marrow stroma, causing the G0-G1 cell cycle arrest and hence ensuring the survival of quiescent CML progenitor cells.',\n",
       " 'In KBM5 and K562 cells, imatinib, INNO-406, or IFN-alpha increased CXCR4 expression and migration.',\n",
       " 'We proposed that tyrosine kinase inhibitors, imatinib or INNO-406, may restore CXCR4 expression and cause the migration of CML cells to bone marrow microenvironment niches, which in turn results in acquisition of stroma-mediated chemoresistance of CML progenitor cells.',\n",
       " 'In contrast to the metabolic syndrome, GnRH agonists increase subcutaneous fat mass, HDL cholesterol, and adiponectin, and do not alter the waist-to-hip ratio, blood pressure, or C-reactive protein level.',\n",
       " 'In contrast to the metabolic syndrome, GnRH agonists increase subcutaneous fat mass, HDL cholesterol, and adiponectin, and do not alter the waist-to-hip ratio, blood pressure, or C-reactive protein level.',\n",
       " 'In contrast to the metabolic syndrome, GnRH agonists increase subcutaneous fat mass, HDL cholesterol, and adiponectin, and do not alter the waist-to-hip ratio, blood pressure, or C-reactive protein level.',\n",
       " 'Also upregulated were genes inhibited by progesterone, such as insulin-like growth factor binding protein 5.',\n",
       " 'Furthermore, down-regulation of GLI transcription factors using antisense oligonucleotides not only resulted in significantly (P < 0.001) decreased proliferation of the MCL cells but also significantly (P < 0.05) increased their susceptibility to chemotherapeutic drug, doxorubicin.',\n",
       " 'RZG treatment led to a limitation of oxidative stress exemplified by an increase of GPx and SOD expression.',\n",
       " 'We demonstrated that RZG beneficial effects on insulin secretion and apoptosis did not imply PDX-1 or insulin gene modulation.',\n",
       " 'We demonstrated that RZG beneficial effects on insulin secretion and apoptosis did not imply PDX-1 or insulin gene modulation.',\n",
       " 'RZG treatment led to a limitation of oxidative stress exemplified by an increase of GPx and SOD expression.',\n",
       " 'The apoptotic effects by the agonists were antagonized by bisphenol A diglycidyl ether, a PPARgamma antagonist, and by knockdown of PPARgamma expression, indicating the involvement of PPARgamma in these actions.',\n",
       " 'Up-regulated expression of p53/56 Lyn kinase, both at the mRNA and protein level, was found in one of the resistant cell lines and Lyn silencing by small interfering RNA restored sensitivity to nilotinib.',\n",
       " 'We showed that nilotinib is a substrate of the multidrug resistance gene product, P-glycoprotein, using verapamil or PSC833 to block binding.',\n",
       " 'Evidence that resistance to nilotinib may be due to BCR-ABL, Pgp, or Src kinase overexpression.',\n",
       " 'Evidence that resistance to nilotinib may be due to BCR-ABL, Pgp, or Src kinase overexpression.',\n",
       " 'In contrast, dasatinib, a dual Bcr-Abl and Src kinase inhibitor, inhibited the phosphorylation of both BCR-ABL and Lyn, and induced apoptosis of the Bcr-Abl cell line overexpressing p53/56 Lyn.',\n",
       " 'Two Src kinase inhibitors (PP1 and PP2) partially removed resistance but did not significantly inhibit Bcr-Abl tyrosine kinase activity.',\n",
       " 'Two Src kinase inhibitors (PP1 and PP2) partially removed resistance but did not significantly inhibit Bcr-Abl tyrosine kinase activity.',\n",
       " 'We showed that nilotinib is a substrate of the multidrug resistance gene product, P-glycoprotein, using verapamil or PSC833 to block binding.',\n",
       " 'Up-regulated expression of p53/56 Lyn kinase, both at the mRNA and protein level, was found in one of the resistant cell lines and Lyn silencing by small interfering RNA restored sensitivity to nilotinib.',\n",
       " 'In contrast, dasatinib, a dual Bcr-Abl and Src kinase inhibitor, inhibited the phosphorylation of both BCR-ABL and Lyn, and induced apoptosis of the Bcr-Abl cell line overexpressing p53/56 Lyn.',\n",
       " 'We showed that nilotinib is a substrate of the multidrug resistance gene product, P-glycoprotein, using verapamil or PSC833 to block binding.',\n",
       " 'Such mechanisms of resistance are close to those observed in imatinib-resistant cell lines and emphasize the critical role of Lyn in nilotinib resistance.',\n",
       " 'Moreover, failure of nilotinib treatment was accompanied by an increase of Lyn mRNA expression in patients with resistant CML.',\n",
       " 'In contrast, dasatinib, a dual Bcr-Abl and Src kinase inhibitor, inhibited the phosphorylation of both BCR-ABL and Lyn, and induced apoptosis of the Bcr-Abl cell line overexpressing p53/56 Lyn.',\n",
       " 'Two Src kinase inhibitors (PP1 and PP2) partially removed resistance but did not significantly inhibit Bcr-Abl tyrosine kinase activity.',\n",
       " 'Such mechanisms of resistance are close to those observed in imatinib-resistant cell lines and emphasize the critical role of Lyn in nilotinib resistance.',\n",
       " 'Evidence that resistance to nilotinib may be due to BCR-ABL, Pgp, or Src kinase overexpression.',\n",
       " 'Inhibition of P-glycoprotein (ABCB1)- and multidrug resistance-associated protein 1 (ABCC1)-mediated transport by the orally administered inhibitor, CBT-1((R)).',\n",
       " 'Inhibition of P-glycoprotein (ABCB1)- and multidrug resistance-associated protein 1 (ABCC1)-mediated transport by the orally administered inhibitor, CBT-1((R)).',\n",
       " 'Inhibition of P-glycoprotein (ABCB1)- and multidrug resistance-associated protein 1 (ABCC1)-mediated transport by the orally administered inhibitor, CBT-1((R)).',\n",
       " 'CBT-1 was found to compete [(125)I]-IAAP labeling of Pgp with an IC(50) of 0.14 microM, and low concentrations of CBT-1 (<1 microM) stimulated Pgp-mediated ATP hydrolysis.',\n",
       " 'CBT-1 at 25 microM did not have a significant effect on ABCG2-mediated pheophorbide a transport.',\n",
       " 'Additionally, 1 microM completely reversed Pgp-mediated resistance to vinblastine, paclitaxel and depsipeptide in SW620 Ad20 cells.',\n",
       " 'In MRP1-overexpressing cells, 10 microM CBT-1 was found to completely inhibit MRP1-mediated calcein transport.',\n",
       " 'CBT-1 is able to inhibit the ABC transporters Pgp and MRP1, making it an attractive candidate for clinical trials in cancers where Pgp and/or MRP1 might be overexpressed.',\n",
       " 'CBT-1 is able to inhibit the ABC transporters Pgp and MRP1, making it an attractive candidate for clinical trials in cancers where Pgp and/or MRP1 might be overexpressed.',\n",
       " 'Inhibition of P-glycoprotein (ABCB1)- and multidrug resistance-associated protein 1 (ABCC1)-mediated transport by the orally administered inhibitor, CBT-1((R)).',\n",
       " 'CBT-1 is a bisbenzylisoquinoline plant alkyloid currently in development as a Pgp inhibitor.',\n",
       " 'Additionally, 1 microM completely reversed Pgp-mediated resistance to vinblastine, paclitaxel and depsipeptide in SW620 Ad20 cells.',\n",
       " 'CBT-1 is able to inhibit the ABC transporters Pgp and MRP1, making it an attractive candidate for clinical trials in cancers where Pgp and/or MRP1 might be overexpressed.',\n",
       " 'A recent in vitro study has shown that paroxetine is a substrate of P-glycoprotein.',\n",
       " 'The present study demonstrated that the bioavailability of paroxetine was increased by itraconazole, suggesting a possible involvement of P-glycoprotein in the pharmacokinetics of paroxetine.',\n",
       " 'However, there was no in vivo information indicating the involvement of P-glycoprotein on the pharmacokinetics of paroxetine.',\n",
       " 'A continuous epidural infusion of ropivacaine inhibits CYP2D6 activity in patients who are extensive metabolizers resulting in a twofold increase in the MR for debrisoquine hydroxylation.',\n",
       " 'Ropivacaine and one of its metabolites, pipecoloxylidide, inhibit CYP2D6 in.',\n",
       " 'Patients received 10 mg debrisoquine (a marker for CYP2D6 activity) before surgery and after 40 h epidural infusion.',\n",
       " 'Ropivacaine and one of its metabolites, pipecoloxylidide, inhibit CYP2D6 in.',\n",
       " 'A continuous epidural infusion of ropivacaine inhibits CYP2D6 activity in patients who are extensive metabolizers resulting in a twofold increase in the MR for debrisoquine hydroxylation.',\n",
       " 'Our work supported LRP5 genetic variants as possible susceptibility factors for osteoporosis and fractures in humans.',\n",
       " 'Especially, the SNP rs491347 and its strongly associated SNPs (e.g., rs1784235) could be important to human osteoporosis phenotypes.',\n",
       " 'Especially, the SNP rs491347 and its strongly associated SNPs (e.g., rs1784235) could be important to human osteoporosis phenotypes.',\n",
       " 'The HBS1L-MYB intergenic region on chromosome 6q23 is a quantitative trait locus controlling fetal haemoglobin level in carriers of beta-thalassaemia.',\n",
       " 'Fetal haemoglobin (HbF) level modifies the clinical severity of HBB disorders.',\n",
       " 'Fetal haemoglobin (HbF) level modifies the clinical severity of HBB disorders.',\n",
       " 'The HBS1L-MYB intergenic region on chromosome 6q23 is a quantitative trait locus controlling fetal haemoglobin level in carriers of beta-thalassaemia.',\n",
       " 'The HBS1L-MYB intergenic region on chromosome 6q23 is a quantitative trait locus controlling fetal haemoglobin level in carriers of beta-thalassaemia.',\n",
       " 'Functional studies to unravel the biological significance of this region in regulating HbF production is clearly indicated, which may lead to new strategies to modify the disease course of severe HBB disorders.',\n",
       " 'IL-1, IL-1R and TNFalpha gene polymorphisms in Iranian patients with multiple sclerosis.',\n",
       " 'On the other hand the frequency of IL-1alpha TT -889 genotype (p=0.028), IL-1R C pst1 1970 allele (p=0.0001) and CC genotype (p=0.00006), TNFalpha G -308 allele (p=0.0002) and GG genotype (p=0.000001) decreased significantly in the patients versus normal subjects.These results suggest that polymorphic variations of these pro-inflammatory cytokines may play an important role in susceptibility of Iranian multiple sclerosis patients.',\n",
       " 'On the other hand the frequency of IL-1alpha TT -889 genotype (p=0.028), IL-1R C pst1 1970 allele (p=0.0001) and CC genotype (p=0.00006), TNFalpha G -308 allele (p=0.0002) and GG genotype (p=0.000001) decreased significantly in the patients versus normal subjects.These results suggest that polymorphic variations of these pro-inflammatory cytokines may play an important role in susceptibility of Iranian multiple sclerosis patients.',\n",
       " 'IL-1, IL-1R and TNFalpha gene polymorphisms in Iranian patients with multiple sclerosis.',\n",
       " 'Overall and relapse-free survival in oropharyngeal and hypopharyngeal squamous cell carcinoma are associated with genotypes of T393C polymorphism of the GNAS1 gene.',\n",
       " 'Overall and relapse-free survival in oropharyngeal and hypopharyngeal squamous cell carcinoma are associated with genotypes of T393C polymorphism of the GNAS1 gene.',\n",
       " 'The T393C SNP could be considered as a genetic marker to predict the clinical course of patients suffering from oropharyngeal and hypopharyngeal cancer.',\n",
       " 'The T393C SNP could be considered as a genetic marker to predict the clinical course of patients suffering from oropharyngeal and hypopharyngeal cancer.',\n",
       " 'The prognostic value of the T393C SNP was evaluated in an unselected series of patients treated with curative intent for oropharyngeal and hypopharyngeal squamous cell carcinomas, including all tumor stages with different therapeutic regimens.',\n",
       " 'However, the majority of colon cancer cells have deregulation of the Wnt/beta-catenin pathway.',\n",
       " 'Lysophosphatidic acid facilitates proliferation of colon cancer cells via induction of Krppel-like factor 5.',\n",
       " 'A recent study showed that LPA-mediated proliferation of colon cancer cells requires activation of beta-catenin.',\n",
       " 'On multivariate analysis the CYP3A5 A6986G genotype *3/*3 (OR 8.205, 95% CI 1.616-41.667, p = 0.011) and smaller number of treatment cycles (OR 0.156, 95% CI 0.037-0.659, p = 0.011) were independent factors for leukocytopenia (grade 3 or greater) throughout the period of chemotherapy.',\n",
       " 'The A6986G polymorphism of CYP3A5, which is involved in the metabolism of vinblastine and doxorubicin, might be a genetic predictor of the severity of leukocytopenia induced by chemotherapy with methotrexate, vinblastine, doxorubicin and cisplatin.',\n",
       " 'XRCC1 genotyping might make tailor chemotherapy possible for gastric cancer patients treated with oxaliplatin-based chemotherapy.',\n",
       " 'Polymorphism of XRCC1 predicts overall survival of gastric cancer patients receiving oxaliplatin-based chemotherapy in Chinese population.',\n",
       " 'This study assessed associations between the CYP4F2 gene and myocardial infarction (MI), using a haplotype-based case-control study of 234 MI patients and 248 controls genotyped for 5 single-nucleotide polymorphisms (rs3093105, rs3093135, rs1558139, rs2108622, rs3093200).',\n",
       " 'A haplotype of the CYP4F2 gene associated with myocardial infarction in Japanese men.',\n",
       " 'For men, G allele frequency of rs2108622 and frequency of the T-C-G haplotype were significantly higher, and frequency of the T-C-A haplotype was significantly lower for MI patients than for controls (P=0.006, P=0.001 and P=0.002, respectively).',\n",
       " 'This study assessed associations between the CYP4F2 gene and myocardial infarction (MI), using a haplotype-based case-control study of 234 MI patients and 248 controls genotyped for 5 single-nucleotide polymorphisms (rs3093105, rs3093135, rs1558139, rs2108622, rs3093200).',\n",
       " 'When stratified by ALDH2 Ex1+82A>G polymorphism, alcohol-related increases in stomach cancer risk were restricted to individuals with the AG/GG genotypes, with a more than 2-fold risk among daily drinkers (OR=2.63, 95% CI=1.00-6.88) and 3-fold risk (OR=3.66, 95% CI=1.19-11.24) among those with 40 or more drink-years.',\n",
       " 'The COL1A2 gene at 7q22.1 has been shown to be associated with familial intracranial aneurysms (IAs) in the Japanese population.',\n",
       " 'The COL1A2 gene at 7q22.1 has been shown to be associated with familial intracranial aneurysms (IAs) in the Japanese population.',\n",
       " 'The rs42524 polymorphism of COL1A2 could be a genetic risk factor for sporadic IAs among individuals of Chinese Han ethnicity.',\n",
       " 'In the present study, the authors investigated the correlation between the presence of the rs42524 polymorphism in COL1A2 and the occurrence of sporadic IAs in Chinese patients.',\n",
       " 'This study is the first to confirm the association between COL1A2 and IAs.',\n",
       " 'The rs42524 polymorphism of COL1A2 could be a genetic risk factor for sporadic IAs among individuals of Chinese Han ethnicity.',\n",
       " 'Surprisingly, the 602S allele is associated with a decreased incidence of leprosy, suggesting that Mycobacterium leprae subverts the TLR system as a mechanism of immune evasion.',\n",
       " 'Cutting edge: A common polymorphism impairs cell surface trafficking and functional responses of TLR1 but protects against leprosy.',\n",
       " 'Surprisingly, the 602S allele is associated with a decreased incidence of leprosy, suggesting that Mycobacterium leprae subverts the TLR system as a mechanism of immune evasion.',\n",
       " 'These results suggest that combination of HDACi with adenoviral TRAIL gene therapy may be a new therapeutic approach for the treatment of prostate cancer that warrants further investigation.',\n",
       " 'Allelic and non-allelic heterogeneities in pyridoxine dependent seizures revealed by ALDH7A1 mutational analysis.',\n",
       " 'Recently, mutations have been identified in the ALDH7A1 gene in Caucasian families with PDS.',\n",
       " 'Cytochrome P450 1A1 is a major enzyme in the bioactivation of exogenous procarcinogens of hepatocellular carcinoma (HCC).',\n",
       " 'However, the contribution of common genetic variants in CYP1A1 to the HCC risk in Chinese populations has not been thoroughly investigated.',\n",
       " 'Cytochrome P450 1A1 is a major enzyme in the bioactivation of exogenous procarcinogens of hepatocellular carcinoma (HCC).',\n",
       " 'Interestingly, the diplotype TTAC/CCAG also conferred an increased risk of HCC (OR 1.76, 95% CI 1.22-2.54, P=0.003).',\n",
       " 'To summarise, we detected an increased HCC risk in rs4646421 variant carriers (OR 1.30, 95% CI 1.05-1.61) and rs2198843 variant carriers (OR 1.33, 95% CI 1.05-1.69), and a reduced risk of HCC (OR 0.70. 95% CI 0.52-0.94) associated with homozygote carriers of rs4886605 variant.',\n",
       " 'To summarise, we detected an increased HCC risk in rs4646421 variant carriers (OR 1.30, 95% CI 1.05-1.61) and rs2198843 variant carriers (OR 1.33, 95% CI 1.05-1.69), and a reduced risk of HCC (OR 0.70. 95% CI 0.52-0.94) associated with homozygote carriers of rs4886605 variant.',\n",
       " 'Compared to the most common CYP1A1 haplotype CCAG, the haplotype TTGC conferred an increased risk of HCC (OR 1.26, 95% CI 1.04-1.52).',\n",
       " 'In this study, we examined the association between HCC and four selected tagging single nucleotide polymorphisms (SNPs) of CYP1A1, and the risk of CYP1A1 haplotypes/diplotypes in 1006 pathologically confirmed HCC patients and 1015 cancer-free controls, from a Han Chinese population.',\n",
       " 'Our results suggested that common genetic variants in CYP1A1 may modulate the risk of developing HCC in the study population, particularly in non-smokers.',\n",
       " \"Amyloid beta protein (Abeta) levels are elevated in the brain of Alzheimer's disease patients.\",\n",
       " \"Amyloid beta protein (Abeta) levels are elevated in the brain of Alzheimer's disease patients.\",\n",
       " \"Anti-amyloid beta protein antibody passage across the blood-brain barrier in the SAMP8 mouse model of Alzheimer's disease: an age-related selective uptake with reversal of learning impairment.\",\n",
       " 'The results of a phase I clinical trial of the topoisomerase I (Topo I) poison CPT-11 followed by the cyclin-dependent kinase inhibitor flavopiridol in patients with advanced solid tumors indicate that patients whose tumors were wild-type, but not mutant, for p53 obtained the most clinical benefit from this combination therapy.',\n",
       " 'To study the (functional) relevance of single nucleotide polymorphisms (SNPs) in genes encoding matrix metalloproteinases (MMP)-1, -2, -3, -9, tissue inhibitors of metalloproteinases (TIMP)-1, -2 and tumor necrosis factor (TNF)-alpha in the etiopathogenesis of inflammatory bowel diseases (IBD), that may enhance susceptibility and/or disease severity.',\n",
       " 'To study the (functional) relevance of single nucleotide polymorphisms (SNPs) in genes encoding matrix metalloproteinases (MMP)-1, -2, -3, -9, tissue inhibitors of metalloproteinases (TIMP)-1, -2 and tumor necrosis factor (TNF)-alpha in the etiopathogenesis of inflammatory bowel diseases (IBD), that may enhance susceptibility and/or disease severity.',\n",
       " 'The TIMP-1 genotype TT in women and T in men at SNP +372 T/C was found to increase CD susceptibility (39% vs 23.8%, P = 0.018 and 67.9% vs 51.6%, P = 0.055, respectively), while women with this genotype were less prone to development of fistulae during follow-up (41.4% vs 68.3%, P = 0.025).',\n",
       " 'The TIMP-1 genotype TT in women and T in men at SNP +372 T/C was found to increase CD susceptibility (39% vs 23.8%, P = 0.018 and 67.9% vs 51.6%, P = 0.055, respectively), while women with this genotype were less prone to development of fistulae during follow-up (41.4% vs 68.3%, P = 0.025).',\n",
       " 'The 5T5T genotype at MMP-3 SNP -1613 5T/6T increased the chance of stenotic complications in CD during follow-up (91.2% vs 71.8%, P = 0.022) but seemed to protect against colonic involvement of this disease at first endoscopic/radiologic examination (35.3% vs 59.5%, P = 0.017).',\n",
       " 'Allelic composition at the examined SNPs in genes coding for TIMP-1 and MMP-3 affect CD susceptibility and/or phenotype, i.e., fistulizing disease, stricture pathogenesis and first disease localisation.',\n",
       " 'Allelic composition at the examined SNPs in genes coding for TIMP-1 and MMP-3 affect CD susceptibility and/or phenotype, i.e., fistulizing disease, stricture pathogenesis and first disease localisation.',\n",
       " 'To study the (functional) relevance of single nucleotide polymorphisms (SNPs) in genes encoding matrix metalloproteinases (MMP)-1, -2, -3, -9, tissue inhibitors of metalloproteinases (TIMP)-1, -2 and tumor necrosis factor (TNF)-alpha in the etiopathogenesis of inflammatory bowel diseases (IBD), that may enhance susceptibility and/or disease severity.',\n",
       " 'To study the (functional) relevance of single nucleotide polymorphisms (SNPs) in genes encoding matrix metalloproteinases (MMP)-1, -2, -3, -9, tissue inhibitors of metalloproteinases (TIMP)-1, -2 and tumor necrosis factor (TNF)-alpha in the etiopathogenesis of inflammatory bowel diseases (IBD), that may enhance susceptibility and/or disease severity.',\n",
       " 'To study the (functional) relevance of single nucleotide polymorphisms (SNPs) in genes encoding matrix metalloproteinases (MMP)-1, -2, -3, -9, tissue inhibitors of metalloproteinases (TIMP)-1, -2 and tumor necrosis factor (TNF)-alpha in the etiopathogenesis of inflammatory bowel diseases (IBD), that may enhance susceptibility and/or disease severity.',\n",
       " 'To study the (functional) relevance of single nucleotide polymorphisms (SNPs) in genes encoding matrix metalloproteinases (MMP)-1, -2, -3, -9, tissue inhibitors of metalloproteinases (TIMP)-1, -2 and tumor necrosis factor (TNF)-alpha in the etiopathogenesis of inflammatory bowel diseases (IBD), that may enhance susceptibility and/or disease severity.',\n",
       " 'The TIMP-1 genotype TT in women and T in men at SNP +372 T/C was found to increase CD susceptibility (39% vs 23.8%, P = 0.018 and 67.9% vs 51.6%, P = 0.055, respectively), while women with this genotype were less prone to development of fistulae during follow-up (41.4% vs 68.3%, P = 0.025).',\n",
       " 'The TIMP-1 genotype TT in women and T in men at SNP +372 T/C was found to increase CD susceptibility (39% vs 23.8%, P = 0.018 and 67.9% vs 51.6%, P = 0.055, respectively), while women with this genotype were less prone to development of fistulae during follow-up (41.4% vs 68.3%, P = 0.025).',\n",
       " 'The 5T5T genotype at MMP-3 SNP -1613 5T/6T increased the chance of stenotic complications in CD during follow-up (91.2% vs 71.8%, P = 0.022) but seemed to protect against colonic involvement of this disease at first endoscopic/radiologic examination (35.3% vs 59.5%, P = 0.017).',\n",
       " \"Ala394Thr polymorphism in the clock gene NPAS2: a circadian modifier for the risk of non-Hodgkin's lymphoma.\",\n",
       " \"Ala394Thr polymorphism in the clock gene NPAS2: a circadian modifier for the risk of non-Hodgkin's lymphoma.\",\n",
       " 'STEC strains carrying stx2 were more frequently associated with clinical manifestations of hemolytic-uremic syndrome (HUS) or bloody diarrhea than those carrying stx2vha.',\n",
       " 'STEC strains carrying stx2 were more frequently associated with clinical manifestations of hemolytic-uremic syndrome (HUS) or bloody diarrhea than those carrying stx2vha.',\n",
       " 'STEC strains carrying stx2 were more frequently associated with clinical manifestations of hemolytic-uremic syndrome (HUS) or bloody diarrhea than those carrying stx2vha.',\n",
       " 'We conclude that stx genotype is one of the important factors of clinical outcome of STEC O157 infection and that pathogenicity for humans was higher in the stx2 genotype strains than in the stx2vha genotype strains, as reported previously by other researchers.',\n",
       " 'Subsequent analysis of individual SNPs in strong linkage disequilibrium with the ME2 gene revealed one SNP and one haplotype associated with the phenotype of psychosis in the CVCR sample.',\n",
       " 'ME2 interacts directly with the malate shuttle system, which has been shown to be altered in schizophrenia and bipolar disorder, and has roles in neuronal synthesis of glutamate and gamma-amino butyric acid.',\n",
       " 'ME2 interacts directly with the malate shuttle system, which has been shown to be altered in schizophrenia and bipolar disorder, and has roles in neuronal synthesis of glutamate and gamma-amino butyric acid.',\n",
       " 'The present study suggests that genetic variation in or near the ME2 gene is associated with both psychotic and manic disorders, including schizophrenia and bipolar disorder.',\n",
       " 'The present study suggests that genetic variation in or near the ME2 gene is associated with both psychotic and manic disorders, including schizophrenia and bipolar disorder.',\n",
       " 'The present study suggests that genetic variation in or near the ME2 gene is associated with both psychotic and manic disorders, including schizophrenia and bipolar disorder.',\n",
       " 'The present study suggests that genetic variation in or near the ME2 gene is associated with both psychotic and manic disorders, including schizophrenia and bipolar disorder.',\n",
       " 'Genetic alterations within the p53 gene have been shown to have a direct correlation with cancer development and have been shown to occur in nearly 50% of all cancers.',\n",
       " 'This review discusses the role of p53 from normal function and its dysfunction in pre-cancerous lesions and non-melanoma skin cancers.',\n",
       " 'We sought to evaluate 2 single-nucleotide polymorphisms (SNPs) in the C-reactive protein (CRP) gene promoter region for their effects on CRP levels in chronic kidney disease (CKD) patients before and after a successful kidney transplantation.',\n",
       " 'We sought to evaluate 2 single-nucleotide polymorphisms (SNPs) in the C-reactive protein (CRP) gene promoter region for their effects on CRP levels in chronic kidney disease (CKD) patients before and after a successful kidney transplantation.',\n",
       " 'The study investigated the possible association of NRG3 gene and schizophrenia in a Han Chinese population.',\n",
       " 'In the haplotype-transmission disequilibrium test (TDT) for allelic combination of rs1937970-rs677221, significant under-transmission for haplotype AG (uncorrected p = .006) and over-transmission for haplotype GC (uncorrected p = .004) to the affected schizophrenia offspring were observed.',\n",
       " 'In case-control samples, two SNPs (rs1937970 and rs677221) showed significant genotypic and allelic association with schizophrenia (all p < .05) with rs677221-C being the risk allele for schizophrenia (uncorrected p = .001, odds ratio = 1.439, 95% confidence interval = 1.115-1.858).',\n",
       " 'In case-control samples, two SNPs (rs1937970 and rs677221) showed significant genotypic and allelic association with schizophrenia (all p < .05) with rs677221-C being the risk allele for schizophrenia (uncorrected p = .001, odds ratio = 1.439, 95% confidence interval = 1.115-1.858).',\n",
       " 'The result supports that the NRG3 gene is a susceptibility gene for schizophrenia.',\n",
       " 'Haplotypes GC constructed by the two SNPs was also significantly associated with schizophrenia (permutation p value = .0047).',\n",
       " 'In the haplotype-transmission disequilibrium test (TDT) for allelic combination of rs1937970-rs677221, significant under-transmission for haplotype AG (uncorrected p = .006) and over-transmission for haplotype GC (uncorrected p = .004) to the affected schizophrenia offspring were observed.',\n",
       " 'In the independent trio samples, rs1937970-A and rs677221-G consistently showed significant under-transmission to schizophrenic offspring (unadjusted p = .003 and p = .004, respectively).',\n",
       " 'In the independent trio samples, rs1937970-A and rs677221-G consistently showed significant under-transmission to schizophrenic offspring (unadjusted p = .003 and p = .004, respectively).',\n",
       " 'In the haplotype-transmission disequilibrium test (TDT) for allelic combination of rs1937970-rs677221, significant under-transmission for haplotype AG (uncorrected p = .006) and over-transmission for haplotype GC (uncorrected p = .004) to the affected schizophrenia offspring were observed.',\n",
       " 'Neuregulin 3 genetic variations and susceptibility to schizophrenia in a Chinese population.',\n",
       " 'In case-control samples, two SNPs (rs1937970 and rs677221) showed significant genotypic and allelic association with schizophrenia (all p < .05) with rs677221-C being the risk allele for schizophrenia (uncorrected p = .001, odds ratio = 1.439, 95% confidence interval = 1.115-1.858).',\n",
       " \"These results suggest that the NLRP3 region is also implicated in the susceptibility of more common inflammatory diseases such as Crohn's disease.\",\n",
       " \"We used a candidate gene approach to identify a set of SNPs, located in a predicted regulatory region on chromosome 1q44 downstream of NLRP3 (previously known as CIAS1 and NALP3) that are associated with Crohn's disease.\",\n",
       " \"We used a candidate gene approach to identify a set of SNPs, located in a predicted regulatory region on chromosome 1q44 downstream of NLRP3 (previously known as CIAS1 and NALP3) that are associated with Crohn's disease.\",\n",
       " \"Common variants in the NLRP3 region contribute to Crohn's disease susceptibility.\",\n",
       " 'Therefore, the mutations of the MDR1 gene are thought to be related with the pathogenesis of inflammatory bowel disease.',\n",
       " \"In this study, the G2677T/A polymorphism observed in the MDR1 gene was not found to be a risk factor for Crohn's disease or ulcerative colitis.\",\n",
       " \"In this study, the G2677T/A polymorphism observed in the MDR1 gene was not found to be a risk factor for Crohn's disease or ulcerative colitis.\",\n",
       " \"In this study, the G2677T/A polymorphism observed in the MDR1 gene was not found to be a risk factor for Crohn's disease or ulcerative colitis.\",\n",
       " \"In this study, the G2677T/A polymorphism observed in the MDR1 gene was not found to be a risk factor for Crohn's disease or ulcerative colitis.\",\n",
       " 'Regulation of hairy and enhancer of split homologue-1 (HES-1) by estradiol and all-trans retinoic acid affects proliferation of human breast cancer cells.',\n",
       " \"Estrogen-dependent downregulation of hairy and enhancer of split homolog-1 gene expression in breast cancer cells is mediated via a 3' distal element.\",\n",
       " 'Regulation of hairy and enhancer of split homologue-1 (HES-1) by estradiol and all-trans retinoic acid affects proliferation of human breast cancer cells.',\n",
       " 'Moreover, protective alleles for four disease-associated SNPs in the MHC locus (rs2395029, rs13199524, rs12198173 and rs3093662) were strikingly over-represented among forty-five Long Term HIV controllers.',\n",
       " 'Previous studies of the HIV-1 disease have shown that HLA and Chemokine receptor genetic variants influence disease progression and early viral load.',\n",
       " 'Furthermore, we show that the HIV-DNA levels (reflecting the HIV reservoir) are associated with the same four SNPs, but also with two additional SNPs on chromosome 17 (rs6503919; intergenic region flanked by the DDX40 and YPEL2 genes) and chromosome 8 (rs2575735; within the Syndecan 2 gene).',\n",
       " 'Moreover, protective alleles for four disease-associated SNPs in the MHC locus (rs2395029, rs13199524, rs12198173 and rs3093662) were strikingly over-represented among forty-five Long Term HIV controllers.',\n",
       " 'Previous studies of the HIV-1 disease have shown that HLA and Chemokine receptor genetic variants influence disease progression and early viral load.',\n",
       " 'Furthermore, we show that the HIV-DNA levels (reflecting the HIV reservoir) are associated with the same four SNPs, but also with two additional SNPs on chromosome 17 (rs6503919; intergenic region flanked by the DDX40 and YPEL2 genes) and chromosome 8 (rs2575735; within the Syndecan 2 gene).',\n",
       " 'Moreover, protective alleles for four disease-associated SNPs in the MHC locus (rs2395029, rs13199524, rs12198173 and rs3093662) were strikingly over-represented among forty-five Long Term HIV controllers.',\n",
       " 'Moreover, protective alleles for four disease-associated SNPs in the MHC locus (rs2395029, rs13199524, rs12198173 and rs3093662) were strikingly over-represented among forty-five Long Term HIV controllers.',\n",
       " 'Our data provide evidence that the MHC controls both HIV replication and HIV reservoir.',\n",
       " 'Moreover, protective alleles for four disease-associated SNPs in the MHC locus (rs2395029, rs13199524, rs12198173 and rs3093662) were strikingly over-represented among forty-five Long Term HIV controllers.',\n",
       " 'Furthermore, we show that the HIV-DNA levels (reflecting the HIV reservoir) are associated with the same four SNPs, but also with two additional SNPs on chromosome 17 (rs6503919; intergenic region flanked by the DDX40 and YPEL2 genes) and chromosome 8 (rs2575735; within the Syndecan 2 gene).',\n",
       " 'The commonly deleted region of the 5q- syndrome extends between the genes SH3TC2 (proximal boundary) and GLRA1 (distal boundary) and measures 2.9 Mb.',\n",
       " 'The commonly deleted region of the 5q- syndrome extends between the genes SH3TC2 (proximal boundary) and GLRA1 (distal boundary) and measures 2.9 Mb.',\n",
       " 'Aberrant expression of chitinase 3-like 1 (CHI3L1), also known as YKL-40 or HC gp-39, is involved in the pathogenesis of inflammatory and allergic diseases.',\n",
       " 'These results strongly suggest that the g.-247C/T polymorphism in the CHI3L1 promoter region is associated with the risk of atopy.',\n",
       " 'Genetic variation in the promoter region of chitinase 3-like 1 is associated with atopy.',\n",
       " 'In the case-control association analysis, the g.-247C/T polymorphism at the promoter region (rs10399805; P = 0.0062) and the IVS7+82C/T polymorphism at intron 7 (rs2275353; P = 0.0056) of CHI3L1 showed a significant association with atopy.',\n",
       " 'In the case-control association analysis, the g.-247C/T polymorphism at the promoter region (rs10399805; P = 0.0062) and the IVS7+82C/T polymorphism at intron 7 (rs2275353; P = 0.0056) of CHI3L1 showed a significant association with atopy.',\n",
       " 'These results strongly suggest that the g.-247C/T polymorphism in the CHI3L1 promoter region is associated with the risk of atopy.',\n",
       " 'The genetic contribution of CHI3L1 gene to atopic susceptibility was investigated using an integrated population genetic and molecular analysis.',\n",
       " 'Genetic variations in CHI3L1 were identified and genotyped in 295 unrelated patients with atopy and 180 control subjects.',\n",
       " 'In the case-control association analysis, the g.-247C/T polymorphism at the promoter region (rs10399805; P = 0.0062) and the IVS7+82C/T polymorphism at intron 7 (rs2275353; P = 0.0056) of CHI3L1 showed a significant association with atopy.',\n",
       " 'In the case-control association analysis, the g.-247C/T polymorphism at the promoter region (rs10399805; P = 0.0062) and the IVS7+82C/T polymorphism at intron 7 (rs2275353; P = 0.0056) of CHI3L1 showed a significant association with atopy.',\n",
       " 'In the case-control association analysis, the g.-247C/T polymorphism at the promoter region (rs10399805; P = 0.0062) and the IVS7+82C/T polymorphism at intron 7 (rs2275353; P = 0.0056) of CHI3L1 showed a significant association with atopy.',\n",
       " 'In humans, loss-of-function of the cilia-centrosomal protein CEP290/NPHP6 is associated with Joubert and Meckel syndromes, whereas hypomorphic mutations result in Leber congenital amaurosis (LCA), a form of early-onset retinal dystrophy.',\n",
       " 'Hypomorphic CEP290/NPHP6 mutations result in anosmia caused by the selective loss of G proteins in cilia of olfactory sensory neurons.',\n",
       " 'In humans, loss-of-function of the cilia-centrosomal protein CEP290/NPHP6 is associated with Joubert and Meckel syndromes, whereas hypomorphic mutations result in Leber congenital amaurosis (LCA), a form of early-onset retinal dystrophy.',\n",
       " 'In humans, loss-of-function of the cilia-centrosomal protein CEP290/NPHP6 is associated with Joubert and Meckel syndromes, whereas hypomorphic mutations result in Leber congenital amaurosis (LCA), a form of early-onset retinal dystrophy.',\n",
       " 'Association between donor MBL promoter haplotype and graft survival and the development of BOS after lung transplantation.',\n",
       " 'Compared with the epsilon3 homozygotes, neither the epsilon2 nor the epsilon4 carrier status was associated with hypertension (adjusted prevalence ratios = 0.94, 95%CI = 0.83-1.07 and 0.98, 0.89-1.07, respectively).',\n",
       " 'Compared with the epsilon3 homozygotes, neither the epsilon2 nor the epsilon4 carrier status was associated with hypertension (adjusted prevalence ratios = 0.94, 95%CI = 0.83-1.07 and 0.98, 0.89-1.07, respectively).',\n",
       " 'Apolipoprotein E (ApoE) polymorphism influences lipid metabolism, but its association with arterial hypertension is controversial.',\n",
       " 'This study provides epidemiologic evidence that the ApoE genotype is not associated with prevalent hypertension in old age.',\n",
       " 'Analysis yielded the following Yale-generated observations: (1) TAA is a genetic disease with a predominantly autosomal dominant mode of inheritance; (2) matrix metalloproteinase (MMP) enzymes are activated in the pathogenesis of TAA; (3) wall tension in TAA approaches the tensile limits of aortic tissue at a diameter of 6 cm; (4) by the time a TAA reaches a clinical diameter of 6 cm, 34 percent of affected patients have suffered dissection or rupture; (5) extreme physical exertion or severe emotion often precipitate acute dissection; and (6) single nucleotide polymorphisms (SNPs) and RNA expression profile changes are being identified that predispose a patient to TAA and can serve as biomarkers for screening for this virulent disease.',\n",
       " 'Analysis yielded the following Yale-generated observations: (1) TAA is a genetic disease with a predominantly autosomal dominant mode of inheritance; (2) matrix metalloproteinase (MMP) enzymes are activated in the pathogenesis of TAA; (3) wall tension in TAA approaches the tensile limits of aortic tissue at a diameter of 6 cm; (4) by the time a TAA reaches a clinical diameter of 6 cm, 34 percent of affected patients have suffered dissection or rupture; (5) extreme physical exertion or severe emotion often precipitate acute dissection; and (6) single nucleotide polymorphisms (SNPs) and RNA expression profile changes are being identified that predispose a patient to TAA and can serve as biomarkers for screening for this virulent disease.',\n",
       " 'Two hundred and twenty-three incident papillary thyroid cancer cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.',\n",
       " 'Two hundred and twenty-three incident papillary thyroid cancer cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.',\n",
       " 'RAD52 polymorphisms contribute to the development of papillary thyroid cancer susceptibility in Middle Eastern population.',\n",
       " 'Two hundred and twenty-three incident papillary thyroid cancer cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.',\n",
       " 'Two hundred and twenty-three incident papillary thyroid cancer cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.',\n",
       " 'Two hundred and twenty-three incident papillary thyroid cancer cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.',\n",
       " 'Two hundred and twenty-three incident papillary thyroid cancer cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.',\n",
       " 'Of the 21 loci screened, RAD52 2259 and RAD52 GLN221GLU may be of importance to disease process and may be associated with papillary thyroid cancer risk in Saudi Arabian population.',\n",
       " 'Two hundred and twenty-three incident papillary thyroid cancer cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.',\n",
       " 'Two hundred and twenty-three incident papillary thyroid cancer cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.',\n",
       " 'Two hundred and twenty-three incident papillary thyroid cancer cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.',\n",
       " 'Two hundred and twenty-three incident papillary thyroid cancer cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.',\n",
       " 'Two hundred and twenty-three incident papillary thyroid cancer cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.',\n",
       " 'Two hundred and twenty-three incident papillary thyroid cancer cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.',\n",
       " 'RAD52 GLN221GLU genotypes CG and variants carrying G allele showed statistical significance and very high risk of developing thyroid cancer compared to wild type [CG vs CC; p<0.001, odds ratio (OR)=15.57, 95% confidence interval (CI)=6.56-36.98, CG+GG vs CC; p<0.001, OR=17.58, 95% CI=7.44-41.58].',\n",
       " 'Two hundred and twenty-three incident papillary thyroid cancer cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.',\n",
       " 'Two hundred and twenty-three incident papillary thyroid cancer cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.',\n",
       " 'Two hundred and twenty-three incident papillary thyroid cancer cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.',\n",
       " 'Two hundred and twenty-three incident papillary thyroid cancer cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.',\n",
       " 'Two hundred and twenty-three incident papillary thyroid cancer cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.',\n",
       " 'An anti-inflammatory and anticarcinogenic potential has been inferred from the development of colitis and intestinal cancer in GPx1 and GPx2 double knockout mice.',\n",
       " 'An anti-inflammatory and anticarcinogenic potential has been inferred from the development of colitis and intestinal cancer in GPx1 and GPx2 double knockout mice.',\n",
       " 'Thus, GPx2 may prevent undue responses to inflammatory stimuli and, in consequence, inflammation-driven initiation of carcinogenesis.',\n",
       " 'In contrast, enhanced COX-2 expression is consistently associated with inflammation.',\n",
       " 'An anti-inflammatory and anticarcinogenic potential has been inferred from the development of colitis and intestinal cancer in GPx1 and GPx2 double knockout mice.',\n",
       " 'An anti-inflammatory and anticarcinogenic potential has been inferred from the development of colitis and intestinal cancer in GPx1 and GPx2 double knockout mice.',\n",
       " 'For the remaining markers, a susceptibility role was attributed also confirming that markers on CARD15 gene, in particular G908R and L1007fsinsC, are involved with CD to the same extent as FcGIIIA G559T and TNF-alpha-G308A.',\n",
       " 'For the remaining markers, a susceptibility role was attributed also confirming that markers on CARD15 gene, in particular G908R and L1007fsinsC, are involved with CD to the same extent as FcGIIIA G559T and TNF-alpha-G308A.',\n",
       " 'For the remaining markers, a susceptibility role was attributed also confirming that markers on CARD15 gene, in particular G908R and L1007fsinsC, are involved with CD to the same extent as FcGIIIA G559T and TNF-alpha-G308A.',\n",
       " 'For the remaining markers, a susceptibility role was attributed also confirming that markers on CARD15 gene, in particular G908R and L1007fsinsC, are involved with CD to the same extent as FcGIIIA G559T and TNF-alpha-G308A.',\n",
       " 'The NF kappaB -94ATTG variants was found to be irrelevant for CD.',\n",
       " 'For the remaining markers, a susceptibility role was attributed also confirming that markers on CARD15 gene, in particular G908R and L1007fsinsC, are involved with CD to the same extent as FcGIIIA G559T and TNF-alpha-G308A.',\n",
       " 'The C-allele of PKLR rs3020781 and the T-allele of NOS1AP rs7538490 are reported to strongly associate with type 2 diabetes in various European-descent populations comprising a total of 2,198 individuals with a combined odds ratio (OR) of 1.33 [1.16-1.54] and 1.53 [1.28-1.81], respectively.',\n",
       " 'Additionally, the PKLR and the NOS1AP genotypes were demonstrated not to have a major influence on diabetes-related quantitative metabolic phenotypes.',\n",
       " 'We failed to provide evidence of an association between PKLR rs3020781 and NOS1AP rs7538490 and type 2 diabetes, overweight, obesity or related quantitative metabolic phenotypes in large-scale studies of Danes.',\n",
       " 'The C-allele of PKLR rs3020781 and the T-allele of NOS1AP rs7538490 are reported to strongly associate with type 2 diabetes in various European-descent populations comprising a total of 2,198 individuals with a combined odds ratio (OR) of 1.33 [1.16-1.54] and 1.53 [1.28-1.81], respectively.',\n",
       " 'We failed to provide evidence of an association between PKLR rs3020781 and NOS1AP rs7538490 and type 2 diabetes, overweight, obesity or related quantitative metabolic phenotypes in large-scale studies of Danes.',\n",
       " 'No significant associations were observed for type 2 diabetes (rs3020781: pAF = 0.49, OR = 1.02 [0.96-1.10]; rs7538490: pAF = 0.84, OR = 0.99 [0.93-1.06]).',\n",
       " 'Lack of association between PKLR rs3020781 and NOS1AP rs7538490 and type 2 diabetes, overweight, obesity and related metabolic phenotypes in a Danish large-scale study: case-control studies and analyses of quantitative traits.',\n",
       " 'Lack of association between PKLR rs3020781 and NOS1AP rs7538490 and type 2 diabetes, overweight, obesity and related metabolic phenotypes in a Danish large-scale study: case-control studies and analyses of quantitative traits.',\n",
       " 'We failed to provide evidence of an association between PKLR rs3020781 and NOS1AP rs7538490 and type 2 diabetes, overweight, obesity or related quantitative metabolic phenotypes in large-scale studies of Danes.',\n",
       " 'Lack of association between PKLR rs3020781 and NOS1AP rs7538490 and type 2 diabetes, overweight, obesity and related metabolic phenotypes in a Danish large-scale study: case-control studies and analyses of quantitative traits.',\n",
       " 'The C-allele of PKLR rs3020781 and the T-allele of NOS1AP rs7538490 are reported to strongly associate with type 2 diabetes in various European-descent populations comprising a total of 2,198 individuals with a combined odds ratio (OR) of 1.33 [1.16-1.54] and 1.53 [1.28-1.81], respectively.',\n",
       " 'Lack of association between PKLR rs3020781 and NOS1AP rs7538490 and type 2 diabetes, overweight, obesity and related metabolic phenotypes in a Danish large-scale study: case-control studies and analyses of quantitative traits.',\n",
       " 'We failed to provide evidence of an association between PKLR rs3020781 and NOS1AP rs7538490 and type 2 diabetes, overweight, obesity or related quantitative metabolic phenotypes in large-scale studies of Danes.',\n",
       " 'Additionally, the PKLR and the NOS1AP genotypes were demonstrated not to have a major influence on diabetes-related quantitative metabolic phenotypes.',\n",
       " 'No significant associations were observed for type 2 diabetes (rs3020781: pAF = 0.49, OR = 1.02 [0.96-1.10]; rs7538490: pAF = 0.84, OR = 0.99 [0.93-1.06]).',\n",
       " 'The C-allele of PKLR rs3020781 and the T-allele of NOS1AP rs7538490 are reported to strongly associate with type 2 diabetes in various European-descent populations comprising a total of 2,198 individuals with a combined odds ratio (OR) of 1.33 [1.16-1.54] and 1.53 [1.28-1.81], respectively.',\n",
       " 'We failed to provide evidence of an association between PKLR rs3020781 and NOS1AP rs7538490 and type 2 diabetes, overweight, obesity or related quantitative metabolic phenotypes in large-scale studies of Danes.',\n",
       " 'Lack of association between PKLR rs3020781 and NOS1AP rs7538490 and type 2 diabetes, overweight, obesity and related metabolic phenotypes in a Danish large-scale study: case-control studies and analyses of quantitative traits.',\n",
       " 'Lack of association between PKLR rs3020781 and NOS1AP rs7538490 and type 2 diabetes, overweight, obesity and related metabolic phenotypes in a Danish large-scale study: case-control studies and analyses of quantitative traits.',\n",
       " 'Although COX-2 is commonly overexpressed in a variety of premalignant and malignant conditions including oral leukoplakia and squamous cell carcinoma, relatively little research has compared the effects of various COX-2 inhibitors (celecoxib, NS-398, nimesulide and meloxicam).',\n",
       " 'Although COX-2 is commonly overexpressed in a variety of premalignant and malignant conditions including oral leukoplakia and squamous cell carcinoma, relatively little research has compared the effects of various COX-2 inhibitors (celecoxib, NS-398, nimesulide and meloxicam).',\n",
       " 'Taken together, celecoxib is a good therapeutic candidate for treating OSCC through the suppression of cell proliferation and the induction of apoptosis in a COX-2 independent manner.',\n",
       " 'From the Cover: Whole-genome association study identifies STK39 as a hypertension susceptibility gene.',\n",
       " \"Recently an association was shown between the single nucleotide polymorphism (SNP), rs11209026, within the interleukin-23 receptor (IL23R) locus and Crohn's disease (CD) as a consequence of a genome-wide association study of this disease in adults.\",\n",
       " \"Recently an association was shown between the single nucleotide polymorphism (SNP), rs11209026, within the interleukin-23 receptor (IL23R) locus and Crohn's disease (CD) as a consequence of a genome-wide association study of this disease in adults.\",\n",
       " \"Recently an association was shown between the single nucleotide polymorphism (SNP), rs11209026, within the interleukin-23 receptor (IL23R) locus and Crohn's disease (CD) as a consequence of a genome-wide association study of this disease in adults.\",\n",
       " \"Recently an association was shown between the single nucleotide polymorphism (SNP), rs11209026, within the interleukin-23 receptor (IL23R) locus and Crohn's disease (CD) as a consequence of a genome-wide association study of this disease in adults.\",\n",
       " 'By using data from our ongoing genome-wide association study in our cohort of 142 pediatric CD patients and 281 matched controls, we investigated the association of the previously reported SNPs at the IL23R locus with the childhood form of this disease.',\n",
       " 'As such, variants in the IL23R gene confer a similar magnitude of risk of CD to children as for their adult counterparts.',\n",
       " 'The OR of the IL23R variant in our pediatric study is highly comparable with that reported previously in a non-Jewish adult inflammatory bowel disease case-control cohort (OR, 0.26).',\n",
       " \"Association of variants of the interleukin-23 receptor gene with susceptibility to pediatric Crohn's disease.\",\n",
       " 'Variations in the interleukin-1 receptor antagonist gene impact on survival of patients with advanced colorectal cancer.',\n",
       " 'The interleukin-1 receptor antagonist (IL-1RA) cytokine is thought to counteract tumor angiogenesis/metastasis.',\n",
       " 'The interleukin-1 receptor antagonist (IL-1RA) cytokine is thought to counteract tumor angiogenesis/metastasis.',\n",
       " 'A total of 180 patients with metastatic colorectal cancer were categorized as high IL-1RA producers if they were carriers of at least one of the rs4251961 T/T or rs579543 T/T genotypes (T/T carriers).',\n",
       " 'A total of 180 patients with metastatic colorectal cancer were categorized as high IL-1RA producers if they were carriers of at least one of the rs4251961 T/T or rs579543 T/T genotypes (T/T carriers).',\n",
       " 'A total of 180 patients with metastatic colorectal cancer were categorized as high IL-1RA producers if they were carriers of at least one of the rs4251961 T/T or rs579543 T/T genotypes (T/T carriers).',\n",
       " 'Vitamin D receptor (VDR) genotypes may influence cancer risk; however, no epidemiological studies in sporadic breast cancer (BC) or malignant melanoma (MM) have been performed in a southern European population.',\n",
       " 'Vitamin D receptor (VDR) genotypes may influence cancer risk; however, no epidemiological studies in sporadic breast cancer (BC) or malignant melanoma (MM) have been performed in a southern European population.',\n",
       " 'Vitamin D receptor (VDR) genotypes may influence cancer risk; however, no epidemiological studies in sporadic breast cancer (BC) or malignant melanoma (MM) have been performed in a southern European population.',\n",
       " 'The synonymous variant rs731236 (TaqI) appeared to be associated with protection from BC (OR = 0.80, 95%CI = 0.64-0.99; p = 0.047).',\n",
       " 'Vitamin D receptor (VDR) genotypes may influence cancer risk; however, no epidemiological studies in sporadic breast cancer (BC) or malignant melanoma (MM) have been performed in a southern European population.',\n",
       " 'Vitamin D receptor (VDR) genotypes may influence cancer risk; however, no epidemiological studies in sporadic breast cancer (BC) or malignant melanoma (MM) have been performed in a southern European population.',\n",
       " 'In summary, we observed associations between SNPs in the VDR gene and BC risk, and a comprehensive analysis using clinical and tumour characteristics as outcome variables has revealed potential associations with MM.',\n",
       " 'An association with the minor allele A of the non-synonymous SNP rs2228570 (rs10735810, FokI, Met1Thr) was observed for BC, with an estimated odds ratio (OR) of 1.26 (95% CI = 1.02-1.57; p = 0.036).',\n",
       " 'An association with the minor allele A of the non-synonymous SNP rs2228570 (rs10735810, FokI, Met1Thr) was observed for BC, with an estimated odds ratio (OR) of 1.26 (95% CI = 1.02-1.57; p = 0.036).',\n",
       " 'In summary, we observed associations between SNPs in the VDR gene and BC risk, and a comprehensive analysis using clinical and tumour characteristics as outcome variables has revealed potential associations with MM.',\n",
       " 'A common SNP upstream of the INSIG2 gene, rs7566605 (g.-10,1025G>C, Chr2:118,552,255, NT_022135.15), was reported to be associated with obesity (Body Mass Index, [BMI]) in a genome-wide association scan using the Framingham Heart Study but has not been reproduced in other cohorts.',\n",
       " 'A common SNP upstream of the INSIG2 gene, rs7566605 (g.-10,1025G>C, Chr2:118,552,255, NT_022135.15), was reported to be associated with obesity (Body Mass Index, [BMI]) in a genome-wide association scan using the Framingham Heart Study but has not been reproduced in other cohorts.',\n",
       " 'This supports and extends the original finding that there is an association between measures of obesity and INSIG2 rs7566605 and further implicates this polymorphism in fat regulation.',\n",
       " 'Our results show that the INSIG2 rs7566605 polymorphism underlies variation in subcutaneous adiposity in young adult women and suppresses the positive effects of resistance training on men.',\n",
       " \"Our previous study demonstrated that expression of HCNPpp mRNA was decreased in the hippocampi of autopsied brains of Alzheimer's disease (AD) patients, indicating the association of HCNP with the pathogenesis of AD.\",\n",
       " \"Our previous study demonstrated that expression of HCNPpp mRNA was decreased in the hippocampi of autopsied brains of Alzheimer's disease (AD) patients, indicating the association of HCNP with the pathogenesis of AD.\",\n",
       " 'To clarify the involvement of gene variations in the promoter region of the gene encoding HCNPpp in this mRNA reduction, we analyzed DNA polymorphisms or mutations within this gene promoter region in AD patients by direct sequencing.',\n",
       " \"Our previous study demonstrated that expression of HCNPpp mRNA was decreased in the hippocampi of autopsied brains of Alzheimer's disease (AD) patients, indicating the association of HCNP with the pathogenesis of AD.\",\n",
       " \"Our previous study demonstrated that expression of HCNPpp mRNA was decreased in the hippocampi of autopsied brains of Alzheimer's disease (AD) patients, indicating the association of HCNP with the pathogenesis of AD.\",\n",
       " 'The K121Q polymorphism in the ectonucleotide pyrophosphatase/phosphodiesterase (ENPP)-1 gene and the rs7566605 genotype located near insulin-induced gene 2 have been shown to be associated with insulin resistance and obesity.',\n",
       " 'The K121Q polymorphism in the ectonucleotide pyrophosphatase/phosphodiesterase (ENPP)-1 gene and the rs7566605 genotype located near insulin-induced gene 2 have been shown to be associated with insulin resistance and obesity.',\n",
       " 'Association of a genetic polymorphism in ectonucleotide pyrophosphatase/phosphodiesterase 1 with hepatitis C virus infection and hepatitis C virus core antigen levels in subjects in a hyperendemic area of Japan.',\n",
       " 'In contrast, the rs7566605 genotype was not associated with hepatitis C viremia or with the HCV core antigen level.',\n",
       " 'The K121Q variant of ENPP1 may be associated with hepatitis C viremia and core antigen levels in HCV carriers.',\n",
       " 'The K121Q polymorphism in the ectonucleotide pyrophosphatase/phosphodiesterase (ENPP)-1 gene and the rs7566605 genotype located near insulin-induced gene 2 have been shown to be associated with insulin resistance and obesity.',\n",
       " 'The K121Q polymorphism in the ectonucleotide pyrophosphatase/phosphodiesterase (ENPP)-1 gene and the rs7566605 genotype located near insulin-induced gene 2 have been shown to be associated with insulin resistance and obesity.',\n",
       " 'This study examined whether the K121Q polymorphism in ENPP1 or the rs7566605 genotype is associated with the clinical course of HCV infection.',\n",
       " 'This study examined whether the K121Q polymorphism in ENPP1 or the rs7566605 genotype is associated with the clinical course of HCV infection.',\n",
       " 'This study examined whether the K121Q polymorphism in ENPP1 or the rs7566605 genotype is associated with the clinical course of HCV infection.',\n",
       " 'The K121Q polymorphism in the ectonucleotide pyrophosphatase/phosphodiesterase (ENPP)-1 gene and the rs7566605 genotype located near insulin-induced gene 2 have been shown to be associated with insulin resistance and obesity.',\n",
       " 'The K121Q variant of ENPP1 may be associated with hepatitis C viremia and core antigen levels in HCV carriers.',\n",
       " 'The K121Q polymorphism in the ectonucleotide pyrophosphatase/phosphodiesterase (ENPP)-1 gene and the rs7566605 genotype located near insulin-induced gene 2 have been shown to be associated with insulin resistance and obesity.',\n",
       " 'Finally, we tested IL-10 production in peripheral blood mononuclear cells stimulated with Mycobacterium leprae antigens and found that -819T carriers produced lower levels of IL-10 when compared with non-carriers.',\n",
       " 'Taken together, these data suggest that low levels of IL-10 during the disease outcome can drive patients to a chronic and unprotective response that culminates with leprosy.',\n",
       " 'Genetic, epidemiological and biological analysis of interleukin-10 promoter single-nucleotide polymorphisms suggests a definitive role for -819C/T in leprosy susceptibility.',\n",
       " 'Here, we combined a case-control study (374 patients and 380 controls), with meta-analysis (5 studies; 2702 individuals) and biological study to test the epidemiological and physiological relevance of the interleukin-10 (IL-10) genetic markers in leprosy.',\n",
       " 'Genetic, epidemiological and biological analysis of interleukin-10 promoter single-nucleotide polymorphisms suggests a definitive role for -819C/T in leprosy susceptibility.',\n",
       " 'Haplotypes combining promoter single-nucleotide polymorphisms also implicated a haplotype carrying the -819T allele in leprosy susceptibility (odds ratio (OR)=1.40; P=0.01).',\n",
       " 'Finally, we tested IL-10 production in peripheral blood mononuclear cells stimulated with Mycobacterium leprae antigens and found that -819T carriers produced lower levels of IL-10 when compared with non-carriers.',\n",
       " 'We observed that the -819T allele is associated with leprosy susceptibility either in the case-control or in the meta-analysis studies.',\n",
       " 'The implicated LOXL1 polymorphisms have not been associated with primary open-angle glaucoma (POAG).',\n",
       " 'Individual LOXL1 SNPs, rs1048661, rs3825942, and rs2165241, were not associated with POAG in the Chinese population.',\n",
       " 'The lysyl oxidase-like protein 1 (LOXL1) gene is strongly associated with exfoliation glaucoma, which is very rare in the Chinese population.',\n",
       " 'The low frequencies of the at-risk alleles at rs1048661 and rs2165241 may be one of the factors that led to the low prevalence of exfoliation syndrome in the general populations of the Chinese.',\n",
       " 'Individual LOXL1 SNPs, rs1048661, rs3825942, and rs2165241, were not associated with POAG in the Chinese population.',\n",
       " 'The low frequencies of the at-risk alleles at rs1048661 and rs2165241 may be one of the factors that led to the low prevalence of exfoliation syndrome in the general populations of the Chinese.',\n",
       " 'Individual LOXL1 SNPs, rs1048661, rs3825942, and rs2165241, were not associated with POAG in the Chinese population.',\n",
       " 'Individual LOXL1 SNPs, rs1048661, rs3825942, and rs2165241, were not associated with POAG in the Chinese population.',\n",
       " 'Compound heterozygosity for the C677T and A1298C mutations of the MTHFR gene in a case of hyperhomocysteinemia with recurrent deep thrombosis at young age.',\n",
       " 'Compound heterozygosity for the C677T and A1298C mutations of the MTHFR gene in a case of hyperhomocysteinemia with recurrent deep thrombosis at young age.',\n",
       " 'In CD patients, TLR-induced GM-CSF secretion was impaired by both NOD2-dependent and -independent mechanisms.',\n",
       " 'The defect in GM-CSF secretion suggests a hitherto unknown role of NOD2 in the pathogenesis of CD and is consistent with the hypothesis that impaired GM-CSF secretion in part constitutes a NOD2-dependent disease risk factor.',\n",
       " 'Based on NOD2 SNP analyses, 41 CD patients and 12 healthy controls were studied.',\n",
       " \"Toll-like receptor-induced granulocyte-macrophage colony-stimulating factor secretion is impaired in Crohn's disease by nucleotide oligomerization domain 2-dependent and -independent pathways.\",\n",
       " \"Toll-like receptor-induced granulocyte-macrophage colony-stimulating factor secretion is impaired in Crohn's disease by nucleotide oligomerization domain 2-dependent and -independent pathways.\",\n",
       " 'Moreover, TNF-alpha production was induced by a TLR-2 ligand, but a down-regulatory function by the NOD2 ligand, muramyl dipeptide, was impaired significantly in CD patients.',\n",
       " 'CD patients have impaired GM-CSF secretion via NOD2-dependent and -independent pathways and display an impaired NOD2-dependent down-regulation of TNF-alpha secretion.',\n",
       " 'CD patients have impaired GM-CSF secretion via NOD2-dependent and -independent pathways and display an impaired NOD2-dependent down-regulation of TNF-alpha secretion.',\n",
       " \"Single nucleotide polymorphisms (SNPs) in the intracellular pattern recognition receptor nucleotide-binding oligomerization domain-containing protein (NOD2, nucleotide oligomerization domain 2) are associated with Crohn's disease (CD).\",\n",
       " \"Single nucleotide polymorphisms (SNPs) in the intracellular pattern recognition receptor nucleotide-binding oligomerization domain-containing protein (NOD2, nucleotide oligomerization domain 2) are associated with Crohn's disease (CD).\",\n",
       " 'CD patients with NOD2 mutations were able to secrete TNF-alpha, but not GM-CSF, upon stimulation with NOD2 and TLR-7 ligands.',\n",
       " 'The defect in GM-CSF secretion suggests a hitherto unknown role of NOD2 in the pathogenesis of CD and is consistent with the hypothesis that impaired GM-CSF secretion in part constitutes a NOD2-dependent disease risk factor.',\n",
       " 'CD patients have impaired GM-CSF secretion via NOD2-dependent and -independent pathways and display an impaired NOD2-dependent down-regulation of TNF-alpha secretion.',\n",
       " \"Single nucleotide polymorphisms (SNPs) in the intracellular pattern recognition receptor nucleotide-binding oligomerization domain-containing protein (NOD2, nucleotide oligomerization domain 2) are associated with Crohn's disease (CD).\",\n",
       " \"Single nucleotide polymorphisms (SNPs) in the intracellular pattern recognition receptor nucleotide-binding oligomerization domain-containing protein (NOD2, nucleotide oligomerization domain 2) are associated with Crohn's disease (CD).\",\n",
       " 'In CD patients, TLR-induced GM-CSF secretion was impaired by both NOD2-dependent and -independent mechanisms.',\n",
       " \"Toll-like receptor-induced granulocyte-macrophage colony-stimulating factor secretion is impaired in Crohn's disease by nucleotide oligomerization domain 2-dependent and -independent pathways.\",\n",
       " 'Moreover, TNF-alpha production was induced by a TLR-2 ligand, but a down-regulatory function by the NOD2 ligand, muramyl dipeptide, was impaired significantly in CD patients.',\n",
       " 'In CD patients, TLR-induced GM-CSF secretion was impaired by both NOD2-dependent and -independent mechanisms.',\n",
       " 'The IL-23 pathway plays a pivotal role in the development of chronic mucosal inflammation seen in the inflammatory bowel diseases.',\n",
       " \"IL23R haplotypes provide a large population attributable risk for Crohn's disease.\",\n",
       " \"Multiple studies have now established the contribution of the interleukin 23 receptor gene (IL23R) to Crohn's disease (CD) risk in general and of the IL23R R381Q variant in particular.\",\n",
       " 'These observations suggest that IL23R makes a substantial contribution to CD susceptibility, larger than that estimated from the population frequency of the R381Q variant.',\n",
       " \"Multiple studies have now established the contribution of the interleukin 23 receptor gene (IL23R) to Crohn's disease (CD) risk in general and of the IL23R R381Q variant in particular.\",\n",
       " 'The IL-23 pathway plays a pivotal role in the development of chronic mucosal inflammation seen in the inflammatory bowel diseases.',\n",
       " \"Multiple studies have now established the contribution of the interleukin 23 receptor gene (IL23R) to Crohn's disease (CD) risk in general and of the IL23R R381Q variant in particular.\",\n",
       " 'These observations suggest that IL23R makes a substantial contribution to CD susceptibility, larger than that estimated from the population frequency of the R381Q variant.',\n",
       " \"Multiple studies have now established the contribution of the interleukin 23 receptor gene (IL23R) to Crohn's disease (CD) risk in general and of the IL23R R381Q variant in particular.\",\n",
       " 'In all, 763 CD subjects and 254 controls were genotyped for single nucleotide polymorphisms in the IL23R gene using Illumina and ABI methods.',\n",
       " 'Identification and replication of three novel myopia common susceptibility gene loci on chromosome 3q26 using linkage and linkage disequilibrium mapping.',\n",
       " \"In a family, we observed c.+119A > T in the 3'-UTR associated with ASD type II.\",\n",
       " 'Elevation of growth hormone-releasing hormone receptor messenger ribonucleic acid expression in growth hormone-secreting pituitary adenoma with Gsalpha protein mutation.',\n",
       " 'The expression of GHRH receptor (GHRHR) is regulated by GHRH, both of which are known to be expressed in human GH-secreting pituitary adenoma cells.',\n",
       " 'These results suggest that gsp mutations up-regulate GHRHR mRNA expression in GH-secreting pituitary adenoma cells, and that gsp mutations desensitize the adenoma cells to GHRH in terms of their GHRHR mRNA expression probably because of their saturation of GHRH signaling.',\n",
       " 'The expression of GHRH receptor (GHRHR) is regulated by GHRH, both of which are known to be expressed in human GH-secreting pituitary adenoma cells.',\n",
       " 'These results suggest that gsp mutations up-regulate GHRHR mRNA expression in GH-secreting pituitary adenoma cells, and that gsp mutations desensitize the adenoma cells to GHRH in terms of their GHRHR mRNA expression probably because of their saturation of GHRH signaling.',\n",
       " 'Cdc6 play crucial roles in DNA replication and carcinogenesis.',\n",
       " 'Our data provide the first evidence that the Cdc6 G1321A polymorphism is associated with decreased risk of cancer.',\n",
       " 'To assess clinical significance, 93 breast cancer lesions were evaluated for expression of VEGF and VEGFR-1 by immunohistochemistry.',\n",
       " 'To assess clinical significance, 93 breast cancer lesions were evaluated for expression of VEGF and VEGFR-1 by immunohistochemistry.',\n",
       " 'Expression of VEGFR-1 (Flt-1) in breast cancer is associated with VEGF expression and with node-negative tumour stage.',\n",
       " 'Expression of VEGFR-1 (Flt-1) in breast cancer is associated with VEGF expression and with node-negative tumour stage.',\n",
       " 'VEGF was expressed in 60% and VEGFR-1 in 39% of breast cancer specimens.',\n",
       " 'VEGF was expressed in 60% and VEGFR-1 in 39% of breast cancer specimens.',\n",
       " 'Vascular endothelial growth factor (VEGF) promotes breast cancer progression by inducing angiogenesis via VEGF receptors on endothelial cells but also signals directly through receptors such as VEGFR-1 (Flt-1) expressed on tumour cells.',\n",
       " 'Vascular endothelial growth factor (VEGF) promotes breast cancer progression by inducing angiogenesis via VEGF receptors on endothelial cells but also signals directly through receptors such as VEGFR-1 (Flt-1) expressed on tumour cells.',\n",
       " 'We genotyped the four single-nucleotide polymorphisms (rs706778, rs3118470, ss52580101, and rs11594656) of the IL2RA in 885 patients with type 1 diabetes and 606 control subjects of Japanese origin.',\n",
       " 'Our objective was to determine whether variants in the IL2RA gene are associated with type 1 diabetes in the Japanese population.',\n",
       " 'We genotyped the four single-nucleotide polymorphisms (rs706778, rs3118470, ss52580101, and rs11594656) of the IL2RA in 885 patients with type 1 diabetes and 606 control subjects of Japanese origin.',\n",
       " 'The present data confirm the type 1 diabetes association with IL2RA and provide evidence that the different contributions of the IL2RA in the susceptibility to acute-onset and other forms of type 1 diabetes in the Japanese population.',\n",
       " 'We genotyped the four single-nucleotide polymorphisms (rs706778, rs3118470, ss52580101, and rs11594656) of the IL2RA in 885 patients with type 1 diabetes and 606 control subjects of Japanese origin.',\n",
       " 'We genotyped the four single-nucleotide polymorphisms (rs706778, rs3118470, ss52580101, and rs11594656) of the IL2RA in 885 patients with type 1 diabetes and 606 control subjects of Japanese origin.',\n",
       " 'We found evidence of association with acute-onset, but not slow-onset and fulminant, type 1 diabetes for two of the four single-nucleotide polymorphisms genotyped (rs706778 and rs3118470).',\n",
       " 'We found evidence of association with acute-onset, but not slow-onset and fulminant, type 1 diabetes for two of the four single-nucleotide polymorphisms genotyped (rs706778 and rs3118470).',\n",
       " 'We genotyped the four single-nucleotide polymorphisms (rs706778, rs3118470, ss52580101, and rs11594656) of the IL2RA in 885 patients with type 1 diabetes and 606 control subjects of Japanese origin.',\n",
       " 'TGFBIp/betaig-h3 protein is an extracellular matrix molecule initially cloned from human adenocarcinoma cells treated with TGF-beta.',\n",
       " 'Polymorphisms in the regulatory region of the Cyclophilin A gene influence the susceptibility for HIV-1 infection.',\n",
       " 'Previous studies have demonstrated an association between polymorphisms in the regulatory regions of Cyclophilin A (CypA) and susceptibility to both HIV-1 infection and disease progression.',\n",
       " 'Previous studies have demonstrated an association between polymorphisms in the regulatory regions of Cyclophilin A (CypA) and susceptibility to both HIV-1 infection and disease progression.',\n",
       " 'The results obtained in this study suggest that the A1650G polymorphism in the regulatory region of the CypA gene may be associated with protection from HIV-1 infection, while the 1604G allele may have a weak association with the clinical course of infection in DU.',\n",
       " 'Women carrying homozygous Asp1104Asp genotypes had a significantly decreased risk of cervical or cervical squamous cell carcinoma compared to His1104Asp or His1104His genotypes.',\n",
       " 'No association of XRCC3 Thr241Met or XPD Lys751Gln and cervical carcinoma was found.',\n",
       " 'DNA repair gene polymorphisms, such as those of XRCC3 and xeroderma pigmentosum, complementation group D and G (XPD, XPG), contribute to carcinogenesis.',\n",
       " 'Similarly, XPD Asn312Asn (AA) reduced the risk of cervical or cervical squamous cell carcinoma.',\n",
       " 'No association of XRCC3 Thr241Met or XPD Lys751Gln and cervical carcinoma was found.',\n",
       " 'Women carrying homozygous Asp1104Asp genotypes had a significantly decreased risk of cervical or cervical squamous cell carcinoma compared to His1104Asp or His1104His genotypes.',\n",
       " 'Women carrying homozygous Asp1104Asp genotypes had a significantly decreased risk of cervical or cervical squamous cell carcinoma compared to His1104Asp or His1104His genotypes.',\n",
       " 'Much of this data has been correlative, until recently with the development of polymerase gamma deficient mice which accumulate high levels of mtDNA mutations and show a premature aging phenotype, that a more causative role has been proposed.',\n",
       " 'A recent study demonstrated the association of TNFSF4 haplotypes located in the upstream region with risk for or protection from systemic lupus erythematosus (SLE).',\n",
       " 'A recent study demonstrated the association of TNFSF4 haplotypes located in the upstream region with risk for or protection from systemic lupus erythematosus (SLE).',\n",
       " 'The association of TNFSF4 with SLE was replicated in all the sets except Spain.',\n",
       " 'Replication of the TNFSF4 (OX40L) promoter region association with systemic lupus erythematosus.',\n",
       " 'This first replication study confirms the association of genetic variation in the upstream region of TNFSF4 with susceptibility to SLE.',\n",
       " 'These results suggest that NPTN may be involved in genetic susceptibility to schizophrenia.',\n",
       " \"The haplotypes constructed from the three SNPs (rs3840846, rs3826047 and rs3743500, in order) in the 5'-upstream of NPTN showed a significant association with schizophrenia (permutation P=0.036), in that T-G-T (permutation P=0.028) and del-G-G (permutation P=0.040) were under-represented and over-represented, respectively, in schizophrenia.\",\n",
       " \"The haplotypes constructed from the three SNPs (rs3840846, rs3826047 and rs3743500, in order) in the 5'-upstream of NPTN showed a significant association with schizophrenia (permutation P=0.036), in that T-G-T (permutation P=0.028) and del-G-G (permutation P=0.040) were under-represented and over-represented, respectively, in schizophrenia.\",\n",
       " \"The haplotypes constructed from the three SNPs (rs3840846, rs3826047 and rs3743500, in order) in the 5'-upstream of NPTN showed a significant association with schizophrenia (permutation P=0.036), in that T-G-T (permutation P=0.028) and del-G-G (permutation P=0.040) were under-represented and over-represented, respectively, in schizophrenia.\",\n",
       " \"The haplotypes constructed from the three SNPs (rs3840846, rs3826047 and rs3743500, in order) in the 5'-upstream of NPTN showed a significant association with schizophrenia (permutation P=0.036), in that T-G-T (permutation P=0.028) and del-G-G (permutation P=0.040) were under-represented and over-represented, respectively, in schizophrenia.\",\n",
       " 'Chronic rhinosinusitis with nasal polyps is associated with decreased expression of mucosal interleukin 22 receptor.',\n",
       " 'IL-22R1 mRNA was expressed in 100% of the controls and CRSsNP.',\n",
       " 'However, IL-22R1 was only expressed in 55% of patients with recalcitrant CRSwNP.',\n",
       " 'Further research is needed to determine the potential of IL-22R1 as a therapeutic target in CRSwNP.',\n",
       " 'Additionally, levels of IL22R1 were significantly lower in recalcitrant CRSwNP compared to controls and CRSsNP.',\n",
       " 'Additionally, levels of IL22R1 were significantly lower in recalcitrant CRSwNP compared to controls and CRSsNP.',\n",
       " 'Failure of medical and surgical therapy in CRSwNP is associated with significantly decreased expression of IL-22R1.',\n",
       " 'Fetuin-A is a calcification inhibitor and correlates negatively with increased vascular stiffness in dialysis patients.',\n",
       " 'Male fetuin-A SerSer carriers demonstrate particularly high aortic stiffness, possibly implying a status of increased cardiovascular risk.',\n",
       " 'The fetuin-A polymorphism (Thr256Ser) is associated with reduced fetuin levels and accelerated vascular calcification in dialysis patients.',\n",
       " 'EGFR gene expression in pancreatic adenocarcinoma cells significantly surpassed that in normal pancreatic cells.',\n",
       " 'Role of epidermal growth factor gene in the development of pancreatic cancer and efficiency of inhibitors of this gene in the treatment of pancreatic carcinoma.',\n",
       " 'On the other hand, AA genome and A allele polymorphism in the EGF gene nucleotide pair G-A 61 is a significant risk factor for pancreatic cancer.',\n",
       " 'Body height, weight and obesity increase the risk of venous thrombosis, especially obesity in women using oral contraceptives.',\n",
       " 'Cardiovascular thromboembolic adverse effects associated with cyclooxygenase-2 selective inhibitors and nonselective antiinflammatory drugs.',\n",
       " 'Cardiovascular thromboembolic adverse effects associated with cyclooxygenase-2 selective inhibitors and nonselective antiinflammatory drugs.',\n",
       " 'The frequency of PONV did not correlate to the amounts of alfentanil, propofol, postoperative antiemetics consumed, or to female gender, non-smoking status, and history of PONV or motion sickness.',\n",
       " 'The frequency of PONV did not correlate to the amounts of alfentanil, propofol, postoperative antiemetics consumed, or to female gender, non-smoking status, and history of PONV or motion sickness.',\n",
       " \"However, decreased tear production after botulinum toxin injection for crow's feet is a possible complication and patients should be advised of the small but definite risk of a temporary dry eye.\",\n",
       " 'Botulinum toxins are potent neurotoxins used in a variety of neurological disorders.',\n",
       " 'We describe the case of a 10-year-old boy who developed systemic weakness following treatment of spasticity with botulinum toxin type B.',\n",
       " 'We describe the case of a 10-year-old boy who developed systemic weakness following treatment of spasticity with botulinum toxin type B.',\n",
       " 'Gingival samples were collected from eight normal healthy individuals, eight patients with periodontitis, and eight patients with cyclosporin A (CsA)-induced gingival overgrowth.',\n",
       " 'ET-1 mRNA expression was significantly higher in patients with CsA-induced gingival overgrowth (P <0.001) than in patients with periodontitis and the controls.',\n",
       " 'ET-1 mRNA expression was significantly higher in patients with CsA-induced gingival overgrowth (P <0.001) than in patients with periodontitis and the controls.',\n",
       " 'These results suggest that CsA can modulate the expression of ET-1 in gingival fibroblasts and CsA-induced gingival overgrowth.',\n",
       " 'Gingival samples were collected from eight normal healthy individuals, eight patients with periodontitis, and eight patients with cyclosporin A (CsA)-induced gingival overgrowth.',\n",
       " 'Gingival samples were collected from eight normal healthy individuals, eight patients with periodontitis, and eight patients with cyclosporin A (CsA)-induced gingival overgrowth.',\n",
       " 'The evidence suggests that montelukast is an effective monotherapy controller in children with mild asthma.',\n",
       " 'Review of recent results of montelukast use as a monotherapy in children with mild asthma.',\n",
       " 'This article reviewed recent results from randomized, double-blind studies of children with mild asthma treated with montelukast, a leukotriene receptor antagonist that is approved for the treatment of asthma and allergic rhinitis in children and adults.',\n",
       " 'A literature search of MEDLINE was conducted to gather relevant, English-language articles using search terms such as randomized controlled studies, double-blind studies, montelukast, leukotriene receptor antagonist, pediatric asthma, mild asthma, exercise-induced asthma, and bronchoconstriction.',\n",
       " 'The results from these studies, encompassing end points measuring lung function and symptoms, found that montelukast provided effective and beneficial asthma control to children aged 2 to 14 years with mild asthma.',\n",
       " 'This article reviewed recent results from randomized, double-blind studies of children with mild asthma treated with montelukast, a leukotriene receptor antagonist that is approved for the treatment of asthma and allergic rhinitis in children and adults.',\n",
       " 'The combination of high-dose MTX with procarbazine and CCNU is feasible and effective and results in a low rate of leukoencephalopathy.',\n",
       " 'The combination of high-dose MTX with procarbazine and CCNU is feasible and effective and results in a low rate of leukoencephalopathy.',\n",
       " 'The combination of high-dose MTX with procarbazine and CCNU is feasible and effective and results in a low rate of leukoencephalopathy.',\n",
       " 'Intra-articular injection of lidocaine before closed reduction of anterior shoulder dislocation produces the same pain relief as intravenous meperidine and diazepam.',\n",
       " 'Intra-articular injection of lidocaine before closed reduction of anterior shoulder dislocation produces the same pain relief as intravenous meperidine and diazepam.',\n",
       " 'Intra-articular injection of lidocaine before closed reduction of anterior shoulder dislocation produces the same pain relief as intravenous meperidine and diazepam.',\n",
       " 'Intra-articular injection of lidocaine before closed reduction of anterior shoulder dislocation produces the same pain relief as intravenous meperidine and diazepam.',\n",
       " 'Intra-articular injection of lidocaine before closed reduction of anterior shoulder dislocation produces the same pain relief as intravenous meperidine and diazepam.',\n",
       " 'Mean pain (mm) recorded before injection, before reduction, and after reduction in the intra-articular lidocaine group was 84.3 (95% confidence interval (CI) 79.8 to 88.8), 52.6 (95% CI 45.2 to 60.1), and 27.3 (95% CI 19.9 to 34.7), respectively.',\n",
       " 'Intra-articular injection of lidocaine before closed reduction of anterior shoulder dislocation produces the same pain relief as intravenous meperidine and diazepam.',\n",
       " 'The aim of this study was to evaluate the effects of indomethacin-loaded nanocapsules and indomethacin ethyl ester-loaded nanocapsules on glioma cell lines.',\n",
       " 'Another important finding was that the cytotoxic effect induced by 25 microM or 50 microM of indomethacin-loaded nanocapsules or indomethacin ethyl ester-loaded nanocapsules, in glioma cells was not observed in the organotypic cultures, indicating selective cytotoxicity of those formulations for tumoral cells.',\n",
       " 'Selective cytotoxicity of indomethacin and indomethacin ethyl ester-loaded nanocapsules against glioma cell lines: an in vitro study.',\n",
       " 'The main finding of the present study is that indomethacin-loaded nanocapsules formulation was more potent than a solution of indomethacin in decreasing the viability and cell proliferation of glioma lines.',\n",
       " 'The main finding of the present study is that indomethacin-loaded nanocapsules formulation was more potent than a solution of indomethacin in decreasing the viability and cell proliferation of glioma lines.',\n",
       " 'In addition, when the glioma cells were exposed to 25 microM of indomethacin-loaded nanocapsules or indomethacin ethyl ester-loaded nanocapsules, a necrotic cell death was observed.',\n",
       " 'Selective cytotoxicity of indomethacin and indomethacin ethyl ester-loaded nanocapsules against glioma cell lines: an in vitro study.',\n",
       " 'In addition, when the glioma cells were exposed to 25 microM of indomethacin-loaded nanocapsules or indomethacin ethyl ester-loaded nanocapsules, a necrotic cell death was observed.',\n",
       " 'Another important finding was that the cytotoxic effect induced by 25 microM or 50 microM of indomethacin-loaded nanocapsules or indomethacin ethyl ester-loaded nanocapsules, in glioma cells was not observed in the organotypic cultures, indicating selective cytotoxicity of those formulations for tumoral cells.',\n",
       " 'Further investigations using in vivo glioma model should be helpful to confirm the distinct effects of indomethacin-loaded nanocapsules and indomethacin ethyl ester-loaded nanocapsules, in normal versus tumoral cells.',\n",
       " 'The aim of this study was to evaluate the effects of indomethacin-loaded nanocapsules and indomethacin ethyl ester-loaded nanocapsules on glioma cell lines.',\n",
       " 'Indomethacin and indomethacin ethyl ester associated together in the same nanocapsule formulation caused a synergic effect decreasing glioma cell proliferation.',\n",
       " 'Indomethacin and indomethacin ethyl ester associated together in the same nanocapsule formulation caused a synergic effect decreasing glioma cell proliferation.',\n",
       " 'Interestingly, 5 microM of indomethacin-loaded nanocapsules was able to cause an antiproliferative effect without promoting necrosis in glioma cells.',\n",
       " 'Further investigations using in vivo glioma model should be helpful to confirm the distinct effects of indomethacin-loaded nanocapsules and indomethacin ethyl ester-loaded nanocapsules, in normal versus tumoral cells.',\n",
       " 'Quantification of circulating varicella-zoster virus DNA for follow-up in a case of visceral varicella-zoster infection ameliorated with intravenous acyclovir.',\n",
       " 'We describe a patient with acute lymphocytic leukemia (ALL) who developed visceral varicella-zoster virus (VZV) infection following cord blood stem cell transplantation (CBSCT) and was successfully treated with intravenous acyclovir (ACV).',\n",
       " 'We describe a patient with acute lymphocytic leukemia (ALL) who developed visceral varicella-zoster virus (VZV) infection following cord blood stem cell transplantation (CBSCT) and was successfully treated with intravenous acyclovir (ACV).',\n",
       " 'Available studies in the literature using clozapine in the pediatric population are summarized and the NIMH experience in treating refractory childhood-onset schizophrenia cases with clozapine is discussed.',\n",
       " 'Although the role of clozapine is well established for treatment-resistant schizophrenia, it is rarely used in pediatric populations, mainly due to its potentially serious adverse effects.',\n",
       " 'To summarize practical aspects of use of clozapine in treating children with schizophrenia and management of associated adverse effects.',\n",
       " 'Despite a higher incidence of adverse effects in children, clozapine appears to be a uniquely beneficial second-line agent for treating children with refractory schizophrenia.',\n",
       " 'Keratoacanthoma occurring within the red dye of a tattoo.',\n",
       " 'Past use of antimetabolites, T-cell inhibitors, alkylating agents, and other immunosuppressives is ascertained from medical records of approximately 9,250 ocular inflammation patients at five tertiary centers over up to 30 years.',\n",
       " 'Information from the SITE Cohort Study should clarify whether use of these immunosuppressive drugs for ocular inflammation increases the risk of mortality and fatal cancer.',\n",
       " 'Calculated detectable differences for mortality/fatal malignancy with respect to the general population are 22%/49% for antimetabolites, 28%/62% for T-cell inhibitors, and 36%/81% for alkylating agents.',\n",
       " 'Past use of antimetabolites, T-cell inhibitors, alkylating agents, and other immunosuppressives is ascertained from medical records of approximately 9,250 ocular inflammation patients at five tertiary centers over up to 30 years.',\n",
       " 'Past use of antimetabolites, T-cell inhibitors, alkylating agents, and other immunosuppressives is ascertained from medical records of approximately 9,250 ocular inflammation patients at five tertiary centers over up to 30 years.',\n",
       " 'Calculated detectable differences for mortality/fatal malignancy with respect to the general population are 22%/49% for antimetabolites, 28%/62% for T-cell inhibitors, and 36%/81% for alkylating agents.',\n",
       " 'Information from the SITE Cohort Study should clarify whether use of these immunosuppressive drugs for ocular inflammation increases the risk of mortality and fatal cancer.',\n",
       " 'Past use of antimetabolites, T-cell inhibitors, alkylating agents, and other immunosuppressives is ascertained from medical records of approximately 9,250 ocular inflammation patients at five tertiary centers over up to 30 years.',\n",
       " 'Calculated detectable differences for mortality/fatal malignancy with respect to the general population are 22%/49% for antimetabolites, 28%/62% for T-cell inhibitors, and 36%/81% for alkylating agents.',\n",
       " 'There were consistent significant miosis in the right eyes with instilled Garcinia kola nut extract compared to the left eyes at 15, 30 and 45 minutes (p=0.0000).',\n",
       " 'There is evidence in the literature that inhaled corticosteroids (ICSs) are safe for pregnant women with asthma and their infants.',\n",
       " 'There is evidence in the literature that inhaled corticosteroids (ICSs) are safe for pregnant women with asthma and their infants.',\n",
       " 'An inverse trend was observed between dose and multiplicity of colonic dysplasias in all drug-treated groups (P = 0.03), with animals receiving 75 mg/kg 5-ASA exhibiting 56% of the number of dysplasias of the AOM/DSS controls (mean +/- SEM: 7.6 +/- 1.4 and 13.6 +/- 2.7, respectively).',\n",
       " 'An inverse trend was observed between dose and multiplicity of colonic dysplasias in all drug-treated groups (P = 0.03), with animals receiving 75 mg/kg 5-ASA exhibiting 56% of the number of dysplasias of the AOM/DSS controls (mean +/- SEM: 7.6 +/- 1.4 and 13.6 +/- 2.7, respectively).',\n",
       " '5-aminosalicylic acid inhibits colitis-associated colorectal dysplasias in the mouse model of azoxymethane/dextran sulfate sodium-induced colitis.',\n",
       " '5-aminosalicylic acid inhibits colitis-associated colorectal dysplasias in the mouse model of azoxymethane/dextran sulfate sodium-induced colitis.',\n",
       " 'The chemopreventive activity of 5-ASA was evaluated in the Swiss Webster model of azoxymethane (AOM)/dextran sulfate sodium (DSS)-induced colitis-associated neoplasia.',\n",
       " 'These data suggest that low-dose 5-ASA may be efficacious in preventing colitis-associated dysplasias and provide strong support for optimizing this therapy for the prevention of colonic neoplasms in patients with ulcerative colitis.',\n",
       " 'These data suggest that low-dose 5-ASA may be efficacious in preventing colitis-associated dysplasias and provide strong support for optimizing this therapy for the prevention of colonic neoplasms in patients with ulcerative colitis.',\n",
       " 'These data suggest that low-dose 5-ASA may be efficacious in preventing colitis-associated dysplasias and provide strong support for optimizing this therapy for the prevention of colonic neoplasms in patients with ulcerative colitis.',\n",
       " 'The impact of the antiinflammatory agent 5-aminosalicylic acid (5-ASA) on the risk for colitis-associated colorectal cancer remains controversial.',\n",
       " 'The chemopreventive activity of 5-ASA was evaluated in the Swiss Webster model of azoxymethane (AOM)/dextran sulfate sodium (DSS)-induced colitis-associated neoplasia.',\n",
       " 'Administration of 75 mg/kg 5-ASA decreased both the mean multiplicity of flat dysplasias (1.8 +/- 0.4 for drug-treated versus 5.6 +/- 1.2 for AOM/DSS control) and the burden of polypoid dysplasias (tumor burden: 6.7 +/- 2.7 for drug-treated versus 14.9 +/- 3.9 units for AOM/DSS controls) significantly (P = 0.002 and 0.04, respectively).',\n",
       " 'Administration of 75 mg/kg 5-ASA decreased both the mean multiplicity of flat dysplasias (1.8 +/- 0.4 for drug-treated versus 5.6 +/- 1.2 for AOM/DSS control) and the burden of polypoid dysplasias (tumor burden: 6.7 +/- 2.7 for drug-treated versus 14.9 +/- 3.9 units for AOM/DSS controls) significantly (P = 0.002 and 0.04, respectively).',\n",
       " 'An inverse trend was observed between dose and multiplicity of colonic dysplasias in all drug-treated groups (P = 0.03), with animals receiving 75 mg/kg 5-ASA exhibiting 56% of the number of dysplasias of the AOM/DSS controls (mean +/- SEM: 7.6 +/- 1.4 and 13.6 +/- 2.7, respectively).',\n",
       " 'Administration of 75 mg/kg 5-ASA decreased both the mean multiplicity of flat dysplasias (1.8 +/- 0.4 for drug-treated versus 5.6 +/- 1.2 for AOM/DSS control) and the burden of polypoid dysplasias (tumor burden: 6.7 +/- 2.7 for drug-treated versus 14.9 +/- 3.9 units for AOM/DSS controls) significantly (P = 0.002 and 0.04, respectively).',\n",
       " 'The chemopreventive activity of 5-ASA was evaluated in the Swiss Webster model of azoxymethane (AOM)/dextran sulfate sodium (DSS)-induced colitis-associated neoplasia.',\n",
       " 'An inverse trend was observed between dose and multiplicity of colonic dysplasias in all drug-treated groups (P = 0.03), with animals receiving 75 mg/kg 5-ASA exhibiting 56% of the number of dysplasias of the AOM/DSS controls (mean +/- SEM: 7.6 +/- 1.4 and 13.6 +/- 2.7, respectively).',\n",
       " 'Spinal cord infarction secondary to cocaine use.',\n",
       " 'Cocaine abuse is associated with cerebrovascular events; spinal cord effects are rarely reported.',\n",
       " 'Although uncommon, cocaine abuse can cause spinal cord infarction.',\n",
       " 'We report two rheumatoid arthritis patients developing sarcoidosis possibly induced by etanercept.',\n",
       " 'Recently, there have been reports of noninfectious granulomatous syndromes in patients receiving etanercept for a variety of diseases.',\n",
       " 'Development of sarcoidosis in etanercept-treated rheumatoid arthritis patients.',\n",
       " 'Development of sarcoidosis in etanercept-treated rheumatoid arthritis patients.',\n",
       " 'The other developed erythema nodosum and a plaque lesion on the right arm after 1 year of etanercept.',\n",
       " 'Furthermore, there may be a relationship between statin dose and cancer.',\n",
       " 'BiRD (Biaxin [clarithromycin]/Revlimid [lenalidomide]/dexamethasone) combination therapy results in high complete- and overall-response rates in treatment-naive symptomatic multiple myeloma.',\n",
       " 'This trial determined the safety and efficacy of the combination regimen clarithromycin (Biaxin), lenalidomide (Revlimid), and dexamethasone (BiRD) as first-line therapy for multiple myeloma.',\n",
       " 'BiRD is an effective regimen with manageable side effects in the treatment of symptomatic, newly diagnosed multiple myeloma.',\n",
       " 'Recent prospective studies from Europe suggest the use of intracameral antibiotics for prophylaxis of endophthalmitis, although the studies did not make a comparison with the most common United States prophylaxis techniques.',\n",
       " 'A multipronged approach to limit endophthalmitis risk is also needed, with antibiotics as only part of the strategy.',\n",
       " 'In this study, a 2-year-old girl with nephropathic cystinosis and severe gastrointestinal dysmotility was treated with intravenous (i.v.) administration of cysteamine hydrochloride (HCl).',\n",
       " 'The most common adverse effects associated with the use of posaconazole include headache, fever, nausea, vomiting, and diarrhea.',\n",
       " 'Posaconazole is noninferior to fluconazole for treatment of oropharyngeal candidiasis (95% CI -6.6 to 5.0), but necessity for this indication remains unclear, as many other treatment options exist.',\n",
       " 'Similarly, the same regimen of posaconazole reduced invasive fungal infections (95% CI -9.7 to -2.5) and aspergillosis (CI not reported, p < 0.001) when compared with fluconazole and itraconazole in neutropenic patients.',\n",
       " 'Similarly, the same regimen of posaconazole reduced invasive fungal infections (95% CI -9.7 to -2.5) and aspergillosis (CI not reported, p < 0.001) when compared with fluconazole and itraconazole in neutropenic patients.',\n",
       " 'The most common adverse effects associated with the use of posaconazole include headache, fever, nausea, vomiting, and diarrhea.',\n",
       " 'The most common adverse effects associated with the use of posaconazole include headache, fever, nausea, vomiting, and diarrhea.',\n",
       " 'Similarly, the same regimen of posaconazole reduced invasive fungal infections (95% CI -9.7 to -2.5) and aspergillosis (CI not reported, p < 0.001) when compared with fluconazole and itraconazole in neutropenic patients.',\n",
       " 'Similarly, the same regimen of posaconazole reduced invasive fungal infections (95% CI -9.7 to -2.5) and aspergillosis (CI not reported, p < 0.001) when compared with fluconazole and itraconazole in neutropenic patients.',\n",
       " 'The most common adverse effects associated with the use of posaconazole include headache, fever, nausea, vomiting, and diarrhea.',\n",
       " 'At this time, posaconazole should probably be reserved for prophylaxis in patients at high risk for invasive fungal infection, as salvage therapy in refractory or resistant infections, or for patients with intolerance to other therapies.',\n",
       " 'At this time, posaconazole should probably be reserved for prophylaxis in patients at high risk for invasive fungal infection, as salvage therapy in refractory or resistant infections, or for patients with intolerance to other therapies.',\n",
       " 'Similarly, the same regimen of posaconazole reduced invasive fungal infections (95% CI -9.7 to -2.5) and aspergillosis (CI not reported, p < 0.001) when compared with fluconazole and itraconazole in neutropenic patients.',\n",
       " 'Similarly, the same regimen of posaconazole reduced invasive fungal infections (95% CI -9.7 to -2.5) and aspergillosis (CI not reported, p < 0.001) when compared with fluconazole and itraconazole in neutropenic patients.',\n",
       " 'Posaconazole, in doses of 200 mg 3 times daily, reduced breakthrough invasive fungal infections (OR 0.30; 95% CI 0.12 to 0.71) and aspergillosis incidence (OR 0.31; 95% CI 0.13 to 0.75) in patients receiving hematopoietic stem-cell transplants compared with those receiving fluconazole.',\n",
       " 'Posaconazole, in doses of 200 mg 3 times daily, reduced breakthrough invasive fungal infections (OR 0.30; 95% CI 0.12 to 0.71) and aspergillosis incidence (OR 0.31; 95% CI 0.13 to 0.75) in patients receiving hematopoietic stem-cell transplants compared with those receiving fluconazole.',\n",
       " 'Posaconazole is noninferior to fluconazole for treatment of oropharyngeal candidiasis (95% CI -6.6 to 5.0), but necessity for this indication remains unclear, as many other treatment options exist.',\n",
       " 'Posaconazole, in doses of 200 mg 3 times daily, reduced breakthrough invasive fungal infections (OR 0.30; 95% CI 0.12 to 0.71) and aspergillosis incidence (OR 0.31; 95% CI 0.13 to 0.75) in patients receiving hematopoietic stem-cell transplants compared with those receiving fluconazole.',\n",
       " 'Posaconazole, in doses of 200 mg 3 times daily, reduced breakthrough invasive fungal infections (OR 0.30; 95% CI 0.12 to 0.71) and aspergillosis incidence (OR 0.31; 95% CI 0.13 to 0.75) in patients receiving hematopoietic stem-cell transplants compared with those receiving fluconazole.',\n",
       " 'While some beneficial neuromotor effects of succimer therapy were observed in the present study there remains several unanswered questions such as how long these effects will persist and how succimer therapy modifies lead-associated cerebellar deficits manifesting as perturbations in vestibular and/or proprioception systems for postural balance and functional locomotion.',\n",
       " 'Long-term immunomodulatory drug (IMD) treatment is now common in multiple sclerosis (MS).',\n",
       " 'It is well known that tobacco smoke exposure is related to the risk of developing cardiovascular diseases and events.',\n",
       " 'Tibolone is a selective tissue estrogenic activity regulator, approved for the treatment of vasomotor symptoms in postmenopausal women.',\n",
       " 'In ER+ breast tumors, 2.5 mg/d tibolone given for 14 days has no significant effect on tumor cell proliferation.',\n",
       " 'In ER+ breast tumors, 2.5 mg/d tibolone given for 14 days has no significant effect on tumor cell proliferation.',\n",
       " 'Exposure to Benzodiazepines (BZD) during foetal life has been suggested to contribute to neonatal morbidity and some congenital malformations, for example, orofacial clefts.',\n",
       " 'Exposure to Benzodiazepines (BZD) during foetal life has been suggested to contribute to neonatal morbidity and some congenital malformations, for example, orofacial clefts.',\n",
       " 'Exposure to Benzodiazepines (BZD) during foetal life has been suggested to contribute to neonatal morbidity and some congenital malformations, for example, orofacial clefts.',\n",
       " 'Maternal use of BZD and/or HBRA may increase the risk for preterm birth and low birth weight and cause neonatal symptoms, but does not appear to have a strong teratogenic potential.',\n",
       " 'Exposure to Benzodiazepines (BZD) during foetal life has been suggested to contribute to neonatal morbidity and some congenital malformations, for example, orofacial clefts.',\n",
       " 'We found no evidence of impaired control of the carbohydrate and lipid metabolism or aggravation of vascular lesions during the two years an etonogestrel implant was used by diabetic women.',\n",
       " 'Oritavancin: a new promising agent in the treatment of infections due to Gram-positive pathogens.',\n",
       " 'Our findings support that ecstasy use, or ecstasy/cannabis synergic effects, are responsible for the sub-clinical deficits observed in ecstasy polydrug users, and provides additional evidence for long-term cognitive impairment owing to ecstasy consumption in the context of polydrug use.',\n",
       " 'After two years ecstasy users showed persistent deficits on verbal fluency, working memory and processing speed.',\n",
       " 'When ecstasy users were classified according to lifetime use of ecstasy, the more severe users (more than 100 tablets) showed additional deficits on episodic memory.',\n",
       " 'No significant differences were observed between FeSO4+citrate and NaFe-EDTA fortification, regarding mitigation of iron-deficiency anemia (IDA) or regarding CRP, growth, infections, or side-effects.',\n",
       " 'No significant differences were observed between FeSO4+citrate and NaFe-EDTA fortification, regarding mitigation of iron-deficiency anemia (IDA) or regarding CRP, growth, infections, or side-effects.',\n",
       " 'No significant differences were observed between FeSO4+citrate and NaFe-EDTA fortification, regarding mitigation of iron-deficiency anemia (IDA) or regarding CRP, growth, infections, or side-effects.',\n",
       " 'No significant differences were observed between FeSO4+citrate and NaFe-EDTA fortification, regarding mitigation of iron-deficiency anemia (IDA) or regarding CRP, growth, infections, or side-effects.',\n",
       " 'Sustained virologic response (SVR) rates of 50%-60% have been achieved in patients with chronic hepatitis C genotype 4 treated with peginterferon plus ribavirin.',\n",
       " 'Adverse events were similar across treatment groups except for higher rates of anemia in the groups receiving ribavirin.',\n",
       " 'Sustained virologic response (SVR) rates of 50%-60% have been achieved in patients with chronic hepatitis C genotype 4 treated with peginterferon plus ribavirin.',\n",
       " 'Exposure to radioisotopes of metals and halogen elements occurring in medical practice may cause spontaneous abortions.',\n",
       " 'For exposure levels within standard recommended guidelines, radioisotopes are far more likely to play a role in the occurrence of spontaneous abortions than X-rays.',\n",
       " 'Women exposed to radioisotopes experienced at least a threefold higher rate of spontaneous abortions than those exposed to X-ray (OR = 3.68, 95% CI = 1.39-9.74, P < 0.01).',\n",
       " 'An open multicenter phase II trial of weekly docetaxel for advanced-stage non-small-cell lung cancer in elderly patients with significant comorbidity and/or poor performance status: The GFPC 02-02b study.',\n",
       " 'Contrarily, LABA showed a significant increase in asthma-related deaths (Relative Risk=3.83; 95% CI, 1.21-12.14).',\n",
       " 'Primary outcomes were asthma exacerbations (AE) requiring systemic corticosteroids or hospitalization, life-threatening exacerbations and asthma-related deaths.',\n",
       " 'Forty-one patients [30 males and 11 females, median age 47 years] consecutively diagnosed with PTCL received three courses of high-dose cyclophosphamide 2000 mg/m(2)/day, adriamycin 90 mg/m(2)/day, vincristine and prednisone alternating with three courses of etoposide, cisplatin, cytarabine and prednisone.',\n",
       " 'Forty-one patients [30 males and 11 females, median age 47 years] consecutively diagnosed with PTCL received three courses of high-dose cyclophosphamide 2000 mg/m(2)/day, adriamycin 90 mg/m(2)/day, vincristine and prednisone alternating with three courses of etoposide, cisplatin, cytarabine and prednisone.',\n",
       " 'Forty-one patients [30 males and 11 females, median age 47 years] consecutively diagnosed with PTCL received three courses of high-dose cyclophosphamide 2000 mg/m(2)/day, adriamycin 90 mg/m(2)/day, vincristine and prednisone alternating with three courses of etoposide, cisplatin, cytarabine and prednisone.',\n",
       " 'Forty-one patients [30 males and 11 females, median age 47 years] consecutively diagnosed with PTCL received three courses of high-dose cyclophosphamide 2000 mg/m(2)/day, adriamycin 90 mg/m(2)/day, vincristine and prednisone alternating with three courses of etoposide, cisplatin, cytarabine and prednisone.',\n",
       " 'Forty-one patients [30 males and 11 females, median age 47 years] consecutively diagnosed with PTCL received three courses of high-dose cyclophosphamide 2000 mg/m(2)/day, adriamycin 90 mg/m(2)/day, vincristine and prednisone alternating with three courses of etoposide, cisplatin, cytarabine and prednisone.',\n",
       " 'Forty-one patients [30 males and 11 females, median age 47 years] consecutively diagnosed with PTCL received three courses of high-dose cyclophosphamide 2000 mg/m(2)/day, adriamycin 90 mg/m(2)/day, vincristine and prednisone alternating with three courses of etoposide, cisplatin, cytarabine and prednisone.',\n",
       " 'Forty-one patients [30 males and 11 females, median age 47 years] consecutively diagnosed with PTCL received three courses of high-dose cyclophosphamide 2000 mg/m(2)/day, adriamycin 90 mg/m(2)/day, vincristine and prednisone alternating with three courses of etoposide, cisplatin, cytarabine and prednisone.',\n",
       " 'Plasma ziprasidone levels ranged from 20 ng/mL to 160 ng/mL (mean: 75.8 ng/mL) and were significantly related to the improvement in negative symptoms.',\n",
       " 'The study showed that ziprasidone was effective and tolerable, that use of ziprasidone was characterized by an absence of extrapyramidal symptoms and weight gain, and that no alterations in clinical laboratory tests occurred.',\n",
       " 'Characteristic features of an inflammation induced by bevacizumab injection include an early onset with painless loss in VA mostly without conjunctival or ciliary injection.',\n",
       " 'Administration of full-dose R-CHOP (rituximab/cyclophosphamide/doxorubicin/vincristine/prednisone) chemotherapy is important to maximize response in patients with intermediate-or high-grade non-Hodgkin lymphoma but might be difficult in older patients.',\n",
       " 'Administration of full-dose R-CHOP (rituximab/cyclophosphamide/doxorubicin/vincristine/prednisone) chemotherapy is important to maximize response in patients with intermediate-or high-grade non-Hodgkin lymphoma but might be difficult in older patients.',\n",
       " 'Administration of full-dose R-CHOP (rituximab/cyclophosphamide/doxorubicin/vincristine/prednisone) chemotherapy is important to maximize response in patients with intermediate-or high-grade non-Hodgkin lymphoma but might be difficult in older patients.',\n",
       " 'Administration of full-dose R-CHOP (rituximab/cyclophosphamide/doxorubicin/vincristine/prednisone) chemotherapy is important to maximize response in patients with intermediate-or high-grade non-Hodgkin lymphoma but might be difficult in older patients.',\n",
       " 'Administration of full-dose R-CHOP (rituximab/cyclophosphamide/doxorubicin/vincristine/prednisone) chemotherapy is important to maximize response in patients with intermediate-or high-grade non-Hodgkin lymphoma but might be difficult in older patients.',\n",
       " \"Compared with the general population, methotrexate-treated RA patients have an increased incidence of melanoma, non-Hodgkin's lymphoma, and lung cancer.\",\n",
       " \"Compared with the general population, methotrexate-treated RA patients have an increased incidence of melanoma, non-Hodgkin's lymphoma, and lung cancer.\",\n",
       " \"Compared with the general population, methotrexate-treated RA patients have an increased incidence of melanoma, non-Hodgkin's lymphoma, and lung cancer.\",\n",
       " \"There was an estimated 50% excess risk of malignancy among methotrexate-exposed RA patients relative to the general population (SIR 1.5, 95% confidence interval [95% CI] 1.2-1.9), with a 3-fold increase in melanoma (SIR 3.0, 95% CI 1.2-6.2), a 5-fold increase in non-Hodgkin's lymphoma (SIR 5.1, 95% CI 2.2-10.0), and an almost 3-fold increase in lung cancer (SIR 2.9, 95% CI 1.6-4.8).\",\n",
       " \"There was an estimated 50% excess risk of malignancy among methotrexate-exposed RA patients relative to the general population (SIR 1.5, 95% confidence interval [95% CI] 1.2-1.9), with a 3-fold increase in melanoma (SIR 3.0, 95% CI 1.2-6.2), a 5-fold increase in non-Hodgkin's lymphoma (SIR 5.1, 95% CI 2.2-10.0), and an almost 3-fold increase in lung cancer (SIR 2.9, 95% CI 1.6-4.8).\",\n",
       " \"There was an estimated 50% excess risk of malignancy among methotrexate-exposed RA patients relative to the general population (SIR 1.5, 95% confidence interval [95% CI] 1.2-1.9), with a 3-fold increase in melanoma (SIR 3.0, 95% CI 1.2-6.2), a 5-fold increase in non-Hodgkin's lymphoma (SIR 5.1, 95% CI 2.2-10.0), and an almost 3-fold increase in lung cancer (SIR 2.9, 95% CI 1.6-4.8).\",\n",
       " \"There was an estimated 50% excess risk of malignancy among methotrexate-exposed RA patients relative to the general population (SIR 1.5, 95% confidence interval [95% CI] 1.2-1.9), with a 3-fold increase in melanoma (SIR 3.0, 95% CI 1.2-6.2), a 5-fold increase in non-Hodgkin's lymphoma (SIR 5.1, 95% CI 2.2-10.0), and an almost 3-fold increase in lung cancer (SIR 2.9, 95% CI 1.6-4.8).\",\n",
       " 'Incidence of melanoma and other malignancies among rheumatoid arthritis patients treated with methotrexate.',\n",
       " 'To determine cancer risk in a cohort of 459 rheumatoid arthritis (RA) patients treated with methotrexate in community practice.',\n",
       " 'To determine cancer risk in a cohort of 459 rheumatoid arthritis (RA) patients treated with methotrexate in community practice.',\n",
       " 'Incidence of melanoma and other malignancies among rheumatoid arthritis patients treated with methotrexate.',\n",
       " 'Incidence of melanoma and other malignancies among rheumatoid arthritis patients treated with methotrexate.',\n",
       " 'Recombinant hirudin is used as an alternative anticoagulant, particularly in patients with heparin-induced thrombocytopenia type II.',\n",
       " 'Absence of villin predisposes mice to dextran sodium sulfate-induced colitis by promoting apoptosis.',\n",
       " 'Dental surgery for these children has historically consisted of decreasing and/or discontinuing the oral anticoagulant and instituting heparin therapy prior to the planned dental procedure, which can result in thromboembolism and increased morbidity and mortality.',\n",
       " 'Children with prosthetic cardiac valves and other invasive mechanical devices that direct blood flow require anticoagulant medication for prevention of thrombosis.',\n",
       " 'Dental surgery for these children has historically consisted of decreasing and/or discontinuing the oral anticoagulant and instituting heparin therapy prior to the planned dental procedure, which can result in thromboembolism and increased morbidity and mortality.',\n",
       " \"Finally, in non-small cell lung cancer (NSCLC) in patients' progressing on chemotherapy sutent was able to achieve a 10% response rate, a level of activity similar to those documented by other agents approved for lung cancer.\",\n",
       " 'In several phase I/II/III studies, sutent was found to be effective as second and first line treatment in metastatic renal cell carcinoma (RCC).',\n",
       " \"Finally, in non-small cell lung cancer (NSCLC) in patients' progressing on chemotherapy sutent was able to achieve a 10% response rate, a level of activity similar to those documented by other agents approved for lung cancer.\",\n",
       " 'Sutent was also effective as second line treatment in patients with gastrointestinal stromal tumors (GIST) with 8% response rate, 70% stable disease and a 20-month median survival.',\n",
       " 'In addition, a phase II study in multitreated women with breast cancer, sutent demonstrated a moderate activity with 16% clinical benefit.',\n",
       " 'Epoetin beta effectively increases hemoglobin levels, reduces the need for transfusions and improves the quality of life in patients with symptomatic chemotherapy-induced anemia with a range of solid tumors and lymphoid malignancies.',\n",
       " 'This once-weekly regimen is generally well tolerated, and studies to date have reported that epoetin beta has a neutral effect on survival of patients with cancer.',\n",
       " 'Epoetin beta once weekly: review of its efficacy and safety in patients with chemotherapy-induced anemia.',\n",
       " 'During the induction phase, tacrolimus or cyclosporine, mycophenolate mofetil, and methylprednisolone were used for immunosuppression.',\n",
       " 'During the induction phase, tacrolimus or cyclosporine, mycophenolate mofetil, and methylprednisolone were used for immunosuppression.',\n",
       " 'During the induction phase, tacrolimus or cyclosporine, mycophenolate mofetil, and methylprednisolone were used for immunosuppression.',\n",
       " 'During the induction phase, tacrolimus or cyclosporine, mycophenolate mofetil, and methylprednisolone were used for immunosuppression.',\n",
       " 'The most frequent and the most troublesome adverse effect of interferon plus ribavirin-based therapy is anaemia.',\n",
       " 'In multivariate analysis the risk of anaemia was significantly associated with zidovudine (OR, 3.27 95% CI, 1.64-6.54, P = 0.0008) and peg-IFN (OR, 2.35; 95% CI, 1.16-4.57, P = 0.0179).',\n",
       " 'Zidovudine discontinuation could help to avoid anaemia associated with anti-HCV therapy.',\n",
       " 'The risk of anaemia was lower in patients with higher baseline haemoglobin levels (OR, 0.35 95% CI, 0.26-0.49, P < 0.0001) and in patients receiving protease inhibitor-based antiretroviral therapy (OR, 0.51 95% CI, 0.30-0.86, P = 0.0114).',\n",
       " 'The most frequent and the most troublesome adverse effect of interferon plus ribavirin-based therapy is anaemia.',\n",
       " 'This study demonstrated that both low-dose topiramate and propranolol could significantly reduce migraine headache frequency, intensity, and duration.',\n",
       " 'This study demonstrated that both low-dose topiramate and propranolol could significantly reduce migraine headache frequency, intensity, and duration.',\n",
       " 'Results - The topiramate group showed a reduction in the mean (+/-SD) of monthly migraine frequency from 6.07 (+/-1.89) to 1.83 (+/-1.39) episodes per month, headache intensity from 7.1 (+/-1.45) to 3.67 (+/-2.1) based on the Visual Analog Scale, and headache duration from 16.37 (+/-7.26) to 6.23 (+/-5.22) hours (P < 0.001).',\n",
       " 'Results - The topiramate group showed a reduction in the mean (+/-SD) of monthly migraine frequency from 6.07 (+/-1.89) to 1.83 (+/-1.39) episodes per month, headache intensity from 7.1 (+/-1.45) to 3.67 (+/-2.1) based on the Visual Analog Scale, and headache duration from 16.37 (+/-7.26) to 6.23 (+/-5.22) hours (P < 0.001).',\n",
       " 'Long-term exposure to medium-dose glucocorticoid therapy associates with hypertension in patients with rheumatoid arthritis.',\n",
       " 'Long-term exposure to medium-dose glucocorticoid therapy associates with hypertension in patients with rheumatoid arthritis.',\n",
       " 'Compared with both diuretics and contemporary agents, amlodipine decreases cardiovascular events to a similar or greater extent without evidence for increased coronary heart disease, gastrointestinal bleeding or cancer.',\n",
       " 'Dihydropyridine calcium channel antagonists may exert effects that protect against stroke that are independent of their blood pressure-lowering mechanism.',\n",
       " 'Collectively, the cardiovascular benefit, metabolic neutrality and homogeneous blood pressure response illuminated in recent studies, and reviewed here, represent a reaffirmation of the benefit of long-acting dihydropyridine calcium channel antagonists and should serve to help reinforce the critical importance of these agents in the therapeutic armamentarium against cardiovascular disease.',\n",
       " 'Compared with both diuretics and contemporary agents, amlodipine decreases cardiovascular events to a similar or greater extent without evidence for increased coronary heart disease, gastrointestinal bleeding or cancer.',\n",
       " 'Compared with both diuretics and contemporary agents, amlodipine decreases cardiovascular events to a similar or greater extent without evidence for increased coronary heart disease, gastrointestinal bleeding or cancer.',\n",
       " 'Compared with both diuretics and contemporary agents, amlodipine decreases cardiovascular events to a similar or greater extent without evidence for increased coronary heart disease, gastrointestinal bleeding or cancer.',\n",
       " 'Dihydropyridine calcium channel antagonists have several noteworthy attributes that merit consideration in the management of hypertension.',\n",
       " 'All three patients had recurrent admissions for stomal bleeding and stomal varices secondary to portal hypertension and were initially treated with local measures (pressure, silver nitrate, and suture ligation).',\n",
       " 'All three patients had recurrent admissions for stomal bleeding and stomal varices secondary to portal hypertension and were initially treated with local measures (pressure, silver nitrate, and suture ligation).',\n",
       " 'At all doses studied, febuxostat more effectively lowered and maintained serum urate levels <6.0 mg/dl than did allopurinol (300 or 100 mg) or placebo in subjects with hyperuricemia and gout, including those with mild to moderately impaired renal function.',\n",
       " 'At all doses studied, febuxostat more effectively lowered and maintained serum urate levels <6.0 mg/dl than did allopurinol (300 or 100 mg) or placebo in subjects with hyperuricemia and gout, including those with mild to moderately impaired renal function.',\n",
       " 'A significantly (P < 0.05) higher percentage of subjects with impaired renal function treated with febuxostat 80 mg (4 [44%] of 9), 120 mg (5 [45%] of 11), and 240 mg (3 [60%] of 5) achieved the primary end point compared with those treated with 100 mg of allopurinol (0 [0%] of 10).',\n",
       " 'The primary reasons for withdrawal were similar across groups except for gout flares, which were more frequent with febuxostat than with allopurinol.',\n",
       " 'At all doses studied, febuxostat more effectively lowered and maintained serum urate levels <6.0 mg/dl than did allopurinol (300 or 100 mg) or placebo in subjects with hyperuricemia and gout, including those with mild to moderately impaired renal function.',\n",
       " 'At all doses studied, febuxostat more effectively lowered and maintained serum urate levels <6.0 mg/dl than did allopurinol (300 or 100 mg) or placebo in subjects with hyperuricemia and gout, including those with mild to moderately impaired renal function.',\n",
       " 'At all doses studied, febuxostat more effectively lowered and maintained serum urate levels <6.0 mg/dl than did allopurinol (300 or 100 mg) or placebo in subjects with hyperuricemia and gout, including those with mild to moderately impaired renal function.',\n",
       " 'A significantly (P < 0.05) higher percentage of subjects with impaired renal function treated with febuxostat 80 mg (4 [44%] of 9), 120 mg (5 [45%] of 11), and 240 mg (3 [60%] of 5) achieved the primary end point compared with those treated with 100 mg of allopurinol (0 [0%] of 10).',\n",
       " 'The primary reasons for withdrawal were similar across groups except for gout flares, which were more frequent with febuxostat than with allopurinol.',\n",
       " 'Proportions of subjects experiencing any adverse event or serious adverse event were similar across groups, although diarrhea and dizziness were more frequent in the febuxostat 240 mg group.',\n",
       " 'Proportions of subjects experiencing any adverse event or serious adverse event were similar across groups, although diarrhea and dizziness were more frequent in the febuxostat 240 mg group.',\n",
       " 'The established teratogenicity of antiepileptic drugs raises important issues in women of child-bearing age.',\n",
       " 'While the association between neural tube defects and antiepileptic drugs is well recognised, other congenital malformations are known to occur.',\n",
       " 'While the association between neural tube defects and antiepileptic drugs is well recognised, other congenital malformations are known to occur.',\n",
       " 'Data of our study revealed an unexpected high rate of hypogonadism irrespective of cyclophosphamide use, and subclinical involvement of the testes by the vasculitis itself might be an alternative explanation.',\n",
       " 'Data of our study revealed an unexpected high rate of hypogonadism irrespective of cyclophosphamide use, and subclinical involvement of the testes by the vasculitis itself might be an alternative explanation.',\n",
       " 'The patient was on corticosteroids and azathioprine for autoimmune hepatitis at the time of her presentation.',\n",
       " 'Pulmonary alveolar proteinosis: a rare pulmonary toxicity of sirolimus.',\n",
       " 'PAP is a very rare complication of SRL therapy with only a few cases described.',\n",
       " 'Two years after initiating SRL, she presented complaints of progressive dyspnoea, nonproductive cough, chest pain and low-grade fever of 1 month duration.',\n",
       " 'Two years after initiating SRL, she presented complaints of progressive dyspnoea, nonproductive cough, chest pain and low-grade fever of 1 month duration.',\n",
       " 'The only patient with leucoencephalopathy showed improved neurologic status after SRL conversion.',\n",
       " 'All patients converted to SRL because of GI side effects of MMF showed improvements, and none of those converted because of hyperglycemia experienced improvement.',\n",
       " 'We concluded that conversion to SRL in pancreas transplantation should be considered an important alternative strategy, particularly for CNI nephrotoxicity and neurotoxicity, and in cases of severe diarrhea due to MMF.',\n",
       " 'The reasons for conversion were calcineurin inhibitors (CNI) nephrotoxicity (n = 24; 73%), severe neurotoxicity owing to CNI (n = 1; 3%), severe and/or recurrent acute rejection episodes (n = 7; 21%), gastrointestinal (GI) side effects of mycophenolate mofetil (MMF; n = 5; 15%), and hyperglycemia (n = 4; 12%).',\n",
       " 'The reasons for conversion were calcineurin inhibitors (CNI) nephrotoxicity (n = 24; 73%), severe neurotoxicity owing to CNI (n = 1; 3%), severe and/or recurrent acute rejection episodes (n = 7; 21%), gastrointestinal (GI) side effects of mycophenolate mofetil (MMF; n = 5; 15%), and hyperglycemia (n = 4; 12%).',\n",
       " 'Moreover, oxcarbazepine can be a valid choice when long-term therapy is required because of the low interaction with other drugs and the low hematological side effects.',\n",
       " 'Our data showed that oxcarbazepine can be a good alternative to traditional antiepileptic agents in the prevention of perioperative seizures being efficacy, ease of use (rapid titration in 3 days, not requiring close plasma concentration monitoring) and good tolerability (no major side effects during titration and during the first postoperative week) the key factors.',\n",
       " 'Our data showed that oxcarbazepine can be a good alternative to traditional antiepileptic agents in the prevention of perioperative seizures being efficacy, ease of use (rapid titration in 3 days, not requiring close plasma concentration monitoring) and good tolerability (no major side effects during titration and during the first postoperative week) the key factors.',\n",
       " 'Furthermore, the efficacy of the new generation of antiepileptic agents in the prophylaxis of perioperative seizures has not been assessed so far.',\n",
       " 'We tested the hypothesis that oral beclomethasone dipropionate (BDP) would control gastrointestinal graft-versus-host disease (GVHD) in patients with anorexia, vomiting, and diarrhea.',\n",
       " 'We tested the hypothesis that oral beclomethasone dipropionate (BDP) would control gastrointestinal graft-versus-host disease (GVHD) in patients with anorexia, vomiting, and diarrhea.',\n",
       " 'Oral BDP prevents relapses of gastrointestinal GVHD following tapering of prednisone; survival is statistically significantly better among patients receiving BDP.',\n",
       " 'Oral BDP prevents relapses of gastrointestinal GVHD following tapering of prednisone; survival is statistically significantly better among patients receiving BDP.',\n",
       " 'Grade 3 or 4 leukopenia and edema and various grade 1 or 2 adverse events were more frequent in patients receiving eight TAC cycles than in those receiving six cycles.',\n",
       " 'Grade 3 or 4 leukopenia and edema and various grade 1 or 2 adverse events were more frequent in patients receiving eight TAC cycles than in those receiving six cycles.']"
      ]
     },
     "execution_count": 113,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "sentences"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 114,
   "metadata": {},
   "outputs": [],
   "source": [
    "#########################  tokenisation ###############################################\n",
    "documents = []\n",
    "for row in sentences:\n",
    "    try:\n",
    "        documents.append(row.lower().split())\n",
    "    except AttributeError:\n",
    "        pass\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 116,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[['gefitinib',\n",
       "  'inhibition',\n",
       "  'of',\n",
       "  'drug',\n",
       "  'resistance',\n",
       "  'to',\n",
       "  'doxorubicin',\n",
       "  'by',\n",
       "  'inactivating',\n",
       "  'abcg2',\n",
       "  'in',\n",
       "  'thyroid',\n",
       "  'cancer',\n",
       "  'cell',\n",
       "  'lines.'],\n",
       " ['inactivation',\n",
       "  'of',\n",
       "  'egfr',\n",
       "  'kinase',\n",
       "  'by',\n",
       "  'gefitinib',\n",
       "  'was',\n",
       "  'analyzed',\n",
       "  'by',\n",
       "  'western',\n",
       "  'blot',\n",
       "  'analysis',\n",
       "  'and',\n",
       "  'immunofluorescence.'],\n",
       " ['gefitinib',\n",
       "  'inhibition',\n",
       "  'of',\n",
       "  'drug',\n",
       "  'resistance',\n",
       "  'to',\n",
       "  'doxorubicin',\n",
       "  'by',\n",
       "  'inactivating',\n",
       "  'abcg2',\n",
       "  'in',\n",
       "  'thyroid',\n",
       "  'cancer',\n",
       "  'cell',\n",
       "  'lines.'],\n",
       " ['extrusion',\n",
       "  'assays',\n",
       "  'using',\n",
       "  'flow',\n",
       "  'cytometry',\n",
       "  'analysis',\n",
       "  'were',\n",
       "  'used',\n",
       "  'to',\n",
       "  'determine',\n",
       "  'the',\n",
       "  'ability',\n",
       "  'of',\n",
       "  'thyroid',\n",
       "  'cancer',\n",
       "  'cells',\n",
       "  'to',\n",
       "  'extrude',\n",
       "  'the',\n",
       "  'chemotherapy',\n",
       "  'drug,',\n",
       "  'doxorubicin,',\n",
       "  'via',\n",
       "  'the',\n",
       "  'abcg2',\n",
       "  'drug',\n",
       "  'transporter',\n",
       "  'in',\n",
       "  'the',\n",
       "  'presence',\n",
       "  'or',\n",
       "  'absence',\n",
       "  'of',\n",
       "  'gefitinib.'],\n",
       " ['inactivation',\n",
       "  'of',\n",
       "  'the',\n",
       "  'egfr',\n",
       "  'kinase',\n",
       "  'by',\n",
       "  'gefitinib',\n",
       "  'potentiates',\n",
       "  'the',\n",
       "  'cytotoxic',\n",
       "  'effect',\n",
       "  'of',\n",
       "  'doxorubicin',\n",
       "  'in',\n",
       "  'thyroid',\n",
       "  'cancer,',\n",
       "  'most',\n",
       "  'likely',\n",
       "  'by',\n",
       "  'decreasing',\n",
       "  'the',\n",
       "  'ability',\n",
       "  'of',\n",
       "  'the',\n",
       "  'cell',\n",
       "  'to',\n",
       "  'extrude',\n",
       "  'doxorubicin.'],\n",
       " ['inhibition',\n",
       "  'of',\n",
       "  'egfr',\n",
       "  'kinase',\n",
       "  'activity',\n",
       "  'by',\n",
       "  'gefitinib',\n",
       "  'causes',\n",
       "  'the',\n",
       "  'translocation',\n",
       "  'of',\n",
       "  'the',\n",
       "  'abcg2',\n",
       "  'drug',\n",
       "  'transporter',\n",
       "  'away',\n",
       "  'from',\n",
       "  'the',\n",
       "  'plasma',\n",
       "  'membrane,',\n",
       "  'resulting',\n",
       "  'in',\n",
       "  'a',\n",
       "  'concomitant',\n",
       "  'decrease',\n",
       "  'in',\n",
       "  'doxorubicin',\n",
       "  'extrusion',\n",
       "  'in',\n",
       "  'thyroid',\n",
       "  'cancer',\n",
       "  'cell',\n",
       "  'lines.'],\n",
       " ['a',\n",
       "  'terminal',\n",
       "  'deoxynucleotidyl',\n",
       "  'transferase-mediated',\n",
       "  'deoxyuridine',\n",
       "  'triphosphate',\n",
       "  'nick-end',\n",
       "  'labeling',\n",
       "  'assay',\n",
       "  'was',\n",
       "  'performed',\n",
       "  'to',\n",
       "  'demonstrate',\n",
       "  'abcg2-mediated',\n",
       "  'apoptosis',\n",
       "  'in',\n",
       "  'the',\n",
       "  'presence',\n",
       "  'of',\n",
       "  'doxorubicin.'],\n",
       " ['both',\n",
       "  'aro',\n",
       "  'and',\n",
       "  'wro',\n",
       "  'demonstrated',\n",
       "  'differential',\n",
       "  'abcg2',\n",
       "  'expression,',\n",
       "  'whereas',\n",
       "  'both',\n",
       "  'were',\n",
       "  'sensitized',\n",
       "  'to',\n",
       "  'doxorubicin-induced',\n",
       "  'apoptosis',\n",
       "  'on',\n",
       "  'abcg2',\n",
       "  'knockdown',\n",
       "  'with',\n",
       "  'short',\n",
       "  'interfering',\n",
       "  'rna.'],\n",
       " ['inactivation',\n",
       "  'of',\n",
       "  'the',\n",
       "  'egfr',\n",
       "  'kinase',\n",
       "  'by',\n",
       "  'gefitinib',\n",
       "  'potentiates',\n",
       "  'the',\n",
       "  'cytotoxic',\n",
       "  'effect',\n",
       "  'of',\n",
       "  'doxorubicin',\n",
       "  'in',\n",
       "  'thyroid',\n",
       "  'cancer,',\n",
       "  'most',\n",
       "  'likely',\n",
       "  'by',\n",
       "  'decreasing',\n",
       "  'the',\n",
       "  'ability',\n",
       "  'of',\n",
       "  'the',\n",
       "  'cell',\n",
       "  'to',\n",
       "  'extrude',\n",
       "  'doxorubicin.'],\n",
       " ['inhibition',\n",
       "  'of',\n",
       "  'egfr',\n",
       "  'kinase',\n",
       "  'activity',\n",
       "  'by',\n",
       "  'gefitinib',\n",
       "  'causes',\n",
       "  'the',\n",
       "  'translocation',\n",
       "  'of',\n",
       "  'the',\n",
       "  'abcg2',\n",
       "  'drug',\n",
       "  'transporter',\n",
       "  'away',\n",
       "  'from',\n",
       "  'the',\n",
       "  'plasma',\n",
       "  'membrane,',\n",
       "  'resulting',\n",
       "  'in',\n",
       "  'a',\n",
       "  'concomitant',\n",
       "  'decrease',\n",
       "  'in',\n",
       "  'doxorubicin',\n",
       "  'extrusion',\n",
       "  'in',\n",
       "  'thyroid',\n",
       "  'cancer',\n",
       "  'cell',\n",
       "  'lines.'],\n",
       " ['inhibition',\n",
       "  'of',\n",
       "  'egfr',\n",
       "  'kinase',\n",
       "  'activity',\n",
       "  'by',\n",
       "  'gefitinib',\n",
       "  'causes',\n",
       "  'the',\n",
       "  'translocation',\n",
       "  'of',\n",
       "  'the',\n",
       "  'abcg2',\n",
       "  'drug',\n",
       "  'transporter',\n",
       "  'away',\n",
       "  'from',\n",
       "  'the',\n",
       "  'plasma',\n",
       "  'membrane,',\n",
       "  'resulting',\n",
       "  'in',\n",
       "  'a',\n",
       "  'concomitant',\n",
       "  'decrease',\n",
       "  'in',\n",
       "  'doxorubicin',\n",
       "  'extrusion',\n",
       "  'in',\n",
       "  'thyroid',\n",
       "  'cancer',\n",
       "  'cell',\n",
       "  'lines.'],\n",
       " ['the',\n",
       "  'expression',\n",
       "  'of',\n",
       "  'abcg2',\n",
       "  'may',\n",
       "  'explain',\n",
       "  'in',\n",
       "  'part',\n",
       "  'the',\n",
       "  'ineffectiveness',\n",
       "  'of',\n",
       "  'doxorubicin',\n",
       "  'as',\n",
       "  'a',\n",
       "  'single',\n",
       "  'modality',\n",
       "  'treatment',\n",
       "  'for',\n",
       "  'anaplastic',\n",
       "  'thyroid',\n",
       "  'cancer',\n",
       "  'or',\n",
       "  'for',\n",
       "  'treatment',\n",
       "  'of',\n",
       "  'metastatic',\n",
       "  'follicular',\n",
       "  'thyroid',\n",
       "  'cancer.'],\n",
       " ['inhibition',\n",
       "  'of',\n",
       "  'egfr',\n",
       "  'kinase',\n",
       "  'activity',\n",
       "  'by',\n",
       "  'gefitinib',\n",
       "  'causes',\n",
       "  'the',\n",
       "  'translocation',\n",
       "  'of',\n",
       "  'the',\n",
       "  'abcg2',\n",
       "  'drug',\n",
       "  'transporter',\n",
       "  'away',\n",
       "  'from',\n",
       "  'the',\n",
       "  'plasma',\n",
       "  'membrane,',\n",
       "  'resulting',\n",
       "  'in',\n",
       "  'a',\n",
       "  'concomitant',\n",
       "  'decrease',\n",
       "  'in',\n",
       "  'doxorubicin',\n",
       "  'extrusion',\n",
       "  'in',\n",
       "  'thyroid',\n",
       "  'cancer',\n",
       "  'cell',\n",
       "  'lines.'],\n",
       " ['gsk221149a',\n",
       "  'had',\n",
       "  'similar',\n",
       "  'affinity',\n",
       "  '(k(i)',\n",
       "  '=',\n",
       "  '4.1',\n",
       "  'nm)',\n",
       "  'and',\n",
       "  'selectivity',\n",
       "  'for',\n",
       "  'native',\n",
       "  'oxytocin',\n",
       "  'receptors',\n",
       "  'from',\n",
       "  'rat',\n",
       "  'and',\n",
       "  'produced',\n",
       "  'a',\n",
       "  'functional,',\n",
       "  'competitive',\n",
       "  'block',\n",
       "  'of',\n",
       "  'oxytocin-induced',\n",
       "  'contractions',\n",
       "  'in',\n",
       "  'isolated',\n",
       "  'rat',\n",
       "  'myometrial',\n",
       "  'strips',\n",
       "  'with',\n",
       "  'a',\n",
       "  'pa(2)',\n",
       "  'value',\n",
       "  'of',\n",
       "  '8.18.'],\n",
       " ['oral',\n",
       "  'administration',\n",
       "  'of',\n",
       "  'gsk221149a',\n",
       "  '(5',\n",
       "  'mg/kg)',\n",
       "  'was',\n",
       "  'effective',\n",
       "  'in',\n",
       "  'inhibiting',\n",
       "  'oxytocin-induced',\n",
       "  'uterine',\n",
       "  'contractions',\n",
       "  'after',\n",
       "  'single',\n",
       "  'and',\n",
       "  'multiple',\n",
       "  '(4-day)',\n",
       "  'dosing.'],\n",
       " ['intravenous',\n",
       "  'administration',\n",
       "  'of',\n",
       "  'gsk221149a',\n",
       "  'produced',\n",
       "  'a',\n",
       "  'dose-dependent',\n",
       "  'decrease',\n",
       "  'in',\n",
       "  'oxytocin-induced',\n",
       "  'uterine',\n",
       "  'contractions',\n",
       "  'in',\n",
       "  'anesthetized',\n",
       "  'rats',\n",
       "  'with',\n",
       "  'an',\n",
       "  'id(50)',\n",
       "  '=',\n",
       "  '0.27',\n",
       "  '+/-',\n",
       "  '0.60',\n",
       "  'mg/kg',\n",
       "  '(corresponding',\n",
       "  'plasma',\n",
       "  'concentrations',\n",
       "  'were',\n",
       "  '88',\n",
       "  'ng/ml).'],\n",
       " ['pml/raralpha',\n",
       "  'is',\n",
       "  'directly',\n",
       "  'targeted',\n",
       "  'by',\n",
       "  'all-trans-retinoic',\n",
       "  'acid',\n",
       "  '(atra),',\n",
       "  'which',\n",
       "  'degrades',\n",
       "  'the',\n",
       "  'oncoprotein',\n",
       "  'and',\n",
       "  'induces',\n",
       "  'complete',\n",
       "  'remission',\n",
       "  'of',\n",
       "  'malignancies.'],\n",
       " ['atra',\n",
       "  'co-operated',\n",
       "  'with',\n",
       "  'mek',\n",
       "  'inhibitor',\n",
       "  'to',\n",
       "  'increase',\n",
       "  'degradation',\n",
       "  'of',\n",
       "  'pml/raralpha',\n",
       "  'and',\n",
       "  'exhibited',\n",
       "  'a',\n",
       "  'convergence',\n",
       "  'point',\n",
       "  'in',\n",
       "  'caspase',\n",
       "  'activation',\n",
       "  'with',\n",
       "  'mek',\n",
       "  'inhibitors.'],\n",
       " ['assessment',\n",
       "  'of',\n",
       "  '1177',\n",
       "  'human',\n",
       "  'immunodeficiency',\n",
       "  'virus',\n",
       "  '(hiv)',\n",
       "  'resistance',\n",
       "  'genotypes',\n",
       "  'at',\n",
       "  'an',\n",
       "  'hiv/aids',\n",
       "  'clinic',\n",
       "  'showed',\n",
       "  'a',\n",
       "  'decrease',\n",
       "  'in',\n",
       "  'the',\n",
       "  'incidence',\n",
       "  'of',\n",
       "  'the',\n",
       "  'k65r',\n",
       "  'mutation,',\n",
       "  'from',\n",
       "  '15.2%',\n",
       "  'of',\n",
       "  'isolates',\n",
       "  'during',\n",
       "  'the',\n",
       "  'period',\n",
       "  '2002-2004',\n",
       "  'to',\n",
       "  '2.7%',\n",
       "  'of',\n",
       "  'isolates',\n",
       "  'during',\n",
       "  'the',\n",
       "  'period',\n",
       "  '2005-2006',\n",
       "  '(p',\n",
       "  '<',\n",
       "  '.001),',\n",
       "  'despite',\n",
       "  'elevated',\n",
       "  'and',\n",
       "  'stable',\n",
       "  'rates',\n",
       "  'of',\n",
       "  'tenofovir',\n",
       "  'use.'],\n",
       " ['one',\n",
       "  'among',\n",
       "  'the',\n",
       "  '17',\n",
       "  'genes',\n",
       "  'studied',\n",
       "  'is',\n",
       "  'atp7b',\n",
       "  'which',\n",
       "  'is',\n",
       "  'involved',\n",
       "  'in',\n",
       "  'the',\n",
       "  'transport',\n",
       "  'of',\n",
       "  'copper',\n",
       "  'ions',\n",
       "  'across',\n",
       "  'the',\n",
       "  'cell',\n",
       "  'membrane',\n",
       "  'into',\n",
       "  'the',\n",
       "  'cell.'],\n",
       " ['topoisomerase',\n",
       "  'iibeta',\n",
       "  'mediated',\n",
       "  'dna',\n",
       "  'double-strand',\n",
       "  'breaks:',\n",
       "  'implications',\n",
       "  'in',\n",
       "  'doxorubicin',\n",
       "  'cardiotoxicity',\n",
       "  'and',\n",
       "  'prevention',\n",
       "  'by',\n",
       "  'dexrazoxane.'],\n",
       " ['topoisomerase',\n",
       "  'iibeta',\n",
       "  'mediated',\n",
       "  'dna',\n",
       "  'double-strand',\n",
       "  'breaks:',\n",
       "  'implications',\n",
       "  'in',\n",
       "  'doxorubicin',\n",
       "  'cardiotoxicity',\n",
       "  'and',\n",
       "  'prevention',\n",
       "  'by',\n",
       "  'dexrazoxane.'],\n",
       " ['furthermore,',\n",
       "  'in',\n",
       "  'addition',\n",
       "  'to',\n",
       "  'antagonizing',\n",
       "  'top2',\n",
       "  'cleavage',\n",
       "  'complex',\n",
       "  'formation,',\n",
       "  'dexrazoxane',\n",
       "  'also',\n",
       "  'induced',\n",
       "  'rapid',\n",
       "  'degradation',\n",
       "  'of',\n",
       "  'top2beta,',\n",
       "  'which',\n",
       "  'paralleled',\n",
       "  'the',\n",
       "  'reduction',\n",
       "  'of',\n",
       "  'doxorubicin-induced',\n",
       "  'dna',\n",
       "  'damage.'],\n",
       " ['doxorubicin-induced',\n",
       "  'dna',\n",
       "  'damage',\n",
       "  'was',\n",
       "  'also',\n",
       "  'specifically',\n",
       "  'abolished',\n",
       "  'by',\n",
       "  'the',\n",
       "  'proteasome',\n",
       "  'inhibitors',\n",
       "  'bortezomib',\n",
       "  'and',\n",
       "  'mg132',\n",
       "  'and',\n",
       "  'much',\n",
       "  'reduced',\n",
       "  'in',\n",
       "  'top2beta(-/-)',\n",
       "  'mouse',\n",
       "  'embryonic',\n",
       "  'fibroblasts',\n",
       "  '(mef)',\n",
       "  'compared',\n",
       "  'with',\n",
       "  'top2beta(+/+)',\n",
       "  'mefs,',\n",
       "  'suggesting',\n",
       "  'the',\n",
       "  'involvement',\n",
       "  'of',\n",
       "  'proteasome',\n",
       "  'and',\n",
       "  'dna',\n",
       "  'topoisomerase',\n",
       "  'iibeta',\n",
       "  '(top2beta).'],\n",
       " ['doxorubicin-induced',\n",
       "  'dna',\n",
       "  'damage',\n",
       "  'was',\n",
       "  'also',\n",
       "  'specifically',\n",
       "  'abolished',\n",
       "  'by',\n",
       "  'the',\n",
       "  'proteasome',\n",
       "  'inhibitors',\n",
       "  'bortezomib',\n",
       "  'and',\n",
       "  'mg132',\n",
       "  'and',\n",
       "  'much',\n",
       "  'reduced',\n",
       "  'in',\n",
       "  'top2beta(-/-)',\n",
       "  'mouse',\n",
       "  'embryonic',\n",
       "  'fibroblasts',\n",
       "  '(mef)',\n",
       "  'compared',\n",
       "  'with',\n",
       "  'top2beta(+/+)',\n",
       "  'mefs,',\n",
       "  'suggesting',\n",
       "  'the',\n",
       "  'involvement',\n",
       "  'of',\n",
       "  'proteasome',\n",
       "  'and',\n",
       "  'dna',\n",
       "  'topoisomerase',\n",
       "  'iibeta',\n",
       "  '(top2beta).'],\n",
       " ['doxorubicin-induced',\n",
       "  'dna',\n",
       "  'damage',\n",
       "  'was',\n",
       "  'also',\n",
       "  'specifically',\n",
       "  'abolished',\n",
       "  'by',\n",
       "  'the',\n",
       "  'proteasome',\n",
       "  'inhibitors',\n",
       "  'bortezomib',\n",
       "  'and',\n",
       "  'mg132',\n",
       "  'and',\n",
       "  'much',\n",
       "  'reduced',\n",
       "  'in',\n",
       "  'top2beta(-/-)',\n",
       "  'mouse',\n",
       "  'embryonic',\n",
       "  'fibroblasts',\n",
       "  '(mef)',\n",
       "  'compared',\n",
       "  'with',\n",
       "  'top2beta(+/+)',\n",
       "  'mefs,',\n",
       "  'suggesting',\n",
       "  'the',\n",
       "  'involvement',\n",
       "  'of',\n",
       "  'proteasome',\n",
       "  'and',\n",
       "  'dna',\n",
       "  'topoisomerase',\n",
       "  'iibeta',\n",
       "  '(top2beta).'],\n",
       " ['together,',\n",
       "  'our',\n",
       "  'results',\n",
       "  'suggest',\n",
       "  'that',\n",
       "  'dexrazoxane',\n",
       "  'antagonizes',\n",
       "  'doxorubicin-induced',\n",
       "  'dna',\n",
       "  'damage',\n",
       "  'through',\n",
       "  'its',\n",
       "  'interference',\n",
       "  'with',\n",
       "  'top2beta,',\n",
       "  'which',\n",
       "  'could',\n",
       "  'implicate',\n",
       "  'top2beta',\n",
       "  'in',\n",
       "  'doxorubicin',\n",
       "  'cardiotoxicity.'],\n",
       " ['furthermore,',\n",
       "  'in',\n",
       "  'addition',\n",
       "  'to',\n",
       "  'antagonizing',\n",
       "  'top2',\n",
       "  'cleavage',\n",
       "  'complex',\n",
       "  'formation,',\n",
       "  'dexrazoxane',\n",
       "  'also',\n",
       "  'induced',\n",
       "  'rapid',\n",
       "  'degradation',\n",
       "  'of',\n",
       "  'top2beta,',\n",
       "  'which',\n",
       "  'paralleled',\n",
       "  'the',\n",
       "  'reduction',\n",
       "  'of',\n",
       "  'doxorubicin-induced',\n",
       "  'dna',\n",
       "  'damage.'],\n",
       " ['together,',\n",
       "  'our',\n",
       "  'results',\n",
       "  'suggest',\n",
       "  'that',\n",
       "  'dexrazoxane',\n",
       "  'antagonizes',\n",
       "  'doxorubicin-induced',\n",
       "  'dna',\n",
       "  'damage',\n",
       "  'through',\n",
       "  'its',\n",
       "  'interference',\n",
       "  'with',\n",
       "  'top2beta,',\n",
       "  'which',\n",
       "  'could',\n",
       "  'implicate',\n",
       "  'top2beta',\n",
       "  'in',\n",
       "  'doxorubicin',\n",
       "  'cardiotoxicity.'],\n",
       " ['the',\n",
       "  'specific',\n",
       "  'involvement',\n",
       "  'of',\n",
       "  'proteasome',\n",
       "  'and',\n",
       "  'top2beta',\n",
       "  'in',\n",
       "  'doxorubicin-induced',\n",
       "  'dna',\n",
       "  'damage',\n",
       "  'is',\n",
       "  'consistent',\n",
       "  'with',\n",
       "  'a',\n",
       "  'model',\n",
       "  'in',\n",
       "  'which',\n",
       "  'proteasomal',\n",
       "  'processing',\n",
       "  'of',\n",
       "  'doxorubicin-induced',\n",
       "  'top2beta-dna',\n",
       "  'covalent',\n",
       "  'complexes',\n",
       "  'exposes',\n",
       "  'the',\n",
       "  'top2beta-concealed',\n",
       "  'dna',\n",
       "  'double-strand',\n",
       "  'breaks.'],\n",
       " ['doxorubicin-induced',\n",
       "  'dna',\n",
       "  'damage',\n",
       "  'was',\n",
       "  'also',\n",
       "  'specifically',\n",
       "  'abolished',\n",
       "  'by',\n",
       "  'the',\n",
       "  'proteasome',\n",
       "  'inhibitors',\n",
       "  'bortezomib',\n",
       "  'and',\n",
       "  'mg132',\n",
       "  'and',\n",
       "  'much',\n",
       "  'reduced',\n",
       "  'in',\n",
       "  'top2beta(-/-)',\n",
       "  'mouse',\n",
       "  'embryonic',\n",
       "  'fibroblasts',\n",
       "  '(mef)',\n",
       "  'compared',\n",
       "  'with',\n",
       "  'top2beta(+/+)',\n",
       "  'mefs,',\n",
       "  'suggesting',\n",
       "  'the',\n",
       "  'involvement',\n",
       "  'of',\n",
       "  'proteasome',\n",
       "  'and',\n",
       "  'dna',\n",
       "  'topoisomerase',\n",
       "  'iibeta',\n",
       "  '(top2beta).'],\n",
       " ['doxorubicin-induced',\n",
       "  'dna',\n",
       "  'damage',\n",
       "  'was',\n",
       "  'also',\n",
       "  'specifically',\n",
       "  'abolished',\n",
       "  'by',\n",
       "  'the',\n",
       "  'proteasome',\n",
       "  'inhibitors',\n",
       "  'bortezomib',\n",
       "  'and',\n",
       "  'mg132',\n",
       "  'and',\n",
       "  'much',\n",
       "  'reduced',\n",
       "  'in',\n",
       "  'top2beta(-/-)',\n",
       "  'mouse',\n",
       "  'embryonic',\n",
       "  'fibroblasts',\n",
       "  '(mef)',\n",
       "  'compared',\n",
       "  'with',\n",
       "  'top2beta(+/+)',\n",
       "  'mefs,',\n",
       "  'suggesting',\n",
       "  'the',\n",
       "  'involvement',\n",
       "  'of',\n",
       "  'proteasome',\n",
       "  'and',\n",
       "  'dna',\n",
       "  'topoisomerase',\n",
       "  'iibeta',\n",
       "  '(top2beta).'],\n",
       " ['after',\n",
       "  'feeding',\n",
       "  'a',\n",
       "  'diet',\n",
       "  'containing',\n",
       "  'fos',\n",
       "  '(100',\n",
       "  'g/kg',\n",
       "  'diet)',\n",
       "  'to',\n",
       "  'rats',\n",
       "  'for',\n",
       "  '2',\n",
       "  'd,',\n",
       "  'we',\n",
       "  'investigated',\n",
       "  'gene',\n",
       "  'transcripts',\n",
       "  'of',\n",
       "  'transient',\n",
       "  'receptor',\n",
       "  'potential',\n",
       "  'vanilloid',\n",
       "  'type',\n",
       "  '6',\n",
       "  '(trpv6),',\n",
       "  'calbindin-d9k,',\n",
       "  'and',\n",
       "  'plasma',\n",
       "  'membrane',\n",
       "  'calcium-atpase',\n",
       "  '1b',\n",
       "  '(pmca1b).'],\n",
       " ['after',\n",
       "  'feeding',\n",
       "  'a',\n",
       "  'diet',\n",
       "  'containing',\n",
       "  'fos',\n",
       "  '(100',\n",
       "  'g/kg',\n",
       "  'diet)',\n",
       "  'to',\n",
       "  'rats',\n",
       "  'for',\n",
       "  '2',\n",
       "  'd,',\n",
       "  'we',\n",
       "  'investigated',\n",
       "  'gene',\n",
       "  'transcripts',\n",
       "  'of',\n",
       "  'transient',\n",
       "  'receptor',\n",
       "  'potential',\n",
       "  'vanilloid',\n",
       "  'type',\n",
       "  '6',\n",
       "  '(trpv6),',\n",
       "  'calbindin-d9k,',\n",
       "  'and',\n",
       "  'plasma',\n",
       "  'membrane',\n",
       "  'calcium-atpase',\n",
       "  '1b',\n",
       "  '(pmca1b).'],\n",
       " ['we',\n",
       "  'found',\n",
       "  'for',\n",
       "  'the',\n",
       "  'first',\n",
       "  'time,',\n",
       "  'to',\n",
       "  'our',\n",
       "  'knowledge,',\n",
       "  'that',\n",
       "  'regulation',\n",
       "  'of',\n",
       "  'trpv6',\n",
       "  'gene',\n",
       "  'expression',\n",
       "  'by',\n",
       "  'scfa',\n",
       "  'may',\n",
       "  'be',\n",
       "  'a',\n",
       "  'molecular',\n",
       "  'mechanism',\n",
       "  'involved',\n",
       "  'in',\n",
       "  'the',\n",
       "  'promotion',\n",
       "  'of',\n",
       "  'calcium',\n",
       "  'absorption',\n",
       "  'by',\n",
       "  'fos',\n",
       "  'in',\n",
       "  'rats.'],\n",
       " ['the',\n",
       "  'fos',\n",
       "  'diet',\n",
       "  'increased',\n",
       "  'expression',\n",
       "  'of',\n",
       "  'trpv6',\n",
       "  'and',\n",
       "  'calbindin-d9k',\n",
       "  'but',\n",
       "  'did',\n",
       "  'not',\n",
       "  'affect',\n",
       "  'pmca1b',\n",
       "  'expression.'],\n",
       " ['the',\n",
       "  'fos',\n",
       "  'diet',\n",
       "  'increased',\n",
       "  'expression',\n",
       "  'of',\n",
       "  'trpv6',\n",
       "  'and',\n",
       "  'calbindin-d9k',\n",
       "  'but',\n",
       "  'did',\n",
       "  'not',\n",
       "  'affect',\n",
       "  'pmca1b',\n",
       "  'expression.'],\n",
       " ['the',\n",
       "  'fos',\n",
       "  'diet',\n",
       "  'increased',\n",
       "  'expression',\n",
       "  'of',\n",
       "  'trpv6',\n",
       "  'and',\n",
       "  'calbindin-d9k',\n",
       "  'but',\n",
       "  'did',\n",
       "  'not',\n",
       "  'affect',\n",
       "  'pmca1b',\n",
       "  'expression.'],\n",
       " ['after',\n",
       "  'feeding',\n",
       "  'a',\n",
       "  'diet',\n",
       "  'containing',\n",
       "  'fos',\n",
       "  '(100',\n",
       "  'g/kg',\n",
       "  'diet)',\n",
       "  'to',\n",
       "  'rats',\n",
       "  'for',\n",
       "  '2',\n",
       "  'd,',\n",
       "  'we',\n",
       "  'investigated',\n",
       "  'gene',\n",
       "  'transcripts',\n",
       "  'of',\n",
       "  'transient',\n",
       "  'receptor',\n",
       "  'potential',\n",
       "  'vanilloid',\n",
       "  'type',\n",
       "  '6',\n",
       "  '(trpv6),',\n",
       "  'calbindin-d9k,',\n",
       "  'and',\n",
       "  'plasma',\n",
       "  'membrane',\n",
       "  'calcium-atpase',\n",
       "  '1b',\n",
       "  '(pmca1b).'],\n",
       " ['after',\n",
       "  'feeding',\n",
       "  'a',\n",
       "  'diet',\n",
       "  'containing',\n",
       "  'fos',\n",
       "  '(100',\n",
       "  'g/kg',\n",
       "  'diet)',\n",
       "  'to',\n",
       "  'rats',\n",
       "  'for',\n",
       "  '2',\n",
       "  'd,',\n",
       "  'we',\n",
       "  'investigated',\n",
       "  'gene',\n",
       "  'transcripts',\n",
       "  'of',\n",
       "  'transient',\n",
       "  'receptor',\n",
       "  'potential',\n",
       "  'vanilloid',\n",
       "  'type',\n",
       "  '6',\n",
       "  '(trpv6),',\n",
       "  'calbindin-d9k,',\n",
       "  'and',\n",
       "  'plasma',\n",
       "  'membrane',\n",
       "  'calcium-atpase',\n",
       "  '1b',\n",
       "  '(pmca1b).'],\n",
       " ['these',\n",
       "  'results',\n",
       "  'suggest',\n",
       "  'that',\n",
       "  'fos',\n",
       "  'increase',\n",
       "  'calcium',\n",
       "  'absorption',\n",
       "  'by',\n",
       "  'increasing',\n",
       "  'mrna',\n",
       "  'expression',\n",
       "  'of',\n",
       "  'trpv6',\n",
       "  'in',\n",
       "  'rat',\n",
       "  'colorectum,',\n",
       "  'and',\n",
       "  'cell',\n",
       "  'culture',\n",
       "  'analysis',\n",
       "  'indicated',\n",
       "  'that',\n",
       "  'scfa,',\n",
       "  'as',\n",
       "  'fermentation',\n",
       "  'products',\n",
       "  'of',\n",
       "  'fos,',\n",
       "  'are',\n",
       "  'involved',\n",
       "  'in',\n",
       "  'the',\n",
       "  'increased',\n",
       "  'mrna',\n",
       "  'expression',\n",
       "  'of',\n",
       "  'trpv6.'],\n",
       " ['adalimumab',\n",
       "  'is',\n",
       "  'a',\n",
       "  'subcutaneously',\n",
       "  'administered,',\n",
       "  'recombinant,',\n",
       "  'human',\n",
       "  'igg1',\n",
       "  'monoclonal',\n",
       "  'antibody',\n",
       "  'specific',\n",
       "  'for',\n",
       "  'human',\n",
       "  'tumor',\n",
       "  'necrosis',\n",
       "  'factor',\n",
       "  '(tnf).'],\n",
       " ['adalimumab',\n",
       "  'is',\n",
       "  'a',\n",
       "  'subcutaneously',\n",
       "  'administered,',\n",
       "  'recombinant,',\n",
       "  'human',\n",
       "  'igg1',\n",
       "  'monoclonal',\n",
       "  'antibody',\n",
       "  'specific',\n",
       "  'for',\n",
       "  'human',\n",
       "  'tumor',\n",
       "  'necrosis',\n",
       "  'factor',\n",
       "  '(tnf).'],\n",
       " ['[3h]a-804598',\n",
       "  '([3h]2-cyano-1-[(1s)-1-phenylethyl]-3-quinolin-5-ylguanidine)',\n",
       "  'is',\n",
       "  'a',\n",
       "  'novel,',\n",
       "  'potent,',\n",
       "  'and',\n",
       "  'selective',\n",
       "  'antagonist',\n",
       "  'radioligand',\n",
       "  'for',\n",
       "  'p2x7',\n",
       "  'receptors.'],\n",
       " ['while',\n",
       "  'several',\n",
       "  'species',\n",
       "  'selective',\n",
       "  'p2x7',\n",
       "  'antagonists',\n",
       "  'exist,',\n",
       "  'a-804598',\n",
       "  'represents',\n",
       "  'a',\n",
       "  'structurally',\n",
       "  'novel,',\n",
       "  'competitive,',\n",
       "  'and',\n",
       "  'selective',\n",
       "  'antagonist',\n",
       "  'that',\n",
       "  'has',\n",
       "  'equivalent',\n",
       "  'high',\n",
       "  'affinity',\n",
       "  'at',\n",
       "  'rat',\n",
       "  '(ic50',\n",
       "  '=',\n",
       "  '10',\n",
       "  'nm),',\n",
       "  'mouse',\n",
       "  '(ic50',\n",
       "  '=',\n",
       "  '9',\n",
       "  'nm)',\n",
       "  'and',\n",
       "  'human',\n",
       "  '(ic50',\n",
       "  '=',\n",
       "  '11',\n",
       "  'nm)',\n",
       "  'p2x7',\n",
       "  'receptors.'],\n",
       " ['the',\n",
       "  'pharmacological',\n",
       "  'profile',\n",
       "  'for',\n",
       "  'p2x',\n",
       "  'antagonists',\n",
       "  'to',\n",
       "  'inhibit',\n",
       "  '[3h]a-804598',\n",
       "  'binding',\n",
       "  'correlated',\n",
       "  'with',\n",
       "  'their',\n",
       "  'ability',\n",
       "  'to',\n",
       "  'block',\n",
       "  'functional',\n",
       "  'activation',\n",
       "  'of',\n",
       "  'p2x7',\n",
       "  'receptors',\n",
       "  '(r=0.95,',\n",
       "  'p<0.05).'],\n",
       " ['the',\n",
       "  'pharmacological',\n",
       "  'profile',\n",
       "  'for',\n",
       "  'p2x',\n",
       "  'antagonists',\n",
       "  'to',\n",
       "  'inhibit',\n",
       "  '[3h]a-804598',\n",
       "  'binding',\n",
       "  'correlated',\n",
       "  'with',\n",
       "  'their',\n",
       "  'ability',\n",
       "  'to',\n",
       "  'block',\n",
       "  'functional',\n",
       "  'activation',\n",
       "  'of',\n",
       "  'p2x7',\n",
       "  'receptors',\n",
       "  '(r=0.95,',\n",
       "  'p<0.05).'],\n",
       " ['a-804598',\n",
       "  'also',\n",
       "  'potently',\n",
       "  'blocked',\n",
       "  'agonist',\n",
       "  'stimulated',\n",
       "  'release',\n",
       "  'of',\n",
       "  'il-1beta',\n",
       "  'and',\n",
       "  'yo-pro',\n",
       "  'uptake',\n",
       "  'from',\n",
       "  'differentiated',\n",
       "  'thp-1',\n",
       "  'cells',\n",
       "  'that',\n",
       "  'natively',\n",
       "  'express',\n",
       "  'human',\n",
       "  'p2x7',\n",
       "  'receptors.'],\n",
       " ['a-804598',\n",
       "  'also',\n",
       "  'potently',\n",
       "  'blocked',\n",
       "  'agonist',\n",
       "  'stimulated',\n",
       "  'release',\n",
       "  'of',\n",
       "  'il-1beta',\n",
       "  'and',\n",
       "  'yo-pro',\n",
       "  'uptake',\n",
       "  'from',\n",
       "  'differentiated',\n",
       "  'thp-1',\n",
       "  'cells',\n",
       "  'that',\n",
       "  'natively',\n",
       "  'express',\n",
       "  'human',\n",
       "  'p2x7',\n",
       "  'receptors.'],\n",
       " ['these',\n",
       "  'data',\n",
       "  'demonstrate',\n",
       "  'that',\n",
       "  'a-804598',\n",
       "  'is',\n",
       "  'one',\n",
       "  'of',\n",
       "  'the',\n",
       "  'most',\n",
       "  'potent',\n",
       "  'and',\n",
       "  'selective',\n",
       "  'antagonists',\n",
       "  'for',\n",
       "  'mammalian',\n",
       "  'p2x7',\n",
       "  'receptors',\n",
       "  'described',\n",
       "  'to',\n",
       "  'date',\n",
       "  'and',\n",
       "  '[3h]a-804598',\n",
       "  'is',\n",
       "  'a',\n",
       "  'high',\n",
       "  'affinity',\n",
       "  'antagonist',\n",
       "  'radioligand',\n",
       "  'that',\n",
       "  'specifically',\n",
       "  'labels',\n",
       "  'rat',\n",
       "  'p2x7',\n",
       "  'receptors.'],\n",
       " ['ma',\n",
       "  'and',\n",
       "  'md',\n",
       "  'were',\n",
       "  'reversible',\n",
       "  'inhibitors',\n",
       "  'of',\n",
       "  'cyp3a',\n",
       "  'with',\n",
       "  'competitive',\n",
       "  'ki',\n",
       "  'values',\n",
       "  'of',\n",
       "  '2.7',\n",
       "  'and',\n",
       "  '0.2',\n",
       "  'microm,',\n",
       "  'respectively.'],\n",
       " ['md', 'did', 'not', 'inactivate', 'cyp3a.'],\n",
       " ['sequential',\n",
       "  'metabolism',\n",
       "  'is',\n",
       "  'responsible',\n",
       "  'for',\n",
       "  'diltiazem-induced',\n",
       "  'time-dependent',\n",
       "  'loss',\n",
       "  'of',\n",
       "  'cyp3a.'],\n",
       " ['we',\n",
       "  'previously',\n",
       "  'reported',\n",
       "  'that',\n",
       "  'microsomal',\n",
       "  'inactivation',\n",
       "  'kinetic',\n",
       "  'parameters',\n",
       "  'of',\n",
       "  'diltiazem',\n",
       "  'underpredicted',\n",
       "  'cyp3a',\n",
       "  'inactivation',\n",
       "  'in',\n",
       "  'hepatocytes.'],\n",
       " ['inactivation',\n",
       "  'of',\n",
       "  'cyp3a',\n",
       "  'by',\n",
       "  'diltiazem',\n",
       "  'was',\n",
       "  'dependent',\n",
       "  'on',\n",
       "  'microsomal',\n",
       "  'protein',\n",
       "  'concentration',\n",
       "  '(25,',\n",
       "  '36,',\n",
       "  'and',\n",
       "  '41%',\n",
       "  'decrease',\n",
       "  'in',\n",
       "  'cyp3a',\n",
       "  'activity',\n",
       "  'at',\n",
       "  '0.2,',\n",
       "  '0.4,',\n",
       "  'and',\n",
       "  '0.8',\n",
       "  'mg/ml',\n",
       "  'microsomal',\n",
       "  'protein,',\n",
       "  'respectively,',\n",
       "  'incubated',\n",
       "  'with',\n",
       "  '10',\n",
       "  'microm',\n",
       "  'diltiazem',\n",
       "  'over',\n",
       "  '20',\n",
       "  'min),',\n",
       "  'whereas',\n",
       "  'inactivation',\n",
       "  'by',\n",
       "  'ma',\n",
       "  'did',\n",
       "  'not',\n",
       "  'seem',\n",
       "  'to',\n",
       "  'be',\n",
       "  'protein',\n",
       "  'concentration-dependent.'],\n",
       " ['inactivation',\n",
       "  'of',\n",
       "  'cyp3a',\n",
       "  'by',\n",
       "  'diltiazem',\n",
       "  'was',\n",
       "  'dependent',\n",
       "  'on',\n",
       "  'microsomal',\n",
       "  'protein',\n",
       "  'concentration',\n",
       "  '(25,',\n",
       "  '36,',\n",
       "  'and',\n",
       "  '41%',\n",
       "  'decrease',\n",
       "  'in',\n",
       "  'cyp3a',\n",
       "  'activity',\n",
       "  'at',\n",
       "  '0.2,',\n",
       "  '0.4,',\n",
       "  'and',\n",
       "  '0.8',\n",
       "  'mg/ml',\n",
       "  'microsomal',\n",
       "  'protein,',\n",
       "  'respectively,',\n",
       "  'incubated',\n",
       "  'with',\n",
       "  '10',\n",
       "  'microm',\n",
       "  'diltiazem',\n",
       "  'over',\n",
       "  '20',\n",
       "  'min),',\n",
       "  'whereas',\n",
       "  'inactivation',\n",
       "  'by',\n",
       "  'ma',\n",
       "  'did',\n",
       "  'not',\n",
       "  'seem',\n",
       "  'to',\n",
       "  'be',\n",
       "  'protein',\n",
       "  'concentration-dependent.'],\n",
       " ['in',\n",
       "  'summary,',\n",
       "  'time-dependent',\n",
       "  'cyp3a',\n",
       "  'inactivation',\n",
       "  'by',\n",
       "  'ma',\n",
       "  'seems',\n",
       "  'to',\n",
       "  'be',\n",
       "  'the',\n",
       "  'major',\n",
       "  'contributor',\n",
       "  'responsible',\n",
       "  'for',\n",
       "  'the',\n",
       "  'loss',\n",
       "  'of',\n",
       "  'cyp3a',\n",
       "  'in',\n",
       "  'human',\n",
       "  'liver',\n",
       "  'microsomes',\n",
       "  'and',\n",
       "  'human',\n",
       "  'hepatocytes',\n",
       "  'incubated',\n",
       "  'with',\n",
       "  'diltiazem.'],\n",
       " ['in',\n",
       "  'cryopreserved',\n",
       "  'hepatocytes',\n",
       "  'incubated',\n",
       "  'with',\n",
       "  'diltiazem,',\n",
       "  'time-dependent',\n",
       "  'loss',\n",
       "  'of',\n",
       "  'cyp3a',\n",
       "  'was',\n",
       "  'accompanied',\n",
       "  'by',\n",
       "  'increased',\n",
       "  'formation',\n",
       "  'of',\n",
       "  'ma',\n",
       "  'and',\n",
       "  'md,',\n",
       "  'with',\n",
       "  'the',\n",
       "  'ma',\n",
       "  'level',\n",
       "  'similar',\n",
       "  'to',\n",
       "  'its',\n",
       "  'k(i)',\n",
       "  'at',\n",
       "  'higher',\n",
       "  'diltiazem',\n",
       "  'concentrations.'],\n",
       " ['in',\n",
       "  'cryopreserved',\n",
       "  'hepatocytes',\n",
       "  'incubated',\n",
       "  'with',\n",
       "  'diltiazem,',\n",
       "  'time-dependent',\n",
       "  'loss',\n",
       "  'of',\n",
       "  'cyp3a',\n",
       "  'was',\n",
       "  'accompanied',\n",
       "  'by',\n",
       "  'increased',\n",
       "  'formation',\n",
       "  'of',\n",
       "  'ma',\n",
       "  'and',\n",
       "  'md,',\n",
       "  'with',\n",
       "  'the',\n",
       "  'ma',\n",
       "  'level',\n",
       "  'similar',\n",
       "  'to',\n",
       "  'its',\n",
       "  'k(i)',\n",
       "  'at',\n",
       "  'higher',\n",
       "  'diltiazem',\n",
       "  'concentrations.'],\n",
       " ['in',\n",
       "  'human',\n",
       "  'liver',\n",
       "  'microsomes,',\n",
       "  'ma',\n",
       "  'was',\n",
       "  'a',\n",
       "  'more',\n",
       "  'potent',\n",
       "  'time-dependent',\n",
       "  'inactivator',\n",
       "  'of',\n",
       "  'cyp3a',\n",
       "  'than',\n",
       "  'its',\n",
       "  'parent',\n",
       "  'drug,',\n",
       "  'with',\n",
       "  'apparent',\n",
       "  'k(inact)',\n",
       "  'approximately',\n",
       "  '4-fold',\n",
       "  'higher',\n",
       "  'than',\n",
       "  'that',\n",
       "  'of',\n",
       "  'diltiazem',\n",
       "  'at',\n",
       "  'a',\n",
       "  'microsomal',\n",
       "  'protein',\n",
       "  'concentration',\n",
       "  'of',\n",
       "  '0.2',\n",
       "  'mg/ml.'],\n",
       " ['in',\n",
       "  'cryopreserved',\n",
       "  'hepatocytes',\n",
       "  'incubated',\n",
       "  'with',\n",
       "  'diltiazem,',\n",
       "  'time-dependent',\n",
       "  'loss',\n",
       "  'of',\n",
       "  'cyp3a',\n",
       "  'was',\n",
       "  'accompanied',\n",
       "  'by',\n",
       "  'increased',\n",
       "  'formation',\n",
       "  'of',\n",
       "  'ma',\n",
       "  'and',\n",
       "  'md,',\n",
       "  'with',\n",
       "  'the',\n",
       "  'ma',\n",
       "  'level',\n",
       "  'similar',\n",
       "  'to',\n",
       "  'its',\n",
       "  'k(i)',\n",
       "  'at',\n",
       "  'higher',\n",
       "  'diltiazem',\n",
       "  'concentrations.'],\n",
       " ['in',\n",
       "  'human',\n",
       "  'liver',\n",
       "  'microsomes,',\n",
       "  'ma',\n",
       "  'was',\n",
       "  'a',\n",
       "  'more',\n",
       "  'potent',\n",
       "  'time-dependent',\n",
       "  'inactivator',\n",
       "  'of',\n",
       "  'cyp3a',\n",
       "  'than',\n",
       "  'its',\n",
       "  'parent',\n",
       "  'drug,',\n",
       "  'with',\n",
       "  'apparent',\n",
       "  'k(inact)',\n",
       "  'approximately',\n",
       "  '4-fold',\n",
       "  'higher',\n",
       "  'than',\n",
       "  'that',\n",
       "  'of',\n",
       "  'diltiazem',\n",
       "  'at',\n",
       "  'a',\n",
       "  'microsomal',\n",
       "  'protein',\n",
       "  'concentration',\n",
       "  'of',\n",
       "  '0.2',\n",
       "  'mg/ml.'],\n",
       " ['ma',\n",
       "  'and',\n",
       "  'md',\n",
       "  'were',\n",
       "  'reversible',\n",
       "  'inhibitors',\n",
       "  'of',\n",
       "  'cyp3a',\n",
       "  'with',\n",
       "  'competitive',\n",
       "  'ki',\n",
       "  'values',\n",
       "  'of',\n",
       "  '2.7',\n",
       "  'and',\n",
       "  '0.2',\n",
       "  'microm,',\n",
       "  'respectively.'],\n",
       " ['in',\n",
       "  'bcr-abl-positive',\n",
       "  'mouse',\n",
       "  'bone',\n",
       "  'marrow',\n",
       "  'cells,',\n",
       "  'nonphosphorylatable',\n",
       "  'hsp90beta',\n",
       "  'expression',\n",
       "  'conferred',\n",
       "  'imatinib',\n",
       "  '(gleevec)',\n",
       "  'resistance.'],\n",
       " ['in',\n",
       "  'bcr-abl-positive',\n",
       "  'mouse',\n",
       "  'bone',\n",
       "  'marrow',\n",
       "  'cells,',\n",
       "  'nonphosphorylatable',\n",
       "  'hsp90beta',\n",
       "  'expression',\n",
       "  'conferred',\n",
       "  'imatinib',\n",
       "  '(gleevec)',\n",
       "  'resistance.'],\n",
       " ['we',\n",
       "  'then',\n",
       "  'established',\n",
       "  'that',\n",
       "  'localized',\n",
       "  'intra-abdominal',\n",
       "  'desensitization',\n",
       "  'of',\n",
       "  'trpv1',\n",
       "  'channels',\n",
       "  'with',\n",
       "  'intraperitoneal',\n",
       "  'resiniferatoxin',\n",
       "  'blocks',\n",
       "  'the',\n",
       "  't(b)',\n",
       "  'response',\n",
       "  'to',\n",
       "  'systemic',\n",
       "  'amg0347;',\n",
       "  'the',\n",
       "  'extent',\n",
       "  'of',\n",
       "  'desensitization',\n",
       "  'was',\n",
       "  'determined',\n",
       "  'by',\n",
       "  'using',\n",
       "  'a',\n",
       "  'comprehensive',\n",
       "  'battery',\n",
       "  'of',\n",
       "  'functional',\n",
       "  'tests.'],\n",
       " ['we',\n",
       "  'then',\n",
       "  'found',\n",
       "  'that',\n",
       "  'this',\n",
       "  'drug',\n",
       "  'is',\n",
       "  'the',\n",
       "  'most',\n",
       "  'potent',\n",
       "  'trpv1',\n",
       "  'antagonist',\n",
       "  'known',\n",
       "  'to',\n",
       "  'increase',\n",
       "  't(b)',\n",
       "  'of',\n",
       "  'rats',\n",
       "  'and',\n",
       "  'mice',\n",
       "  'and',\n",
       "  'showed',\n",
       "  '(by',\n",
       "  'using',\n",
       "  'knock-out',\n",
       "  'mice)',\n",
       "  'that',\n",
       "  'the',\n",
       "  'entire',\n",
       "  'hyperthermic',\n",
       "  'effect',\n",
       "  'of',\n",
       "  'amg0347',\n",
       "  'is',\n",
       "  'trpv1',\n",
       "  'dependent.'],\n",
       " ['the',\n",
       "  'magnitude',\n",
       "  'of',\n",
       "  'the',\n",
       "  'hyperthermic',\n",
       "  'response',\n",
       "  'depended',\n",
       "  'on',\n",
       "  'neither',\n",
       "  't(b)',\n",
       "  'nor',\n",
       "  'tail-skin',\n",
       "  'temperature',\n",
       "  'at',\n",
       "  'the',\n",
       "  'time',\n",
       "  'of',\n",
       "  'amg0347',\n",
       "  'administration,',\n",
       "  'thus',\n",
       "  'indicating',\n",
       "  'that',\n",
       "  'amg0347-induced',\n",
       "  'hyperthermia',\n",
       "  'results',\n",
       "  'from',\n",
       "  'blockade',\n",
       "  'of',\n",
       "  'tonic',\n",
       "  'trpv1',\n",
       "  'activation',\n",
       "  'by',\n",
       "  'nonthermal',\n",
       "  'factors.'],\n",
       " ['paeonol',\n",
       "  'suppresses',\n",
       "  'intercellular',\n",
       "  'adhesion',\n",
       "  'molecule-1',\n",
       "  'expression',\n",
       "  'in',\n",
       "  'tumor',\n",
       "  'necrosis',\n",
       "  'factor-alpha-stimulated',\n",
       "  'human',\n",
       "  'umbilical',\n",
       "  'vein',\n",
       "  'endothelial',\n",
       "  'cells',\n",
       "  'by',\n",
       "  'blocking',\n",
       "  'p38,',\n",
       "  'erk',\n",
       "  'and',\n",
       "  'nuclear',\n",
       "  'factor-kappab',\n",
       "  'signaling',\n",
       "  'pathways.'],\n",
       " ['paeonol',\n",
       "  'suppresses',\n",
       "  'intercellular',\n",
       "  'adhesion',\n",
       "  'molecule-1',\n",
       "  'expression',\n",
       "  'in',\n",
       "  'tumor',\n",
       "  'necrosis',\n",
       "  'factor-alpha-stimulated',\n",
       "  'human',\n",
       "  'umbilical',\n",
       "  'vein',\n",
       "  'endothelial',\n",
       "  'cells',\n",
       "  'by',\n",
       "  'blocking',\n",
       "  'p38,',\n",
       "  'erk',\n",
       "  'and',\n",
       "  'nuclear',\n",
       "  'factor-kappab',\n",
       "  'signaling',\n",
       "  'pathways.'],\n",
       " ['paeonol',\n",
       "  'suppresses',\n",
       "  'intercellular',\n",
       "  'adhesion',\n",
       "  'molecule-1',\n",
       "  'expression',\n",
       "  'in',\n",
       "  'tumor',\n",
       "  'necrosis',\n",
       "  'factor-alpha-stimulated',\n",
       "  'human',\n",
       "  'umbilical',\n",
       "  'vein',\n",
       "  'endothelial',\n",
       "  'cells',\n",
       "  'by',\n",
       "  'blocking',\n",
       "  'p38,',\n",
       "  'erk',\n",
       "  'and',\n",
       "  'nuclear',\n",
       "  'factor-kappab',\n",
       "  'signaling',\n",
       "  'pathways.'],\n",
       " ['the',\n",
       "  'inhibitory',\n",
       "  'effect',\n",
       "  'of',\n",
       "  'paeonol',\n",
       "  'on',\n",
       "  'icam-1',\n",
       "  'production',\n",
       "  'might',\n",
       "  'be',\n",
       "  'mediated',\n",
       "  'by',\n",
       "  'inhibiting',\n",
       "  'p38,',\n",
       "  'erk',\n",
       "  'and',\n",
       "  'nf-kappab',\n",
       "  'signaling',\n",
       "  'pathways,',\n",
       "  'which',\n",
       "  'are',\n",
       "  'involved',\n",
       "  'in',\n",
       "  'tnf-alpha-induced',\n",
       "  'icam-1',\n",
       "  'production.'],\n",
       " ['the',\n",
       "  'inhibitory',\n",
       "  'effect',\n",
       "  'of',\n",
       "  'paeonol',\n",
       "  'on',\n",
       "  'icam-1',\n",
       "  'production',\n",
       "  'might',\n",
       "  'be',\n",
       "  'mediated',\n",
       "  'by',\n",
       "  'inhibiting',\n",
       "  'p38,',\n",
       "  'erk',\n",
       "  'and',\n",
       "  'nf-kappab',\n",
       "  'signaling',\n",
       "  'pathways,',\n",
       "  'which',\n",
       "  'are',\n",
       "  'involved',\n",
       "  'in',\n",
       "  'tnf-alpha-induced',\n",
       "  'icam-1',\n",
       "  'production.'],\n",
       " ['paeonol',\n",
       "  'suppresses',\n",
       "  'intercellular',\n",
       "  'adhesion',\n",
       "  'molecule-1',\n",
       "  'expression',\n",
       "  'in',\n",
       "  'tumor',\n",
       "  'necrosis',\n",
       "  'factor-alpha-stimulated',\n",
       "  'human',\n",
       "  'umbilical',\n",
       "  'vein',\n",
       "  'endothelial',\n",
       "  'cells',\n",
       "  'by',\n",
       "  'blocking',\n",
       "  'p38,',\n",
       "  'erk',\n",
       "  'and',\n",
       "  'nuclear',\n",
       "  'factor-kappab',\n",
       "  'signaling',\n",
       "  'pathways.'],\n",
       " ['the',\n",
       "  'inhibitory',\n",
       "  'effect',\n",
       "  'of',\n",
       "  'paeonol',\n",
       "  'on',\n",
       "  'icam-1',\n",
       "  'production',\n",
       "  'might',\n",
       "  'be',\n",
       "  'mediated',\n",
       "  'by',\n",
       "  'inhibiting',\n",
       "  'p38,',\n",
       "  'erk',\n",
       "  'and',\n",
       "  'nf-kappab',\n",
       "  'signaling',\n",
       "  'pathways,',\n",
       "  'which',\n",
       "  'are',\n",
       "  'involved',\n",
       "  'in',\n",
       "  'tnf-alpha-induced',\n",
       "  'icam-1',\n",
       "  'production.'],\n",
       " ['the',\n",
       "  'inhibitory',\n",
       "  'effect',\n",
       "  'of',\n",
       "  'paeonol',\n",
       "  'on',\n",
       "  'icam-1',\n",
       "  'production',\n",
       "  'might',\n",
       "  'be',\n",
       "  'mediated',\n",
       "  'by',\n",
       "  'inhibiting',\n",
       "  'p38,',\n",
       "  'erk',\n",
       "  'and',\n",
       "  'nf-kappab',\n",
       "  'signaling',\n",
       "  'pathways,',\n",
       "  'which',\n",
       "  'are',\n",
       "  'involved',\n",
       "  'in',\n",
       "  'tnf-alpha-induced',\n",
       "  'icam-1',\n",
       "  'production.'],\n",
       " ['paeonol',\n",
       "  'concentration-dependently',\n",
       "  'inhibited',\n",
       "  'the',\n",
       "  'production',\n",
       "  'of',\n",
       "  'icam-1;',\n",
       "  'it',\n",
       "  'inhibited',\n",
       "  'nuclear',\n",
       "  'factor-kappab',\n",
       "  '(nf-kappab)',\n",
       "  'p65',\n",
       "  'translocation',\n",
       "  'into',\n",
       "  'the',\n",
       "  'nucleus',\n",
       "  'and',\n",
       "  'the',\n",
       "  'phosphorylation',\n",
       "  'of',\n",
       "  'inhibitory',\n",
       "  'factor',\n",
       "  'kappabalpha',\n",
       "  '(ikappabalpha).'],\n",
       " ['paeonol',\n",
       "  'concentration-dependently',\n",
       "  'inhibited',\n",
       "  'the',\n",
       "  'production',\n",
       "  'of',\n",
       "  'icam-1;',\n",
       "  'it',\n",
       "  'inhibited',\n",
       "  'nuclear',\n",
       "  'factor-kappab',\n",
       "  '(nf-kappab)',\n",
       "  'p65',\n",
       "  'translocation',\n",
       "  'into',\n",
       "  'the',\n",
       "  'nucleus',\n",
       "  'and',\n",
       "  'the',\n",
       "  'phosphorylation',\n",
       "  'of',\n",
       "  'inhibitory',\n",
       "  'factor',\n",
       "  'kappabalpha',\n",
       "  '(ikappabalpha).'],\n",
       " ['paeonol',\n",
       "  'concentration-dependently',\n",
       "  'inhibited',\n",
       "  'the',\n",
       "  'production',\n",
       "  'of',\n",
       "  'icam-1;',\n",
       "  'it',\n",
       "  'inhibited',\n",
       "  'nuclear',\n",
       "  'factor-kappab',\n",
       "  '(nf-kappab)',\n",
       "  'p65',\n",
       "  'translocation',\n",
       "  'into',\n",
       "  'the',\n",
       "  'nucleus',\n",
       "  'and',\n",
       "  'the',\n",
       "  'phosphorylation',\n",
       "  'of',\n",
       "  'inhibitory',\n",
       "  'factor',\n",
       "  'kappabalpha',\n",
       "  '(ikappabalpha).'],\n",
       " ['paeonol',\n",
       "  'suppresses',\n",
       "  'intercellular',\n",
       "  'adhesion',\n",
       "  'molecule-1',\n",
       "  'expression',\n",
       "  'in',\n",
       "  'tumor',\n",
       "  'necrosis',\n",
       "  'factor-alpha-stimulated',\n",
       "  'human',\n",
       "  'umbilical',\n",
       "  'vein',\n",
       "  'endothelial',\n",
       "  'cells',\n",
       "  'by',\n",
       "  'blocking',\n",
       "  'p38,',\n",
       "  'erk',\n",
       "  'and',\n",
       "  'nuclear',\n",
       "  'factor-kappab',\n",
       "  'signaling',\n",
       "  'pathways.'],\n",
       " ['paeonol',\n",
       "  'inhibited',\n",
       "  'u937',\n",
       "  'monocyte',\n",
       "  'adhesion',\n",
       "  'to',\n",
       "  'huvecs',\n",
       "  'stimulated',\n",
       "  'by',\n",
       "  'tnf-alpha,',\n",
       "  'suggesting',\n",
       "  'that',\n",
       "  'it',\n",
       "  'may',\n",
       "  'inhibit',\n",
       "  'the',\n",
       "  'binding',\n",
       "  'of',\n",
       "  'monocytes',\n",
       "  'to',\n",
       "  'endothelium',\n",
       "  'by',\n",
       "  'regulating',\n",
       "  'the',\n",
       "  'production',\n",
       "  'of',\n",
       "  'critical',\n",
       "  'adhesion',\n",
       "  'molecules',\n",
       "  'by',\n",
       "  'tnf-alpha.'],\n",
       " ['we',\n",
       "  'studied',\n",
       "  'how',\n",
       "  'the',\n",
       "  'levels',\n",
       "  'of',\n",
       "  'intercellular',\n",
       "  'adhesion',\n",
       "  'molecule-1',\n",
       "  '(icam-1),',\n",
       "  'one',\n",
       "  'of',\n",
       "  'the',\n",
       "  'key',\n",
       "  'molecules',\n",
       "  'in',\n",
       "  'the',\n",
       "  'development',\n",
       "  'of',\n",
       "  'atherosclerosis,',\n",
       "  'might',\n",
       "  'be',\n",
       "  'affected',\n",
       "  'by',\n",
       "  'paeonol',\n",
       "  'in',\n",
       "  'tumor',\n",
       "  'necrosis',\n",
       "  'factor-alpha',\n",
       "  '(tnf-alpha)-activated',\n",
       "  'human',\n",
       "  'umbilical',\n",
       "  'vein',\n",
       "  'endothelial',\n",
       "  'cells',\n",
       "  '(huvecs).'],\n",
       " ['paeonol',\n",
       "  'concentration-dependently',\n",
       "  'inhibited',\n",
       "  'the',\n",
       "  'production',\n",
       "  'of',\n",
       "  'icam-1;',\n",
       "  'it',\n",
       "  'inhibited',\n",
       "  'nuclear',\n",
       "  'factor-kappab',\n",
       "  '(nf-kappab)',\n",
       "  'p65',\n",
       "  'translocation',\n",
       "  'into',\n",
       "  'the',\n",
       "  'nucleus',\n",
       "  'and',\n",
       "  'the',\n",
       "  'phosphorylation',\n",
       "  'of',\n",
       "  'inhibitory',\n",
       "  'factor',\n",
       "  'kappabalpha',\n",
       "  '(ikappabalpha).'],\n",
       " ['paeonol',\n",
       "  'concentration-dependently',\n",
       "  'inhibited',\n",
       "  'the',\n",
       "  'production',\n",
       "  'of',\n",
       "  'icam-1;',\n",
       "  'it',\n",
       "  'inhibited',\n",
       "  'nuclear',\n",
       "  'factor-kappab',\n",
       "  '(nf-kappab)',\n",
       "  'p65',\n",
       "  'translocation',\n",
       "  'into',\n",
       "  'the',\n",
       "  'nucleus',\n",
       "  'and',\n",
       "  'the',\n",
       "  'phosphorylation',\n",
       "  'of',\n",
       "  'inhibitory',\n",
       "  'factor',\n",
       "  'kappabalpha',\n",
       "  '(ikappabalpha).'],\n",
       " ['paeonol',\n",
       "  'concentration-dependently',\n",
       "  'inhibited',\n",
       "  'the',\n",
       "  'production',\n",
       "  'of',\n",
       "  'icam-1;',\n",
       "  'it',\n",
       "  'inhibited',\n",
       "  'nuclear',\n",
       "  'factor-kappab',\n",
       "  '(nf-kappab)',\n",
       "  'p65',\n",
       "  'translocation',\n",
       "  'into',\n",
       "  'the',\n",
       "  'nucleus',\n",
       "  'and',\n",
       "  'the',\n",
       "  'phosphorylation',\n",
       "  'of',\n",
       "  'inhibitory',\n",
       "  'factor',\n",
       "  'kappabalpha',\n",
       "  '(ikappabalpha).'],\n",
       " ['the',\n",
       "  'inhibitory',\n",
       "  'effect',\n",
       "  'of',\n",
       "  'paeonol',\n",
       "  'on',\n",
       "  'icam-1',\n",
       "  'production',\n",
       "  'might',\n",
       "  'be',\n",
       "  'mediated',\n",
       "  'by',\n",
       "  'inhibiting',\n",
       "  'p38,',\n",
       "  'erk',\n",
       "  'and',\n",
       "  'nf-kappab',\n",
       "  'signaling',\n",
       "  'pathways,',\n",
       "  'which',\n",
       "  'are',\n",
       "  'involved',\n",
       "  'in',\n",
       "  'tnf-alpha-induced',\n",
       "  'icam-1',\n",
       "  'production.'],\n",
       " ['here',\n",
       "  'we',\n",
       "  'report',\n",
       "  'that',\n",
       "  'osteoblastic',\n",
       "  'cells',\n",
       "  'express',\n",
       "  'scavenger',\n",
       "  'receptors',\n",
       "  'of',\n",
       "  'class',\n",
       "  'b',\n",
       "  'that',\n",
       "  'are',\n",
       "  'implicated',\n",
       "  'in',\n",
       "  'the',\n",
       "  'uptake',\n",
       "  'of',\n",
       "  'cholesterol',\n",
       "  'and',\n",
       "  'estradiol',\n",
       "  'from',\n",
       "  'ldl',\n",
       "  'and',\n",
       "  'hdl3.'],\n",
       " ['scavenger',\n",
       "  'receptor',\n",
       "  'of',\n",
       "  'class',\n",
       "  'b',\n",
       "  'expressed',\n",
       "  'by',\n",
       "  'osteoblastic',\n",
       "  'cells',\n",
       "  'are',\n",
       "  'implicated',\n",
       "  'in',\n",
       "  'the',\n",
       "  'uptake',\n",
       "  'of',\n",
       "  'cholesteryl',\n",
       "  'ester',\n",
       "  'and',\n",
       "  'estradiol',\n",
       "  'from',\n",
       "  'ldl',\n",
       "  'and',\n",
       "  'hdl3.'],\n",
       " ['scavenger',\n",
       "  'receptor',\n",
       "  'of',\n",
       "  'class',\n",
       "  'b',\n",
       "  'expressed',\n",
       "  'by',\n",
       "  'osteoblastic',\n",
       "  'cells',\n",
       "  'are',\n",
       "  'implicated',\n",
       "  'in',\n",
       "  'the',\n",
       "  'uptake',\n",
       "  'of',\n",
       "  'cholesteryl',\n",
       "  'ester',\n",
       "  'and',\n",
       "  'estradiol',\n",
       "  'from',\n",
       "  'ldl',\n",
       "  'and',\n",
       "  'hdl3.'],\n",
       " ['here',\n",
       "  'we',\n",
       "  'report',\n",
       "  'that',\n",
       "  'osteoblastic',\n",
       "  'cells',\n",
       "  'express',\n",
       "  'scavenger',\n",
       "  'receptors',\n",
       "  'of',\n",
       "  'class',\n",
       "  'b',\n",
       "  'that',\n",
       "  'are',\n",
       "  'implicated',\n",
       "  'in',\n",
       "  'the',\n",
       "  'uptake',\n",
       "  'of',\n",
       "  'cholesterol',\n",
       "  'and',\n",
       "  'estradiol',\n",
       "  'from',\n",
       "  'ldl',\n",
       "  'and',\n",
       "  'hdl3.'],\n",
       " ['scavenger',\n",
       "  'receptor',\n",
       "  'of',\n",
       "  'class',\n",
       "  'b',\n",
       "  'expressed',\n",
       "  'by',\n",
       "  'osteoblastic',\n",
       "  'cells',\n",
       "  'are',\n",
       "  'implicated',\n",
       "  'in',\n",
       "  'the',\n",
       "  'uptake',\n",
       "  'of',\n",
       "  'cholesteryl',\n",
       "  'ester',\n",
       "  'and',\n",
       "  'estradiol',\n",
       "  'from',\n",
       "  'ldl',\n",
       "  'and',\n",
       "  'hdl3.'],\n",
       " ['here',\n",
       "  'we',\n",
       "  'report',\n",
       "  'that',\n",
       "  'osteoblastic',\n",
       "  'cells',\n",
       "  'express',\n",
       "  'scavenger',\n",
       "  'receptors',\n",
       "  'of',\n",
       "  'class',\n",
       "  'b',\n",
       "  'that',\n",
       "  'are',\n",
       "  'implicated',\n",
       "  'in',\n",
       "  'the',\n",
       "  'uptake',\n",
       "  'of',\n",
       "  'cholesterol',\n",
       "  'and',\n",
       "  'estradiol',\n",
       "  'from',\n",
       "  'ldl',\n",
       "  'and',\n",
       "  'hdl3.'],\n",
       " ['overall,',\n",
       "  'our',\n",
       "  'results',\n",
       "  'suggest',\n",
       "  'a',\n",
       "  'novel',\n",
       "  'mechanism',\n",
       "  'for',\n",
       "  'the',\n",
       "  'routing',\n",
       "  'of',\n",
       "  'cholesterol',\n",
       "  'and',\n",
       "  'estradiol',\n",
       "  'to',\n",
       "  'osteoblasts',\n",
       "  'involving',\n",
       "  'the',\n",
       "  'metabolism',\n",
       "  'of',\n",
       "  'ldl',\n",
       "  'and',\n",
       "  'hdl3',\n",
       "  'by',\n",
       "  'sr-b',\n",
       "  'receptors.'],\n",
       " ['overall,',\n",
       "  'our',\n",
       "  'results',\n",
       "  'suggest',\n",
       "  'a',\n",
       "  'novel',\n",
       "  'mechanism',\n",
       "  'for',\n",
       "  'the',\n",
       "  'routing',\n",
       "  'of',\n",
       "  'cholesterol',\n",
       "  'and',\n",
       "  'estradiol',\n",
       "  'to',\n",
       "  'osteoblasts',\n",
       "  'involving',\n",
       "  'the',\n",
       "  'metabolism',\n",
       "  'of',\n",
       "  'ldl',\n",
       "  'and',\n",
       "  'hdl3',\n",
       "  'by',\n",
       "  'sr-b',\n",
       "  'receptors.'],\n",
       " ['finally,',\n",
       "  'estradiol',\n",
       "  'carried',\n",
       "  'by',\n",
       "  'ldl',\n",
       "  'and',\n",
       "  'hdl3',\n",
       "  'was',\n",
       "  'selectively',\n",
       "  'transferred',\n",
       "  'to',\n",
       "  'the',\n",
       "  'osteoblastic',\n",
       "  'cells',\n",
       "  'also',\n",
       "  'through',\n",
       "  'sr-b',\n",
       "  'receptors.'],\n",
       " ['finally,',\n",
       "  'estradiol',\n",
       "  'carried',\n",
       "  'by',\n",
       "  'ldl',\n",
       "  'and',\n",
       "  'hdl3',\n",
       "  'was',\n",
       "  'selectively',\n",
       "  'transferred',\n",
       "  'to',\n",
       "  'the',\n",
       "  'osteoblastic',\n",
       "  'cells',\n",
       "  'also',\n",
       "  'through',\n",
       "  'sr-b',\n",
       "  'receptors.'],\n",
       " ['finally,',\n",
       "  'estradiol',\n",
       "  'carried',\n",
       "  'by',\n",
       "  'ldl',\n",
       "  'and',\n",
       "  'hdl3',\n",
       "  'was',\n",
       "  'selectively',\n",
       "  'transferred',\n",
       "  'to',\n",
       "  'the',\n",
       "  'osteoblastic',\n",
       "  'cells',\n",
       "  'also',\n",
       "  'through',\n",
       "  'sr-b',\n",
       "  'receptors.'],\n",
       " ['overall,',\n",
       "  'our',\n",
       "  'results',\n",
       "  'suggest',\n",
       "  'a',\n",
       "  'novel',\n",
       "  'mechanism',\n",
       "  'for',\n",
       "  'the',\n",
       "  'routing',\n",
       "  'of',\n",
       "  'cholesterol',\n",
       "  'and',\n",
       "  'estradiol',\n",
       "  'to',\n",
       "  'osteoblasts',\n",
       "  'involving',\n",
       "  'the',\n",
       "  'metabolism',\n",
       "  'of',\n",
       "  'ldl',\n",
       "  'and',\n",
       "  'hdl3',\n",
       "  'by',\n",
       "  'sr-b',\n",
       "  'receptors.'],\n",
       " ['on',\n",
       "  'the',\n",
       "  'one',\n",
       "  'hand,',\n",
       "  'endocannabinoids',\n",
       "  'have',\n",
       "  'been',\n",
       "  'implicated',\n",
       "  'in',\n",
       "  'the',\n",
       "  'protective',\n",
       "  'effects',\n",
       "  'of',\n",
       "  'ipc',\n",
       "  'through',\n",
       "  'cannabinoid',\n",
       "  'cb1/cb2',\n",
       "  'receptor-dependent',\n",
       "  'and',\n",
       "  '-independent',\n",
       "  'mechanisms.'],\n",
       " ['on',\n",
       "  'the',\n",
       "  'one',\n",
       "  'hand,',\n",
       "  'endocannabinoids',\n",
       "  'have',\n",
       "  'been',\n",
       "  'implicated',\n",
       "  'in',\n",
       "  'the',\n",
       "  'protective',\n",
       "  'effects',\n",
       "  'of',\n",
       "  'ipc',\n",
       "  'through',\n",
       "  'cannabinoid',\n",
       "  'cb1/cb2',\n",
       "  'receptor-dependent',\n",
       "  'and',\n",
       "  '-independent',\n",
       "  'mechanisms.'],\n",
       " ['previous',\n",
       "  'studies',\n",
       "  'using',\n",
       "  'synthetic',\n",
       "  'cb1',\n",
       "  'receptor',\n",
       "  'agonists',\n",
       "  'or',\n",
       "  'knockout',\n",
       "  'mice',\n",
       "  'demonstrated',\n",
       "  'cb1',\n",
       "  'receptor-dependent',\n",
       "  'protection',\n",
       "  'against',\n",
       "  'cerebral',\n",
       "  'i/r',\n",
       "  'injury',\n",
       "  'in',\n",
       "  'various',\n",
       "  'animal',\n",
       "  'models.'],\n",
       " ['this',\n",
       "  'review',\n",
       "  'is',\n",
       "  'aimed',\n",
       "  'to',\n",
       "  'discuss',\n",
       "  'the',\n",
       "  'role',\n",
       "  'of',\n",
       "  'endocannabinoids',\n",
       "  'and',\n",
       "  'cb',\n",
       "  'receptors',\n",
       "  'in',\n",
       "  'various',\n",
       "  'forms',\n",
       "  'of',\n",
       "  'i/r',\n",
       "  'injury',\n",
       "  '(myocardial,',\n",
       "  'cerebral,',\n",
       "  'hepatic',\n",
       "  'and',\n",
       "  'circulatory',\n",
       "  'shock)',\n",
       "  'and',\n",
       "  'preconditioning,',\n",
       "  'and',\n",
       "  'to',\n",
       "  'delineate',\n",
       "  'the',\n",
       "  'evidence',\n",
       "  'supporting',\n",
       "  'the',\n",
       "  'therapeutic',\n",
       "  'utility',\n",
       "  'of',\n",
       "  'selective',\n",
       "  'cb2',\n",
       "  'receptor',\n",
       "  'agonists,',\n",
       "  'which',\n",
       "  'are',\n",
       "  'devoid',\n",
       "  'of',\n",
       "  'psychoactive',\n",
       "  'effects,',\n",
       "  'as',\n",
       "  'a',\n",
       "  'promising',\n",
       "  'new',\n",
       "  'approach',\n",
       "  'to',\n",
       "  'limit',\n",
       "  'i/r-induced',\n",
       "  'tissue',\n",
       "  'damage.'],\n",
       " ['excitedly,',\n",
       "  'emerging',\n",
       "  'studies',\n",
       "  'using',\n",
       "  'potent',\n",
       "  'cb2',\n",
       "  'receptor',\n",
       "  'agonists',\n",
       "  'and/or',\n",
       "  'knockout',\n",
       "  'mice',\n",
       "  'have',\n",
       "  'provided',\n",
       "  'compelling',\n",
       "  'evidence',\n",
       "  'that',\n",
       "  'cb2',\n",
       "  'receptor',\n",
       "  'activation',\n",
       "  'is',\n",
       "  'protective',\n",
       "  'against',\n",
       "  'myocardial,',\n",
       "  'cerebral',\n",
       "  'and',\n",
       "  'hepatic',\n",
       "  'i/r',\n",
       "  'injuries',\n",
       "  'by',\n",
       "  'decreasing',\n",
       "  'the',\n",
       "  'endothelial',\n",
       "  'cell',\n",
       "  'activation/inflammatory',\n",
       "  'response',\n",
       "  '(for',\n",
       "  'example,',\n",
       "  'expression',\n",
       "  'of',\n",
       "  'adhesion',\n",
       "  'molecules,',\n",
       "  'secretion',\n",
       "  'of',\n",
       "  'chemokines,',\n",
       "  'and',\n",
       "  'so',\n",
       "  'on),',\n",
       "  'and',\n",
       "  'by',\n",
       "  'attenuating',\n",
       "  'the',\n",
       "  'leukocyte',\n",
       "  'chemotaxis,',\n",
       "  'rolling,',\n",
       "  'adhesion',\n",
       "  'to',\n",
       "  'endothelium,',\n",
       "  'activation',\n",
       "  'and',\n",
       "  'transendothelial',\n",
       "  'migration,',\n",
       "  'and',\n",
       "  'interrelated',\n",
       "  'oxidative/nitrosative',\n",
       "  'damage.'],\n",
       " ['we',\n",
       "  'have',\n",
       "  'developed',\n",
       "  'a',\n",
       "  'small-molecule',\n",
       "  'inhibitor',\n",
       "  'of',\n",
       "  'all',\n",
       "  'three',\n",
       "  'vascular',\n",
       "  'endothelial',\n",
       "  'growth',\n",
       "  'factor',\n",
       "  '(vegf)',\n",
       "  'receptors',\n",
       "  '(vegfr),',\n",
       "  'platelet-derived',\n",
       "  'growth',\n",
       "  'factor',\n",
       "  'receptor,',\n",
       "  'and',\n",
       "  'c-kit',\n",
       "  'tyrosine',\n",
       "  'kinases,',\n",
       "  'pazopanib',\n",
       "  '(gw786034),',\n",
       "  'which',\n",
       "  'selectively',\n",
       "  'inhibits',\n",
       "  'vegf-induced',\n",
       "  'endothelial',\n",
       "  'cell',\n",
       "  'proliferation.'],\n",
       " ['we',\n",
       "  'have',\n",
       "  'developed',\n",
       "  'a',\n",
       "  'small-molecule',\n",
       "  'inhibitor',\n",
       "  'of',\n",
       "  'all',\n",
       "  'three',\n",
       "  'vascular',\n",
       "  'endothelial',\n",
       "  'growth',\n",
       "  'factor',\n",
       "  '(vegf)',\n",
       "  'receptors',\n",
       "  '(vegfr),',\n",
       "  'platelet-derived',\n",
       "  'growth',\n",
       "  'factor',\n",
       "  'receptor,',\n",
       "  'and',\n",
       "  'c-kit',\n",
       "  'tyrosine',\n",
       "  'kinases,',\n",
       "  'pazopanib',\n",
       "  '(gw786034),',\n",
       "  'which',\n",
       "  'selectively',\n",
       "  'inhibits',\n",
       "  'vegf-induced',\n",
       "  'endothelial',\n",
       "  'cell',\n",
       "  'proliferation.'],\n",
       " ['we',\n",
       "  'have',\n",
       "  'developed',\n",
       "  'a',\n",
       "  'small-molecule',\n",
       "  'inhibitor',\n",
       "  'of',\n",
       "  'all',\n",
       "  'three',\n",
       "  'vascular',\n",
       "  'endothelial',\n",
       "  'growth',\n",
       "  'factor',\n",
       "  '(vegf)',\n",
       "  'receptors',\n",
       "  '(vegfr),',\n",
       "  'platelet-derived',\n",
       "  'growth',\n",
       "  'factor',\n",
       "  'receptor,',\n",
       "  'and',\n",
       "  'c-kit',\n",
       "  'tyrosine',\n",
       "  'kinases,',\n",
       "  'pazopanib',\n",
       "  '(gw786034),',\n",
       "  'which',\n",
       "  'selectively',\n",
       "  'inhibits',\n",
       "  'vegf-induced',\n",
       "  'endothelial',\n",
       "  'cell',\n",
       "  'proliferation.'],\n",
       " ['we',\n",
       "  'have',\n",
       "  'developed',\n",
       "  'a',\n",
       "  'small-molecule',\n",
       "  'inhibitor',\n",
       "  'of',\n",
       "  'all',\n",
       "  'three',\n",
       "  'vascular',\n",
       "  'endothelial',\n",
       "  'growth',\n",
       "  'factor',\n",
       "  '(vegf)',\n",
       "  'receptors',\n",
       "  '(vegfr),',\n",
       "  'platelet-derived',\n",
       "  'growth',\n",
       "  'factor',\n",
       "  'receptor,',\n",
       "  'and',\n",
       "  'c-kit',\n",
       "  'tyrosine',\n",
       "  'kinases,',\n",
       "  'pazopanib',\n",
       "  '(gw786034),',\n",
       "  'which',\n",
       "  'selectively',\n",
       "  'inhibits',\n",
       "  'vegf-induced',\n",
       "  'endothelial',\n",
       "  'cell',\n",
       "  'proliferation.'],\n",
       " ['we',\n",
       "  'have',\n",
       "  'developed',\n",
       "  'a',\n",
       "  'small-molecule',\n",
       "  'inhibitor',\n",
       "  'of',\n",
       "  'all',\n",
       "  'three',\n",
       "  'vascular',\n",
       "  'endothelial',\n",
       "  'growth',\n",
       "  'factor',\n",
       "  '(vegf)',\n",
       "  'receptors',\n",
       "  '(vegfr),',\n",
       "  'platelet-derived',\n",
       "  'growth',\n",
       "  'factor',\n",
       "  'receptor,',\n",
       "  'and',\n",
       "  'c-kit',\n",
       "  'tyrosine',\n",
       "  'kinases,',\n",
       "  'pazopanib',\n",
       "  '(gw786034),',\n",
       "  'which',\n",
       "  'selectively',\n",
       "  'inhibits',\n",
       "  'vegf-induced',\n",
       "  'endothelial',\n",
       "  'cell',\n",
       "  'proliferation.'],\n",
       " ['we',\n",
       "  'have',\n",
       "  'developed',\n",
       "  'a',\n",
       "  'small-molecule',\n",
       "  'inhibitor',\n",
       "  'of',\n",
       "  'all',\n",
       "  'three',\n",
       "  'vascular',\n",
       "  'endothelial',\n",
       "  'growth',\n",
       "  'factor',\n",
       "  '(vegf)',\n",
       "  'receptors',\n",
       "  '(vegfr),',\n",
       "  'platelet-derived',\n",
       "  'growth',\n",
       "  'factor',\n",
       "  'receptor,',\n",
       "  'and',\n",
       "  'c-kit',\n",
       "  'tyrosine',\n",
       "  'kinases,',\n",
       "  'pazopanib',\n",
       "  '(gw786034),',\n",
       "  'which',\n",
       "  'selectively',\n",
       "  'inhibits',\n",
       "  'vegf-induced',\n",
       "  'endothelial',\n",
       "  'cell',\n",
       "  'proliferation.'],\n",
       " ['we',\n",
       "  'have',\n",
       "  'developed',\n",
       "  'a',\n",
       "  'small-molecule',\n",
       "  'inhibitor',\n",
       "  'of',\n",
       "  'all',\n",
       "  'three',\n",
       "  'vascular',\n",
       "  'endothelial',\n",
       "  'growth',\n",
       "  'factor',\n",
       "  '(vegf)',\n",
       "  'receptors',\n",
       "  '(vegfr),',\n",
       "  'platelet-derived',\n",
       "  'growth',\n",
       "  'factor',\n",
       "  'receptor,',\n",
       "  'and',\n",
       "  'c-kit',\n",
       "  'tyrosine',\n",
       "  'kinases,',\n",
       "  'pazopanib',\n",
       "  '(gw786034),',\n",
       "  'which',\n",
       "  'selectively',\n",
       "  'inhibits',\n",
       "  'vegf-induced',\n",
       "  'endothelial',\n",
       "  'cell',\n",
       "  'proliferation.'],\n",
       " ['we',\n",
       "  'have',\n",
       "  'developed',\n",
       "  'a',\n",
       "  'small-molecule',\n",
       "  'inhibitor',\n",
       "  'of',\n",
       "  'all',\n",
       "  'three',\n",
       "  'vascular',\n",
       "  'endothelial',\n",
       "  'growth',\n",
       "  'factor',\n",
       "  '(vegf)',\n",
       "  'receptors',\n",
       "  '(vegfr),',\n",
       "  'platelet-derived',\n",
       "  'growth',\n",
       "  'factor',\n",
       "  'receptor,',\n",
       "  'and',\n",
       "  'c-kit',\n",
       "  'tyrosine',\n",
       "  'kinases,',\n",
       "  'pazopanib',\n",
       "  '(gw786034),',\n",
       "  'which',\n",
       "  'selectively',\n",
       "  'inhibits',\n",
       "  'vegf-induced',\n",
       "  'endothelial',\n",
       "  'cell',\n",
       "  'proliferation.'],\n",
       " ['we',\n",
       "  'have',\n",
       "  'developed',\n",
       "  'a',\n",
       "  'small-molecule',\n",
       "  'inhibitor',\n",
       "  'of',\n",
       "  'all',\n",
       "  'three',\n",
       "  'vascular',\n",
       "  'endothelial',\n",
       "  'growth',\n",
       "  'factor',\n",
       "  '(vegf)',\n",
       "  'receptors',\n",
       "  '(vegfr),',\n",
       "  'platelet-derived',\n",
       "  'growth',\n",
       "  'factor',\n",
       "  'receptor,',\n",
       "  'and',\n",
       "  'c-kit',\n",
       "  'tyrosine',\n",
       "  'kinases,',\n",
       "  'pazopanib',\n",
       "  '(gw786034),',\n",
       "  'which',\n",
       "  'selectively',\n",
       "  'inhibits',\n",
       "  'vegf-induced',\n",
       "  'endothelial',\n",
       "  'cell',\n",
       "  'proliferation.'],\n",
       " ['we',\n",
       "  'have',\n",
       "  'developed',\n",
       "  'a',\n",
       "  'small-molecule',\n",
       "  'inhibitor',\n",
       "  'of',\n",
       "  'all',\n",
       "  'three',\n",
       "  'vascular',\n",
       "  'endothelial',\n",
       "  'growth',\n",
       "  'factor',\n",
       "  '(vegf)',\n",
       "  'receptors',\n",
       "  '(vegfr),',\n",
       "  'platelet-derived',\n",
       "  'growth',\n",
       "  'factor',\n",
       "  'receptor,',\n",
       "  'and',\n",
       "  'c-kit',\n",
       "  'tyrosine',\n",
       "  'kinases,',\n",
       "  'pazopanib',\n",
       "  '(gw786034),',\n",
       "  'which',\n",
       "  'selectively',\n",
       "  'inhibits',\n",
       "  'vegf-induced',\n",
       "  'endothelial',\n",
       "  'cell',\n",
       "  'proliferation.'],\n",
       " ['the',\n",
       "  'pharmacokinetics',\n",
       "  'of',\n",
       "  'the',\n",
       "  'three',\n",
       "  '5ht3',\n",
       "  'antagonists',\n",
       "  'investigated',\n",
       "  'were',\n",
       "  'dominated',\n",
       "  'by',\n",
       "  'cyp3a4',\n",
       "  '(and/or',\n",
       "  '2c9)',\n",
       "  'compared',\n",
       "  'with',\n",
       "  'cyp1a2',\n",
       "  'in',\n",
       "  'man,',\n",
       "  'possibly',\n",
       "  'determined',\n",
       "  'by',\n",
       "  'enzyme',\n",
       "  'capacity',\n",
       "  'rather',\n",
       "  'than',\n",
       "  'relative',\n",
       "  'enzyme',\n",
       "  'affinity.'],\n",
       " ['the',\n",
       "  'pharmacokinetics',\n",
       "  'of',\n",
       "  'the',\n",
       "  'three',\n",
       "  '5ht3',\n",
       "  'antagonists',\n",
       "  'investigated',\n",
       "  'were',\n",
       "  'dominated',\n",
       "  'by',\n",
       "  'cyp3a4',\n",
       "  '(and/or',\n",
       "  '2c9)',\n",
       "  'compared',\n",
       "  'with',\n",
       "  'cyp1a2',\n",
       "  'in',\n",
       "  'man,',\n",
       "  'possibly',\n",
       "  'determined',\n",
       "  'by',\n",
       "  'enzyme',\n",
       "  'capacity',\n",
       "  'rather',\n",
       "  'than',\n",
       "  'relative',\n",
       "  'enzyme',\n",
       "  'affinity.'],\n",
       " ['novel',\n",
       "  'iminobenzoxathiolone',\n",
       "  'compound',\n",
       "  'inhibits',\n",
       "  'nuclear',\n",
       "  'factor-kappab',\n",
       "  'activation',\n",
       "  'targeting',\n",
       "  'inhibitory',\n",
       "  'kappab',\n",
       "  'kinase',\n",
       "  'beta',\n",
       "  'and',\n",
       "  'down-regulating',\n",
       "  'interleukin-1beta',\n",
       "  'expression',\n",
       "  'in',\n",
       "  'lipopolysaccharide-activated',\n",
       "  'macrophages.'],\n",
       " ['in',\n",
       "  'this',\n",
       "  'study,',\n",
       "  'a',\n",
       "  'novel',\n",
       "  'iminobenzoxathiolone',\n",
       "  'lyr-71',\n",
       "  'of',\n",
       "  '6-methyl-2-propylimino-6,7-dihydro-5h-benzo[1,3]oxathiol-4-one',\n",
       "  'has',\n",
       "  'been',\n",
       "  'demonstrated',\n",
       "  'to',\n",
       "  'inhibit',\n",
       "  'in',\n",
       "  'vitro',\n",
       "  'catalytic',\n",
       "  'activity',\n",
       "  'of',\n",
       "  'inhibitory',\n",
       "  'kappab',\n",
       "  '(ikappab)',\n",
       "  'kinase',\n",
       "  'beta',\n",
       "  '(ikkbeta),',\n",
       "  'a',\n",
       "  'key',\n",
       "  'enzyme',\n",
       "  'required',\n",
       "  'for',\n",
       "  'nf-kappab',\n",
       "  'activation,',\n",
       "  'with',\n",
       "  'an',\n",
       "  'ic(50)',\n",
       "  'value',\n",
       "  'of',\n",
       "  '7',\n",
       "  'microm.'],\n",
       " ['in',\n",
       "  'this',\n",
       "  'study,',\n",
       "  'a',\n",
       "  'novel',\n",
       "  'iminobenzoxathiolone',\n",
       "  'lyr-71',\n",
       "  'of',\n",
       "  '6-methyl-2-propylimino-6,7-dihydro-5h-benzo[1,3]oxathiol-4-one',\n",
       "  'has',\n",
       "  'been',\n",
       "  'demonstrated',\n",
       "  'to',\n",
       "  'inhibit',\n",
       "  'in',\n",
       "  'vitro',\n",
       "  'catalytic',\n",
       "  'activity',\n",
       "  'of',\n",
       "  'inhibitory',\n",
       "  'kappab',\n",
       "  '(ikappab)',\n",
       "  'kinase',\n",
       "  'beta',\n",
       "  '(ikkbeta),',\n",
       "  'a',\n",
       "  'key',\n",
       "  'enzyme',\n",
       "  'required',\n",
       "  'for',\n",
       "  'nf-kappab',\n",
       "  'activation,',\n",
       "  'with',\n",
       "  'an',\n",
       "  'ic(50)',\n",
       "  'value',\n",
       "  'of',\n",
       "  '7',\n",
       "  'microm.'],\n",
       " ['novel',\n",
       "  'iminobenzoxathiolone',\n",
       "  'compound',\n",
       "  'inhibits',\n",
       "  'nuclear',\n",
       "  'factor-kappab',\n",
       "  'activation',\n",
       "  'targeting',\n",
       "  'inhibitory',\n",
       "  'kappab',\n",
       "  'kinase',\n",
       "  'beta',\n",
       "  'and',\n",
       "  'down-regulating',\n",
       "  'interleukin-1beta',\n",
       "  'expression',\n",
       "  'in',\n",
       "  'lipopolysaccharide-activated',\n",
       "  'macrophages.'],\n",
       " ['furthermore,',\n",
       "  'lyr-71',\n",
       "  'down-regulated',\n",
       "  'lps-induced',\n",
       "  'transcription',\n",
       "  'of',\n",
       "  'interleukin',\n",
       "  '(il)-1beta',\n",
       "  'or',\n",
       "  'other',\n",
       "  'cytokines',\n",
       "  'in',\n",
       "  'the',\n",
       "  'cells,',\n",
       "  'and',\n",
       "  'inhibited',\n",
       "  'expression',\n",
       "  'vector',\n",
       "  'ikkbeta-elicited',\n",
       "  'il-1beta',\n",
       "  'promoter',\n",
       "  'activity.'],\n",
       " ['furthermore,',\n",
       "  'lyr-71',\n",
       "  'down-regulated',\n",
       "  'lps-induced',\n",
       "  'transcription',\n",
       "  'of',\n",
       "  'interleukin',\n",
       "  '(il)-1beta',\n",
       "  'or',\n",
       "  'other',\n",
       "  'cytokines',\n",
       "  'in',\n",
       "  'the',\n",
       "  'cells,',\n",
       "  'and',\n",
       "  'inhibited',\n",
       "  'expression',\n",
       "  'vector',\n",
       "  'ikkbeta-elicited',\n",
       "  'il-1beta',\n",
       "  'promoter',\n",
       "  'activity.'],\n",
       " ['in',\n",
       "  'this',\n",
       "  'study,',\n",
       "  'a',\n",
       "  'novel',\n",
       "  'iminobenzoxathiolone',\n",
       "  'lyr-71',\n",
       "  'of',\n",
       "  '6-methyl-2-propylimino-6,7-dihydro-5h-benzo[1,3]oxathiol-4-one',\n",
       "  'has',\n",
       "  'been',\n",
       "  'demonstrated',\n",
       "  'to',\n",
       "  'inhibit',\n",
       "  'in',\n",
       "  'vitro',\n",
       "  'catalytic',\n",
       "  'activity',\n",
       "  'of',\n",
       "  'inhibitory',\n",
       "  'kappab',\n",
       "  '(ikappab)',\n",
       "  'kinase',\n",
       "  'beta',\n",
       "  '(ikkbeta),',\n",
       "  'a',\n",
       "  'key',\n",
       "  'enzyme',\n",
       "  'required',\n",
       "  'for',\n",
       "  'nf-kappab',\n",
       "  'activation,',\n",
       "  'with',\n",
       "  'an',\n",
       "  'ic(50)',\n",
       "  'value',\n",
       "  'of',\n",
       "  '7',\n",
       "  'microm.'],\n",
       " ['lyr-71',\n",
       "  'inhibited',\n",
       "  'ikkbeta-mediated',\n",
       "  'phosphorylation',\n",
       "  'of',\n",
       "  'cytoplasmic',\n",
       "  'ikappabalpha',\n",
       "  'in',\n",
       "  'lipopolysaccharide',\n",
       "  '(lps)-activated',\n",
       "  'macrophages,',\n",
       "  'and',\n",
       "  'sequentially',\n",
       "  'preventing',\n",
       "  'ikappabalpha',\n",
       "  'degradation',\n",
       "  'as',\n",
       "  'well',\n",
       "  'as',\n",
       "  'transcriptional',\n",
       "  'activation',\n",
       "  'of',\n",
       "  'nf-kappab.'],\n",
       " ['taken',\n",
       "  'together,',\n",
       "  'lyr-71',\n",
       "  'was',\n",
       "  'an',\n",
       "  'efficient',\n",
       "  'inhibitor',\n",
       "  'of',\n",
       "  'ikkbeta,',\n",
       "  'preventing',\n",
       "  'nf-kappab',\n",
       "  'activation',\n",
       "  'in',\n",
       "  'macrophages,',\n",
       "  'and',\n",
       "  'this',\n",
       "  'mechanism',\n",
       "  'of',\n",
       "  'action',\n",
       "  'could',\n",
       "  'contribute',\n",
       "  'its',\n",
       "  'down-regulatory',\n",
       "  'effect',\n",
       "  'on',\n",
       "  'lps-induced',\n",
       "  'expression',\n",
       "  'of',\n",
       "  'inflammatory',\n",
       "  'cytokines',\n",
       "  'at',\n",
       "  'the',\n",
       "  'transcription',\n",
       "  'level.'],\n",
       " ['taken',\n",
       "  'together,',\n",
       "  'lyr-71',\n",
       "  'was',\n",
       "  'an',\n",
       "  'efficient',\n",
       "  'inhibitor',\n",
       "  'of',\n",
       "  'ikkbeta,',\n",
       "  'preventing',\n",
       "  'nf-kappab',\n",
       "  'activation',\n",
       "  'in',\n",
       "  'macrophages,',\n",
       "  'and',\n",
       "  'this',\n",
       "  'mechanism',\n",
       "  'of',\n",
       "  'action',\n",
       "  'could',\n",
       "  'contribute',\n",
       "  'its',\n",
       "  'down-regulatory',\n",
       "  'effect',\n",
       "  'on',\n",
       "  'lps-induced',\n",
       "  'expression',\n",
       "  'of',\n",
       "  'inflammatory',\n",
       "  'cytokines',\n",
       "  'at',\n",
       "  'the',\n",
       "  'transcription',\n",
       "  'level.'],\n",
       " ['lyr-71',\n",
       "  'inhibited',\n",
       "  'ikkbeta-mediated',\n",
       "  'phosphorylation',\n",
       "  'of',\n",
       "  'cytoplasmic',\n",
       "  'ikappabalpha',\n",
       "  'in',\n",
       "  'lipopolysaccharide',\n",
       "  '(lps)-activated',\n",
       "  'macrophages,',\n",
       "  'and',\n",
       "  'sequentially',\n",
       "  'preventing',\n",
       "  'ikappabalpha',\n",
       "  'degradation',\n",
       "  'as',\n",
       "  'well',\n",
       "  'as',\n",
       "  'transcriptional',\n",
       "  'activation',\n",
       "  'of',\n",
       "  'nf-kappab.'],\n",
       " ['lyr-71',\n",
       "  'inhibited',\n",
       "  'ikkbeta-mediated',\n",
       "  'phosphorylation',\n",
       "  'of',\n",
       "  'cytoplasmic',\n",
       "  'ikappabalpha',\n",
       "  'in',\n",
       "  'lipopolysaccharide',\n",
       "  '(lps)-activated',\n",
       "  'macrophages,',\n",
       "  'and',\n",
       "  'sequentially',\n",
       "  'preventing',\n",
       "  'ikappabalpha',\n",
       "  'degradation',\n",
       "  'as',\n",
       "  'well',\n",
       "  'as',\n",
       "  'transcriptional',\n",
       "  'activation',\n",
       "  'of',\n",
       "  'nf-kappab.'],\n",
       " ['taken',\n",
       "  'together,',\n",
       "  'lyr-71',\n",
       "  'was',\n",
       "  'an',\n",
       "  'efficient',\n",
       "  'inhibitor',\n",
       "  'of',\n",
       "  'ikkbeta,',\n",
       "  'preventing',\n",
       "  'nf-kappab',\n",
       "  'activation',\n",
       "  'in',\n",
       "  'macrophages,',\n",
       "  'and',\n",
       "  'this',\n",
       "  'mechanism',\n",
       "  'of',\n",
       "  'action',\n",
       "  'could',\n",
       "  'contribute',\n",
       "  'its',\n",
       "  'down-regulatory',\n",
       "  'effect',\n",
       "  'on',\n",
       "  'lps-induced',\n",
       "  'expression',\n",
       "  'of',\n",
       "  'inflammatory',\n",
       "  'cytokines',\n",
       "  'at',\n",
       "  'the',\n",
       "  'transcription',\n",
       "  'level.'],\n",
       " ['novel',\n",
       "  'iminobenzoxathiolone',\n",
       "  'compound',\n",
       "  'inhibits',\n",
       "  'nuclear',\n",
       "  'factor-kappab',\n",
       "  'activation',\n",
       "  'targeting',\n",
       "  'inhibitory',\n",
       "  'kappab',\n",
       "  'kinase',\n",
       "  'beta',\n",
       "  'and',\n",
       "  'down-regulating',\n",
       "  'interleukin-1beta',\n",
       "  'expression',\n",
       "  'in',\n",
       "  'lipopolysaccharide-activated',\n",
       "  'macrophages.'],\n",
       " ['to',\n",
       "  'counter',\n",
       "  'this,',\n",
       "  'we',\n",
       "  'have',\n",
       "  'studied',\n",
       "  'the',\n",
       "  'pharmacokinetics',\n",
       "  'in',\n",
       "  'mice',\n",
       "  'of',\n",
       "  'two',\n",
       "  'murine',\n",
       "  'analogs',\n",
       "  'of',\n",
       "  'human',\n",
       "  'tnf',\n",
       "  'blockers,',\n",
       "  'a',\n",
       "  'murine',\n",
       "  'p75-fc',\n",
       "  'fusion',\n",
       "  'protein',\n",
       "  '(analogous',\n",
       "  'to',\n",
       "  'etanercept),',\n",
       "  'and',\n",
       "  'the',\n",
       "  'rat',\n",
       "  'mp6-xt22',\n",
       "  'anti-murine',\n",
       "  'tnf',\n",
       "  'mab',\n",
       "  '(analogous',\n",
       "  'to',\n",
       "  'infliximab).'],\n",
       " ['phosphorylation',\n",
       "  'of',\n",
       "  'egfr',\n",
       "  'and',\n",
       "  'activated',\n",
       "  'downstream',\n",
       "  'signaling',\n",
       "  'proteins,',\n",
       "  'such',\n",
       "  'as',\n",
       "  'erk1,',\n",
       "  'jnk',\n",
       "  'and',\n",
       "  'p38,',\n",
       "  'were',\n",
       "  'found',\n",
       "  'to',\n",
       "  'be',\n",
       "  'depressed',\n",
       "  'after',\n",
       "  'incubation',\n",
       "  'with',\n",
       "  'f90',\n",
       "  'for',\n",
       "  '48',\n",
       "  'hours',\n",
       "  'in',\n",
       "  'vitro.'],\n",
       " ['phosphorylation',\n",
       "  'of',\n",
       "  'egfr',\n",
       "  'and',\n",
       "  'activated',\n",
       "  'downstream',\n",
       "  'signaling',\n",
       "  'proteins,',\n",
       "  'such',\n",
       "  'as',\n",
       "  'erk1,',\n",
       "  'jnk',\n",
       "  'and',\n",
       "  'p38,',\n",
       "  'were',\n",
       "  'found',\n",
       "  'to',\n",
       "  'be',\n",
       "  'depressed',\n",
       "  'after',\n",
       "  'incubation',\n",
       "  'with',\n",
       "  'f90',\n",
       "  'for',\n",
       "  '48',\n",
       "  'hours',\n",
       "  'in',\n",
       "  'vitro.'],\n",
       " ['phosphorylation',\n",
       "  'of',\n",
       "  'egfr',\n",
       "  'and',\n",
       "  'activated',\n",
       "  'downstream',\n",
       "  'signaling',\n",
       "  'proteins,',\n",
       "  'such',\n",
       "  'as',\n",
       "  'erk1,',\n",
       "  'jnk',\n",
       "  'and',\n",
       "  'p38,',\n",
       "  'were',\n",
       "  'found',\n",
       "  'to',\n",
       "  'be',\n",
       "  'depressed',\n",
       "  'after',\n",
       "  'incubation',\n",
       "  'with',\n",
       "  'f90',\n",
       "  'for',\n",
       "  '48',\n",
       "  'hours',\n",
       "  'in',\n",
       "  'vitro.'],\n",
       " ['phosphorylation',\n",
       "  'of',\n",
       "  'egfr',\n",
       "  'and',\n",
       "  'activated',\n",
       "  'downstream',\n",
       "  'signaling',\n",
       "  'proteins,',\n",
       "  'such',\n",
       "  'as',\n",
       "  'erk1,',\n",
       "  'jnk',\n",
       "  'and',\n",
       "  'p38,',\n",
       "  'were',\n",
       "  'found',\n",
       "  'to',\n",
       "  'be',\n",
       "  'depressed',\n",
       "  'after',\n",
       "  'incubation',\n",
       "  'with',\n",
       "  'f90',\n",
       "  'for',\n",
       "  '48',\n",
       "  'hours',\n",
       "  'in',\n",
       "  'vitro.'],\n",
       " ['two',\n",
       "  'monoclonal',\n",
       "  'antibodies,',\n",
       "  'cetuximab,',\n",
       "  'which',\n",
       "  'targets',\n",
       "  'egfr,',\n",
       "  'and',\n",
       "  'bevacizumab,',\n",
       "  'which',\n",
       "  'target',\n",
       "  'the',\n",
       "  'vegf',\n",
       "  'signaling',\n",
       "  'pathway,',\n",
       "  'are',\n",
       "  'being',\n",
       "  'evaluated',\n",
       "  'as',\n",
       "  'monotherapy',\n",
       "  'and',\n",
       "  'in',\n",
       "  'combination',\n",
       "  'with',\n",
       "  'other',\n",
       "  'agents',\n",
       "  'and/or',\n",
       "  'radiotherapy',\n",
       "  'for',\n",
       "  'the',\n",
       "  'treatment',\n",
       "  'of',\n",
       "  'cervical',\n",
       "  'cancer.'],\n",
       " ['two',\n",
       "  'monoclonal',\n",
       "  'antibodies,',\n",
       "  'cetuximab,',\n",
       "  'which',\n",
       "  'targets',\n",
       "  'egfr,',\n",
       "  'and',\n",
       "  'bevacizumab,',\n",
       "  'which',\n",
       "  'target',\n",
       "  'the',\n",
       "  'vegf',\n",
       "  'signaling',\n",
       "  'pathway,',\n",
       "  'are',\n",
       "  'being',\n",
       "  'evaluated',\n",
       "  'as',\n",
       "  'monotherapy',\n",
       "  'and',\n",
       "  'in',\n",
       "  'combination',\n",
       "  'with',\n",
       "  'other',\n",
       "  'agents',\n",
       "  'and/or',\n",
       "  'radiotherapy',\n",
       "  'for',\n",
       "  'the',\n",
       "  'treatment',\n",
       "  'of',\n",
       "  'cervical',\n",
       "  'cancer.'],\n",
       " ['using',\n",
       "  'these',\n",
       "  'methods,',\n",
       "  'we',\n",
       "  'show',\n",
       "  'that',\n",
       "  'egfr',\n",
       "  'kinase',\n",
       "  'inhibitors',\n",
       "  'sensitize',\n",
       "  'colorectal',\n",
       "  'sw-480',\n",
       "  'tumor',\n",
       "  'cells',\n",
       "  'for',\n",
       "  '5-fluorouracil-induced',\n",
       "  'apoptosis,',\n",
       "  'indicating',\n",
       "  'that',\n",
       "  'egfr-mediated',\n",
       "  'survival',\n",
       "  'signaling',\n",
       "  'contributes',\n",
       "  'to',\n",
       "  'apoptosis',\n",
       "  'resistance',\n",
       "  'via',\n",
       "  'its',\n",
       "  'intrinsic',\n",
       "  'kinase',\n",
       "  'activity.'],\n",
       " ['in',\n",
       "  'cells',\n",
       "  'grown',\n",
       "  'under',\n",
       "  'hypoxia',\n",
       "  'for',\n",
       "  '6',\n",
       "  'h,',\n",
       "  'brca1',\n",
       "  'was',\n",
       "  'not',\n",
       "  'decreased,',\n",
       "  'but',\n",
       "  'induction',\n",
       "  'of',\n",
       "  'cyp1a1',\n",
       "  'by',\n",
       "  'tcdd',\n",
       "  'was',\n",
       "  'significantly',\n",
       "  'decreased.'],\n",
       " ['treatment',\n",
       "  'with',\n",
       "  '2,3,7,8-tetrachlorodibenzo-p-dioxin',\n",
       "  '(tcdd)',\n",
       "  'induces',\n",
       "  'cyp1a1',\n",
       "  'protein',\n",
       "  'and',\n",
       "  'mrna',\n",
       "  'levels',\n",
       "  'and',\n",
       "  'also',\n",
       "  'activates',\n",
       "  'inhibitory',\n",
       "  'ahr-eralpha',\n",
       "  'crosstalk',\n",
       "  'associated',\n",
       "  'with',\n",
       "  'hormone-induced',\n",
       "  'reporter',\n",
       "  'gene',\n",
       "  'expression.'],\n",
       " ['cotreatment',\n",
       "  'of',\n",
       "  'zr-75',\n",
       "  'cells',\n",
       "  'with',\n",
       "  'tcdd',\n",
       "  'plus',\n",
       "  'the',\n",
       "  'protein',\n",
       "  'synthesis',\n",
       "  'inhibitor',\n",
       "  'cycloheximide',\n",
       "  'for',\n",
       "  '6',\n",
       "  'h',\n",
       "  'enhanced',\n",
       "  'cyp1a1',\n",
       "  'expression',\n",
       "  'in',\n",
       "  'cells',\n",
       "  'grown',\n",
       "  'under',\n",
       "  'hypoxia',\n",
       "  'and',\n",
       "  'normoxia.'],\n",
       " ['cotreatment',\n",
       "  'of',\n",
       "  'zr-75',\n",
       "  'cells',\n",
       "  'with',\n",
       "  'tcdd',\n",
       "  'plus',\n",
       "  'the',\n",
       "  'protein',\n",
       "  'synthesis',\n",
       "  'inhibitor',\n",
       "  'cycloheximide',\n",
       "  'for',\n",
       "  '6',\n",
       "  'h',\n",
       "  'enhanced',\n",
       "  'cyp1a1',\n",
       "  'expression',\n",
       "  'in',\n",
       "  'cells',\n",
       "  'grown',\n",
       "  'under',\n",
       "  'hypoxia',\n",
       "  'and',\n",
       "  'normoxia.'],\n",
       " ['treatment',\n",
       "  'with',\n",
       "  '2,3,7,8-tetrachlorodibenzo-p-dioxin',\n",
       "  '(tcdd)',\n",
       "  'induces',\n",
       "  'cyp1a1',\n",
       "  'protein',\n",
       "  'and',\n",
       "  'mrna',\n",
       "  'levels',\n",
       "  'and',\n",
       "  'also',\n",
       "  'activates',\n",
       "  'inhibitory',\n",
       "  'ahr-eralpha',\n",
       "  'crosstalk',\n",
       "  'associated',\n",
       "  'with',\n",
       "  'hormone-induced',\n",
       "  'reporter',\n",
       "  'gene',\n",
       "  'expression.'],\n",
       " ['in',\n",
       "  'zr-75',\n",
       "  'cells',\n",
       "  'grown',\n",
       "  'under',\n",
       "  'hypoxia,',\n",
       "  'induction',\n",
       "  'of',\n",
       "  'these',\n",
       "  'ahr-mediated',\n",
       "  'responses',\n",
       "  'by',\n",
       "  'tcdd',\n",
       "  'was',\n",
       "  'significantly',\n",
       "  'inhibited.'],\n",
       " ['here',\n",
       "  'we',\n",
       "  'show',\n",
       "  'the',\n",
       "  'reversal',\n",
       "  'effects',\n",
       "  'of',\n",
       "  'an',\n",
       "  'extensive',\n",
       "  'panel',\n",
       "  'of',\n",
       "  'flavonoids',\n",
       "  'upon',\n",
       "  'bcrp-,',\n",
       "  'p-gp-,',\n",
       "  'and',\n",
       "  'mrp1-mediated',\n",
       "  'drug',\n",
       "  'resistance.'],\n",
       " ['here',\n",
       "  'we',\n",
       "  'show',\n",
       "  'the',\n",
       "  'reversal',\n",
       "  'effects',\n",
       "  'of',\n",
       "  'an',\n",
       "  'extensive',\n",
       "  'panel',\n",
       "  'of',\n",
       "  'flavonoids',\n",
       "  'upon',\n",
       "  'bcrp-,',\n",
       "  'p-gp-,',\n",
       "  'and',\n",
       "  'mrp1-mediated',\n",
       "  'drug',\n",
       "  'resistance.'],\n",
       " ['we',\n",
       "  'previously',\n",
       "  'reported',\n",
       "  'that',\n",
       "  'some',\n",
       "  'flavonoids',\n",
       "  'have',\n",
       "  'bcrp-inhibitory',\n",
       "  'activity.'],\n",
       " ['among',\n",
       "  'these',\n",
       "  'active',\n",
       "  'compounds,',\n",
       "  \"3',4',7-trimethoxyflavone\",\n",
       "  'showed',\n",
       "  'the',\n",
       "  'strongest',\n",
       "  'anti-bcrp',\n",
       "  'activity',\n",
       "  'with',\n",
       "  'ri(50)',\n",
       "  'values',\n",
       "  'of',\n",
       "  '0.012',\n",
       "  'microm',\n",
       "  'for',\n",
       "  'sn-38',\n",
       "  'and',\n",
       "  '0.044',\n",
       "  'mum',\n",
       "  'for',\n",
       "  'mitoxantrone.'],\n",
       " ['flavonoids',\n",
       "  'inhibit',\n",
       "  'breast',\n",
       "  'cancer',\n",
       "  'resistance',\n",
       "  'protein-mediated',\n",
       "  'drug',\n",
       "  'resistance:',\n",
       "  'transporter',\n",
       "  'specificity',\n",
       "  'and',\n",
       "  'structure-activity',\n",
       "  'relationship.'],\n",
       " ['here',\n",
       "  'we',\n",
       "  'show',\n",
       "  'the',\n",
       "  'reversal',\n",
       "  'effects',\n",
       "  'of',\n",
       "  'an',\n",
       "  'extensive',\n",
       "  'panel',\n",
       "  'of',\n",
       "  'flavonoids',\n",
       "  'upon',\n",
       "  'bcrp-,',\n",
       "  'p-gp-,',\n",
       "  'and',\n",
       "  'mrp1-mediated',\n",
       "  'drug',\n",
       "  'resistance.'],\n",
       " ['reversal',\n",
       "  'effects',\n",
       "  'of',\n",
       "  'flavonoids',\n",
       "  'upon',\n",
       "  'bcrp-,',\n",
       "  'p-gp-,',\n",
       "  'or',\n",
       "  'mrp1-mediated',\n",
       "  'drug',\n",
       "  'resistance',\n",
       "  'were',\n",
       "  'examined',\n",
       "  'in',\n",
       "  'the',\n",
       "  'bcrp-',\n",
       "  'or',\n",
       "  'mdr1-transduced',\n",
       "  'human',\n",
       "  'leukemia',\n",
       "  'k562',\n",
       "  'cells',\n",
       "  'or',\n",
       "  'in',\n",
       "  'the',\n",
       "  'mrp1-transfected',\n",
       "  'human',\n",
       "  'epidermoid',\n",
       "  'carcinoma',\n",
       "  'kb-3-1',\n",
       "  'cells',\n",
       "  'using',\n",
       "  'cell',\n",
       "  'growth',\n",
       "  'inhibition',\n",
       "  'assays.'],\n",
       " ['none',\n",
       "  'of',\n",
       "  'the',\n",
       "  'flavonoids',\n",
       "  'that',\n",
       "  'we',\n",
       "  'tested',\n",
       "  'inhibited',\n",
       "  'mrp1.'],\n",
       " ['among',\n",
       "  'these',\n",
       "  'active',\n",
       "  'compounds,',\n",
       "  \"3',4',7-trimethoxyflavone\",\n",
       "  'showed',\n",
       "  'the',\n",
       "  'strongest',\n",
       "  'anti-bcrp',\n",
       "  'activity',\n",
       "  'with',\n",
       "  'ri(50)',\n",
       "  'values',\n",
       "  'of',\n",
       "  '0.012',\n",
       "  'microm',\n",
       "  'for',\n",
       "  'sn-38',\n",
       "  'and',\n",
       "  '0.044',\n",
       "  'mum',\n",
       "  'for',\n",
       "  'mitoxantrone.'],\n",
       " ['two',\n",
       "  'of',\n",
       "  'the',\n",
       "  'flavones,',\n",
       "  \"3',4',7-trimethoxyflavone\",\n",
       "  'and',\n",
       "  'acacetin,',\n",
       "  'showed',\n",
       "  'only',\n",
       "  'low',\n",
       "  'anti-p-gp',\n",
       "  'activity,',\n",
       "  'with',\n",
       "  'the',\n",
       "  'remainder',\n",
       "  'displaying',\n",
       "  'no',\n",
       "  'suppressive',\n",
       "  'effects',\n",
       "  'against',\n",
       "  'p-gp.'],\n",
       " ['the',\n",
       "  'reversal',\n",
       "  'of',\n",
       "  'bcrp',\n",
       "  'activity',\n",
       "  'was',\n",
       "  'tested',\n",
       "  'by',\n",
       "  'measuring',\n",
       "  'the',\n",
       "  'fluorescence',\n",
       "  'of',\n",
       "  'intracellular',\n",
       "  'topotecan.'],\n",
       " ['two',\n",
       "  'of',\n",
       "  'the',\n",
       "  'flavones,',\n",
       "  \"3',4',7-trimethoxyflavone\",\n",
       "  'and',\n",
       "  'acacetin,',\n",
       "  'showed',\n",
       "  'only',\n",
       "  'low',\n",
       "  'anti-p-gp',\n",
       "  'activity,',\n",
       "  'with',\n",
       "  'the',\n",
       "  'remainder',\n",
       "  'displaying',\n",
       "  'no',\n",
       "  'suppressive',\n",
       "  'effects',\n",
       "  'against',\n",
       "  'p-gp.'],\n",
       " ['our',\n",
       "  'present',\n",
       "  'results',\n",
       "  'thus',\n",
       "  'indicate',\n",
       "  'that',\n",
       "  'many',\n",
       "  'flavonoids',\n",
       "  'selectively',\n",
       "  'inhibit',\n",
       "  'bcrp',\n",
       "  'only.'],\n",
       " ['reversal',\n",
       "  'effects',\n",
       "  'of',\n",
       "  'flavonoids',\n",
       "  'upon',\n",
       "  'bcrp-,',\n",
       "  'p-gp-,',\n",
       "  'or',\n",
       "  'mrp1-mediated',\n",
       "  'drug',\n",
       "  'resistance',\n",
       "  'were',\n",
       "  'examined',\n",
       "  'in',\n",
       "  'the',\n",
       "  'bcrp-',\n",
       "  'or',\n",
       "  'mdr1-transduced',\n",
       "  'human',\n",
       "  'leukemia',\n",
       "  'k562',\n",
       "  'cells',\n",
       "  'or',\n",
       "  'in',\n",
       "  'the',\n",
       "  'mrp1-transfected',\n",
       "  'human',\n",
       "  'epidermoid',\n",
       "  'carcinoma',\n",
       "  'kb-3-1',\n",
       "  'cells',\n",
       "  'using',\n",
       "  'cell',\n",
       "  'growth',\n",
       "  'inhibition',\n",
       "  'assays.'],\n",
       " ['reversal',\n",
       "  'effects',\n",
       "  'of',\n",
       "  'flavonoids',\n",
       "  'upon',\n",
       "  'bcrp-,',\n",
       "  'p-gp-,',\n",
       "  'or',\n",
       "  'mrp1-mediated',\n",
       "  'drug',\n",
       "  'resistance',\n",
       "  'were',\n",
       "  'examined',\n",
       "  'in',\n",
       "  'the',\n",
       "  'bcrp-',\n",
       "  'or',\n",
       "  'mdr1-transduced',\n",
       "  'human',\n",
       "  'leukemia',\n",
       "  'k562',\n",
       "  'cells',\n",
       "  'or',\n",
       "  'in',\n",
       "  'the',\n",
       "  'mrp1-transfected',\n",
       "  'human',\n",
       "  'epidermoid',\n",
       "  'carcinoma',\n",
       "  'kb-3-1',\n",
       "  'cells',\n",
       "  'using',\n",
       "  'cell',\n",
       "  'growth',\n",
       "  'inhibition',\n",
       "  'assays.'],\n",
       " ['among',\n",
       "  'these',\n",
       "  'active',\n",
       "  'compounds,',\n",
       "  \"3',4',7-trimethoxyflavone\",\n",
       "  'showed',\n",
       "  'the',\n",
       "  'strongest',\n",
       "  'anti-bcrp',\n",
       "  'activity',\n",
       "  'with',\n",
       "  'ri(50)',\n",
       "  'values',\n",
       "  'of',\n",
       "  '0.012',\n",
       "  'microm',\n",
       "  'for',\n",
       "  'sn-38',\n",
       "  'and',\n",
       "  '0.044',\n",
       "  'mum',\n",
       "  'for',\n",
       "  'mitoxantrone.'],\n",
       " ['we',\n",
       "  'report',\n",
       "  'here',\n",
       "  'the',\n",
       "  'chemical',\n",
       "  'synthesis',\n",
       "  'and',\n",
       "  'pharmacological',\n",
       "  'characterization',\n",
       "  'of',\n",
       "  'sha',\n",
       "  '66',\n",
       "  '(3-oxo-1,1-diphenyl-tetrahydro-oxazolo[3,4-a]pyrazine-7-carboxylic',\n",
       "  'acid',\n",
       "  'benzylamide)',\n",
       "  'and',\n",
       "  'sha',\n",
       "  '68',\n",
       "  '(3-oxo-1,1-diphenyl-tetrahydro-oxazolo[3,4-a]pyrazine-7-carboxylic',\n",
       "  'acid',\n",
       "  '4-fluoro-benzylamide),',\n",
       "  'two',\n",
       "  'closely',\n",
       "  'related',\n",
       "  'bicyclic',\n",
       "  'piperazines',\n",
       "  'with',\n",
       "  'antagonistic',\n",
       "  'properties',\n",
       "  'at',\n",
       "  'the',\n",
       "  'nps',\n",
       "  'receptor',\n",
       "  '(npsr).'],\n",
       " ['we',\n",
       "  'report',\n",
       "  'here',\n",
       "  'the',\n",
       "  'chemical',\n",
       "  'synthesis',\n",
       "  'and',\n",
       "  'pharmacological',\n",
       "  'characterization',\n",
       "  'of',\n",
       "  'sha',\n",
       "  '66',\n",
       "  '(3-oxo-1,1-diphenyl-tetrahydro-oxazolo[3,4-a]pyrazine-7-carboxylic',\n",
       "  'acid',\n",
       "  'benzylamide)',\n",
       "  'and',\n",
       "  'sha',\n",
       "  '68',\n",
       "  '(3-oxo-1,1-diphenyl-tetrahydro-oxazolo[3,4-a]pyrazine-7-carboxylic',\n",
       "  'acid',\n",
       "  '4-fluoro-benzylamide),',\n",
       "  'two',\n",
       "  'closely',\n",
       "  'related',\n",
       "  'bicyclic',\n",
       "  'piperazines',\n",
       "  'with',\n",
       "  'antagonistic',\n",
       "  'properties',\n",
       "  'at',\n",
       "  'the',\n",
       "  'nps',\n",
       "  'receptor',\n",
       "  '(npsr).'],\n",
       " ['furthermore,',\n",
       "  'peripheral',\n",
       "  'administration',\n",
       "  'of',\n",
       "  'sha',\n",
       "  '68',\n",
       "  'in',\n",
       "  'mice',\n",
       "  '(50',\n",
       "  'mg/kg',\n",
       "  'i.p.)',\n",
       "  'is',\n",
       "  'able',\n",
       "  'to',\n",
       "  'antagonize',\n",
       "  'nps-induced',\n",
       "  'horizontal',\n",
       "  'and',\n",
       "  'vertical',\n",
       "  'activity',\n",
       "  'as',\n",
       "  'well',\n",
       "  'as',\n",
       "  'stereotypic',\n",
       "  'behavior.'],\n",
       " ['synthesis',\n",
       "  'and',\n",
       "  'pharmacological',\n",
       "  'in',\n",
       "  'vitro',\n",
       "  'and',\n",
       "  'in',\n",
       "  'vivo',\n",
       "  'profile',\n",
       "  'of',\n",
       "  '3-oxo-1,1-diphenyl-tetrahydro-oxazolo[3,4-a]pyrazine-7-carboxylic',\n",
       "  'acid',\n",
       "  '4-fluoro-benzylamide',\n",
       "  '(sha',\n",
       "  '68),',\n",
       "  'a',\n",
       "  'selective',\n",
       "  'antagonist',\n",
       "  'of',\n",
       "  'the',\n",
       "  'neuropeptide',\n",
       "  's',\n",
       "  'receptor.'],\n",
       " ['we',\n",
       "  'report',\n",
       "  'here',\n",
       "  'the',\n",
       "  'chemical',\n",
       "  'synthesis',\n",
       "  'and',\n",
       "  'pharmacological',\n",
       "  'characterization',\n",
       "  'of',\n",
       "  'sha',\n",
       "  '66',\n",
       "  '(3-oxo-1,1-diphenyl-tetrahydro-oxazolo[3,4-a]pyrazine-7-carboxylic',\n",
       "  'acid',\n",
       "  'benzylamide)',\n",
       "  'and',\n",
       "  'sha',\n",
       "  '68',\n",
       "  '(3-oxo-1,1-diphenyl-tetrahydro-oxazolo[3,4-a]pyrazine-7-carboxylic',\n",
       "  'acid',\n",
       "  '4-fluoro-benzylamide),',\n",
       "  'two',\n",
       "  'closely',\n",
       "  'related',\n",
       "  'bicyclic',\n",
       "  'piperazines',\n",
       "  'with',\n",
       "  'antagonistic',\n",
       "  'properties',\n",
       "  'at',\n",
       "  'the',\n",
       "  'nps',\n",
       "  'receptor',\n",
       "  '(npsr).'],\n",
       " ['we',\n",
       "  'report',\n",
       "  'here',\n",
       "  'the',\n",
       "  'chemical',\n",
       "  'synthesis',\n",
       "  'and',\n",
       "  'pharmacological',\n",
       "  'characterization',\n",
       "  'of',\n",
       "  'sha',\n",
       "  '66',\n",
       "  '(3-oxo-1,1-diphenyl-tetrahydro-oxazolo[3,4-a]pyrazine-7-carboxylic',\n",
       "  'acid',\n",
       "  'benzylamide)',\n",
       "  'and',\n",
       "  'sha',\n",
       "  '68',\n",
       "  '(3-oxo-1,1-diphenyl-tetrahydro-oxazolo[3,4-a]pyrazine-7-carboxylic',\n",
       "  'acid',\n",
       "  '4-fluoro-benzylamide),',\n",
       "  'two',\n",
       "  'closely',\n",
       "  'related',\n",
       "  'bicyclic',\n",
       "  'piperazines',\n",
       "  'with',\n",
       "  'antagonistic',\n",
       "  'properties',\n",
       "  'at',\n",
       "  'the',\n",
       "  'nps',\n",
       "  'receptor',\n",
       "  '(npsr).'],\n",
       " ['the',\n",
       "  'compounds',\n",
       "  'block',\n",
       "  'nps-induced',\n",
       "  'ca2+',\n",
       "  'mobilization,',\n",
       "  'and',\n",
       "  'sha',\n",
       "  '68',\n",
       "  'shows',\n",
       "  'displaceable',\n",
       "  'binding',\n",
       "  'to',\n",
       "  'npsr',\n",
       "  'in',\n",
       "  'the',\n",
       "  'nanomolar',\n",
       "  'range.'],\n",
       " ['therefore,',\n",
       "  'sha',\n",
       "  '68',\n",
       "  'could',\n",
       "  'be',\n",
       "  'a',\n",
       "  'useful',\n",
       "  'tool',\n",
       "  'to',\n",
       "  'characterize',\n",
       "  'physiological',\n",
       "  'functions',\n",
       "  'and',\n",
       "  'pharmacological',\n",
       "  'parameters',\n",
       "  'of',\n",
       "  'the',\n",
       "  'nps',\n",
       "  'system',\n",
       "  'in',\n",
       "  'vitro',\n",
       "  'and',\n",
       "  'in',\n",
       "  'vivo.'],\n",
       " ['in',\n",
       "  'vitro',\n",
       "  'studies',\n",
       "  'using',\n",
       "  'western',\n",
       "  'blot',\n",
       "  'analysis',\n",
       "  'and',\n",
       "  'cell-based',\n",
       "  'elisa',\n",
       "  'assays',\n",
       "  'showed',\n",
       "  'that',\n",
       "  'p2281',\n",
       "  'inhibits',\n",
       "  'mtor',\n",
       "  'activity',\n",
       "  'in',\n",
       "  'colon',\n",
       "  'cancer',\n",
       "  'cells.'],\n",
       " ['in',\n",
       "  'the',\n",
       "  'dextran',\n",
       "  'sulfate',\n",
       "  'sodium',\n",
       "  '(dss)',\n",
       "  'model',\n",
       "  'of',\n",
       "  'colitis,',\n",
       "  '1)',\n",
       "  'macroscopic',\n",
       "  'colon',\n",
       "  'observations',\n",
       "  'demonstrated',\n",
       "  'that',\n",
       "  'p2281',\n",
       "  'significantly',\n",
       "  'inhibited',\n",
       "  'dss-induced',\n",
       "  'weight',\n",
       "  'loss,',\n",
       "  'improved',\n",
       "  'rectal',\n",
       "  'bleeding',\n",
       "  'index,',\n",
       "  'decreased',\n",
       "  'disease',\n",
       "  'activity',\n",
       "  'index,',\n",
       "  'and',\n",
       "  'reversed',\n",
       "  'dss-induced',\n",
       "  'shortening',\n",
       "  'of',\n",
       "  'the',\n",
       "  'colon;',\n",
       "  '2)',\n",
       "  'histological',\n",
       "  'analyses',\n",
       "  'of',\n",
       "  'colonic',\n",
       "  'tissues',\n",
       "  'revealed',\n",
       "  'that',\n",
       "  'p2281',\n",
       "  'distinctly',\n",
       "  'attenuated',\n",
       "  'dss-induced',\n",
       "  'edema,',\n",
       "  'prominently',\n",
       "  'diminished',\n",
       "  'the',\n",
       "  'leukocyte',\n",
       "  'infiltration',\n",
       "  'in',\n",
       "  'the',\n",
       "  'colonic',\n",
       "  'mucosa,',\n",
       "  'and',\n",
       "  'resulted',\n",
       "  'in',\n",
       "  'protection',\n",
       "  'against',\n",
       "  'dss-induced',\n",
       "  'crypt',\n",
       "  'damage;',\n",
       "  'and',\n",
       "  '3)',\n",
       "  'western',\n",
       "  'blot',\n",
       "  'analysis',\n",
       "  'showed',\n",
       "  'that',\n",
       "  'p2281',\n",
       "  'blocks',\n",
       "  'dss-induced',\n",
       "  'activation',\n",
       "  'of',\n",
       "  'mtor.'],\n",
       " ['in',\n",
       "  'vitro',\n",
       "  'and',\n",
       "  'in',\n",
       "  'vivo',\n",
       "  'assays',\n",
       "  'of',\n",
       "  'proinflammatory',\n",
       "  'cytokine',\n",
       "  'production',\n",
       "  'revealed',\n",
       "  'that',\n",
       "  'p2281',\n",
       "  'diminishes',\n",
       "  'induced',\n",
       "  'ifn-gamma',\n",
       "  'production',\n",
       "  'but',\n",
       "  'not',\n",
       "  'tnf-alpha',\n",
       "  'production,',\n",
       "  'indicating',\n",
       "  'preferential',\n",
       "  'inhibitory',\n",
       "  'effects',\n",
       "  'of',\n",
       "  'p2281',\n",
       "  'on',\n",
       "  't',\n",
       "  'cell',\n",
       "  'function.'],\n",
       " ['in',\n",
       "  'vitro',\n",
       "  'and',\n",
       "  'in',\n",
       "  'vivo',\n",
       "  'assays',\n",
       "  'of',\n",
       "  'proinflammatory',\n",
       "  'cytokine',\n",
       "  'production',\n",
       "  'revealed',\n",
       "  'that',\n",
       "  'p2281',\n",
       "  'diminishes',\n",
       "  'induced',\n",
       "  'ifn-gamma',\n",
       "  'production',\n",
       "  'but',\n",
       "  'not',\n",
       "  'tnf-alpha',\n",
       "  'production,',\n",
       "  'indicating',\n",
       "  'preferential',\n",
       "  'inhibitory',\n",
       "  'effects',\n",
       "  'of',\n",
       "  'p2281',\n",
       "  'on',\n",
       "  't',\n",
       "  'cell',\n",
       "  'function.'],\n",
       " ['in',\n",
       "  'the',\n",
       "  'dextran',\n",
       "  'sulfate',\n",
       "  'sodium',\n",
       "  '(dss)',\n",
       "  'model',\n",
       "  'of',\n",
       "  'colitis,',\n",
       "  '1)',\n",
       "  'macroscopic',\n",
       "  'colon',\n",
       "  'observations',\n",
       "  'demonstrated',\n",
       "  'that',\n",
       "  'p2281',\n",
       "  'significantly',\n",
       "  'inhibited',\n",
       "  'dss-induced',\n",
       "  'weight',\n",
       "  'loss,',\n",
       "  'improved',\n",
       "  'rectal',\n",
       "  'bleeding',\n",
       "  'index,',\n",
       "  'decreased',\n",
       "  'disease',\n",
       "  'activity',\n",
       "  'index,',\n",
       "  'and',\n",
       "  'reversed',\n",
       "  'dss-induced',\n",
       "  'shortening',\n",
       "  'of',\n",
       "  'the',\n",
       "  'colon;',\n",
       "  '2)',\n",
       "  'histological',\n",
       "  'analyses',\n",
       "  'of',\n",
       "  'colonic',\n",
       "  'tissues',\n",
       "  'revealed',\n",
       "  'that',\n",
       "  'p2281',\n",
       "  'distinctly',\n",
       "  'attenuated',\n",
       "  'dss-induced',\n",
       "  'edema,',\n",
       "  'prominently',\n",
       "  'diminished',\n",
       "  'the',\n",
       "  'leukocyte',\n",
       "  'infiltration',\n",
       "  'in',\n",
       "  'the',\n",
       "  'colonic',\n",
       "  'mucosa,',\n",
       "  'and',\n",
       "  'resulted',\n",
       "  'in',\n",
       "  'protection',\n",
       "  'against',\n",
       "  'dss-induced',\n",
       "  'crypt',\n",
       "  'damage;',\n",
       "  'and',\n",
       "  '3)',\n",
       "  'western',\n",
       "  'blot',\n",
       "  'analysis',\n",
       "  'showed',\n",
       "  'that',\n",
       "  'p2281',\n",
       "  'blocks',\n",
       "  'dss-induced',\n",
       "  'activation',\n",
       "  'of',\n",
       "  'mtor.'],\n",
       " ['in',\n",
       "  'the',\n",
       "  'dextran',\n",
       "  'sulfate',\n",
       "  'sodium',\n",
       "  '(dss)',\n",
       "  'model',\n",
       "  'of',\n",
       "  'colitis,',\n",
       "  '1)',\n",
       "  'macroscopic',\n",
       "  'colon',\n",
       "  'observations',\n",
       "  'demonstrated',\n",
       "  'that',\n",
       "  'p2281',\n",
       "  'significantly',\n",
       "  'inhibited',\n",
       "  'dss-induced',\n",
       "  'weight',\n",
       "  'loss,',\n",
       "  'improved',\n",
       "  'rectal',\n",
       "  'bleeding',\n",
       "  'index,',\n",
       "  'decreased',\n",
       "  'disease',\n",
       "  'activity',\n",
       "  'index,',\n",
       "  'and',\n",
       "  'reversed',\n",
       "  'dss-induced',\n",
       "  'shortening',\n",
       "  'of',\n",
       "  'the',\n",
       "  'colon;',\n",
       "  '2)',\n",
       "  'histological',\n",
       "  'analyses',\n",
       "  'of',\n",
       "  'colonic',\n",
       "  'tissues',\n",
       "  'revealed',\n",
       "  'that',\n",
       "  'p2281',\n",
       "  'distinctly',\n",
       "  'attenuated',\n",
       "  'dss-induced',\n",
       "  'edema,',\n",
       "  'prominently',\n",
       "  'diminished',\n",
       "  'the',\n",
       "  'leukocyte',\n",
       "  'infiltration',\n",
       "  'in',\n",
       "  'the',\n",
       "  'colonic',\n",
       "  'mucosa,',\n",
       "  'and',\n",
       "  'resulted',\n",
       "  'in',\n",
       "  'protection',\n",
       "  'against',\n",
       "  'dss-induced',\n",
       "  'crypt',\n",
       "  'damage;',\n",
       "  'and',\n",
       "  '3)',\n",
       "  'western',\n",
       "  'blot',\n",
       "  'analysis',\n",
       "  'showed',\n",
       "  'that',\n",
       "  'p2281',\n",
       "  'blocks',\n",
       "  'dss-induced',\n",
       "  'activation',\n",
       "  'of',\n",
       "  'mtor.'],\n",
       " ['in',\n",
       "  'the',\n",
       "  'sh-sy5y',\n",
       "  'studies,',\n",
       "  'treatment',\n",
       "  'with',\n",
       "  'l-165041',\n",
       "  'or',\n",
       "  'gw501516',\n",
       "  'significantly',\n",
       "  'and',\n",
       "  'concentration-dependently',\n",
       "  'attenuated',\n",
       "  'cell',\n",
       "  'death',\n",
       "  'following',\n",
       "  'thapsigargin,',\n",
       "  '1-methyl-4-phenylpyridinium,',\n",
       "  'or',\n",
       "  'staurosporine',\n",
       "  'exposure,',\n",
       "  'with',\n",
       "  'the',\n",
       "  'extent',\n",
       "  'of',\n",
       "  'damage',\n",
       "  'correlated',\n",
       "  'with',\n",
       "  'the',\n",
       "  'level',\n",
       "  'of',\n",
       "  'caspase-3',\n",
       "  'inhibition.'],\n",
       " ['in',\n",
       "  'the',\n",
       "  'sh-sy5y',\n",
       "  'studies,',\n",
       "  'treatment',\n",
       "  'with',\n",
       "  'l-165041',\n",
       "  'or',\n",
       "  'gw501516',\n",
       "  'significantly',\n",
       "  'and',\n",
       "  'concentration-dependently',\n",
       "  'attenuated',\n",
       "  'cell',\n",
       "  'death',\n",
       "  'following',\n",
       "  'thapsigargin,',\n",
       "  '1-methyl-4-phenylpyridinium,',\n",
       "  'or',\n",
       "  'staurosporine',\n",
       "  'exposure,',\n",
       "  'with',\n",
       "  'the',\n",
       "  'extent',\n",
       "  'of',\n",
       "  'damage',\n",
       "  'correlated',\n",
       "  'with',\n",
       "  'the',\n",
       "  'level',\n",
       "  'of',\n",
       "  'caspase-3',\n",
       "  'inhibition.'],\n",
       " ['acute',\n",
       "  'myeloid',\n",
       "  'leukaemia',\n",
       "  'blast',\n",
       "  'cells',\n",
       "  'with',\n",
       "  'a',\n",
       "  'tyrosine',\n",
       "  'kinase',\n",
       "  'domain',\n",
       "  'mutation',\n",
       "  'of',\n",
       "  'flt3',\n",
       "  'are',\n",
       "  'less',\n",
       "  'sensitive',\n",
       "  'to',\n",
       "  'lestaurtinib',\n",
       "  'than',\n",
       "  'those',\n",
       "  'with',\n",
       "  'a',\n",
       "  'flt3',\n",
       "  'internal',\n",
       "  'tandem',\n",
       "  'duplication.'],\n",
       " ['flt3/tkd+',\n",
       "  'cells',\n",
       "  'showed',\n",
       "  'a',\n",
       "  'similar',\n",
       "  'response',\n",
       "  'to',\n",
       "  'lestaurtinib',\n",
       "  'as',\n",
       "  'flt3/wt',\n",
       "  'cells,',\n",
       "  'whereas',\n",
       "  'flt3/itd+',\n",
       "  'cells',\n",
       "  'were',\n",
       "  'more',\n",
       "  'sensitive',\n",
       "  '(p',\n",
       "  '=',\n",
       "  '0.004).'],\n",
       " ['whilst',\n",
       "  'flt3/itd+',\n",
       "  'cells',\n",
       "  'are',\n",
       "  'more',\n",
       "  'susceptible',\n",
       "  'to',\n",
       "  'the',\n",
       "  'cytotoxic',\n",
       "  'effects',\n",
       "  'of',\n",
       "  'flt3',\n",
       "  'inhibitors',\n",
       "  'than',\n",
       "  'wild',\n",
       "  'type',\n",
       "  '(wt)',\n",
       "  'cells,',\n",
       "  'the',\n",
       "  'sensitivity',\n",
       "  'of',\n",
       "  'flt3/tkd+',\n",
       "  'cells',\n",
       "  'to',\n",
       "  'therapeutic',\n",
       "  'agents',\n",
       "  'is',\n",
       "  'unclear,',\n",
       "  'as',\n",
       "  'is',\n",
       "  'the',\n",
       "  'importance',\n",
       "  'of',\n",
       "  'the',\n",
       "  'mutant',\n",
       "  'level.'],\n",
       " ['acute',\n",
       "  'myeloid',\n",
       "  'leukaemia',\n",
       "  'blast',\n",
       "  'cells',\n",
       "  'with',\n",
       "  'a',\n",
       "  'tyrosine',\n",
       "  'kinase',\n",
       "  'domain',\n",
       "  'mutation',\n",
       "  'of',\n",
       "  'flt3',\n",
       "  'are',\n",
       "  'less',\n",
       "  'sensitive',\n",
       "  'to',\n",
       "  'lestaurtinib',\n",
       "  'than',\n",
       "  'those',\n",
       "  'with',\n",
       "  'a',\n",
       "  'flt3',\n",
       "  'internal',\n",
       "  'tandem',\n",
       "  'duplication.'],\n",
       " ['all',\n",
       "  'three',\n",
       "  'groups',\n",
       "  'showed',\n",
       "  'similar',\n",
       "  'sensitivity',\n",
       "  'to',\n",
       "  'the',\n",
       "  'cytotoxic',\n",
       "  'effects',\n",
       "  'of',\n",
       "  'cytarabine',\n",
       "  'but',\n",
       "  'flt3/itd',\n",
       "  'mutant',\n",
       "  'level',\n",
       "  'was',\n",
       "  'inversely',\n",
       "  'correlated',\n",
       "  'with',\n",
       "  'cytarabine',\n",
       "  'cytotoxicity',\n",
       "  '(p',\n",
       "  '=',\n",
       "  '0.04)',\n",
       "  'whereas',\n",
       "  'flt3/tkd',\n",
       "  'mutant',\n",
       "  'level',\n",
       "  'had',\n",
       "  'no',\n",
       "  'impact.'],\n",
       " ['acute',\n",
       "  'myeloid',\n",
       "  'leukaemia',\n",
       "  'blast',\n",
       "  'cells',\n",
       "  'with',\n",
       "  'a',\n",
       "  'tyrosine',\n",
       "  'kinase',\n",
       "  'domain',\n",
       "  'mutation',\n",
       "  'of',\n",
       "  'flt3',\n",
       "  'are',\n",
       "  'less',\n",
       "  'sensitive',\n",
       "  'to',\n",
       "  'lestaurtinib',\n",
       "  'than',\n",
       "  'those',\n",
       "  'with',\n",
       "  'a',\n",
       "  'flt3',\n",
       "  'internal',\n",
       "  'tandem',\n",
       "  'duplication.'],\n",
       " ['these',\n",
       "  'results',\n",
       "  'suggest',\n",
       "  'that',\n",
       "  'flt3/tkd+',\n",
       "  'and',\n",
       "  'flt3/wt',\n",
       "  'cases',\n",
       "  'should',\n",
       "  'not',\n",
       "  'be',\n",
       "  'differentiated',\n",
       "  'when',\n",
       "  'considering',\n",
       "  'patients',\n",
       "  'for',\n",
       "  'treatment',\n",
       "  'with',\n",
       "  'flt3',\n",
       "  'inhibitors.'],\n",
       " ['there',\n",
       "  'was',\n",
       "  'no',\n",
       "  'correlation',\n",
       "  'between',\n",
       "  'mutant',\n",
       "  'level',\n",
       "  'and',\n",
       "  'lestaurtinib',\n",
       "  'sensitivity',\n",
       "  'for',\n",
       "  'either',\n",
       "  'flt3/itd+',\n",
       "  'or',\n",
       "  'flt3/tkd+',\n",
       "  'cells.'],\n",
       " ['flt3/tkd+',\n",
       "  'cells',\n",
       "  'showed',\n",
       "  'a',\n",
       "  'similar',\n",
       "  'response',\n",
       "  'to',\n",
       "  'lestaurtinib',\n",
       "  'as',\n",
       "  'flt3/wt',\n",
       "  'cells,',\n",
       "  'whereas',\n",
       "  'flt3/itd+',\n",
       "  'cells',\n",
       "  'were',\n",
       "  'more',\n",
       "  'sensitive',\n",
       "  '(p',\n",
       "  '=',\n",
       "  '0.004).'],\n",
       " ['these',\n",
       "  'results',\n",
       "  'suggest',\n",
       "  'that',\n",
       "  'flt3/tkd+',\n",
       "  'and',\n",
       "  'flt3/wt',\n",
       "  'cases',\n",
       "  'should',\n",
       "  'not',\n",
       "  'be',\n",
       "  'differentiated',\n",
       "  'when',\n",
       "  'considering',\n",
       "  'patients',\n",
       "  'for',\n",
       "  'treatment',\n",
       "  'with',\n",
       "  'flt3',\n",
       "  'inhibitors.'],\n",
       " ['all',\n",
       "  'three',\n",
       "  'groups',\n",
       "  'showed',\n",
       "  'similar',\n",
       "  'sensitivity',\n",
       "  'to',\n",
       "  'the',\n",
       "  'cytotoxic',\n",
       "  'effects',\n",
       "  'of',\n",
       "  'cytarabine',\n",
       "  'but',\n",
       "  'flt3/itd',\n",
       "  'mutant',\n",
       "  'level',\n",
       "  'was',\n",
       "  'inversely',\n",
       "  'correlated',\n",
       "  'with',\n",
       "  'cytarabine',\n",
       "  'cytotoxicity',\n",
       "  '(p',\n",
       "  '=',\n",
       "  '0.04)',\n",
       "  'whereas',\n",
       "  'flt3/tkd',\n",
       "  'mutant',\n",
       "  'level',\n",
       "  'had',\n",
       "  'no',\n",
       "  'impact.'],\n",
       " ['the',\n",
       "  'treatment',\n",
       "  'of',\n",
       "  'adenocarcinoma',\n",
       "  'cells',\n",
       "  'with',\n",
       "  'telomerase',\n",
       "  'inhibitor,',\n",
       "  'grn163l,',\n",
       "  'led',\n",
       "  'to',\n",
       "  'loss',\n",
       "  'of',\n",
       "  'telomerase',\n",
       "  'activity,',\n",
       "  'reduction',\n",
       "  'in',\n",
       "  'telomere',\n",
       "  'length,',\n",
       "  'and',\n",
       "  'growth',\n",
       "  'arrest',\n",
       "  'through',\n",
       "  'induction',\n",
       "  'of',\n",
       "  'both',\n",
       "  'the',\n",
       "  'senescence',\n",
       "  'and',\n",
       "  'apoptosis.'],\n",
       " ['the',\n",
       "  'fact',\n",
       "  'that',\n",
       "  'nsaids',\n",
       "  'delay',\n",
       "  'the',\n",
       "  'onset',\n",
       "  'of',\n",
       "  'and',\n",
       "  'reduce',\n",
       "  'the',\n",
       "  'risk',\n",
       "  'of',\n",
       "  'developing',\n",
       "  \"alzheimer's\",\n",
       "  'disease',\n",
       "  '(ad),',\n",
       "  'while',\n",
       "  'also',\n",
       "  'binding',\n",
       "  'to',\n",
       "  'and',\n",
       "  'activating',\n",
       "  'ppargamma,',\n",
       "  'led',\n",
       "  'to',\n",
       "  'the',\n",
       "  'hypothesis',\n",
       "  'that',\n",
       "  'one',\n",
       "  'dimension',\n",
       "  'of',\n",
       "  'nsaid',\n",
       "  'protection',\n",
       "  'in',\n",
       "  'ad',\n",
       "  'is',\n",
       "  'mediated',\n",
       "  'by',\n",
       "  'ppargamma.'],\n",
       " ['the',\n",
       "  'fact',\n",
       "  'that',\n",
       "  'nsaids',\n",
       "  'delay',\n",
       "  'the',\n",
       "  'onset',\n",
       "  'of',\n",
       "  'and',\n",
       "  'reduce',\n",
       "  'the',\n",
       "  'risk',\n",
       "  'of',\n",
       "  'developing',\n",
       "  \"alzheimer's\",\n",
       "  'disease',\n",
       "  '(ad),',\n",
       "  'while',\n",
       "  'also',\n",
       "  'binding',\n",
       "  'to',\n",
       "  'and',\n",
       "  'activating',\n",
       "  'ppargamma,',\n",
       "  'led',\n",
       "  'to',\n",
       "  'the',\n",
       "  'hypothesis',\n",
       "  'that',\n",
       "  'one',\n",
       "  'dimension',\n",
       "  'of',\n",
       "  'nsaid',\n",
       "  'protection',\n",
       "  'in',\n",
       "  'ad',\n",
       "  'is',\n",
       "  'mediated',\n",
       "  'by',\n",
       "  'ppargamma.'],\n",
       " ['decreased',\n",
       "  'plasma',\n",
       "  'soluble',\n",
       "  'rage',\n",
       "  'in',\n",
       "  'patients',\n",
       "  'with',\n",
       "  'hypercholesterolemia:',\n",
       "  'effects',\n",
       "  'of',\n",
       "  'statins.'],\n",
       " ['in',\n",
       "  'kbm5',\n",
       "  'and',\n",
       "  'k562',\n",
       "  'cells,',\n",
       "  'imatinib,',\n",
       "  'inno-406,',\n",
       "  'or',\n",
       "  'ifn-alpha',\n",
       "  'increased',\n",
       "  'cxcr4',\n",
       "  'expression',\n",
       "  'and',\n",
       "  'migration.'],\n",
       " ['we',\n",
       "  'proposed',\n",
       "  'that',\n",
       "  'tyrosine',\n",
       "  'kinase',\n",
       "  'inhibitors,',\n",
       "  'imatinib',\n",
       "  'or',\n",
       "  'inno-406,',\n",
       "  'may',\n",
       "  'restore',\n",
       "  'cxcr4',\n",
       "  'expression',\n",
       "  'and',\n",
       "  'cause',\n",
       "  'the',\n",
       "  'migration',\n",
       "  'of',\n",
       "  'cml',\n",
       "  'cells',\n",
       "  'to',\n",
       "  'bone',\n",
       "  'marrow',\n",
       "  'microenvironment',\n",
       "  'niches,',\n",
       "  'which',\n",
       "  'in',\n",
       "  'turn',\n",
       "  'results',\n",
       "  'in',\n",
       "  'acquisition',\n",
       "  'of',\n",
       "  'stroma-mediated',\n",
       "  'chemoresistance',\n",
       "  'of',\n",
       "  'cml',\n",
       "  'progenitor',\n",
       "  'cells.'],\n",
       " ['this',\n",
       "  'increase',\n",
       "  'in',\n",
       "  'cxcr4',\n",
       "  'levels',\n",
       "  'on',\n",
       "  'cml',\n",
       "  'progenitor',\n",
       "  'cells',\n",
       "  'was',\n",
       "  'likewise',\n",
       "  'found',\n",
       "  'in',\n",
       "  'samples',\n",
       "  'from',\n",
       "  'cml',\n",
       "  'patients',\n",
       "  'treated',\n",
       "  'with',\n",
       "  'imatinib',\n",
       "  'or',\n",
       "  'ifn-alpha.'],\n",
       " ['cxcr4',\n",
       "  'up-regulation',\n",
       "  'by',\n",
       "  'imatinib',\n",
       "  'induces',\n",
       "  'chronic',\n",
       "  'myelogenous',\n",
       "  'leukemia',\n",
       "  '(cml)',\n",
       "  'cell',\n",
       "  'migration',\n",
       "  'to',\n",
       "  'bone',\n",
       "  'marrow',\n",
       "  'stroma',\n",
       "  'and',\n",
       "  'promotes',\n",
       "  'survival',\n",
       "  'of',\n",
       "  'quiescent',\n",
       "  'cml',\n",
       "  'cells.'],\n",
       " ['this',\n",
       "  'increase',\n",
       "  'in',\n",
       "  'cxcr4',\n",
       "  'levels',\n",
       "  'on',\n",
       "  'cml',\n",
       "  'progenitor',\n",
       "  'cells',\n",
       "  'was',\n",
       "  'likewise',\n",
       "  'found',\n",
       "  'in',\n",
       "  'samples',\n",
       "  'from',\n",
       "  'cml',\n",
       "  'patients',\n",
       "  'treated',\n",
       "  'with',\n",
       "  'imatinib',\n",
       "  'or',\n",
       "  'ifn-alpha.'],\n",
       " ['in',\n",
       "  'kbm5',\n",
       "  'and',\n",
       "  'k562',\n",
       "  'cells,',\n",
       "  'imatinib,',\n",
       "  'inno-406,',\n",
       "  'or',\n",
       "  'ifn-alpha',\n",
       "  'increased',\n",
       "  'cxcr4',\n",
       "  'expression',\n",
       "  'and',\n",
       "  'migration.'],\n",
       " ['altogether,',\n",
       "  'these',\n",
       "  'findings',\n",
       "  'suggest',\n",
       "  'that',\n",
       "  'the',\n",
       "  'up-regulation',\n",
       "  'of',\n",
       "  'cxcr4',\n",
       "  'by',\n",
       "  'imatinib',\n",
       "  'promotes',\n",
       "  'migration',\n",
       "  'of',\n",
       "  'cml',\n",
       "  'cells',\n",
       "  'to',\n",
       "  'bone',\n",
       "  'marrow',\n",
       "  'stroma,',\n",
       "  'causing',\n",
       "  'the',\n",
       "  'g0-g1',\n",
       "  'cell',\n",
       "  'cycle',\n",
       "  'arrest',\n",
       "  'and',\n",
       "  'hence',\n",
       "  'ensuring',\n",
       "  'the',\n",
       "  'survival',\n",
       "  'of',\n",
       "  'quiescent',\n",
       "  'cml',\n",
       "  'progenitor',\n",
       "  'cells.'],\n",
       " ['in',\n",
       "  'kbm5',\n",
       "  'and',\n",
       "  'k562',\n",
       "  'cells,',\n",
       "  'imatinib,',\n",
       "  'inno-406,',\n",
       "  'or',\n",
       "  'ifn-alpha',\n",
       "  'increased',\n",
       "  'cxcr4',\n",
       "  'expression',\n",
       "  'and',\n",
       "  'migration.'],\n",
       " ['we',\n",
       "  'proposed',\n",
       "  'that',\n",
       "  'tyrosine',\n",
       "  'kinase',\n",
       "  'inhibitors,',\n",
       "  'imatinib',\n",
       "  'or',\n",
       "  'inno-406,',\n",
       "  'may',\n",
       "  'restore',\n",
       "  'cxcr4',\n",
       "  'expression',\n",
       "  'and',\n",
       "  'cause',\n",
       "  'the',\n",
       "  'migration',\n",
       "  'of',\n",
       "  'cml',\n",
       "  'cells',\n",
       "  'to',\n",
       "  'bone',\n",
       "  'marrow',\n",
       "  'microenvironment',\n",
       "  'niches,',\n",
       "  'which',\n",
       "  'in',\n",
       "  'turn',\n",
       "  'results',\n",
       "  'in',\n",
       "  'acquisition',\n",
       "  'of',\n",
       "  'stroma-mediated',\n",
       "  'chemoresistance',\n",
       "  'of',\n",
       "  'cml',\n",
       "  'progenitor',\n",
       "  'cells.'],\n",
       " ['in',\n",
       "  'contrast',\n",
       "  'to',\n",
       "  'the',\n",
       "  'metabolic',\n",
       "  'syndrome,',\n",
       "  'gnrh',\n",
       "  'agonists',\n",
       "  'increase',\n",
       "  'subcutaneous',\n",
       "  'fat',\n",
       "  'mass,',\n",
       "  'hdl',\n",
       "  'cholesterol,',\n",
       "  'and',\n",
       "  'adiponectin,',\n",
       "  'and',\n",
       "  'do',\n",
       "  'not',\n",
       "  'alter',\n",
       "  'the',\n",
       "  'waist-to-hip',\n",
       "  'ratio,',\n",
       "  'blood',\n",
       "  'pressure,',\n",
       "  'or',\n",
       "  'c-reactive',\n",
       "  'protein',\n",
       "  'level.'],\n",
       " ['in',\n",
       "  'contrast',\n",
       "  'to',\n",
       "  'the',\n",
       "  'metabolic',\n",
       "  'syndrome,',\n",
       "  'gnrh',\n",
       "  'agonists',\n",
       "  'increase',\n",
       "  'subcutaneous',\n",
       "  'fat',\n",
       "  'mass,',\n",
       "  'hdl',\n",
       "  'cholesterol,',\n",
       "  'and',\n",
       "  'adiponectin,',\n",
       "  'and',\n",
       "  'do',\n",
       "  'not',\n",
       "  'alter',\n",
       "  'the',\n",
       "  'waist-to-hip',\n",
       "  'ratio,',\n",
       "  'blood',\n",
       "  'pressure,',\n",
       "  'or',\n",
       "  'c-reactive',\n",
       "  'protein',\n",
       "  'level.'],\n",
       " ['in',\n",
       "  'contrast',\n",
       "  'to',\n",
       "  'the',\n",
       "  'metabolic',\n",
       "  'syndrome,',\n",
       "  'gnrh',\n",
       "  'agonists',\n",
       "  'increase',\n",
       "  'subcutaneous',\n",
       "  'fat',\n",
       "  'mass,',\n",
       "  'hdl',\n",
       "  'cholesterol,',\n",
       "  'and',\n",
       "  'adiponectin,',\n",
       "  'and',\n",
       "  'do',\n",
       "  'not',\n",
       "  'alter',\n",
       "  'the',\n",
       "  'waist-to-hip',\n",
       "  'ratio,',\n",
       "  'blood',\n",
       "  'pressure,',\n",
       "  'or',\n",
       "  'c-reactive',\n",
       "  'protein',\n",
       "  'level.'],\n",
       " ['also',\n",
       "  'upregulated',\n",
       "  'were',\n",
       "  'genes',\n",
       "  'inhibited',\n",
       "  'by',\n",
       "  'progesterone,',\n",
       "  'such',\n",
       "  'as',\n",
       "  'insulin-like',\n",
       "  'growth',\n",
       "  'factor',\n",
       "  'binding',\n",
       "  'protein',\n",
       "  '5.'],\n",
       " ['furthermore,',\n",
       "  'down-regulation',\n",
       "  'of',\n",
       "  'gli',\n",
       "  'transcription',\n",
       "  'factors',\n",
       "  'using',\n",
       "  'antisense',\n",
       "  'oligonucleotides',\n",
       "  'not',\n",
       "  'only',\n",
       "  'resulted',\n",
       "  'in',\n",
       "  'significantly',\n",
       "  '(p',\n",
       "  '<',\n",
       "  '0.001)',\n",
       "  'decreased',\n",
       "  'proliferation',\n",
       "  'of',\n",
       "  'the',\n",
       "  'mcl',\n",
       "  'cells',\n",
       "  'but',\n",
       "  'also',\n",
       "  'significantly',\n",
       "  '(p',\n",
       "  '<',\n",
       "  '0.05)',\n",
       "  'increased',\n",
       "  'their',\n",
       "  'susceptibility',\n",
       "  'to',\n",
       "  'chemotherapeutic',\n",
       "  'drug,',\n",
       "  'doxorubicin.'],\n",
       " ['rzg',\n",
       "  'treatment',\n",
       "  'led',\n",
       "  'to',\n",
       "  'a',\n",
       "  'limitation',\n",
       "  'of',\n",
       "  'oxidative',\n",
       "  'stress',\n",
       "  'exemplified',\n",
       "  'by',\n",
       "  'an',\n",
       "  'increase',\n",
       "  'of',\n",
       "  'gpx',\n",
       "  'and',\n",
       "  'sod',\n",
       "  'expression.'],\n",
       " ['we',\n",
       "  'demonstrated',\n",
       "  'that',\n",
       "  'rzg',\n",
       "  'beneficial',\n",
       "  'effects',\n",
       "  'on',\n",
       "  'insulin',\n",
       "  'secretion',\n",
       "  'and',\n",
       "  'apoptosis',\n",
       "  'did',\n",
       "  'not',\n",
       "  'imply',\n",
       "  'pdx-1',\n",
       "  'or',\n",
       "  'insulin',\n",
       "  'gene',\n",
       "  'modulation.'],\n",
       " ['we',\n",
       "  'demonstrated',\n",
       "  'that',\n",
       "  'rzg',\n",
       "  'beneficial',\n",
       "  'effects',\n",
       "  'on',\n",
       "  'insulin',\n",
       "  'secretion',\n",
       "  'and',\n",
       "  'apoptosis',\n",
       "  'did',\n",
       "  'not',\n",
       "  'imply',\n",
       "  'pdx-1',\n",
       "  'or',\n",
       "  'insulin',\n",
       "  'gene',\n",
       "  'modulation.'],\n",
       " ['rzg',\n",
       "  'treatment',\n",
       "  'led',\n",
       "  'to',\n",
       "  'a',\n",
       "  'limitation',\n",
       "  'of',\n",
       "  'oxidative',\n",
       "  'stress',\n",
       "  'exemplified',\n",
       "  'by',\n",
       "  'an',\n",
       "  'increase',\n",
       "  'of',\n",
       "  'gpx',\n",
       "  'and',\n",
       "  'sod',\n",
       "  'expression.'],\n",
       " ['the',\n",
       "  'apoptotic',\n",
       "  'effects',\n",
       "  'by',\n",
       "  'the',\n",
       "  'agonists',\n",
       "  'were',\n",
       "  'antagonized',\n",
       "  'by',\n",
       "  'bisphenol',\n",
       "  'a',\n",
       "  'diglycidyl',\n",
       "  'ether,',\n",
       "  'a',\n",
       "  'ppargamma',\n",
       "  'antagonist,',\n",
       "  'and',\n",
       "  'by',\n",
       "  'knockdown',\n",
       "  'of',\n",
       "  'ppargamma',\n",
       "  'expression,',\n",
       "  'indicating',\n",
       "  'the',\n",
       "  'involvement',\n",
       "  'of',\n",
       "  'ppargamma',\n",
       "  'in',\n",
       "  'these',\n",
       "  'actions.'],\n",
       " ['up-regulated',\n",
       "  'expression',\n",
       "  'of',\n",
       "  'p53/56',\n",
       "  'lyn',\n",
       "  'kinase,',\n",
       "  'both',\n",
       "  'at',\n",
       "  'the',\n",
       "  'mrna',\n",
       "  'and',\n",
       "  'protein',\n",
       "  'level,',\n",
       "  'was',\n",
       "  'found',\n",
       "  'in',\n",
       "  'one',\n",
       "  'of',\n",
       "  'the',\n",
       "  'resistant',\n",
       "  'cell',\n",
       "  'lines',\n",
       "  'and',\n",
       "  'lyn',\n",
       "  'silencing',\n",
       "  'by',\n",
       "  'small',\n",
       "  'interfering',\n",
       "  'rna',\n",
       "  'restored',\n",
       "  'sensitivity',\n",
       "  'to',\n",
       "  'nilotinib.'],\n",
       " ['we',\n",
       "  'showed',\n",
       "  'that',\n",
       "  'nilotinib',\n",
       "  'is',\n",
       "  'a',\n",
       "  'substrate',\n",
       "  'of',\n",
       "  'the',\n",
       "  'multidrug',\n",
       "  'resistance',\n",
       "  'gene',\n",
       "  'product,',\n",
       "  'p-glycoprotein,',\n",
       "  'using',\n",
       "  'verapamil',\n",
       "  'or',\n",
       "  'psc833',\n",
       "  'to',\n",
       "  'block',\n",
       "  'binding.'],\n",
       " ['evidence',\n",
       "  'that',\n",
       "  'resistance',\n",
       "  'to',\n",
       "  'nilotinib',\n",
       "  'may',\n",
       "  'be',\n",
       "  'due',\n",
       "  'to',\n",
       "  'bcr-abl,',\n",
       "  'pgp,',\n",
       "  'or',\n",
       "  'src',\n",
       "  'kinase',\n",
       "  'overexpression.'],\n",
       " ['evidence',\n",
       "  'that',\n",
       "  'resistance',\n",
       "  'to',\n",
       "  'nilotinib',\n",
       "  'may',\n",
       "  'be',\n",
       "  'due',\n",
       "  'to',\n",
       "  'bcr-abl,',\n",
       "  'pgp,',\n",
       "  'or',\n",
       "  'src',\n",
       "  'kinase',\n",
       "  'overexpression.'],\n",
       " ['in',\n",
       "  'contrast,',\n",
       "  'dasatinib,',\n",
       "  'a',\n",
       "  'dual',\n",
       "  'bcr-abl',\n",
       "  'and',\n",
       "  'src',\n",
       "  'kinase',\n",
       "  'inhibitor,',\n",
       "  'inhibited',\n",
       "  'the',\n",
       "  'phosphorylation',\n",
       "  'of',\n",
       "  'both',\n",
       "  'bcr-abl',\n",
       "  'and',\n",
       "  'lyn,',\n",
       "  'and',\n",
       "  'induced',\n",
       "  'apoptosis',\n",
       "  'of',\n",
       "  'the',\n",
       "  'bcr-abl',\n",
       "  'cell',\n",
       "  'line',\n",
       "  'overexpressing',\n",
       "  'p53/56',\n",
       "  'lyn.'],\n",
       " ['two',\n",
       "  'src',\n",
       "  'kinase',\n",
       "  'inhibitors',\n",
       "  '(pp1',\n",
       "  'and',\n",
       "  'pp2)',\n",
       "  'partially',\n",
       "  'removed',\n",
       "  'resistance',\n",
       "  'but',\n",
       "  'did',\n",
       "  'not',\n",
       "  'significantly',\n",
       "  'inhibit',\n",
       "  'bcr-abl',\n",
       "  'tyrosine',\n",
       "  'kinase',\n",
       "  'activity.'],\n",
       " ['two',\n",
       "  'src',\n",
       "  'kinase',\n",
       "  'inhibitors',\n",
       "  '(pp1',\n",
       "  'and',\n",
       "  'pp2)',\n",
       "  'partially',\n",
       "  'removed',\n",
       "  'resistance',\n",
       "  'but',\n",
       "  'did',\n",
       "  'not',\n",
       "  'significantly',\n",
       "  'inhibit',\n",
       "  'bcr-abl',\n",
       "  'tyrosine',\n",
       "  'kinase',\n",
       "  'activity.'],\n",
       " ['we',\n",
       "  'showed',\n",
       "  'that',\n",
       "  'nilotinib',\n",
       "  'is',\n",
       "  'a',\n",
       "  'substrate',\n",
       "  'of',\n",
       "  'the',\n",
       "  'multidrug',\n",
       "  'resistance',\n",
       "  'gene',\n",
       "  'product,',\n",
       "  'p-glycoprotein,',\n",
       "  'using',\n",
       "  'verapamil',\n",
       "  'or',\n",
       "  'psc833',\n",
       "  'to',\n",
       "  'block',\n",
       "  'binding.'],\n",
       " ['up-regulated',\n",
       "  'expression',\n",
       "  'of',\n",
       "  'p53/56',\n",
       "  'lyn',\n",
       "  'kinase,',\n",
       "  'both',\n",
       "  'at',\n",
       "  'the',\n",
       "  'mrna',\n",
       "  'and',\n",
       "  'protein',\n",
       "  'level,',\n",
       "  'was',\n",
       "  'found',\n",
       "  'in',\n",
       "  'one',\n",
       "  'of',\n",
       "  'the',\n",
       "  'resistant',\n",
       "  'cell',\n",
       "  'lines',\n",
       "  'and',\n",
       "  'lyn',\n",
       "  'silencing',\n",
       "  'by',\n",
       "  'small',\n",
       "  'interfering',\n",
       "  'rna',\n",
       "  'restored',\n",
       "  'sensitivity',\n",
       "  'to',\n",
       "  'nilotinib.'],\n",
       " ['in',\n",
       "  'contrast,',\n",
       "  'dasatinib,',\n",
       "  'a',\n",
       "  'dual',\n",
       "  'bcr-abl',\n",
       "  'and',\n",
       "  'src',\n",
       "  'kinase',\n",
       "  'inhibitor,',\n",
       "  'inhibited',\n",
       "  'the',\n",
       "  'phosphorylation',\n",
       "  'of',\n",
       "  'both',\n",
       "  'bcr-abl',\n",
       "  'and',\n",
       "  'lyn,',\n",
       "  'and',\n",
       "  'induced',\n",
       "  'apoptosis',\n",
       "  'of',\n",
       "  'the',\n",
       "  'bcr-abl',\n",
       "  'cell',\n",
       "  'line',\n",
       "  'overexpressing',\n",
       "  'p53/56',\n",
       "  'lyn.'],\n",
       " ['we',\n",
       "  'showed',\n",
       "  'that',\n",
       "  'nilotinib',\n",
       "  'is',\n",
       "  'a',\n",
       "  'substrate',\n",
       "  'of',\n",
       "  'the',\n",
       "  'multidrug',\n",
       "  'resistance',\n",
       "  'gene',\n",
       "  'product,',\n",
       "  'p-glycoprotein,',\n",
       "  'using',\n",
       "  'verapamil',\n",
       "  'or',\n",
       "  'psc833',\n",
       "  'to',\n",
       "  'block',\n",
       "  'binding.'],\n",
       " ['such',\n",
       "  'mechanisms',\n",
       "  'of',\n",
       "  'resistance',\n",
       "  'are',\n",
       "  'close',\n",
       "  'to',\n",
       "  'those',\n",
       "  'observed',\n",
       "  'in',\n",
       "  'imatinib-resistant',\n",
       "  'cell',\n",
       "  'lines',\n",
       "  'and',\n",
       "  'emphasize',\n",
       "  'the',\n",
       "  'critical',\n",
       "  'role',\n",
       "  'of',\n",
       "  'lyn',\n",
       "  'in',\n",
       "  'nilotinib',\n",
       "  'resistance.'],\n",
       " ['moreover,',\n",
       "  'failure',\n",
       "  'of',\n",
       "  'nilotinib',\n",
       "  'treatment',\n",
       "  'was',\n",
       "  'accompanied',\n",
       "  'by',\n",
       "  'an',\n",
       "  'increase',\n",
       "  'of',\n",
       "  'lyn',\n",
       "  'mrna',\n",
       "  'expression',\n",
       "  'in',\n",
       "  'patients',\n",
       "  'with',\n",
       "  'resistant',\n",
       "  'cml.'],\n",
       " ['in',\n",
       "  'contrast,',\n",
       "  'dasatinib,',\n",
       "  'a',\n",
       "  'dual',\n",
       "  'bcr-abl',\n",
       "  'and',\n",
       "  'src',\n",
       "  'kinase',\n",
       "  'inhibitor,',\n",
       "  'inhibited',\n",
       "  'the',\n",
       "  'phosphorylation',\n",
       "  'of',\n",
       "  'both',\n",
       "  'bcr-abl',\n",
       "  'and',\n",
       "  'lyn,',\n",
       "  'and',\n",
       "  'induced',\n",
       "  'apoptosis',\n",
       "  'of',\n",
       "  'the',\n",
       "  'bcr-abl',\n",
       "  'cell',\n",
       "  'line',\n",
       "  'overexpressing',\n",
       "  'p53/56',\n",
       "  'lyn.'],\n",
       " ['two',\n",
       "  'src',\n",
       "  'kinase',\n",
       "  'inhibitors',\n",
       "  '(pp1',\n",
       "  'and',\n",
       "  'pp2)',\n",
       "  'partially',\n",
       "  'removed',\n",
       "  'resistance',\n",
       "  'but',\n",
       "  'did',\n",
       "  'not',\n",
       "  'significantly',\n",
       "  'inhibit',\n",
       "  'bcr-abl',\n",
       "  'tyrosine',\n",
       "  'kinase',\n",
       "  'activity.'],\n",
       " ['such',\n",
       "  'mechanisms',\n",
       "  'of',\n",
       "  'resistance',\n",
       "  'are',\n",
       "  'close',\n",
       "  'to',\n",
       "  'those',\n",
       "  'observed',\n",
       "  'in',\n",
       "  'imatinib-resistant',\n",
       "  'cell',\n",
       "  'lines',\n",
       "  'and',\n",
       "  'emphasize',\n",
       "  'the',\n",
       "  'critical',\n",
       "  'role',\n",
       "  'of',\n",
       "  'lyn',\n",
       "  'in',\n",
       "  'nilotinib',\n",
       "  'resistance.'],\n",
       " ['evidence',\n",
       "  'that',\n",
       "  'resistance',\n",
       "  'to',\n",
       "  'nilotinib',\n",
       "  'may',\n",
       "  'be',\n",
       "  'due',\n",
       "  'to',\n",
       "  'bcr-abl,',\n",
       "  'pgp,',\n",
       "  'or',\n",
       "  'src',\n",
       "  'kinase',\n",
       "  'overexpression.'],\n",
       " ['inhibition',\n",
       "  'of',\n",
       "  'p-glycoprotein',\n",
       "  '(abcb1)-',\n",
       "  'and',\n",
       "  'multidrug',\n",
       "  'resistance-associated',\n",
       "  'protein',\n",
       "  '1',\n",
       "  '(abcc1)-mediated',\n",
       "  'transport',\n",
       "  'by',\n",
       "  'the',\n",
       "  'orally',\n",
       "  'administered',\n",
       "  'inhibitor,',\n",
       "  'cbt-1((r)).'],\n",
       " ['inhibition',\n",
       "  'of',\n",
       "  'p-glycoprotein',\n",
       "  '(abcb1)-',\n",
       "  'and',\n",
       "  'multidrug',\n",
       "  'resistance-associated',\n",
       "  'protein',\n",
       "  '1',\n",
       "  '(abcc1)-mediated',\n",
       "  'transport',\n",
       "  'by',\n",
       "  'the',\n",
       "  'orally',\n",
       "  'administered',\n",
       "  'inhibitor,',\n",
       "  'cbt-1((r)).'],\n",
       " ['inhibition',\n",
       "  'of',\n",
       "  'p-glycoprotein',\n",
       "  '(abcb1)-',\n",
       "  'and',\n",
       "  'multidrug',\n",
       "  'resistance-associated',\n",
       "  'protein',\n",
       "  '1',\n",
       "  '(abcc1)-mediated',\n",
       "  'transport',\n",
       "  'by',\n",
       "  'the',\n",
       "  'orally',\n",
       "  'administered',\n",
       "  'inhibitor,',\n",
       "  'cbt-1((r)).'],\n",
       " ['cbt-1',\n",
       "  'was',\n",
       "  'found',\n",
       "  'to',\n",
       "  'compete',\n",
       "  '[(125)i]-iaap',\n",
       "  'labeling',\n",
       "  'of',\n",
       "  'pgp',\n",
       "  'with',\n",
       "  'an',\n",
       "  'ic(50)',\n",
       "  'of',\n",
       "  '0.14',\n",
       "  'microm,',\n",
       "  'and',\n",
       "  'low',\n",
       "  'concentrations',\n",
       "  'of',\n",
       "  'cbt-1',\n",
       "  '(<1',\n",
       "  'microm)',\n",
       "  'stimulated',\n",
       "  'pgp-mediated',\n",
       "  'atp',\n",
       "  'hydrolysis.'],\n",
       " ['cbt-1',\n",
       "  'at',\n",
       "  '25',\n",
       "  'microm',\n",
       "  'did',\n",
       "  'not',\n",
       "  'have',\n",
       "  'a',\n",
       "  'significant',\n",
       "  'effect',\n",
       "  'on',\n",
       "  'abcg2-mediated',\n",
       "  'pheophorbide',\n",
       "  'a',\n",
       "  'transport.'],\n",
       " ['additionally,',\n",
       "  '1',\n",
       "  'microm',\n",
       "  'completely',\n",
       "  'reversed',\n",
       "  'pgp-mediated',\n",
       "  'resistance',\n",
       "  'to',\n",
       "  'vinblastine,',\n",
       "  'paclitaxel',\n",
       "  'and',\n",
       "  'depsipeptide',\n",
       "  'in',\n",
       "  'sw620',\n",
       "  'ad20',\n",
       "  'cells.'],\n",
       " ['in',\n",
       "  'mrp1-overexpressing',\n",
       "  'cells,',\n",
       "  '10',\n",
       "  'microm',\n",
       "  'cbt-1',\n",
       "  'was',\n",
       "  'found',\n",
       "  'to',\n",
       "  'completely',\n",
       "  'inhibit',\n",
       "  'mrp1-mediated',\n",
       "  'calcein',\n",
       "  'transport.'],\n",
       " ['cbt-1',\n",
       "  'is',\n",
       "  'able',\n",
       "  'to',\n",
       "  'inhibit',\n",
       "  'the',\n",
       "  'abc',\n",
       "  'transporters',\n",
       "  'pgp',\n",
       "  'and',\n",
       "  'mrp1,',\n",
       "  'making',\n",
       "  'it',\n",
       "  'an',\n",
       "  'attractive',\n",
       "  'candidate',\n",
       "  'for',\n",
       "  'clinical',\n",
       "  'trials',\n",
       "  'in',\n",
       "  'cancers',\n",
       "  'where',\n",
       "  'pgp',\n",
       "  'and/or',\n",
       "  'mrp1',\n",
       "  'might',\n",
       "  'be',\n",
       "  'overexpressed.'],\n",
       " ['cbt-1',\n",
       "  'is',\n",
       "  'able',\n",
       "  'to',\n",
       "  'inhibit',\n",
       "  'the',\n",
       "  'abc',\n",
       "  'transporters',\n",
       "  'pgp',\n",
       "  'and',\n",
       "  'mrp1,',\n",
       "  'making',\n",
       "  'it',\n",
       "  'an',\n",
       "  'attractive',\n",
       "  'candidate',\n",
       "  'for',\n",
       "  'clinical',\n",
       "  'trials',\n",
       "  'in',\n",
       "  'cancers',\n",
       "  'where',\n",
       "  'pgp',\n",
       "  'and/or',\n",
       "  'mrp1',\n",
       "  'might',\n",
       "  'be',\n",
       "  'overexpressed.'],\n",
       " ['inhibition',\n",
       "  'of',\n",
       "  'p-glycoprotein',\n",
       "  '(abcb1)-',\n",
       "  'and',\n",
       "  'multidrug',\n",
       "  'resistance-associated',\n",
       "  'protein',\n",
       "  '1',\n",
       "  '(abcc1)-mediated',\n",
       "  'transport',\n",
       "  'by',\n",
       "  'the',\n",
       "  'orally',\n",
       "  'administered',\n",
       "  'inhibitor,',\n",
       "  'cbt-1((r)).'],\n",
       " ['cbt-1',\n",
       "  'is',\n",
       "  'a',\n",
       "  'bisbenzylisoquinoline',\n",
       "  'plant',\n",
       "  'alkyloid',\n",
       "  'currently',\n",
       "  'in',\n",
       "  'development',\n",
       "  'as',\n",
       "  'a',\n",
       "  'pgp',\n",
       "  'inhibitor.'],\n",
       " ['additionally,',\n",
       "  '1',\n",
       "  'microm',\n",
       "  'completely',\n",
       "  'reversed',\n",
       "  'pgp-mediated',\n",
       "  'resistance',\n",
       "  'to',\n",
       "  'vinblastine,',\n",
       "  'paclitaxel',\n",
       "  'and',\n",
       "  'depsipeptide',\n",
       "  'in',\n",
       "  'sw620',\n",
       "  'ad20',\n",
       "  'cells.'],\n",
       " ['cbt-1',\n",
       "  'is',\n",
       "  'able',\n",
       "  'to',\n",
       "  'inhibit',\n",
       "  'the',\n",
       "  'abc',\n",
       "  'transporters',\n",
       "  'pgp',\n",
       "  'and',\n",
       "  'mrp1,',\n",
       "  'making',\n",
       "  'it',\n",
       "  'an',\n",
       "  'attractive',\n",
       "  'candidate',\n",
       "  'for',\n",
       "  'clinical',\n",
       "  'trials',\n",
       "  'in',\n",
       "  'cancers',\n",
       "  'where',\n",
       "  'pgp',\n",
       "  'and/or',\n",
       "  'mrp1',\n",
       "  'might',\n",
       "  'be',\n",
       "  'overexpressed.'],\n",
       " ['a',\n",
       "  'recent',\n",
       "  'in',\n",
       "  'vitro',\n",
       "  'study',\n",
       "  'has',\n",
       "  'shown',\n",
       "  'that',\n",
       "  'paroxetine',\n",
       "  'is',\n",
       "  'a',\n",
       "  'substrate',\n",
       "  'of',\n",
       "  'p-glycoprotein.'],\n",
       " ['the',\n",
       "  'present',\n",
       "  'study',\n",
       "  'demonstrated',\n",
       "  'that',\n",
       "  'the',\n",
       "  'bioavailability',\n",
       "  'of',\n",
       "  'paroxetine',\n",
       "  'was',\n",
       "  'increased',\n",
       "  'by',\n",
       "  'itraconazole,',\n",
       "  'suggesting',\n",
       "  'a',\n",
       "  'possible',\n",
       "  'involvement',\n",
       "  'of',\n",
       "  'p-glycoprotein',\n",
       "  'in',\n",
       "  'the',\n",
       "  'pharmacokinetics',\n",
       "  'of',\n",
       "  'paroxetine.'],\n",
       " ['however,',\n",
       "  'there',\n",
       "  'was',\n",
       "  'no',\n",
       "  'in',\n",
       "  'vivo',\n",
       "  'information',\n",
       "  'indicating',\n",
       "  'the',\n",
       "  'involvement',\n",
       "  'of',\n",
       "  'p-glycoprotein',\n",
       "  'on',\n",
       "  'the',\n",
       "  'pharmacokinetics',\n",
       "  'of',\n",
       "  'paroxetine.'],\n",
       " ['a',\n",
       "  'continuous',\n",
       "  'epidural',\n",
       "  'infusion',\n",
       "  'of',\n",
       "  'ropivacaine',\n",
       "  'inhibits',\n",
       "  'cyp2d6',\n",
       "  'activity',\n",
       "  'in',\n",
       "  'patients',\n",
       "  'who',\n",
       "  'are',\n",
       "  'extensive',\n",
       "  'metabolizers',\n",
       "  'resulting',\n",
       "  'in',\n",
       "  'a',\n",
       "  'twofold',\n",
       "  'increase',\n",
       "  'in',\n",
       "  'the',\n",
       "  'mr',\n",
       "  'for',\n",
       "  'debrisoquine',\n",
       "  'hydroxylation.'],\n",
       " ['ropivacaine',\n",
       "  'and',\n",
       "  'one',\n",
       "  'of',\n",
       "  'its',\n",
       "  'metabolites,',\n",
       "  'pipecoloxylidide,',\n",
       "  'inhibit',\n",
       "  'cyp2d6',\n",
       "  'in.'],\n",
       " ['patients',\n",
       "  'received',\n",
       "  '10',\n",
       "  'mg',\n",
       "  'debrisoquine',\n",
       "  '(a',\n",
       "  'marker',\n",
       "  'for',\n",
       "  'cyp2d6',\n",
       "  'activity)',\n",
       "  'before',\n",
       "  'surgery',\n",
       "  'and',\n",
       "  'after',\n",
       "  '40',\n",
       "  'h',\n",
       "  'epidural',\n",
       "  'infusion.'],\n",
       " ['ropivacaine',\n",
       "  'and',\n",
       "  'one',\n",
       "  'of',\n",
       "  'its',\n",
       "  'metabolites,',\n",
       "  'pipecoloxylidide,',\n",
       "  'inhibit',\n",
       "  'cyp2d6',\n",
       "  'in.'],\n",
       " ['a',\n",
       "  'continuous',\n",
       "  'epidural',\n",
       "  'infusion',\n",
       "  'of',\n",
       "  'ropivacaine',\n",
       "  'inhibits',\n",
       "  'cyp2d6',\n",
       "  'activity',\n",
       "  'in',\n",
       "  'patients',\n",
       "  'who',\n",
       "  'are',\n",
       "  'extensive',\n",
       "  'metabolizers',\n",
       "  'resulting',\n",
       "  'in',\n",
       "  'a',\n",
       "  'twofold',\n",
       "  'increase',\n",
       "  'in',\n",
       "  'the',\n",
       "  'mr',\n",
       "  'for',\n",
       "  'debrisoquine',\n",
       "  'hydroxylation.'],\n",
       " ['our',\n",
       "  'work',\n",
       "  'supported',\n",
       "  'lrp5',\n",
       "  'genetic',\n",
       "  'variants',\n",
       "  'as',\n",
       "  'possible',\n",
       "  'susceptibility',\n",
       "  'factors',\n",
       "  'for',\n",
       "  'osteoporosis',\n",
       "  'and',\n",
       "  'fractures',\n",
       "  'in',\n",
       "  'humans.'],\n",
       " ['especially,',\n",
       "  'the',\n",
       "  'snp',\n",
       "  'rs491347',\n",
       "  'and',\n",
       "  'its',\n",
       "  'strongly',\n",
       "  'associated',\n",
       "  'snps',\n",
       "  '(e.g.,',\n",
       "  'rs1784235)',\n",
       "  'could',\n",
       "  'be',\n",
       "  'important',\n",
       "  'to',\n",
       "  'human',\n",
       "  'osteoporosis',\n",
       "  'phenotypes.'],\n",
       " ['especially,',\n",
       "  'the',\n",
       "  'snp',\n",
       "  'rs491347',\n",
       "  'and',\n",
       "  'its',\n",
       "  'strongly',\n",
       "  'associated',\n",
       "  'snps',\n",
       "  '(e.g.,',\n",
       "  'rs1784235)',\n",
       "  'could',\n",
       "  'be',\n",
       "  'important',\n",
       "  'to',\n",
       "  'human',\n",
       "  'osteoporosis',\n",
       "  'phenotypes.'],\n",
       " ['the',\n",
       "  'hbs1l-myb',\n",
       "  'intergenic',\n",
       "  'region',\n",
       "  'on',\n",
       "  'chromosome',\n",
       "  '6q23',\n",
       "  'is',\n",
       "  'a',\n",
       "  'quantitative',\n",
       "  'trait',\n",
       "  'locus',\n",
       "  'controlling',\n",
       "  'fetal',\n",
       "  'haemoglobin',\n",
       "  'level',\n",
       "  'in',\n",
       "  'carriers',\n",
       "  'of',\n",
       "  'beta-thalassaemia.'],\n",
       " ['fetal',\n",
       "  'haemoglobin',\n",
       "  '(hbf)',\n",
       "  'level',\n",
       "  'modifies',\n",
       "  'the',\n",
       "  'clinical',\n",
       "  'severity',\n",
       "  'of',\n",
       "  'hbb',\n",
       "  'disorders.'],\n",
       " ['fetal',\n",
       "  'haemoglobin',\n",
       "  '(hbf)',\n",
       "  'level',\n",
       "  'modifies',\n",
       "  'the',\n",
       "  'clinical',\n",
       "  'severity',\n",
       "  'of',\n",
       "  'hbb',\n",
       "  'disorders.'],\n",
       " ['the',\n",
       "  'hbs1l-myb',\n",
       "  'intergenic',\n",
       "  'region',\n",
       "  'on',\n",
       "  'chromosome',\n",
       "  '6q23',\n",
       "  'is',\n",
       "  'a',\n",
       "  'quantitative',\n",
       "  'trait',\n",
       "  'locus',\n",
       "  'controlling',\n",
       "  'fetal',\n",
       "  'haemoglobin',\n",
       "  'level',\n",
       "  'in',\n",
       "  'carriers',\n",
       "  'of',\n",
       "  'beta-thalassaemia.'],\n",
       " ['the',\n",
       "  'hbs1l-myb',\n",
       "  'intergenic',\n",
       "  'region',\n",
       "  'on',\n",
       "  'chromosome',\n",
       "  '6q23',\n",
       "  'is',\n",
       "  'a',\n",
       "  'quantitative',\n",
       "  'trait',\n",
       "  'locus',\n",
       "  'controlling',\n",
       "  'fetal',\n",
       "  'haemoglobin',\n",
       "  'level',\n",
       "  'in',\n",
       "  'carriers',\n",
       "  'of',\n",
       "  'beta-thalassaemia.'],\n",
       " ['functional',\n",
       "  'studies',\n",
       "  'to',\n",
       "  'unravel',\n",
       "  'the',\n",
       "  'biological',\n",
       "  'significance',\n",
       "  'of',\n",
       "  'this',\n",
       "  'region',\n",
       "  'in',\n",
       "  'regulating',\n",
       "  'hbf',\n",
       "  'production',\n",
       "  'is',\n",
       "  'clearly',\n",
       "  'indicated,',\n",
       "  'which',\n",
       "  'may',\n",
       "  'lead',\n",
       "  'to',\n",
       "  'new',\n",
       "  'strategies',\n",
       "  'to',\n",
       "  'modify',\n",
       "  'the',\n",
       "  'disease',\n",
       "  'course',\n",
       "  'of',\n",
       "  'severe',\n",
       "  'hbb',\n",
       "  'disorders.'],\n",
       " ['il-1,',\n",
       "  'il-1r',\n",
       "  'and',\n",
       "  'tnfalpha',\n",
       "  'gene',\n",
       "  'polymorphisms',\n",
       "  'in',\n",
       "  'iranian',\n",
       "  'patients',\n",
       "  'with',\n",
       "  'multiple',\n",
       "  'sclerosis.'],\n",
       " ['on',\n",
       "  'the',\n",
       "  'other',\n",
       "  'hand',\n",
       "  'the',\n",
       "  'frequency',\n",
       "  'of',\n",
       "  'il-1alpha',\n",
       "  'tt',\n",
       "  '-889',\n",
       "  'genotype',\n",
       "  '(p=0.028),',\n",
       "  'il-1r',\n",
       "  'c',\n",
       "  'pst1',\n",
       "  '1970',\n",
       "  'allele',\n",
       "  '(p=0.0001)',\n",
       "  'and',\n",
       "  'cc',\n",
       "  'genotype',\n",
       "  '(p=0.00006),',\n",
       "  'tnfalpha',\n",
       "  'g',\n",
       "  '-308',\n",
       "  'allele',\n",
       "  '(p=0.0002)',\n",
       "  'and',\n",
       "  'gg',\n",
       "  'genotype',\n",
       "  '(p=0.000001)',\n",
       "  'decreased',\n",
       "  'significantly',\n",
       "  'in',\n",
       "  'the',\n",
       "  'patients',\n",
       "  'versus',\n",
       "  'normal',\n",
       "  'subjects.these',\n",
       "  'results',\n",
       "  'suggest',\n",
       "  'that',\n",
       "  'polymorphic',\n",
       "  'variations',\n",
       "  'of',\n",
       "  'these',\n",
       "  'pro-inflammatory',\n",
       "  'cytokines',\n",
       "  'may',\n",
       "  'play',\n",
       "  'an',\n",
       "  'important',\n",
       "  'role',\n",
       "  'in',\n",
       "  'susceptibility',\n",
       "  'of',\n",
       "  'iranian',\n",
       "  'multiple',\n",
       "  'sclerosis',\n",
       "  'patients.'],\n",
       " ['on',\n",
       "  'the',\n",
       "  'other',\n",
       "  'hand',\n",
       "  'the',\n",
       "  'frequency',\n",
       "  'of',\n",
       "  'il-1alpha',\n",
       "  'tt',\n",
       "  '-889',\n",
       "  'genotype',\n",
       "  '(p=0.028),',\n",
       "  'il-1r',\n",
       "  'c',\n",
       "  'pst1',\n",
       "  '1970',\n",
       "  'allele',\n",
       "  '(p=0.0001)',\n",
       "  'and',\n",
       "  'cc',\n",
       "  'genotype',\n",
       "  '(p=0.00006),',\n",
       "  'tnfalpha',\n",
       "  'g',\n",
       "  '-308',\n",
       "  'allele',\n",
       "  '(p=0.0002)',\n",
       "  'and',\n",
       "  'gg',\n",
       "  'genotype',\n",
       "  '(p=0.000001)',\n",
       "  'decreased',\n",
       "  'significantly',\n",
       "  'in',\n",
       "  'the',\n",
       "  'patients',\n",
       "  'versus',\n",
       "  'normal',\n",
       "  'subjects.these',\n",
       "  'results',\n",
       "  'suggest',\n",
       "  'that',\n",
       "  'polymorphic',\n",
       "  'variations',\n",
       "  'of',\n",
       "  'these',\n",
       "  'pro-inflammatory',\n",
       "  'cytokines',\n",
       "  'may',\n",
       "  'play',\n",
       "  'an',\n",
       "  'important',\n",
       "  'role',\n",
       "  'in',\n",
       "  'susceptibility',\n",
       "  'of',\n",
       "  'iranian',\n",
       "  'multiple',\n",
       "  'sclerosis',\n",
       "  'patients.'],\n",
       " ['il-1,',\n",
       "  'il-1r',\n",
       "  'and',\n",
       "  'tnfalpha',\n",
       "  'gene',\n",
       "  'polymorphisms',\n",
       "  'in',\n",
       "  'iranian',\n",
       "  'patients',\n",
       "  'with',\n",
       "  'multiple',\n",
       "  'sclerosis.'],\n",
       " ['overall',\n",
       "  'and',\n",
       "  'relapse-free',\n",
       "  'survival',\n",
       "  'in',\n",
       "  'oropharyngeal',\n",
       "  'and',\n",
       "  'hypopharyngeal',\n",
       "  'squamous',\n",
       "  'cell',\n",
       "  'carcinoma',\n",
       "  'are',\n",
       "  'associated',\n",
       "  'with',\n",
       "  'genotypes',\n",
       "  'of',\n",
       "  't393c',\n",
       "  'polymorphism',\n",
       "  'of',\n",
       "  'the',\n",
       "  'gnas1',\n",
       "  'gene.'],\n",
       " ['overall',\n",
       "  'and',\n",
       "  'relapse-free',\n",
       "  'survival',\n",
       "  'in',\n",
       "  'oropharyngeal',\n",
       "  'and',\n",
       "  'hypopharyngeal',\n",
       "  'squamous',\n",
       "  'cell',\n",
       "  'carcinoma',\n",
       "  'are',\n",
       "  'associated',\n",
       "  'with',\n",
       "  'genotypes',\n",
       "  'of',\n",
       "  't393c',\n",
       "  'polymorphism',\n",
       "  'of',\n",
       "  'the',\n",
       "  'gnas1',\n",
       "  'gene.'],\n",
       " ['the',\n",
       "  't393c',\n",
       "  'snp',\n",
       "  'could',\n",
       "  'be',\n",
       "  'considered',\n",
       "  'as',\n",
       "  'a',\n",
       "  'genetic',\n",
       "  'marker',\n",
       "  'to',\n",
       "  'predict',\n",
       "  'the',\n",
       "  'clinical',\n",
       "  'course',\n",
       "  'of',\n",
       "  'patients',\n",
       "  'suffering',\n",
       "  'from',\n",
       "  'oropharyngeal',\n",
       "  'and',\n",
       "  'hypopharyngeal',\n",
       "  'cancer.'],\n",
       " ['the',\n",
       "  't393c',\n",
       "  'snp',\n",
       "  'could',\n",
       "  'be',\n",
       "  'considered',\n",
       "  'as',\n",
       "  'a',\n",
       "  'genetic',\n",
       "  'marker',\n",
       "  'to',\n",
       "  'predict',\n",
       "  'the',\n",
       "  'clinical',\n",
       "  'course',\n",
       "  'of',\n",
       "  'patients',\n",
       "  'suffering',\n",
       "  'from',\n",
       "  'oropharyngeal',\n",
       "  'and',\n",
       "  'hypopharyngeal',\n",
       "  'cancer.'],\n",
       " ['the',\n",
       "  'prognostic',\n",
       "  'value',\n",
       "  'of',\n",
       "  'the',\n",
       "  't393c',\n",
       "  'snp',\n",
       "  'was',\n",
       "  'evaluated',\n",
       "  'in',\n",
       "  'an',\n",
       "  'unselected',\n",
       "  'series',\n",
       "  'of',\n",
       "  'patients',\n",
       "  'treated',\n",
       "  'with',\n",
       "  'curative',\n",
       "  'intent',\n",
       "  'for',\n",
       "  'oropharyngeal',\n",
       "  'and',\n",
       "  'hypopharyngeal',\n",
       "  'squamous',\n",
       "  'cell',\n",
       "  'carcinomas,',\n",
       "  'including',\n",
       "  'all',\n",
       "  'tumor',\n",
       "  'stages',\n",
       "  'with',\n",
       "  'different',\n",
       "  'therapeutic',\n",
       "  'regimens.'],\n",
       " ['however,',\n",
       "  'the',\n",
       "  'majority',\n",
       "  'of',\n",
       "  'colon',\n",
       "  'cancer',\n",
       "  'cells',\n",
       "  'have',\n",
       "  'deregulation',\n",
       "  'of',\n",
       "  'the',\n",
       "  'wnt/beta-catenin',\n",
       "  'pathway.'],\n",
       " ['lysophosphatidic',\n",
       "  'acid',\n",
       "  'facilitates',\n",
       "  'proliferation',\n",
       "  'of',\n",
       "  'colon',\n",
       "  'cancer',\n",
       "  'cells',\n",
       "  'via',\n",
       "  'induction',\n",
       "  'of',\n",
       "  'krppel-like',\n",
       "  'factor',\n",
       "  '5.'],\n",
       " ['a',\n",
       "  'recent',\n",
       "  'study',\n",
       "  'showed',\n",
       "  'that',\n",
       "  'lpa-mediated',\n",
       "  'proliferation',\n",
       "  'of',\n",
       "  'colon',\n",
       "  'cancer',\n",
       "  'cells',\n",
       "  'requires',\n",
       "  'activation',\n",
       "  'of',\n",
       "  'beta-catenin.'],\n",
       " ['on',\n",
       "  'multivariate',\n",
       "  'analysis',\n",
       "  'the',\n",
       "  'cyp3a5',\n",
       "  'a6986g',\n",
       "  'genotype',\n",
       "  '*3/*3',\n",
       "  '(or',\n",
       "  '8.205,',\n",
       "  '95%',\n",
       "  'ci',\n",
       "  '1.616-41.667,',\n",
       "  'p',\n",
       "  '=',\n",
       "  '0.011)',\n",
       "  'and',\n",
       "  'smaller',\n",
       "  'number',\n",
       "  'of',\n",
       "  'treatment',\n",
       "  'cycles',\n",
       "  '(or',\n",
       "  '0.156,',\n",
       "  '95%',\n",
       "  'ci',\n",
       "  '0.037-0.659,',\n",
       "  'p',\n",
       "  '=',\n",
       "  '0.011)',\n",
       "  'were',\n",
       "  'independent',\n",
       "  'factors',\n",
       "  'for',\n",
       "  'leukocytopenia',\n",
       "  '(grade',\n",
       "  '3',\n",
       "  'or',\n",
       "  'greater)',\n",
       "  'throughout',\n",
       "  'the',\n",
       "  'period',\n",
       "  'of',\n",
       "  'chemotherapy.'],\n",
       " ['the',\n",
       "  'a6986g',\n",
       "  'polymorphism',\n",
       "  'of',\n",
       "  'cyp3a5,',\n",
       "  'which',\n",
       "  'is',\n",
       "  'involved',\n",
       "  'in',\n",
       "  'the',\n",
       "  'metabolism',\n",
       "  'of',\n",
       "  'vinblastine',\n",
       "  'and',\n",
       "  'doxorubicin,',\n",
       "  'might',\n",
       "  'be',\n",
       "  'a',\n",
       "  'genetic',\n",
       "  'predictor',\n",
       "  'of',\n",
       "  'the',\n",
       "  'severity',\n",
       "  'of',\n",
       "  'leukocytopenia',\n",
       "  'induced',\n",
       "  'by',\n",
       "  'chemotherapy',\n",
       "  'with',\n",
       "  'methotrexate,',\n",
       "  'vinblastine,',\n",
       "  'doxorubicin',\n",
       "  'and',\n",
       "  'cisplatin.'],\n",
       " ['xrcc1',\n",
       "  'genotyping',\n",
       "  'might',\n",
       "  'make',\n",
       "  'tailor',\n",
       "  'chemotherapy',\n",
       "  'possible',\n",
       "  'for',\n",
       "  'gastric',\n",
       "  'cancer',\n",
       "  'patients',\n",
       "  'treated',\n",
       "  'with',\n",
       "  'oxaliplatin-based',\n",
       "  'chemotherapy.'],\n",
       " ['polymorphism',\n",
       "  'of',\n",
       "  'xrcc1',\n",
       "  'predicts',\n",
       "  'overall',\n",
       "  'survival',\n",
       "  'of',\n",
       "  'gastric',\n",
       "  'cancer',\n",
       "  'patients',\n",
       "  'receiving',\n",
       "  'oxaliplatin-based',\n",
       "  'chemotherapy',\n",
       "  'in',\n",
       "  'chinese',\n",
       "  'population.'],\n",
       " ['this',\n",
       "  'study',\n",
       "  'assessed',\n",
       "  'associations',\n",
       "  'between',\n",
       "  'the',\n",
       "  'cyp4f2',\n",
       "  'gene',\n",
       "  'and',\n",
       "  'myocardial',\n",
       "  'infarction',\n",
       "  '(mi),',\n",
       "  'using',\n",
       "  'a',\n",
       "  'haplotype-based',\n",
       "  'case-control',\n",
       "  'study',\n",
       "  'of',\n",
       "  '234',\n",
       "  'mi',\n",
       "  'patients',\n",
       "  'and',\n",
       "  '248',\n",
       "  'controls',\n",
       "  'genotyped',\n",
       "  'for',\n",
       "  '5',\n",
       "  'single-nucleotide',\n",
       "  'polymorphisms',\n",
       "  '(rs3093105,',\n",
       "  'rs3093135,',\n",
       "  'rs1558139,',\n",
       "  'rs2108622,',\n",
       "  'rs3093200).'],\n",
       " ['a',\n",
       "  'haplotype',\n",
       "  'of',\n",
       "  'the',\n",
       "  'cyp4f2',\n",
       "  'gene',\n",
       "  'associated',\n",
       "  'with',\n",
       "  'myocardial',\n",
       "  'infarction',\n",
       "  'in',\n",
       "  'japanese',\n",
       "  'men.'],\n",
       " ['for',\n",
       "  'men,',\n",
       "  'g',\n",
       "  'allele',\n",
       "  'frequency',\n",
       "  'of',\n",
       "  'rs2108622',\n",
       "  'and',\n",
       "  'frequency',\n",
       "  'of',\n",
       "  'the',\n",
       "  't-c-g',\n",
       "  'haplotype',\n",
       "  'were',\n",
       "  'significantly',\n",
       "  'higher,',\n",
       "  'and',\n",
       "  'frequency',\n",
       "  'of',\n",
       "  'the',\n",
       "  't-c-a',\n",
       "  'haplotype',\n",
       "  'was',\n",
       "  'significantly',\n",
       "  'lower',\n",
       "  'for',\n",
       "  'mi',\n",
       "  'patients',\n",
       "  'than',\n",
       "  'for',\n",
       "  'controls',\n",
       "  '(p=0.006,',\n",
       "  'p=0.001',\n",
       "  'and',\n",
       "  'p=0.002,',\n",
       "  'respectively).'],\n",
       " ['this',\n",
       "  'study',\n",
       "  'assessed',\n",
       "  'associations',\n",
       "  'between',\n",
       "  'the',\n",
       "  'cyp4f2',\n",
       "  'gene',\n",
       "  'and',\n",
       "  'myocardial',\n",
       "  'infarction',\n",
       "  '(mi),',\n",
       "  'using',\n",
       "  'a',\n",
       "  'haplotype-based',\n",
       "  'case-control',\n",
       "  'study',\n",
       "  'of',\n",
       "  '234',\n",
       "  'mi',\n",
       "  'patients',\n",
       "  'and',\n",
       "  '248',\n",
       "  'controls',\n",
       "  'genotyped',\n",
       "  'for',\n",
       "  '5',\n",
       "  'single-nucleotide',\n",
       "  'polymorphisms',\n",
       "  '(rs3093105,',\n",
       "  'rs3093135,',\n",
       "  'rs1558139,',\n",
       "  'rs2108622,',\n",
       "  'rs3093200).'],\n",
       " ['when',\n",
       "  'stratified',\n",
       "  'by',\n",
       "  'aldh2',\n",
       "  'ex1+82a>g',\n",
       "  'polymorphism,',\n",
       "  'alcohol-related',\n",
       "  'increases',\n",
       "  'in',\n",
       "  'stomach',\n",
       "  'cancer',\n",
       "  'risk',\n",
       "  'were',\n",
       "  'restricted',\n",
       "  'to',\n",
       "  'individuals',\n",
       "  'with',\n",
       "  'the',\n",
       "  'ag/gg',\n",
       "  'genotypes,',\n",
       "  'with',\n",
       "  'a',\n",
       "  'more',\n",
       "  'than',\n",
       "  '2-fold',\n",
       "  'risk',\n",
       "  'among',\n",
       "  'daily',\n",
       "  'drinkers',\n",
       "  '(or=2.63,',\n",
       "  '95%',\n",
       "  'ci=1.00-6.88)',\n",
       "  'and',\n",
       "  '3-fold',\n",
       "  'risk',\n",
       "  '(or=3.66,',\n",
       "  '95%',\n",
       "  'ci=1.19-11.24)',\n",
       "  'among',\n",
       "  'those',\n",
       "  'with',\n",
       "  '40',\n",
       "  'or',\n",
       "  'more',\n",
       "  'drink-years.'],\n",
       " ['the',\n",
       "  'col1a2',\n",
       "  'gene',\n",
       "  'at',\n",
       "  '7q22.1',\n",
       "  'has',\n",
       "  'been',\n",
       "  'shown',\n",
       "  'to',\n",
       "  'be',\n",
       "  'associated',\n",
       "  'with',\n",
       "  'familial',\n",
       "  'intracranial',\n",
       "  'aneurysms',\n",
       "  '(ias)',\n",
       "  'in',\n",
       "  'the',\n",
       "  'japanese',\n",
       "  'population.'],\n",
       " ['the',\n",
       "  'col1a2',\n",
       "  'gene',\n",
       "  'at',\n",
       "  '7q22.1',\n",
       "  'has',\n",
       "  'been',\n",
       "  'shown',\n",
       "  'to',\n",
       "  'be',\n",
       "  'associated',\n",
       "  'with',\n",
       "  'familial',\n",
       "  'intracranial',\n",
       "  'aneurysms',\n",
       "  '(ias)',\n",
       "  'in',\n",
       "  'the',\n",
       "  'japanese',\n",
       "  'population.'],\n",
       " ['the',\n",
       "  'rs42524',\n",
       "  'polymorphism',\n",
       "  'of',\n",
       "  'col1a2',\n",
       "  'could',\n",
       "  'be',\n",
       "  'a',\n",
       "  'genetic',\n",
       "  'risk',\n",
       "  'factor',\n",
       "  'for',\n",
       "  'sporadic',\n",
       "  'ias',\n",
       "  'among',\n",
       "  'individuals',\n",
       "  'of',\n",
       "  'chinese',\n",
       "  'han',\n",
       "  'ethnicity.'],\n",
       " ['in',\n",
       "  'the',\n",
       "  'present',\n",
       "  'study,',\n",
       "  'the',\n",
       "  'authors',\n",
       "  'investigated',\n",
       "  'the',\n",
       "  'correlation',\n",
       "  'between',\n",
       "  'the',\n",
       "  'presence',\n",
       "  'of',\n",
       "  'the',\n",
       "  'rs42524',\n",
       "  'polymorphism',\n",
       "  'in',\n",
       "  'col1a2',\n",
       "  'and',\n",
       "  'the',\n",
       "  'occurrence',\n",
       "  'of',\n",
       "  'sporadic',\n",
       "  'ias',\n",
       "  'in',\n",
       "  'chinese',\n",
       "  'patients.'],\n",
       " ['this',\n",
       "  'study',\n",
       "  'is',\n",
       "  'the',\n",
       "  'first',\n",
       "  'to',\n",
       "  'confirm',\n",
       "  'the',\n",
       "  'association',\n",
       "  'between',\n",
       "  'col1a2',\n",
       "  'and',\n",
       "  'ias.'],\n",
       " ['the',\n",
       "  'rs42524',\n",
       "  'polymorphism',\n",
       "  'of',\n",
       "  'col1a2',\n",
       "  'could',\n",
       "  'be',\n",
       "  'a',\n",
       "  'genetic',\n",
       "  'risk',\n",
       "  'factor',\n",
       "  'for',\n",
       "  'sporadic',\n",
       "  'ias',\n",
       "  'among',\n",
       "  'individuals',\n",
       "  'of',\n",
       "  'chinese',\n",
       "  'han',\n",
       "  'ethnicity.'],\n",
       " ['surprisingly,',\n",
       "  'the',\n",
       "  '602s',\n",
       "  'allele',\n",
       "  'is',\n",
       "  'associated',\n",
       "  'with',\n",
       "  'a',\n",
       "  'decreased',\n",
       "  'incidence',\n",
       "  'of',\n",
       "  'leprosy,',\n",
       "  'suggesting',\n",
       "  'that',\n",
       "  'mycobacterium',\n",
       "  'leprae',\n",
       "  'subverts',\n",
       "  'the',\n",
       "  'tlr',\n",
       "  'system',\n",
       "  'as',\n",
       "  'a',\n",
       "  'mechanism',\n",
       "  'of',\n",
       "  'immune',\n",
       "  'evasion.'],\n",
       " ['cutting',\n",
       "  'edge:',\n",
       "  'a',\n",
       "  'common',\n",
       "  'polymorphism',\n",
       "  'impairs',\n",
       "  'cell',\n",
       "  'surface',\n",
       "  'trafficking',\n",
       "  'and',\n",
       "  'functional',\n",
       "  'responses',\n",
       "  'of',\n",
       "  'tlr1',\n",
       "  'but',\n",
       "  'protects',\n",
       "  'against',\n",
       "  'leprosy.'],\n",
       " ['surprisingly,',\n",
       "  'the',\n",
       "  '602s',\n",
       "  'allele',\n",
       "  'is',\n",
       "  'associated',\n",
       "  'with',\n",
       "  'a',\n",
       "  'decreased',\n",
       "  'incidence',\n",
       "  'of',\n",
       "  'leprosy,',\n",
       "  'suggesting',\n",
       "  'that',\n",
       "  'mycobacterium',\n",
       "  'leprae',\n",
       "  'subverts',\n",
       "  'the',\n",
       "  'tlr',\n",
       "  'system',\n",
       "  'as',\n",
       "  'a',\n",
       "  'mechanism',\n",
       "  'of',\n",
       "  'immune',\n",
       "  'evasion.'],\n",
       " ['these',\n",
       "  'results',\n",
       "  'suggest',\n",
       "  'that',\n",
       "  'combination',\n",
       "  'of',\n",
       "  'hdaci',\n",
       "  'with',\n",
       "  'adenoviral',\n",
       "  'trail',\n",
       "  'gene',\n",
       "  'therapy',\n",
       "  'may',\n",
       "  'be',\n",
       "  'a',\n",
       "  'new',\n",
       "  'therapeutic',\n",
       "  'approach',\n",
       "  'for',\n",
       "  'the',\n",
       "  'treatment',\n",
       "  'of',\n",
       "  'prostate',\n",
       "  'cancer',\n",
       "  'that',\n",
       "  'warrants',\n",
       "  'further',\n",
       "  'investigation.'],\n",
       " ['allelic',\n",
       "  'and',\n",
       "  'non-allelic',\n",
       "  'heterogeneities',\n",
       "  'in',\n",
       "  'pyridoxine',\n",
       "  'dependent',\n",
       "  'seizures',\n",
       "  'revealed',\n",
       "  'by',\n",
       "  'aldh7a1',\n",
       "  'mutational',\n",
       "  'analysis.'],\n",
       " ['recently,',\n",
       "  'mutations',\n",
       "  'have',\n",
       "  'been',\n",
       "  'identified',\n",
       "  'in',\n",
       "  'the',\n",
       "  'aldh7a1',\n",
       "  'gene',\n",
       "  'in',\n",
       "  'caucasian',\n",
       "  'families',\n",
       "  'with',\n",
       "  'pds.'],\n",
       " ['cytochrome',\n",
       "  'p450',\n",
       "  '1a1',\n",
       "  'is',\n",
       "  'a',\n",
       "  'major',\n",
       "  'enzyme',\n",
       "  'in',\n",
       "  'the',\n",
       "  'bioactivation',\n",
       "  'of',\n",
       "  'exogenous',\n",
       "  'procarcinogens',\n",
       "  'of',\n",
       "  'hepatocellular',\n",
       "  'carcinoma',\n",
       "  '(hcc).'],\n",
       " ['however,',\n",
       "  'the',\n",
       "  'contribution',\n",
       "  'of',\n",
       "  'common',\n",
       "  'genetic',\n",
       "  'variants',\n",
       "  'in',\n",
       "  'cyp1a1',\n",
       "  'to',\n",
       "  'the',\n",
       "  'hcc',\n",
       "  'risk',\n",
       "  'in',\n",
       "  'chinese',\n",
       "  'populations',\n",
       "  'has',\n",
       "  'not',\n",
       "  'been',\n",
       "  'thoroughly',\n",
       "  'investigated.'],\n",
       " ['cytochrome',\n",
       "  'p450',\n",
       "  '1a1',\n",
       "  'is',\n",
       "  'a',\n",
       "  'major',\n",
       "  'enzyme',\n",
       "  'in',\n",
       "  'the',\n",
       "  'bioactivation',\n",
       "  'of',\n",
       "  'exogenous',\n",
       "  'procarcinogens',\n",
       "  'of',\n",
       "  'hepatocellular',\n",
       "  'carcinoma',\n",
       "  '(hcc).'],\n",
       " ['interestingly,',\n",
       "  'the',\n",
       "  'diplotype',\n",
       "  'ttac/ccag',\n",
       "  'also',\n",
       "  'conferred',\n",
       "  'an',\n",
       "  'increased',\n",
       "  'risk',\n",
       "  'of',\n",
       "  'hcc',\n",
       "  '(or',\n",
       "  '1.76,',\n",
       "  '95%',\n",
       "  'ci',\n",
       "  '1.22-2.54,',\n",
       "  'p=0.003).'],\n",
       " ['to',\n",
       "  'summarise,',\n",
       "  'we',\n",
       "  'detected',\n",
       "  'an',\n",
       "  'increased',\n",
       "  'hcc',\n",
       "  'risk',\n",
       "  'in',\n",
       "  'rs4646421',\n",
       "  'variant',\n",
       "  'carriers',\n",
       "  '(or',\n",
       "  '1.30,',\n",
       "  '95%',\n",
       "  'ci',\n",
       "  '1.05-1.61)',\n",
       "  'and',\n",
       "  'rs2198843',\n",
       "  'variant',\n",
       "  'carriers',\n",
       "  '(or',\n",
       "  '1.33,',\n",
       "  '95%',\n",
       "  'ci',\n",
       "  '1.05-1.69),',\n",
       "  'and',\n",
       "  'a',\n",
       "  'reduced',\n",
       "  'risk',\n",
       "  'of',\n",
       "  'hcc',\n",
       "  '(or',\n",
       "  '0.70.',\n",
       "  '95%',\n",
       "  'ci',\n",
       "  '0.52-0.94)',\n",
       "  'associated',\n",
       "  'with',\n",
       "  'homozygote',\n",
       "  'carriers',\n",
       "  'of',\n",
       "  'rs4886605',\n",
       "  'variant.'],\n",
       " ['to',\n",
       "  'summarise,',\n",
       "  'we',\n",
       "  'detected',\n",
       "  'an',\n",
       "  'increased',\n",
       "  'hcc',\n",
       "  'risk',\n",
       "  'in',\n",
       "  'rs4646421',\n",
       "  'variant',\n",
       "  'carriers',\n",
       "  '(or',\n",
       "  '1.30,',\n",
       "  '95%',\n",
       "  'ci',\n",
       "  '1.05-1.61)',\n",
       "  'and',\n",
       "  'rs2198843',\n",
       "  'variant',\n",
       "  'carriers',\n",
       "  '(or',\n",
       "  '1.33,',\n",
       "  '95%',\n",
       "  'ci',\n",
       "  '1.05-1.69),',\n",
       "  'and',\n",
       "  'a',\n",
       "  'reduced',\n",
       "  'risk',\n",
       "  'of',\n",
       "  'hcc',\n",
       "  '(or',\n",
       "  '0.70.',\n",
       "  '95%',\n",
       "  'ci',\n",
       "  '0.52-0.94)',\n",
       "  'associated',\n",
       "  'with',\n",
       "  'homozygote',\n",
       "  'carriers',\n",
       "  'of',\n",
       "  'rs4886605',\n",
       "  'variant.'],\n",
       " ['compared',\n",
       "  'to',\n",
       "  'the',\n",
       "  'most',\n",
       "  'common',\n",
       "  'cyp1a1',\n",
       "  'haplotype',\n",
       "  'ccag,',\n",
       "  'the',\n",
       "  'haplotype',\n",
       "  'ttgc',\n",
       "  'conferred',\n",
       "  'an',\n",
       "  'increased',\n",
       "  'risk',\n",
       "  'of',\n",
       "  'hcc',\n",
       "  '(or',\n",
       "  '1.26,',\n",
       "  '95%',\n",
       "  'ci',\n",
       "  '1.04-1.52).'],\n",
       " ['in',\n",
       "  'this',\n",
       "  'study,',\n",
       "  'we',\n",
       "  'examined',\n",
       "  'the',\n",
       "  'association',\n",
       "  'between',\n",
       "  'hcc',\n",
       "  'and',\n",
       "  'four',\n",
       "  'selected',\n",
       "  'tagging',\n",
       "  'single',\n",
       "  'nucleotide',\n",
       "  'polymorphisms',\n",
       "  '(snps)',\n",
       "  'of',\n",
       "  'cyp1a1,',\n",
       "  'and',\n",
       "  'the',\n",
       "  'risk',\n",
       "  'of',\n",
       "  'cyp1a1',\n",
       "  'haplotypes/diplotypes',\n",
       "  'in',\n",
       "  '1006',\n",
       "  'pathologically',\n",
       "  'confirmed',\n",
       "  'hcc',\n",
       "  'patients',\n",
       "  'and',\n",
       "  '1015',\n",
       "  'cancer-free',\n",
       "  'controls,',\n",
       "  'from',\n",
       "  'a',\n",
       "  'han',\n",
       "  'chinese',\n",
       "  'population.'],\n",
       " ['our',\n",
       "  'results',\n",
       "  'suggested',\n",
       "  'that',\n",
       "  'common',\n",
       "  'genetic',\n",
       "  'variants',\n",
       "  'in',\n",
       "  'cyp1a1',\n",
       "  'may',\n",
       "  'modulate',\n",
       "  'the',\n",
       "  'risk',\n",
       "  'of',\n",
       "  'developing',\n",
       "  'hcc',\n",
       "  'in',\n",
       "  'the',\n",
       "  'study',\n",
       "  'population,',\n",
       "  'particularly',\n",
       "  'in',\n",
       "  'non-smokers.'],\n",
       " ['amyloid',\n",
       "  'beta',\n",
       "  'protein',\n",
       "  '(abeta)',\n",
       "  'levels',\n",
       "  'are',\n",
       "  'elevated',\n",
       "  'in',\n",
       "  'the',\n",
       "  'brain',\n",
       "  'of',\n",
       "  \"alzheimer's\",\n",
       "  'disease',\n",
       "  'patients.'],\n",
       " ['amyloid',\n",
       "  'beta',\n",
       "  'protein',\n",
       "  '(abeta)',\n",
       "  'levels',\n",
       "  'are',\n",
       "  'elevated',\n",
       "  'in',\n",
       "  'the',\n",
       "  'brain',\n",
       "  'of',\n",
       "  \"alzheimer's\",\n",
       "  'disease',\n",
       "  'patients.'],\n",
       " ['anti-amyloid',\n",
       "  'beta',\n",
       "  'protein',\n",
       "  'antibody',\n",
       "  'passage',\n",
       "  'across',\n",
       "  'the',\n",
       "  'blood-brain',\n",
       "  'barrier',\n",
       "  'in',\n",
       "  'the',\n",
       "  'samp8',\n",
       "  'mouse',\n",
       "  'model',\n",
       "  'of',\n",
       "  \"alzheimer's\",\n",
       "  'disease:',\n",
       "  'an',\n",
       "  'age-related',\n",
       "  'selective',\n",
       "  'uptake',\n",
       "  'with',\n",
       "  'reversal',\n",
       "  'of',\n",
       "  'learning',\n",
       "  'impairment.'],\n",
       " ['the',\n",
       "  'results',\n",
       "  'of',\n",
       "  'a',\n",
       "  'phase',\n",
       "  'i',\n",
       "  'clinical',\n",
       "  'trial',\n",
       "  'of',\n",
       "  'the',\n",
       "  'topoisomerase',\n",
       "  'i',\n",
       "  '(topo',\n",
       "  'i)',\n",
       "  'poison',\n",
       "  'cpt-11',\n",
       "  'followed',\n",
       "  'by',\n",
       "  'the',\n",
       "  'cyclin-dependent',\n",
       "  'kinase',\n",
       "  'inhibitor',\n",
       "  'flavopiridol',\n",
       "  'in',\n",
       "  'patients',\n",
       "  'with',\n",
       "  'advanced',\n",
       "  'solid',\n",
       "  'tumors',\n",
       "  'indicate',\n",
       "  'that',\n",
       "  'patients',\n",
       "  'whose',\n",
       "  'tumors',\n",
       "  'were',\n",
       "  'wild-type,',\n",
       "  'but',\n",
       "  'not',\n",
       "  'mutant,',\n",
       "  'for',\n",
       "  'p53',\n",
       "  'obtained',\n",
       "  'the',\n",
       "  'most',\n",
       "  'clinical',\n",
       "  'benefit',\n",
       "  'from',\n",
       "  'this',\n",
       "  'combination',\n",
       "  'therapy.'],\n",
       " ['to',\n",
       "  'study',\n",
       "  'the',\n",
       "  '(functional)',\n",
       "  'relevance',\n",
       "  'of',\n",
       "  'single',\n",
       "  'nucleotide',\n",
       "  'polymorphisms',\n",
       "  '(snps)',\n",
       "  'in',\n",
       "  'genes',\n",
       "  'encoding',\n",
       "  'matrix',\n",
       "  'metalloproteinases',\n",
       "  '(mmp)-1,',\n",
       "  '-2,',\n",
       "  '-3,',\n",
       "  '-9,',\n",
       "  'tissue',\n",
       "  'inhibitors',\n",
       "  'of',\n",
       "  'metalloproteinases',\n",
       "  '(timp)-1,',\n",
       "  '-2',\n",
       "  'and',\n",
       "  'tumor',\n",
       "  'necrosis',\n",
       "  'factor',\n",
       "  '(tnf)-alpha',\n",
       "  'in',\n",
       "  'the',\n",
       "  'etiopathogenesis',\n",
       "  'of',\n",
       "  'inflammatory',\n",
       "  'bowel',\n",
       "  'diseases',\n",
       "  '(ibd),',\n",
       "  'that',\n",
       "  'may',\n",
       "  'enhance',\n",
       "  'susceptibility',\n",
       "  'and/or',\n",
       "  'disease',\n",
       "  'severity.'],\n",
       " ['to',\n",
       "  'study',\n",
       "  'the',\n",
       "  '(functional)',\n",
       "  'relevance',\n",
       "  'of',\n",
       "  'single',\n",
       "  'nucleotide',\n",
       "  'polymorphisms',\n",
       "  '(snps)',\n",
       "  'in',\n",
       "  'genes',\n",
       "  'encoding',\n",
       "  'matrix',\n",
       "  'metalloproteinases',\n",
       "  '(mmp)-1,',\n",
       "  '-2,',\n",
       "  '-3,',\n",
       "  '-9,',\n",
       "  'tissue',\n",
       "  'inhibitors',\n",
       "  'of',\n",
       "  'metalloproteinases',\n",
       "  '(timp)-1,',\n",
       "  '-2',\n",
       "  'and',\n",
       "  'tumor',\n",
       "  'necrosis',\n",
       "  'factor',\n",
       "  '(tnf)-alpha',\n",
       "  'in',\n",
       "  'the',\n",
       "  'etiopathogenesis',\n",
       "  'of',\n",
       "  'inflammatory',\n",
       "  'bowel',\n",
       "  'diseases',\n",
       "  '(ibd),',\n",
       "  'that',\n",
       "  'may',\n",
       "  'enhance',\n",
       "  'susceptibility',\n",
       "  'and/or',\n",
       "  'disease',\n",
       "  'severity.'],\n",
       " ['the',\n",
       "  'timp-1',\n",
       "  'genotype',\n",
       "  'tt',\n",
       "  'in',\n",
       "  'women',\n",
       "  'and',\n",
       "  't',\n",
       "  'in',\n",
       "  'men',\n",
       "  'at',\n",
       "  'snp',\n",
       "  '+372',\n",
       "  't/c',\n",
       "  'was',\n",
       "  'found',\n",
       "  'to',\n",
       "  'increase',\n",
       "  'cd',\n",
       "  'susceptibility',\n",
       "  '(39%',\n",
       "  'vs',\n",
       "  '23.8%,',\n",
       "  'p',\n",
       "  '=',\n",
       "  '0.018',\n",
       "  'and',\n",
       "  '67.9%',\n",
       "  'vs',\n",
       "  '51.6%,',\n",
       "  'p',\n",
       "  '=',\n",
       "  '0.055,',\n",
       "  'respectively),',\n",
       "  'while',\n",
       "  'women',\n",
       "  'with',\n",
       "  'this',\n",
       "  'genotype',\n",
       "  'were',\n",
       "  'less',\n",
       "  'prone',\n",
       "  'to',\n",
       "  'development',\n",
       "  'of',\n",
       "  'fistulae',\n",
       "  'during',\n",
       "  'follow-up',\n",
       "  '(41.4%',\n",
       "  'vs',\n",
       "  '68.3%,',\n",
       "  'p',\n",
       "  '=',\n",
       "  '0.025).'],\n",
       " ['the',\n",
       "  'timp-1',\n",
       "  'genotype',\n",
       "  'tt',\n",
       "  'in',\n",
       "  'women',\n",
       "  'and',\n",
       "  't',\n",
       "  'in',\n",
       "  'men',\n",
       "  'at',\n",
       "  'snp',\n",
       "  '+372',\n",
       "  't/c',\n",
       "  'was',\n",
       "  'found',\n",
       "  'to',\n",
       "  'increase',\n",
       "  'cd',\n",
       "  'susceptibility',\n",
       "  '(39%',\n",
       "  'vs',\n",
       "  '23.8%,',\n",
       "  'p',\n",
       "  '=',\n",
       "  '0.018',\n",
       "  'and',\n",
       "  '67.9%',\n",
       "  'vs',\n",
       "  '51.6%,',\n",
       "  'p',\n",
       "  '=',\n",
       "  '0.055,',\n",
       "  'respectively),',\n",
       "  'while',\n",
       "  'women',\n",
       "  'with',\n",
       "  'this',\n",
       "  'genotype',\n",
       "  'were',\n",
       "  'less',\n",
       "  'prone',\n",
       "  'to',\n",
       "  'development',\n",
       "  'of',\n",
       "  'fistulae',\n",
       "  'during',\n",
       "  'follow-up',\n",
       "  '(41.4%',\n",
       "  'vs',\n",
       "  '68.3%,',\n",
       "  'p',\n",
       "  '=',\n",
       "  '0.025).'],\n",
       " ['the',\n",
       "  '5t5t',\n",
       "  'genotype',\n",
       "  'at',\n",
       "  'mmp-3',\n",
       "  'snp',\n",
       "  '-1613',\n",
       "  '5t/6t',\n",
       "  'increased',\n",
       "  'the',\n",
       "  'chance',\n",
       "  'of',\n",
       "  'stenotic',\n",
       "  'complications',\n",
       "  'in',\n",
       "  'cd',\n",
       "  'during',\n",
       "  'follow-up',\n",
       "  '(91.2%',\n",
       "  'vs',\n",
       "  '71.8%,',\n",
       "  'p',\n",
       "  '=',\n",
       "  '0.022)',\n",
       "  'but',\n",
       "  'seemed',\n",
       "  'to',\n",
       "  'protect',\n",
       "  'against',\n",
       "  'colonic',\n",
       "  'involvement',\n",
       "  'of',\n",
       "  'this',\n",
       "  'disease',\n",
       "  'at',\n",
       "  'first',\n",
       "  'endoscopic/radiologic',\n",
       "  'examination',\n",
       "  '(35.3%',\n",
       "  'vs',\n",
       "  '59.5%,',\n",
       "  'p',\n",
       "  '=',\n",
       "  '0.017).'],\n",
       " ['allelic',\n",
       "  'composition',\n",
       "  'at',\n",
       "  'the',\n",
       "  'examined',\n",
       "  'snps',\n",
       "  'in',\n",
       "  'genes',\n",
       "  'coding',\n",
       "  'for',\n",
       "  'timp-1',\n",
       "  'and',\n",
       "  'mmp-3',\n",
       "  'affect',\n",
       "  'cd',\n",
       "  'susceptibility',\n",
       "  'and/or',\n",
       "  'phenotype,',\n",
       "  'i.e.,',\n",
       "  'fistulizing',\n",
       "  'disease,',\n",
       "  'stricture',\n",
       "  'pathogenesis',\n",
       "  'and',\n",
       "  'first',\n",
       "  'disease',\n",
       "  'localisation.'],\n",
       " ['allelic',\n",
       "  'composition',\n",
       "  'at',\n",
       "  'the',\n",
       "  'examined',\n",
       "  'snps',\n",
       "  'in',\n",
       "  'genes',\n",
       "  'coding',\n",
       "  'for',\n",
       "  'timp-1',\n",
       "  'and',\n",
       "  'mmp-3',\n",
       "  'affect',\n",
       "  'cd',\n",
       "  'susceptibility',\n",
       "  'and/or',\n",
       "  'phenotype,',\n",
       "  'i.e.,',\n",
       "  'fistulizing',\n",
       "  'disease,',\n",
       "  'stricture',\n",
       "  'pathogenesis',\n",
       "  'and',\n",
       "  'first',\n",
       "  'disease',\n",
       "  'localisation.'],\n",
       " ['to',\n",
       "  'study',\n",
       "  'the',\n",
       "  '(functional)',\n",
       "  'relevance',\n",
       "  'of',\n",
       "  'single',\n",
       "  'nucleotide',\n",
       "  'polymorphisms',\n",
       "  '(snps)',\n",
       "  'in',\n",
       "  'genes',\n",
       "  'encoding',\n",
       "  'matrix',\n",
       "  'metalloproteinases',\n",
       "  '(mmp)-1,',\n",
       "  '-2,',\n",
       "  '-3,',\n",
       "  '-9,',\n",
       "  'tissue',\n",
       "  'inhibitors',\n",
       "  'of',\n",
       "  'metalloproteinases',\n",
       "  '(timp)-1,',\n",
       "  '-2',\n",
       "  'and',\n",
       "  'tumor',\n",
       "  'necrosis',\n",
       "  'factor',\n",
       "  '(tnf)-alpha',\n",
       "  'in',\n",
       "  'the',\n",
       "  'etiopathogenesis',\n",
       "  'of',\n",
       "  'inflammatory',\n",
       "  'bowel',\n",
       "  'diseases',\n",
       "  '(ibd),',\n",
       "  'that',\n",
       "  'may',\n",
       "  'enhance',\n",
       "  'susceptibility',\n",
       "  'and/or',\n",
       "  'disease',\n",
       "  'severity.'],\n",
       " ['to',\n",
       "  'study',\n",
       "  'the',\n",
       "  '(functional)',\n",
       "  'relevance',\n",
       "  'of',\n",
       "  'single',\n",
       "  'nucleotide',\n",
       "  'polymorphisms',\n",
       "  '(snps)',\n",
       "  'in',\n",
       "  'genes',\n",
       "  'encoding',\n",
       "  'matrix',\n",
       "  'metalloproteinases',\n",
       "  '(mmp)-1,',\n",
       "  '-2,',\n",
       "  '-3,',\n",
       "  '-9,',\n",
       "  'tissue',\n",
       "  'inhibitors',\n",
       "  'of',\n",
       "  'metalloproteinases',\n",
       "  '(timp)-1,',\n",
       "  '-2',\n",
       "  'and',\n",
       "  'tumor',\n",
       "  'necrosis',\n",
       "  'factor',\n",
       "  '(tnf)-alpha',\n",
       "  'in',\n",
       "  'the',\n",
       "  'etiopathogenesis',\n",
       "  'of',\n",
       "  'inflammatory',\n",
       "  'bowel',\n",
       "  'diseases',\n",
       "  '(ibd),',\n",
       "  'that',\n",
       "  'may',\n",
       "  'enhance',\n",
       "  'susceptibility',\n",
       "  'and/or',\n",
       "  'disease',\n",
       "  'severity.'],\n",
       " ['to',\n",
       "  'study',\n",
       "  'the',\n",
       "  '(functional)',\n",
       "  'relevance',\n",
       "  'of',\n",
       "  'single',\n",
       "  'nucleotide',\n",
       "  'polymorphisms',\n",
       "  '(snps)',\n",
       "  'in',\n",
       "  'genes',\n",
       "  'encoding',\n",
       "  'matrix',\n",
       "  'metalloproteinases',\n",
       "  '(mmp)-1,',\n",
       "  '-2,',\n",
       "  '-3,',\n",
       "  '-9,',\n",
       "  'tissue',\n",
       "  'inhibitors',\n",
       "  'of',\n",
       "  'metalloproteinases',\n",
       "  '(timp)-1,',\n",
       "  '-2',\n",
       "  'and',\n",
       "  'tumor',\n",
       "  'necrosis',\n",
       "  'factor',\n",
       "  '(tnf)-alpha',\n",
       "  'in',\n",
       "  'the',\n",
       "  'etiopathogenesis',\n",
       "  'of',\n",
       "  'inflammatory',\n",
       "  'bowel',\n",
       "  'diseases',\n",
       "  '(ibd),',\n",
       "  'that',\n",
       "  'may',\n",
       "  'enhance',\n",
       "  'susceptibility',\n",
       "  'and/or',\n",
       "  'disease',\n",
       "  'severity.'],\n",
       " ['to',\n",
       "  'study',\n",
       "  'the',\n",
       "  '(functional)',\n",
       "  'relevance',\n",
       "  'of',\n",
       "  'single',\n",
       "  'nucleotide',\n",
       "  'polymorphisms',\n",
       "  '(snps)',\n",
       "  'in',\n",
       "  'genes',\n",
       "  'encoding',\n",
       "  'matrix',\n",
       "  'metalloproteinases',\n",
       "  '(mmp)-1,',\n",
       "  '-2,',\n",
       "  '-3,',\n",
       "  '-9,',\n",
       "  'tissue',\n",
       "  'inhibitors',\n",
       "  'of',\n",
       "  'metalloproteinases',\n",
       "  '(timp)-1,',\n",
       "  '-2',\n",
       "  'and',\n",
       "  'tumor',\n",
       "  'necrosis',\n",
       "  'factor',\n",
       "  '(tnf)-alpha',\n",
       "  'in',\n",
       "  'the',\n",
       "  'etiopathogenesis',\n",
       "  'of',\n",
       "  'inflammatory',\n",
       "  'bowel',\n",
       "  'diseases',\n",
       "  '(ibd),',\n",
       "  'that',\n",
       "  'may',\n",
       "  'enhance',\n",
       "  'susceptibility',\n",
       "  'and/or',\n",
       "  'disease',\n",
       "  'severity.'],\n",
       " ['the',\n",
       "  'timp-1',\n",
       "  'genotype',\n",
       "  'tt',\n",
       "  'in',\n",
       "  'women',\n",
       "  'and',\n",
       "  't',\n",
       "  'in',\n",
       "  'men',\n",
       "  'at',\n",
       "  'snp',\n",
       "  '+372',\n",
       "  't/c',\n",
       "  'was',\n",
       "  'found',\n",
       "  'to',\n",
       "  'increase',\n",
       "  'cd',\n",
       "  'susceptibility',\n",
       "  '(39%',\n",
       "  'vs',\n",
       "  '23.8%,',\n",
       "  'p',\n",
       "  '=',\n",
       "  '0.018',\n",
       "  'and',\n",
       "  '67.9%',\n",
       "  'vs',\n",
       "  '51.6%,',\n",
       "  'p',\n",
       "  '=',\n",
       "  '0.055,',\n",
       "  'respectively),',\n",
       "  'while',\n",
       "  'women',\n",
       "  'with',\n",
       "  'this',\n",
       "  'genotype',\n",
       "  'were',\n",
       "  'less',\n",
       "  'prone',\n",
       "  'to',\n",
       "  'development',\n",
       "  'of',\n",
       "  'fistulae',\n",
       "  'during',\n",
       "  'follow-up',\n",
       "  '(41.4%',\n",
       "  'vs',\n",
       "  '68.3%,',\n",
       "  'p',\n",
       "  '=',\n",
       "  '0.025).'],\n",
       " ['the',\n",
       "  'timp-1',\n",
       "  'genotype',\n",
       "  'tt',\n",
       "  'in',\n",
       "  'women',\n",
       "  'and',\n",
       "  't',\n",
       "  'in',\n",
       "  'men',\n",
       "  'at',\n",
       "  'snp',\n",
       "  '+372',\n",
       "  't/c',\n",
       "  'was',\n",
       "  'found',\n",
       "  'to',\n",
       "  'increase',\n",
       "  'cd',\n",
       "  'susceptibility',\n",
       "  '(39%',\n",
       "  'vs',\n",
       "  '23.8%,',\n",
       "  'p',\n",
       "  '=',\n",
       "  '0.018',\n",
       "  'and',\n",
       "  '67.9%',\n",
       "  'vs',\n",
       "  '51.6%,',\n",
       "  'p',\n",
       "  '=',\n",
       "  '0.055,',\n",
       "  'respectively),',\n",
       "  'while',\n",
       "  'women',\n",
       "  'with',\n",
       "  'this',\n",
       "  'genotype',\n",
       "  'were',\n",
       "  'less',\n",
       "  'prone',\n",
       "  'to',\n",
       "  'development',\n",
       "  'of',\n",
       "  'fistulae',\n",
       "  'during',\n",
       "  'follow-up',\n",
       "  '(41.4%',\n",
       "  'vs',\n",
       "  '68.3%,',\n",
       "  'p',\n",
       "  '=',\n",
       "  '0.025).'],\n",
       " ['the',\n",
       "  '5t5t',\n",
       "  'genotype',\n",
       "  'at',\n",
       "  'mmp-3',\n",
       "  'snp',\n",
       "  '-1613',\n",
       "  '5t/6t',\n",
       "  'increased',\n",
       "  'the',\n",
       "  'chance',\n",
       "  'of',\n",
       "  'stenotic',\n",
       "  'complications',\n",
       "  'in',\n",
       "  'cd',\n",
       "  'during',\n",
       "  'follow-up',\n",
       "  '(91.2%',\n",
       "  'vs',\n",
       "  '71.8%,',\n",
       "  'p',\n",
       "  '=',\n",
       "  '0.022)',\n",
       "  'but',\n",
       "  'seemed',\n",
       "  'to',\n",
       "  'protect',\n",
       "  'against',\n",
       "  'colonic',\n",
       "  'involvement',\n",
       "  'of',\n",
       "  'this',\n",
       "  'disease',\n",
       "  'at',\n",
       "  'first',\n",
       "  'endoscopic/radiologic',\n",
       "  'examination',\n",
       "  '(35.3%',\n",
       "  'vs',\n",
       "  '59.5%,',\n",
       "  'p',\n",
       "  '=',\n",
       "  '0.017).'],\n",
       " ['ala394thr',\n",
       "  'polymorphism',\n",
       "  'in',\n",
       "  'the',\n",
       "  'clock',\n",
       "  'gene',\n",
       "  'npas2:',\n",
       "  'a',\n",
       "  'circadian',\n",
       "  'modifier',\n",
       "  'for',\n",
       "  'the',\n",
       "  'risk',\n",
       "  'of',\n",
       "  \"non-hodgkin's\",\n",
       "  'lymphoma.'],\n",
       " ['ala394thr',\n",
       "  'polymorphism',\n",
       "  'in',\n",
       "  'the',\n",
       "  'clock',\n",
       "  'gene',\n",
       "  'npas2:',\n",
       "  'a',\n",
       "  'circadian',\n",
       "  'modifier',\n",
       "  'for',\n",
       "  'the',\n",
       "  'risk',\n",
       "  'of',\n",
       "  \"non-hodgkin's\",\n",
       "  'lymphoma.'],\n",
       " ['stec',\n",
       "  'strains',\n",
       "  'carrying',\n",
       "  'stx2',\n",
       "  'were',\n",
       "  'more',\n",
       "  'frequently',\n",
       "  'associated',\n",
       "  'with',\n",
       "  'clinical',\n",
       "  'manifestations',\n",
       "  'of',\n",
       "  'hemolytic-uremic',\n",
       "  'syndrome',\n",
       "  '(hus)',\n",
       "  'or',\n",
       "  'bloody',\n",
       "  'diarrhea',\n",
       "  'than',\n",
       "  'those',\n",
       "  'carrying',\n",
       "  'stx2vha.'],\n",
       " ['stec',\n",
       "  'strains',\n",
       "  'carrying',\n",
       "  'stx2',\n",
       "  'were',\n",
       "  'more',\n",
       "  'frequently',\n",
       "  'associated',\n",
       "  'with',\n",
       "  'clinical',\n",
       "  'manifestations',\n",
       "  'of',\n",
       "  'hemolytic-uremic',\n",
       "  'syndrome',\n",
       "  '(hus)',\n",
       "  'or',\n",
       "  'bloody',\n",
       "  'diarrhea',\n",
       "  'than',\n",
       "  'those',\n",
       "  'carrying',\n",
       "  'stx2vha.'],\n",
       " ['stec',\n",
       "  'strains',\n",
       "  'carrying',\n",
       "  'stx2',\n",
       "  'were',\n",
       "  'more',\n",
       "  'frequently',\n",
       "  'associated',\n",
       "  'with',\n",
       "  'clinical',\n",
       "  'manifestations',\n",
       "  'of',\n",
       "  'hemolytic-uremic',\n",
       "  'syndrome',\n",
       "  '(hus)',\n",
       "  'or',\n",
       "  'bloody',\n",
       "  'diarrhea',\n",
       "  'than',\n",
       "  'those',\n",
       "  'carrying',\n",
       "  'stx2vha.'],\n",
       " ['we',\n",
       "  'conclude',\n",
       "  'that',\n",
       "  'stx',\n",
       "  'genotype',\n",
       "  'is',\n",
       "  'one',\n",
       "  'of',\n",
       "  'the',\n",
       "  'important',\n",
       "  'factors',\n",
       "  'of',\n",
       "  'clinical',\n",
       "  'outcome',\n",
       "  'of',\n",
       "  'stec',\n",
       "  'o157',\n",
       "  'infection',\n",
       "  'and',\n",
       "  'that',\n",
       "  'pathogenicity',\n",
       "  'for',\n",
       "  'humans',\n",
       "  'was',\n",
       "  'higher',\n",
       "  'in',\n",
       "  'the',\n",
       "  'stx2',\n",
       "  'genotype',\n",
       "  'strains',\n",
       "  'than',\n",
       "  'in',\n",
       "  'the',\n",
       "  'stx2vha',\n",
       "  'genotype',\n",
       "  'strains,',\n",
       "  'as',\n",
       "  'reported',\n",
       "  'previously',\n",
       "  'by',\n",
       "  'other',\n",
       "  'researchers.'],\n",
       " ['subsequent',\n",
       "  'analysis',\n",
       "  'of',\n",
       "  'individual',\n",
       "  'snps',\n",
       "  'in',\n",
       "  'strong',\n",
       "  'linkage',\n",
       "  'disequilibrium',\n",
       "  'with',\n",
       "  'the',\n",
       "  'me2',\n",
       "  'gene',\n",
       "  'revealed',\n",
       "  'one',\n",
       "  'snp',\n",
       "  'and',\n",
       "  'one',\n",
       "  'haplotype',\n",
       "  'associated',\n",
       "  'with',\n",
       "  'the',\n",
       "  'phenotype',\n",
       "  'of',\n",
       "  'psychosis',\n",
       "  'in',\n",
       "  'the',\n",
       "  'cvcr',\n",
       "  'sample.'],\n",
       " ['me2',\n",
       "  'interacts',\n",
       "  'directly',\n",
       "  'with',\n",
       "  'the',\n",
       "  'malate',\n",
       "  'shuttle',\n",
       "  'system,',\n",
       "  'which',\n",
       "  'has',\n",
       "  'been',\n",
       "  'shown',\n",
       "  'to',\n",
       "  'be',\n",
       "  'altered',\n",
       "  'in',\n",
       "  'schizophrenia',\n",
       "  'and',\n",
       "  'bipolar',\n",
       "  'disorder,',\n",
       "  'and',\n",
       "  'has',\n",
       "  'roles',\n",
       "  'in',\n",
       "  'neuronal',\n",
       "  'synthesis',\n",
       "  'of',\n",
       "  'glutamate',\n",
       "  'and',\n",
       "  'gamma-amino',\n",
       "  'butyric',\n",
       "  'acid.'],\n",
       " ['me2',\n",
       "  'interacts',\n",
       "  'directly',\n",
       "  'with',\n",
       "  'the',\n",
       "  'malate',\n",
       "  'shuttle',\n",
       "  'system,',\n",
       "  'which',\n",
       "  'has',\n",
       "  'been',\n",
       "  'shown',\n",
       "  'to',\n",
       "  'be',\n",
       "  'altered',\n",
       "  'in',\n",
       "  'schizophrenia',\n",
       "  'and',\n",
       "  'bipolar',\n",
       "  'disorder,',\n",
       "  'and',\n",
       "  'has',\n",
       "  'roles',\n",
       "  'in',\n",
       "  'neuronal',\n",
       "  'synthesis',\n",
       "  'of',\n",
       "  'glutamate',\n",
       "  'and',\n",
       "  'gamma-amino',\n",
       "  'butyric',\n",
       "  'acid.'],\n",
       " ['the',\n",
       "  'present',\n",
       "  'study',\n",
       "  'suggests',\n",
       "  'that',\n",
       "  'genetic',\n",
       "  'variation',\n",
       "  'in',\n",
       "  'or',\n",
       "  'near',\n",
       "  'the',\n",
       "  'me2',\n",
       "  'gene',\n",
       "  'is',\n",
       "  'associated',\n",
       "  'with',\n",
       "  'both',\n",
       "  'psychotic',\n",
       "  'and',\n",
       "  'manic',\n",
       "  'disorders,',\n",
       "  'including',\n",
       "  'schizophrenia',\n",
       "  'and',\n",
       "  'bipolar',\n",
       "  'disorder.'],\n",
       " ['the',\n",
       "  'present',\n",
       "  'study',\n",
       "  'suggests',\n",
       "  'that',\n",
       "  'genetic',\n",
       "  'variation',\n",
       "  'in',\n",
       "  'or',\n",
       "  'near',\n",
       "  'the',\n",
       "  'me2',\n",
       "  'gene',\n",
       "  'is',\n",
       "  'associated',\n",
       "  'with',\n",
       "  'both',\n",
       "  'psychotic',\n",
       "  'and',\n",
       "  'manic',\n",
       "  'disorders,',\n",
       "  'including',\n",
       "  'schizophrenia',\n",
       "  'and',\n",
       "  'bipolar',\n",
       "  'disorder.'],\n",
       " ['the',\n",
       "  'present',\n",
       "  'study',\n",
       "  'suggests',\n",
       "  'that',\n",
       "  'genetic',\n",
       "  'variation',\n",
       "  'in',\n",
       "  'or',\n",
       "  'near',\n",
       "  'the',\n",
       "  'me2',\n",
       "  'gene',\n",
       "  'is',\n",
       "  'associated',\n",
       "  'with',\n",
       "  'both',\n",
       "  'psychotic',\n",
       "  'and',\n",
       "  'manic',\n",
       "  'disorders,',\n",
       "  'including',\n",
       "  'schizophrenia',\n",
       "  'and',\n",
       "  'bipolar',\n",
       "  'disorder.'],\n",
       " ['the',\n",
       "  'present',\n",
       "  'study',\n",
       "  'suggests',\n",
       "  'that',\n",
       "  'genetic',\n",
       "  'variation',\n",
       "  'in',\n",
       "  'or',\n",
       "  'near',\n",
       "  'the',\n",
       "  'me2',\n",
       "  'gene',\n",
       "  'is',\n",
       "  'associated',\n",
       "  'with',\n",
       "  'both',\n",
       "  'psychotic',\n",
       "  'and',\n",
       "  'manic',\n",
       "  'disorders,',\n",
       "  'including',\n",
       "  'schizophrenia',\n",
       "  'and',\n",
       "  'bipolar',\n",
       "  'disorder.'],\n",
       " ['genetic',\n",
       "  'alterations',\n",
       "  'within',\n",
       "  'the',\n",
       "  'p53',\n",
       "  'gene',\n",
       "  'have',\n",
       "  'been',\n",
       "  'shown',\n",
       "  'to',\n",
       "  'have',\n",
       "  'a',\n",
       "  'direct',\n",
       "  'correlation',\n",
       "  'with',\n",
       "  'cancer',\n",
       "  'development',\n",
       "  'and',\n",
       "  'have',\n",
       "  'been',\n",
       "  'shown',\n",
       "  'to',\n",
       "  'occur',\n",
       "  'in',\n",
       "  'nearly',\n",
       "  '50%',\n",
       "  'of',\n",
       "  'all',\n",
       "  'cancers.'],\n",
       " ['this',\n",
       "  'review',\n",
       "  'discusses',\n",
       "  'the',\n",
       "  'role',\n",
       "  'of',\n",
       "  'p53',\n",
       "  'from',\n",
       "  'normal',\n",
       "  'function',\n",
       "  'and',\n",
       "  'its',\n",
       "  'dysfunction',\n",
       "  'in',\n",
       "  'pre-cancerous',\n",
       "  'lesions',\n",
       "  'and',\n",
       "  'non-melanoma',\n",
       "  'skin',\n",
       "  'cancers.'],\n",
       " ['we',\n",
       "  'sought',\n",
       "  'to',\n",
       "  'evaluate',\n",
       "  '2',\n",
       "  'single-nucleotide',\n",
       "  'polymorphisms',\n",
       "  '(snps)',\n",
       "  'in',\n",
       "  'the',\n",
       "  'c-reactive',\n",
       "  'protein',\n",
       "  '(crp)',\n",
       "  'gene',\n",
       "  'promoter',\n",
       "  'region',\n",
       "  'for',\n",
       "  'their',\n",
       "  'effects',\n",
       "  'on',\n",
       "  'crp',\n",
       "  'levels',\n",
       "  'in',\n",
       "  'chronic',\n",
       "  'kidney',\n",
       "  'disease',\n",
       "  '(ckd)',\n",
       "  'patients',\n",
       "  'before',\n",
       "  'and',\n",
       "  'after',\n",
       "  'a',\n",
       "  'successful',\n",
       "  'kidney',\n",
       "  'transplantation.'],\n",
       " ['we',\n",
       "  'sought',\n",
       "  'to',\n",
       "  'evaluate',\n",
       "  '2',\n",
       "  'single-nucleotide',\n",
       "  'polymorphisms',\n",
       "  '(snps)',\n",
       "  'in',\n",
       "  'the',\n",
       "  'c-reactive',\n",
       "  'protein',\n",
       "  '(crp)',\n",
       "  'gene',\n",
       "  'promoter',\n",
       "  'region',\n",
       "  'for',\n",
       "  'their',\n",
       "  'effects',\n",
       "  'on',\n",
       "  'crp',\n",
       "  'levels',\n",
       "  'in',\n",
       "  'chronic',\n",
       "  'kidney',\n",
       "  'disease',\n",
       "  '(ckd)',\n",
       "  'patients',\n",
       "  'before',\n",
       "  'and',\n",
       "  'after',\n",
       "  'a',\n",
       "  'successful',\n",
       "  'kidney',\n",
       "  'transplantation.'],\n",
       " ['the',\n",
       "  'study',\n",
       "  'investigated',\n",
       "  'the',\n",
       "  'possible',\n",
       "  'association',\n",
       "  'of',\n",
       "  'nrg3',\n",
       "  'gene',\n",
       "  'and',\n",
       "  'schizophrenia',\n",
       "  'in',\n",
       "  'a',\n",
       "  'han',\n",
       "  'chinese',\n",
       "  'population.'],\n",
       " ['in',\n",
       "  'the',\n",
       "  'haplotype-transmission',\n",
       "  'disequilibrium',\n",
       "  'test',\n",
       "  '(tdt)',\n",
       "  'for',\n",
       "  'allelic',\n",
       "  'combination',\n",
       "  'of',\n",
       "  'rs1937970-rs677221,',\n",
       "  'significant',\n",
       "  'under-transmission',\n",
       "  'for',\n",
       "  'haplotype',\n",
       "  'ag',\n",
       "  '(uncorrected',\n",
       "  'p',\n",
       "  '=',\n",
       "  '.006)',\n",
       "  'and',\n",
       "  'over-transmission',\n",
       "  'for',\n",
       "  'haplotype',\n",
       "  'gc',\n",
       "  '(uncorrected',\n",
       "  'p',\n",
       "  '=',\n",
       "  '.004)',\n",
       "  'to',\n",
       "  'the',\n",
       "  'affected',\n",
       "  'schizophrenia',\n",
       "  'offspring',\n",
       "  'were',\n",
       "  'observed.'],\n",
       " ['in',\n",
       "  'case-control',\n",
       "  'samples,',\n",
       "  'two',\n",
       "  'snps',\n",
       "  '(rs1937970',\n",
       "  'and',\n",
       "  'rs677221)',\n",
       "  'showed',\n",
       "  'significant',\n",
       "  'genotypic',\n",
       "  'and',\n",
       "  'allelic',\n",
       "  'association',\n",
       "  'with',\n",
       "  'schizophrenia',\n",
       "  '(all',\n",
       "  'p',\n",
       "  '<',\n",
       "  '.05)',\n",
       "  'with',\n",
       "  'rs677221-c',\n",
       "  'being',\n",
       "  'the',\n",
       "  'risk',\n",
       "  'allele',\n",
       "  'for',\n",
       "  'schizophrenia',\n",
       "  '(uncorrected',\n",
       "  'p',\n",
       "  '=',\n",
       "  '.001,',\n",
       "  'odds',\n",
       "  'ratio',\n",
       "  '=',\n",
       "  '1.439,',\n",
       "  '95%',\n",
       "  'confidence',\n",
       "  'interval',\n",
       "  '=',\n",
       "  '1.115-1.858).'],\n",
       " ['in',\n",
       "  'case-control',\n",
       "  'samples,',\n",
       "  'two',\n",
       "  'snps',\n",
       "  '(rs1937970',\n",
       "  'and',\n",
       "  'rs677221)',\n",
       "  'showed',\n",
       "  'significant',\n",
       "  'genotypic',\n",
       "  'and',\n",
       "  'allelic',\n",
       "  'association',\n",
       "  'with',\n",
       "  'schizophrenia',\n",
       "  '(all',\n",
       "  'p',\n",
       "  '<',\n",
       "  '.05)',\n",
       "  'with',\n",
       "  'rs677221-c',\n",
       "  'being',\n",
       "  'the',\n",
       "  'risk',\n",
       "  'allele',\n",
       "  'for',\n",
       "  'schizophrenia',\n",
       "  '(uncorrected',\n",
       "  'p',\n",
       "  '=',\n",
       "  '.001,',\n",
       "  'odds',\n",
       "  'ratio',\n",
       "  '=',\n",
       "  '1.439,',\n",
       "  '95%',\n",
       "  'confidence',\n",
       "  'interval',\n",
       "  '=',\n",
       "  '1.115-1.858).'],\n",
       " ['the',\n",
       "  'result',\n",
       "  'supports',\n",
       "  'that',\n",
       "  'the',\n",
       "  'nrg3',\n",
       "  'gene',\n",
       "  'is',\n",
       "  'a',\n",
       "  'susceptibility',\n",
       "  'gene',\n",
       "  'for',\n",
       "  'schizophrenia.'],\n",
       " ['haplotypes',\n",
       "  'gc',\n",
       "  'constructed',\n",
       "  'by',\n",
       "  'the',\n",
       "  'two',\n",
       "  'snps',\n",
       "  'was',\n",
       "  'also',\n",
       "  'significantly',\n",
       "  'associated',\n",
       "  'with',\n",
       "  'schizophrenia',\n",
       "  '(permutation',\n",
       "  'p',\n",
       "  'value',\n",
       "  '=',\n",
       "  '.0047).'],\n",
       " ['in',\n",
       "  'the',\n",
       "  'haplotype-transmission',\n",
       "  'disequilibrium',\n",
       "  'test',\n",
       "  '(tdt)',\n",
       "  'for',\n",
       "  'allelic',\n",
       "  'combination',\n",
       "  'of',\n",
       "  'rs1937970-rs677221,',\n",
       "  'significant',\n",
       "  'under-transmission',\n",
       "  'for',\n",
       "  'haplotype',\n",
       "  'ag',\n",
       "  '(uncorrected',\n",
       "  'p',\n",
       "  '=',\n",
       "  '.006)',\n",
       "  'and',\n",
       "  'over-transmission',\n",
       "  'for',\n",
       "  'haplotype',\n",
       "  'gc',\n",
       "  '(uncorrected',\n",
       "  'p',\n",
       "  '=',\n",
       "  '.004)',\n",
       "  'to',\n",
       "  'the',\n",
       "  'affected',\n",
       "  'schizophrenia',\n",
       "  'offspring',\n",
       "  'were',\n",
       "  'observed.'],\n",
       " ['in',\n",
       "  'the',\n",
       "  'independent',\n",
       "  'trio',\n",
       "  'samples,',\n",
       "  'rs1937970-a',\n",
       "  'and',\n",
       "  'rs677221-g',\n",
       "  'consistently',\n",
       "  'showed',\n",
       "  'significant',\n",
       "  'under-transmission',\n",
       "  'to',\n",
       "  'schizophrenic',\n",
       "  'offspring',\n",
       "  '(unadjusted',\n",
       "  'p',\n",
       "  '=',\n",
       "  '.003',\n",
       "  'and',\n",
       "  'p',\n",
       "  '=',\n",
       "  '.004,',\n",
       "  'respectively).'],\n",
       " ['in',\n",
       "  'the',\n",
       "  'independent',\n",
       "  'trio',\n",
       "  'samples,',\n",
       "  'rs1937970-a',\n",
       "  'and',\n",
       "  'rs677221-g',\n",
       "  'consistently',\n",
       "  'showed',\n",
       "  'significant',\n",
       "  'under-transmission',\n",
       "  'to',\n",
       "  'schizophrenic',\n",
       "  'offspring',\n",
       "  '(unadjusted',\n",
       "  'p',\n",
       "  '=',\n",
       "  '.003',\n",
       "  'and',\n",
       "  'p',\n",
       "  '=',\n",
       "  '.004,',\n",
       "  'respectively).'],\n",
       " ['in',\n",
       "  'the',\n",
       "  'haplotype-transmission',\n",
       "  'disequilibrium',\n",
       "  'test',\n",
       "  '(tdt)',\n",
       "  'for',\n",
       "  'allelic',\n",
       "  'combination',\n",
       "  'of',\n",
       "  'rs1937970-rs677221,',\n",
       "  'significant',\n",
       "  'under-transmission',\n",
       "  'for',\n",
       "  'haplotype',\n",
       "  'ag',\n",
       "  '(uncorrected',\n",
       "  'p',\n",
       "  '=',\n",
       "  '.006)',\n",
       "  'and',\n",
       "  'over-transmission',\n",
       "  'for',\n",
       "  'haplotype',\n",
       "  'gc',\n",
       "  '(uncorrected',\n",
       "  'p',\n",
       "  '=',\n",
       "  '.004)',\n",
       "  'to',\n",
       "  'the',\n",
       "  'affected',\n",
       "  'schizophrenia',\n",
       "  'offspring',\n",
       "  'were',\n",
       "  'observed.'],\n",
       " ['neuregulin',\n",
       "  '3',\n",
       "  'genetic',\n",
       "  'variations',\n",
       "  'and',\n",
       "  'susceptibility',\n",
       "  'to',\n",
       "  'schizophrenia',\n",
       "  'in',\n",
       "  'a',\n",
       "  'chinese',\n",
       "  'population.'],\n",
       " ['in',\n",
       "  'case-control',\n",
       "  'samples,',\n",
       "  'two',\n",
       "  'snps',\n",
       "  '(rs1937970',\n",
       "  'and',\n",
       "  'rs677221)',\n",
       "  'showed',\n",
       "  'significant',\n",
       "  'genotypic',\n",
       "  'and',\n",
       "  'allelic',\n",
       "  'association',\n",
       "  'with',\n",
       "  'schizophrenia',\n",
       "  '(all',\n",
       "  'p',\n",
       "  '<',\n",
       "  '.05)',\n",
       "  'with',\n",
       "  'rs677221-c',\n",
       "  'being',\n",
       "  'the',\n",
       "  'risk',\n",
       "  'allele',\n",
       "  'for',\n",
       "  'schizophrenia',\n",
       "  '(uncorrected',\n",
       "  'p',\n",
       "  '=',\n",
       "  '.001,',\n",
       "  'odds',\n",
       "  'ratio',\n",
       "  '=',\n",
       "  '1.439,',\n",
       "  '95%',\n",
       "  'confidence',\n",
       "  'interval',\n",
       "  '=',\n",
       "  '1.115-1.858).'],\n",
       " ['these',\n",
       "  'results',\n",
       "  'suggest',\n",
       "  'that',\n",
       "  'the',\n",
       "  'nlrp3',\n",
       "  'region',\n",
       "  'is',\n",
       "  'also',\n",
       "  'implicated',\n",
       "  'in',\n",
       "  'the',\n",
       "  'susceptibility',\n",
       "  'of',\n",
       "  'more',\n",
       "  'common',\n",
       "  'inflammatory',\n",
       "  'diseases',\n",
       "  'such',\n",
       "  'as',\n",
       "  \"crohn's\",\n",
       "  'disease.'],\n",
       " ['we',\n",
       "  'used',\n",
       "  'a',\n",
       "  'candidate',\n",
       "  'gene',\n",
       "  'approach',\n",
       "  'to',\n",
       "  'identify',\n",
       "  'a',\n",
       "  'set',\n",
       "  'of',\n",
       "  'snps,',\n",
       "  'located',\n",
       "  'in',\n",
       "  'a',\n",
       "  'predicted',\n",
       "  'regulatory',\n",
       "  'region',\n",
       "  'on',\n",
       "  'chromosome',\n",
       "  '1q44',\n",
       "  'downstream',\n",
       "  'of',\n",
       "  'nlrp3',\n",
       "  '(previously',\n",
       "  'known',\n",
       "  'as',\n",
       "  'cias1',\n",
       "  'and',\n",
       "  'nalp3)',\n",
       "  'that',\n",
       "  'are',\n",
       "  'associated',\n",
       "  'with',\n",
       "  \"crohn's\",\n",
       "  'disease.'],\n",
       " ['we',\n",
       "  'used',\n",
       "  'a',\n",
       "  'candidate',\n",
       "  'gene',\n",
       "  'approach',\n",
       "  'to',\n",
       "  'identify',\n",
       "  'a',\n",
       "  'set',\n",
       "  'of',\n",
       "  'snps,',\n",
       "  'located',\n",
       "  'in',\n",
       "  'a',\n",
       "  'predicted',\n",
       "  'regulatory',\n",
       "  'region',\n",
       "  'on',\n",
       "  'chromosome',\n",
       "  '1q44',\n",
       "  'downstream',\n",
       "  'of',\n",
       "  'nlrp3',\n",
       "  '(previously',\n",
       "  'known',\n",
       "  'as',\n",
       "  'cias1',\n",
       "  'and',\n",
       "  'nalp3)',\n",
       "  'that',\n",
       "  'are',\n",
       "  'associated',\n",
       "  'with',\n",
       "  \"crohn's\",\n",
       "  'disease.'],\n",
       " ['common',\n",
       "  'variants',\n",
       "  'in',\n",
       "  'the',\n",
       "  'nlrp3',\n",
       "  'region',\n",
       "  'contribute',\n",
       "  'to',\n",
       "  \"crohn's\",\n",
       "  'disease',\n",
       "  'susceptibility.'],\n",
       " ['therefore,',\n",
       "  'the',\n",
       "  'mutations',\n",
       "  'of',\n",
       "  'the',\n",
       "  'mdr1',\n",
       "  'gene',\n",
       "  'are',\n",
       "  'thought',\n",
       "  'to',\n",
       "  'be',\n",
       "  'related',\n",
       "  'with',\n",
       "  'the',\n",
       "  'pathogenesis',\n",
       "  'of',\n",
       "  'inflammatory',\n",
       "  'bowel',\n",
       "  'disease.'],\n",
       " ['in',\n",
       "  'this',\n",
       "  'study,',\n",
       "  'the',\n",
       "  'g2677t/a',\n",
       "  'polymorphism',\n",
       "  'observed',\n",
       "  'in',\n",
       "  'the',\n",
       "  'mdr1',\n",
       "  'gene',\n",
       "  'was',\n",
       "  'not',\n",
       "  'found',\n",
       "  'to',\n",
       "  'be',\n",
       "  'a',\n",
       "  'risk',\n",
       "  'factor',\n",
       "  'for',\n",
       "  \"crohn's\",\n",
       "  'disease',\n",
       "  'or',\n",
       "  'ulcerative',\n",
       "  'colitis.'],\n",
       " ['in',\n",
       "  'this',\n",
       "  'study,',\n",
       "  'the',\n",
       "  'g2677t/a',\n",
       "  'polymorphism',\n",
       "  'observed',\n",
       "  'in',\n",
       "  'the',\n",
       "  'mdr1',\n",
       "  'gene',\n",
       "  'was',\n",
       "  'not',\n",
       "  'found',\n",
       "  'to',\n",
       "  'be',\n",
       "  'a',\n",
       "  'risk',\n",
       "  'factor',\n",
       "  'for',\n",
       "  \"crohn's\",\n",
       "  'disease',\n",
       "  'or',\n",
       "  'ulcerative',\n",
       "  'colitis.'],\n",
       " ['in',\n",
       "  'this',\n",
       "  'study,',\n",
       "  'the',\n",
       "  'g2677t/a',\n",
       "  'polymorphism',\n",
       "  'observed',\n",
       "  'in',\n",
       "  'the',\n",
       "  'mdr1',\n",
       "  'gene',\n",
       "  'was',\n",
       "  'not',\n",
       "  'found',\n",
       "  'to',\n",
       "  'be',\n",
       "  'a',\n",
       "  'risk',\n",
       "  'factor',\n",
       "  'for',\n",
       "  \"crohn's\",\n",
       "  'disease',\n",
       "  'or',\n",
       "  'ulcerative',\n",
       "  'colitis.'],\n",
       " ['in',\n",
       "  'this',\n",
       "  'study,',\n",
       "  'the',\n",
       "  'g2677t/a',\n",
       "  'polymorphism',\n",
       "  'observed',\n",
       "  'in',\n",
       "  'the',\n",
       "  'mdr1',\n",
       "  'gene',\n",
       "  'was',\n",
       "  'not',\n",
       "  'found',\n",
       "  'to',\n",
       "  'be',\n",
       "  'a',\n",
       "  'risk',\n",
       "  'factor',\n",
       "  'for',\n",
       "  \"crohn's\",\n",
       "  'disease',\n",
       "  'or',\n",
       "  'ulcerative',\n",
       "  'colitis.'],\n",
       " ['regulation',\n",
       "  'of',\n",
       "  'hairy',\n",
       "  'and',\n",
       "  'enhancer',\n",
       "  'of',\n",
       "  'split',\n",
       "  'homologue-1',\n",
       "  '(hes-1)',\n",
       "  'by',\n",
       "  'estradiol',\n",
       "  'and',\n",
       "  'all-trans',\n",
       "  'retinoic',\n",
       "  'acid',\n",
       "  'affects',\n",
       "  'proliferation',\n",
       "  'of',\n",
       "  'human',\n",
       "  'breast',\n",
       "  'cancer',\n",
       "  'cells.'],\n",
       " ['estrogen-dependent',\n",
       "  'downregulation',\n",
       "  'of',\n",
       "  'hairy',\n",
       "  'and',\n",
       "  'enhancer',\n",
       "  'of',\n",
       "  'split',\n",
       "  'homolog-1',\n",
       "  'gene',\n",
       "  'expression',\n",
       "  'in',\n",
       "  'breast',\n",
       "  'cancer',\n",
       "  'cells',\n",
       "  'is',\n",
       "  'mediated',\n",
       "  'via',\n",
       "  'a',\n",
       "  \"3'\",\n",
       "  'distal',\n",
       "  'element.'],\n",
       " ['regulation',\n",
       "  'of',\n",
       "  'hairy',\n",
       "  'and',\n",
       "  'enhancer',\n",
       "  'of',\n",
       "  'split',\n",
       "  'homologue-1',\n",
       "  '(hes-1)',\n",
       "  'by',\n",
       "  'estradiol',\n",
       "  'and',\n",
       "  'all-trans',\n",
       "  'retinoic',\n",
       "  'acid',\n",
       "  'affects',\n",
       "  'proliferation',\n",
       "  'of',\n",
       "  'human',\n",
       "  'breast',\n",
       "  'cancer',\n",
       "  'cells.'],\n",
       " ['moreover,',\n",
       "  'protective',\n",
       "  'alleles',\n",
       "  'for',\n",
       "  'four',\n",
       "  'disease-associated',\n",
       "  'snps',\n",
       "  'in',\n",
       "  'the',\n",
       "  'mhc',\n",
       "  'locus',\n",
       "  '(rs2395029,',\n",
       "  'rs13199524,',\n",
       "  'rs12198173',\n",
       "  'and',\n",
       "  'rs3093662)',\n",
       "  'were',\n",
       "  'strikingly',\n",
       "  'over-represented',\n",
       "  'among',\n",
       "  'forty-five',\n",
       "  'long',\n",
       "  'term',\n",
       "  'hiv',\n",
       "  'controllers.'],\n",
       " ['previous',\n",
       "  'studies',\n",
       "  'of',\n",
       "  'the',\n",
       "  'hiv-1',\n",
       "  'disease',\n",
       "  'have',\n",
       "  'shown',\n",
       "  'that',\n",
       "  'hla',\n",
       "  'and',\n",
       "  'chemokine',\n",
       "  'receptor',\n",
       "  'genetic',\n",
       "  'variants',\n",
       "  'influence',\n",
       "  'disease',\n",
       "  'progression',\n",
       "  'and',\n",
       "  'early',\n",
       "  'viral',\n",
       "  'load.'],\n",
       " ['furthermore,',\n",
       "  'we',\n",
       "  'show',\n",
       "  'that',\n",
       "  'the',\n",
       "  'hiv-dna',\n",
       "  'levels',\n",
       "  '(reflecting',\n",
       "  'the',\n",
       "  'hiv',\n",
       "  'reservoir)',\n",
       "  'are',\n",
       "  'associated',\n",
       "  'with',\n",
       "  'the',\n",
       "  'same',\n",
       "  'four',\n",
       "  'snps,',\n",
       "  'but',\n",
       "  'also',\n",
       "  'with',\n",
       "  'two',\n",
       "  'additional',\n",
       "  'snps',\n",
       "  'on',\n",
       "  'chromosome',\n",
       "  '17',\n",
       "  '(rs6503919;',\n",
       "  'intergenic',\n",
       "  'region',\n",
       "  'flanked',\n",
       "  'by',\n",
       "  'the',\n",
       "  'ddx40',\n",
       "  'and',\n",
       "  'ypel2',\n",
       "  'genes)',\n",
       "  'and',\n",
       "  'chromosome',\n",
       "  '8',\n",
       "  '(rs2575735;',\n",
       "  'within',\n",
       "  'the',\n",
       "  'syndecan',\n",
       "  '2',\n",
       "  'gene).'],\n",
       " ['moreover,',\n",
       "  'protective',\n",
       "  'alleles',\n",
       "  'for',\n",
       "  'four',\n",
       "  'disease-associated',\n",
       "  'snps',\n",
       "  'in',\n",
       "  'the',\n",
       "  'mhc',\n",
       "  'locus',\n",
       "  '(rs2395029,',\n",
       "  'rs13199524,',\n",
       "  'rs12198173',\n",
       "  'and',\n",
       "  'rs3093662)',\n",
       "  'were',\n",
       "  'strikingly',\n",
       "  'over-represented',\n",
       "  'among',\n",
       "  'forty-five',\n",
       "  'long',\n",
       "  'term',\n",
       "  'hiv',\n",
       "  'controllers.'],\n",
       " ['previous',\n",
       "  'studies',\n",
       "  'of',\n",
       "  'the',\n",
       "  'hiv-1',\n",
       "  'disease',\n",
       "  'have',\n",
       "  'shown',\n",
       "  'that',\n",
       "  'hla',\n",
       "  'and',\n",
       "  'chemokine',\n",
       "  'receptor',\n",
       "  'genetic',\n",
       "  'variants',\n",
       "  'influence',\n",
       "  'disease',\n",
       "  'progression',\n",
       "  'and',\n",
       "  'early',\n",
       "  'viral',\n",
       "  'load.'],\n",
       " ['furthermore,',\n",
       "  'we',\n",
       "  'show',\n",
       "  'that',\n",
       "  'the',\n",
       "  'hiv-dna',\n",
       "  'levels',\n",
       "  '(reflecting',\n",
       "  'the',\n",
       "  'hiv',\n",
       "  'reservoir)',\n",
       "  'are',\n",
       "  'associated',\n",
       "  'with',\n",
       "  'the',\n",
       "  'same',\n",
       "  'four',\n",
       "  'snps,',\n",
       "  'but',\n",
       "  'also',\n",
       "  'with',\n",
       "  'two',\n",
       "  'additional',\n",
       "  'snps',\n",
       "  'on',\n",
       "  'chromosome',\n",
       "  '17',\n",
       "  '(rs6503919;',\n",
       "  'intergenic',\n",
       "  'region',\n",
       "  'flanked',\n",
       "  'by',\n",
       "  'the',\n",
       "  'ddx40',\n",
       "  'and',\n",
       "  'ypel2',\n",
       "  'genes)',\n",
       "  'and',\n",
       "  'chromosome',\n",
       "  '8',\n",
       "  '(rs2575735;',\n",
       "  'within',\n",
       "  'the',\n",
       "  'syndecan',\n",
       "  '2',\n",
       "  'gene).'],\n",
       " ['moreover,',\n",
       "  'protective',\n",
       "  'alleles',\n",
       "  'for',\n",
       "  'four',\n",
       "  'disease-associated',\n",
       "  'snps',\n",
       "  'in',\n",
       "  'the',\n",
       "  'mhc',\n",
       "  'locus',\n",
       "  '(rs2395029,',\n",
       "  'rs13199524,',\n",
       "  'rs12198173',\n",
       "  'and',\n",
       "  'rs3093662)',\n",
       "  'were',\n",
       "  'strikingly',\n",
       "  'over-represented',\n",
       "  'among',\n",
       "  'forty-five',\n",
       "  'long',\n",
       "  'term',\n",
       "  'hiv',\n",
       "  'controllers.'],\n",
       " ['moreover,',\n",
       "  'protective',\n",
       "  'alleles',\n",
       "  'for',\n",
       "  'four',\n",
       "  'disease-associated',\n",
       "  'snps',\n",
       "  'in',\n",
       "  'the',\n",
       "  'mhc',\n",
       "  'locus',\n",
       "  '(rs2395029,',\n",
       "  'rs13199524,',\n",
       "  'rs12198173',\n",
       "  'and',\n",
       "  'rs3093662)',\n",
       "  'were',\n",
       "  'strikingly',\n",
       "  'over-represented',\n",
       "  'among',\n",
       "  'forty-five',\n",
       "  'long',\n",
       "  'term',\n",
       "  'hiv',\n",
       "  'controllers.'],\n",
       " ['our',\n",
       "  'data',\n",
       "  'provide',\n",
       "  'evidence',\n",
       "  'that',\n",
       "  'the',\n",
       "  'mhc',\n",
       "  'controls',\n",
       "  'both',\n",
       "  'hiv',\n",
       "  'replication',\n",
       "  'and',\n",
       "  'hiv',\n",
       "  'reservoir.'],\n",
       " ['moreover,',\n",
       "  'protective',\n",
       "  'alleles',\n",
       "  'for',\n",
       "  'four',\n",
       "  'disease-associated',\n",
       "  'snps',\n",
       "  'in',\n",
       "  'the',\n",
       "  'mhc',\n",
       "  'locus',\n",
       "  '(rs2395029,',\n",
       "  'rs13199524,',\n",
       "  'rs12198173',\n",
       "  'and',\n",
       "  'rs3093662)',\n",
       "  'were',\n",
       "  'strikingly',\n",
       "  'over-represented',\n",
       "  'among',\n",
       "  'forty-five',\n",
       "  'long',\n",
       "  'term',\n",
       "  'hiv',\n",
       "  'controllers.'],\n",
       " ['furthermore,',\n",
       "  'we',\n",
       "  'show',\n",
       "  'that',\n",
       "  'the',\n",
       "  'hiv-dna',\n",
       "  'levels',\n",
       "  '(reflecting',\n",
       "  'the',\n",
       "  'hiv',\n",
       "  'reservoir)',\n",
       "  'are',\n",
       "  'associated',\n",
       "  'with',\n",
       "  'the',\n",
       "  'same',\n",
       "  'four',\n",
       "  'snps,',\n",
       "  'but',\n",
       "  'also',\n",
       "  'with',\n",
       "  'two',\n",
       "  'additional',\n",
       "  'snps',\n",
       "  'on',\n",
       "  'chromosome',\n",
       "  '17',\n",
       "  '(rs6503919;',\n",
       "  'intergenic',\n",
       "  'region',\n",
       "  'flanked',\n",
       "  'by',\n",
       "  'the',\n",
       "  'ddx40',\n",
       "  'and',\n",
       "  'ypel2',\n",
       "  'genes)',\n",
       "  'and',\n",
       "  'chromosome',\n",
       "  '8',\n",
       "  '(rs2575735;',\n",
       "  'within',\n",
       "  'the',\n",
       "  'syndecan',\n",
       "  '2',\n",
       "  'gene).'],\n",
       " ['the',\n",
       "  'commonly',\n",
       "  'deleted',\n",
       "  'region',\n",
       "  'of',\n",
       "  'the',\n",
       "  '5q-',\n",
       "  'syndrome',\n",
       "  'extends',\n",
       "  'between',\n",
       "  'the',\n",
       "  'genes',\n",
       "  'sh3tc2',\n",
       "  '(proximal',\n",
       "  'boundary)',\n",
       "  'and',\n",
       "  'glra1',\n",
       "  '(distal',\n",
       "  'boundary)',\n",
       "  'and',\n",
       "  'measures',\n",
       "  '2.9',\n",
       "  'mb.'],\n",
       " ['the',\n",
       "  'commonly',\n",
       "  'deleted',\n",
       "  'region',\n",
       "  'of',\n",
       "  'the',\n",
       "  '5q-',\n",
       "  'syndrome',\n",
       "  'extends',\n",
       "  'between',\n",
       "  'the',\n",
       "  'genes',\n",
       "  'sh3tc2',\n",
       "  '(proximal',\n",
       "  'boundary)',\n",
       "  'and',\n",
       "  'glra1',\n",
       "  '(distal',\n",
       "  'boundary)',\n",
       "  'and',\n",
       "  'measures',\n",
       "  '2.9',\n",
       "  'mb.'],\n",
       " ['aberrant',\n",
       "  'expression',\n",
       "  'of',\n",
       "  'chitinase',\n",
       "  '3-like',\n",
       "  '1',\n",
       "  '(chi3l1),',\n",
       "  'also',\n",
       "  'known',\n",
       "  'as',\n",
       "  'ykl-40',\n",
       "  'or',\n",
       "  'hc',\n",
       "  'gp-39,',\n",
       "  'is',\n",
       "  'involved',\n",
       "  'in',\n",
       "  'the',\n",
       "  'pathogenesis',\n",
       "  'of',\n",
       "  'inflammatory',\n",
       "  'and',\n",
       "  'allergic',\n",
       "  'diseases.'],\n",
       " ['these',\n",
       "  'results',\n",
       "  'strongly',\n",
       "  'suggest',\n",
       "  'that',\n",
       "  'the',\n",
       "  'g.-247c/t',\n",
       "  'polymorphism',\n",
       "  'in',\n",
       "  'the',\n",
       "  'chi3l1',\n",
       "  'promoter',\n",
       "  'region',\n",
       "  'is',\n",
       "  'associated',\n",
       "  'with',\n",
       "  'the',\n",
       "  'risk',\n",
       "  'of',\n",
       "  'atopy.'],\n",
       " ['genetic',\n",
       "  'variation',\n",
       "  'in',\n",
       "  'the',\n",
       "  'promoter',\n",
       "  'region',\n",
       "  'of',\n",
       "  'chitinase',\n",
       "  '3-like',\n",
       "  '1',\n",
       "  'is',\n",
       "  'associated',\n",
       "  'with',\n",
       "  'atopy.'],\n",
       " ['in',\n",
       "  'the',\n",
       "  'case-control',\n",
       "  'association',\n",
       "  'analysis,',\n",
       "  'the',\n",
       "  'g.-247c/t',\n",
       "  'polymorphism',\n",
       "  'at',\n",
       "  'the',\n",
       "  'promoter',\n",
       "  'region',\n",
       "  '(rs10399805;',\n",
       "  'p',\n",
       "  '=',\n",
       "  '0.0062)',\n",
       "  'and',\n",
       "  'the',\n",
       "  'ivs7+82c/t',\n",
       "  'polymorphism',\n",
       "  'at',\n",
       "  'intron',\n",
       "  '7',\n",
       "  '(rs2275353;',\n",
       "  'p',\n",
       "  '=',\n",
       "  '0.0056)',\n",
       "  'of',\n",
       "  'chi3l1',\n",
       "  'showed',\n",
       "  'a',\n",
       "  'significant',\n",
       "  'association',\n",
       "  'with',\n",
       "  'atopy.'],\n",
       " ['in',\n",
       "  'the',\n",
       "  'case-control',\n",
       "  'association',\n",
       "  'analysis,',\n",
       "  'the',\n",
       "  'g.-247c/t',\n",
       "  'polymorphism',\n",
       "  'at',\n",
       "  'the',\n",
       "  'promoter',\n",
       "  'region',\n",
       "  '(rs10399805;',\n",
       "  'p',\n",
       "  '=',\n",
       "  '0.0062)',\n",
       "  'and',\n",
       "  'the',\n",
       "  'ivs7+82c/t',\n",
       "  'polymorphism',\n",
       "  'at',\n",
       "  'intron',\n",
       "  '7',\n",
       "  '(rs2275353;',\n",
       "  'p',\n",
       "  '=',\n",
       "  '0.0056)',\n",
       "  'of',\n",
       "  'chi3l1',\n",
       "  'showed',\n",
       "  'a',\n",
       "  'significant',\n",
       "  'association',\n",
       "  'with',\n",
       "  'atopy.'],\n",
       " ['these',\n",
       "  'results',\n",
       "  'strongly',\n",
       "  'suggest',\n",
       "  'that',\n",
       "  'the',\n",
       "  'g.-247c/t',\n",
       "  'polymorphism',\n",
       "  'in',\n",
       "  'the',\n",
       "  'chi3l1',\n",
       "  'promoter',\n",
       "  'region',\n",
       "  'is',\n",
       "  'associated',\n",
       "  'with',\n",
       "  'the',\n",
       "  'risk',\n",
       "  'of',\n",
       "  'atopy.'],\n",
       " ['the',\n",
       "  'genetic',\n",
       "  'contribution',\n",
       "  'of',\n",
       "  'chi3l1',\n",
       "  'gene',\n",
       "  'to',\n",
       "  'atopic',\n",
       "  'susceptibility',\n",
       "  'was',\n",
       "  'investigated',\n",
       "  'using',\n",
       "  'an',\n",
       "  'integrated',\n",
       "  'population',\n",
       "  'genetic',\n",
       "  'and',\n",
       "  'molecular',\n",
       "  'analysis.'],\n",
       " ['genetic',\n",
       "  'variations',\n",
       "  'in',\n",
       "  'chi3l1',\n",
       "  'were',\n",
       "  'identified',\n",
       "  'and',\n",
       "  'genotyped',\n",
       "  'in',\n",
       "  '295',\n",
       "  'unrelated',\n",
       "  'patients',\n",
       "  'with',\n",
       "  'atopy',\n",
       "  'and',\n",
       "  '180',\n",
       "  'control',\n",
       "  'subjects.'],\n",
       " ['in',\n",
       "  'the',\n",
       "  'case-control',\n",
       "  'association',\n",
       "  'analysis,',\n",
       "  'the',\n",
       "  'g.-247c/t',\n",
       "  'polymorphism',\n",
       "  'at',\n",
       "  'the',\n",
       "  'promoter',\n",
       "  'region',\n",
       "  '(rs10399805;',\n",
       "  'p',\n",
       "  '=',\n",
       "  '0.0062)',\n",
       "  'and',\n",
       "  'the',\n",
       "  'ivs7+82c/t',\n",
       "  'polymorphism',\n",
       "  'at',\n",
       "  'intron',\n",
       "  '7',\n",
       "  '(rs2275353;',\n",
       "  'p',\n",
       "  '=',\n",
       "  '0.0056)',\n",
       "  'of',\n",
       "  'chi3l1',\n",
       "  'showed',\n",
       "  'a',\n",
       "  'significant',\n",
       "  'association',\n",
       "  'with',\n",
       "  'atopy.'],\n",
       " ['in',\n",
       "  'the',\n",
       "  'case-control',\n",
       "  'association',\n",
       "  'analysis,',\n",
       "  'the',\n",
       "  'g.-247c/t',\n",
       "  'polymorphism',\n",
       "  'at',\n",
       "  'the',\n",
       "  'promoter',\n",
       "  'region',\n",
       "  '(rs10399805;',\n",
       "  'p',\n",
       "  '=',\n",
       "  '0.0062)',\n",
       "  'and',\n",
       "  'the',\n",
       "  'ivs7+82c/t',\n",
       "  'polymorphism',\n",
       "  'at',\n",
       "  'intron',\n",
       "  '7',\n",
       "  '(rs2275353;',\n",
       "  'p',\n",
       "  '=',\n",
       "  '0.0056)',\n",
       "  'of',\n",
       "  'chi3l1',\n",
       "  'showed',\n",
       "  'a',\n",
       "  'significant',\n",
       "  'association',\n",
       "  'with',\n",
       "  'atopy.'],\n",
       " ['in',\n",
       "  'the',\n",
       "  'case-control',\n",
       "  'association',\n",
       "  'analysis,',\n",
       "  'the',\n",
       "  'g.-247c/t',\n",
       "  'polymorphism',\n",
       "  'at',\n",
       "  'the',\n",
       "  'promoter',\n",
       "  'region',\n",
       "  '(rs10399805;',\n",
       "  'p',\n",
       "  '=',\n",
       "  '0.0062)',\n",
       "  'and',\n",
       "  'the',\n",
       "  'ivs7+82c/t',\n",
       "  'polymorphism',\n",
       "  'at',\n",
       "  'intron',\n",
       "  '7',\n",
       "  '(rs2275353;',\n",
       "  'p',\n",
       "  '=',\n",
       "  '0.0056)',\n",
       "  'of',\n",
       "  'chi3l1',\n",
       "  'showed',\n",
       "  'a',\n",
       "  'significant',\n",
       "  'association',\n",
       "  'with',\n",
       "  'atopy.'],\n",
       " ['in',\n",
       "  'humans,',\n",
       "  'loss-of-function',\n",
       "  'of',\n",
       "  'the',\n",
       "  'cilia-centrosomal',\n",
       "  'protein',\n",
       "  'cep290/nphp6',\n",
       "  'is',\n",
       "  'associated',\n",
       "  'with',\n",
       "  'joubert',\n",
       "  'and',\n",
       "  'meckel',\n",
       "  'syndromes,',\n",
       "  'whereas',\n",
       "  'hypomorphic',\n",
       "  'mutations',\n",
       "  'result',\n",
       "  'in',\n",
       "  'leber',\n",
       "  'congenital',\n",
       "  'amaurosis',\n",
       "  '(lca),',\n",
       "  'a',\n",
       "  'form',\n",
       "  'of',\n",
       "  'early-onset',\n",
       "  'retinal',\n",
       "  'dystrophy.'],\n",
       " ['hypomorphic',\n",
       "  'cep290/nphp6',\n",
       "  'mutations',\n",
       "  'result',\n",
       "  'in',\n",
       "  'anosmia',\n",
       "  'caused',\n",
       "  'by',\n",
       "  'the',\n",
       "  'selective',\n",
       "  'loss',\n",
       "  'of',\n",
       "  'g',\n",
       "  'proteins',\n",
       "  'in',\n",
       "  'cilia',\n",
       "  'of',\n",
       "  'olfactory',\n",
       "  'sensory',\n",
       "  'neurons.'],\n",
       " ['in',\n",
       "  'humans,',\n",
       "  'loss-of-function',\n",
       "  'of',\n",
       "  'the',\n",
       "  'cilia-centrosomal',\n",
       "  'protein',\n",
       "  'cep290/nphp6',\n",
       "  'is',\n",
       "  'associated',\n",
       "  'with',\n",
       "  'joubert',\n",
       "  'and',\n",
       "  'meckel',\n",
       "  'syndromes,',\n",
       "  'whereas',\n",
       "  'hypomorphic',\n",
       "  'mutations',\n",
       "  'result',\n",
       "  'in',\n",
       "  'leber',\n",
       "  'congenital',\n",
       "  'amaurosis',\n",
       "  '(lca),',\n",
       "  'a',\n",
       "  'form',\n",
       "  'of',\n",
       "  'early-onset',\n",
       "  'retinal',\n",
       "  'dystrophy.'],\n",
       " ['in',\n",
       "  'humans,',\n",
       "  'loss-of-function',\n",
       "  'of',\n",
       "  'the',\n",
       "  'cilia-centrosomal',\n",
       "  'protein',\n",
       "  'cep290/nphp6',\n",
       "  'is',\n",
       "  'associated',\n",
       "  'with',\n",
       "  'joubert',\n",
       "  'and',\n",
       "  'meckel',\n",
       "  'syndromes,',\n",
       "  'whereas',\n",
       "  'hypomorphic',\n",
       "  'mutations',\n",
       "  'result',\n",
       "  'in',\n",
       "  'leber',\n",
       "  'congenital',\n",
       "  'amaurosis',\n",
       "  '(lca),',\n",
       "  'a',\n",
       "  'form',\n",
       "  'of',\n",
       "  'early-onset',\n",
       "  'retinal',\n",
       "  'dystrophy.'],\n",
       " ['association',\n",
       "  'between',\n",
       "  'donor',\n",
       "  'mbl',\n",
       "  'promoter',\n",
       "  'haplotype',\n",
       "  'and',\n",
       "  'graft',\n",
       "  'survival',\n",
       "  'and',\n",
       "  'the',\n",
       "  'development',\n",
       "  'of',\n",
       "  'bos',\n",
       "  'after',\n",
       "  'lung',\n",
       "  'transplantation.'],\n",
       " ['compared',\n",
       "  'with',\n",
       "  'the',\n",
       "  'epsilon3',\n",
       "  'homozygotes,',\n",
       "  'neither',\n",
       "  'the',\n",
       "  'epsilon2',\n",
       "  'nor',\n",
       "  'the',\n",
       "  'epsilon4',\n",
       "  'carrier',\n",
       "  'status',\n",
       "  'was',\n",
       "  'associated',\n",
       "  'with',\n",
       "  'hypertension',\n",
       "  '(adjusted',\n",
       "  'prevalence',\n",
       "  'ratios',\n",
       "  '=',\n",
       "  '0.94,',\n",
       "  '95%ci',\n",
       "  '=',\n",
       "  '0.83-1.07',\n",
       "  'and',\n",
       "  '0.98,',\n",
       "  '0.89-1.07,',\n",
       "  'respectively).'],\n",
       " ['compared',\n",
       "  'with',\n",
       "  'the',\n",
       "  'epsilon3',\n",
       "  'homozygotes,',\n",
       "  'neither',\n",
       "  'the',\n",
       "  'epsilon2',\n",
       "  'nor',\n",
       "  'the',\n",
       "  'epsilon4',\n",
       "  'carrier',\n",
       "  'status',\n",
       "  'was',\n",
       "  'associated',\n",
       "  'with',\n",
       "  'hypertension',\n",
       "  '(adjusted',\n",
       "  'prevalence',\n",
       "  'ratios',\n",
       "  '=',\n",
       "  '0.94,',\n",
       "  '95%ci',\n",
       "  '=',\n",
       "  '0.83-1.07',\n",
       "  'and',\n",
       "  '0.98,',\n",
       "  '0.89-1.07,',\n",
       "  'respectively).'],\n",
       " ['apolipoprotein',\n",
       "  'e',\n",
       "  '(apoe)',\n",
       "  'polymorphism',\n",
       "  'influences',\n",
       "  'lipid',\n",
       "  'metabolism,',\n",
       "  'but',\n",
       "  'its',\n",
       "  'association',\n",
       "  'with',\n",
       "  'arterial',\n",
       "  'hypertension',\n",
       "  'is',\n",
       "  'controversial.'],\n",
       " ['this',\n",
       "  'study',\n",
       "  'provides',\n",
       "  'epidemiologic',\n",
       "  'evidence',\n",
       "  'that',\n",
       "  'the',\n",
       "  'apoe',\n",
       "  'genotype',\n",
       "  'is',\n",
       "  'not',\n",
       "  'associated',\n",
       "  'with',\n",
       "  'prevalent',\n",
       "  'hypertension',\n",
       "  'in',\n",
       "  'old',\n",
       "  'age.'],\n",
       " ['analysis',\n",
       "  'yielded',\n",
       "  'the',\n",
       "  'following',\n",
       "  'yale-generated',\n",
       "  'observations:',\n",
       "  '(1)',\n",
       "  'taa',\n",
       "  'is',\n",
       "  'a',\n",
       "  'genetic',\n",
       "  'disease',\n",
       "  'with',\n",
       "  'a',\n",
       "  'predominantly',\n",
       "  'autosomal',\n",
       "  'dominant',\n",
       "  'mode',\n",
       "  'of',\n",
       "  'inheritance;',\n",
       "  '(2)',\n",
       "  'matrix',\n",
       "  'metalloproteinase',\n",
       "  '(mmp)',\n",
       "  'enzymes',\n",
       "  'are',\n",
       "  'activated',\n",
       "  'in',\n",
       "  'the',\n",
       "  'pathogenesis',\n",
       "  'of',\n",
       "  'taa;',\n",
       "  '(3)',\n",
       "  'wall',\n",
       "  'tension',\n",
       "  'in',\n",
       "  'taa',\n",
       "  'approaches',\n",
       "  'the',\n",
       "  'tensile',\n",
       "  'limits',\n",
       "  'of',\n",
       "  'aortic',\n",
       "  'tissue',\n",
       "  'at',\n",
       "  'a',\n",
       "  'diameter',\n",
       "  'of',\n",
       "  '6',\n",
       "  'cm;',\n",
       "  '(4)',\n",
       "  'by',\n",
       "  'the',\n",
       "  'time',\n",
       "  'a',\n",
       "  'taa',\n",
       "  'reaches',\n",
       "  'a',\n",
       "  'clinical',\n",
       "  'diameter',\n",
       "  'of',\n",
       "  '6',\n",
       "  'cm,',\n",
       "  '34',\n",
       "  'percent',\n",
       "  'of',\n",
       "  'affected',\n",
       "  'patients',\n",
       "  'have',\n",
       "  'suffered',\n",
       "  'dissection',\n",
       "  'or',\n",
       "  'rupture;',\n",
       "  '(5)',\n",
       "  'extreme',\n",
       "  'physical',\n",
       "  'exertion',\n",
       "  'or',\n",
       "  'severe',\n",
       "  'emotion',\n",
       "  'often',\n",
       "  'precipitate',\n",
       "  'acute',\n",
       "  'dissection;',\n",
       "  'and',\n",
       "  '(6)',\n",
       "  'single',\n",
       "  'nucleotide',\n",
       "  'polymorphisms',\n",
       "  '(snps)',\n",
       "  'and',\n",
       "  'rna',\n",
       "  'expression',\n",
       "  'profile',\n",
       "  'changes',\n",
       "  'are',\n",
       "  'being',\n",
       "  'identified',\n",
       "  'that',\n",
       "  'predispose',\n",
       "  'a',\n",
       "  'patient',\n",
       "  'to',\n",
       "  'taa',\n",
       "  'and',\n",
       "  'can',\n",
       "  'serve',\n",
       "  'as',\n",
       "  'biomarkers',\n",
       "  'for',\n",
       "  'screening',\n",
       "  'for',\n",
       "  'this',\n",
       "  'virulent',\n",
       "  'disease.'],\n",
       " ['analysis',\n",
       "  'yielded',\n",
       "  'the',\n",
       "  'following',\n",
       "  'yale-generated',\n",
       "  'observations:',\n",
       "  '(1)',\n",
       "  'taa',\n",
       "  'is',\n",
       "  'a',\n",
       "  'genetic',\n",
       "  'disease',\n",
       "  'with',\n",
       "  'a',\n",
       "  'predominantly',\n",
       "  'autosomal',\n",
       "  'dominant',\n",
       "  'mode',\n",
       "  'of',\n",
       "  'inheritance;',\n",
       "  '(2)',\n",
       "  'matrix',\n",
       "  'metalloproteinase',\n",
       "  '(mmp)',\n",
       "  'enzymes',\n",
       "  'are',\n",
       "  'activated',\n",
       "  'in',\n",
       "  'the',\n",
       "  'pathogenesis',\n",
       "  'of',\n",
       "  'taa;',\n",
       "  '(3)',\n",
       "  'wall',\n",
       "  'tension',\n",
       "  'in',\n",
       "  'taa',\n",
       "  'approaches',\n",
       "  'the',\n",
       "  'tensile',\n",
       "  'limits',\n",
       "  'of',\n",
       "  'aortic',\n",
       "  'tissue',\n",
       "  'at',\n",
       "  'a',\n",
       "  'diameter',\n",
       "  'of',\n",
       "  '6',\n",
       "  'cm;',\n",
       "  '(4)',\n",
       "  'by',\n",
       "  'the',\n",
       "  'time',\n",
       "  'a',\n",
       "  'taa',\n",
       "  'reaches',\n",
       "  'a',\n",
       "  'clinical',\n",
       "  'diameter',\n",
       "  'of',\n",
       "  '6',\n",
       "  'cm,',\n",
       "  '34',\n",
       "  'percent',\n",
       "  'of',\n",
       "  'affected',\n",
       "  'patients',\n",
       "  'have',\n",
       "  'suffered',\n",
       "  'dissection',\n",
       "  'or',\n",
       "  'rupture;',\n",
       "  '(5)',\n",
       "  'extreme',\n",
       "  'physical',\n",
       "  'exertion',\n",
       "  'or',\n",
       "  'severe',\n",
       "  'emotion',\n",
       "  'often',\n",
       "  'precipitate',\n",
       "  'acute',\n",
       "  'dissection;',\n",
       "  'and',\n",
       "  '(6)',\n",
       "  'single',\n",
       "  'nucleotide',\n",
       "  'polymorphisms',\n",
       "  '(snps)',\n",
       "  'and',\n",
       "  'rna',\n",
       "  'expression',\n",
       "  'profile',\n",
       "  'changes',\n",
       "  'are',\n",
       "  'being',\n",
       "  'identified',\n",
       "  'that',\n",
       "  'predispose',\n",
       "  'a',\n",
       "  'patient',\n",
       "  'to',\n",
       "  'taa',\n",
       "  'and',\n",
       "  'can',\n",
       "  'serve',\n",
       "  'as',\n",
       "  'biomarkers',\n",
       "  'for',\n",
       "  'screening',\n",
       "  'for',\n",
       "  'this',\n",
       "  'virulent',\n",
       "  'disease.'],\n",
       " ['two',\n",
       "  'hundred',\n",
       "  'and',\n",
       "  'twenty-three',\n",
       "  'incident',\n",
       "  'papillary',\n",
       "  'thyroid',\n",
       "  'cancer',\n",
       "  'cases',\n",
       "  'and',\n",
       "  '229',\n",
       "  'controls',\n",
       "  'recruited',\n",
       "  'from',\n",
       "  'saudi',\n",
       "  'arabian',\n",
       "  'population',\n",
       "  'were',\n",
       "  'analyzed',\n",
       "  'for',\n",
       "  '21',\n",
       "  'loci',\n",
       "  'in',\n",
       "  '8',\n",
       "  'selected',\n",
       "  'dna',\n",
       "  'repair',\n",
       "  'genes',\n",
       "  'by',\n",
       "  'pcr-restriction',\n",
       "  'fragment',\n",
       "  'length',\n",
       "  'polymorphism',\n",
       "  'including',\n",
       "  'non-homologous',\n",
       "  'end',\n",
       "  'joining',\n",
       "  'pathway',\n",
       "  'genes',\n",
       "  'ligiv',\n",
       "  '(liglv',\n",
       "  'asp62his,',\n",
       "  'pro231ser,',\n",
       "  'trp46ter),',\n",
       "  'xrcc4',\n",
       "  'splice',\n",
       "  '33243301g>a',\n",
       "  'and',\n",
       "  'xrcc7',\n",
       "  'ile3434thr;',\n",
       "  'homologous',\n",
       "  'recombination',\n",
       "  'pathway',\n",
       "  'genes',\n",
       "  'xrcc3',\n",
       "  'arg94his',\n",
       "  'and',\n",
       "  'thr241met,',\n",
       "  'rad51',\n",
       "  'utr',\n",
       "  '15452658t>c,',\n",
       "  '15455419a>g,',\n",
       "  'rad52',\n",
       "  '2259',\n",
       "  'and',\n",
       "  'gln221glu,',\n",
       "  'conserved',\n",
       "  'dna',\n",
       "  'damage',\n",
       "  'response',\n",
       "  'gene',\n",
       "  'tp53',\n",
       "  'pro47ser,',\n",
       "  'pro72arg,',\n",
       "  'tp53',\n",
       "  'utr',\n",
       "  '7178189a>c',\n",
       "  'and',\n",
       "  'base',\n",
       "  'excision',\n",
       "  'repair',\n",
       "  'gene',\n",
       "  'xrcc1',\n",
       "  'arg194trp,',\n",
       "  'arg280his,',\n",
       "  'arg399gln,',\n",
       "  'arg559gln.'],\n",
       " ['two',\n",
       "  'hundred',\n",
       "  'and',\n",
       "  'twenty-three',\n",
       "  'incident',\n",
       "  'papillary',\n",
       "  'thyroid',\n",
       "  'cancer',\n",
       "  'cases',\n",
       "  'and',\n",
       "  '229',\n",
       "  'controls',\n",
       "  'recruited',\n",
       "  'from',\n",
       "  'saudi',\n",
       "  'arabian',\n",
       "  'population',\n",
       "  'were',\n",
       "  'analyzed',\n",
       "  'for',\n",
       "  '21',\n",
       "  'loci',\n",
       "  'in',\n",
       "  '8',\n",
       "  'selected',\n",
       "  'dna',\n",
       "  'repair',\n",
       "  'genes',\n",
       "  'by',\n",
       "  'pcr-restriction',\n",
       "  'fragment',\n",
       "  'length',\n",
       "  'polymorphism',\n",
       "  'including',\n",
       "  'non-homologous',\n",
       "  'end',\n",
       "  'joining',\n",
       "  'pathway',\n",
       "  'genes',\n",
       "  'ligiv',\n",
       "  '(liglv',\n",
       "  'asp62his,',\n",
       "  'pro231ser,',\n",
       "  'trp46ter),',\n",
       "  'xrcc4',\n",
       "  'splice',\n",
       "  '33243301g>a',\n",
       "  'and',\n",
       "  'xrcc7',\n",
       "  'ile3434thr;',\n",
       "  'homologous',\n",
       "  'recombination',\n",
       "  'pathway',\n",
       "  'genes',\n",
       "  'xrcc3',\n",
       "  'arg94his',\n",
       "  'and',\n",
       "  'thr241met,',\n",
       "  'rad51',\n",
       "  'utr',\n",
       "  '15452658t>c,',\n",
       "  '15455419a>g,',\n",
       "  'rad52',\n",
       "  '2259',\n",
       "  'and',\n",
       "  'gln221glu,',\n",
       "  'conserved',\n",
       "  'dna',\n",
       "  'damage',\n",
       "  'response',\n",
       "  'gene',\n",
       "  'tp53',\n",
       "  'pro47ser,',\n",
       "  'pro72arg,',\n",
       "  'tp53',\n",
       "  'utr',\n",
       "  '7178189a>c',\n",
       "  'and',\n",
       "  'base',\n",
       "  'excision',\n",
       "  'repair',\n",
       "  'gene',\n",
       "  'xrcc1',\n",
       "  'arg194trp,',\n",
       "  'arg280his,',\n",
       "  'arg399gln,',\n",
       "  'arg559gln.'],\n",
       " ['rad52',\n",
       "  'polymorphisms',\n",
       "  'contribute',\n",
       "  'to',\n",
       "  'the',\n",
       "  'development',\n",
       "  'of',\n",
       "  'papillary',\n",
       "  'thyroid',\n",
       "  'cancer',\n",
       "  'susceptibility',\n",
       "  'in',\n",
       "  'middle',\n",
       "  'eastern',\n",
       "  'population.'],\n",
       " ['two',\n",
       "  'hundred',\n",
       "  'and',\n",
       "  'twenty-three',\n",
       "  'incident',\n",
       "  'papillary',\n",
       "  'thyroid',\n",
       "  'cancer',\n",
       "  'cases',\n",
       "  'and',\n",
       "  '229',\n",
       "  'controls',\n",
       "  'recruited',\n",
       "  'from',\n",
       "  'saudi',\n",
       "  'arabian',\n",
       "  'population',\n",
       "  'were',\n",
       "  'analyzed',\n",
       "  'for',\n",
       "  '21',\n",
       "  'loci',\n",
       "  'in',\n",
       "  '8',\n",
       "  'selected',\n",
       "  'dna',\n",
       "  'repair',\n",
       "  'genes',\n",
       "  'by',\n",
       "  'pcr-restriction',\n",
       "  'fragment',\n",
       "  'length',\n",
       "  'polymorphism',\n",
       "  'including',\n",
       "  'non-homologous',\n",
       "  'end',\n",
       "  'joining',\n",
       "  'pathway',\n",
       "  'genes',\n",
       "  'ligiv',\n",
       "  '(liglv',\n",
       "  'asp62his,',\n",
       "  'pro231ser,',\n",
       "  'trp46ter),',\n",
       "  'xrcc4',\n",
       "  'splice',\n",
       "  '33243301g>a',\n",
       "  'and',\n",
       "  'xrcc7',\n",
       "  'ile3434thr;',\n",
       "  'homologous',\n",
       "  'recombination',\n",
       "  'pathway',\n",
       "  'genes',\n",
       "  'xrcc3',\n",
       "  'arg94his',\n",
       "  'and',\n",
       "  'thr241met,',\n",
       "  'rad51',\n",
       "  'utr',\n",
       "  '15452658t>c,',\n",
       "  '15455419a>g,',\n",
       "  'rad52',\n",
       "  '2259',\n",
       "  'and',\n",
       "  'gln221glu,',\n",
       "  'conserved',\n",
       "  'dna',\n",
       "  'damage',\n",
       "  'response',\n",
       "  'gene',\n",
       "  'tp53',\n",
       "  'pro47ser,',\n",
       "  'pro72arg,',\n",
       "  'tp53',\n",
       "  'utr',\n",
       "  '7178189a>c',\n",
       "  'and',\n",
       "  'base',\n",
       "  'excision',\n",
       "  'repair',\n",
       "  'gene',\n",
       "  'xrcc1',\n",
       "  'arg194trp,',\n",
       "  'arg280his,',\n",
       "  'arg399gln,',\n",
       "  'arg559gln.'],\n",
       " ['two',\n",
       "  'hundred',\n",
       "  'and',\n",
       "  'twenty-three',\n",
       "  'incident',\n",
       "  'papillary',\n",
       "  'thyroid',\n",
       "  'cancer',\n",
       "  'cases',\n",
       "  'and',\n",
       "  '229',\n",
       "  'controls',\n",
       "  'recruited',\n",
       "  'from',\n",
       "  'saudi',\n",
       "  'arabian',\n",
       "  'population',\n",
       "  'were',\n",
       "  'analyzed',\n",
       "  'for',\n",
       "  '21',\n",
       "  'loci',\n",
       "  'in',\n",
       "  '8',\n",
       "  'selected',\n",
       "  'dna',\n",
       "  'repair',\n",
       "  'genes',\n",
       "  'by',\n",
       "  'pcr-restriction',\n",
       "  'fragment',\n",
       "  'length',\n",
       "  'polymorphism',\n",
       "  'including',\n",
       "  'non-homologous',\n",
       "  'end',\n",
       "  'joining',\n",
       "  'pathway',\n",
       "  'genes',\n",
       "  'ligiv',\n",
       "  '(liglv',\n",
       "  'asp62his,',\n",
       "  'pro231ser,',\n",
       "  'trp46ter),',\n",
       "  'xrcc4',\n",
       "  'splice',\n",
       "  '33243301g>a',\n",
       "  'and',\n",
       "  'xrcc7',\n",
       "  'ile3434thr;',\n",
       "  'homologous',\n",
       "  'recombination',\n",
       "  'pathway',\n",
       "  'genes',\n",
       "  'xrcc3',\n",
       "  'arg94his',\n",
       "  'and',\n",
       "  'thr241met,',\n",
       "  'rad51',\n",
       "  'utr',\n",
       "  '15452658t>c,',\n",
       "  '15455419a>g,',\n",
       "  'rad52',\n",
       "  '2259',\n",
       "  'and',\n",
       "  'gln221glu,',\n",
       "  'conserved',\n",
       "  'dna',\n",
       "  'damage',\n",
       "  'response',\n",
       "  'gene',\n",
       "  'tp53',\n",
       "  'pro47ser,',\n",
       "  'pro72arg,',\n",
       "  'tp53',\n",
       "  'utr',\n",
       "  '7178189a>c',\n",
       "  'and',\n",
       "  'base',\n",
       "  'excision',\n",
       "  'repair',\n",
       "  'gene',\n",
       "  'xrcc1',\n",
       "  'arg194trp,',\n",
       "  'arg280his,',\n",
       "  'arg399gln,',\n",
       "  'arg559gln.'],\n",
       " ['two',\n",
       "  'hundred',\n",
       "  'and',\n",
       "  'twenty-three',\n",
       "  'incident',\n",
       "  'papillary',\n",
       "  'thyroid',\n",
       "  'cancer',\n",
       "  'cases',\n",
       "  'and',\n",
       "  '229',\n",
       "  'controls',\n",
       "  'recruited',\n",
       "  'from',\n",
       "  'saudi',\n",
       "  'arabian',\n",
       "  'population',\n",
       "  'were',\n",
       "  'analyzed',\n",
       "  'for',\n",
       "  '21',\n",
       "  'loci',\n",
       "  'in',\n",
       "  '8',\n",
       "  'selected',\n",
       "  'dna',\n",
       "  'repair',\n",
       "  'genes',\n",
       "  'by',\n",
       "  'pcr-restriction',\n",
       "  'fragment',\n",
       "  'length',\n",
       "  'polymorphism',\n",
       "  'including',\n",
       "  'non-homologous',\n",
       "  'end',\n",
       "  'joining',\n",
       "  'pathway',\n",
       "  'genes',\n",
       "  'ligiv',\n",
       "  '(liglv',\n",
       "  'asp62his,',\n",
       "  'pro231ser,',\n",
       "  'trp46ter),',\n",
       "  'xrcc4',\n",
       "  'splice',\n",
       "  '33243301g>a',\n",
       "  'and',\n",
       "  'xrcc7',\n",
       "  'ile3434thr;',\n",
       "  'homologous',\n",
       "  'recombination',\n",
       "  'pathway',\n",
       "  'genes',\n",
       "  'xrcc3',\n",
       "  'arg94his',\n",
       "  'and',\n",
       "  'thr241met,',\n",
       "  'rad51',\n",
       "  'utr',\n",
       "  '15452658t>c,',\n",
       "  '15455419a>g,',\n",
       "  'rad52',\n",
       "  '2259',\n",
       "  'and',\n",
       "  'gln221glu,',\n",
       "  'conserved',\n",
       "  'dna',\n",
       "  'damage',\n",
       "  'response',\n",
       "  'gene',\n",
       "  'tp53',\n",
       "  'pro47ser,',\n",
       "  'pro72arg,',\n",
       "  'tp53',\n",
       "  'utr',\n",
       "  '7178189a>c',\n",
       "  'and',\n",
       "  'base',\n",
       "  'excision',\n",
       "  'repair',\n",
       "  'gene',\n",
       "  'xrcc1',\n",
       "  'arg194trp,',\n",
       "  'arg280his,',\n",
       "  'arg399gln,',\n",
       "  'arg559gln.'],\n",
       " ['two',\n",
       "  'hundred',\n",
       "  'and',\n",
       "  'twenty-three',\n",
       "  'incident',\n",
       "  'papillary',\n",
       "  'thyroid',\n",
       "  'cancer',\n",
       "  'cases',\n",
       "  'and',\n",
       "  '229',\n",
       "  'controls',\n",
       "  'recruited',\n",
       "  'from',\n",
       "  'saudi',\n",
       "  'arabian',\n",
       "  'population',\n",
       "  'were',\n",
       "  'analyzed',\n",
       "  'for',\n",
       "  '21',\n",
       "  'loci',\n",
       "  'in',\n",
       "  '8',\n",
       "  'selected',\n",
       "  'dna',\n",
       "  'repair',\n",
       "  'genes',\n",
       "  'by',\n",
       "  'pcr-restriction',\n",
       "  'fragment',\n",
       "  'length',\n",
       "  'polymorphism',\n",
       "  'including',\n",
       "  'non-homologous',\n",
       "  'end',\n",
       "  'joining',\n",
       "  'pathway',\n",
       "  'genes',\n",
       "  'ligiv',\n",
       "  '(liglv',\n",
       "  'asp62his,',\n",
       "  'pro231ser,',\n",
       "  'trp46ter),',\n",
       "  'xrcc4',\n",
       "  'splice',\n",
       "  '33243301g>a',\n",
       "  'and',\n",
       "  'xrcc7',\n",
       "  'ile3434thr;',\n",
       "  'homologous',\n",
       "  'recombination',\n",
       "  'pathway',\n",
       "  'genes',\n",
       "  'xrcc3',\n",
       "  'arg94his',\n",
       "  'and',\n",
       "  'thr241met,',\n",
       "  'rad51',\n",
       "  'utr',\n",
       "  '15452658t>c,',\n",
       "  '15455419a>g,',\n",
       "  'rad52',\n",
       "  '2259',\n",
       "  'and',\n",
       "  'gln221glu,',\n",
       "  'conserved',\n",
       "  'dna',\n",
       "  'damage',\n",
       "  'response',\n",
       "  'gene',\n",
       "  'tp53',\n",
       "  'pro47ser,',\n",
       "  'pro72arg,',\n",
       "  'tp53',\n",
       "  'utr',\n",
       "  '7178189a>c',\n",
       "  'and',\n",
       "  'base',\n",
       "  'excision',\n",
       "  'repair',\n",
       "  'gene',\n",
       "  'xrcc1',\n",
       "  'arg194trp,',\n",
       "  'arg280his,',\n",
       "  'arg399gln,',\n",
       "  'arg559gln.'],\n",
       " ['of',\n",
       "  'the',\n",
       "  '21',\n",
       "  'loci',\n",
       "  'screened,',\n",
       "  'rad52',\n",
       "  '2259',\n",
       "  'and',\n",
       "  'rad52',\n",
       "  'gln221glu',\n",
       "  'may',\n",
       "  'be',\n",
       "  'of',\n",
       "  'importance',\n",
       "  'to',\n",
       "  'disease',\n",
       "  'process',\n",
       "  'and',\n",
       "  'may',\n",
       "  'be',\n",
       "  'associated',\n",
       "  'with',\n",
       "  'papillary',\n",
       "  'thyroid',\n",
       "  'cancer',\n",
       "  'risk',\n",
       "  'in',\n",
       "  'saudi',\n",
       "  'arabian',\n",
       "  'population.'],\n",
       " ['two',\n",
       "  'hundred',\n",
       "  'and',\n",
       "  'twenty-three',\n",
       "  'incident',\n",
       "  'papillary',\n",
       "  'thyroid',\n",
       "  'cancer',\n",
       "  'cases',\n",
       "  'and',\n",
       "  '229',\n",
       "  'controls',\n",
       "  'recruited',\n",
       "  'from',\n",
       "  'saudi',\n",
       "  'arabian',\n",
       "  'population',\n",
       "  'were',\n",
       "  'analyzed',\n",
       "  'for',\n",
       "  '21',\n",
       "  'loci',\n",
       "  'in',\n",
       "  '8',\n",
       "  'selected',\n",
       "  'dna',\n",
       "  'repair',\n",
       "  'genes',\n",
       "  'by',\n",
       "  'pcr-restriction',\n",
       "  'fragment',\n",
       "  'length',\n",
       "  'polymorphism',\n",
       "  'including',\n",
       "  'non-homologous',\n",
       "  'end',\n",
       "  'joining',\n",
       "  'pathway',\n",
       "  'genes',\n",
       "  'ligiv',\n",
       "  '(liglv',\n",
       "  'asp62his,',\n",
       "  'pro231ser,',\n",
       "  'trp46ter),',\n",
       "  'xrcc4',\n",
       "  'splice',\n",
       "  '33243301g>a',\n",
       "  'and',\n",
       "  'xrcc7',\n",
       "  'ile3434thr;',\n",
       "  'homologous',\n",
       "  'recombination',\n",
       "  'pathway',\n",
       "  'genes',\n",
       "  'xrcc3',\n",
       "  'arg94his',\n",
       "  'and',\n",
       "  'thr241met,',\n",
       "  'rad51',\n",
       "  'utr',\n",
       "  '15452658t>c,',\n",
       "  '15455419a>g,',\n",
       "  'rad52',\n",
       "  '2259',\n",
       "  'and',\n",
       "  'gln221glu,',\n",
       "  'conserved',\n",
       "  'dna',\n",
       "  'damage',\n",
       "  'response',\n",
       "  'gene',\n",
       "  'tp53',\n",
       "  'pro47ser,',\n",
       "  'pro72arg,',\n",
       "  'tp53',\n",
       "  'utr',\n",
       "  '7178189a>c',\n",
       "  'and',\n",
       "  'base',\n",
       "  'excision',\n",
       "  'repair',\n",
       "  'gene',\n",
       "  'xrcc1',\n",
       "  'arg194trp,',\n",
       "  'arg280his,',\n",
       "  'arg399gln,',\n",
       "  'arg559gln.'],\n",
       " ['two',\n",
       "  'hundred',\n",
       "  'and',\n",
       "  'twenty-three',\n",
       "  'incident',\n",
       "  'papillary',\n",
       "  'thyroid',\n",
       "  'cancer',\n",
       "  'cases',\n",
       "  'and',\n",
       "  '229',\n",
       "  'controls',\n",
       "  'recruited',\n",
       "  'from',\n",
       "  'saudi',\n",
       "  'arabian',\n",
       "  'population',\n",
       "  'were',\n",
       "  'analyzed',\n",
       "  'for',\n",
       "  '21',\n",
       "  'loci',\n",
       "  'in',\n",
       "  '8',\n",
       "  'selected',\n",
       "  'dna',\n",
       "  'repair',\n",
       "  'genes',\n",
       "  'by',\n",
       "  'pcr-restriction',\n",
       "  'fragment',\n",
       "  'length',\n",
       "  'polymorphism',\n",
       "  'including',\n",
       "  'non-homologous',\n",
       "  'end',\n",
       "  'joining',\n",
       "  'pathway',\n",
       "  'genes',\n",
       "  'ligiv',\n",
       "  '(liglv',\n",
       "  'asp62his,',\n",
       "  'pro231ser,',\n",
       "  'trp46ter),',\n",
       "  'xrcc4',\n",
       "  'splice',\n",
       "  '33243301g>a',\n",
       "  'and',\n",
       "  'xrcc7',\n",
       "  'ile3434thr;',\n",
       "  'homologous',\n",
       "  'recombination',\n",
       "  'pathway',\n",
       "  'genes',\n",
       "  'xrcc3',\n",
       "  'arg94his',\n",
       "  'and',\n",
       "  'thr241met,',\n",
       "  'rad51',\n",
       "  'utr',\n",
       "  '15452658t>c,',\n",
       "  '15455419a>g,',\n",
       "  'rad52',\n",
       "  '2259',\n",
       "  'and',\n",
       "  'gln221glu,',\n",
       "  'conserved',\n",
       "  'dna',\n",
       "  'damage',\n",
       "  'response',\n",
       "  'gene',\n",
       "  'tp53',\n",
       "  'pro47ser,',\n",
       "  'pro72arg,',\n",
       "  'tp53',\n",
       "  'utr',\n",
       "  '7178189a>c',\n",
       "  'and',\n",
       "  'base',\n",
       "  'excision',\n",
       "  'repair',\n",
       "  'gene',\n",
       "  'xrcc1',\n",
       "  'arg194trp,',\n",
       "  'arg280his,',\n",
       "  'arg399gln,',\n",
       "  'arg559gln.'],\n",
       " ['two',\n",
       "  'hundred',\n",
       "  'and',\n",
       "  'twenty-three',\n",
       "  'incident',\n",
       "  'papillary',\n",
       "  'thyroid',\n",
       "  'cancer',\n",
       "  'cases',\n",
       "  'and',\n",
       "  '229',\n",
       "  'controls',\n",
       "  'recruited',\n",
       "  'from',\n",
       "  'saudi',\n",
       "  'arabian',\n",
       "  'population',\n",
       "  'were',\n",
       "  'analyzed',\n",
       "  'for',\n",
       "  '21',\n",
       "  'loci',\n",
       "  'in',\n",
       "  '8',\n",
       "  'selected',\n",
       "  'dna',\n",
       "  'repair',\n",
       "  'genes',\n",
       "  'by',\n",
       "  'pcr-restriction',\n",
       "  'fragment',\n",
       "  'length',\n",
       "  'polymorphism',\n",
       "  'including',\n",
       "  'non-homologous',\n",
       "  'end',\n",
       "  'joining',\n",
       "  'pathway',\n",
       "  'genes',\n",
       "  'ligiv',\n",
       "  '(liglv',\n",
       "  'asp62his,',\n",
       "  'pro231ser,',\n",
       "  'trp46ter),',\n",
       "  'xrcc4',\n",
       "  'splice',\n",
       "  '33243301g>a',\n",
       "  'and',\n",
       "  'xrcc7',\n",
       "  'ile3434thr;',\n",
       "  'homologous',\n",
       "  'recombination',\n",
       "  'pathway',\n",
       "  'genes',\n",
       "  'xrcc3',\n",
       "  'arg94his',\n",
       "  'and',\n",
       "  'thr241met,',\n",
       "  'rad51',\n",
       "  'utr',\n",
       "  '15452658t>c,',\n",
       "  '15455419a>g,',\n",
       "  'rad52',\n",
       "  '2259',\n",
       "  'and',\n",
       "  'gln221glu,',\n",
       "  'conserved',\n",
       "  'dna',\n",
       "  'damage',\n",
       "  'response',\n",
       "  'gene',\n",
       "  'tp53',\n",
       "  'pro47ser,',\n",
       "  'pro72arg,',\n",
       "  'tp53',\n",
       "  'utr',\n",
       "  '7178189a>c',\n",
       "  'and',\n",
       "  'base',\n",
       "  'excision',\n",
       "  'repair',\n",
       "  'gene',\n",
       "  'xrcc1',\n",
       "  'arg194trp,',\n",
       "  'arg280his,',\n",
       "  'arg399gln,',\n",
       "  'arg559gln.'],\n",
       " ['two',\n",
       "  'hundred',\n",
       "  'and',\n",
       "  'twenty-three',\n",
       "  'incident',\n",
       "  'papillary',\n",
       "  'thyroid',\n",
       "  'cancer',\n",
       "  'cases',\n",
       "  'and',\n",
       "  '229',\n",
       "  'controls',\n",
       "  'recruited',\n",
       "  'from',\n",
       "  'saudi',\n",
       "  'arabian',\n",
       "  'population',\n",
       "  'were',\n",
       "  'analyzed',\n",
       "  'for',\n",
       "  '21',\n",
       "  'loci',\n",
       "  'in',\n",
       "  '8',\n",
       "  'selected',\n",
       "  'dna',\n",
       "  'repair',\n",
       "  'genes',\n",
       "  'by',\n",
       "  'pcr-restriction',\n",
       "  'fragment',\n",
       "  'length',\n",
       "  'polymorphism',\n",
       "  'including',\n",
       "  'non-homologous',\n",
       "  'end',\n",
       "  'joining',\n",
       "  'pathway',\n",
       "  'genes',\n",
       "  'ligiv',\n",
       "  '(liglv',\n",
       "  'asp62his,',\n",
       "  'pro231ser,',\n",
       "  'trp46ter),',\n",
       "  'xrcc4',\n",
       "  'splice',\n",
       "  '33243301g>a',\n",
       "  'and',\n",
       "  'xrcc7',\n",
       "  'ile3434thr;',\n",
       "  'homologous',\n",
       "  'recombination',\n",
       "  'pathway',\n",
       "  'genes',\n",
       "  'xrcc3',\n",
       "  'arg94his',\n",
       "  'and',\n",
       "  'thr241met,',\n",
       "  'rad51',\n",
       "  'utr',\n",
       "  '15452658t>c,',\n",
       "  '15455419a>g,',\n",
       "  'rad52',\n",
       "  '2259',\n",
       "  'and',\n",
       "  'gln221glu,',\n",
       "  'conserved',\n",
       "  'dna',\n",
       "  'damage',\n",
       "  'response',\n",
       "  'gene',\n",
       "  'tp53',\n",
       "  'pro47ser,',\n",
       "  'pro72arg,',\n",
       "  'tp53',\n",
       "  'utr',\n",
       "  '7178189a>c',\n",
       "  'and',\n",
       "  'base',\n",
       "  'excision',\n",
       "  'repair',\n",
       "  'gene',\n",
       "  'xrcc1',\n",
       "  'arg194trp,',\n",
       "  'arg280his,',\n",
       "  'arg399gln,',\n",
       "  'arg559gln.'],\n",
       " ['two',\n",
       "  'hundred',\n",
       "  'and',\n",
       "  'twenty-three',\n",
       "  'incident',\n",
       "  'papillary',\n",
       "  'thyroid',\n",
       "  'cancer',\n",
       "  'cases',\n",
       "  'and',\n",
       "  '229',\n",
       "  'controls',\n",
       "  'recruited',\n",
       "  'from',\n",
       "  'saudi',\n",
       "  'arabian',\n",
       "  'population',\n",
       "  'were',\n",
       "  'analyzed',\n",
       "  'for',\n",
       "  '21',\n",
       "  'loci',\n",
       "  'in',\n",
       "  '8',\n",
       "  'selected',\n",
       "  'dna',\n",
       "  'repair',\n",
       "  'genes',\n",
       "  'by',\n",
       "  'pcr-restriction',\n",
       "  'fragment',\n",
       "  'length',\n",
       "  'polymorphism',\n",
       "  'including',\n",
       "  'non-homologous',\n",
       "  'end',\n",
       "  'joining',\n",
       "  'pathway',\n",
       "  'genes',\n",
       "  'ligiv',\n",
       "  '(liglv',\n",
       "  'asp62his,',\n",
       "  'pro231ser,',\n",
       "  'trp46ter),',\n",
       "  'xrcc4',\n",
       "  'splice',\n",
       "  '33243301g>a',\n",
       "  'and',\n",
       "  'xrcc7',\n",
       "  'ile3434thr;',\n",
       "  'homologous',\n",
       "  'recombination',\n",
       "  'pathway',\n",
       "  'genes',\n",
       "  'xrcc3',\n",
       "  'arg94his',\n",
       "  'and',\n",
       "  'thr241met,',\n",
       "  'rad51',\n",
       "  'utr',\n",
       "  '15452658t>c,',\n",
       "  '15455419a>g,',\n",
       "  'rad52',\n",
       "  '2259',\n",
       "  'and',\n",
       "  'gln221glu,',\n",
       "  'conserved',\n",
       "  'dna',\n",
       "  'damage',\n",
       "  'response',\n",
       "  'gene',\n",
       "  'tp53',\n",
       "  'pro47ser,',\n",
       "  'pro72arg,',\n",
       "  'tp53',\n",
       "  'utr',\n",
       "  '7178189a>c',\n",
       "  'and',\n",
       "  'base',\n",
       "  'excision',\n",
       "  'repair',\n",
       "  'gene',\n",
       "  'xrcc1',\n",
       "  'arg194trp,',\n",
       "  'arg280his,',\n",
       "  'arg399gln,',\n",
       "  'arg559gln.'],\n",
       " ['two',\n",
       "  'hundred',\n",
       "  'and',\n",
       "  'twenty-three',\n",
       "  'incident',\n",
       "  'papillary',\n",
       "  'thyroid',\n",
       "  'cancer',\n",
       "  'cases',\n",
       "  'and',\n",
       "  '229',\n",
       "  'controls',\n",
       "  'recruited',\n",
       "  'from',\n",
       "  'saudi',\n",
       "  'arabian',\n",
       "  'population',\n",
       "  'were',\n",
       "  'analyzed',\n",
       "  'for',\n",
       "  '21',\n",
       "  'loci',\n",
       "  'in',\n",
       "  '8',\n",
       "  'selected',\n",
       "  'dna',\n",
       "  'repair',\n",
       "  'genes',\n",
       "  'by',\n",
       "  'pcr-restriction',\n",
       "  'fragment',\n",
       "  'length',\n",
       "  'polymorphism',\n",
       "  'including',\n",
       "  'non-homologous',\n",
       "  'end',\n",
       "  'joining',\n",
       "  'pathway',\n",
       "  'genes',\n",
       "  'ligiv',\n",
       "  '(liglv',\n",
       "  'asp62his,',\n",
       "  'pro231ser,',\n",
       "  'trp46ter),',\n",
       "  'xrcc4',\n",
       "  'splice',\n",
       "  '33243301g>a',\n",
       "  'and',\n",
       "  'xrcc7',\n",
       "  'ile3434thr;',\n",
       "  'homologous',\n",
       "  'recombination',\n",
       "  'pathway',\n",
       "  'genes',\n",
       "  'xrcc3',\n",
       "  'arg94his',\n",
       "  'and',\n",
       "  'thr241met,',\n",
       "  'rad51',\n",
       "  'utr',\n",
       "  '15452658t>c,',\n",
       "  '15455419a>g,',\n",
       "  'rad52',\n",
       "  '2259',\n",
       "  'and',\n",
       "  'gln221glu,',\n",
       "  'conserved',\n",
       "  'dna',\n",
       "  'damage',\n",
       "  'response',\n",
       "  'gene',\n",
       "  'tp53',\n",
       "  'pro47ser,',\n",
       "  'pro72arg,',\n",
       "  'tp53',\n",
       "  'utr',\n",
       "  '7178189a>c',\n",
       "  'and',\n",
       "  'base',\n",
       "  'excision',\n",
       "  'repair',\n",
       "  'gene',\n",
       "  'xrcc1',\n",
       "  'arg194trp,',\n",
       "  'arg280his,',\n",
       "  'arg399gln,',\n",
       "  'arg559gln.'],\n",
       " ['rad52',\n",
       "  'gln221glu',\n",
       "  'genotypes',\n",
       "  'cg',\n",
       "  'and',\n",
       "  'variants',\n",
       "  'carrying',\n",
       "  'g',\n",
       "  'allele',\n",
       "  'showed',\n",
       "  'statistical',\n",
       "  'significance',\n",
       "  'and',\n",
       "  'very',\n",
       "  'high',\n",
       "  'risk',\n",
       "  'of',\n",
       "  'developing',\n",
       "  'thyroid',\n",
       "  'cancer',\n",
       "  'compared',\n",
       "  'to',\n",
       "  'wild',\n",
       "  'type',\n",
       "  '[cg',\n",
       "  'vs',\n",
       "  'cc;',\n",
       "  'p<0.001,',\n",
       "  'odds',\n",
       "  'ratio',\n",
       "  '(or)=15.57,',\n",
       "  '95%',\n",
       "  'confidence',\n",
       "  'interval',\n",
       "  '(ci)=6.56-36.98,',\n",
       "  'cg+gg',\n",
       "  'vs',\n",
       "  'cc;',\n",
       "  'p<0.001,',\n",
       "  'or=17.58,',\n",
       "  '95%',\n",
       "  'ci=7.44-41.58].'],\n",
       " ['two',\n",
       "  'hundred',\n",
       "  'and',\n",
       "  'twenty-three',\n",
       "  'incident',\n",
       "  'papillary',\n",
       "  'thyroid',\n",
       "  'cancer',\n",
       "  'cases',\n",
       "  'and',\n",
       "  '229',\n",
       "  'controls',\n",
       "  'recruited',\n",
       "  'from',\n",
       "  'saudi',\n",
       "  'arabian',\n",
       "  'population',\n",
       "  'were',\n",
       "  'analyzed',\n",
       "  'for',\n",
       "  '21',\n",
       "  'loci',\n",
       "  'in',\n",
       "  '8',\n",
       "  'selected',\n",
       "  'dna',\n",
       "  'repair',\n",
       "  'genes',\n",
       "  'by',\n",
       "  'pcr-restriction',\n",
       "  'fragment',\n",
       "  'length',\n",
       "  'polymorphism',\n",
       "  'including',\n",
       "  'non-homologous',\n",
       "  'end',\n",
       "  'joining',\n",
       "  'pathway',\n",
       "  'genes',\n",
       "  'ligiv',\n",
       "  '(liglv',\n",
       "  'asp62his,',\n",
       "  'pro231ser,',\n",
       "  'trp46ter),',\n",
       "  'xrcc4',\n",
       "  'splice',\n",
       "  '33243301g>a',\n",
       "  'and',\n",
       "  'xrcc7',\n",
       "  'ile3434thr;',\n",
       "  'homologous',\n",
       "  'recombination',\n",
       "  'pathway',\n",
       "  'genes',\n",
       "  'xrcc3',\n",
       "  'arg94his',\n",
       "  'and',\n",
       "  'thr241met,',\n",
       "  'rad51',\n",
       "  'utr',\n",
       "  '15452658t>c,',\n",
       "  '15455419a>g,',\n",
       "  'rad52',\n",
       "  '2259',\n",
       "  'and',\n",
       "  'gln221glu,',\n",
       "  'conserved',\n",
       "  'dna',\n",
       "  'damage',\n",
       "  'response',\n",
       "  'gene',\n",
       "  'tp53',\n",
       "  'pro47ser,',\n",
       "  'pro72arg,',\n",
       "  'tp53',\n",
       "  'utr',\n",
       "  '7178189a>c',\n",
       "  'and',\n",
       "  'base',\n",
       "  'excision',\n",
       "  'repair',\n",
       "  'gene',\n",
       "  'xrcc1',\n",
       "  'arg194trp,',\n",
       "  'arg280his,',\n",
       "  'arg399gln,',\n",
       "  'arg559gln.'],\n",
       " ['two',\n",
       "  'hundred',\n",
       "  'and',\n",
       "  'twenty-three',\n",
       "  'incident',\n",
       "  'papillary',\n",
       "  'thyroid',\n",
       "  'cancer',\n",
       "  'cases',\n",
       "  'and',\n",
       "  '229',\n",
       "  'controls',\n",
       "  'recruited',\n",
       "  'from',\n",
       "  'saudi',\n",
       "  'arabian',\n",
       "  'population',\n",
       "  'were',\n",
       "  'analyzed',\n",
       "  'for',\n",
       "  '21',\n",
       "  'loci',\n",
       "  'in',\n",
       "  '8',\n",
       "  'selected',\n",
       "  'dna',\n",
       "  'repair',\n",
       "  'genes',\n",
       "  'by',\n",
       "  'pcr-restriction',\n",
       "  'fragment',\n",
       "  'length',\n",
       "  'polymorphism',\n",
       "  'including',\n",
       "  'non-homologous',\n",
       "  'end',\n",
       "  'joining',\n",
       "  'pathway',\n",
       "  'genes',\n",
       "  'ligiv',\n",
       "  '(liglv',\n",
       "  'asp62his,',\n",
       "  'pro231ser,',\n",
       "  'trp46ter),',\n",
       "  'xrcc4',\n",
       "  'splice',\n",
       "  '33243301g>a',\n",
       "  'and',\n",
       "  'xrcc7',\n",
       "  'ile3434thr;',\n",
       "  'homologous',\n",
       "  'recombination',\n",
       "  'pathway',\n",
       "  'genes',\n",
       "  'xrcc3',\n",
       "  'arg94his',\n",
       "  'and',\n",
       "  'thr241met,',\n",
       "  'rad51',\n",
       "  'utr',\n",
       "  '15452658t>c,',\n",
       "  '15455419a>g,',\n",
       "  'rad52',\n",
       "  '2259',\n",
       "  'and',\n",
       "  'gln221glu,',\n",
       "  'conserved',\n",
       "  'dna',\n",
       "  'damage',\n",
       "  'response',\n",
       "  'gene',\n",
       "  'tp53',\n",
       "  'pro47ser,',\n",
       "  'pro72arg,',\n",
       "  'tp53',\n",
       "  'utr',\n",
       "  '7178189a>c',\n",
       "  'and',\n",
       "  'base',\n",
       "  'excision',\n",
       "  'repair',\n",
       "  'gene',\n",
       "  'xrcc1',\n",
       "  'arg194trp,',\n",
       "  'arg280his,',\n",
       "  'arg399gln,',\n",
       "  'arg559gln.'],\n",
       " ['two',\n",
       "  'hundred',\n",
       "  'and',\n",
       "  'twenty-three',\n",
       "  'incident',\n",
       "  'papillary',\n",
       "  'thyroid',\n",
       "  'cancer',\n",
       "  'cases',\n",
       "  'and',\n",
       "  '229',\n",
       "  'controls',\n",
       "  'recruited',\n",
       "  'from',\n",
       "  'saudi',\n",
       "  'arabian',\n",
       "  'population',\n",
       "  'were',\n",
       "  'analyzed',\n",
       "  'for',\n",
       "  '21',\n",
       "  'loci',\n",
       "  'in',\n",
       "  '8',\n",
       "  'selected',\n",
       "  'dna',\n",
       "  'repair',\n",
       "  'genes',\n",
       "  'by',\n",
       "  'pcr-restriction',\n",
       "  'fragment',\n",
       "  'length',\n",
       "  'polymorphism',\n",
       "  'including',\n",
       "  'non-homologous',\n",
       "  'end',\n",
       "  'joining',\n",
       "  'pathway',\n",
       "  'genes',\n",
       "  'ligiv',\n",
       "  '(liglv',\n",
       "  'asp62his,',\n",
       "  'pro231ser,',\n",
       "  'trp46ter),',\n",
       "  'xrcc4',\n",
       "  'splice',\n",
       "  '33243301g>a',\n",
       "  'and',\n",
       "  'xrcc7',\n",
       "  'ile3434thr;',\n",
       "  'homologous',\n",
       "  'recombination',\n",
       "  'pathway',\n",
       "  'genes',\n",
       "  'xrcc3',\n",
       "  'arg94his',\n",
       "  'and',\n",
       "  'thr241met,',\n",
       "  'rad51',\n",
       "  'utr',\n",
       "  '15452658t>c,',\n",
       "  '15455419a>g,',\n",
       "  'rad52',\n",
       "  '2259',\n",
       "  'and',\n",
       "  'gln221glu,',\n",
       "  'conserved',\n",
       "  'dna',\n",
       "  'damage',\n",
       "  'response',\n",
       "  'gene',\n",
       "  'tp53',\n",
       "  'pro47ser,',\n",
       "  'pro72arg,',\n",
       "  'tp53',\n",
       "  'utr',\n",
       "  '7178189a>c',\n",
       "  'and',\n",
       "  'base',\n",
       "  'excision',\n",
       "  'repair',\n",
       "  'gene',\n",
       "  'xrcc1',\n",
       "  'arg194trp,',\n",
       "  'arg280his,',\n",
       "  'arg399gln,',\n",
       "  'arg559gln.'],\n",
       " ['two',\n",
       "  'hundred',\n",
       "  'and',\n",
       "  'twenty-three',\n",
       "  'incident',\n",
       "  'papillary',\n",
       "  'thyroid',\n",
       "  'cancer',\n",
       "  'cases',\n",
       "  'and',\n",
       "  '229',\n",
       "  'controls',\n",
       "  'recruited',\n",
       "  'from',\n",
       "  'saudi',\n",
       "  'arabian',\n",
       "  'population',\n",
       "  'were',\n",
       "  'analyzed',\n",
       "  'for',\n",
       "  '21',\n",
       "  'loci',\n",
       "  'in',\n",
       "  '8',\n",
       "  'selected',\n",
       "  'dna',\n",
       "  'repair',\n",
       "  'genes',\n",
       "  'by',\n",
       "  'pcr-restriction',\n",
       "  'fragment',\n",
       "  'length',\n",
       "  'polymorphism',\n",
       "  'including',\n",
       "  'non-homologous',\n",
       "  'end',\n",
       "  'joining',\n",
       "  'pathway',\n",
       "  'genes',\n",
       "  'ligiv',\n",
       "  '(liglv',\n",
       "  'asp62his,',\n",
       "  'pro231ser,',\n",
       "  'trp46ter),',\n",
       "  'xrcc4',\n",
       "  'splice',\n",
       "  '33243301g>a',\n",
       "  'and',\n",
       "  'xrcc7',\n",
       "  'ile3434thr;',\n",
       "  'homologous',\n",
       "  'recombination',\n",
       "  'pathway',\n",
       "  'genes',\n",
       "  'xrcc3',\n",
       "  'arg94his',\n",
       "  'and',\n",
       "  'thr241met,',\n",
       "  'rad51',\n",
       "  'utr',\n",
       "  '15452658t>c,',\n",
       "  '15455419a>g,',\n",
       "  'rad52',\n",
       "  '2259',\n",
       "  'and',\n",
       "  'gln221glu,',\n",
       "  'conserved',\n",
       "  'dna',\n",
       "  'damage',\n",
       "  'response',\n",
       "  'gene',\n",
       "  'tp53',\n",
       "  'pro47ser,',\n",
       "  'pro72arg,',\n",
       "  'tp53',\n",
       "  'utr',\n",
       "  '7178189a>c',\n",
       "  'and',\n",
       "  'base',\n",
       "  'excision',\n",
       "  'repair',\n",
       "  'gene',\n",
       "  'xrcc1',\n",
       "  'arg194trp,',\n",
       "  'arg280his,',\n",
       "  'arg399gln,',\n",
       "  'arg559gln.'],\n",
       " ['two',\n",
       "  'hundred',\n",
       "  'and',\n",
       "  'twenty-three',\n",
       "  'incident',\n",
       "  'papillary',\n",
       "  'thyroid',\n",
       "  'cancer',\n",
       "  'cases',\n",
       "  'and',\n",
       "  '229',\n",
       "  'controls',\n",
       "  'recruited',\n",
       "  'from',\n",
       "  'saudi',\n",
       "  'arabian',\n",
       "  'population',\n",
       "  'were',\n",
       "  'analyzed',\n",
       "  'for',\n",
       "  '21',\n",
       "  'loci',\n",
       "  'in',\n",
       "  '8',\n",
       "  'selected',\n",
       "  'dna',\n",
       "  'repair',\n",
       "  'genes',\n",
       "  'by',\n",
       "  'pcr-restriction',\n",
       "  'fragment',\n",
       "  'length',\n",
       "  'polymorphism',\n",
       "  'including',\n",
       "  'non-homologous',\n",
       "  'end',\n",
       "  'joining',\n",
       "  'pathway',\n",
       "  'genes',\n",
       "  'ligiv',\n",
       "  '(liglv',\n",
       "  'asp62his,',\n",
       "  'pro231ser,',\n",
       "  'trp46ter),',\n",
       "  'xrcc4',\n",
       "  'splice',\n",
       "  '33243301g>a',\n",
       "  'and',\n",
       "  'xrcc7',\n",
       "  'ile3434thr;',\n",
       "  'homologous',\n",
       "  'recombination',\n",
       "  'pathway',\n",
       "  'genes',\n",
       "  'xrcc3',\n",
       "  'arg94his',\n",
       "  'and',\n",
       "  'thr241met,',\n",
       "  'rad51',\n",
       "  'utr',\n",
       "  '15452658t>c,',\n",
       "  '15455419a>g,',\n",
       "  'rad52',\n",
       "  '2259',\n",
       "  'and',\n",
       "  'gln221glu,',\n",
       "  'conserved',\n",
       "  'dna',\n",
       "  'damage',\n",
       "  'response',\n",
       "  'gene',\n",
       "  'tp53',\n",
       "  'pro47ser,',\n",
       "  'pro72arg,',\n",
       "  'tp53',\n",
       "  'utr',\n",
       "  '7178189a>c',\n",
       "  'and',\n",
       "  'base',\n",
       "  'excision',\n",
       "  'repair',\n",
       "  'gene',\n",
       "  'xrcc1',\n",
       "  'arg194trp,',\n",
       "  'arg280his,',\n",
       "  'arg399gln,',\n",
       "  'arg559gln.'],\n",
       " ['an',\n",
       "  'anti-inflammatory',\n",
       "  'and',\n",
       "  'anticarcinogenic',\n",
       "  'potential',\n",
       "  'has',\n",
       "  'been',\n",
       "  'inferred',\n",
       "  'from',\n",
       "  'the',\n",
       "  'development',\n",
       "  'of',\n",
       "  'colitis',\n",
       "  'and',\n",
       "  'intestinal',\n",
       "  'cancer',\n",
       "  'in',\n",
       "  'gpx1',\n",
       "  'and',\n",
       "  'gpx2',\n",
       "  'double',\n",
       "  'knockout',\n",
       "  'mice.'],\n",
       " ['an',\n",
       "  'anti-inflammatory',\n",
       "  'and',\n",
       "  'anticarcinogenic',\n",
       "  'potential',\n",
       "  'has',\n",
       "  'been',\n",
       "  'inferred',\n",
       "  'from',\n",
       "  'the',\n",
       "  'development',\n",
       "  'of',\n",
       "  'colitis',\n",
       "  'and',\n",
       "  'intestinal',\n",
       "  'cancer',\n",
       "  'in',\n",
       "  'gpx1',\n",
       "  'and',\n",
       "  'gpx2',\n",
       "  'double',\n",
       "  'knockout',\n",
       "  'mice.'],\n",
       " ['thus,',\n",
       "  'gpx2',\n",
       "  'may',\n",
       "  'prevent',\n",
       "  'undue',\n",
       "  'responses',\n",
       "  'to',\n",
       "  'inflammatory',\n",
       "  'stimuli',\n",
       "  'and,',\n",
       "  'in',\n",
       "  'consequence,',\n",
       "  'inflammation-driven',\n",
       "  'initiation',\n",
       "  'of',\n",
       "  'carcinogenesis.'],\n",
       " ['in',\n",
       "  'contrast,',\n",
       "  'enhanced',\n",
       "  'cox-2',\n",
       "  'expression',\n",
       "  'is',\n",
       "  'consistently',\n",
       "  'associated',\n",
       "  'with',\n",
       "  'inflammation.'],\n",
       " ['an',\n",
       "  'anti-inflammatory',\n",
       "  'and',\n",
       "  'anticarcinogenic',\n",
       "  'potential',\n",
       "  'has',\n",
       "  'been',\n",
       "  'inferred',\n",
       "  'from',\n",
       "  'the',\n",
       "  'development',\n",
       "  'of',\n",
       "  'colitis',\n",
       "  'and',\n",
       "  'intestinal',\n",
       "  'cancer',\n",
       "  'in',\n",
       "  'gpx1',\n",
       "  'and',\n",
       "  'gpx2',\n",
       "  'double',\n",
       "  'knockout',\n",
       "  'mice.'],\n",
       " ['an',\n",
       "  'anti-inflammatory',\n",
       "  'and',\n",
       "  'anticarcinogenic',\n",
       "  'potential',\n",
       "  'has',\n",
       "  'been',\n",
       "  'inferred',\n",
       "  'from',\n",
       "  'the',\n",
       "  'development',\n",
       "  'of',\n",
       "  'colitis',\n",
       "  'and',\n",
       "  'intestinal',\n",
       "  'cancer',\n",
       "  'in',\n",
       "  'gpx1',\n",
       "  'and',\n",
       "  'gpx2',\n",
       "  'double',\n",
       "  'knockout',\n",
       "  'mice.'],\n",
       " ['for',\n",
       "  'the',\n",
       "  'remaining',\n",
       "  'markers,',\n",
       "  'a',\n",
       "  'susceptibility',\n",
       "  'role',\n",
       "  'was',\n",
       "  'attributed',\n",
       "  'also',\n",
       "  'confirming',\n",
       "  'that',\n",
       "  'markers',\n",
       "  'on',\n",
       "  'card15',\n",
       "  'gene,',\n",
       "  'in',\n",
       "  'particular',\n",
       "  'g908r',\n",
       "  'and',\n",
       "  'l1007fsinsc,',\n",
       "  'are',\n",
       "  'involved',\n",
       "  'with',\n",
       "  'cd',\n",
       "  'to',\n",
       "  'the',\n",
       "  'same',\n",
       "  'extent',\n",
       "  'as',\n",
       "  'fcgiiia',\n",
       "  'g559t',\n",
       "  'and',\n",
       "  'tnf-alpha-g308a.'],\n",
       " ['for',\n",
       "  'the',\n",
       "  'remaining',\n",
       "  'markers,',\n",
       "  'a',\n",
       "  'susceptibility',\n",
       "  'role',\n",
       "  'was',\n",
       "  'attributed',\n",
       "  'also',\n",
       "  'confirming',\n",
       "  'that',\n",
       "  'markers',\n",
       "  'on',\n",
       "  'card15',\n",
       "  'gene,',\n",
       "  'in',\n",
       "  'particular',\n",
       "  'g908r',\n",
       "  'and',\n",
       "  'l1007fsinsc,',\n",
       "  'are',\n",
       "  'involved',\n",
       "  'with',\n",
       "  'cd',\n",
       "  'to',\n",
       "  'the',\n",
       "  'same',\n",
       "  'extent',\n",
       "  'as',\n",
       "  'fcgiiia',\n",
       "  'g559t',\n",
       "  'and',\n",
       "  'tnf-alpha-g308a.'],\n",
       " ['for',\n",
       "  'the',\n",
       "  'remaining',\n",
       "  'markers,',\n",
       "  'a',\n",
       "  'susceptibility',\n",
       "  'role',\n",
       "  'was',\n",
       "  'attributed',\n",
       "  'also',\n",
       "  'confirming',\n",
       "  'that',\n",
       "  'markers',\n",
       "  'on',\n",
       "  'card15',\n",
       "  'gene,',\n",
       "  'in',\n",
       "  'particular',\n",
       "  'g908r',\n",
       "  'and',\n",
       "  'l1007fsinsc,',\n",
       "  'are',\n",
       "  'involved',\n",
       "  'with',\n",
       "  'cd',\n",
       "  'to',\n",
       "  'the',\n",
       "  'same',\n",
       "  'extent',\n",
       "  'as',\n",
       "  'fcgiiia',\n",
       "  'g559t',\n",
       "  'and',\n",
       "  'tnf-alpha-g308a.'],\n",
       " ['for',\n",
       "  'the',\n",
       "  'remaining',\n",
       "  'markers,',\n",
       "  'a',\n",
       "  'susceptibility',\n",
       "  'role',\n",
       "  'was',\n",
       "  'attributed',\n",
       "  'also',\n",
       "  'confirming',\n",
       "  'that',\n",
       "  'markers',\n",
       "  'on',\n",
       "  'card15',\n",
       "  'gene,',\n",
       "  'in',\n",
       "  'particular',\n",
       "  'g908r',\n",
       "  'and',\n",
       "  'l1007fsinsc,',\n",
       "  'are',\n",
       "  'involved',\n",
       "  'with',\n",
       "  'cd',\n",
       "  'to',\n",
       "  'the',\n",
       "  'same',\n",
       "  'extent',\n",
       "  'as',\n",
       "  'fcgiiia',\n",
       "  'g559t',\n",
       "  'and',\n",
       "  'tnf-alpha-g308a.'],\n",
       " ['the',\n",
       "  'nf',\n",
       "  'kappab',\n",
       "  '-94attg',\n",
       "  'variants',\n",
       "  'was',\n",
       "  'found',\n",
       "  'to',\n",
       "  'be',\n",
       "  'irrelevant',\n",
       "  'for',\n",
       "  'cd.'],\n",
       " ['for',\n",
       "  'the',\n",
       "  'remaining',\n",
       "  'markers,',\n",
       "  'a',\n",
       "  'susceptibility',\n",
       "  'role',\n",
       "  'was',\n",
       "  'attributed',\n",
       "  'also',\n",
       "  'confirming',\n",
       "  'that',\n",
       "  'markers',\n",
       "  'on',\n",
       "  'card15',\n",
       "  'gene,',\n",
       "  'in',\n",
       "  'particular',\n",
       "  'g908r',\n",
       "  'and',\n",
       "  'l1007fsinsc,',\n",
       "  'are',\n",
       "  'involved',\n",
       "  'with',\n",
       "  'cd',\n",
       "  'to',\n",
       "  'the',\n",
       "  'same',\n",
       "  'extent',\n",
       "  'as',\n",
       "  'fcgiiia',\n",
       "  'g559t',\n",
       "  'and',\n",
       "  'tnf-alpha-g308a.'],\n",
       " ['the',\n",
       "  'c-allele',\n",
       "  'of',\n",
       "  'pklr',\n",
       "  'rs3020781',\n",
       "  'and',\n",
       "  'the',\n",
       "  't-allele',\n",
       "  'of',\n",
       "  'nos1ap',\n",
       "  'rs7538490',\n",
       "  'are',\n",
       "  'reported',\n",
       "  'to',\n",
       "  'strongly',\n",
       "  'associate',\n",
       "  'with',\n",
       "  'type',\n",
       "  '2',\n",
       "  'diabetes',\n",
       "  'in',\n",
       "  'various',\n",
       "  'european-descent',\n",
       "  'populations',\n",
       "  'comprising',\n",
       "  'a',\n",
       "  'total',\n",
       "  'of',\n",
       "  '2,198',\n",
       "  'individuals',\n",
       "  'with',\n",
       "  'a',\n",
       "  'combined',\n",
       "  'odds',\n",
       "  'ratio',\n",
       "  '(or)',\n",
       "  'of',\n",
       "  '1.33',\n",
       "  '[1.16-1.54]',\n",
       "  'and',\n",
       "  '1.53',\n",
       "  '[1.28-1.81],',\n",
       "  'respectively.'],\n",
       " ['additionally,',\n",
       "  'the',\n",
       "  'pklr',\n",
       "  'and',\n",
       "  'the',\n",
       "  'nos1ap',\n",
       "  'genotypes',\n",
       "  'were',\n",
       "  'demonstrated',\n",
       "  'not',\n",
       "  'to',\n",
       "  'have',\n",
       "  'a',\n",
       "  'major',\n",
       "  'influence',\n",
       "  'on',\n",
       "  'diabetes-related',\n",
       "  'quantitative',\n",
       "  'metabolic',\n",
       "  'phenotypes.'],\n",
       " ['we',\n",
       "  'failed',\n",
       "  'to',\n",
       "  'provide',\n",
       "  'evidence',\n",
       "  'of',\n",
       "  'an',\n",
       "  'association',\n",
       "  'between',\n",
       "  'pklr',\n",
       "  'rs3020781',\n",
       "  'and',\n",
       "  'nos1ap',\n",
       "  'rs7538490',\n",
       "  'and',\n",
       "  'type',\n",
       "  '2',\n",
       "  'diabetes,',\n",
       "  'overweight,',\n",
       "  'obesity',\n",
       "  'or',\n",
       "  'related',\n",
       "  'quantitative',\n",
       "  'metabolic',\n",
       "  'phenotypes',\n",
       "  'in',\n",
       "  'large-scale',\n",
       "  'studies',\n",
       "  'of',\n",
       "  'danes.'],\n",
       " ['the',\n",
       "  'c-allele',\n",
       "  'of',\n",
       "  'pklr',\n",
       "  'rs3020781',\n",
       "  'and',\n",
       "  'the',\n",
       "  't-allele',\n",
       "  'of',\n",
       "  'nos1ap',\n",
       "  'rs7538490',\n",
       "  'are',\n",
       "  'reported',\n",
       "  'to',\n",
       "  'strongly',\n",
       "  'associate',\n",
       "  'with',\n",
       "  'type',\n",
       "  '2',\n",
       "  'diabetes',\n",
       "  'in',\n",
       "  'various',\n",
       "  'european-descent',\n",
       "  'populations',\n",
       "  'comprising',\n",
       "  'a',\n",
       "  'total',\n",
       "  'of',\n",
       "  '2,198',\n",
       "  'individuals',\n",
       "  'with',\n",
       "  'a',\n",
       "  'combined',\n",
       "  'odds',\n",
       "  'ratio',\n",
       "  '(or)',\n",
       "  'of',\n",
       "  '1.33',\n",
       "  '[1.16-1.54]',\n",
       "  'and',\n",
       "  '1.53',\n",
       "  '[1.28-1.81],',\n",
       "  'respectively.'],\n",
       " ['we',\n",
       "  'failed',\n",
       "  'to',\n",
       "  'provide',\n",
       "  'evidence',\n",
       "  'of',\n",
       "  'an',\n",
       "  'association',\n",
       "  'between',\n",
       "  'pklr',\n",
       "  'rs3020781',\n",
       "  'and',\n",
       "  'nos1ap',\n",
       "  'rs7538490',\n",
       "  'and',\n",
       "  'type',\n",
       "  '2',\n",
       "  'diabetes,',\n",
       "  'overweight,',\n",
       "  'obesity',\n",
       "  'or',\n",
       "  'related',\n",
       "  'quantitative',\n",
       "  'metabolic',\n",
       "  'phenotypes',\n",
       "  'in',\n",
       "  'large-scale',\n",
       "  'studies',\n",
       "  'of',\n",
       "  'danes.'],\n",
       " ['no',\n",
       "  'significant',\n",
       "  'associations',\n",
       "  'were',\n",
       "  'observed',\n",
       "  'for',\n",
       "  'type',\n",
       "  '2',\n",
       "  'diabetes',\n",
       "  '(rs3020781:',\n",
       "  'paf',\n",
       "  '=',\n",
       "  '0.49,',\n",
       "  'or',\n",
       "  '=',\n",
       "  '1.02',\n",
       "  '[0.96-1.10];',\n",
       "  'rs7538490:',\n",
       "  'paf',\n",
       "  '=',\n",
       "  '0.84,',\n",
       "  'or',\n",
       "  '=',\n",
       "  '0.99',\n",
       "  '[0.93-1.06]).'],\n",
       " ['lack',\n",
       "  'of',\n",
       "  'association',\n",
       "  'between',\n",
       "  'pklr',\n",
       "  'rs3020781',\n",
       "  'and',\n",
       "  'nos1ap',\n",
       "  'rs7538490',\n",
       "  'and',\n",
       "  'type',\n",
       "  '2',\n",
       "  'diabetes,',\n",
       "  'overweight,',\n",
       "  'obesity',\n",
       "  'and',\n",
       "  'related',\n",
       "  'metabolic',\n",
       "  'phenotypes',\n",
       "  'in',\n",
       "  'a',\n",
       "  'danish',\n",
       "  'large-scale',\n",
       "  'study:',\n",
       "  'case-control',\n",
       "  'studies',\n",
       "  'and',\n",
       "  'analyses',\n",
       "  'of',\n",
       "  'quantitative',\n",
       "  'traits.'],\n",
       " ['lack',\n",
       "  'of',\n",
       "  'association',\n",
       "  'between',\n",
       "  'pklr',\n",
       "  'rs3020781',\n",
       "  'and',\n",
       "  'nos1ap',\n",
       "  'rs7538490',\n",
       "  'and',\n",
       "  'type',\n",
       "  '2',\n",
       "  'diabetes,',\n",
       "  'overweight,',\n",
       "  'obesity',\n",
       "  'and',\n",
       "  'related',\n",
       "  'metabolic',\n",
       "  'phenotypes',\n",
       "  'in',\n",
       "  'a',\n",
       "  'danish',\n",
       "  'large-scale',\n",
       "  'study:',\n",
       "  'case-control',\n",
       "  'studies',\n",
       "  'and',\n",
       "  'analyses',\n",
       "  'of',\n",
       "  'quantitative',\n",
       "  'traits.'],\n",
       " ['we',\n",
       "  'failed',\n",
       "  'to',\n",
       "  'provide',\n",
       "  'evidence',\n",
       "  'of',\n",
       "  'an',\n",
       "  'association',\n",
       "  'between',\n",
       "  'pklr',\n",
       "  'rs3020781',\n",
       "  'and',\n",
       "  'nos1ap',\n",
       "  'rs7538490',\n",
       "  'and',\n",
       "  'type',\n",
       "  '2',\n",
       "  'diabetes,',\n",
       "  'overweight,',\n",
       "  'obesity',\n",
       "  'or',\n",
       "  'related',\n",
       "  'quantitative',\n",
       "  'metabolic',\n",
       "  'phenotypes',\n",
       "  'in',\n",
       "  'large-scale',\n",
       "  'studies',\n",
       "  'of',\n",
       "  'danes.'],\n",
       " ['lack',\n",
       "  'of',\n",
       "  'association',\n",
       "  'between',\n",
       "  'pklr',\n",
       "  'rs3020781',\n",
       "  'and',\n",
       "  'nos1ap',\n",
       "  'rs7538490',\n",
       "  'and',\n",
       "  'type',\n",
       "  '2',\n",
       "  'diabetes,',\n",
       "  'overweight,',\n",
       "  'obesity',\n",
       "  'and',\n",
       "  'related',\n",
       "  'metabolic',\n",
       "  'phenotypes',\n",
       "  'in',\n",
       "  'a',\n",
       "  'danish',\n",
       "  'large-scale',\n",
       "  'study:',\n",
       "  'case-control',\n",
       "  'studies',\n",
       "  'and',\n",
       "  'analyses',\n",
       "  'of',\n",
       "  'quantitative',\n",
       "  'traits.'],\n",
       " ['the',\n",
       "  'c-allele',\n",
       "  'of',\n",
       "  'pklr',\n",
       "  'rs3020781',\n",
       "  'and',\n",
       "  'the',\n",
       "  't-allele',\n",
       "  'of',\n",
       "  'nos1ap',\n",
       "  'rs7538490',\n",
       "  'are',\n",
       "  'reported',\n",
       "  'to',\n",
       "  'strongly',\n",
       "  'associate',\n",
       "  'with',\n",
       "  'type',\n",
       "  '2',\n",
       "  'diabetes',\n",
       "  'in',\n",
       "  'various',\n",
       "  'european-descent',\n",
       "  'populations',\n",
       "  'comprising',\n",
       "  'a',\n",
       "  'total',\n",
       "  'of',\n",
       "  '2,198',\n",
       "  'individuals',\n",
       "  'with',\n",
       "  'a',\n",
       "  'combined',\n",
       "  'odds',\n",
       "  'ratio',\n",
       "  '(or)',\n",
       "  'of',\n",
       "  '1.33',\n",
       "  '[1.16-1.54]',\n",
       "  'and',\n",
       "  '1.53',\n",
       "  '[1.28-1.81],',\n",
       "  'respectively.'],\n",
       " ['lack',\n",
       "  'of',\n",
       "  'association',\n",
       "  'between',\n",
       "  'pklr',\n",
       "  'rs3020781',\n",
       "  'and',\n",
       "  'nos1ap',\n",
       "  'rs7538490',\n",
       "  'and',\n",
       "  'type',\n",
       "  '2',\n",
       "  'diabetes,',\n",
       "  'overweight,',\n",
       "  'obesity',\n",
       "  'and',\n",
       "  'related',\n",
       "  'metabolic',\n",
       "  'phenotypes',\n",
       "  'in',\n",
       "  'a',\n",
       "  'danish',\n",
       "  'large-scale',\n",
       "  'study:',\n",
       "  'case-control',\n",
       "  'studies',\n",
       "  'and',\n",
       "  'analyses',\n",
       "  'of',\n",
       "  'quantitative',\n",
       "  'traits.'],\n",
       " ['we',\n",
       "  'failed',\n",
       "  'to',\n",
       "  'provide',\n",
       "  'evidence',\n",
       "  'of',\n",
       "  'an',\n",
       "  'association',\n",
       "  'between',\n",
       "  'pklr',\n",
       "  'rs3020781',\n",
       "  'and',\n",
       "  'nos1ap',\n",
       "  'rs7538490',\n",
       "  'and',\n",
       "  'type',\n",
       "  '2',\n",
       "  'diabetes,',\n",
       "  'overweight,',\n",
       "  'obesity',\n",
       "  'or',\n",
       "  'related',\n",
       "  'quantitative',\n",
       "  'metabolic',\n",
       "  'phenotypes',\n",
       "  'in',\n",
       "  'large-scale',\n",
       "  'studies',\n",
       "  'of',\n",
       "  'danes.'],\n",
       " ['additionally,',\n",
       "  'the',\n",
       "  'pklr',\n",
       "  'and',\n",
       "  'the',\n",
       "  'nos1ap',\n",
       "  'genotypes',\n",
       "  'were',\n",
       "  'demonstrated',\n",
       "  'not',\n",
       "  'to',\n",
       "  'have',\n",
       "  'a',\n",
       "  'major',\n",
       "  'influence',\n",
       "  'on',\n",
       "  'diabetes-related',\n",
       "  'quantitative',\n",
       "  'metabolic',\n",
       "  'phenotypes.'],\n",
       " ['no',\n",
       "  'significant',\n",
       "  'associations',\n",
       "  'were',\n",
       "  'observed',\n",
       "  'for',\n",
       "  'type',\n",
       "  '2',\n",
       "  'diabetes',\n",
       "  '(rs3020781:',\n",
       "  'paf',\n",
       "  '=',\n",
       "  '0.49,',\n",
       "  'or',\n",
       "  '=',\n",
       "  '1.02',\n",
       "  '[0.96-1.10];',\n",
       "  'rs7538490:',\n",
       "  'paf',\n",
       "  '=',\n",
       "  '0.84,',\n",
       "  'or',\n",
       "  '=',\n",
       "  '0.99',\n",
       "  '[0.93-1.06]).'],\n",
       " ['the',\n",
       "  'c-allele',\n",
       "  'of',\n",
       "  'pklr',\n",
       "  'rs3020781',\n",
       "  'and',\n",
       "  'the',\n",
       "  't-allele',\n",
       "  'of',\n",
       "  'nos1ap',\n",
       "  'rs7538490',\n",
       "  'are',\n",
       "  'reported',\n",
       "  'to',\n",
       "  'strongly',\n",
       "  'associate',\n",
       "  'with',\n",
       "  'type',\n",
       "  '2',\n",
       "  'diabetes',\n",
       "  'in',\n",
       "  'various',\n",
       "  'european-descent',\n",
       "  'populations',\n",
       "  'comprising',\n",
       "  'a',\n",
       "  'total',\n",
       "  'of',\n",
       "  '2,198',\n",
       "  'individuals',\n",
       "  'with',\n",
       "  'a',\n",
       "  'combined',\n",
       "  'odds',\n",
       "  'ratio',\n",
       "  '(or)',\n",
       "  'of',\n",
       "  '1.33',\n",
       "  '[1.16-1.54]',\n",
       "  'and',\n",
       "  '1.53',\n",
       "  '[1.28-1.81],',\n",
       "  'respectively.'],\n",
       " ['we',\n",
       "  'failed',\n",
       "  'to',\n",
       "  'provide',\n",
       "  'evidence',\n",
       "  'of',\n",
       "  'an',\n",
       "  'association',\n",
       "  'between',\n",
       "  'pklr',\n",
       "  'rs3020781',\n",
       "  'and',\n",
       "  'nos1ap',\n",
       "  'rs7538490',\n",
       "  'and',\n",
       "  'type',\n",
       "  '2',\n",
       "  'diabetes,',\n",
       "  'overweight,',\n",
       "  'obesity',\n",
       "  'or',\n",
       "  'related',\n",
       "  'quantitative',\n",
       "  'metabolic',\n",
       "  'phenotypes',\n",
       "  'in',\n",
       "  'large-scale',\n",
       "  'studies',\n",
       "  'of',\n",
       "  'danes.'],\n",
       " ['lack',\n",
       "  'of',\n",
       "  'association',\n",
       "  'between',\n",
       "  'pklr',\n",
       "  'rs3020781',\n",
       "  'and',\n",
       "  'nos1ap',\n",
       "  'rs7538490',\n",
       "  'and',\n",
       "  'type',\n",
       "  '2',\n",
       "  'diabetes,',\n",
       "  'overweight,',\n",
       "  'obesity',\n",
       "  'and',\n",
       "  'related',\n",
       "  'metabolic',\n",
       "  'phenotypes',\n",
       "  'in',\n",
       "  'a',\n",
       "  'danish',\n",
       "  'large-scale',\n",
       "  'study:',\n",
       "  'case-control',\n",
       "  'studies',\n",
       "  'and',\n",
       "  'analyses',\n",
       "  'of',\n",
       "  'quantitative',\n",
       "  'traits.'],\n",
       " ['lack',\n",
       "  'of',\n",
       "  'association',\n",
       "  'between',\n",
       "  'pklr',\n",
       "  'rs3020781',\n",
       "  'and',\n",
       "  'nos1ap',\n",
       "  'rs7538490',\n",
       "  'and',\n",
       "  'type',\n",
       "  '2',\n",
       "  'diabetes,',\n",
       "  'overweight,',\n",
       "  'obesity',\n",
       "  'and',\n",
       "  'related',\n",
       "  'metabolic',\n",
       "  'phenotypes',\n",
       "  'in',\n",
       "  'a',\n",
       "  'danish',\n",
       "  'large-scale',\n",
       "  'study:',\n",
       "  'case-control',\n",
       "  'studies',\n",
       "  'and',\n",
       "  'analyses',\n",
       "  'of',\n",
       "  'quantitative',\n",
       "  'traits.'],\n",
       " ['although',\n",
       "  'cox-2',\n",
       "  'is',\n",
       "  'commonly',\n",
       "  'overexpressed',\n",
       "  'in',\n",
       "  'a',\n",
       "  'variety',\n",
       "  'of',\n",
       "  'premalignant',\n",
       "  'and',\n",
       "  'malignant',\n",
       "  'conditions',\n",
       "  'including',\n",
       "  'oral',\n",
       "  'leukoplakia',\n",
       "  'and',\n",
       "  'squamous',\n",
       "  'cell',\n",
       "  'carcinoma,',\n",
       "  'relatively',\n",
       "  'little',\n",
       "  'research',\n",
       "  'has',\n",
       "  'compared',\n",
       "  'the',\n",
       "  'effects',\n",
       "  'of',\n",
       "  'various',\n",
       "  'cox-2',\n",
       "  'inhibitors',\n",
       "  '(celecoxib,',\n",
       "  'ns-398,',\n",
       "  'nimesulide',\n",
       "  'and',\n",
       "  'meloxicam).'],\n",
       " ['although',\n",
       "  'cox-2',\n",
       "  'is',\n",
       "  'commonly',\n",
       "  'overexpressed',\n",
       "  'in',\n",
       "  'a',\n",
       "  'variety',\n",
       "  'of',\n",
       "  'premalignant',\n",
       "  'and',\n",
       "  'malignant',\n",
       "  'conditions',\n",
       "  'including',\n",
       "  'oral',\n",
       "  'leukoplakia',\n",
       "  'and',\n",
       "  'squamous',\n",
       "  'cell',\n",
       "  'carcinoma,',\n",
       "  'relatively',\n",
       "  'little',\n",
       "  'research',\n",
       "  'has',\n",
       "  'compared',\n",
       "  'the',\n",
       "  'effects',\n",
       "  'of',\n",
       "  'various',\n",
       "  'cox-2',\n",
       "  'inhibitors',\n",
       "  '(celecoxib,',\n",
       "  'ns-398,',\n",
       "  'nimesulide',\n",
       "  'and',\n",
       "  'meloxicam).'],\n",
       " ['taken',\n",
       "  'together,',\n",
       "  'celecoxib',\n",
       "  'is',\n",
       "  'a',\n",
       "  'good',\n",
       "  'therapeutic',\n",
       "  'candidate',\n",
       "  'for',\n",
       "  'treating',\n",
       "  'oscc',\n",
       "  'through',\n",
       "  'the',\n",
       "  'suppression',\n",
       "  'of',\n",
       "  'cell',\n",
       "  'proliferation',\n",
       "  'and',\n",
       "  'the',\n",
       "  'induction',\n",
       "  'of',\n",
       "  'apoptosis',\n",
       "  'in',\n",
       "  'a',\n",
       "  'cox-2',\n",
       "  'independent',\n",
       "  'manner.'],\n",
       " ['from',\n",
       "  'the',\n",
       "  'cover:',\n",
       "  'whole-genome',\n",
       "  'association',\n",
       "  'study',\n",
       "  'identifies',\n",
       "  'stk39',\n",
       "  'as',\n",
       "  'a',\n",
       "  'hypertension',\n",
       "  'susceptibility',\n",
       "  'gene.'],\n",
       " ['recently',\n",
       "  'an',\n",
       "  'association',\n",
       "  'was',\n",
       "  'shown',\n",
       "  'between',\n",
       "  'the',\n",
       "  'single',\n",
       "  'nucleotide',\n",
       "  'polymorphism',\n",
       "  '(snp),',\n",
       "  'rs11209026,',\n",
       "  'within',\n",
       "  'the',\n",
       "  'interleukin-23',\n",
       "  'receptor',\n",
       "  '(il23r)',\n",
       "  'locus',\n",
       "  'and',\n",
       "  \"crohn's\",\n",
       "  'disease',\n",
       "  '(cd)',\n",
       "  'as',\n",
       "  'a',\n",
       "  'consequence',\n",
       "  'of',\n",
       "  'a',\n",
       "  'genome-wide',\n",
       "  'association',\n",
       "  'study',\n",
       "  'of',\n",
       "  'this',\n",
       "  'disease',\n",
       "  'in',\n",
       "  'adults.'],\n",
       " ['recently',\n",
       "  'an',\n",
       "  'association',\n",
       "  'was',\n",
       "  'shown',\n",
       "  'between',\n",
       "  'the',\n",
       "  'single',\n",
       "  'nucleotide',\n",
       "  'polymorphism',\n",
       "  '(snp),',\n",
       "  'rs11209026,',\n",
       "  'within',\n",
       "  'the',\n",
       "  'interleukin-23',\n",
       "  'receptor',\n",
       "  '(il23r)',\n",
       "  'locus',\n",
       "  'and',\n",
       "  \"crohn's\",\n",
       "  'disease',\n",
       "  '(cd)',\n",
       "  'as',\n",
       "  'a',\n",
       "  'consequence',\n",
       "  'of',\n",
       "  'a',\n",
       "  'genome-wide',\n",
       "  'association',\n",
       "  'study',\n",
       "  'of',\n",
       "  'this',\n",
       "  'disease',\n",
       "  'in',\n",
       "  'adults.'],\n",
       " ['recently',\n",
       "  'an',\n",
       "  'association',\n",
       "  'was',\n",
       "  'shown',\n",
       "  'between',\n",
       "  'the',\n",
       "  'single',\n",
       "  'nucleotide',\n",
       "  'polymorphism',\n",
       "  '(snp),',\n",
       "  'rs11209026,',\n",
       "  'within',\n",
       "  'the',\n",
       "  'interleukin-23',\n",
       "  'receptor',\n",
       "  '(il23r)',\n",
       "  'locus',\n",
       "  'and',\n",
       "  \"crohn's\",\n",
       "  'disease',\n",
       "  '(cd)',\n",
       "  'as',\n",
       "  'a',\n",
       "  'consequence',\n",
       "  'of',\n",
       "  'a',\n",
       "  'genome-wide',\n",
       "  'association',\n",
       "  'study',\n",
       "  'of',\n",
       "  'this',\n",
       "  'disease',\n",
       "  'in',\n",
       "  'adults.'],\n",
       " ['recently',\n",
       "  'an',\n",
       "  'association',\n",
       "  'was',\n",
       "  'shown',\n",
       "  'between',\n",
       "  'the',\n",
       "  'single',\n",
       "  'nucleotide',\n",
       "  'polymorphism',\n",
       "  '(snp),',\n",
       "  'rs11209026,',\n",
       "  'within',\n",
       "  'the',\n",
       "  'interleukin-23',\n",
       "  'receptor',\n",
       "  '(il23r)',\n",
       "  'locus',\n",
       "  'and',\n",
       "  \"crohn's\",\n",
       "  'disease',\n",
       "  '(cd)',\n",
       "  'as',\n",
       "  'a',\n",
       "  'consequence',\n",
       "  'of',\n",
       "  'a',\n",
       "  'genome-wide',\n",
       "  'association',\n",
       "  'study',\n",
       "  'of',\n",
       "  'this',\n",
       "  'disease',\n",
       "  'in',\n",
       "  'adults.'],\n",
       " ['by',\n",
       "  'using',\n",
       "  'data',\n",
       "  'from',\n",
       "  'our',\n",
       "  'ongoing',\n",
       "  'genome-wide',\n",
       "  'association',\n",
       "  'study',\n",
       "  'in',\n",
       "  'our',\n",
       "  'cohort',\n",
       "  'of',\n",
       "  '142',\n",
       "  'pediatric',\n",
       "  'cd',\n",
       "  'patients',\n",
       "  'and',\n",
       "  '281',\n",
       "  'matched',\n",
       "  'controls,',\n",
       "  'we',\n",
       "  'investigated',\n",
       "  'the',\n",
       "  'association',\n",
       "  'of',\n",
       "  'the',\n",
       "  'previously',\n",
       "  'reported',\n",
       "  'snps',\n",
       "  'at',\n",
       "  'the',\n",
       "  'il23r',\n",
       "  'locus',\n",
       "  'with',\n",
       "  'the',\n",
       "  'childhood',\n",
       "  'form',\n",
       "  'of',\n",
       "  'this',\n",
       "  'disease.'],\n",
       " ['as',\n",
       "  'such,',\n",
       "  'variants',\n",
       "  'in',\n",
       "  'the',\n",
       "  'il23r',\n",
       "  'gene',\n",
       "  'confer',\n",
       "  'a',\n",
       "  'similar',\n",
       "  'magnitude',\n",
       "  'of',\n",
       "  'risk',\n",
       "  'of',\n",
       "  'cd',\n",
       "  'to',\n",
       "  'children',\n",
       "  'as',\n",
       "  'for',\n",
       "  'their',\n",
       "  'adult',\n",
       "  'counterparts.'],\n",
       " ['the',\n",
       "  'or',\n",
       "  'of',\n",
       "  'the',\n",
       "  'il23r',\n",
       "  'variant',\n",
       "  'in',\n",
       "  'our',\n",
       "  'pediatric',\n",
       "  'study',\n",
       "  'is',\n",
       "  'highly',\n",
       "  'comparable',\n",
       "  'with',\n",
       "  'that',\n",
       "  'reported',\n",
       "  'previously',\n",
       "  'in',\n",
       "  'a',\n",
       "  'non-jewish',\n",
       "  'adult',\n",
       "  'inflammatory',\n",
       "  'bowel',\n",
       "  'disease',\n",
       "  'case-control',\n",
       "  'cohort',\n",
       "  '(or,',\n",
       "  '0.26).'],\n",
       " ['association',\n",
       "  'of',\n",
       "  'variants',\n",
       "  'of',\n",
       "  'the',\n",
       "  'interleukin-23',\n",
       "  'receptor',\n",
       "  'gene',\n",
       "  'with',\n",
       "  'susceptibility',\n",
       "  'to',\n",
       "  'pediatric',\n",
       "  \"crohn's\",\n",
       "  'disease.'],\n",
       " ['variations',\n",
       "  'in',\n",
       "  'the',\n",
       "  'interleukin-1',\n",
       "  'receptor',\n",
       "  'antagonist',\n",
       "  'gene',\n",
       "  'impact',\n",
       "  'on',\n",
       "  'survival',\n",
       "  'of',\n",
       "  'patients',\n",
       "  'with',\n",
       "  'advanced',\n",
       "  'colorectal',\n",
       "  'cancer.'],\n",
       " ['the',\n",
       "  'interleukin-1',\n",
       "  'receptor',\n",
       "  'antagonist',\n",
       "  '(il-1ra)',\n",
       "  'cytokine',\n",
       "  'is',\n",
       "  'thought',\n",
       "  'to',\n",
       "  'counteract',\n",
       "  'tumor',\n",
       "  'angiogenesis/metastasis.'],\n",
       " ['the',\n",
       "  'interleukin-1',\n",
       "  'receptor',\n",
       "  'antagonist',\n",
       "  '(il-1ra)',\n",
       "  'cytokine',\n",
       "  'is',\n",
       "  'thought',\n",
       "  'to',\n",
       "  'counteract',\n",
       "  'tumor',\n",
       "  'angiogenesis/metastasis.'],\n",
       " ['a',\n",
       "  'total',\n",
       "  'of',\n",
       "  '180',\n",
       "  'patients',\n",
       "  'with',\n",
       "  'metastatic',\n",
       "  'colorectal',\n",
       "  'cancer',\n",
       "  'were',\n",
       "  'categorized',\n",
       "  'as',\n",
       "  'high',\n",
       "  'il-1ra',\n",
       "  'producers',\n",
       "  'if',\n",
       "  'they',\n",
       "  'were',\n",
       "  'carriers',\n",
       "  'of',\n",
       "  'at',\n",
       "  'least',\n",
       "  'one',\n",
       "  'of',\n",
       "  'the',\n",
       "  'rs4251961',\n",
       "  't/t',\n",
       "  'or',\n",
       "  'rs579543',\n",
       "  't/t',\n",
       "  'genotypes',\n",
       "  '(t/t',\n",
       "  'carriers).'],\n",
       " ['a',\n",
       "  'total',\n",
       "  'of',\n",
       "  '180',\n",
       "  'patients',\n",
       "  'with',\n",
       "  'metastatic',\n",
       "  'colorectal',\n",
       "  'cancer',\n",
       "  'were',\n",
       "  'categorized',\n",
       "  'as',\n",
       "  'high',\n",
       "  'il-1ra',\n",
       "  'producers',\n",
       "  'if',\n",
       "  'they',\n",
       "  'were',\n",
       "  'carriers',\n",
       "  'of',\n",
       "  'at',\n",
       "  'least',\n",
       "  'one',\n",
       "  'of',\n",
       "  'the',\n",
       "  'rs4251961',\n",
       "  't/t',\n",
       "  'or',\n",
       "  'rs579543',\n",
       "  't/t',\n",
       "  'genotypes',\n",
       "  '(t/t',\n",
       "  'carriers).'],\n",
       " ['a',\n",
       "  'total',\n",
       "  'of',\n",
       "  '180',\n",
       "  'patients',\n",
       "  'with',\n",
       "  'metastatic',\n",
       "  'colorectal',\n",
       "  'cancer',\n",
       "  'were',\n",
       "  'categorized',\n",
       "  'as',\n",
       "  'high',\n",
       "  'il-1ra',\n",
       "  'producers',\n",
       "  'if',\n",
       "  'they',\n",
       "  'were',\n",
       "  'carriers',\n",
       "  'of',\n",
       "  'at',\n",
       "  'least',\n",
       "  'one',\n",
       "  'of',\n",
       "  'the',\n",
       "  'rs4251961',\n",
       "  't/t',\n",
       "  'or',\n",
       "  'rs579543',\n",
       "  't/t',\n",
       "  'genotypes',\n",
       "  '(t/t',\n",
       "  'carriers).'],\n",
       " ['vitamin',\n",
       "  'd',\n",
       "  'receptor',\n",
       "  '(vdr)',\n",
       "  'genotypes',\n",
       "  'may',\n",
       "  'influence',\n",
       "  'cancer',\n",
       "  'risk;',\n",
       "  'however,',\n",
       "  'no',\n",
       "  'epidemiological',\n",
       "  'studies',\n",
       "  'in',\n",
       "  'sporadic',\n",
       "  'breast',\n",
       "  'cancer',\n",
       "  '(bc)',\n",
       "  'or',\n",
       "  'malignant',\n",
       "  'melanoma',\n",
       "  '(mm)',\n",
       "  'have',\n",
       "  'been',\n",
       "  'performed',\n",
       "  'in',\n",
       "  'a',\n",
       "  'southern',\n",
       "  'european',\n",
       "  'population.'],\n",
       " ['vitamin',\n",
       "  'd',\n",
       "  'receptor',\n",
       "  '(vdr)',\n",
       "  'genotypes',\n",
       "  'may',\n",
       "  'influence',\n",
       "  'cancer',\n",
       "  'risk;',\n",
       "  'however,',\n",
       "  'no',\n",
       "  'epidemiological',\n",
       "  'studies',\n",
       "  'in',\n",
       "  'sporadic',\n",
       "  'breast',\n",
       "  'cancer',\n",
       "  '(bc)',\n",
       "  'or',\n",
       "  'malignant',\n",
       "  'melanoma',\n",
       "  '(mm)',\n",
       "  'have',\n",
       "  'been',\n",
       "  'performed',\n",
       "  'in',\n",
       "  'a',\n",
       "  'southern',\n",
       "  'european',\n",
       "  'population.'],\n",
       " ['vitamin',\n",
       "  'd',\n",
       "  'receptor',\n",
       "  '(vdr)',\n",
       "  'genotypes',\n",
       "  'may',\n",
       "  'influence',\n",
       "  'cancer',\n",
       "  'risk;',\n",
       "  'however,',\n",
       "  'no',\n",
       "  'epidemiological',\n",
       "  'studies',\n",
       "  'in',\n",
       "  'sporadic',\n",
       "  'breast',\n",
       "  'cancer',\n",
       "  '(bc)',\n",
       "  'or',\n",
       "  'malignant',\n",
       "  'melanoma',\n",
       "  '(mm)',\n",
       "  'have',\n",
       "  'been',\n",
       "  'performed',\n",
       "  'in',\n",
       "  'a',\n",
       "  'southern',\n",
       "  'european',\n",
       "  'population.'],\n",
       " ['the',\n",
       "  'synonymous',\n",
       "  'variant',\n",
       "  'rs731236',\n",
       "  '(taqi)',\n",
       "  'appeared',\n",
       "  'to',\n",
       "  'be',\n",
       "  'associated',\n",
       "  'with',\n",
       "  'protection',\n",
       "  'from',\n",
       "  'bc',\n",
       "  '(or',\n",
       "  '=',\n",
       "  '0.80,',\n",
       "  '95%ci',\n",
       "  '=',\n",
       "  '0.64-0.99;',\n",
       "  'p',\n",
       "  '=',\n",
       "  '0.047).'],\n",
       " ['vitamin',\n",
       "  'd',\n",
       "  'receptor',\n",
       "  '(vdr)',\n",
       "  'genotypes',\n",
       "  'may',\n",
       "  'influence',\n",
       "  'cancer',\n",
       "  'risk;',\n",
       "  'however,',\n",
       "  'no',\n",
       "  'epidemiological',\n",
       "  'studies',\n",
       "  'in',\n",
       "  'sporadic',\n",
       "  'breast',\n",
       "  'cancer',\n",
       "  '(bc)',\n",
       "  'or',\n",
       "  'malignant',\n",
       "  'melanoma',\n",
       "  '(mm)',\n",
       "  'have',\n",
       "  'been',\n",
       "  'performed',\n",
       "  'in',\n",
       "  'a',\n",
       "  'southern',\n",
       "  'european',\n",
       "  'population.'],\n",
       " ['vitamin',\n",
       "  'd',\n",
       "  'receptor',\n",
       "  '(vdr)',\n",
       "  'genotypes',\n",
       "  'may',\n",
       "  'influence',\n",
       "  'cancer',\n",
       "  'risk;',\n",
       "  'however,',\n",
       "  'no',\n",
       "  'epidemiological',\n",
       "  'studies',\n",
       "  'in',\n",
       "  'sporadic',\n",
       "  'breast',\n",
       "  'cancer',\n",
       "  '(bc)',\n",
       "  'or',\n",
       "  'malignant',\n",
       "  'melanoma',\n",
       "  '(mm)',\n",
       "  'have',\n",
       "  'been',\n",
       "  'performed',\n",
       "  'in',\n",
       "  'a',\n",
       "  'southern',\n",
       "  'european',\n",
       "  'population.'],\n",
       " ['in',\n",
       "  'summary,',\n",
       "  'we',\n",
       "  'observed',\n",
       "  'associations',\n",
       "  'between',\n",
       "  'snps',\n",
       "  'in',\n",
       "  'the',\n",
       "  'vdr',\n",
       "  'gene',\n",
       "  'and',\n",
       "  'bc',\n",
       "  'risk,',\n",
       "  'and',\n",
       "  'a',\n",
       "  'comprehensive',\n",
       "  'analysis',\n",
       "  'using',\n",
       "  'clinical',\n",
       "  'and',\n",
       "  'tumour',\n",
       "  'characteristics',\n",
       "  'as',\n",
       "  'outcome',\n",
       "  'variables',\n",
       "  'has',\n",
       "  'revealed',\n",
       "  'potential',\n",
       "  'associations',\n",
       "  'with',\n",
       "  'mm.'],\n",
       " ['an',\n",
       "  'association',\n",
       "  'with',\n",
       "  'the',\n",
       "  'minor',\n",
       "  'allele',\n",
       "  'a',\n",
       "  'of',\n",
       "  'the',\n",
       "  'non-synonymous',\n",
       "  'snp',\n",
       "  'rs2228570',\n",
       "  '(rs10735810,',\n",
       "  'foki,',\n",
       "  'met1thr)',\n",
       "  'was',\n",
       "  'observed',\n",
       "  'for',\n",
       "  'bc,',\n",
       "  'with',\n",
       "  'an',\n",
       "  'estimated',\n",
       "  'odds',\n",
       "  'ratio',\n",
       "  '(or)',\n",
       "  'of',\n",
       "  '1.26',\n",
       "  '(95%',\n",
       "  'ci',\n",
       "  '=',\n",
       "  '1.02-1.57;',\n",
       "  'p',\n",
       "  '=',\n",
       "  '0.036).'],\n",
       " ['an',\n",
       "  'association',\n",
       "  'with',\n",
       "  'the',\n",
       "  'minor',\n",
       "  'allele',\n",
       "  'a',\n",
       "  'of',\n",
       "  'the',\n",
       "  'non-synonymous',\n",
       "  'snp',\n",
       "  'rs2228570',\n",
       "  '(rs10735810,',\n",
       "  'foki,',\n",
       "  'met1thr)',\n",
       "  'was',\n",
       "  'observed',\n",
       "  'for',\n",
       "  'bc,',\n",
       "  'with',\n",
       "  'an',\n",
       "  'estimated',\n",
       "  'odds',\n",
       "  'ratio',\n",
       "  '(or)',\n",
       "  'of',\n",
       "  '1.26',\n",
       "  '(95%',\n",
       "  'ci',\n",
       "  '=',\n",
       "  '1.02-1.57;',\n",
       "  'p',\n",
       "  '=',\n",
       "  '0.036).'],\n",
       " ['in',\n",
       "  'summary,',\n",
       "  'we',\n",
       "  'observed',\n",
       "  'associations',\n",
       "  'between',\n",
       "  'snps',\n",
       "  'in',\n",
       "  'the',\n",
       "  'vdr',\n",
       "  'gene',\n",
       "  'and',\n",
       "  'bc',\n",
       "  'risk,',\n",
       "  'and',\n",
       "  'a',\n",
       "  'comprehensive',\n",
       "  'analysis',\n",
       "  'using',\n",
       "  'clinical',\n",
       "  'and',\n",
       "  'tumour',\n",
       "  'characteristics',\n",
       "  'as',\n",
       "  'outcome',\n",
       "  'variables',\n",
       "  'has',\n",
       "  'revealed',\n",
       "  'potential',\n",
       "  'associations',\n",
       "  'with',\n",
       "  'mm.'],\n",
       " ['a',\n",
       "  'common',\n",
       "  'snp',\n",
       "  'upstream',\n",
       "  'of',\n",
       "  'the',\n",
       "  'insig2',\n",
       "  'gene,',\n",
       "  'rs7566605',\n",
       "  '(g.-10,1025g>c,',\n",
       "  'chr2:118,552,255,',\n",
       "  'nt_022135.15),',\n",
       "  'was',\n",
       "  'reported',\n",
       "  'to',\n",
       "  'be',\n",
       "  'associated',\n",
       "  'with',\n",
       "  'obesity',\n",
       "  '(body',\n",
       "  'mass',\n",
       "  'index,',\n",
       "  '[bmi])',\n",
       "  'in',\n",
       "  'a',\n",
       "  'genome-wide',\n",
       "  'association',\n",
       "  'scan',\n",
       "  'using',\n",
       "  'the',\n",
       "  'framingham',\n",
       "  'heart',\n",
       "  'study',\n",
       "  'but',\n",
       "  'has',\n",
       "  'not',\n",
       "  'been',\n",
       "  'reproduced',\n",
       "  'in',\n",
       "  'other',\n",
       "  'cohorts.'],\n",
       " ['a',\n",
       "  'common',\n",
       "  'snp',\n",
       "  'upstream',\n",
       "  'of',\n",
       "  'the',\n",
       "  'insig2',\n",
       "  'gene,',\n",
       "  'rs7566605',\n",
       "  '(g.-10,1025g>c,',\n",
       "  'chr2:118,552,255,',\n",
       "  'nt_022135.15),',\n",
       "  'was',\n",
       "  'reported',\n",
       "  'to',\n",
       "  'be',\n",
       "  'associated',\n",
       "  'with',\n",
       "  'obesity',\n",
       "  '(body',\n",
       "  'mass',\n",
       "  'index,',\n",
       "  '[bmi])',\n",
       "  'in',\n",
       "  'a',\n",
       "  'genome-wide',\n",
       "  'association',\n",
       "  'scan',\n",
       "  'using',\n",
       "  'the',\n",
       "  'framingham',\n",
       "  'heart',\n",
       "  'study',\n",
       "  'but',\n",
       "  'has',\n",
       "  'not',\n",
       "  'been',\n",
       "  'reproduced',\n",
       "  'in',\n",
       "  'other',\n",
       "  'cohorts.'],\n",
       " ['this',\n",
       "  'supports',\n",
       "  'and',\n",
       "  'extends',\n",
       "  'the',\n",
       "  'original',\n",
       "  'finding',\n",
       "  'that',\n",
       "  'there',\n",
       "  'is',\n",
       "  'an',\n",
       "  'association',\n",
       "  'between',\n",
       "  'measures',\n",
       "  'of',\n",
       "  'obesity',\n",
       "  'and',\n",
       "  'insig2',\n",
       "  'rs7566605',\n",
       "  'and',\n",
       "  'further',\n",
       "  'implicates',\n",
       "  'this',\n",
       "  'polymorphism',\n",
       "  'in',\n",
       "  'fat',\n",
       "  'regulation.'],\n",
       " ['our',\n",
       "  'results',\n",
       "  'show',\n",
       "  'that',\n",
       "  'the',\n",
       "  'insig2',\n",
       "  'rs7566605',\n",
       "  'polymorphism',\n",
       "  'underlies',\n",
       "  'variation',\n",
       "  'in',\n",
       "  'subcutaneous',\n",
       "  'adiposity',\n",
       "  'in',\n",
       "  'young',\n",
       "  'adult',\n",
       "  'women',\n",
       "  'and',\n",
       "  'suppresses',\n",
       "  'the',\n",
       "  'positive',\n",
       "  'effects',\n",
       "  'of',\n",
       "  'resistance',\n",
       "  'training',\n",
       "  'on',\n",
       "  'men.'],\n",
       " ['our',\n",
       "  'previous',\n",
       "  'study',\n",
       "  'demonstrated',\n",
       "  'that',\n",
       "  'expression',\n",
       "  'of',\n",
       "  'hcnppp',\n",
       "  'mrna',\n",
       "  'was',\n",
       "  'decreased',\n",
       "  'in',\n",
       "  'the',\n",
       "  'hippocampi',\n",
       "  'of',\n",
       "  'autopsied',\n",
       "  'brains',\n",
       "  'of',\n",
       "  \"alzheimer's\",\n",
       "  'disease',\n",
       "  '(ad)',\n",
       "  'patients,',\n",
       "  'indicating',\n",
       "  'the',\n",
       "  'association',\n",
       "  'of',\n",
       "  'hcnp',\n",
       "  'with',\n",
       "  'the',\n",
       "  'pathogenesis',\n",
       "  'of',\n",
       "  'ad.'],\n",
       " ['our',\n",
       "  'previous',\n",
       "  'study',\n",
       "  'demonstrated',\n",
       "  'that',\n",
       "  'expression',\n",
       "  'of',\n",
       "  'hcnppp',\n",
       "  'mrna',\n",
       "  'was',\n",
       "  'decreased',\n",
       "  'in',\n",
       "  'the',\n",
       "  'hippocampi',\n",
       "  'of',\n",
       "  'autopsied',\n",
       "  'brains',\n",
       "  'of',\n",
       "  \"alzheimer's\",\n",
       "  'disease',\n",
       "  '(ad)',\n",
       "  'patients,',\n",
       "  'indicating',\n",
       "  'the',\n",
       "  'association',\n",
       "  'of',\n",
       "  'hcnp',\n",
       "  'with',\n",
       "  'the',\n",
       "  'pathogenesis',\n",
       "  'of',\n",
       "  'ad.'],\n",
       " ['to',\n",
       "  'clarify',\n",
       "  'the',\n",
       "  'involvement',\n",
       "  'of',\n",
       "  'gene',\n",
       "  'variations',\n",
       "  'in',\n",
       "  'the',\n",
       "  'promoter',\n",
       "  'region',\n",
       "  'of',\n",
       "  'the',\n",
       "  'gene',\n",
       "  'encoding',\n",
       "  'hcnppp',\n",
       "  'in',\n",
       "  'this',\n",
       "  'mrna',\n",
       "  'reduction,',\n",
       "  'we',\n",
       "  'analyzed',\n",
       "  'dna',\n",
       "  'polymorphisms',\n",
       "  'or',\n",
       "  'mutations',\n",
       "  'within',\n",
       "  'this',\n",
       "  'gene',\n",
       "  'promoter',\n",
       "  'region',\n",
       "  'in',\n",
       "  'ad',\n",
       "  'patients',\n",
       "  'by',\n",
       "  'direct',\n",
       "  'sequencing.'],\n",
       " ['our',\n",
       "  'previous',\n",
       "  'study',\n",
       "  'demonstrated',\n",
       "  'that',\n",
       "  'expression',\n",
       "  'of',\n",
       "  'hcnppp',\n",
       "  'mrna',\n",
       "  'was',\n",
       "  'decreased',\n",
       "  'in',\n",
       "  'the',\n",
       "  'hippocampi',\n",
       "  'of',\n",
       "  'autopsied',\n",
       "  'brains',\n",
       "  'of',\n",
       "  \"alzheimer's\",\n",
       "  'disease',\n",
       "  '(ad)',\n",
       "  'patients,',\n",
       "  'indicating',\n",
       "  'the',\n",
       "  'association',\n",
       "  'of',\n",
       "  'hcnp',\n",
       "  'with',\n",
       "  'the',\n",
       "  'pathogenesis',\n",
       "  'of',\n",
       "  'ad.'],\n",
       " ['our',\n",
       "  'previous',\n",
       "  'study',\n",
       "  'demonstrated',\n",
       "  'that',\n",
       "  'expression',\n",
       "  'of',\n",
       "  'hcnppp',\n",
       "  'mrna',\n",
       "  'was',\n",
       "  'decreased',\n",
       "  'in',\n",
       "  'the',\n",
       "  'hippocampi',\n",
       "  'of',\n",
       "  'autopsied',\n",
       "  'brains',\n",
       "  'of',\n",
       "  \"alzheimer's\",\n",
       "  'disease',\n",
       "  '(ad)',\n",
       "  'patients,',\n",
       "  'indicating',\n",
       "  'the',\n",
       "  'association',\n",
       "  'of',\n",
       "  'hcnp',\n",
       "  'with',\n",
       "  'the',\n",
       "  'pathogenesis',\n",
       "  'of',\n",
       "  'ad.'],\n",
       " ['the',\n",
       "  'k121q',\n",
       "  'polymorphism',\n",
       "  'in',\n",
       "  'the',\n",
       "  'ectonucleotide',\n",
       "  'pyrophosphatase/phosphodiesterase',\n",
       "  '(enpp)-1',\n",
       "  'gene',\n",
       "  'and',\n",
       "  'the',\n",
       "  'rs7566605',\n",
       "  'genotype',\n",
       "  'located',\n",
       "  'near',\n",
       "  'insulin-induced',\n",
       "  'gene',\n",
       "  '2',\n",
       "  'have',\n",
       "  'been',\n",
       "  'shown',\n",
       "  'to',\n",
       "  'be',\n",
       "  'associated',\n",
       "  'with',\n",
       "  'insulin',\n",
       "  'resistance',\n",
       "  'and',\n",
       "  'obesity.'],\n",
       " ['the',\n",
       "  'k121q',\n",
       "  'polymorphism',\n",
       "  'in',\n",
       "  'the',\n",
       "  'ectonucleotide',\n",
       "  'pyrophosphatase/phosphodiesterase',\n",
       "  '(enpp)-1',\n",
       "  'gene',\n",
       "  'and',\n",
       "  'the',\n",
       "  'rs7566605',\n",
       "  'genotype',\n",
       "  'located',\n",
       "  'near',\n",
       "  'insulin-induced',\n",
       "  'gene',\n",
       "  '2',\n",
       "  'have',\n",
       "  'been',\n",
       "  'shown',\n",
       "  'to',\n",
       "  'be',\n",
       "  'associated',\n",
       "  'with',\n",
       "  'insulin',\n",
       "  'resistance',\n",
       "  'and',\n",
       "  'obesity.'],\n",
       " ['association',\n",
       "  'of',\n",
       "  'a',\n",
       "  'genetic',\n",
       "  'polymorphism',\n",
       "  'in',\n",
       "  'ectonucleotide',\n",
       "  'pyrophosphatase/phosphodiesterase',\n",
       "  '1',\n",
       "  'with',\n",
       "  'hepatitis',\n",
       "  'c',\n",
       "  'virus',\n",
       "  'infection',\n",
       "  'and',\n",
       "  'hepatitis',\n",
       "  'c',\n",
       "  'virus',\n",
       "  'core',\n",
       "  'antigen',\n",
       "  'levels',\n",
       "  'in',\n",
       "  'subjects',\n",
       "  'in',\n",
       "  'a',\n",
       "  'hyperendemic',\n",
       "  'area',\n",
       "  'of',\n",
       "  'japan.'],\n",
       " ['in',\n",
       "  'contrast,',\n",
       "  'the',\n",
       "  'rs7566605',\n",
       "  'genotype',\n",
       "  'was',\n",
       "  'not',\n",
       "  'associated',\n",
       "  'with',\n",
       "  'hepatitis',\n",
       "  'c',\n",
       "  'viremia',\n",
       "  'or',\n",
       "  'with',\n",
       "  'the',\n",
       "  'hcv',\n",
       "  'core',\n",
       "  'antigen',\n",
       "  'level.'],\n",
       " ['the',\n",
       "  'k121q',\n",
       "  'variant',\n",
       "  'of',\n",
       "  'enpp1',\n",
       "  'may',\n",
       "  'be',\n",
       "  'associated',\n",
       "  'with',\n",
       "  'hepatitis',\n",
       "  'c',\n",
       "  'viremia',\n",
       "  'and',\n",
       "  'core',\n",
       "  'antigen',\n",
       "  'levels',\n",
       "  'in',\n",
       "  'hcv',\n",
       "  'carriers.'],\n",
       " ['the',\n",
       "  'k121q',\n",
       "  'polymorphism',\n",
       "  'in',\n",
       "  'the',\n",
       "  'ectonucleotide',\n",
       "  'pyrophosphatase/phosphodiesterase',\n",
       "  '(enpp)-1',\n",
       "  'gene',\n",
       "  'and',\n",
       "  'the',\n",
       "  'rs7566605',\n",
       "  'genotype',\n",
       "  'located',\n",
       "  'near',\n",
       "  'insulin-induced',\n",
       "  'gene',\n",
       "  '2',\n",
       "  'have',\n",
       "  'been',\n",
       "  'shown',\n",
       "  'to',\n",
       "  'be',\n",
       "  'associated',\n",
       "  'with',\n",
       "  'insulin',\n",
       "  'resistance',\n",
       "  'and',\n",
       "  'obesity.'],\n",
       " ['the',\n",
       "  'k121q',\n",
       "  'polymorphism',\n",
       "  'in',\n",
       "  'the',\n",
       "  'ectonucleotide',\n",
       "  'pyrophosphatase/phosphodiesterase',\n",
       "  '(enpp)-1',\n",
       "  'gene',\n",
       "  'and',\n",
       "  'the',\n",
       "  'rs7566605',\n",
       "  'genotype',\n",
       "  'located',\n",
       "  'near',\n",
       "  'insulin-induced',\n",
       "  'gene',\n",
       "  '2',\n",
       "  'have',\n",
       "  'been',\n",
       "  'shown',\n",
       "  'to',\n",
       "  'be',\n",
       "  'associated',\n",
       "  'with',\n",
       "  'insulin',\n",
       "  'resistance',\n",
       "  'and',\n",
       "  'obesity.'],\n",
       " ['this',\n",
       "  'study',\n",
       "  'examined',\n",
       "  'whether',\n",
       "  'the',\n",
       "  'k121q',\n",
       "  'polymorphism',\n",
       "  'in',\n",
       "  'enpp1',\n",
       "  'or',\n",
       "  'the',\n",
       "  'rs7566605',\n",
       "  'genotype',\n",
       "  'is',\n",
       "  'associated',\n",
       "  'with',\n",
       "  'the',\n",
       "  'clinical',\n",
       "  'course',\n",
       "  'of',\n",
       "  'hcv',\n",
       "  'infection.'],\n",
       " ['this',\n",
       "  'study',\n",
       "  'examined',\n",
       "  'whether',\n",
       "  'the',\n",
       "  'k121q',\n",
       "  'polymorphism',\n",
       "  'in',\n",
       "  'enpp1',\n",
       "  'or',\n",
       "  'the',\n",
       "  'rs7566605',\n",
       "  'genotype',\n",
       "  'is',\n",
       "  'associated',\n",
       "  'with',\n",
       "  'the',\n",
       "  'clinical',\n",
       "  'course',\n",
       "  'of',\n",
       "  'hcv',\n",
       "  'infection.'],\n",
       " ['this',\n",
       "  'study',\n",
       "  'examined',\n",
       "  'whether',\n",
       "  'the',\n",
       "  'k121q',\n",
       "  'polymorphism',\n",
       "  'in',\n",
       "  'enpp1',\n",
       "  'or',\n",
       "  'the',\n",
       "  'rs7566605',\n",
       "  'genotype',\n",
       "  'is',\n",
       "  'associated',\n",
       "  'with',\n",
       "  'the',\n",
       "  'clinical',\n",
       "  'course',\n",
       "  'of',\n",
       "  'hcv',\n",
       "  'infection.'],\n",
       " ['the',\n",
       "  'k121q',\n",
       "  'polymorphism',\n",
       "  'in',\n",
       "  'the',\n",
       "  'ectonucleotide',\n",
       "  'pyrophosphatase/phosphodiesterase',\n",
       "  '(enpp)-1',\n",
       "  'gene',\n",
       "  'and',\n",
       "  'the',\n",
       "  'rs7566605',\n",
       "  'genotype',\n",
       "  'located',\n",
       "  'near',\n",
       "  'insulin-induced',\n",
       "  'gene',\n",
       "  '2',\n",
       "  'have',\n",
       "  'been',\n",
       "  'shown',\n",
       "  'to',\n",
       "  'be',\n",
       "  'associated',\n",
       "  'with',\n",
       "  'insulin',\n",
       "  'resistance',\n",
       "  'and',\n",
       "  'obesity.'],\n",
       " ['the',\n",
       "  'k121q',\n",
       "  'variant',\n",
       "  'of',\n",
       "  'enpp1',\n",
       "  'may',\n",
       "  'be',\n",
       "  'associated',\n",
       "  'with',\n",
       "  'hepatitis',\n",
       "  'c',\n",
       "  'viremia',\n",
       "  'and',\n",
       "  'core',\n",
       "  'antigen',\n",
       "  'levels',\n",
       "  'in',\n",
       "  'hcv',\n",
       "  'carriers.'],\n",
       " ['the',\n",
       "  'k121q',\n",
       "  'polymorphism',\n",
       "  'in',\n",
       "  'the',\n",
       "  'ectonucleotide',\n",
       "  'pyrophosphatase/phosphodiesterase',\n",
       "  '(enpp)-1',\n",
       "  'gene',\n",
       "  'and',\n",
       "  'the',\n",
       "  'rs7566605',\n",
       "  'genotype',\n",
       "  'located',\n",
       "  'near',\n",
       "  'insulin-induced',\n",
       "  'gene',\n",
       "  '2',\n",
       "  'have',\n",
       "  'been',\n",
       "  'shown',\n",
       "  'to',\n",
       "  'be',\n",
       "  'associated',\n",
       "  'with',\n",
       "  'insulin',\n",
       "  'resistance',\n",
       "  'and',\n",
       "  'obesity.'],\n",
       " ['finally,',\n",
       "  'we',\n",
       "  'tested',\n",
       "  'il-10',\n",
       "  'production',\n",
       "  'in',\n",
       "  'peripheral',\n",
       "  'blood',\n",
       "  'mononuclear',\n",
       "  'cells',\n",
       "  'stimulated',\n",
       "  'with',\n",
       "  'mycobacterium',\n",
       "  'leprae',\n",
       "  'antigens',\n",
       "  'and',\n",
       "  'found',\n",
       "  'that',\n",
       "  '-819t',\n",
       "  'carriers',\n",
       "  'produced',\n",
       "  'lower',\n",
       "  'levels',\n",
       "  'of',\n",
       "  'il-10',\n",
       "  'when',\n",
       "  'compared',\n",
       "  'with',\n",
       "  'non-carriers.'],\n",
       " ['taken',\n",
       "  'together,',\n",
       "  'these',\n",
       "  'data',\n",
       "  'suggest',\n",
       "  'that',\n",
       "  'low',\n",
       "  'levels',\n",
       "  'of',\n",
       "  'il-10',\n",
       "  'during',\n",
       "  'the',\n",
       "  'disease',\n",
       "  'outcome',\n",
       "  'can',\n",
       "  'drive',\n",
       "  'patients',\n",
       "  'to',\n",
       "  'a',\n",
       "  'chronic',\n",
       "  'and',\n",
       "  'unprotective',\n",
       "  'response',\n",
       "  'that',\n",
       "  'culminates',\n",
       "  'with',\n",
       "  'leprosy.'],\n",
       " ['genetic,',\n",
       "  'epidemiological',\n",
       "  'and',\n",
       "  'biological',\n",
       "  'analysis',\n",
       "  'of',\n",
       "  'interleukin-10',\n",
       "  'promoter',\n",
       "  'single-nucleotide',\n",
       "  'polymorphisms',\n",
       "  'suggests',\n",
       "  'a',\n",
       "  'definitive',\n",
       "  'role',\n",
       "  'for',\n",
       "  '-819c/t',\n",
       "  'in',\n",
       "  'leprosy',\n",
       "  'susceptibility.'],\n",
       " ['here,',\n",
       "  'we',\n",
       "  'combined',\n",
       "  'a',\n",
       "  'case-control',\n",
       "  'study',\n",
       "  '(374',\n",
       "  'patients',\n",
       "  'and',\n",
       "  '380',\n",
       "  'controls),',\n",
       "  'with',\n",
       "  'meta-analysis',\n",
       "  '(5',\n",
       "  'studies;',\n",
       "  '2702',\n",
       "  'individuals)',\n",
       "  'and',\n",
       "  'biological',\n",
       "  'study',\n",
       "  'to',\n",
       "  'test',\n",
       "  'the',\n",
       "  'epidemiological',\n",
       "  'and',\n",
       "  'physiological',\n",
       "  'relevance',\n",
       "  'of',\n",
       "  'the',\n",
       "  'interleukin-10',\n",
       "  '(il-10)',\n",
       "  'genetic',\n",
       "  'markers',\n",
       "  'in',\n",
       "  'leprosy.'],\n",
       " ['genetic,',\n",
       "  'epidemiological',\n",
       "  'and',\n",
       "  'biological',\n",
       "  'analysis',\n",
       "  'of',\n",
       "  'interleukin-10',\n",
       "  'promoter',\n",
       "  'single-nucleotide',\n",
       "  'polymorphisms',\n",
       "  'suggests',\n",
       "  'a',\n",
       "  'definitive',\n",
       "  'role',\n",
       "  'for',\n",
       "  '-819c/t',\n",
       "  'in',\n",
       "  'leprosy',\n",
       "  'susceptibility.'],\n",
       " ['haplotypes',\n",
       "  'combining',\n",
       "  'promoter',\n",
       "  'single-nucleotide',\n",
       "  'polymorphisms',\n",
       "  'also',\n",
       "  'implicated',\n",
       "  'a',\n",
       "  'haplotype',\n",
       "  'carrying',\n",
       "  'the',\n",
       "  '-819t',\n",
       "  'allele',\n",
       "  'in',\n",
       "  'leprosy',\n",
       "  'susceptibility',\n",
       "  '(odds',\n",
       "  'ratio',\n",
       "  '(or)=1.40;',\n",
       "  'p=0.01).'],\n",
       " ['finally,',\n",
       "  'we',\n",
       "  'tested',\n",
       "  'il-10',\n",
       "  'production',\n",
       "  'in',\n",
       "  'peripheral',\n",
       "  'blood',\n",
       "  'mononuclear',\n",
       "  'cells',\n",
       "  'stimulated',\n",
       "  'with',\n",
       "  'mycobacterium',\n",
       "  'leprae',\n",
       "  'antigens',\n",
       "  'and',\n",
       "  'found',\n",
       "  'that',\n",
       "  '-819t',\n",
       "  'carriers',\n",
       "  'produced',\n",
       "  'lower',\n",
       "  'levels',\n",
       "  'of',\n",
       "  'il-10',\n",
       "  'when',\n",
       "  'compared',\n",
       "  'with',\n",
       "  'non-carriers.'],\n",
       " ['we',\n",
       "  'observed',\n",
       "  'that',\n",
       "  'the',\n",
       "  '-819t',\n",
       "  'allele',\n",
       "  'is',\n",
       "  'associated',\n",
       "  'with',\n",
       "  'leprosy',\n",
       "  'susceptibility',\n",
       "  'either',\n",
       "  'in',\n",
       "  'the',\n",
       "  'case-control',\n",
       "  'or',\n",
       "  'in',\n",
       "  'the',\n",
       "  'meta-analysis',\n",
       "  'studies.'],\n",
       " ['the',\n",
       "  'implicated',\n",
       "  'loxl1',\n",
       "  'polymorphisms',\n",
       "  'have',\n",
       "  'not',\n",
       "  'been',\n",
       "  'associated',\n",
       "  'with',\n",
       "  'primary',\n",
       "  'open-angle',\n",
       "  'glaucoma',\n",
       "  '(poag).'],\n",
       " ['individual',\n",
       "  'loxl1',\n",
       "  'snps,',\n",
       "  'rs1048661,',\n",
       "  'rs3825942,',\n",
       "  'and',\n",
       "  'rs2165241,',\n",
       "  'were',\n",
       "  'not',\n",
       "  'associated',\n",
       "  'with',\n",
       "  'poag',\n",
       "  'in',\n",
       "  'the',\n",
       "  'chinese',\n",
       "  'population.'],\n",
       " ['the',\n",
       "  'lysyl',\n",
       "  'oxidase-like',\n",
       "  'protein',\n",
       "  '1',\n",
       "  '(loxl1)',\n",
       "  'gene',\n",
       "  'is',\n",
       "  'strongly',\n",
       "  'associated',\n",
       "  'with',\n",
       "  'exfoliation',\n",
       "  'glaucoma,',\n",
       "  'which',\n",
       "  'is',\n",
       "  'very',\n",
       "  'rare',\n",
       "  'in',\n",
       "  'the',\n",
       "  'chinese',\n",
       "  'population.'],\n",
       " ['the',\n",
       "  'low',\n",
       "  'frequencies',\n",
       "  'of',\n",
       "  'the',\n",
       "  'at-risk',\n",
       "  'alleles',\n",
       "  'at',\n",
       "  'rs1048661',\n",
       "  'and',\n",
       "  'rs2165241',\n",
       "  'may',\n",
       "  'be',\n",
       "  'one',\n",
       "  'of',\n",
       "  'the',\n",
       "  'factors',\n",
       "  'that',\n",
       "  'led',\n",
       "  'to',\n",
       "  'the',\n",
       "  'low',\n",
       "  'prevalence',\n",
       "  'of',\n",
       "  'exfoliation',\n",
       "  'syndrome',\n",
       "  'in',\n",
       "  'the',\n",
       "  'general',\n",
       "  'populations',\n",
       "  'of',\n",
       "  'the',\n",
       "  'chinese.'],\n",
       " ['individual',\n",
       "  'loxl1',\n",
       "  'snps,',\n",
       "  'rs1048661,',\n",
       "  'rs3825942,',\n",
       "  'and',\n",
       "  'rs2165241,',\n",
       "  'were',\n",
       "  'not',\n",
       "  'associated',\n",
       "  'with',\n",
       "  'poag',\n",
       "  'in',\n",
       "  'the',\n",
       "  'chinese',\n",
       "  'population.'],\n",
       " ['the',\n",
       "  'low',\n",
       "  'frequencies',\n",
       "  'of',\n",
       "  'the',\n",
       "  'at-risk',\n",
       "  'alleles',\n",
       "  'at',\n",
       "  'rs1048661',\n",
       "  'and',\n",
       "  'rs2165241',\n",
       "  'may',\n",
       "  'be',\n",
       "  'one',\n",
       "  'of',\n",
       "  'the',\n",
       "  'factors',\n",
       "  'that',\n",
       "  'led',\n",
       "  'to',\n",
       "  'the',\n",
       "  'low',\n",
       "  'prevalence',\n",
       "  'of',\n",
       "  'exfoliation',\n",
       "  'syndrome',\n",
       "  'in',\n",
       "  'the',\n",
       "  'general',\n",
       "  'populations',\n",
       "  'of',\n",
       "  'the',\n",
       "  'chinese.'],\n",
       " ['individual',\n",
       "  'loxl1',\n",
       "  'snps,',\n",
       "  'rs1048661,',\n",
       "  'rs3825942,',\n",
       "  'and',\n",
       "  'rs2165241,',\n",
       "  'were',\n",
       "  'not',\n",
       "  'associated',\n",
       "  'with',\n",
       "  'poag',\n",
       "  'in',\n",
       "  'the',\n",
       "  'chinese',\n",
       "  'population.'],\n",
       " ['individual',\n",
       "  'loxl1',\n",
       "  'snps,',\n",
       "  'rs1048661,',\n",
       "  'rs3825942,',\n",
       "  'and',\n",
       "  'rs2165241,',\n",
       "  'were',\n",
       "  'not',\n",
       "  'associated',\n",
       "  'with',\n",
       "  'poag',\n",
       "  'in',\n",
       "  'the',\n",
       "  'chinese',\n",
       "  'population.'],\n",
       " ['compound',\n",
       "  'heterozygosity',\n",
       "  'for',\n",
       "  'the',\n",
       "  'c677t',\n",
       "  'and',\n",
       "  'a1298c',\n",
       "  'mutations',\n",
       "  'of',\n",
       "  'the',\n",
       "  'mthfr',\n",
       "  'gene',\n",
       "  'in',\n",
       "  'a',\n",
       "  'case',\n",
       "  'of',\n",
       "  'hyperhomocysteinemia',\n",
       "  'with',\n",
       "  'recurrent',\n",
       "  'deep',\n",
       "  'thrombosis',\n",
       "  'at',\n",
       "  'young',\n",
       "  'age.'],\n",
       " ['compound',\n",
       "  'heterozygosity',\n",
       "  'for',\n",
       "  'the',\n",
       "  'c677t',\n",
       "  'and',\n",
       "  'a1298c',\n",
       "  'mutations',\n",
       "  'of',\n",
       "  'the',\n",
       "  'mthfr',\n",
       "  'gene',\n",
       "  'in',\n",
       "  'a',\n",
       "  'case',\n",
       "  'of',\n",
       "  'hyperhomocysteinemia',\n",
       "  'with',\n",
       "  'recurrent',\n",
       "  'deep',\n",
       "  'thrombosis',\n",
       "  'at',\n",
       "  'young',\n",
       "  'age.'],\n",
       " ['in',\n",
       "  'cd',\n",
       "  'patients,',\n",
       "  'tlr-induced',\n",
       "  'gm-csf',\n",
       "  'secretion',\n",
       "  'was',\n",
       "  'impaired',\n",
       "  'by',\n",
       "  'both',\n",
       "  'nod2-dependent',\n",
       "  'and',\n",
       "  '-independent',\n",
       "  'mechanisms.'],\n",
       " ['the',\n",
       "  'defect',\n",
       "  'in',\n",
       "  'gm-csf',\n",
       "  'secretion',\n",
       "  'suggests',\n",
       "  'a',\n",
       "  'hitherto',\n",
       "  'unknown',\n",
       "  'role',\n",
       "  'of',\n",
       "  'nod2',\n",
       "  'in',\n",
       "  'the',\n",
       "  'pathogenesis',\n",
       "  'of',\n",
       "  'cd',\n",
       "  'and',\n",
       "  'is',\n",
       "  'consistent',\n",
       "  'with',\n",
       "  'the',\n",
       "  'hypothesis',\n",
       "  'that',\n",
       "  'impaired',\n",
       "  'gm-csf',\n",
       "  'secretion',\n",
       "  'in',\n",
       "  'part',\n",
       "  'constitutes',\n",
       "  'a',\n",
       "  'nod2-dependent',\n",
       "  'disease',\n",
       "  'risk',\n",
       "  'factor.'],\n",
       " ['based',\n",
       "  'on',\n",
       "  'nod2',\n",
       "  'snp',\n",
       "  'analyses,',\n",
       "  '41',\n",
       "  'cd',\n",
       "  'patients',\n",
       "  'and',\n",
       "  '12',\n",
       "  'healthy',\n",
       "  'controls',\n",
       "  'were',\n",
       "  'studied.'],\n",
       " ['toll-like',\n",
       "  'receptor-induced',\n",
       "  'granulocyte-macrophage',\n",
       "  'colony-stimulating',\n",
       "  'factor',\n",
       "  'secretion',\n",
       "  'is',\n",
       "  'impaired',\n",
       "  'in',\n",
       "  \"crohn's\",\n",
       "  'disease',\n",
       "  'by',\n",
       "  'nucleotide',\n",
       "  'oligomerization',\n",
       "  'domain',\n",
       "  '2-dependent',\n",
       "  'and',\n",
       "  '-independent',\n",
       "  'pathways.'],\n",
       " ['toll-like',\n",
       "  'receptor-induced',\n",
       "  'granulocyte-macrophage',\n",
       "  'colony-stimulating',\n",
       "  'factor',\n",
       "  'secretion',\n",
       "  'is',\n",
       "  'impaired',\n",
       "  'in',\n",
       "  \"crohn's\",\n",
       "  'disease',\n",
       "  'by',\n",
       "  'nucleotide',\n",
       "  'oligomerization',\n",
       "  'domain',\n",
       "  '2-dependent',\n",
       "  'and',\n",
       "  '-independent',\n",
       "  'pathways.'],\n",
       " ['moreover,',\n",
       "  'tnf-alpha',\n",
       "  'production',\n",
       "  'was',\n",
       "  'induced',\n",
       "  'by',\n",
       "  'a',\n",
       "  'tlr-2',\n",
       "  'ligand,',\n",
       "  'but',\n",
       "  'a',\n",
       "  'down-regulatory',\n",
       "  'function',\n",
       "  'by',\n",
       "  'the',\n",
       "  'nod2',\n",
       "  'ligand,',\n",
       "  'muramyl',\n",
       "  'dipeptide,',\n",
       "  'was',\n",
       "  'impaired',\n",
       "  'significantly',\n",
       "  'in',\n",
       "  'cd',\n",
       "  'patients.'],\n",
       " ['cd',\n",
       "  'patients',\n",
       "  'have',\n",
       "  'impaired',\n",
       "  'gm-csf',\n",
       "  'secretion',\n",
       "  'via',\n",
       "  'nod2-dependent',\n",
       "  'and',\n",
       "  '-independent',\n",
       "  'pathways',\n",
       "  'and',\n",
       "  'display',\n",
       "  'an',\n",
       "  'impaired',\n",
       "  'nod2-dependent',\n",
       "  'down-regulation',\n",
       "  'of',\n",
       "  'tnf-alpha',\n",
       "  'secretion.'],\n",
       " ['cd',\n",
       "  'patients',\n",
       "  'have',\n",
       "  'impaired',\n",
       "  'gm-csf',\n",
       "  'secretion',\n",
       "  'via',\n",
       "  'nod2-dependent',\n",
       "  'and',\n",
       "  '-independent',\n",
       "  'pathways',\n",
       "  'and',\n",
       "  'display',\n",
       "  'an',\n",
       "  'impaired',\n",
       "  'nod2-dependent',\n",
       "  'down-regulation',\n",
       "  'of',\n",
       "  'tnf-alpha',\n",
       "  'secretion.'],\n",
       " ['single',\n",
       "  'nucleotide',\n",
       "  'polymorphisms',\n",
       "  '(snps)',\n",
       "  'in',\n",
       "  'the',\n",
       "  'intracellular',\n",
       "  'pattern',\n",
       "  'recognition',\n",
       "  'receptor',\n",
       "  'nucleotide-binding',\n",
       "  'oligomerization',\n",
       "  'domain-containing',\n",
       "  'protein',\n",
       "  '(nod2,',\n",
       "  'nucleotide',\n",
       "  'oligomerization',\n",
       "  'domain',\n",
       "  '2)',\n",
       "  'are',\n",
       "  'associated',\n",
       "  'with',\n",
       "  \"crohn's\",\n",
       "  'disease',\n",
       "  '(cd).'],\n",
       " ['single',\n",
       "  'nucleotide',\n",
       "  'polymorphisms',\n",
       "  '(snps)',\n",
       "  'in',\n",
       "  'the',\n",
       "  'intracellular',\n",
       "  'pattern',\n",
       "  'recognition',\n",
       "  'receptor',\n",
       "  'nucleotide-binding',\n",
       "  'oligomerization',\n",
       "  'domain-containing',\n",
       "  'protein',\n",
       "  '(nod2,',\n",
       "  'nucleotide',\n",
       "  'oligomerization',\n",
       "  'domain',\n",
       "  '2)',\n",
       "  'are',\n",
       "  'associated',\n",
       "  'with',\n",
       "  \"crohn's\",\n",
       "  'disease',\n",
       "  '(cd).'],\n",
       " ['cd',\n",
       "  'patients',\n",
       "  'with',\n",
       "  'nod2',\n",
       "  'mutations',\n",
       "  'were',\n",
       "  'able',\n",
       "  'to',\n",
       "  'secrete',\n",
       "  'tnf-alpha,',\n",
       "  'but',\n",
       "  'not',\n",
       "  'gm-csf,',\n",
       "  'upon',\n",
       "  'stimulation',\n",
       "  'with',\n",
       "  'nod2',\n",
       "  'and',\n",
       "  'tlr-7',\n",
       "  'ligands.'],\n",
       " ['the',\n",
       "  'defect',\n",
       "  'in',\n",
       "  'gm-csf',\n",
       "  'secretion',\n",
       "  'suggests',\n",
       "  'a',\n",
       "  'hitherto',\n",
       "  'unknown',\n",
       "  'role',\n",
       "  'of',\n",
       "  'nod2',\n",
       "  'in',\n",
       "  'the',\n",
       "  'pathogenesis',\n",
       "  'of',\n",
       "  'cd',\n",
       "  'and',\n",
       "  'is',\n",
       "  'consistent',\n",
       "  'with',\n",
       "  'the',\n",
       "  'hypothesis',\n",
       "  'that',\n",
       "  'impaired',\n",
       "  'gm-csf',\n",
       "  'secretion',\n",
       "  'in',\n",
       "  'part',\n",
       "  'constitutes',\n",
       "  'a',\n",
       "  'nod2-dependent',\n",
       "  'disease',\n",
       "  'risk',\n",
       "  'factor.'],\n",
       " ['cd',\n",
       "  'patients',\n",
       "  'have',\n",
       "  'impaired',\n",
       "  'gm-csf',\n",
       "  'secretion',\n",
       "  'via',\n",
       "  'nod2-dependent',\n",
       "  'and',\n",
       "  '-independent',\n",
       "  'pathways',\n",
       "  'and',\n",
       "  'display',\n",
       "  'an',\n",
       "  'impaired',\n",
       "  'nod2-dependent',\n",
       "  'down-regulation',\n",
       "  'of',\n",
       "  'tnf-alpha',\n",
       "  'secretion.'],\n",
       " ['single',\n",
       "  'nucleotide',\n",
       "  'polymorphisms',\n",
       "  '(snps)',\n",
       "  'in',\n",
       "  'the',\n",
       "  'intracellular',\n",
       "  'pattern',\n",
       "  'recognition',\n",
       "  'receptor',\n",
       "  'nucleotide-binding',\n",
       "  'oligomerization',\n",
       "  'domain-containing',\n",
       "  'protein',\n",
       "  '(nod2,',\n",
       "  'nucleotide',\n",
       "  'oligomerization',\n",
       "  'domain',\n",
       "  '2)',\n",
       "  'are',\n",
       "  'associated',\n",
       "  'with',\n",
       "  \"crohn's\",\n",
       "  'disease',\n",
       "  '(cd).'],\n",
       " ['single',\n",
       "  'nucleotide',\n",
       "  'polymorphisms',\n",
       "  '(snps)',\n",
       "  'in',\n",
       "  'the',\n",
       "  'intracellular',\n",
       "  'pattern',\n",
       "  'recognition',\n",
       "  'receptor',\n",
       "  'nucleotide-binding',\n",
       "  'oligomerization',\n",
       "  'domain-containing',\n",
       "  'protein',\n",
       "  '(nod2,',\n",
       "  'nucleotide',\n",
       "  'oligomerization',\n",
       "  'domain',\n",
       "  '2)',\n",
       "  'are',\n",
       "  'associated',\n",
       "  'with',\n",
       "  \"crohn's\",\n",
       "  'disease',\n",
       "  '(cd).'],\n",
       " ['in',\n",
       "  'cd',\n",
       "  'patients,',\n",
       "  'tlr-induced',\n",
       "  'gm-csf',\n",
       "  'secretion',\n",
       "  'was',\n",
       "  'impaired',\n",
       "  'by',\n",
       "  'both',\n",
       "  'nod2-dependent',\n",
       "  'and',\n",
       "  '-independent',\n",
       "  'mechanisms.'],\n",
       " ['toll-like',\n",
       "  'receptor-induced',\n",
       "  'granulocyte-macrophage',\n",
       "  'colony-stimulating',\n",
       "  'factor',\n",
       "  'secretion',\n",
       "  'is',\n",
       "  'impaired',\n",
       "  'in',\n",
       "  \"crohn's\",\n",
       "  'disease',\n",
       "  'by',\n",
       "  'nucleotide',\n",
       "  'oligomerization',\n",
       "  'domain',\n",
       "  '2-dependent',\n",
       "  'and',\n",
       "  '-independent',\n",
       "  'pathways.'],\n",
       " ['moreover,',\n",
       "  'tnf-alpha',\n",
       "  'production',\n",
       "  'was',\n",
       "  'induced',\n",
       "  'by',\n",
       "  'a',\n",
       "  'tlr-2',\n",
       "  'ligand,',\n",
       "  'but',\n",
       "  'a',\n",
       "  'down-regulatory',\n",
       "  'function',\n",
       "  'by',\n",
       "  'the',\n",
       "  'nod2',\n",
       "  'ligand,',\n",
       "  'muramyl',\n",
       "  'dipeptide,',\n",
       "  'was',\n",
       "  'impaired',\n",
       "  'significantly',\n",
       "  'in',\n",
       "  'cd',\n",
       "  'patients.'],\n",
       " ['in',\n",
       "  'cd',\n",
       "  'patients,',\n",
       "  'tlr-induced',\n",
       "  'gm-csf',\n",
       "  'secretion',\n",
       "  'was',\n",
       "  'impaired',\n",
       "  'by',\n",
       "  'both',\n",
       "  'nod2-dependent',\n",
       "  'and',\n",
       "  '-independent',\n",
       "  'mechanisms.'],\n",
       " ['the',\n",
       "  'il-23',\n",
       "  'pathway',\n",
       "  'plays',\n",
       "  'a',\n",
       "  'pivotal',\n",
       "  'role',\n",
       "  'in',\n",
       "  'the',\n",
       "  'development',\n",
       "  'of',\n",
       "  'chronic',\n",
       "  'mucosal',\n",
       "  'inflammation',\n",
       "  'seen',\n",
       "  'in',\n",
       "  'the',\n",
       "  'inflammatory',\n",
       "  'bowel',\n",
       "  'diseases.'],\n",
       " ['il23r',\n",
       "  'haplotypes',\n",
       "  'provide',\n",
       "  'a',\n",
       "  'large',\n",
       "  'population',\n",
       "  'attributable',\n",
       "  'risk',\n",
       "  'for',\n",
       "  \"crohn's\",\n",
       "  'disease.'],\n",
       " ['multiple',\n",
       "  'studies',\n",
       "  'have',\n",
       "  'now',\n",
       "  'established',\n",
       "  'the',\n",
       "  'contribution',\n",
       "  'of',\n",
       "  'the',\n",
       "  'interleukin',\n",
       "  '23',\n",
       "  'receptor',\n",
       "  'gene',\n",
       "  '(il23r)',\n",
       "  'to',\n",
       "  \"crohn's\",\n",
       "  'disease',\n",
       "  '(cd)',\n",
       "  'risk',\n",
       "  'in',\n",
       "  'general',\n",
       "  'and',\n",
       "  'of',\n",
       "  'the',\n",
       "  'il23r',\n",
       "  'r381q',\n",
       "  'variant',\n",
       "  'in',\n",
       "  'particular.'],\n",
       " ['these',\n",
       "  'observations',\n",
       "  'suggest',\n",
       "  'that',\n",
       "  'il23r',\n",
       "  'makes',\n",
       "  'a',\n",
       "  'substantial',\n",
       "  'contribution',\n",
       "  'to',\n",
       "  'cd',\n",
       "  'susceptibility,',\n",
       "  'larger',\n",
       "  'than',\n",
       "  'that',\n",
       "  'estimated',\n",
       "  'from',\n",
       "  'the',\n",
       "  'population',\n",
       "  'frequency',\n",
       "  'of',\n",
       "  'the',\n",
       "  'r381q',\n",
       "  'variant.'],\n",
       " ['multiple',\n",
       "  'studies',\n",
       "  'have',\n",
       "  'now',\n",
       "  'established',\n",
       "  'the',\n",
       "  'contribution',\n",
       "  'of',\n",
       "  'the',\n",
       "  'interleukin',\n",
       "  '23',\n",
       "  'receptor',\n",
       "  'gene',\n",
       "  '(il23r)',\n",
       "  'to',\n",
       "  \"crohn's\",\n",
       "  'disease',\n",
       "  '(cd)',\n",
       "  'risk',\n",
       "  'in',\n",
       "  'general',\n",
       "  'and',\n",
       "  'of',\n",
       "  'the',\n",
       "  'il23r',\n",
       "  'r381q',\n",
       "  'variant',\n",
       "  'in',\n",
       "  'particular.'],\n",
       " ['the',\n",
       "  'il-23',\n",
       "  'pathway',\n",
       "  'plays',\n",
       "  'a',\n",
       "  'pivotal',\n",
       "  'role',\n",
       "  'in',\n",
       "  'the',\n",
       "  'development',\n",
       "  'of',\n",
       "  'chronic',\n",
       "  'mucosal',\n",
       "  'inflammation',\n",
       "  'seen',\n",
       "  'in',\n",
       "  'the',\n",
       "  'inflammatory',\n",
       "  'bowel',\n",
       "  'diseases.'],\n",
       " ['multiple',\n",
       "  'studies',\n",
       "  'have',\n",
       "  'now',\n",
       "  'established',\n",
       "  'the',\n",
       "  'contribution',\n",
       "  'of',\n",
       "  'the',\n",
       "  'interleukin',\n",
       "  '23',\n",
       "  'receptor',\n",
       "  'gene',\n",
       "  '(il23r)',\n",
       "  'to',\n",
       "  \"crohn's\",\n",
       "  'disease',\n",
       "  '(cd)',\n",
       "  'risk',\n",
       "  'in',\n",
       "  'general',\n",
       "  'and',\n",
       "  'of',\n",
       "  'the',\n",
       "  'il23r',\n",
       "  'r381q',\n",
       "  'variant',\n",
       "  'in',\n",
       "  'particular.'],\n",
       " ['these',\n",
       "  'observations',\n",
       "  'suggest',\n",
       "  'that',\n",
       "  'il23r',\n",
       "  'makes',\n",
       "  'a',\n",
       "  'substantial',\n",
       "  'contribution',\n",
       "  'to',\n",
       "  'cd',\n",
       "  'susceptibility,',\n",
       "  'larger',\n",
       "  'than',\n",
       "  'that',\n",
       "  'estimated',\n",
       "  'from',\n",
       "  'the',\n",
       "  'population',\n",
       "  'frequency',\n",
       "  'of',\n",
       "  'the',\n",
       "  'r381q',\n",
       "  'variant.'],\n",
       " ['multiple',\n",
       "  'studies',\n",
       "  'have',\n",
       "  'now',\n",
       "  'established',\n",
       "  'the',\n",
       "  'contribution',\n",
       "  'of',\n",
       "  'the',\n",
       "  'interleukin',\n",
       "  '23',\n",
       "  'receptor',\n",
       "  'gene',\n",
       "  '(il23r)',\n",
       "  'to',\n",
       "  \"crohn's\",\n",
       "  'disease',\n",
       "  '(cd)',\n",
       "  'risk',\n",
       "  'in',\n",
       "  'general',\n",
       "  'and',\n",
       "  'of',\n",
       "  'the',\n",
       "  'il23r',\n",
       "  'r381q',\n",
       "  'variant',\n",
       "  'in',\n",
       "  'particular.'],\n",
       " ['in',\n",
       "  'all,',\n",
       "  '763',\n",
       "  'cd',\n",
       "  'subjects',\n",
       "  'and',\n",
       "  '254',\n",
       "  'controls',\n",
       "  'were',\n",
       "  'genotyped',\n",
       "  'for',\n",
       "  'single',\n",
       "  'nucleotide',\n",
       "  'polymorphisms',\n",
       "  'in',\n",
       "  'the',\n",
       "  'il23r',\n",
       "  'gene',\n",
       "  'using',\n",
       "  'illumina',\n",
       "  'and',\n",
       "  'abi',\n",
       "  'methods.'],\n",
       " ['identification',\n",
       "  'and',\n",
       "  'replication',\n",
       "  'of',\n",
       "  'three',\n",
       "  'novel',\n",
       "  'myopia',\n",
       "  'common',\n",
       "  'susceptibility',\n",
       "  'gene',\n",
       "  'loci',\n",
       "  'on',\n",
       "  'chromosome',\n",
       "  '3q26',\n",
       "  'using',\n",
       "  'linkage',\n",
       "  'and',\n",
       "  'linkage',\n",
       "  'disequilibrium',\n",
       "  'mapping.'],\n",
       " ['in',\n",
       "  'a',\n",
       "  'family,',\n",
       "  'we',\n",
       "  'observed',\n",
       "  'c.+119a',\n",
       "  '>',\n",
       "  't',\n",
       "  'in',\n",
       "  'the',\n",
       "  \"3'-utr\",\n",
       "  'associated',\n",
       "  'with',\n",
       "  'asd',\n",
       "  'type',\n",
       "  'ii.'],\n",
       " ['elevation',\n",
       "  'of',\n",
       "  'growth',\n",
       "  'hormone-releasing',\n",
       "  'hormone',\n",
       "  'receptor',\n",
       "  'messenger',\n",
       "  'ribonucleic',\n",
       "  'acid',\n",
       "  'expression',\n",
       "  'in',\n",
       "  'growth',\n",
       "  'hormone-secreting',\n",
       "  'pituitary',\n",
       "  'adenoma',\n",
       "  'with',\n",
       "  'gsalpha',\n",
       "  'protein',\n",
       "  'mutation.'],\n",
       " ['the',\n",
       "  'expression',\n",
       "  'of',\n",
       "  'ghrh',\n",
       "  'receptor',\n",
       "  '(ghrhr)',\n",
       "  'is',\n",
       "  'regulated',\n",
       "  'by',\n",
       "  'ghrh,',\n",
       "  'both',\n",
       "  'of',\n",
       "  'which',\n",
       "  'are',\n",
       "  'known',\n",
       "  'to',\n",
       "  'be',\n",
       "  'expressed',\n",
       "  'in',\n",
       "  'human',\n",
       "  'gh-secreting',\n",
       "  'pituitary',\n",
       "  'adenoma',\n",
       "  'cells.'],\n",
       " ['these',\n",
       "  'results',\n",
       "  'suggest',\n",
       "  'that',\n",
       "  'gsp',\n",
       "  'mutations',\n",
       "  'up-regulate',\n",
       "  'ghrhr',\n",
       "  'mrna',\n",
       "  'expression',\n",
       "  'in',\n",
       "  'gh-secreting',\n",
       "  'pituitary',\n",
       "  'adenoma',\n",
       "  'cells,',\n",
       "  'and',\n",
       "  'that',\n",
       "  'gsp',\n",
       "  'mutations',\n",
       "  'desensitize',\n",
       "  'the',\n",
       "  'adenoma',\n",
       "  'cells',\n",
       "  'to',\n",
       "  'ghrh',\n",
       "  'in',\n",
       "  'terms',\n",
       "  'of',\n",
       "  'their',\n",
       "  'ghrhr',\n",
       "  'mrna',\n",
       "  'expression',\n",
       "  'probably',\n",
       "  'because',\n",
       "  'of',\n",
       "  'their',\n",
       "  'saturation',\n",
       "  'of',\n",
       "  'ghrh',\n",
       "  'signaling.'],\n",
       " ['the',\n",
       "  'expression',\n",
       "  'of',\n",
       "  'ghrh',\n",
       "  'receptor',\n",
       "  '(ghrhr)',\n",
       "  'is',\n",
       "  'regulated',\n",
       "  'by',\n",
       "  'ghrh,',\n",
       "  'both',\n",
       "  'of',\n",
       "  'which',\n",
       "  'are',\n",
       "  'known',\n",
       "  'to',\n",
       "  'be',\n",
       "  'expressed',\n",
       "  'in',\n",
       "  'human',\n",
       "  'gh-secreting',\n",
       "  'pituitary',\n",
       "  'adenoma',\n",
       "  'cells.'],\n",
       " ['these',\n",
       "  'results',\n",
       "  'suggest',\n",
       "  'that',\n",
       "  'gsp',\n",
       "  'mutations',\n",
       "  'up-regulate',\n",
       "  'ghrhr',\n",
       "  'mrna',\n",
       "  'expression',\n",
       "  'in',\n",
       "  'gh-secreting',\n",
       "  'pituitary',\n",
       "  'adenoma',\n",
       "  'cells,',\n",
       "  'and',\n",
       "  'that',\n",
       "  'gsp',\n",
       "  'mutations',\n",
       "  'desensitize',\n",
       "  'the',\n",
       "  'adenoma',\n",
       "  'cells',\n",
       "  'to',\n",
       "  'ghrh',\n",
       "  'in',\n",
       "  'terms',\n",
       "  'of',\n",
       "  'their',\n",
       "  'ghrhr',\n",
       "  'mrna',\n",
       "  'expression',\n",
       "  'probably',\n",
       "  'because',\n",
       "  'of',\n",
       "  'their',\n",
       "  'saturation',\n",
       "  'of',\n",
       "  'ghrh',\n",
       "  'signaling.'],\n",
       " ['cdc6',\n",
       "  'play',\n",
       "  'crucial',\n",
       "  'roles',\n",
       "  'in',\n",
       "  'dna',\n",
       "  'replication',\n",
       "  'and',\n",
       "  'carcinogenesis.'],\n",
       " ['our',\n",
       "  'data',\n",
       "  'provide',\n",
       "  'the',\n",
       "  'first',\n",
       "  'evidence',\n",
       "  'that',\n",
       "  'the',\n",
       "  'cdc6',\n",
       "  'g1321a',\n",
       "  'polymorphism',\n",
       "  'is',\n",
       "  'associated',\n",
       "  'with',\n",
       "  'decreased',\n",
       "  'risk',\n",
       "  'of',\n",
       "  'cancer.'],\n",
       " ['to',\n",
       "  'assess',\n",
       "  'clinical',\n",
       "  'significance,',\n",
       "  '93',\n",
       "  'breast',\n",
       "  'cancer',\n",
       "  'lesions',\n",
       "  'were',\n",
       "  'evaluated',\n",
       "  'for',\n",
       "  'expression',\n",
       "  'of',\n",
       "  'vegf',\n",
       "  'and',\n",
       "  'vegfr-1',\n",
       "  'by',\n",
       "  'immunohistochemistry.'],\n",
       " ['to',\n",
       "  'assess',\n",
       "  'clinical',\n",
       "  'significance,',\n",
       "  '93',\n",
       "  'breast',\n",
       "  'cancer',\n",
       "  'lesions',\n",
       "  'were',\n",
       "  'evaluated',\n",
       "  'for',\n",
       "  'expression',\n",
       "  'of',\n",
       "  'vegf',\n",
       "  'and',\n",
       "  'vegfr-1',\n",
       "  'by',\n",
       "  'immunohistochemistry.'],\n",
       " ['expression',\n",
       "  'of',\n",
       "  'vegfr-1',\n",
       "  '(flt-1)',\n",
       "  'in',\n",
       "  'breast',\n",
       "  'cancer',\n",
       "  'is',\n",
       "  'associated',\n",
       "  'with',\n",
       "  'vegf',\n",
       "  'expression',\n",
       "  'and',\n",
       "  'with',\n",
       "  'node-negative',\n",
       "  'tumour',\n",
       "  'stage.'],\n",
       " ['expression',\n",
       "  'of',\n",
       "  'vegfr-1',\n",
       "  '(flt-1)',\n",
       "  'in',\n",
       "  'breast',\n",
       "  'cancer',\n",
       "  'is',\n",
       "  'associated',\n",
       "  'with',\n",
       "  'vegf',\n",
       "  'expression',\n",
       "  'and',\n",
       "  'with',\n",
       "  'node-negative',\n",
       "  'tumour',\n",
       "  'stage.'],\n",
       " ['vegf',\n",
       "  'was',\n",
       "  'expressed',\n",
       "  'in',\n",
       "  '60%',\n",
       "  'and',\n",
       "  'vegfr-1',\n",
       "  'in',\n",
       "  '39%',\n",
       "  'of',\n",
       "  'breast',\n",
       "  'cancer',\n",
       "  'specimens.'],\n",
       " ['vegf',\n",
       "  'was',\n",
       "  'expressed',\n",
       "  'in',\n",
       "  '60%',\n",
       "  'and',\n",
       "  'vegfr-1',\n",
       "  'in',\n",
       "  '39%',\n",
       "  'of',\n",
       "  'breast',\n",
       "  'cancer',\n",
       "  'specimens.'],\n",
       " ['vascular',\n",
       "  'endothelial',\n",
       "  'growth',\n",
       "  'factor',\n",
       "  '(vegf)',\n",
       "  'promotes',\n",
       "  'breast',\n",
       "  'cancer',\n",
       "  'progression',\n",
       "  'by',\n",
       "  'inducing',\n",
       "  'angiogenesis',\n",
       "  'via',\n",
       "  'vegf',\n",
       "  'receptors',\n",
       "  'on',\n",
       "  'endothelial',\n",
       "  'cells',\n",
       "  'but',\n",
       "  'also',\n",
       "  'signals',\n",
       "  'directly',\n",
       "  'through',\n",
       "  'receptors',\n",
       "  'such',\n",
       "  'as',\n",
       "  'vegfr-1',\n",
       "  '(flt-1)',\n",
       "  'expressed',\n",
       "  'on',\n",
       "  'tumour',\n",
       "  'cells.'],\n",
       " ['vascular',\n",
       "  'endothelial',\n",
       "  'growth',\n",
       "  'factor',\n",
       "  '(vegf)',\n",
       "  'promotes',\n",
       "  'breast',\n",
       "  'cancer',\n",
       "  'progression',\n",
       "  'by',\n",
       "  'inducing',\n",
       "  'angiogenesis',\n",
       "  'via',\n",
       "  'vegf',\n",
       "  'receptors',\n",
       "  'on',\n",
       "  'endothelial',\n",
       "  'cells',\n",
       "  'but',\n",
       "  'also',\n",
       "  'signals',\n",
       "  'directly',\n",
       "  'through',\n",
       "  'receptors',\n",
       "  'such',\n",
       "  'as',\n",
       "  'vegfr-1',\n",
       "  '(flt-1)',\n",
       "  'expressed',\n",
       "  'on',\n",
       "  'tumour',\n",
       "  'cells.'],\n",
       " ['we',\n",
       "  'genotyped',\n",
       "  'the',\n",
       "  'four',\n",
       "  'single-nucleotide',\n",
       "  'polymorphisms',\n",
       "  '(rs706778,',\n",
       "  'rs3118470,',\n",
       "  'ss52580101,',\n",
       "  'and',\n",
       "  'rs11594656)',\n",
       "  'of',\n",
       "  'the',\n",
       "  'il2ra',\n",
       "  'in',\n",
       "  '885',\n",
       "  'patients',\n",
       "  'with',\n",
       "  'type',\n",
       "  '1',\n",
       "  'diabetes',\n",
       "  'and',\n",
       "  '606',\n",
       "  'control',\n",
       "  'subjects',\n",
       "  'of',\n",
       "  'japanese',\n",
       "  'origin.'],\n",
       " ['our',\n",
       "  'objective',\n",
       "  'was',\n",
       "  'to',\n",
       "  'determine',\n",
       "  'whether',\n",
       "  'variants',\n",
       "  'in',\n",
       "  'the',\n",
       "  'il2ra',\n",
       "  'gene',\n",
       "  'are',\n",
       "  'associated',\n",
       "  'with',\n",
       "  'type',\n",
       "  '1',\n",
       "  'diabetes',\n",
       "  'in',\n",
       "  'the',\n",
       "  'japanese',\n",
       "  'population.'],\n",
       " ['we',\n",
       "  'genotyped',\n",
       "  'the',\n",
       "  'four',\n",
       "  'single-nucleotide',\n",
       "  'polymorphisms',\n",
       "  '(rs706778,',\n",
       "  'rs3118470,',\n",
       "  'ss52580101,',\n",
       "  'and',\n",
       "  'rs11594656)',\n",
       "  'of',\n",
       "  'the',\n",
       "  'il2ra',\n",
       "  'in',\n",
       "  '885',\n",
       "  'patients',\n",
       "  'with',\n",
       "  'type',\n",
       "  '1',\n",
       "  'diabetes',\n",
       "  'and',\n",
       "  '606',\n",
       "  'control',\n",
       "  'subjects',\n",
       "  'of',\n",
       "  'japanese',\n",
       "  'origin.'],\n",
       " ['the',\n",
       "  'present',\n",
       "  'data',\n",
       "  'confirm',\n",
       "  'the',\n",
       "  'type',\n",
       "  '1',\n",
       "  'diabetes',\n",
       "  'association',\n",
       "  'with',\n",
       "  'il2ra',\n",
       "  'and',\n",
       "  'provide',\n",
       "  'evidence',\n",
       "  'that',\n",
       "  'the',\n",
       "  'different',\n",
       "  'contributions',\n",
       "  'of',\n",
       "  'the',\n",
       "  'il2ra',\n",
       "  'in',\n",
       "  'the',\n",
       "  'susceptibility',\n",
       "  'to',\n",
       "  'acute-onset',\n",
       "  'and',\n",
       "  'other',\n",
       "  'forms',\n",
       "  'of',\n",
       "  'type',\n",
       "  '1',\n",
       "  'diabetes',\n",
       "  'in',\n",
       "  'the',\n",
       "  'japanese',\n",
       "  'population.'],\n",
       " ['we',\n",
       "  'genotyped',\n",
       "  'the',\n",
       "  'four',\n",
       "  'single-nucleotide',\n",
       "  'polymorphisms',\n",
       "  '(rs706778,',\n",
       "  'rs3118470,',\n",
       "  'ss52580101,',\n",
       "  'and',\n",
       "  'rs11594656)',\n",
       "  'of',\n",
       "  'the',\n",
       "  'il2ra',\n",
       "  'in',\n",
       "  '885',\n",
       "  'patients',\n",
       "  'with',\n",
       "  'type',\n",
       "  '1',\n",
       "  'diabetes',\n",
       "  'and',\n",
       "  '606',\n",
       "  'control',\n",
       "  'subjects',\n",
       "  'of',\n",
       "  'japanese',\n",
       "  'origin.'],\n",
       " ['we',\n",
       "  'genotyped',\n",
       "  'the',\n",
       "  'four',\n",
       "  'single-nucleotide',\n",
       "  'polymorphisms',\n",
       "  '(rs706778,',\n",
       "  'rs3118470,',\n",
       "  'ss52580101,',\n",
       "  'and',\n",
       "  'rs11594656)',\n",
       "  'of',\n",
       "  'the',\n",
       "  'il2ra',\n",
       "  'in',\n",
       "  '885',\n",
       "  'patients',\n",
       "  'with',\n",
       "  'type',\n",
       "  '1',\n",
       "  'diabetes',\n",
       "  'and',\n",
       "  '606',\n",
       "  'control',\n",
       "  'subjects',\n",
       "  'of',\n",
       "  'japanese',\n",
       "  'origin.'],\n",
       " ['we',\n",
       "  'found',\n",
       "  'evidence',\n",
       "  'of',\n",
       "  'association',\n",
       "  'with',\n",
       "  'acute-onset,',\n",
       "  'but',\n",
       "  'not',\n",
       "  'slow-onset',\n",
       "  'and',\n",
       "  'fulminant,',\n",
       "  'type',\n",
       "  '1',\n",
       "  'diabetes',\n",
       "  'for',\n",
       "  'two',\n",
       "  'of',\n",
       "  'the',\n",
       "  'four',\n",
       "  'single-nucleotide',\n",
       "  'polymorphisms',\n",
       "  'genotyped',\n",
       "  '(rs706778',\n",
       "  'and',\n",
       "  'rs3118470).'],\n",
       " ['we',\n",
       "  'found',\n",
       "  'evidence',\n",
       "  'of',\n",
       "  'association',\n",
       "  'with',\n",
       "  'acute-onset,',\n",
       "  'but',\n",
       "  'not',\n",
       "  'slow-onset',\n",
       "  'and',\n",
       "  'fulminant,',\n",
       "  'type',\n",
       "  '1',\n",
       "  'diabetes',\n",
       "  'for',\n",
       "  'two',\n",
       "  'of',\n",
       "  'the',\n",
       "  'four',\n",
       "  'single-nucleotide',\n",
       "  'polymorphisms',\n",
       "  'genotyped',\n",
       "  '(rs706778',\n",
       "  'and',\n",
       "  'rs3118470).'],\n",
       " ['we',\n",
       "  'genotyped',\n",
       "  'the',\n",
       "  'four',\n",
       "  'single-nucleotide',\n",
       "  'polymorphisms',\n",
       "  '(rs706778,',\n",
       "  'rs3118470,',\n",
       "  'ss52580101,',\n",
       "  'and',\n",
       "  'rs11594656)',\n",
       "  'of',\n",
       "  'the',\n",
       "  'il2ra',\n",
       "  'in',\n",
       "  '885',\n",
       "  'patients',\n",
       "  'with',\n",
       "  'type',\n",
       "  '1',\n",
       "  'diabetes',\n",
       "  'and',\n",
       "  '606',\n",
       "  'control',\n",
       "  'subjects',\n",
       "  'of',\n",
       "  'japanese',\n",
       "  'origin.'],\n",
       " ['tgfbip/betaig-h3',\n",
       "  'protein',\n",
       "  'is',\n",
       "  'an',\n",
       "  'extracellular',\n",
       "  'matrix',\n",
       "  'molecule',\n",
       "  'initially',\n",
       "  'cloned',\n",
       "  'from',\n",
       "  'human',\n",
       "  'adenocarcinoma',\n",
       "  'cells',\n",
       "  'treated',\n",
       "  'with',\n",
       "  'tgf-beta.'],\n",
       " ['polymorphisms',\n",
       "  'in',\n",
       "  'the',\n",
       "  'regulatory',\n",
       "  'region',\n",
       "  'of',\n",
       "  'the',\n",
       "  'cyclophilin',\n",
       "  'a',\n",
       "  'gene',\n",
       "  'influence',\n",
       "  'the',\n",
       "  'susceptibility',\n",
       "  'for',\n",
       "  'hiv-1',\n",
       "  'infection.'],\n",
       " ['previous',\n",
       "  'studies',\n",
       "  'have',\n",
       "  'demonstrated',\n",
       "  'an',\n",
       "  'association',\n",
       "  'between',\n",
       "  'polymorphisms',\n",
       "  'in',\n",
       "  'the',\n",
       "  'regulatory',\n",
       "  'regions',\n",
       "  'of',\n",
       "  'cyclophilin',\n",
       "  'a',\n",
       "  '(cypa)',\n",
       "  'and',\n",
       "  'susceptibility',\n",
       "  'to',\n",
       "  'both',\n",
       "  'hiv-1',\n",
       "  'infection',\n",
       "  'and',\n",
       "  'disease',\n",
       "  'progression.'],\n",
       " ['previous',\n",
       "  'studies',\n",
       "  'have',\n",
       "  'demonstrated',\n",
       "  'an',\n",
       "  'association',\n",
       "  'between',\n",
       "  'polymorphisms',\n",
       "  'in',\n",
       "  'the',\n",
       "  'regulatory',\n",
       "  'regions',\n",
       "  'of',\n",
       "  'cyclophilin',\n",
       "  'a',\n",
       "  '(cypa)',\n",
       "  'and',\n",
       "  'susceptibility',\n",
       "  'to',\n",
       "  'both',\n",
       "  'hiv-1',\n",
       "  'infection',\n",
       "  'and',\n",
       "  'disease',\n",
       "  'progression.'],\n",
       " ['the',\n",
       "  'results',\n",
       "  'obtained',\n",
       "  'in',\n",
       "  'this',\n",
       "  'study',\n",
       "  'suggest',\n",
       "  'that',\n",
       "  'the',\n",
       "  'a1650g',\n",
       "  'polymorphism',\n",
       "  'in',\n",
       "  'the',\n",
       "  'regulatory',\n",
       "  'region',\n",
       "  'of',\n",
       "  'the',\n",
       "  'cypa',\n",
       "  'gene',\n",
       "  'may',\n",
       "  'be',\n",
       "  'associated',\n",
       "  'with',\n",
       "  'protection',\n",
       "  'from',\n",
       "  'hiv-1',\n",
       "  'infection,',\n",
       "  'while',\n",
       "  'the',\n",
       "  '1604g',\n",
       "  'allele',\n",
       "  'may',\n",
       "  'have',\n",
       "  'a',\n",
       "  'weak',\n",
       "  'association',\n",
       "  'with',\n",
       "  'the',\n",
       "  'clinical',\n",
       "  'course',\n",
       "  'of',\n",
       "  'infection',\n",
       "  'in',\n",
       "  'du.'],\n",
       " ['women',\n",
       "  'carrying',\n",
       "  'homozygous',\n",
       "  'asp1104asp',\n",
       "  'genotypes',\n",
       "  'had',\n",
       "  'a',\n",
       "  'significantly',\n",
       "  'decreased',\n",
       "  'risk',\n",
       "  'of',\n",
       "  'cervical',\n",
       "  'or',\n",
       "  'cervical',\n",
       "  'squamous',\n",
       "  'cell',\n",
       "  'carcinoma',\n",
       "  'compared',\n",
       "  'to',\n",
       "  'his1104asp',\n",
       "  'or',\n",
       "  'his1104his',\n",
       "  'genotypes.'],\n",
       " ['no',\n",
       "  'association',\n",
       "  'of',\n",
       "  'xrcc3',\n",
       "  'thr241met',\n",
       "  'or',\n",
       "  'xpd',\n",
       "  'lys751gln',\n",
       "  'and',\n",
       "  'cervical',\n",
       "  'carcinoma',\n",
       "  'was',\n",
       "  'found.'],\n",
       " ['dna',\n",
       "  'repair',\n",
       "  'gene',\n",
       "  'polymorphisms,',\n",
       "  'such',\n",
       "  'as',\n",
       "  'those',\n",
       "  'of',\n",
       "  'xrcc3',\n",
       "  'and',\n",
       "  'xeroderma',\n",
       "  'pigmentosum,',\n",
       "  'complementation',\n",
       "  'group',\n",
       "  'd',\n",
       "  'and',\n",
       "  'g',\n",
       "  '(xpd,',\n",
       "  'xpg),',\n",
       "  'contribute',\n",
       "  'to',\n",
       "  'carcinogenesis.'],\n",
       " ['similarly,',\n",
       "  'xpd',\n",
       "  'asn312asn',\n",
       "  '(aa)',\n",
       "  'reduced',\n",
       "  'the',\n",
       "  'risk',\n",
       "  'of',\n",
       "  'cervical',\n",
       "  'or',\n",
       "  'cervical',\n",
       "  'squamous',\n",
       "  'cell',\n",
       "  'carcinoma.'],\n",
       " ['no',\n",
       "  'association',\n",
       "  'of',\n",
       "  'xrcc3',\n",
       "  'thr241met',\n",
       "  'or',\n",
       "  'xpd',\n",
       "  'lys751gln',\n",
       "  'and',\n",
       "  'cervical',\n",
       "  'carcinoma',\n",
       "  'was',\n",
       "  'found.'],\n",
       " ['women',\n",
       "  'carrying',\n",
       "  'homozygous',\n",
       "  'asp1104asp',\n",
       "  'genotypes',\n",
       "  'had',\n",
       "  'a',\n",
       "  'significantly',\n",
       "  'decreased',\n",
       "  'risk',\n",
       "  'of',\n",
       "  'cervical',\n",
       "  'or',\n",
       "  'cervical',\n",
       "  'squamous',\n",
       "  'cell',\n",
       "  'carcinoma',\n",
       "  'compared',\n",
       "  'to',\n",
       "  'his1104asp',\n",
       "  'or',\n",
       "  'his1104his',\n",
       "  'genotypes.'],\n",
       " ['women',\n",
       "  'carrying',\n",
       "  'homozygous',\n",
       "  'asp1104asp',\n",
       "  'genotypes',\n",
       "  'had',\n",
       "  'a',\n",
       "  'significantly',\n",
       "  'decreased',\n",
       "  'risk',\n",
       "  'of',\n",
       "  'cervical',\n",
       "  'or',\n",
       "  'cervical',\n",
       "  'squamous',\n",
       "  'cell',\n",
       "  'carcinoma',\n",
       "  'compared',\n",
       "  'to',\n",
       "  'his1104asp',\n",
       "  'or',\n",
       "  'his1104his',\n",
       "  'genotypes.'],\n",
       " ['much',\n",
       "  'of',\n",
       "  'this',\n",
       "  'data',\n",
       "  'has',\n",
       "  'been',\n",
       "  'correlative,',\n",
       "  'until',\n",
       "  'recently',\n",
       "  'with',\n",
       "  'the',\n",
       "  'development',\n",
       "  'of',\n",
       "  'polymerase',\n",
       "  'gamma',\n",
       "  'deficient',\n",
       "  'mice',\n",
       "  'which',\n",
       "  'accumulate',\n",
       "  'high',\n",
       "  'levels',\n",
       "  'of',\n",
       "  'mtdna',\n",
       "  'mutations',\n",
       "  'and',\n",
       "  'show',\n",
       "  'a',\n",
       "  'premature',\n",
       "  'aging',\n",
       "  'phenotype,',\n",
       "  'that',\n",
       "  'a',\n",
       "  'more',\n",
       "  'causative',\n",
       "  'role',\n",
       "  'has',\n",
       "  'been',\n",
       "  'proposed.'],\n",
       " ['a',\n",
       "  'recent',\n",
       "  'study',\n",
       "  'demonstrated',\n",
       "  'the',\n",
       "  'association',\n",
       "  'of',\n",
       "  'tnfsf4',\n",
       "  'haplotypes',\n",
       "  'located',\n",
       "  'in',\n",
       "  'the',\n",
       "  'upstream',\n",
       "  'region',\n",
       "  'with',\n",
       "  'risk',\n",
       "  'for',\n",
       "  'or',\n",
       "  'protection',\n",
       "  'from',\n",
       "  'systemic',\n",
       "  'lupus',\n",
       "  'erythematosus',\n",
       "  '(sle).'],\n",
       " ['a',\n",
       "  'recent',\n",
       "  'study',\n",
       "  'demonstrated',\n",
       "  'the',\n",
       "  'association',\n",
       "  'of',\n",
       "  'tnfsf4',\n",
       "  'haplotypes',\n",
       "  'located',\n",
       "  'in',\n",
       "  'the',\n",
       "  'upstream',\n",
       "  'region',\n",
       "  'with',\n",
       "  'risk',\n",
       "  'for',\n",
       "  'or',\n",
       "  'protection',\n",
       "  'from',\n",
       "  'systemic',\n",
       "  'lupus',\n",
       "  'erythematosus',\n",
       "  '(sle).'],\n",
       " ['the',\n",
       "  'association',\n",
       "  'of',\n",
       "  'tnfsf4',\n",
       "  'with',\n",
       "  'sle',\n",
       "  'was',\n",
       "  'replicated',\n",
       "  'in',\n",
       "  'all',\n",
       "  'the',\n",
       "  'sets',\n",
       "  'except',\n",
       "  'spain.'],\n",
       " ['replication',\n",
       "  'of',\n",
       "  'the',\n",
       "  'tnfsf4',\n",
       "  '(ox40l)',\n",
       "  'promoter',\n",
       "  'region',\n",
       "  'association',\n",
       "  'with',\n",
       "  'systemic',\n",
       "  'lupus',\n",
       "  'erythematosus.'],\n",
       " ['this',\n",
       "  'first',\n",
       "  'replication',\n",
       "  'study',\n",
       "  'confirms',\n",
       "  'the',\n",
       "  'association',\n",
       "  'of',\n",
       "  'genetic',\n",
       "  'variation',\n",
       "  'in',\n",
       "  'the',\n",
       "  'upstream',\n",
       "  'region',\n",
       "  'of',\n",
       "  'tnfsf4',\n",
       "  'with',\n",
       "  'susceptibility',\n",
       "  'to',\n",
       "  'sle.'],\n",
       " ['these',\n",
       "  'results',\n",
       "  'suggest',\n",
       "  'that',\n",
       "  'nptn',\n",
       "  'may',\n",
       "  'be',\n",
       "  'involved',\n",
       "  'in',\n",
       "  'genetic',\n",
       "  'susceptibility',\n",
       "  'to',\n",
       "  'schizophrenia.'],\n",
       " ['the',\n",
       "  'haplotypes',\n",
       "  'constructed',\n",
       "  'from',\n",
       "  'the',\n",
       "  'three',\n",
       "  'snps',\n",
       "  '(rs3840846,',\n",
       "  'rs3826047',\n",
       "  'and',\n",
       "  'rs3743500,',\n",
       "  'in',\n",
       "  'order)',\n",
       "  'in',\n",
       "  'the',\n",
       "  \"5'-upstream\",\n",
       "  'of',\n",
       "  'nptn',\n",
       "  'showed',\n",
       "  'a',\n",
       "  'significant',\n",
       "  'association',\n",
       "  'with',\n",
       "  'schizophrenia',\n",
       "  '(permutation',\n",
       "  'p=0.036),',\n",
       "  'in',\n",
       "  'that',\n",
       "  't-g-t',\n",
       "  '(permutation',\n",
       "  'p=0.028)',\n",
       "  'and',\n",
       "  'del-g-g',\n",
       "  '(permutation',\n",
       "  'p=0.040)',\n",
       "  'were',\n",
       "  'under-represented',\n",
       "  'and',\n",
       "  'over-represented,',\n",
       "  'respectively,',\n",
       "  'in',\n",
       "  'schizophrenia.'],\n",
       " ['the',\n",
       "  'haplotypes',\n",
       "  'constructed',\n",
       "  'from',\n",
       "  'the',\n",
       "  'three',\n",
       "  'snps',\n",
       "  '(rs3840846,',\n",
       "  'rs3826047',\n",
       "  'and',\n",
       "  'rs3743500,',\n",
       "  'in',\n",
       "  'order)',\n",
       "  'in',\n",
       "  'the',\n",
       "  \"5'-upstream\",\n",
       "  'of',\n",
       "  'nptn',\n",
       "  'showed',\n",
       "  'a',\n",
       "  'significant',\n",
       "  'association',\n",
       "  'with',\n",
       "  'schizophrenia',\n",
       "  '(permutation',\n",
       "  'p=0.036),',\n",
       "  'in',\n",
       "  'that',\n",
       "  't-g-t',\n",
       "  '(permutation',\n",
       "  'p=0.028)',\n",
       "  'and',\n",
       "  'del-g-g',\n",
       "  '(permutation',\n",
       "  'p=0.040)',\n",
       "  'were',\n",
       "  'under-represented',\n",
       "  'and',\n",
       "  'over-represented,',\n",
       "  'respectively,',\n",
       "  'in',\n",
       "  'schizophrenia.'],\n",
       " ['the',\n",
       "  'haplotypes',\n",
       "  'constructed',\n",
       "  'from',\n",
       "  'the',\n",
       "  'three',\n",
       "  'snps',\n",
       "  '(rs3840846,',\n",
       "  'rs3826047',\n",
       "  'and',\n",
       "  'rs3743500,',\n",
       "  'in',\n",
       "  'order)',\n",
       "  'in',\n",
       "  'the',\n",
       "  \"5'-upstream\",\n",
       "  'of',\n",
       "  'nptn',\n",
       "  'showed',\n",
       "  'a',\n",
       "  'significant',\n",
       "  'association',\n",
       "  'with',\n",
       "  'schizophrenia',\n",
       "  '(permutation',\n",
       "  'p=0.036),',\n",
       "  'in',\n",
       "  'that',\n",
       "  't-g-t',\n",
       "  '(permutation',\n",
       "  'p=0.028)',\n",
       "  'and',\n",
       "  'del-g-g',\n",
       "  '(permutation',\n",
       "  'p=0.040)',\n",
       "  'were',\n",
       "  'under-represented',\n",
       "  'and',\n",
       "  'over-represented,',\n",
       "  'respectively,',\n",
       "  'in',\n",
       "  'schizophrenia.'],\n",
       " ['the',\n",
       "  'haplotypes',\n",
       "  'constructed',\n",
       "  'from',\n",
       "  'the',\n",
       "  'three',\n",
       "  'snps',\n",
       "  '(rs3840846,',\n",
       "  'rs3826047',\n",
       "  'and',\n",
       "  'rs3743500,',\n",
       "  'in',\n",
       "  'order)',\n",
       "  'in',\n",
       "  'the',\n",
       "  \"5'-upstream\",\n",
       "  'of',\n",
       "  'nptn',\n",
       "  'showed',\n",
       "  'a',\n",
       "  'significant',\n",
       "  'association',\n",
       "  'with',\n",
       "  'schizophrenia',\n",
       "  '(permutation',\n",
       "  'p=0.036),',\n",
       "  'in',\n",
       "  'that',\n",
       "  't-g-t',\n",
       "  '(permutation',\n",
       "  'p=0.028)',\n",
       "  'and',\n",
       "  'del-g-g',\n",
       "  '(permutation',\n",
       "  'p=0.040)',\n",
       "  'were',\n",
       "  'under-represented',\n",
       "  'and',\n",
       "  'over-represented,',\n",
       "  'respectively,',\n",
       "  'in',\n",
       "  'schizophrenia.'],\n",
       " ['chronic',\n",
       "  'rhinosinusitis',\n",
       "  'with',\n",
       "  'nasal',\n",
       "  'polyps',\n",
       "  'is',\n",
       "  'associated',\n",
       "  'with',\n",
       "  'decreased',\n",
       "  'expression',\n",
       "  'of',\n",
       "  'mucosal',\n",
       "  'interleukin',\n",
       "  '22',\n",
       "  'receptor.'],\n",
       " ['il-22r1',\n",
       "  'mrna',\n",
       "  'was',\n",
       "  'expressed',\n",
       "  'in',\n",
       "  '100%',\n",
       "  'of',\n",
       "  'the',\n",
       "  'controls',\n",
       "  'and',\n",
       "  'crssnp.'],\n",
       " ['however,',\n",
       "  'il-22r1',\n",
       "  'was',\n",
       "  'only',\n",
       "  'expressed',\n",
       "  'in',\n",
       "  '55%',\n",
       "  'of',\n",
       "  'patients',\n",
       "  'with',\n",
       "  'recalcitrant',\n",
       "  'crswnp.'],\n",
       " ['further',\n",
       "  'research',\n",
       "  'is',\n",
       "  'needed',\n",
       "  'to',\n",
       "  'determine',\n",
       "  'the',\n",
       "  'potential',\n",
       "  'of',\n",
       "  'il-22r1',\n",
       "  'as',\n",
       "  'a',\n",
       "  'therapeutic',\n",
       "  'target',\n",
       "  'in',\n",
       "  'crswnp.'],\n",
       " ['additionally,',\n",
       "  'levels',\n",
       "  'of',\n",
       "  'il22r1',\n",
       "  'were',\n",
       "  'significantly',\n",
       "  'lower',\n",
       "  'in',\n",
       "  'recalcitrant',\n",
       "  'crswnp',\n",
       "  'compared',\n",
       "  'to',\n",
       "  'controls',\n",
       "  'and',\n",
       "  'crssnp.'],\n",
       " ['additionally,',\n",
       "  'levels',\n",
       "  'of',\n",
       "  'il22r1',\n",
       "  'were',\n",
       "  'significantly',\n",
       "  'lower',\n",
       "  'in',\n",
       "  'recalcitrant',\n",
       "  'crswnp',\n",
       "  'compared',\n",
       "  'to',\n",
       "  'controls',\n",
       "  'and',\n",
       "  'crssnp.'],\n",
       " ['failure',\n",
       "  'of',\n",
       "  'medical',\n",
       "  'and',\n",
       "  'surgical',\n",
       "  'therapy',\n",
       "  'in',\n",
       "  'crswnp',\n",
       "  'is',\n",
       "  'associated',\n",
       "  'with',\n",
       "  'significantly',\n",
       "  'decreased',\n",
       "  'expression',\n",
       "  'of',\n",
       "  'il-22r1.'],\n",
       " ['fetuin-a',\n",
       "  'is',\n",
       "  'a',\n",
       "  'calcification',\n",
       "  'inhibitor',\n",
       "  'and',\n",
       "  'correlates',\n",
       "  'negatively',\n",
       "  'with',\n",
       "  'increased',\n",
       "  'vascular',\n",
       "  'stiffness',\n",
       "  'in',\n",
       "  'dialysis',\n",
       "  'patients.'],\n",
       " ['male',\n",
       "  'fetuin-a',\n",
       "  'serser',\n",
       "  'carriers',\n",
       "  'demonstrate',\n",
       "  'particularly',\n",
       "  'high',\n",
       "  'aortic',\n",
       "  'stiffness,',\n",
       "  'possibly',\n",
       "  'implying',\n",
       "  'a',\n",
       "  'status',\n",
       "  'of',\n",
       "  'increased',\n",
       "  'cardiovascular',\n",
       "  'risk.'],\n",
       " ['the',\n",
       "  'fetuin-a',\n",
       "  'polymorphism',\n",
       "  '(thr256ser)',\n",
       "  'is',\n",
       "  'associated',\n",
       "  'with',\n",
       "  'reduced',\n",
       "  'fetuin',\n",
       "  'levels',\n",
       "  'and',\n",
       "  'accelerated',\n",
       "  'vascular',\n",
       "  'calcification',\n",
       "  'in',\n",
       "  'dialysis',\n",
       "  'patients.'],\n",
       " ['egfr',\n",
       "  'gene',\n",
       "  'expression',\n",
       "  'in',\n",
       "  'pancreatic',\n",
       "  'adenocarcinoma',\n",
       "  'cells',\n",
       "  'significantly',\n",
       "  'surpassed',\n",
       "  'that',\n",
       "  'in',\n",
       "  'normal',\n",
       "  'pancreatic',\n",
       "  'cells.'],\n",
       " ['role',\n",
       "  'of',\n",
       "  'epidermal',\n",
       "  'growth',\n",
       "  'factor',\n",
       "  'gene',\n",
       "  'in',\n",
       "  'the',\n",
       "  'development',\n",
       "  'of',\n",
       "  'pancreatic',\n",
       "  'cancer',\n",
       "  'and',\n",
       "  'efficiency',\n",
       "  'of',\n",
       "  'inhibitors',\n",
       "  'of',\n",
       "  'this',\n",
       "  'gene',\n",
       "  'in',\n",
       "  'the',\n",
       "  'treatment',\n",
       "  'of',\n",
       "  'pancreatic',\n",
       "  'carcinoma.'],\n",
       " ['on',\n",
       "  'the',\n",
       "  'other',\n",
       "  'hand,',\n",
       "  'aa',\n",
       "  'genome',\n",
       "  'and',\n",
       "  'a',\n",
       "  'allele',\n",
       "  'polymorphism',\n",
       "  'in',\n",
       "  'the',\n",
       "  'egf',\n",
       "  'gene',\n",
       "  'nucleotide',\n",
       "  'pair',\n",
       "  'g-a',\n",
       "  '61',\n",
       "  'is',\n",
       "  'a',\n",
       "  'significant',\n",
       "  'risk',\n",
       "  'factor',\n",
       "  'for',\n",
       "  'pancreatic',\n",
       "  'cancer.'],\n",
       " ['body',\n",
       "  'height,',\n",
       "  'weight',\n",
       "  'and',\n",
       "  'obesity',\n",
       "  'increase',\n",
       "  'the',\n",
       "  'risk',\n",
       "  'of',\n",
       "  'venous',\n",
       "  'thrombosis,',\n",
       "  'especially',\n",
       "  'obesity',\n",
       "  'in',\n",
       "  'women',\n",
       "  'using',\n",
       "  'oral',\n",
       "  'contraceptives.'],\n",
       " ['cardiovascular',\n",
       "  'thromboembolic',\n",
       "  'adverse',\n",
       "  'effects',\n",
       "  'associated',\n",
       "  'with',\n",
       "  'cyclooxygenase-2',\n",
       "  'selective',\n",
       "  'inhibitors',\n",
       "  'and',\n",
       "  'nonselective',\n",
       "  'antiinflammatory',\n",
       "  'drugs.'],\n",
       " ['cardiovascular',\n",
       "  'thromboembolic',\n",
       "  'adverse',\n",
       "  'effects',\n",
       "  'associated',\n",
       "  'with',\n",
       "  'cyclooxygenase-2',\n",
       "  'selective',\n",
       "  'inhibitors',\n",
       "  'and',\n",
       "  'nonselective',\n",
       "  'antiinflammatory',\n",
       "  'drugs.'],\n",
       " ['the',\n",
       "  'frequency',\n",
       "  'of',\n",
       "  'ponv',\n",
       "  'did',\n",
       "  'not',\n",
       "  'correlate',\n",
       "  'to',\n",
       "  'the',\n",
       "  'amounts',\n",
       "  'of',\n",
       "  'alfentanil,',\n",
       "  'propofol,',\n",
       "  'postoperative',\n",
       "  'antiemetics',\n",
       "  'consumed,',\n",
       "  'or',\n",
       "  'to',\n",
       "  'female',\n",
       "  'gender,',\n",
       "  'non-smoking',\n",
       "  'status,',\n",
       "  'and',\n",
       "  'history',\n",
       "  'of',\n",
       "  'ponv',\n",
       "  'or',\n",
       "  'motion',\n",
       "  'sickness.'],\n",
       " ['the',\n",
       "  'frequency',\n",
       "  'of',\n",
       "  'ponv',\n",
       "  'did',\n",
       "  'not',\n",
       "  'correlate',\n",
       "  'to',\n",
       "  'the',\n",
       "  'amounts',\n",
       "  'of',\n",
       "  'alfentanil,',\n",
       "  'propofol,',\n",
       "  'postoperative',\n",
       "  'antiemetics',\n",
       "  'consumed,',\n",
       "  'or',\n",
       "  'to',\n",
       "  'female',\n",
       "  'gender,',\n",
       "  'non-smoking',\n",
       "  'status,',\n",
       "  'and',\n",
       "  'history',\n",
       "  'of',\n",
       "  'ponv',\n",
       "  'or',\n",
       "  'motion',\n",
       "  'sickness.'],\n",
       " ['however,',\n",
       "  'decreased',\n",
       "  'tear',\n",
       "  'production',\n",
       "  'after',\n",
       "  'botulinum',\n",
       "  'toxin',\n",
       "  'injection',\n",
       "  'for',\n",
       "  \"crow's\",\n",
       "  'feet',\n",
       "  'is',\n",
       "  'a',\n",
       "  'possible',\n",
       "  'complication',\n",
       "  'and',\n",
       "  'patients',\n",
       "  'should',\n",
       "  'be',\n",
       "  'advised',\n",
       "  'of',\n",
       "  'the',\n",
       "  'small',\n",
       "  'but',\n",
       "  'definite',\n",
       "  'risk',\n",
       "  'of',\n",
       "  'a',\n",
       "  'temporary',\n",
       "  'dry',\n",
       "  'eye.'],\n",
       " ['botulinum',\n",
       "  'toxins',\n",
       "  'are',\n",
       "  'potent',\n",
       "  'neurotoxins',\n",
       "  'used',\n",
       "  'in',\n",
       "  'a',\n",
       "  'variety',\n",
       "  'of',\n",
       "  'neurological',\n",
       "  'disorders.'],\n",
       " ['we',\n",
       "  'describe',\n",
       "  'the',\n",
       "  'case',\n",
       "  'of',\n",
       "  'a',\n",
       "  '10-year-old',\n",
       "  'boy',\n",
       "  'who',\n",
       "  'developed',\n",
       "  'systemic',\n",
       "  'weakness',\n",
       "  'following',\n",
       "  'treatment',\n",
       "  'of',\n",
       "  'spasticity',\n",
       "  'with',\n",
       "  'botulinum',\n",
       "  'toxin',\n",
       "  'type',\n",
       "  'b.'],\n",
       " ['we',\n",
       "  'describe',\n",
       "  'the',\n",
       "  'case',\n",
       "  'of',\n",
       "  'a',\n",
       "  '10-year-old',\n",
       "  'boy',\n",
       "  'who',\n",
       "  'developed',\n",
       "  'systemic',\n",
       "  'weakness',\n",
       "  'following',\n",
       "  'treatment',\n",
       "  'of',\n",
       "  'spasticity',\n",
       "  'with',\n",
       "  'botulinum',\n",
       "  'toxin',\n",
       "  'type',\n",
       "  'b.'],\n",
       " ['gingival',\n",
       "  'samples',\n",
       "  'were',\n",
       "  'collected',\n",
       "  'from',\n",
       "  'eight',\n",
       "  'normal',\n",
       "  'healthy',\n",
       "  'individuals,',\n",
       "  'eight',\n",
       "  'patients',\n",
       "  'with',\n",
       "  'periodontitis,',\n",
       "  'and',\n",
       "  'eight',\n",
       "  'patients',\n",
       "  'with',\n",
       "  'cyclosporin',\n",
       "  'a',\n",
       "  '(csa)-induced',\n",
       "  'gingival',\n",
       "  'overgrowth.'],\n",
       " ['et-1',\n",
       "  'mrna',\n",
       "  'expression',\n",
       "  'was',\n",
       "  'significantly',\n",
       "  'higher',\n",
       "  'in',\n",
       "  'patients',\n",
       "  'with',\n",
       "  'csa-induced',\n",
       "  'gingival',\n",
       "  'overgrowth',\n",
       "  '(p',\n",
       "  '<0.001)',\n",
       "  'than',\n",
       "  'in',\n",
       "  'patients',\n",
       "  'with',\n",
       "  'periodontitis',\n",
       "  'and',\n",
       "  'the',\n",
       "  'controls.'],\n",
       " ['et-1',\n",
       "  'mrna',\n",
       "  'expression',\n",
       "  'was',\n",
       "  'significantly',\n",
       "  'higher',\n",
       "  'in',\n",
       "  'patients',\n",
       "  'with',\n",
       "  'csa-induced',\n",
       "  'gingival',\n",
       "  'overgrowth',\n",
       "  '(p',\n",
       "  '<0.001)',\n",
       "  'than',\n",
       "  'in',\n",
       "  'patients',\n",
       "  'with',\n",
       "  'periodontitis',\n",
       "  'and',\n",
       "  'the',\n",
       "  'controls.'],\n",
       " ['these',\n",
       "  'results',\n",
       "  'suggest',\n",
       "  'that',\n",
       "  'csa',\n",
       "  'can',\n",
       "  'modulate',\n",
       "  'the',\n",
       "  'expression',\n",
       "  'of',\n",
       "  'et-1',\n",
       "  'in',\n",
       "  'gingival',\n",
       "  'fibroblasts',\n",
       "  'and',\n",
       "  'csa-induced',\n",
       "  'gingival',\n",
       "  'overgrowth.'],\n",
       " ['gingival',\n",
       "  'samples',\n",
       "  'were',\n",
       "  'collected',\n",
       "  'from',\n",
       "  'eight',\n",
       "  'normal',\n",
       "  'healthy',\n",
       "  'individuals,',\n",
       "  'eight',\n",
       "  'patients',\n",
       "  'with',\n",
       "  'periodontitis,',\n",
       "  'and',\n",
       "  'eight',\n",
       "  'patients',\n",
       "  'with',\n",
       "  'cyclosporin',\n",
       "  'a',\n",
       "  '(csa)-induced',\n",
       "  'gingival',\n",
       "  'overgrowth.'],\n",
       " ['gingival',\n",
       "  'samples',\n",
       "  'were',\n",
       "  'collected',\n",
       "  'from',\n",
       "  'eight',\n",
       "  'normal',\n",
       "  'healthy',\n",
       "  'individuals,',\n",
       "  'eight',\n",
       "  'patients',\n",
       "  'with',\n",
       "  'periodontitis,',\n",
       "  'and',\n",
       "  'eight',\n",
       "  'patients',\n",
       "  'with',\n",
       "  'cyclosporin',\n",
       "  'a',\n",
       "  '(csa)-induced',\n",
       "  'gingival',\n",
       "  'overgrowth.'],\n",
       " ['the',\n",
       "  'evidence',\n",
       "  'suggests',\n",
       "  'that',\n",
       "  'montelukast',\n",
       "  'is',\n",
       "  'an',\n",
       "  'effective',\n",
       "  'monotherapy',\n",
       "  'controller',\n",
       "  'in',\n",
       "  'children',\n",
       "  'with',\n",
       "  'mild',\n",
       "  'asthma.'],\n",
       " ['review',\n",
       "  'of',\n",
       "  'recent',\n",
       "  'results',\n",
       "  'of',\n",
       "  'montelukast',\n",
       "  'use',\n",
       "  'as',\n",
       "  'a',\n",
       "  'monotherapy',\n",
       "  'in',\n",
       "  'children',\n",
       "  'with',\n",
       "  'mild',\n",
       "  'asthma.'],\n",
       " ['this',\n",
       "  'article',\n",
       "  'reviewed',\n",
       "  'recent',\n",
       "  'results',\n",
       "  'from',\n",
       "  'randomized,',\n",
       "  'double-blind',\n",
       "  'studies',\n",
       "  'of',\n",
       "  'children',\n",
       "  'with',\n",
       "  'mild',\n",
       "  'asthma',\n",
       "  'treated',\n",
       "  'with',\n",
       "  'montelukast,',\n",
       "  'a',\n",
       "  'leukotriene',\n",
       "  'receptor',\n",
       "  'antagonist',\n",
       "  'that',\n",
       "  'is',\n",
       "  'approved',\n",
       "  'for',\n",
       "  'the',\n",
       "  'treatment',\n",
       "  'of',\n",
       "  'asthma',\n",
       "  'and',\n",
       "  'allergic',\n",
       "  'rhinitis',\n",
       "  'in',\n",
       "  'children',\n",
       "  'and',\n",
       "  'adults.'],\n",
       " ['a',\n",
       "  'literature',\n",
       "  'search',\n",
       "  'of',\n",
       "  'medline',\n",
       "  'was',\n",
       "  'conducted',\n",
       "  'to',\n",
       "  'gather',\n",
       "  'relevant,',\n",
       "  'english-language',\n",
       "  'articles',\n",
       "  'using',\n",
       "  'search',\n",
       "  'terms',\n",
       "  'such',\n",
       "  'as',\n",
       "  'randomized',\n",
       "  'controlled',\n",
       "  'studies,',\n",
       "  'double-blind',\n",
       "  'studies,',\n",
       "  'montelukast,',\n",
       "  'leukotriene',\n",
       "  'receptor',\n",
       "  'antagonist,',\n",
       "  'pediatric',\n",
       "  'asthma,',\n",
       "  'mild',\n",
       "  'asthma,',\n",
       "  'exercise-induced',\n",
       "  'asthma,',\n",
       "  'and',\n",
       "  'bronchoconstriction.'],\n",
       " ['the',\n",
       "  'results',\n",
       "  'from',\n",
       "  'these',\n",
       "  'studies,',\n",
       "  'encompassing',\n",
       "  'end',\n",
       "  'points',\n",
       "  'measuring',\n",
       "  'lung',\n",
       "  'function',\n",
       "  'and',\n",
       "  'symptoms,',\n",
       "  'found',\n",
       "  'that',\n",
       "  'montelukast',\n",
       "  'provided',\n",
       "  'effective',\n",
       "  'and',\n",
       "  'beneficial',\n",
       "  'asthma',\n",
       "  'control',\n",
       "  'to',\n",
       "  'children',\n",
       "  'aged',\n",
       "  '2',\n",
       "  'to',\n",
       "  '14',\n",
       "  'years',\n",
       "  'with',\n",
       "  'mild',\n",
       "  'asthma.'],\n",
       " ['this',\n",
       "  'article',\n",
       "  'reviewed',\n",
       "  'recent',\n",
       "  'results',\n",
       "  'from',\n",
       "  'randomized,',\n",
       "  'double-blind',\n",
       "  'studies',\n",
       "  'of',\n",
       "  'children',\n",
       "  'with',\n",
       "  'mild',\n",
       "  'asthma',\n",
       "  'treated',\n",
       "  'with',\n",
       "  'montelukast,',\n",
       "  'a',\n",
       "  'leukotriene',\n",
       "  'receptor',\n",
       "  'antagonist',\n",
       "  'that',\n",
       "  'is',\n",
       "  'approved',\n",
       "  'for',\n",
       "  'the',\n",
       "  'treatment',\n",
       "  'of',\n",
       "  'asthma',\n",
       "  'and',\n",
       "  'allergic',\n",
       "  'rhinitis',\n",
       "  'in',\n",
       "  'children',\n",
       "  'and',\n",
       "  'adults.'],\n",
       " ['the',\n",
       "  'combination',\n",
       "  'of',\n",
       "  'high-dose',\n",
       "  'mtx',\n",
       "  'with',\n",
       "  'procarbazine',\n",
       "  'and',\n",
       "  'ccnu',\n",
       "  'is',\n",
       "  'feasible',\n",
       "  'and',\n",
       "  'effective',\n",
       "  'and',\n",
       "  'results',\n",
       "  'in',\n",
       "  'a',\n",
       "  'low',\n",
       "  'rate',\n",
       "  'of',\n",
       "  'leukoencephalopathy.'],\n",
       " ['the',\n",
       "  'combination',\n",
       "  'of',\n",
       "  'high-dose',\n",
       "  'mtx',\n",
       "  'with',\n",
       "  'procarbazine',\n",
       "  'and',\n",
       "  'ccnu',\n",
       "  'is',\n",
       "  'feasible',\n",
       "  'and',\n",
       "  'effective',\n",
       "  'and',\n",
       "  'results',\n",
       "  'in',\n",
       "  'a',\n",
       "  'low',\n",
       "  'rate',\n",
       "  'of',\n",
       "  'leukoencephalopathy.'],\n",
       " ['the',\n",
       "  'combination',\n",
       "  'of',\n",
       "  'high-dose',\n",
       "  'mtx',\n",
       "  'with',\n",
       "  'procarbazine',\n",
       "  'and',\n",
       "  'ccnu',\n",
       "  'is',\n",
       "  'feasible',\n",
       "  'and',\n",
       "  'effective',\n",
       "  'and',\n",
       "  'results',\n",
       "  'in',\n",
       "  'a',\n",
       "  'low',\n",
       "  'rate',\n",
       "  'of',\n",
       "  'leukoencephalopathy.'],\n",
       " ['intra-articular',\n",
       "  'injection',\n",
       "  'of',\n",
       "  'lidocaine',\n",
       "  'before',\n",
       "  'closed',\n",
       "  'reduction',\n",
       "  'of',\n",
       "  'anterior',\n",
       "  'shoulder',\n",
       "  'dislocation',\n",
       "  'produces',\n",
       "  'the',\n",
       "  'same',\n",
       "  'pain',\n",
       "  'relief',\n",
       "  'as',\n",
       "  'intravenous',\n",
       "  'meperidine',\n",
       "  'and',\n",
       "  'diazepam.'],\n",
       " ['intra-articular',\n",
       "  'injection',\n",
       "  'of',\n",
       "  'lidocaine',\n",
       "  'before',\n",
       "  'closed',\n",
       "  'reduction',\n",
       "  'of',\n",
       "  'anterior',\n",
       "  'shoulder',\n",
       "  'dislocation',\n",
       "  'produces',\n",
       "  'the',\n",
       "  'same',\n",
       "  'pain',\n",
       "  'relief',\n",
       "  'as',\n",
       "  'intravenous',\n",
       "  'meperidine',\n",
       "  'and',\n",
       "  'diazepam.'],\n",
       " ['intra-articular',\n",
       "  'injection',\n",
       "  'of',\n",
       "  'lidocaine',\n",
       "  'before',\n",
       "  'closed',\n",
       "  'reduction',\n",
       "  'of',\n",
       "  'anterior',\n",
       "  'shoulder',\n",
       "  'dislocation',\n",
       "  'produces',\n",
       "  'the',\n",
       "  'same',\n",
       "  'pain',\n",
       "  'relief',\n",
       "  'as',\n",
       "  'intravenous',\n",
       "  'meperidine',\n",
       "  'and',\n",
       "  'diazepam.'],\n",
       " ['intra-articular',\n",
       "  'injection',\n",
       "  'of',\n",
       "  'lidocaine',\n",
       "  'before',\n",
       "  'closed',\n",
       "  'reduction',\n",
       "  'of',\n",
       "  'anterior',\n",
       "  'shoulder',\n",
       "  'dislocation',\n",
       "  'produces',\n",
       "  'the',\n",
       "  'same',\n",
       "  'pain',\n",
       "  'relief',\n",
       "  'as',\n",
       "  'intravenous',\n",
       "  'meperidine',\n",
       "  'and',\n",
       "  'diazepam.'],\n",
       " ['intra-articular',\n",
       "  'injection',\n",
       "  'of',\n",
       "  'lidocaine',\n",
       "  'before',\n",
       "  'closed',\n",
       "  'reduction',\n",
       "  'of',\n",
       "  'anterior',\n",
       "  'shoulder',\n",
       "  'dislocation',\n",
       "  'produces',\n",
       "  'the',\n",
       "  'same',\n",
       "  'pain',\n",
       "  'relief',\n",
       "  'as',\n",
       "  'intravenous',\n",
       "  'meperidine',\n",
       "  'and',\n",
       "  'diazepam.'],\n",
       " ['mean',\n",
       "  'pain',\n",
       "  '(mm)',\n",
       "  'recorded',\n",
       "  'before',\n",
       "  'injection,',\n",
       "  'before',\n",
       "  'reduction,',\n",
       "  'and',\n",
       "  'after',\n",
       "  'reduction',\n",
       "  'in',\n",
       "  'the',\n",
       "  'intra-articular',\n",
       "  'lidocaine',\n",
       "  'group',\n",
       "  'was',\n",
       "  '84.3',\n",
       "  '(95%',\n",
       "  'confidence',\n",
       "  'interval',\n",
       "  '(ci)',\n",
       "  '79.8',\n",
       "  'to',\n",
       "  '88.8),',\n",
       "  '52.6',\n",
       "  '(95%',\n",
       "  'ci',\n",
       "  '45.2',\n",
       "  'to',\n",
       "  '60.1),',\n",
       "  'and',\n",
       "  '27.3',\n",
       "  '(95%',\n",
       "  'ci',\n",
       "  '19.9',\n",
       "  'to',\n",
       "  '34.7),',\n",
       "  'respectively.'],\n",
       " ['intra-articular',\n",
       "  'injection',\n",
       "  'of',\n",
       "  'lidocaine',\n",
       "  'before',\n",
       "  'closed',\n",
       "  'reduction',\n",
       "  'of',\n",
       "  'anterior',\n",
       "  'shoulder',\n",
       "  'dislocation',\n",
       "  'produces',\n",
       "  'the',\n",
       "  'same',\n",
       "  'pain',\n",
       "  'relief',\n",
       "  'as',\n",
       "  'intravenous',\n",
       "  'meperidine',\n",
       "  'and',\n",
       "  'diazepam.'],\n",
       " ['the',\n",
       "  'aim',\n",
       "  'of',\n",
       "  'this',\n",
       "  'study',\n",
       "  'was',\n",
       "  'to',\n",
       "  'evaluate',\n",
       "  'the',\n",
       "  'effects',\n",
       "  'of',\n",
       "  'indomethacin-loaded',\n",
       "  'nanocapsules',\n",
       "  'and',\n",
       "  'indomethacin',\n",
       "  'ethyl',\n",
       "  'ester-loaded',\n",
       "  'nanocapsules',\n",
       "  'on',\n",
       "  'glioma',\n",
       "  'cell',\n",
       "  'lines.'],\n",
       " ['another',\n",
       "  'important',\n",
       "  'finding',\n",
       "  'was',\n",
       "  'that',\n",
       "  'the',\n",
       "  'cytotoxic',\n",
       "  'effect',\n",
       "  'induced',\n",
       "  'by',\n",
       "  '25',\n",
       "  'microm',\n",
       "  'or',\n",
       "  '50',\n",
       "  'microm',\n",
       "  'of',\n",
       "  'indomethacin-loaded',\n",
       "  'nanocapsules',\n",
       "  'or',\n",
       "  'indomethacin',\n",
       "  'ethyl',\n",
       "  'ester-loaded',\n",
       "  'nanocapsules,',\n",
       "  'in',\n",
       "  'glioma',\n",
       "  'cells',\n",
       "  'was',\n",
       "  'not',\n",
       "  'observed',\n",
       "  'in',\n",
       "  'the',\n",
       "  'organotypic',\n",
       "  'cultures,',\n",
       "  'indicating',\n",
       "  'selective',\n",
       "  'cytotoxicity',\n",
       "  'of',\n",
       "  'those',\n",
       "  'formulations',\n",
       "  'for',\n",
       "  'tumoral',\n",
       "  'cells.'],\n",
       " ['selective',\n",
       "  'cytotoxicity',\n",
       "  'of',\n",
       "  'indomethacin',\n",
       "  'and',\n",
       "  'indomethacin',\n",
       "  'ethyl',\n",
       "  'ester-loaded',\n",
       "  'nanocapsules',\n",
       "  'against',\n",
       "  'glioma',\n",
       "  'cell',\n",
       "  'lines:',\n",
       "  'an',\n",
       "  'in',\n",
       "  'vitro',\n",
       "  'study.'],\n",
       " ['the',\n",
       "  'main',\n",
       "  'finding',\n",
       "  'of',\n",
       "  'the',\n",
       "  'present',\n",
       "  'study',\n",
       "  'is',\n",
       "  'that',\n",
       "  'indomethacin-loaded',\n",
       "  'nanocapsules',\n",
       "  'formulation',\n",
       "  'was',\n",
       "  'more',\n",
       "  'potent',\n",
       "  'than',\n",
       "  'a',\n",
       "  'solution',\n",
       "  'of',\n",
       "  'indomethacin',\n",
       "  'in',\n",
       "  'decreasing',\n",
       "  'the',\n",
       "  'viability',\n",
       "  'and',\n",
       "  'cell',\n",
       "  'proliferation',\n",
       "  'of',\n",
       "  'glioma',\n",
       "  'lines.'],\n",
       " ['the',\n",
       "  'main',\n",
       "  'finding',\n",
       "  'of',\n",
       "  'the',\n",
       "  'present',\n",
       "  'study',\n",
       "  'is',\n",
       "  'that',\n",
       "  'indomethacin-loaded',\n",
       "  'nanocapsules',\n",
       "  'formulation',\n",
       "  'was',\n",
       "  'more',\n",
       "  'potent',\n",
       "  'than',\n",
       "  'a',\n",
       "  'solution',\n",
       "  'of',\n",
       "  'indomethacin',\n",
       "  'in',\n",
       "  'decreasing',\n",
       "  'the',\n",
       "  'viability',\n",
       "  'and',\n",
       "  'cell',\n",
       "  'proliferation',\n",
       "  'of',\n",
       "  'glioma',\n",
       "  'lines.'],\n",
       " ['in',\n",
       "  'addition,',\n",
       "  'when',\n",
       "  'the',\n",
       "  'glioma',\n",
       "  'cells',\n",
       "  'were',\n",
       "  'exposed',\n",
       "  'to',\n",
       "  '25',\n",
       "  'microm',\n",
       "  'of',\n",
       "  'indomethacin-loaded',\n",
       "  'nanocapsules',\n",
       "  'or',\n",
       "  'indomethacin',\n",
       "  'ethyl',\n",
       "  'ester-loaded',\n",
       "  'nanocapsules,',\n",
       "  'a',\n",
       "  'necrotic',\n",
       "  'cell',\n",
       "  'death',\n",
       "  'was',\n",
       "  'observed.'],\n",
       " ['selective',\n",
       "  'cytotoxicity',\n",
       "  'of',\n",
       "  'indomethacin',\n",
       "  'and',\n",
       "  'indomethacin',\n",
       "  'ethyl',\n",
       "  'ester-loaded',\n",
       "  'nanocapsules',\n",
       "  'against',\n",
       "  'glioma',\n",
       "  'cell',\n",
       "  'lines:',\n",
       "  'an',\n",
       "  'in',\n",
       "  'vitro',\n",
       "  'study.'],\n",
       " ['in',\n",
       "  'addition,',\n",
       "  'when',\n",
       "  'the',\n",
       "  'glioma',\n",
       "  'cells',\n",
       "  'were',\n",
       "  'exposed',\n",
       "  'to',\n",
       "  '25',\n",
       "  'microm',\n",
       "  'of',\n",
       "  'indomethacin-loaded',\n",
       "  'nanocapsules',\n",
       "  'or',\n",
       "  'indomethacin',\n",
       "  'ethyl',\n",
       "  'ester-loaded',\n",
       "  'nanocapsules,',\n",
       "  'a',\n",
       "  'necrotic',\n",
       "  'cell',\n",
       "  'death',\n",
       "  'was',\n",
       "  'observed.'],\n",
       " ['another',\n",
       "  'important',\n",
       "  'finding',\n",
       "  'was',\n",
       "  'that',\n",
       "  'the',\n",
       "  'cytotoxic',\n",
       "  'effect',\n",
       "  'induced',\n",
       "  'by',\n",
       "  '25',\n",
       "  'microm',\n",
       "  'or',\n",
       "  '50',\n",
       "  'microm',\n",
       "  'of',\n",
       "  'indomethacin-loaded',\n",
       "  'nanocapsules',\n",
       "  'or',\n",
       "  'indomethacin',\n",
       "  'ethyl',\n",
       "  'ester-loaded',\n",
       "  'nanocapsules,',\n",
       "  'in',\n",
       "  'glioma',\n",
       "  'cells',\n",
       "  'was',\n",
       "  'not',\n",
       "  'observed',\n",
       "  'in',\n",
       "  'the',\n",
       "  'organotypic',\n",
       "  'cultures,',\n",
       "  'indicating',\n",
       "  'selective',\n",
       "  'cytotoxicity',\n",
       "  'of',\n",
       "  'those',\n",
       "  'formulations',\n",
       "  'for',\n",
       "  'tumoral',\n",
       "  'cells.'],\n",
       " ['further',\n",
       "  'investigations',\n",
       "  'using',\n",
       "  'in',\n",
       "  'vivo',\n",
       "  'glioma',\n",
       "  'model',\n",
       "  'should',\n",
       "  'be',\n",
       "  'helpful',\n",
       "  'to',\n",
       "  'confirm',\n",
       "  'the',\n",
       "  'distinct',\n",
       "  'effects',\n",
       "  'of',\n",
       "  'indomethacin-loaded',\n",
       "  'nanocapsules',\n",
       "  'and',\n",
       "  'indomethacin',\n",
       "  'ethyl',\n",
       "  'ester-loaded',\n",
       "  'nanocapsules,',\n",
       "  'in',\n",
       "  'normal',\n",
       "  'versus',\n",
       "  'tumoral',\n",
       "  'cells.'],\n",
       " ['the',\n",
       "  'aim',\n",
       "  'of',\n",
       "  'this',\n",
       "  'study',\n",
       "  'was',\n",
       "  'to',\n",
       "  'evaluate',\n",
       "  'the',\n",
       "  'effects',\n",
       "  'of',\n",
       "  'indomethacin-loaded',\n",
       "  'nanocapsules',\n",
       "  'and',\n",
       "  'indomethacin',\n",
       "  'ethyl',\n",
       "  'ester-loaded',\n",
       "  'nanocapsules',\n",
       "  'on',\n",
       "  'glioma',\n",
       "  'cell',\n",
       "  'lines.'],\n",
       " ['indomethacin',\n",
       "  'and',\n",
       "  'indomethacin',\n",
       "  'ethyl',\n",
       "  'ester',\n",
       "  'associated',\n",
       "  'together',\n",
       "  'in',\n",
       "  'the',\n",
       "  'same',\n",
       "  'nanocapsule',\n",
       "  'formulation',\n",
       "  'caused',\n",
       "  'a',\n",
       "  'synergic',\n",
       "  'effect',\n",
       "  'decreasing',\n",
       "  'glioma',\n",
       "  'cell',\n",
       "  'proliferation.'],\n",
       " ['indomethacin',\n",
       "  'and',\n",
       "  'indomethacin',\n",
       "  'ethyl',\n",
       "  'ester',\n",
       "  'associated',\n",
       "  'together',\n",
       "  'in',\n",
       "  'the',\n",
       "  'same',\n",
       "  'nanocapsule',\n",
       "  'formulation',\n",
       "  'caused',\n",
       "  'a',\n",
       "  'synergic',\n",
       "  'effect',\n",
       "  'decreasing',\n",
       "  'glioma',\n",
       "  'cell',\n",
       "  'proliferation.'],\n",
       " ['interestingly,',\n",
       "  '5',\n",
       "  'microm',\n",
       "  'of',\n",
       "  'indomethacin-loaded',\n",
       "  'nanocapsules',\n",
       "  'was',\n",
       "  'able',\n",
       "  'to',\n",
       "  'cause',\n",
       "  'an',\n",
       "  'antiproliferative',\n",
       "  'effect',\n",
       "  'without',\n",
       "  'promoting',\n",
       "  'necrosis',\n",
       "  'in',\n",
       "  'glioma',\n",
       "  'cells.'],\n",
       " ['further',\n",
       "  'investigations',\n",
       "  'using',\n",
       "  'in',\n",
       "  'vivo',\n",
       "  'glioma',\n",
       "  'model',\n",
       "  'should',\n",
       "  'be',\n",
       "  'helpful',\n",
       "  'to',\n",
       "  'confirm',\n",
       "  'the',\n",
       "  'distinct',\n",
       "  'effects',\n",
       "  'of',\n",
       "  'indomethacin-loaded',\n",
       "  'nanocapsules',\n",
       "  'and',\n",
       "  'indomethacin',\n",
       "  'ethyl',\n",
       "  'ester-loaded',\n",
       "  'nanocapsules,',\n",
       "  'in',\n",
       "  'normal',\n",
       "  'versus',\n",
       "  'tumoral',\n",
       "  'cells.'],\n",
       " ['quantification',\n",
       "  'of',\n",
       "  'circulating',\n",
       "  'varicella-zoster',\n",
       "  'virus',\n",
       "  'dna',\n",
       "  'for',\n",
       "  'follow-up',\n",
       "  'in',\n",
       "  'a',\n",
       "  'case',\n",
       "  'of',\n",
       "  'visceral',\n",
       "  'varicella-zoster',\n",
       "  'infection',\n",
       "  'ameliorated',\n",
       "  'with',\n",
       "  'intravenous',\n",
       "  'acyclovir.'],\n",
       " ['we',\n",
       "  'describe',\n",
       "  'a',\n",
       "  'patient',\n",
       "  'with',\n",
       "  'acute',\n",
       "  'lymphocytic',\n",
       "  'leukemia',\n",
       "  '(all)',\n",
       "  'who',\n",
       "  'developed',\n",
       "  'visceral',\n",
       "  'varicella-zoster',\n",
       "  'virus',\n",
       "  '(vzv)',\n",
       "  'infection',\n",
       "  'following',\n",
       "  'cord',\n",
       "  'blood',\n",
       "  'stem',\n",
       "  'cell',\n",
       "  'transplantation',\n",
       "  '(cbsct)',\n",
       "  'and',\n",
       "  'was',\n",
       "  'successfully',\n",
       "  'treated',\n",
       "  'with',\n",
       "  'intravenous',\n",
       "  'acyclovir',\n",
       "  '(acv).'],\n",
       " ['we',\n",
       "  'describe',\n",
       "  'a',\n",
       "  'patient',\n",
       "  'with',\n",
       "  'acute',\n",
       "  'lymphocytic',\n",
       "  'leukemia',\n",
       "  '(all)',\n",
       "  'who',\n",
       "  'developed',\n",
       "  'visceral',\n",
       "  'varicella-zoster',\n",
       "  'virus',\n",
       "  '(vzv)',\n",
       "  'infection',\n",
       "  'following',\n",
       "  'cord',\n",
       "  'blood',\n",
       "  'stem',\n",
       "  'cell',\n",
       "  'transplantation',\n",
       "  '(cbsct)',\n",
       "  'and',\n",
       "  'was',\n",
       "  'successfully',\n",
       "  'treated',\n",
       "  'with',\n",
       "  'intravenous',\n",
       "  'acyclovir',\n",
       "  '(acv).'],\n",
       " ['available',\n",
       "  'studies',\n",
       "  'in',\n",
       "  'the',\n",
       "  'literature',\n",
       "  'using',\n",
       "  'clozapine',\n",
       "  'in',\n",
       "  'the',\n",
       "  'pediatric',\n",
       "  'population',\n",
       "  'are',\n",
       "  'summarized',\n",
       "  'and',\n",
       "  'the',\n",
       "  'nimh',\n",
       "  'experience',\n",
       "  'in',\n",
       "  'treating',\n",
       "  'refractory',\n",
       "  'childhood-onset',\n",
       "  'schizophrenia',\n",
       "  'cases',\n",
       "  'with',\n",
       "  'clozapine',\n",
       "  'is',\n",
       "  'discussed.'],\n",
       " ['although',\n",
       "  'the',\n",
       "  'role',\n",
       "  'of',\n",
       "  'clozapine',\n",
       "  'is',\n",
       "  'well',\n",
       "  'established',\n",
       "  'for',\n",
       "  'treatment-resistant',\n",
       "  'schizophrenia,',\n",
       "  'it',\n",
       "  'is',\n",
       "  'rarely',\n",
       "  'used',\n",
       "  'in',\n",
       "  'pediatric',\n",
       "  'populations,',\n",
       "  'mainly',\n",
       "  'due',\n",
       "  'to',\n",
       "  'its',\n",
       "  'potentially',\n",
       "  'serious',\n",
       "  'adverse',\n",
       "  'effects.'],\n",
       " ['to',\n",
       "  'summarize',\n",
       "  'practical',\n",
       "  'aspects',\n",
       "  'of',\n",
       "  'use',\n",
       "  'of',\n",
       "  'clozapine',\n",
       "  'in',\n",
       "  'treating',\n",
       "  'children',\n",
       "  'with',\n",
       "  'schizophrenia',\n",
       "  'and',\n",
       "  'management',\n",
       "  'of',\n",
       "  'associated',\n",
       "  'adverse',\n",
       "  'effects.'],\n",
       " ['despite',\n",
       "  'a',\n",
       "  'higher',\n",
       "  'incidence',\n",
       "  'of',\n",
       "  'adverse',\n",
       "  'effects',\n",
       "  'in',\n",
       "  'children,',\n",
       "  'clozapine',\n",
       "  'appears',\n",
       "  'to',\n",
       "  'be',\n",
       "  'a',\n",
       "  'uniquely',\n",
       "  'beneficial',\n",
       "  'second-line',\n",
       "  'agent',\n",
       "  'for',\n",
       "  'treating',\n",
       "  'children',\n",
       "  'with',\n",
       "  'refractory',\n",
       "  'schizophrenia.'],\n",
       " ['keratoacanthoma',\n",
       "  'occurring',\n",
       "  'within',\n",
       "  'the',\n",
       "  'red',\n",
       "  'dye',\n",
       "  'of',\n",
       "  'a',\n",
       "  'tattoo.'],\n",
       " ['past',\n",
       "  'use',\n",
       "  'of',\n",
       "  'antimetabolites,',\n",
       "  't-cell',\n",
       "  'inhibitors,',\n",
       "  'alkylating',\n",
       "  'agents,',\n",
       "  'and',\n",
       "  'other',\n",
       "  'immunosuppressives',\n",
       "  'is',\n",
       "  'ascertained',\n",
       "  'from',\n",
       "  'medical',\n",
       "  'records',\n",
       "  'of',\n",
       "  'approximately',\n",
       "  '9,250',\n",
       "  'ocular',\n",
       "  'inflammation',\n",
       "  'patients',\n",
       "  'at',\n",
       "  'five',\n",
       "  'tertiary',\n",
       "  'centers',\n",
       "  'over',\n",
       "  'up',\n",
       "  'to',\n",
       "  '30',\n",
       "  'years.'],\n",
       " ['information',\n",
       "  'from',\n",
       "  'the',\n",
       "  'site',\n",
       "  'cohort',\n",
       "  'study',\n",
       "  'should',\n",
       "  'clarify',\n",
       "  'whether',\n",
       "  'use',\n",
       "  'of',\n",
       "  'these',\n",
       "  'immunosuppressive',\n",
       "  'drugs',\n",
       "  'for',\n",
       "  'ocular',\n",
       "  'inflammation',\n",
       "  'increases',\n",
       "  'the',\n",
       "  'risk',\n",
       "  'of',\n",
       "  'mortality',\n",
       "  'and',\n",
       "  'fatal',\n",
       "  'cancer.'],\n",
       " ['calculated',\n",
       "  'detectable',\n",
       "  'differences',\n",
       "  'for',\n",
       "  'mortality/fatal',\n",
       "  'malignancy',\n",
       "  'with',\n",
       "  'respect',\n",
       "  'to',\n",
       "  'the',\n",
       "  'general',\n",
       "  'population',\n",
       "  'are',\n",
       "  '22%/49%',\n",
       "  'for',\n",
       "  'antimetabolites,',\n",
       "  '28%/62%',\n",
       "  'for',\n",
       "  't-cell',\n",
       "  'inhibitors,',\n",
       "  'and',\n",
       "  '36%/81%',\n",
       "  'for',\n",
       "  'alkylating',\n",
       "  'agents.'],\n",
       " ['past',\n",
       "  'use',\n",
       "  'of',\n",
       "  'antimetabolites,',\n",
       "  't-cell',\n",
       "  'inhibitors,',\n",
       "  'alkylating',\n",
       "  'agents,',\n",
       "  'and',\n",
       "  'other',\n",
       "  'immunosuppressives',\n",
       "  'is',\n",
       "  'ascertained',\n",
       "  'from',\n",
       "  'medical',\n",
       "  'records',\n",
       "  'of',\n",
       "  'approximately',\n",
       "  '9,250',\n",
       "  'ocular',\n",
       "  'inflammation',\n",
       "  'patients',\n",
       "  'at',\n",
       "  'five',\n",
       "  'tertiary',\n",
       "  'centers',\n",
       "  'over',\n",
       "  'up',\n",
       "  'to',\n",
       "  '30',\n",
       "  'years.'],\n",
       " ['past',\n",
       "  'use',\n",
       "  'of',\n",
       "  'antimetabolites,',\n",
       "  't-cell',\n",
       "  'inhibitors,',\n",
       "  'alkylating',\n",
       "  'agents,',\n",
       "  'and',\n",
       "  'other',\n",
       "  'immunosuppressives',\n",
       "  'is',\n",
       "  'ascertained',\n",
       "  'from',\n",
       "  'medical',\n",
       "  'records',\n",
       "  'of',\n",
       "  'approximately',\n",
       "  '9,250',\n",
       "  'ocular',\n",
       "  'inflammation',\n",
       "  'patients',\n",
       "  'at',\n",
       "  'five',\n",
       "  'tertiary',\n",
       "  'centers',\n",
       "  'over',\n",
       "  'up',\n",
       "  'to',\n",
       "  '30',\n",
       "  'years.'],\n",
       " ['calculated',\n",
       "  'detectable',\n",
       "  'differences',\n",
       "  'for',\n",
       "  'mortality/fatal',\n",
       "  'malignancy',\n",
       "  'with',\n",
       "  'respect',\n",
       "  'to',\n",
       "  'the',\n",
       "  'general',\n",
       "  'population',\n",
       "  'are',\n",
       "  '22%/49%',\n",
       "  'for',\n",
       "  'antimetabolites,',\n",
       "  '28%/62%',\n",
       "  'for',\n",
       "  't-cell',\n",
       "  'inhibitors,',\n",
       "  'and',\n",
       "  '36%/81%',\n",
       "  'for',\n",
       "  'alkylating',\n",
       "  'agents.'],\n",
       " ['information',\n",
       "  'from',\n",
       "  'the',\n",
       "  'site',\n",
       "  'cohort',\n",
       "  'study',\n",
       "  'should',\n",
       "  'clarify',\n",
       "  'whether',\n",
       "  'use',\n",
       "  'of',\n",
       "  'these',\n",
       "  'immunosuppressive',\n",
       "  'drugs',\n",
       "  'for',\n",
       "  'ocular',\n",
       "  'inflammation',\n",
       "  'increases',\n",
       "  'the',\n",
       "  'risk',\n",
       "  'of',\n",
       "  'mortality',\n",
       "  'and',\n",
       "  'fatal',\n",
       "  'cancer.'],\n",
       " ['past',\n",
       "  'use',\n",
       "  'of',\n",
       "  'antimetabolites,',\n",
       "  't-cell',\n",
       "  'inhibitors,',\n",
       "  'alkylating',\n",
       "  'agents,',\n",
       "  'and',\n",
       "  'other',\n",
       "  'immunosuppressives',\n",
       "  'is',\n",
       "  'ascertained',\n",
       "  'from',\n",
       "  'medical',\n",
       "  'records',\n",
       "  'of',\n",
       "  'approximately',\n",
       "  '9,250',\n",
       "  'ocular',\n",
       "  'inflammation',\n",
       "  'patients',\n",
       "  'at',\n",
       "  'five',\n",
       "  'tertiary',\n",
       "  'centers',\n",
       "  'over',\n",
       "  'up',\n",
       "  'to',\n",
       "  '30',\n",
       "  'years.'],\n",
       " ['calculated',\n",
       "  'detectable',\n",
       "  'differences',\n",
       "  'for',\n",
       "  'mortality/fatal',\n",
       "  'malignancy',\n",
       "  'with',\n",
       "  'respect',\n",
       "  'to',\n",
       "  'the',\n",
       "  'general',\n",
       "  'population',\n",
       "  'are',\n",
       "  '22%/49%',\n",
       "  'for',\n",
       "  'antimetabolites,',\n",
       "  '28%/62%',\n",
       "  'for',\n",
       "  't-cell',\n",
       "  'inhibitors,',\n",
       "  'and',\n",
       "  '36%/81%',\n",
       "  'for',\n",
       "  'alkylating',\n",
       "  'agents.'],\n",
       " ['there',\n",
       "  'were',\n",
       "  'consistent',\n",
       "  'significant',\n",
       "  'miosis',\n",
       "  'in',\n",
       "  'the',\n",
       "  'right',\n",
       "  'eyes',\n",
       "  'with',\n",
       "  'instilled',\n",
       "  'garcinia',\n",
       "  'kola',\n",
       "  'nut',\n",
       "  'extract',\n",
       "  'compared',\n",
       "  'to',\n",
       "  'the',\n",
       "  'left',\n",
       "  'eyes',\n",
       "  'at',\n",
       "  '15,',\n",
       "  '30',\n",
       "  'and',\n",
       "  '45',\n",
       "  'minutes',\n",
       "  '(p=0.0000).'],\n",
       " ['there',\n",
       "  'is',\n",
       "  'evidence',\n",
       "  'in',\n",
       "  'the',\n",
       "  'literature',\n",
       "  'that',\n",
       "  'inhaled',\n",
       "  'corticosteroids',\n",
       "  '(icss)',\n",
       "  'are',\n",
       "  'safe',\n",
       "  'for',\n",
       "  'pregnant',\n",
       "  'women',\n",
       "  'with',\n",
       "  'asthma',\n",
       "  'and',\n",
       "  'their',\n",
       "  'infants.'],\n",
       " ['there',\n",
       "  'is',\n",
       "  'evidence',\n",
       "  'in',\n",
       "  'the',\n",
       "  'literature',\n",
       "  'that',\n",
       "  'inhaled',\n",
       "  'corticosteroids',\n",
       "  '(icss)',\n",
       "  'are',\n",
       "  'safe',\n",
       "  'for',\n",
       "  'pregnant',\n",
       "  'women',\n",
       "  'with',\n",
       "  'asthma',\n",
       "  'and',\n",
       "  'their',\n",
       "  'infants.'],\n",
       " ['an',\n",
       "  'inverse',\n",
       "  'trend',\n",
       "  'was',\n",
       "  'observed',\n",
       "  'between',\n",
       "  'dose',\n",
       "  'and',\n",
       "  'multiplicity',\n",
       "  'of',\n",
       "  'colonic',\n",
       "  'dysplasias',\n",
       "  'in',\n",
       "  'all',\n",
       "  'drug-treated',\n",
       "  'groups',\n",
       "  '(p',\n",
       "  '=',\n",
       "  '0.03),',\n",
       "  'with',\n",
       "  'animals',\n",
       "  'receiving',\n",
       "  '75',\n",
       "  'mg/kg',\n",
       "  '5-asa',\n",
       "  'exhibiting',\n",
       "  '56%',\n",
       "  'of',\n",
       "  'the',\n",
       "  'number',\n",
       "  'of',\n",
       "  'dysplasias',\n",
       "  'of',\n",
       "  'the',\n",
       "  'aom/dss',\n",
       "  'controls',\n",
       "  '(mean',\n",
       "  '+/-',\n",
       "  'sem:',\n",
       "  '7.6',\n",
       "  '+/-',\n",
       "  '1.4',\n",
       "  'and',\n",
       "  '13.6',\n",
       "  '+/-',\n",
       "  '2.7,',\n",
       "  'respectively).'],\n",
       " ['an',\n",
       "  'inverse',\n",
       "  'trend',\n",
       "  'was',\n",
       "  'observed',\n",
       "  'between',\n",
       "  'dose',\n",
       "  'and',\n",
       "  'multiplicity',\n",
       "  'of',\n",
       "  'colonic',\n",
       "  'dysplasias',\n",
       "  'in',\n",
       "  'all',\n",
       "  'drug-treated',\n",
       "  'groups',\n",
       "  '(p',\n",
       "  '=',\n",
       "  '0.03),',\n",
       "  'with',\n",
       "  'animals',\n",
       "  'receiving',\n",
       "  '75',\n",
       "  'mg/kg',\n",
       "  '5-asa',\n",
       "  'exhibiting',\n",
       "  '56%',\n",
       "  'of',\n",
       "  'the',\n",
       "  'number',\n",
       "  'of',\n",
       "  'dysplasias',\n",
       "  'of',\n",
       "  'the',\n",
       "  'aom/dss',\n",
       "  'controls',\n",
       "  '(mean',\n",
       "  '+/-',\n",
       "  'sem:',\n",
       "  '7.6',\n",
       "  '+/-',\n",
       "  '1.4',\n",
       "  'and',\n",
       "  '13.6',\n",
       "  '+/-',\n",
       "  '2.7,',\n",
       "  'respectively).'],\n",
       " ['5-aminosalicylic',\n",
       "  'acid',\n",
       "  'inhibits',\n",
       "  'colitis-associated',\n",
       "  'colorectal',\n",
       "  'dysplasias',\n",
       "  'in',\n",
       "  'the',\n",
       "  'mouse',\n",
       "  'model',\n",
       "  'of',\n",
       "  'azoxymethane/dextran',\n",
       "  'sulfate',\n",
       "  'sodium-induced',\n",
       "  'colitis.'],\n",
       " ['5-aminosalicylic',\n",
       "  'acid',\n",
       "  'inhibits',\n",
       "  'colitis-associated',\n",
       "  'colorectal',\n",
       "  'dysplasias',\n",
       "  'in',\n",
       "  'the',\n",
       "  'mouse',\n",
       "  'model',\n",
       "  'of',\n",
       "  'azoxymethane/dextran',\n",
       "  'sulfate',\n",
       "  'sodium-induced',\n",
       "  'colitis.'],\n",
       " ['the',\n",
       "  'chemopreventive',\n",
       "  'activity',\n",
       "  'of',\n",
       "  '5-asa',\n",
       "  'was',\n",
       "  'evaluated',\n",
       "  'in',\n",
       "  'the',\n",
       "  'swiss',\n",
       "  'webster',\n",
       "  'model',\n",
       "  'of',\n",
       "  'azoxymethane',\n",
       "  '(aom)/dextran',\n",
       "  'sulfate',\n",
       "  'sodium',\n",
       "  '(dss)-induced',\n",
       "  'colitis-associated',\n",
       "  'neoplasia.'],\n",
       " ['these',\n",
       "  'data',\n",
       "  'suggest',\n",
       "  'that',\n",
       "  'low-dose',\n",
       "  '5-asa',\n",
       "  'may',\n",
       "  'be',\n",
       "  'efficacious',\n",
       "  'in',\n",
       "  'preventing',\n",
       "  'colitis-associated',\n",
       "  'dysplasias',\n",
       "  'and',\n",
       "  'provide',\n",
       "  'strong',\n",
       "  'support',\n",
       "  'for',\n",
       "  'optimizing',\n",
       "  'this',\n",
       "  'therapy',\n",
       "  'for',\n",
       "  'the',\n",
       "  'prevention',\n",
       "  'of',\n",
       "  'colonic',\n",
       "  'neoplasms',\n",
       "  'in',\n",
       "  'patients',\n",
       "  'with',\n",
       "  'ulcerative',\n",
       "  'colitis.'],\n",
       " ['these',\n",
       "  'data',\n",
       "  'suggest',\n",
       "  'that',\n",
       "  'low-dose',\n",
       "  '5-asa',\n",
       "  'may',\n",
       "  'be',\n",
       "  'efficacious',\n",
       "  'in',\n",
       "  'preventing',\n",
       "  'colitis-associated',\n",
       "  'dysplasias',\n",
       "  'and',\n",
       "  'provide',\n",
       "  'strong',\n",
       "  'support',\n",
       "  'for',\n",
       "  'optimizing',\n",
       "  'this',\n",
       "  'therapy',\n",
       "  'for',\n",
       "  'the',\n",
       "  'prevention',\n",
       "  'of',\n",
       "  'colonic',\n",
       "  'neoplasms',\n",
       "  'in',\n",
       "  'patients',\n",
       "  'with',\n",
       "  'ulcerative',\n",
       "  'colitis.'],\n",
       " ['these',\n",
       "  'data',\n",
       "  'suggest',\n",
       "  'that',\n",
       "  'low-dose',\n",
       "  '5-asa',\n",
       "  'may',\n",
       "  'be',\n",
       "  'efficacious',\n",
       "  'in',\n",
       "  'preventing',\n",
       "  'colitis-associated',\n",
       "  'dysplasias',\n",
       "  'and',\n",
       "  'provide',\n",
       "  'strong',\n",
       "  'support',\n",
       "  'for',\n",
       "  'optimizing',\n",
       "  'this',\n",
       "  'therapy',\n",
       "  'for',\n",
       "  'the',\n",
       "  'prevention',\n",
       "  'of',\n",
       "  'colonic',\n",
       "  'neoplasms',\n",
       "  'in',\n",
       "  'patients',\n",
       "  'with',\n",
       "  'ulcerative',\n",
       "  'colitis.'],\n",
       " ['the',\n",
       "  'impact',\n",
       "  'of',\n",
       "  'the',\n",
       "  'antiinflammatory',\n",
       "  'agent',\n",
       "  '5-aminosalicylic',\n",
       "  'acid',\n",
       "  '(5-asa)',\n",
       "  'on',\n",
       "  'the',\n",
       "  'risk',\n",
       "  'for',\n",
       "  'colitis-associated',\n",
       "  'colorectal',\n",
       "  'cancer',\n",
       "  'remains',\n",
       "  'controversial.'],\n",
       " ['the',\n",
       "  'chemopreventive',\n",
       "  'activity',\n",
       "  'of',\n",
       "  '5-asa',\n",
       "  'was',\n",
       "  'evaluated',\n",
       "  'in',\n",
       "  'the',\n",
       "  'swiss',\n",
       "  'webster',\n",
       "  'model',\n",
       "  'of',\n",
       "  'azoxymethane',\n",
       "  '(aom)/dextran',\n",
       "  'sulfate',\n",
       "  'sodium',\n",
       "  '(dss)-induced',\n",
       "  'colitis-associated',\n",
       "  'neoplasia.'],\n",
       " ['administration',\n",
       "  'of',\n",
       "  '75',\n",
       "  'mg/kg',\n",
       "  '5-asa',\n",
       "  'decreased',\n",
       "  'both',\n",
       "  'the',\n",
       "  'mean',\n",
       "  'multiplicity',\n",
       "  'of',\n",
       "  'flat',\n",
       "  'dysplasias',\n",
       "  '(1.8',\n",
       "  '+/-',\n",
       "  '0.4',\n",
       "  'for',\n",
       "  'drug-treated',\n",
       "  'versus',\n",
       "  '5.6',\n",
       "  '+/-',\n",
       "  '1.2',\n",
       "  'for',\n",
       "  'aom/dss',\n",
       "  'control)',\n",
       "  'and',\n",
       "  'the',\n",
       "  'burden',\n",
       "  'of',\n",
       "  'polypoid',\n",
       "  'dysplasias',\n",
       "  '(tumor',\n",
       "  'burden:',\n",
       "  '6.7',\n",
       "  '+/-',\n",
       "  '2.7',\n",
       "  'for',\n",
       "  'drug-treated',\n",
       "  'versus',\n",
       "  '14.9',\n",
       "  '+/-',\n",
       "  '3.9',\n",
       "  'units',\n",
       "  'for',\n",
       "  'aom/dss',\n",
       "  'controls)',\n",
       "  'significantly',\n",
       "  '(p',\n",
       "  '=',\n",
       "  '0.002',\n",
       "  'and',\n",
       "  '0.04,',\n",
       "  'respectively).'],\n",
       " ['administration',\n",
       "  'of',\n",
       "  '75',\n",
       "  'mg/kg',\n",
       "  '5-asa',\n",
       "  'decreased',\n",
       "  'both',\n",
       "  'the',\n",
       "  'mean',\n",
       "  'multiplicity',\n",
       "  'of',\n",
       "  'flat',\n",
       "  'dysplasias',\n",
       "  '(1.8',\n",
       "  '+/-',\n",
       "  '0.4',\n",
       "  'for',\n",
       "  'drug-treated',\n",
       "  'versus',\n",
       "  '5.6',\n",
       "  '+/-',\n",
       "  '1.2',\n",
       "  'for',\n",
       "  'aom/dss',\n",
       "  'control)',\n",
       "  'and',\n",
       "  'the',\n",
       "  'burden',\n",
       "  'of',\n",
       "  'polypoid',\n",
       "  'dysplasias',\n",
       "  '(tumor',\n",
       "  'burden:',\n",
       "  '6.7',\n",
       "  '+/-',\n",
       "  '2.7',\n",
       "  'for',\n",
       "  'drug-treated',\n",
       "  'versus',\n",
       "  '14.9',\n",
       "  '+/-',\n",
       "  '3.9',\n",
       "  'units',\n",
       "  'for',\n",
       "  'aom/dss',\n",
       "  'controls)',\n",
       "  'significantly',\n",
       "  '(p',\n",
       "  '=',\n",
       "  '0.002',\n",
       "  'and',\n",
       "  '0.04,',\n",
       "  'respectively).'],\n",
       " ['an',\n",
       "  'inverse',\n",
       "  'trend',\n",
       "  'was',\n",
       "  'observed',\n",
       "  'between',\n",
       "  'dose',\n",
       "  'and',\n",
       "  'multiplicity',\n",
       "  'of',\n",
       "  'colonic',\n",
       "  'dysplasias',\n",
       "  'in',\n",
       "  'all',\n",
       "  'drug-treated',\n",
       "  'groups',\n",
       "  '(p',\n",
       "  '=',\n",
       "  '0.03),',\n",
       "  'with',\n",
       "  'animals',\n",
       "  'receiving',\n",
       "  '75',\n",
       "  'mg/kg',\n",
       "  '5-asa',\n",
       "  'exhibiting',\n",
       "  '56%',\n",
       "  'of',\n",
       "  'the',\n",
       "  'number',\n",
       "  'of',\n",
       "  'dysplasias',\n",
       "  'of',\n",
       "  'the',\n",
       "  'aom/dss',\n",
       "  'controls',\n",
       "  '(mean',\n",
       "  '+/-',\n",
       "  'sem:',\n",
       "  '7.6',\n",
       "  '+/-',\n",
       "  '1.4',\n",
       "  'and',\n",
       "  '13.6',\n",
       "  '+/-',\n",
       "  '2.7,',\n",
       "  'respectively).'],\n",
       " ['administration',\n",
       "  'of',\n",
       "  '75',\n",
       "  'mg/kg',\n",
       "  '5-asa',\n",
       "  'decreased',\n",
       "  'both',\n",
       "  'the',\n",
       "  'mean',\n",
       "  'multiplicity',\n",
       "  'of',\n",
       "  'flat',\n",
       "  'dysplasias',\n",
       "  '(1.8',\n",
       "  '+/-',\n",
       "  '0.4',\n",
       "  'for',\n",
       "  'drug-treated',\n",
       "  'versus',\n",
       "  '5.6',\n",
       "  '+/-',\n",
       "  '1.2',\n",
       "  'for',\n",
       "  'aom/dss',\n",
       "  'control)',\n",
       "  'and',\n",
       "  'the',\n",
       "  'burden',\n",
       "  'of',\n",
       "  'polypoid',\n",
       "  'dysplasias',\n",
       "  '(tumor',\n",
       "  'burden:',\n",
       "  '6.7',\n",
       "  '+/-',\n",
       "  '2.7',\n",
       "  'for',\n",
       "  'drug-treated',\n",
       "  'versus',\n",
       "  '14.9',\n",
       "  '+/-',\n",
       "  '3.9',\n",
       "  'units',\n",
       "  'for',\n",
       "  'aom/dss',\n",
       "  'controls)',\n",
       "  'significantly',\n",
       "  '(p',\n",
       "  '=',\n",
       "  '0.002',\n",
       "  'and',\n",
       "  '0.04,',\n",
       "  'respectively).'],\n",
       " ['the',\n",
       "  'chemopreventive',\n",
       "  'activity',\n",
       "  'of',\n",
       "  '5-asa',\n",
       "  'was',\n",
       "  'evaluated',\n",
       "  'in',\n",
       "  'the',\n",
       "  'swiss',\n",
       "  'webster',\n",
       "  'model',\n",
       "  'of',\n",
       "  'azoxymethane',\n",
       "  '(aom)/dextran',\n",
       "  'sulfate',\n",
       "  'sodium',\n",
       "  '(dss)-induced',\n",
       "  'colitis-associated',\n",
       "  'neoplasia.'],\n",
       " ['an',\n",
       "  'inverse',\n",
       "  'trend',\n",
       "  'was',\n",
       "  'observed',\n",
       "  'between',\n",
       "  'dose',\n",
       "  'and',\n",
       "  'multiplicity',\n",
       "  'of',\n",
       "  'colonic',\n",
       "  'dysplasias',\n",
       "  'in',\n",
       "  'all',\n",
       "  'drug-treated',\n",
       "  'groups',\n",
       "  '(p',\n",
       "  '=',\n",
       "  '0.03),',\n",
       "  'with',\n",
       "  'animals',\n",
       "  'receiving',\n",
       "  '75',\n",
       "  'mg/kg',\n",
       "  '5-asa',\n",
       "  'exhibiting',\n",
       "  '56%',\n",
       "  'of',\n",
       "  'the',\n",
       "  'number',\n",
       "  'of',\n",
       "  'dysplasias',\n",
       "  'of',\n",
       "  'the',\n",
       "  'aom/dss',\n",
       "  'controls',\n",
       "  '(mean',\n",
       "  '+/-',\n",
       "  'sem:',\n",
       "  '7.6',\n",
       "  '+/-',\n",
       "  '1.4',\n",
       "  'and',\n",
       "  '13.6',\n",
       "  '+/-',\n",
       "  '2.7,',\n",
       "  'respectively).'],\n",
       " ['spinal', 'cord', 'infarction', 'secondary', 'to', 'cocaine', 'use.'],\n",
       " ['cocaine',\n",
       "  'abuse',\n",
       "  'is',\n",
       "  'associated',\n",
       "  'with',\n",
       "  'cerebrovascular',\n",
       "  'events;',\n",
       "  'spinal',\n",
       "  'cord',\n",
       "  'effects',\n",
       "  'are',\n",
       "  'rarely',\n",
       "  'reported.'],\n",
       " ['although',\n",
       "  'uncommon,',\n",
       "  'cocaine',\n",
       "  'abuse',\n",
       "  'can',\n",
       "  'cause',\n",
       "  'spinal',\n",
       "  'cord',\n",
       "  'infarction.'],\n",
       " ['we',\n",
       "  'report',\n",
       "  'two',\n",
       "  'rheumatoid',\n",
       "  'arthritis',\n",
       "  'patients',\n",
       "  'developing',\n",
       "  'sarcoidosis',\n",
       "  'possibly',\n",
       "  'induced',\n",
       "  'by',\n",
       "  'etanercept.'],\n",
       " ['recently,',\n",
       "  'there',\n",
       "  'have',\n",
       "  'been',\n",
       "  'reports',\n",
       "  'of',\n",
       "  'noninfectious',\n",
       "  'granulomatous',\n",
       "  'syndromes',\n",
       "  'in',\n",
       "  'patients',\n",
       "  'receiving',\n",
       "  'etanercept',\n",
       "  'for',\n",
       "  'a',\n",
       "  'variety',\n",
       "  'of',\n",
       "  'diseases.'],\n",
       " ['development',\n",
       "  'of',\n",
       "  'sarcoidosis',\n",
       "  'in',\n",
       "  'etanercept-treated',\n",
       "  'rheumatoid',\n",
       "  'arthritis',\n",
       "  'patients.'],\n",
       " ['development',\n",
       "  'of',\n",
       "  'sarcoidosis',\n",
       "  'in',\n",
       "  'etanercept-treated',\n",
       "  'rheumatoid',\n",
       "  'arthritis',\n",
       "  'patients.'],\n",
       " ['the',\n",
       "  'other',\n",
       "  'developed',\n",
       "  'erythema',\n",
       "  'nodosum',\n",
       "  'and',\n",
       "  'a',\n",
       "  'plaque',\n",
       "  'lesion',\n",
       "  'on',\n",
       "  'the',\n",
       "  'right',\n",
       "  'arm',\n",
       "  'after',\n",
       "  '1',\n",
       "  'year',\n",
       "  'of',\n",
       "  'etanercept.'],\n",
       " ['furthermore,',\n",
       "  'there',\n",
       "  'may',\n",
       "  'be',\n",
       "  'a',\n",
       "  'relationship',\n",
       "  'between',\n",
       "  'statin',\n",
       "  'dose',\n",
       "  'and',\n",
       "  'cancer.'],\n",
       " ['bird',\n",
       "  '(biaxin',\n",
       "  '[clarithromycin]/revlimid',\n",
       "  '[lenalidomide]/dexamethasone)',\n",
       "  'combination',\n",
       "  'therapy',\n",
       "  'results',\n",
       "  'in',\n",
       "  'high',\n",
       "  'complete-',\n",
       "  'and',\n",
       "  'overall-response',\n",
       "  'rates',\n",
       "  'in',\n",
       "  'treatment-naive',\n",
       "  'symptomatic',\n",
       "  'multiple',\n",
       "  'myeloma.'],\n",
       " ['this',\n",
       "  'trial',\n",
       "  'determined',\n",
       "  'the',\n",
       "  'safety',\n",
       "  'and',\n",
       "  'efficacy',\n",
       "  'of',\n",
       "  'the',\n",
       "  'combination',\n",
       "  'regimen',\n",
       "  'clarithromycin',\n",
       "  '(biaxin),',\n",
       "  'lenalidomide',\n",
       "  '(revlimid),',\n",
       "  'and',\n",
       "  'dexamethasone',\n",
       "  '(bird)',\n",
       "  'as',\n",
       "  'first-line',\n",
       "  'therapy',\n",
       "  'for',\n",
       "  'multiple',\n",
       "  'myeloma.'],\n",
       " ['bird',\n",
       "  'is',\n",
       "  'an',\n",
       "  'effective',\n",
       "  'regimen',\n",
       "  'with',\n",
       "  'manageable',\n",
       "  'side',\n",
       "  'effects',\n",
       "  'in',\n",
       "  'the',\n",
       "  'treatment',\n",
       "  'of',\n",
       "  'symptomatic,',\n",
       "  'newly',\n",
       "  'diagnosed',\n",
       "  'multiple',\n",
       "  'myeloma.'],\n",
       " ['recent',\n",
       "  'prospective',\n",
       "  'studies',\n",
       "  'from',\n",
       "  'europe',\n",
       "  'suggest',\n",
       "  'the',\n",
       "  'use',\n",
       "  'of',\n",
       "  'intracameral',\n",
       "  'antibiotics',\n",
       "  'for',\n",
       "  'prophylaxis',\n",
       "  'of',\n",
       "  'endophthalmitis,',\n",
       "  'although',\n",
       "  'the',\n",
       "  'studies',\n",
       "  'did',\n",
       "  'not',\n",
       "  'make',\n",
       "  'a',\n",
       "  'comparison',\n",
       "  'with',\n",
       "  'the',\n",
       "  'most',\n",
       "  'common',\n",
       "  'united',\n",
       "  'states',\n",
       "  'prophylaxis',\n",
       "  'techniques.'],\n",
       " ['a',\n",
       "  'multipronged',\n",
       "  'approach',\n",
       "  'to',\n",
       "  'limit',\n",
       "  'endophthalmitis',\n",
       "  'risk',\n",
       "  'is',\n",
       "  'also',\n",
       "  'needed,',\n",
       "  'with',\n",
       "  'antibiotics',\n",
       "  'as',\n",
       "  'only',\n",
       "  'part',\n",
       "  'of',\n",
       "  'the',\n",
       "  'strategy.'],\n",
       " ['in',\n",
       "  'this',\n",
       "  'study,',\n",
       "  'a',\n",
       "  '2-year-old',\n",
       "  'girl',\n",
       "  'with',\n",
       "  'nephropathic',\n",
       "  'cystinosis',\n",
       "  'and',\n",
       "  'severe',\n",
       "  'gastrointestinal',\n",
       "  'dysmotility',\n",
       "  'was',\n",
       "  'treated',\n",
       "  'with',\n",
       "  'intravenous',\n",
       "  '(i.v.)',\n",
       "  'administration',\n",
       "  'of',\n",
       "  'cysteamine',\n",
       "  'hydrochloride',\n",
       "  '(hcl).'],\n",
       " ['the',\n",
       "  'most',\n",
       "  'common',\n",
       "  'adverse',\n",
       "  'effects',\n",
       "  'associated',\n",
       "  'with',\n",
       "  'the',\n",
       "  'use',\n",
       "  'of',\n",
       "  'posaconazole',\n",
       "  'include',\n",
       "  'headache,',\n",
       "  'fever,',\n",
       "  'nausea,',\n",
       "  'vomiting,',\n",
       "  'and',\n",
       "  'diarrhea.'],\n",
       " ['posaconazole',\n",
       "  'is',\n",
       "  'noninferior',\n",
       "  'to',\n",
       "  'fluconazole',\n",
       "  'for',\n",
       "  'treatment',\n",
       "  'of',\n",
       "  'oropharyngeal',\n",
       "  'candidiasis',\n",
       "  '(95%',\n",
       "  'ci',\n",
       "  '-6.6',\n",
       "  'to',\n",
       "  '5.0),',\n",
       "  'but',\n",
       "  'necessity',\n",
       "  'for',\n",
       "  'this',\n",
       "  'indication',\n",
       "  'remains',\n",
       "  'unclear,',\n",
       "  'as',\n",
       "  'many',\n",
       "  'other',\n",
       "  'treatment',\n",
       "  'options',\n",
       "  'exist.'],\n",
       " ['similarly,',\n",
       "  'the',\n",
       "  'same',\n",
       "  'regimen',\n",
       "  'of',\n",
       "  'posaconazole',\n",
       "  'reduced',\n",
       "  'invasive',\n",
       "  'fungal',\n",
       "  'infections',\n",
       "  '(95%',\n",
       "  'ci',\n",
       "  '-9.7',\n",
       "  'to',\n",
       "  '-2.5)',\n",
       "  'and',\n",
       "  'aspergillosis',\n",
       "  '(ci',\n",
       "  'not',\n",
       "  'reported,',\n",
       "  'p',\n",
       "  '<',\n",
       "  '0.001)',\n",
       "  'when',\n",
       "  'compared',\n",
       "  'with',\n",
       "  'fluconazole',\n",
       "  'and',\n",
       "  'itraconazole',\n",
       "  'in',\n",
       "  'neutropenic',\n",
       "  'patients.'],\n",
       " ['similarly,',\n",
       "  'the',\n",
       "  'same',\n",
       "  'regimen',\n",
       "  'of',\n",
       "  'posaconazole',\n",
       "  'reduced',\n",
       "  'invasive',\n",
       "  'fungal',\n",
       "  'infections',\n",
       "  '(95%',\n",
       "  'ci',\n",
       "  '-9.7',\n",
       "  'to',\n",
       "  '-2.5)',\n",
       "  'and',\n",
       "  'aspergillosis',\n",
       "  '(ci',\n",
       "  'not',\n",
       "  'reported,',\n",
       "  'p',\n",
       "  '<',\n",
       "  '0.001)',\n",
       "  'when',\n",
       "  'compared',\n",
       "  'with',\n",
       "  'fluconazole',\n",
       "  'and',\n",
       "  'itraconazole',\n",
       "  'in',\n",
       "  'neutropenic',\n",
       "  'patients.'],\n",
       " ['the',\n",
       "  'most',\n",
       "  'common',\n",
       "  'adverse',\n",
       "  'effects',\n",
       "  'associated',\n",
       "  'with',\n",
       "  'the',\n",
       "  'use',\n",
       "  'of',\n",
       "  'posaconazole',\n",
       "  'include',\n",
       "  'headache,',\n",
       "  'fever,',\n",
       "  'nausea,',\n",
       "  'vomiting,',\n",
       "  'and',\n",
       "  'diarrhea.'],\n",
       " ['the',\n",
       "  'most',\n",
       "  'common',\n",
       "  'adverse',\n",
       "  'effects',\n",
       "  'associated',\n",
       "  'with',\n",
       "  'the',\n",
       "  'use',\n",
       "  'of',\n",
       "  'posaconazole',\n",
       "  'include',\n",
       "  'headache,',\n",
       "  'fever,',\n",
       "  'nausea,',\n",
       "  'vomiting,',\n",
       "  'and',\n",
       "  'diarrhea.'],\n",
       " ['similarly,',\n",
       "  'the',\n",
       "  'same',\n",
       "  'regimen',\n",
       "  'of',\n",
       "  'posaconazole',\n",
       "  'reduced',\n",
       "  'invasive',\n",
       "  'fungal',\n",
       "  'infections',\n",
       "  '(95%',\n",
       "  'ci',\n",
       "  '-9.7',\n",
       "  'to',\n",
       "  '-2.5)',\n",
       "  'and',\n",
       "  'aspergillosis',\n",
       "  '(ci',\n",
       "  'not',\n",
       "  'reported,',\n",
       "  'p',\n",
       "  '<',\n",
       "  '0.001)',\n",
       "  'when',\n",
       "  'compared',\n",
       "  'with',\n",
       "  'fluconazole',\n",
       "  'and',\n",
       "  'itraconazole',\n",
       "  'in',\n",
       "  'neutropenic',\n",
       "  'patients.'],\n",
       " ['similarly,',\n",
       "  'the',\n",
       "  'same',\n",
       "  'regimen',\n",
       "  'of',\n",
       "  'posaconazole',\n",
       "  'reduced',\n",
       "  'invasive',\n",
       "  'fungal',\n",
       "  'infections',\n",
       "  '(95%',\n",
       "  'ci',\n",
       "  '-9.7',\n",
       "  'to',\n",
       "  '-2.5)',\n",
       "  'and',\n",
       "  'aspergillosis',\n",
       "  '(ci',\n",
       "  'not',\n",
       "  'reported,',\n",
       "  'p',\n",
       "  '<',\n",
       "  '0.001)',\n",
       "  'when',\n",
       "  'compared',\n",
       "  'with',\n",
       "  'fluconazole',\n",
       "  'and',\n",
       "  'itraconazole',\n",
       "  'in',\n",
       "  'neutropenic',\n",
       "  'patients.'],\n",
       " ['the',\n",
       "  'most',\n",
       "  'common',\n",
       "  'adverse',\n",
       "  'effects',\n",
       "  'associated',\n",
       "  'with',\n",
       "  'the',\n",
       "  'use',\n",
       "  'of',\n",
       "  'posaconazole',\n",
       "  'include',\n",
       "  'headache,',\n",
       "  'fever,',\n",
       "  'nausea,',\n",
       "  'vomiting,',\n",
       "  'and',\n",
       "  'diarrhea.'],\n",
       " ['at',\n",
       "  'this',\n",
       "  'time,',\n",
       "  'posaconazole',\n",
       "  'should',\n",
       "  'probably',\n",
       "  'be',\n",
       "  'reserved',\n",
       "  'for',\n",
       "  'prophylaxis',\n",
       "  'in',\n",
       "  'patients',\n",
       "  'at',\n",
       "  'high',\n",
       "  'risk',\n",
       "  'for',\n",
       "  'invasive',\n",
       "  'fungal',\n",
       "  'infection,',\n",
       "  'as',\n",
       "  'salvage',\n",
       "  'therapy',\n",
       "  'in',\n",
       "  'refractory',\n",
       "  'or',\n",
       "  'resistant',\n",
       "  'infections,',\n",
       "  'or',\n",
       "  'for',\n",
       "  'patients',\n",
       "  'with',\n",
       "  'intolerance',\n",
       "  'to',\n",
       "  'other',\n",
       "  'therapies.'],\n",
       " ['at',\n",
       "  'this',\n",
       "  'time,',\n",
       "  'posaconazole',\n",
       "  'should',\n",
       "  'probably',\n",
       "  'be',\n",
       "  'reserved',\n",
       "  'for',\n",
       "  'prophylaxis',\n",
       "  'in',\n",
       "  'patients',\n",
       "  'at',\n",
       "  'high',\n",
       "  'risk',\n",
       "  'for',\n",
       "  'invasive',\n",
       "  'fungal',\n",
       "  'infection,',\n",
       "  'as',\n",
       "  'salvage',\n",
       "  'therapy',\n",
       "  'in',\n",
       "  'refractory',\n",
       "  'or',\n",
       "  'resistant',\n",
       "  'infections,',\n",
       "  'or',\n",
       "  'for',\n",
       "  'patients',\n",
       "  'with',\n",
       "  'intolerance',\n",
       "  'to',\n",
       "  'other',\n",
       "  'therapies.'],\n",
       " ['similarly,',\n",
       "  'the',\n",
       "  'same',\n",
       "  'regimen',\n",
       "  'of',\n",
       "  'posaconazole',\n",
       "  'reduced',\n",
       "  'invasive',\n",
       "  'fungal',\n",
       "  'infections',\n",
       "  '(95%',\n",
       "  'ci',\n",
       "  '-9.7',\n",
       "  'to',\n",
       "  '-2.5)',\n",
       "  'and',\n",
       "  'aspergillosis',\n",
       "  '(ci',\n",
       "  'not',\n",
       "  'reported,',\n",
       "  'p',\n",
       "  '<',\n",
       "  '0.001)',\n",
       "  'when',\n",
       "  'compared',\n",
       "  'with',\n",
       "  'fluconazole',\n",
       "  'and',\n",
       "  'itraconazole',\n",
       "  'in',\n",
       "  'neutropenic',\n",
       "  'patients.'],\n",
       " ['similarly,',\n",
       "  'the',\n",
       "  'same',\n",
       "  'regimen',\n",
       "  'of',\n",
       "  'posaconazole',\n",
       "  'reduced',\n",
       "  'invasive',\n",
       "  'fungal',\n",
       "  'infections',\n",
       "  '(95%',\n",
       "  'ci',\n",
       "  '-9.7',\n",
       "  'to',\n",
       "  '-2.5)',\n",
       "  'and',\n",
       "  'aspergillosis',\n",
       "  '(ci',\n",
       "  'not',\n",
       "  'reported,',\n",
       "  'p',\n",
       "  '<',\n",
       "  '0.001)',\n",
       "  'when',\n",
       "  'compared',\n",
       "  'with',\n",
       "  'fluconazole',\n",
       "  'and',\n",
       "  'itraconazole',\n",
       "  'in',\n",
       "  'neutropenic',\n",
       "  'patients.'],\n",
       " ['posaconazole,',\n",
       "  'in',\n",
       "  'doses',\n",
       "  'of',\n",
       "  '200',\n",
       "  'mg',\n",
       "  '3',\n",
       "  'times',\n",
       "  'daily,',\n",
       "  'reduced',\n",
       "  'breakthrough',\n",
       "  'invasive',\n",
       "  'fungal',\n",
       "  'infections',\n",
       "  '(or',\n",
       "  '0.30;',\n",
       "  '95%',\n",
       "  'ci',\n",
       "  '0.12',\n",
       "  'to',\n",
       "  '0.71)',\n",
       "  'and',\n",
       "  'aspergillosis',\n",
       "  'incidence',\n",
       "  '(or',\n",
       "  '0.31;',\n",
       "  '95%',\n",
       "  'ci',\n",
       "  '0.13',\n",
       "  'to',\n",
       "  '0.75)',\n",
       "  'in',\n",
       "  'patients',\n",
       "  'receiving',\n",
       "  'hematopoietic',\n",
       "  'stem-cell',\n",
       "  'transplants',\n",
       "  'compared',\n",
       "  'with',\n",
       "  'those',\n",
       "  'receiving',\n",
       "  'fluconazole.'],\n",
       " ['posaconazole,',\n",
       "  'in',\n",
       "  'doses',\n",
       "  'of',\n",
       "  '200',\n",
       "  'mg',\n",
       "  '3',\n",
       "  'times',\n",
       "  'daily,',\n",
       "  'reduced',\n",
       "  'breakthrough',\n",
       "  'invasive',\n",
       "  'fungal',\n",
       "  'infections',\n",
       "  '(or',\n",
       "  '0.30;',\n",
       "  '95%',\n",
       "  'ci',\n",
       "  '0.12',\n",
       "  'to',\n",
       "  '0.71)',\n",
       "  'and',\n",
       "  'aspergillosis',\n",
       "  'incidence',\n",
       "  '(or',\n",
       "  '0.31;',\n",
       "  '95%',\n",
       "  'ci',\n",
       "  '0.13',\n",
       "  'to',\n",
       "  '0.75)',\n",
       "  'in',\n",
       "  'patients',\n",
       "  'receiving',\n",
       "  'hematopoietic',\n",
       "  'stem-cell',\n",
       "  'transplants',\n",
       "  'compared',\n",
       "  'with',\n",
       "  'those',\n",
       "  'receiving',\n",
       "  'fluconazole.'],\n",
       " ['posaconazole',\n",
       "  'is',\n",
       "  'noninferior',\n",
       "  'to',\n",
       "  'fluconazole',\n",
       "  'for',\n",
       "  'treatment',\n",
       "  'of',\n",
       "  'oropharyngeal',\n",
       "  'candidiasis',\n",
       "  '(95%',\n",
       "  'ci',\n",
       "  '-6.6',\n",
       "  'to',\n",
       "  '5.0),',\n",
       "  'but',\n",
       "  'necessity',\n",
       "  'for',\n",
       "  'this',\n",
       "  'indication',\n",
       "  'remains',\n",
       "  'unclear,',\n",
       "  'as',\n",
       "  'many',\n",
       "  'other',\n",
       "  'treatment',\n",
       "  'options',\n",
       "  'exist.'],\n",
       " ['posaconazole,',\n",
       "  'in',\n",
       "  'doses',\n",
       "  'of',\n",
       "  '200',\n",
       "  'mg',\n",
       "  '3',\n",
       "  'times',\n",
       "  'daily,',\n",
       "  'reduced',\n",
       "  'breakthrough',\n",
       "  'invasive',\n",
       "  'fungal',\n",
       "  'infections',\n",
       "  '(or',\n",
       "  '0.30;',\n",
       "  '95%',\n",
       "  'ci',\n",
       "  '0.12',\n",
       "  'to',\n",
       "  '0.71)',\n",
       "  'and',\n",
       "  'aspergillosis',\n",
       "  'incidence',\n",
       "  '(or',\n",
       "  '0.31;',\n",
       "  '95%',\n",
       "  'ci',\n",
       "  '0.13',\n",
       "  'to',\n",
       "  '0.75)',\n",
       "  'in',\n",
       "  'patients',\n",
       "  'receiving',\n",
       "  'hematopoietic',\n",
       "  'stem-cell',\n",
       "  'transplants',\n",
       "  'compared',\n",
       "  'with',\n",
       "  'those',\n",
       "  'receiving',\n",
       "  'fluconazole.'],\n",
       " ['posaconazole,',\n",
       "  'in',\n",
       "  'doses',\n",
       "  'of',\n",
       "  '200',\n",
       "  'mg',\n",
       "  '3',\n",
       "  'times',\n",
       "  'daily,',\n",
       "  'reduced',\n",
       "  'breakthrough',\n",
       "  'invasive',\n",
       "  'fungal',\n",
       "  'infections',\n",
       "  '(or',\n",
       "  '0.30;',\n",
       "  '95%',\n",
       "  'ci',\n",
       "  '0.12',\n",
       "  'to',\n",
       "  '0.71)',\n",
       "  'and',\n",
       "  'aspergillosis',\n",
       "  'incidence',\n",
       "  '(or',\n",
       "  '0.31;',\n",
       "  '95%',\n",
       "  'ci',\n",
       "  '0.13',\n",
       "  'to',\n",
       "  '0.75)',\n",
       "  'in',\n",
       "  'patients',\n",
       "  'receiving',\n",
       "  'hematopoietic',\n",
       "  'stem-cell',\n",
       "  'transplants',\n",
       "  'compared',\n",
       "  'with',\n",
       "  'those',\n",
       "  'receiving',\n",
       "  'fluconazole.'],\n",
       " ['while',\n",
       "  'some',\n",
       "  'beneficial',\n",
       "  'neuromotor',\n",
       "  'effects',\n",
       "  'of',\n",
       "  'succimer',\n",
       "  'therapy',\n",
       "  'were',\n",
       "  'observed',\n",
       "  'in',\n",
       "  'the',\n",
       "  'present',\n",
       "  'study',\n",
       "  'there',\n",
       "  'remains',\n",
       "  'several',\n",
       "  'unanswered',\n",
       "  'questions',\n",
       "  'such',\n",
       "  'as',\n",
       "  'how',\n",
       "  'long',\n",
       "  'these',\n",
       "  'effects',\n",
       "  'will',\n",
       "  'persist',\n",
       "  'and',\n",
       "  'how',\n",
       "  'succimer',\n",
       "  'therapy',\n",
       "  'modifies',\n",
       "  'lead-associated',\n",
       "  'cerebellar',\n",
       "  'deficits',\n",
       "  'manifesting',\n",
       "  'as',\n",
       "  'perturbations',\n",
       "  'in',\n",
       "  'vestibular',\n",
       "  'and/or',\n",
       "  'proprioception',\n",
       "  'systems',\n",
       "  'for',\n",
       "  'postural',\n",
       "  'balance',\n",
       "  'and',\n",
       "  'functional',\n",
       "  'locomotion.'],\n",
       " ['long-term',\n",
       "  'immunomodulatory',\n",
       "  'drug',\n",
       "  '(imd)',\n",
       "  'treatment',\n",
       "  'is',\n",
       "  'now',\n",
       "  'common',\n",
       "  'in',\n",
       "  'multiple',\n",
       "  'sclerosis',\n",
       "  '(ms).'],\n",
       " ['it',\n",
       "  'is',\n",
       "  'well',\n",
       "  'known',\n",
       "  'that',\n",
       "  'tobacco',\n",
       "  'smoke',\n",
       "  'exposure',\n",
       "  'is',\n",
       "  'related',\n",
       "  'to',\n",
       "  'the',\n",
       "  'risk',\n",
       "  'of',\n",
       "  'developing',\n",
       "  'cardiovascular',\n",
       "  'diseases',\n",
       "  'and',\n",
       "  'events.'],\n",
       " ['tibolone',\n",
       "  'is',\n",
       "  'a',\n",
       "  'selective',\n",
       "  'tissue',\n",
       "  'estrogenic',\n",
       "  'activity',\n",
       "  'regulator,',\n",
       "  'approved',\n",
       "  'for',\n",
       "  'the',\n",
       "  'treatment',\n",
       "  'of',\n",
       "  'vasomotor',\n",
       "  'symptoms',\n",
       "  'in',\n",
       "  'postmenopausal',\n",
       "  'women.'],\n",
       " ['in',\n",
       "  'er+',\n",
       "  'breast',\n",
       "  'tumors,',\n",
       "  '2.5',\n",
       "  'mg/d',\n",
       "  'tibolone',\n",
       "  'given',\n",
       "  'for',\n",
       "  '14',\n",
       "  'days',\n",
       "  'has',\n",
       "  'no',\n",
       "  'significant',\n",
       "  'effect',\n",
       "  'on',\n",
       "  'tumor',\n",
       "  'cell',\n",
       "  'proliferation.'],\n",
       " ['in',\n",
       "  'er+',\n",
       "  'breast',\n",
       "  'tumors,',\n",
       "  '2.5',\n",
       "  'mg/d',\n",
       "  'tibolone',\n",
       "  'given',\n",
       "  'for',\n",
       "  '14',\n",
       "  'days',\n",
       "  'has',\n",
       "  'no',\n",
       "  'significant',\n",
       "  'effect',\n",
       "  'on',\n",
       "  'tumor',\n",
       "  'cell',\n",
       "  'proliferation.'],\n",
       " ['exposure',\n",
       "  'to',\n",
       "  'benzodiazepines',\n",
       "  '(bzd)',\n",
       "  'during',\n",
       "  'foetal',\n",
       "  'life',\n",
       "  'has',\n",
       "  'been',\n",
       "  'suggested',\n",
       "  'to',\n",
       "  'contribute',\n",
       "  'to',\n",
       "  'neonatal',\n",
       "  'morbidity',\n",
       "  'and',\n",
       "  'some',\n",
       "  'congenital',\n",
       "  'malformations,',\n",
       "  'for',\n",
       "  'example,',\n",
       "  'orofacial',\n",
       "  'clefts.'],\n",
       " ['exposure',\n",
       "  'to',\n",
       "  'benzodiazepines',\n",
       "  '(bzd)',\n",
       "  'during',\n",
       "  'foetal',\n",
       "  'life',\n",
       "  'has',\n",
       "  'been',\n",
       "  'suggested',\n",
       "  'to',\n",
       "  'contribute',\n",
       "  'to',\n",
       "  'neonatal',\n",
       "  'morbidity',\n",
       "  'and',\n",
       "  'some',\n",
       "  'congenital',\n",
       "  'malformations,',\n",
       "  'for',\n",
       "  'example,',\n",
       "  'orofacial',\n",
       "  'clefts.'],\n",
       " ['exposure',\n",
       "  'to',\n",
       "  'benzodiazepines',\n",
       "  '(bzd)',\n",
       "  'during',\n",
       "  'foetal',\n",
       "  'life',\n",
       "  'has',\n",
       "  'been',\n",
       "  'suggested',\n",
       "  'to',\n",
       "  'contribute',\n",
       "  'to',\n",
       "  'neonatal',\n",
       "  'morbidity',\n",
       "  'and',\n",
       "  'some',\n",
       "  'congenital',\n",
       "  'malformations,',\n",
       "  'for',\n",
       "  'example,',\n",
       "  'orofacial',\n",
       "  'clefts.'],\n",
       " ['maternal',\n",
       "  'use',\n",
       "  'of',\n",
       "  'bzd',\n",
       "  'and/or',\n",
       "  'hbra',\n",
       "  'may',\n",
       "  'increase',\n",
       "  'the',\n",
       "  'risk',\n",
       "  'for',\n",
       "  'preterm',\n",
       "  'birth',\n",
       "  'and',\n",
       "  'low',\n",
       "  'birth',\n",
       "  'weight',\n",
       "  'and',\n",
       "  'cause',\n",
       "  'neonatal',\n",
       "  'symptoms,',\n",
       "  'but',\n",
       "  'does',\n",
       "  'not',\n",
       "  'appear',\n",
       "  'to',\n",
       "  'have',\n",
       "  'a',\n",
       "  'strong',\n",
       "  'teratogenic',\n",
       "  'potential.'],\n",
       " ['exposure',\n",
       "  'to',\n",
       "  'benzodiazepines',\n",
       "  '(bzd)',\n",
       "  'during',\n",
       "  'foetal',\n",
       "  'life',\n",
       "  'has',\n",
       "  'been',\n",
       "  'suggested',\n",
       "  'to',\n",
       "  'contribute',\n",
       "  'to',\n",
       "  'neonatal',\n",
       "  'morbidity',\n",
       "  'and',\n",
       "  'some',\n",
       "  'congenital',\n",
       "  'malformations,',\n",
       "  'for',\n",
       "  'example,',\n",
       "  'orofacial',\n",
       "  'clefts.'],\n",
       " ['we',\n",
       "  'found',\n",
       "  'no',\n",
       "  'evidence',\n",
       "  'of',\n",
       "  'impaired',\n",
       "  'control',\n",
       "  'of',\n",
       "  'the',\n",
       "  'carbohydrate',\n",
       "  'and',\n",
       "  'lipid',\n",
       "  'metabolism',\n",
       "  'or',\n",
       "  'aggravation',\n",
       "  'of',\n",
       "  'vascular',\n",
       "  'lesions',\n",
       "  'during',\n",
       "  'the',\n",
       "  'two',\n",
       "  'years',\n",
       "  'an',\n",
       "  'etonogestrel',\n",
       "  'implant',\n",
       "  'was',\n",
       "  'used',\n",
       "  'by',\n",
       "  'diabetic',\n",
       "  'women.'],\n",
       " ['oritavancin:',\n",
       "  'a',\n",
       "  'new',\n",
       "  'promising',\n",
       "  'agent',\n",
       "  'in',\n",
       "  'the',\n",
       "  'treatment',\n",
       "  'of',\n",
       "  'infections',\n",
       "  'due',\n",
       "  'to',\n",
       "  'gram-positive',\n",
       "  'pathogens.'],\n",
       " ['our',\n",
       "  'findings',\n",
       "  'support',\n",
       "  'that',\n",
       "  'ecstasy',\n",
       "  'use,',\n",
       "  'or',\n",
       "  'ecstasy/cannabis',\n",
       "  'synergic',\n",
       "  'effects,',\n",
       "  'are',\n",
       "  'responsible',\n",
       "  'for',\n",
       "  'the',\n",
       "  'sub-clinical',\n",
       "  'deficits',\n",
       "  'observed',\n",
       "  'in',\n",
       "  'ecstasy',\n",
       "  'polydrug',\n",
       "  'users,',\n",
       "  'and',\n",
       "  'provides',\n",
       "  'additional',\n",
       "  'evidence',\n",
       "  'for',\n",
       "  'long-term',\n",
       "  'cognitive',\n",
       "  'impairment',\n",
       "  'owing',\n",
       "  'to',\n",
       "  'ecstasy',\n",
       "  'consumption',\n",
       "  'in',\n",
       "  'the',\n",
       "  'context',\n",
       "  'of',\n",
       "  'polydrug',\n",
       "  'use.'],\n",
       " ['after',\n",
       "  'two',\n",
       "  'years',\n",
       "  'ecstasy',\n",
       "  'users',\n",
       "  'showed',\n",
       "  'persistent',\n",
       "  'deficits',\n",
       "  'on',\n",
       "  'verbal',\n",
       "  'fluency,',\n",
       "  'working',\n",
       "  'memory',\n",
       "  'and',\n",
       "  'processing',\n",
       "  'speed.'],\n",
       " ['when',\n",
       "  'ecstasy',\n",
       "  'users',\n",
       "  'were',\n",
       "  'classified',\n",
       "  'according',\n",
       "  'to',\n",
       "  'lifetime',\n",
       "  'use',\n",
       "  'of',\n",
       "  'ecstasy,',\n",
       "  'the',\n",
       "  'more',\n",
       "  'severe',\n",
       "  'users',\n",
       "  '(more',\n",
       "  'than',\n",
       "  '100',\n",
       "  'tablets)',\n",
       "  'showed',\n",
       "  'additional',\n",
       "  'deficits',\n",
       "  'on',\n",
       "  'episodic',\n",
       "  'memory.'],\n",
       " ['no',\n",
       "  'significant',\n",
       "  'differences',\n",
       "  'were',\n",
       "  'observed',\n",
       "  'between',\n",
       "  'feso4+citrate',\n",
       "  'and',\n",
       "  'nafe-edta',\n",
       "  'fortification,',\n",
       "  'regarding',\n",
       "  'mitigation',\n",
       "  'of',\n",
       "  'iron-deficiency',\n",
       "  'anemia',\n",
       "  '(ida)',\n",
       "  'or',\n",
       "  'regarding',\n",
       "  'crp,',\n",
       "  'growth,',\n",
       "  'infections,',\n",
       "  'or',\n",
       "  'side-effects.'],\n",
       " ['no',\n",
       "  'significant',\n",
       "  'differences',\n",
       "  'were',\n",
       "  'observed',\n",
       "  'between',\n",
       "  'feso4+citrate',\n",
       "  'and',\n",
       "  'nafe-edta',\n",
       "  'fortification,',\n",
       "  'regarding',\n",
       "  'mitigation',\n",
       "  'of',\n",
       "  'iron-deficiency',\n",
       "  'anemia',\n",
       "  '(ida)',\n",
       "  'or',\n",
       "  'regarding',\n",
       "  'crp,',\n",
       "  'growth,',\n",
       "  'infections,',\n",
       "  'or',\n",
       "  'side-effects.'],\n",
       " ['no',\n",
       "  'significant',\n",
       "  'differences',\n",
       "  'were',\n",
       "  'observed',\n",
       "  'between',\n",
       "  'feso4+citrate',\n",
       "  'and',\n",
       "  'nafe-edta',\n",
       "  'fortification,',\n",
       "  'regarding',\n",
       "  'mitigation',\n",
       "  'of',\n",
       "  'iron-deficiency',\n",
       "  'anemia',\n",
       "  '(ida)',\n",
       "  'or',\n",
       "  'regarding',\n",
       "  'crp,',\n",
       "  'growth,',\n",
       "  'infections,',\n",
       "  'or',\n",
       "  'side-effects.'],\n",
       " ['no',\n",
       "  'significant',\n",
       "  'differences',\n",
       "  'were',\n",
       "  'observed',\n",
       "  'between',\n",
       "  'feso4+citrate',\n",
       "  'and',\n",
       "  'nafe-edta',\n",
       "  'fortification,',\n",
       "  'regarding',\n",
       "  'mitigation',\n",
       "  'of',\n",
       "  'iron-deficiency',\n",
       "  'anemia',\n",
       "  '(ida)',\n",
       "  'or',\n",
       "  'regarding',\n",
       "  'crp,',\n",
       "  'growth,',\n",
       "  'infections,',\n",
       "  'or',\n",
       "  'side-effects.'],\n",
       " ['sustained',\n",
       "  'virologic',\n",
       "  'response',\n",
       "  '(svr)',\n",
       "  'rates',\n",
       "  'of',\n",
       "  '50%-60%',\n",
       "  'have',\n",
       "  'been',\n",
       "  'achieved',\n",
       "  'in',\n",
       "  'patients',\n",
       "  'with',\n",
       "  'chronic',\n",
       "  'hepatitis',\n",
       "  'c',\n",
       "  'genotype',\n",
       "  '4',\n",
       "  'treated',\n",
       "  'with',\n",
       "  'peginterferon',\n",
       "  'plus',\n",
       "  'ribavirin.'],\n",
       " ['adverse',\n",
       "  'events',\n",
       "  'were',\n",
       "  'similar',\n",
       "  'across',\n",
       "  'treatment',\n",
       "  'groups',\n",
       "  'except',\n",
       "  'for',\n",
       "  'higher',\n",
       "  'rates',\n",
       "  'of',\n",
       "  'anemia',\n",
       "  'in',\n",
       "  'the',\n",
       "  'groups',\n",
       "  'receiving',\n",
       "  'ribavirin.'],\n",
       " ['sustained',\n",
       "  'virologic',\n",
       "  'response',\n",
       "  '(svr)',\n",
       "  'rates',\n",
       "  'of',\n",
       "  '50%-60%',\n",
       "  'have',\n",
       "  'been',\n",
       "  'achieved',\n",
       "  'in',\n",
       "  'patients',\n",
       "  'with',\n",
       "  'chronic',\n",
       "  'hepatitis',\n",
       "  'c',\n",
       "  'genotype',\n",
       "  '4',\n",
       "  'treated',\n",
       "  'with',\n",
       "  'peginterferon',\n",
       "  'plus',\n",
       "  'ribavirin.'],\n",
       " ['exposure',\n",
       "  'to',\n",
       "  'radioisotopes',\n",
       "  'of',\n",
       "  'metals',\n",
       "  'and',\n",
       "  'halogen',\n",
       "  'elements',\n",
       "  'occurring',\n",
       "  'in',\n",
       "  'medical',\n",
       "  'practice',\n",
       "  'may',\n",
       "  'cause',\n",
       "  'spontaneous',\n",
       "  'abortions.'],\n",
       " ['for',\n",
       "  'exposure',\n",
       "  'levels',\n",
       "  'within',\n",
       "  'standard',\n",
       "  'recommended',\n",
       "  'guidelines,',\n",
       "  'radioisotopes',\n",
       "  'are',\n",
       "  'far',\n",
       "  'more',\n",
       "  'likely',\n",
       "  'to',\n",
       "  'play',\n",
       "  'a',\n",
       "  'role',\n",
       "  'in',\n",
       "  'the',\n",
       "  'occurrence',\n",
       "  'of',\n",
       "  'spontaneous',\n",
       "  'abortions',\n",
       "  'than',\n",
       "  'x-rays.'],\n",
       " ['women',\n",
       "  'exposed',\n",
       "  'to',\n",
       "  'radioisotopes',\n",
       "  'experienced',\n",
       "  'at',\n",
       "  'least',\n",
       "  'a',\n",
       "  'threefold',\n",
       "  'higher',\n",
       "  'rate',\n",
       "  'of',\n",
       "  'spontaneous',\n",
       "  'abortions',\n",
       "  'than',\n",
       "  'those',\n",
       "  'exposed',\n",
       "  'to',\n",
       "  'x-ray',\n",
       "  '(or',\n",
       "  '=',\n",
       "  '3.68,',\n",
       "  '95%',\n",
       "  'ci',\n",
       "  '=',\n",
       "  '1.39-9.74,',\n",
       "  'p',\n",
       "  '<',\n",
       "  '0.01).'],\n",
       " ['an',\n",
       "  'open',\n",
       "  'multicenter',\n",
       "  'phase',\n",
       "  'ii',\n",
       "  'trial',\n",
       "  'of',\n",
       "  'weekly',\n",
       "  'docetaxel',\n",
       "  'for',\n",
       "  'advanced-stage',\n",
       "  'non-small-cell',\n",
       "  'lung',\n",
       "  'cancer',\n",
       "  'in',\n",
       "  'elderly',\n",
       "  'patients',\n",
       "  'with',\n",
       "  'significant',\n",
       "  'comorbidity',\n",
       "  'and/or',\n",
       "  'poor',\n",
       "  'performance',\n",
       "  'status:',\n",
       "  'the',\n",
       "  'gfpc',\n",
       "  '02-02b',\n",
       "  'study.'],\n",
       " ['contrarily,',\n",
       "  'laba',\n",
       "  'showed',\n",
       "  'a',\n",
       "  'significant',\n",
       "  'increase',\n",
       "  'in',\n",
       "  'asthma-related',\n",
       "  'deaths',\n",
       "  '(relative',\n",
       "  'risk=3.83;',\n",
       "  '95%',\n",
       "  'ci,',\n",
       "  '1.21-12.14).'],\n",
       " ['primary',\n",
       "  'outcomes',\n",
       "  'were',\n",
       "  'asthma',\n",
       "  'exacerbations',\n",
       "  '(ae)',\n",
       "  'requiring',\n",
       "  'systemic',\n",
       "  'corticosteroids',\n",
       "  'or',\n",
       "  'hospitalization,',\n",
       "  'life-threatening',\n",
       "  'exacerbations',\n",
       "  'and',\n",
       "  'asthma-related',\n",
       "  'deaths.'],\n",
       " ['forty-one',\n",
       "  'patients',\n",
       "  '[30',\n",
       "  'males',\n",
       "  'and',\n",
       "  '11',\n",
       "  'females,',\n",
       "  'median',\n",
       "  'age',\n",
       "  '47',\n",
       "  'years]',\n",
       "  'consecutively',\n",
       "  'diagnosed',\n",
       "  'with',\n",
       "  'ptcl',\n",
       "  'received',\n",
       "  'three',\n",
       "  'courses',\n",
       "  'of',\n",
       "  'high-dose',\n",
       "  'cyclophosphamide',\n",
       "  '2000',\n",
       "  'mg/m(2)/day,',\n",
       "  'adriamycin',\n",
       "  '90',\n",
       "  'mg/m(2)/day,',\n",
       "  'vincristine',\n",
       "  'and',\n",
       "  'prednisone',\n",
       "  'alternating',\n",
       "  'with',\n",
       "  'three',\n",
       "  'courses',\n",
       "  'of',\n",
       "  'etoposide,',\n",
       "  'cisplatin,',\n",
       "  'cytarabine',\n",
       "  'and',\n",
       "  'prednisone.'],\n",
       " ['forty-one',\n",
       "  'patients',\n",
       "  '[30',\n",
       "  'males',\n",
       "  'and',\n",
       "  '11',\n",
       "  'females,',\n",
       "  'median',\n",
       "  'age',\n",
       "  '47',\n",
       "  'years]',\n",
       "  'consecutively',\n",
       "  'diagnosed',\n",
       "  'with',\n",
       "  'ptcl',\n",
       "  'received',\n",
       "  'three',\n",
       "  'courses',\n",
       "  'of',\n",
       "  'high-dose',\n",
       "  'cyclophosphamide',\n",
       "  '2000',\n",
       "  'mg/m(2)/day,',\n",
       "  'adriamycin',\n",
       "  '90',\n",
       "  'mg/m(2)/day,',\n",
       "  'vincristine',\n",
       "  'and',\n",
       "  'prednisone',\n",
       "  'alternating',\n",
       "  'with',\n",
       "  'three',\n",
       "  'courses',\n",
       "  'of',\n",
       "  'etoposide,',\n",
       "  'cisplatin,',\n",
       "  'cytarabine',\n",
       "  'and',\n",
       "  'prednisone.'],\n",
       " ['forty-one',\n",
       "  'patients',\n",
       "  '[30',\n",
       "  'males',\n",
       "  'and',\n",
       "  '11',\n",
       "  'females,',\n",
       "  'median',\n",
       "  'age',\n",
       "  '47',\n",
       "  'years]',\n",
       "  'consecutively',\n",
       "  'diagnosed',\n",
       "  'with',\n",
       "  'ptcl',\n",
       "  'received',\n",
       "  'three',\n",
       "  'courses',\n",
       "  'of',\n",
       "  'high-dose',\n",
       "  'cyclophosphamide',\n",
       "  '2000',\n",
       "  'mg/m(2)/day,',\n",
       "  'adriamycin',\n",
       "  '90',\n",
       "  'mg/m(2)/day,',\n",
       "  'vincristine',\n",
       "  'and',\n",
       "  'prednisone',\n",
       "  'alternating',\n",
       "  'with',\n",
       "  'three',\n",
       "  'courses',\n",
       "  'of',\n",
       "  'etoposide,',\n",
       "  'cisplatin,',\n",
       "  'cytarabine',\n",
       "  'and',\n",
       "  'prednisone.'],\n",
       " ['forty-one',\n",
       "  'patients',\n",
       "  '[30',\n",
       "  'males',\n",
       "  'and',\n",
       "  '11',\n",
       "  'females,',\n",
       "  'median',\n",
       "  'age',\n",
       "  '47',\n",
       "  'years]',\n",
       "  'consecutively',\n",
       "  'diagnosed',\n",
       "  'with',\n",
       "  'ptcl',\n",
       "  'received',\n",
       "  'three',\n",
       "  'courses',\n",
       "  'of',\n",
       "  'high-dose',\n",
       "  'cyclophosphamide',\n",
       "  '2000',\n",
       "  'mg/m(2)/day,',\n",
       "  'adriamycin',\n",
       "  '90',\n",
       "  'mg/m(2)/day,',\n",
       "  'vincristine',\n",
       "  'and',\n",
       "  'prednisone',\n",
       "  'alternating',\n",
       "  'with',\n",
       "  'three',\n",
       "  'courses',\n",
       "  'of',\n",
       "  'etoposide,',\n",
       "  'cisplatin,',\n",
       "  'cytarabine',\n",
       "  'and',\n",
       "  'prednisone.'],\n",
       " ['forty-one',\n",
       "  'patients',\n",
       "  '[30',\n",
       "  'males',\n",
       "  'and',\n",
       "  '11',\n",
       "  'females,',\n",
       "  'median',\n",
       "  'age',\n",
       "  '47',\n",
       "  'years]',\n",
       "  'consecutively',\n",
       "  'diagnosed',\n",
       "  'with',\n",
       "  'ptcl',\n",
       "  'received',\n",
       "  'three',\n",
       "  'courses',\n",
       "  'of',\n",
       "  'high-dose',\n",
       "  'cyclophosphamide',\n",
       "  '2000',\n",
       "  'mg/m(2)/day,',\n",
       "  'adriamycin',\n",
       "  '90',\n",
       "  'mg/m(2)/day,',\n",
       "  'vincristine',\n",
       "  'and',\n",
       "  'prednisone',\n",
       "  'alternating',\n",
       "  'with',\n",
       "  'three',\n",
       "  'courses',\n",
       "  'of',\n",
       "  'etoposide,',\n",
       "  'cisplatin,',\n",
       "  'cytarabine',\n",
       "  'and',\n",
       "  'prednisone.'],\n",
       " ['forty-one',\n",
       "  'patients',\n",
       "  '[30',\n",
       "  'males',\n",
       "  'and',\n",
       "  '11',\n",
       "  'females,',\n",
       "  'median',\n",
       "  'age',\n",
       "  '47',\n",
       "  'years]',\n",
       "  'consecutively',\n",
       "  'diagnosed',\n",
       "  'with',\n",
       "  'ptcl',\n",
       "  'received',\n",
       "  'three',\n",
       "  'courses',\n",
       "  'of',\n",
       "  'high-dose',\n",
       "  'cyclophosphamide',\n",
       "  '2000',\n",
       "  'mg/m(2)/day,',\n",
       "  'adriamycin',\n",
       "  '90',\n",
       "  'mg/m(2)/day,',\n",
       "  'vincristine',\n",
       "  'and',\n",
       "  'prednisone',\n",
       "  'alternating',\n",
       "  'with',\n",
       "  'three',\n",
       "  'courses',\n",
       "  'of',\n",
       "  'etoposide,',\n",
       "  'cisplatin,',\n",
       "  'cytarabine',\n",
       "  'and',\n",
       "  'prednisone.'],\n",
       " ['forty-one',\n",
       "  'patients',\n",
       "  '[30',\n",
       "  'males',\n",
       "  'and',\n",
       "  '11',\n",
       "  'females,',\n",
       "  'median',\n",
       "  'age',\n",
       "  '47',\n",
       "  'years]',\n",
       "  'consecutively',\n",
       "  'diagnosed',\n",
       "  'with',\n",
       "  'ptcl',\n",
       "  'received',\n",
       "  'three',\n",
       "  'courses',\n",
       "  'of',\n",
       "  'high-dose',\n",
       "  'cyclophosphamide',\n",
       "  '2000',\n",
       "  'mg/m(2)/day,',\n",
       "  'adriamycin',\n",
       "  '90',\n",
       "  'mg/m(2)/day,',\n",
       "  'vincristine',\n",
       "  'and',\n",
       "  'prednisone',\n",
       "  'alternating',\n",
       "  'with',\n",
       "  'three',\n",
       "  'courses',\n",
       "  'of',\n",
       "  'etoposide,',\n",
       "  'cisplatin,',\n",
       "  'cytarabine',\n",
       "  'and',\n",
       "  'prednisone.'],\n",
       " ['plasma',\n",
       "  'ziprasidone',\n",
       "  'levels',\n",
       "  'ranged',\n",
       "  'from',\n",
       "  '20',\n",
       "  'ng/ml',\n",
       "  'to',\n",
       "  '160',\n",
       "  'ng/ml',\n",
       "  '(mean:',\n",
       "  '75.8',\n",
       "  'ng/ml)',\n",
       "  'and',\n",
       "  'were',\n",
       "  'significantly',\n",
       "  'related',\n",
       "  'to',\n",
       "  'the',\n",
       "  'improvement',\n",
       "  'in',\n",
       "  'negative',\n",
       "  'symptoms.'],\n",
       " ['the',\n",
       "  'study',\n",
       "  'showed',\n",
       "  'that',\n",
       "  'ziprasidone',\n",
       "  'was',\n",
       "  'effective',\n",
       "  'and',\n",
       "  'tolerable,',\n",
       "  'that',\n",
       "  'use',\n",
       "  'of',\n",
       "  'ziprasidone',\n",
       "  'was',\n",
       "  'characterized',\n",
       "  'by',\n",
       "  'an',\n",
       "  'absence',\n",
       "  'of',\n",
       "  'extrapyramidal',\n",
       "  'symptoms',\n",
       "  'and',\n",
       "  'weight',\n",
       "  'gain,',\n",
       "  'and',\n",
       "  'that',\n",
       "  'no',\n",
       "  'alterations',\n",
       "  'in',\n",
       "  'clinical',\n",
       "  'laboratory',\n",
       "  'tests',\n",
       "  'occurred.'],\n",
       " ['characteristic',\n",
       "  'features',\n",
       "  'of',\n",
       "  'an',\n",
       "  'inflammation',\n",
       "  'induced',\n",
       "  'by',\n",
       "  'bevacizumab',\n",
       "  'injection',\n",
       "  'include',\n",
       "  'an',\n",
       "  'early',\n",
       "  'onset',\n",
       "  'with',\n",
       "  'painless',\n",
       "  'loss',\n",
       "  'in',\n",
       "  'va',\n",
       "  'mostly',\n",
       "  'without',\n",
       "  'conjunctival',\n",
       "  'or',\n",
       "  'ciliary',\n",
       "  'injection.'],\n",
       " ['administration',\n",
       "  'of',\n",
       "  'full-dose',\n",
       "  'r-chop',\n",
       "  '(rituximab/cyclophosphamide/doxorubicin/vincristine/prednisone)',\n",
       "  'chemotherapy',\n",
       "  'is',\n",
       "  'important',\n",
       "  'to',\n",
       "  'maximize',\n",
       "  'response',\n",
       "  'in',\n",
       "  'patients',\n",
       "  'with',\n",
       "  'intermediate-or',\n",
       "  'high-grade',\n",
       "  'non-hodgkin',\n",
       "  'lymphoma',\n",
       "  'but',\n",
       "  'might',\n",
       "  'be',\n",
       "  'difficult',\n",
       "  'in',\n",
       "  'older',\n",
       "  'patients.'],\n",
       " ['administration',\n",
       "  'of',\n",
       "  'full-dose',\n",
       "  'r-chop',\n",
       "  '(rituximab/cyclophosphamide/doxorubicin/vincristine/prednisone)',\n",
       "  'chemotherapy',\n",
       "  'is',\n",
       "  'important',\n",
       "  'to',\n",
       "  'maximize',\n",
       "  'response',\n",
       "  'in',\n",
       "  'patients',\n",
       "  'with',\n",
       "  'intermediate-or',\n",
       "  'high-grade',\n",
       "  'non-hodgkin',\n",
       "  'lymphoma',\n",
       "  'but',\n",
       "  'might',\n",
       "  'be',\n",
       "  'difficult',\n",
       "  'in',\n",
       "  'older',\n",
       "  'patients.'],\n",
       " ['administration',\n",
       "  'of',\n",
       "  'full-dose',\n",
       "  'r-chop',\n",
       "  '(rituximab/cyclophosphamide/doxorubicin/vincristine/prednisone)',\n",
       "  'chemotherapy',\n",
       "  'is',\n",
       "  'important',\n",
       "  'to',\n",
       "  'maximize',\n",
       "  'response',\n",
       "  'in',\n",
       "  'patients',\n",
       "  'with',\n",
       "  'intermediate-or',\n",
       "  'high-grade',\n",
       "  'non-hodgkin',\n",
       "  'lymphoma',\n",
       "  'but',\n",
       "  'might',\n",
       "  'be',\n",
       "  'difficult',\n",
       "  'in',\n",
       "  'older',\n",
       "  'patients.'],\n",
       " ['administration',\n",
       "  'of',\n",
       "  'full-dose',\n",
       "  'r-chop',\n",
       "  '(rituximab/cyclophosphamide/doxorubicin/vincristine/prednisone)',\n",
       "  'chemotherapy',\n",
       "  'is',\n",
       "  'important',\n",
       "  'to',\n",
       "  'maximize',\n",
       "  'response',\n",
       "  'in',\n",
       "  'patients',\n",
       "  'with',\n",
       "  'intermediate-or',\n",
       "  'high-grade',\n",
       "  'non-hodgkin',\n",
       "  'lymphoma',\n",
       "  'but',\n",
       "  'might',\n",
       "  'be',\n",
       "  'difficult',\n",
       "  'in',\n",
       "  'older',\n",
       "  'patients.'],\n",
       " ['administration',\n",
       "  'of',\n",
       "  'full-dose',\n",
       "  'r-chop',\n",
       "  '(rituximab/cyclophosphamide/doxorubicin/vincristine/prednisone)',\n",
       "  'chemotherapy',\n",
       "  'is',\n",
       "  'important',\n",
       "  'to',\n",
       "  'maximize',\n",
       "  'response',\n",
       "  'in',\n",
       "  'patients',\n",
       "  'with',\n",
       "  'intermediate-or',\n",
       "  'high-grade',\n",
       "  'non-hodgkin',\n",
       "  'lymphoma',\n",
       "  'but',\n",
       "  'might',\n",
       "  'be',\n",
       "  'difficult',\n",
       "  'in',\n",
       "  'older',\n",
       "  'patients.'],\n",
       " ['compared',\n",
       "  'with',\n",
       "  'the',\n",
       "  'general',\n",
       "  'population,',\n",
       "  'methotrexate-treated',\n",
       "  'ra',\n",
       "  'patients',\n",
       "  'have',\n",
       "  'an',\n",
       "  'increased',\n",
       "  'incidence',\n",
       "  'of',\n",
       "  'melanoma,',\n",
       "  \"non-hodgkin's\",\n",
       "  'lymphoma,',\n",
       "  'and',\n",
       "  'lung',\n",
       "  'cancer.'],\n",
       " ['compared',\n",
       "  'with',\n",
       "  'the',\n",
       "  'general',\n",
       "  'population,',\n",
       "  'methotrexate-treated',\n",
       "  'ra',\n",
       "  'patients',\n",
       "  'have',\n",
       "  'an',\n",
       "  'increased',\n",
       "  'incidence',\n",
       "  'of',\n",
       "  'melanoma,',\n",
       "  \"non-hodgkin's\",\n",
       "  'lymphoma,',\n",
       "  'and',\n",
       "  'lung',\n",
       "  'cancer.'],\n",
       " ['compared',\n",
       "  'with',\n",
       "  'the',\n",
       "  'general',\n",
       "  'population,',\n",
       "  'methotrexate-treated',\n",
       "  'ra',\n",
       "  'patients',\n",
       "  'have',\n",
       "  'an',\n",
       "  'increased',\n",
       "  'incidence',\n",
       "  'of',\n",
       "  'melanoma,',\n",
       "  \"non-hodgkin's\",\n",
       "  'lymphoma,',\n",
       "  'and',\n",
       "  'lung',\n",
       "  'cancer.'],\n",
       " ['there',\n",
       "  'was',\n",
       "  'an',\n",
       "  'estimated',\n",
       "  '50%',\n",
       "  'excess',\n",
       "  'risk',\n",
       "  'of',\n",
       "  'malignancy',\n",
       "  'among',\n",
       "  'methotrexate-exposed',\n",
       "  'ra',\n",
       "  'patients',\n",
       "  'relative',\n",
       "  'to',\n",
       "  'the',\n",
       "  'general',\n",
       "  'population',\n",
       "  '(sir',\n",
       "  '1.5,',\n",
       "  '95%',\n",
       "  'confidence',\n",
       "  'interval',\n",
       "  '[95%',\n",
       "  'ci]',\n",
       "  '1.2-1.9),',\n",
       "  'with',\n",
       "  'a',\n",
       "  '3-fold',\n",
       "  'increase',\n",
       "  'in',\n",
       "  'melanoma',\n",
       "  '(sir',\n",
       "  '3.0,',\n",
       "  '95%',\n",
       "  'ci',\n",
       "  '1.2-6.2),',\n",
       "  'a',\n",
       "  '5-fold',\n",
       "  'increase',\n",
       "  'in',\n",
       "  \"non-hodgkin's\",\n",
       "  'lymphoma',\n",
       "  '(sir',\n",
       "  '5.1,',\n",
       "  '95%',\n",
       "  'ci',\n",
       "  '2.2-10.0),',\n",
       "  'and',\n",
       "  'an',\n",
       "  'almost',\n",
       "  '3-fold',\n",
       "  'increase',\n",
       "  'in',\n",
       "  'lung',\n",
       "  'cancer',\n",
       "  '(sir',\n",
       "  '2.9,',\n",
       "  '95%',\n",
       "  'ci',\n",
       "  '1.6-4.8).'],\n",
       " ['there',\n",
       "  'was',\n",
       "  'an',\n",
       "  'estimated',\n",
       "  '50%',\n",
       "  'excess',\n",
       "  'risk',\n",
       "  'of',\n",
       "  'malignancy',\n",
       "  'among',\n",
       "  'methotrexate-exposed',\n",
       "  'ra',\n",
       "  'patients',\n",
       "  'relative',\n",
       "  'to',\n",
       "  'the',\n",
       "  'general',\n",
       "  'population',\n",
       "  '(sir',\n",
       "  '1.5,',\n",
       "  '95%',\n",
       "  'confidence',\n",
       "  'interval',\n",
       "  '[95%',\n",
       "  'ci]',\n",
       "  '1.2-1.9),',\n",
       "  'with',\n",
       "  'a',\n",
       "  '3-fold',\n",
       "  'increase',\n",
       "  'in',\n",
       "  'melanoma',\n",
       "  '(sir',\n",
       "  '3.0,',\n",
       "  '95%',\n",
       "  'ci',\n",
       "  '1.2-6.2),',\n",
       "  'a',\n",
       "  '5-fold',\n",
       "  'increase',\n",
       "  'in',\n",
       "  \"non-hodgkin's\",\n",
       "  'lymphoma',\n",
       "  '(sir',\n",
       "  '5.1,',\n",
       "  '95%',\n",
       "  'ci',\n",
       "  '2.2-10.0),',\n",
       "  'and',\n",
       "  'an',\n",
       "  'almost',\n",
       "  '3-fold',\n",
       "  'increase',\n",
       "  'in',\n",
       "  'lung',\n",
       "  'cancer',\n",
       "  '(sir',\n",
       "  '2.9,',\n",
       "  '95%',\n",
       "  'ci',\n",
       "  '1.6-4.8).'],\n",
       " ['there',\n",
       "  'was',\n",
       "  'an',\n",
       "  'estimated',\n",
       "  '50%',\n",
       "  'excess',\n",
       "  'risk',\n",
       "  'of',\n",
       "  'malignancy',\n",
       "  'among',\n",
       "  'methotrexate-exposed',\n",
       "  'ra',\n",
       "  'patients',\n",
       "  'relative',\n",
       "  'to',\n",
       "  'the',\n",
       "  'general',\n",
       "  'population',\n",
       "  '(sir',\n",
       "  '1.5,',\n",
       "  '95%',\n",
       "  'confidence',\n",
       "  'interval',\n",
       "  '[95%',\n",
       "  'ci]',\n",
       "  '1.2-1.9),',\n",
       "  'with',\n",
       "  'a',\n",
       "  '3-fold',\n",
       "  'increase',\n",
       "  'in',\n",
       "  'melanoma',\n",
       "  '(sir',\n",
       "  '3.0,',\n",
       "  '95%',\n",
       "  'ci',\n",
       "  '1.2-6.2),',\n",
       "  'a',\n",
       "  '5-fold',\n",
       "  'increase',\n",
       "  'in',\n",
       "  \"non-hodgkin's\",\n",
       "  'lymphoma',\n",
       "  '(sir',\n",
       "  '5.1,',\n",
       "  '95%',\n",
       "  'ci',\n",
       "  '2.2-10.0),',\n",
       "  'and',\n",
       "  'an',\n",
       "  'almost',\n",
       "  '3-fold',\n",
       "  'increase',\n",
       "  'in',\n",
       "  'lung',\n",
       "  'cancer',\n",
       "  '(sir',\n",
       "  '2.9,',\n",
       "  '95%',\n",
       "  'ci',\n",
       "  '1.6-4.8).'],\n",
       " ['there',\n",
       "  'was',\n",
       "  'an',\n",
       "  'estimated',\n",
       "  '50%',\n",
       "  'excess',\n",
       "  'risk',\n",
       "  'of',\n",
       "  'malignancy',\n",
       "  'among',\n",
       "  'methotrexate-exposed',\n",
       "  'ra',\n",
       "  'patients',\n",
       "  'relative',\n",
       "  'to',\n",
       "  'the',\n",
       "  'general',\n",
       "  'population',\n",
       "  '(sir',\n",
       "  '1.5,',\n",
       "  '95%',\n",
       "  'confidence',\n",
       "  'interval',\n",
       "  '[95%',\n",
       "  'ci]',\n",
       "  '1.2-1.9),',\n",
       "  'with',\n",
       "  'a',\n",
       "  '3-fold',\n",
       "  'increase',\n",
       "  'in',\n",
       "  'melanoma',\n",
       "  '(sir',\n",
       "  '3.0,',\n",
       "  '95%',\n",
       "  'ci',\n",
       "  '1.2-6.2),',\n",
       "  'a',\n",
       "  '5-fold',\n",
       "  'increase',\n",
       "  'in',\n",
       "  \"non-hodgkin's\",\n",
       "  'lymphoma',\n",
       "  '(sir',\n",
       "  '5.1,',\n",
       "  '95%',\n",
       "  'ci',\n",
       "  '2.2-10.0),',\n",
       "  'and',\n",
       "  'an',\n",
       "  'almost',\n",
       "  '3-fold',\n",
       "  'increase',\n",
       "  'in',\n",
       "  'lung',\n",
       "  'cancer',\n",
       "  '(sir',\n",
       "  '2.9,',\n",
       "  '95%',\n",
       "  'ci',\n",
       "  '1.6-4.8).'],\n",
       " ['incidence',\n",
       "  'of',\n",
       "  'melanoma',\n",
       "  'and',\n",
       "  'other',\n",
       "  'malignancies',\n",
       "  'among',\n",
       "  'rheumatoid',\n",
       "  'arthritis',\n",
       "  'patients',\n",
       "  'treated',\n",
       "  'with',\n",
       "  'methotrexate.'],\n",
       " ['to',\n",
       "  'determine',\n",
       "  'cancer',\n",
       "  'risk',\n",
       "  'in',\n",
       "  'a',\n",
       "  'cohort',\n",
       "  'of',\n",
       "  '459',\n",
       "  'rheumatoid',\n",
       "  'arthritis',\n",
       "  '(ra)',\n",
       "  'patients',\n",
       "  'treated',\n",
       "  'with',\n",
       "  'methotrexate',\n",
       "  'in',\n",
       "  'community',\n",
       "  'practice.'],\n",
       " ['to',\n",
       "  'determine',\n",
       "  'cancer',\n",
       "  'risk',\n",
       "  'in',\n",
       "  'a',\n",
       "  'cohort',\n",
       "  'of',\n",
       "  '459',\n",
       "  'rheumatoid',\n",
       "  'arthritis',\n",
       "  '(ra)',\n",
       "  'patients',\n",
       "  'treated',\n",
       "  'with',\n",
       "  'methotrexate',\n",
       "  'in',\n",
       "  'community',\n",
       "  'practice.'],\n",
       " ['incidence',\n",
       "  'of',\n",
       "  'melanoma',\n",
       "  'and',\n",
       "  'other',\n",
       "  'malignancies',\n",
       "  'among',\n",
       "  'rheumatoid',\n",
       "  'arthritis',\n",
       "  'patients',\n",
       "  'treated',\n",
       "  'with',\n",
       "  'methotrexate.'],\n",
       " ['incidence',\n",
       "  'of',\n",
       "  'melanoma',\n",
       "  'and',\n",
       "  'other',\n",
       "  'malignancies',\n",
       "  'among',\n",
       "  'rheumatoid',\n",
       "  'arthritis',\n",
       "  'patients',\n",
       "  'treated',\n",
       "  'with',\n",
       "  'methotrexate.'],\n",
       " ['recombinant',\n",
       "  'hirudin',\n",
       "  'is',\n",
       "  'used',\n",
       "  'as',\n",
       "  'an',\n",
       "  'alternative',\n",
       "  'anticoagulant,',\n",
       "  'particularly',\n",
       "  'in',\n",
       "  'patients',\n",
       "  'with',\n",
       "  'heparin-induced',\n",
       "  'thrombocytopenia',\n",
       "  'type',\n",
       "  'ii.'],\n",
       " ['absence',\n",
       "  'of',\n",
       "  'villin',\n",
       "  'predisposes',\n",
       "  'mice',\n",
       "  'to',\n",
       "  'dextran',\n",
       "  'sodium',\n",
       "  'sulfate-induced',\n",
       "  'colitis',\n",
       "  'by',\n",
       "  'promoting',\n",
       "  'apoptosis.'],\n",
       " ['dental',\n",
       "  'surgery',\n",
       "  'for',\n",
       "  'these',\n",
       "  'children',\n",
       "  'has',\n",
       "  'historically',\n",
       "  'consisted',\n",
       "  'of',\n",
       "  'decreasing',\n",
       "  'and/or',\n",
       "  'discontinuing',\n",
       "  'the',\n",
       "  'oral',\n",
       "  'anticoagulant',\n",
       "  'and',\n",
       "  'instituting',\n",
       "  'heparin',\n",
       "  'therapy',\n",
       "  'prior',\n",
       "  'to',\n",
       "  'the',\n",
       "  'planned',\n",
       "  'dental',\n",
       "  'procedure,',\n",
       "  'which',\n",
       "  'can',\n",
       "  'result',\n",
       "  'in',\n",
       "  'thromboembolism',\n",
       "  'and',\n",
       "  'increased',\n",
       "  'morbidity',\n",
       "  'and',\n",
       "  'mortality.'],\n",
       " ['children',\n",
       "  'with',\n",
       "  'prosthetic',\n",
       "  'cardiac',\n",
       "  'valves',\n",
       "  'and',\n",
       "  'other',\n",
       "  'invasive',\n",
       "  'mechanical',\n",
       "  'devices',\n",
       "  'that',\n",
       "  'direct',\n",
       "  'blood',\n",
       "  'flow',\n",
       "  'require',\n",
       "  'anticoagulant',\n",
       "  'medication',\n",
       "  'for',\n",
       "  'prevention',\n",
       "  'of',\n",
       "  'thrombosis.'],\n",
       " ['dental',\n",
       "  'surgery',\n",
       "  'for',\n",
       "  'these',\n",
       "  'children',\n",
       "  'has',\n",
       "  'historically',\n",
       "  'consisted',\n",
       "  'of',\n",
       "  'decreasing',\n",
       "  'and/or',\n",
       "  'discontinuing',\n",
       "  'the',\n",
       "  'oral',\n",
       "  'anticoagulant',\n",
       "  'and',\n",
       "  'instituting',\n",
       "  'heparin',\n",
       "  'therapy',\n",
       "  'prior',\n",
       "  'to',\n",
       "  'the',\n",
       "  'planned',\n",
       "  'dental',\n",
       "  'procedure,',\n",
       "  'which',\n",
       "  'can',\n",
       "  'result',\n",
       "  'in',\n",
       "  'thromboembolism',\n",
       "  'and',\n",
       "  'increased',\n",
       "  'morbidity',\n",
       "  'and',\n",
       "  'mortality.'],\n",
       " ['finally,',\n",
       "  'in',\n",
       "  'non-small',\n",
       "  'cell',\n",
       "  'lung',\n",
       "  'cancer',\n",
       "  '(nsclc)',\n",
       "  'in',\n",
       "  \"patients'\",\n",
       "  'progressing',\n",
       "  'on',\n",
       "  'chemotherapy',\n",
       "  'sutent',\n",
       "  'was',\n",
       "  'able',\n",
       "  'to',\n",
       "  'achieve',\n",
       "  'a',\n",
       "  '10%',\n",
       "  'response',\n",
       "  'rate,',\n",
       "  'a',\n",
       "  'level',\n",
       "  'of',\n",
       "  'activity',\n",
       "  'similar',\n",
       "  'to',\n",
       "  'those',\n",
       "  'documented',\n",
       "  'by',\n",
       "  'other',\n",
       "  'agents',\n",
       "  'approved',\n",
       "  'for',\n",
       "  'lung',\n",
       "  'cancer.'],\n",
       " ['in',\n",
       "  'several',\n",
       "  'phase',\n",
       "  'i/ii/iii',\n",
       "  'studies,',\n",
       "  'sutent',\n",
       "  'was',\n",
       "  'found',\n",
       "  'to',\n",
       "  'be',\n",
       "  'effective',\n",
       "  'as',\n",
       "  'second',\n",
       "  'and',\n",
       "  'first',\n",
       "  'line',\n",
       "  'treatment',\n",
       "  'in',\n",
       "  'metastatic',\n",
       "  'renal',\n",
       "  'cell',\n",
       "  'carcinoma',\n",
       "  '(rcc).'],\n",
       " ['finally,',\n",
       "  'in',\n",
       "  'non-small',\n",
       "  'cell',\n",
       "  'lung',\n",
       "  'cancer',\n",
       "  '(nsclc)',\n",
       "  'in',\n",
       "  \"patients'\",\n",
       "  'progressing',\n",
       "  'on',\n",
       "  'chemotherapy',\n",
       "  'sutent',\n",
       "  'was',\n",
       "  'able',\n",
       "  'to',\n",
       "  'achieve',\n",
       "  'a',\n",
       "  '10%',\n",
       "  'response',\n",
       "  'rate,',\n",
       "  'a',\n",
       "  'level',\n",
       "  'of',\n",
       "  'activity',\n",
       "  'similar',\n",
       "  'to',\n",
       "  'those',\n",
       "  'documented',\n",
       "  'by',\n",
       "  'other',\n",
       "  'agents',\n",
       "  'approved',\n",
       "  'for',\n",
       "  'lung',\n",
       "  'cancer.'],\n",
       " ['sutent',\n",
       "  'was',\n",
       "  'also',\n",
       "  'effective',\n",
       "  'as',\n",
       "  'second',\n",
       "  'line',\n",
       "  'treatment',\n",
       "  'in',\n",
       "  'patients',\n",
       "  'with',\n",
       "  'gastrointestinal',\n",
       "  'stromal',\n",
       "  'tumors',\n",
       "  '(gist)',\n",
       "  'with',\n",
       "  '8%',\n",
       "  'response',\n",
       "  'rate,',\n",
       "  '70%',\n",
       "  'stable',\n",
       "  'disease',\n",
       "  'and',\n",
       "  'a',\n",
       "  '20-month',\n",
       "  'median',\n",
       "  'survival.'],\n",
       " ['in',\n",
       "  'addition,',\n",
       "  'a',\n",
       "  'phase',\n",
       "  'ii',\n",
       "  'study',\n",
       "  'in',\n",
       "  'multitreated',\n",
       "  'women',\n",
       "  'with',\n",
       "  'breast',\n",
       "  'cancer,',\n",
       "  'sutent',\n",
       "  'demonstrated',\n",
       "  'a',\n",
       "  'moderate',\n",
       "  'activity',\n",
       "  'with',\n",
       "  '16%',\n",
       "  'clinical',\n",
       "  'benefit.'],\n",
       " ['epoetin',\n",
       "  'beta',\n",
       "  'effectively',\n",
       "  'increases',\n",
       "  'hemoglobin',\n",
       "  'levels,',\n",
       "  'reduces',\n",
       "  'the',\n",
       "  'need',\n",
       "  'for',\n",
       "  'transfusions',\n",
       "  'and',\n",
       "  'improves',\n",
       "  'the',\n",
       "  'quality',\n",
       "  'of',\n",
       "  'life',\n",
       "  'in',\n",
       "  'patients',\n",
       "  'with',\n",
       "  'symptomatic',\n",
       "  'chemotherapy-induced',\n",
       "  'anemia',\n",
       "  'with',\n",
       "  'a',\n",
       "  'range',\n",
       "  'of',\n",
       "  'solid',\n",
       "  'tumors',\n",
       "  'and',\n",
       "  'lymphoid',\n",
       "  'malignancies.'],\n",
       " ['this',\n",
       "  'once-weekly',\n",
       "  'regimen',\n",
       "  'is',\n",
       "  'generally',\n",
       "  'well',\n",
       "  'tolerated,',\n",
       "  'and',\n",
       "  'studies',\n",
       "  'to',\n",
       "  'date',\n",
       "  'have',\n",
       "  'reported',\n",
       "  'that',\n",
       "  'epoetin',\n",
       "  'beta',\n",
       "  'has',\n",
       "  'a',\n",
       "  'neutral',\n",
       "  'effect',\n",
       "  'on',\n",
       "  'survival',\n",
       "  'of',\n",
       "  'patients',\n",
       "  'with',\n",
       "  'cancer.'],\n",
       " ['epoetin',\n",
       "  'beta',\n",
       "  'once',\n",
       "  'weekly:',\n",
       "  'review',\n",
       "  'of',\n",
       "  'its',\n",
       "  'efficacy',\n",
       "  'and',\n",
       "  'safety',\n",
       "  'in',\n",
       "  'patients',\n",
       "  'with',\n",
       "  'chemotherapy-induced',\n",
       "  'anemia.'],\n",
       " ['during',\n",
       "  'the',\n",
       "  'induction',\n",
       "  'phase,',\n",
       "  'tacrolimus',\n",
       "  'or',\n",
       "  'cyclosporine,',\n",
       "  'mycophenolate',\n",
       "  'mofetil,',\n",
       "  'and',\n",
       "  'methylprednisolone',\n",
       "  'were',\n",
       "  'used',\n",
       "  'for',\n",
       "  'immunosuppression.'],\n",
       " ['during',\n",
       "  'the',\n",
       "  'induction',\n",
       "  'phase,',\n",
       "  'tacrolimus',\n",
       "  'or',\n",
       "  'cyclosporine,',\n",
       "  'mycophenolate',\n",
       "  'mofetil,',\n",
       "  'and',\n",
       "  'methylprednisolone',\n",
       "  'were',\n",
       "  'used',\n",
       "  'for',\n",
       "  'immunosuppression.'],\n",
       " ['during',\n",
       "  'the',\n",
       "  'induction',\n",
       "  'phase,',\n",
       "  'tacrolimus',\n",
       "  'or',\n",
       "  'cyclosporine,',\n",
       "  'mycophenolate',\n",
       "  'mofetil,',\n",
       "  'and',\n",
       "  'methylprednisolone',\n",
       "  'were',\n",
       "  'used',\n",
       "  'for',\n",
       "  'immunosuppression.'],\n",
       " ['during',\n",
       "  'the',\n",
       "  'induction',\n",
       "  'phase,',\n",
       "  'tacrolimus',\n",
       "  'or',\n",
       "  'cyclosporine,',\n",
       "  'mycophenolate',\n",
       "  'mofetil,',\n",
       "  'and',\n",
       "  'methylprednisolone',\n",
       "  'were',\n",
       "  'used',\n",
       "  'for',\n",
       "  'immunosuppression.'],\n",
       " ['the',\n",
       "  'most',\n",
       "  'frequent',\n",
       "  'and',\n",
       "  'the',\n",
       "  'most',\n",
       "  'troublesome',\n",
       "  'adverse',\n",
       "  'effect',\n",
       "  'of',\n",
       "  'interferon',\n",
       "  'plus',\n",
       "  'ribavirin-based',\n",
       "  'therapy',\n",
       "  'is',\n",
       "  'anaemia.'],\n",
       " ['in',\n",
       "  'multivariate',\n",
       "  'analysis',\n",
       "  'the',\n",
       "  'risk',\n",
       "  'of',\n",
       "  'anaemia',\n",
       "  'was',\n",
       "  'significantly',\n",
       "  'associated',\n",
       "  'with',\n",
       "  'zidovudine',\n",
       "  '(or,',\n",
       "  '3.27',\n",
       "  '95%',\n",
       "  'ci,',\n",
       "  '1.64-6.54,',\n",
       "  'p',\n",
       "  '=',\n",
       "  '0.0008)',\n",
       "  'and',\n",
       "  'peg-ifn',\n",
       "  '(or,',\n",
       "  '2.35;',\n",
       "  '95%',\n",
       "  'ci,',\n",
       "  '1.16-4.57,',\n",
       "  'p',\n",
       "  '=',\n",
       "  '0.0179).'],\n",
       " ['zidovudine',\n",
       "  'discontinuation',\n",
       "  'could',\n",
       "  'help',\n",
       "  'to',\n",
       "  'avoid',\n",
       "  'anaemia',\n",
       "  'associated',\n",
       "  'with',\n",
       "  'anti-hcv',\n",
       "  'therapy.'],\n",
       " ['the',\n",
       "  'risk',\n",
       "  'of',\n",
       "  'anaemia',\n",
       "  'was',\n",
       "  'lower',\n",
       "  'in',\n",
       "  'patients',\n",
       "  'with',\n",
       "  'higher',\n",
       "  'baseline',\n",
       "  'haemoglobin',\n",
       "  'levels',\n",
       "  '(or,',\n",
       "  '0.35',\n",
       "  '95%',\n",
       "  'ci,',\n",
       "  '0.26-0.49,',\n",
       "  'p',\n",
       "  '<',\n",
       "  '0.0001)',\n",
       "  'and',\n",
       "  'in',\n",
       "  'patients',\n",
       "  'receiving',\n",
       "  'protease',\n",
       "  'inhibitor-based',\n",
       "  'antiretroviral',\n",
       "  'therapy',\n",
       "  '(or,',\n",
       "  '0.51',\n",
       "  '95%',\n",
       "  'ci,',\n",
       "  '0.30-0.86,',\n",
       "  'p',\n",
       "  '=',\n",
       "  '0.0114).'],\n",
       " ['the',\n",
       "  'most',\n",
       "  'frequent',\n",
       "  'and',\n",
       "  'the',\n",
       "  'most',\n",
       "  'troublesome',\n",
       "  'adverse',\n",
       "  'effect',\n",
       "  'of',\n",
       "  'interferon',\n",
       "  'plus',\n",
       "  'ribavirin-based',\n",
       "  'therapy',\n",
       "  'is',\n",
       "  'anaemia.'],\n",
       " ['this',\n",
       "  'study',\n",
       "  'demonstrated',\n",
       "  'that',\n",
       "  'both',\n",
       "  'low-dose',\n",
       "  'topiramate',\n",
       "  'and',\n",
       "  'propranolol',\n",
       "  'could',\n",
       "  'significantly',\n",
       "  'reduce',\n",
       "  'migraine',\n",
       "  'headache',\n",
       "  'frequency,',\n",
       "  'intensity,',\n",
       "  'and',\n",
       "  'duration.'],\n",
       " ['this',\n",
       "  'study',\n",
       "  'demonstrated',\n",
       "  'that',\n",
       "  'both',\n",
       "  'low-dose',\n",
       "  'topiramate',\n",
       "  'and',\n",
       "  'propranolol',\n",
       "  'could',\n",
       "  'significantly',\n",
       "  'reduce',\n",
       "  'migraine',\n",
       "  'headache',\n",
       "  'frequency,',\n",
       "  'intensity,',\n",
       "  'and',\n",
       "  'duration.'],\n",
       " ['results',\n",
       "  '-',\n",
       "  'the',\n",
       "  'topiramate',\n",
       "  'group',\n",
       "  'showed',\n",
       "  'a',\n",
       "  'reduction',\n",
       "  'in',\n",
       "  'the',\n",
       "  'mean',\n",
       "  '(+/-sd)',\n",
       "  'of',\n",
       "  'monthly',\n",
       "  'migraine',\n",
       "  'frequency',\n",
       "  'from',\n",
       "  '6.07',\n",
       "  '(+/-1.89)',\n",
       "  'to',\n",
       "  '1.83',\n",
       "  '(+/-1.39)',\n",
       "  'episodes',\n",
       "  'per',\n",
       "  'month,',\n",
       "  'headache',\n",
       "  'intensity',\n",
       "  'from',\n",
       "  '7.1',\n",
       "  '(+/-1.45)',\n",
       "  'to',\n",
       "  '3.67',\n",
       "  '(+/-2.1)',\n",
       "  'based',\n",
       "  'on',\n",
       "  'the',\n",
       "  'visual',\n",
       "  'analog',\n",
       "  'scale,',\n",
       "  'and',\n",
       "  'headache',\n",
       "  'duration',\n",
       "  'from',\n",
       "  '16.37',\n",
       "  '(+/-7.26)',\n",
       "  'to',\n",
       "  '6.23',\n",
       "  '(+/-5.22)',\n",
       "  'hours',\n",
       "  '(p',\n",
       "  '<',\n",
       "  '0.001).'],\n",
       " ['results',\n",
       "  '-',\n",
       "  'the',\n",
       "  'topiramate',\n",
       "  'group',\n",
       "  'showed',\n",
       "  'a',\n",
       "  'reduction',\n",
       "  'in',\n",
       "  'the',\n",
       "  'mean',\n",
       "  '(+/-sd)',\n",
       "  'of',\n",
       "  'monthly',\n",
       "  'migraine',\n",
       "  'frequency',\n",
       "  'from',\n",
       "  '6.07',\n",
       "  '(+/-1.89)',\n",
       "  'to',\n",
       "  '1.83',\n",
       "  '(+/-1.39)',\n",
       "  'episodes',\n",
       "  'per',\n",
       "  'month,',\n",
       "  'headache',\n",
       "  'intensity',\n",
       "  'from',\n",
       "  '7.1',\n",
       "  '(+/-1.45)',\n",
       "  'to',\n",
       "  '3.67',\n",
       "  '(+/-2.1)',\n",
       "  'based',\n",
       "  'on',\n",
       "  'the',\n",
       "  'visual',\n",
       "  'analog',\n",
       "  'scale,',\n",
       "  'and',\n",
       "  'headache',\n",
       "  'duration',\n",
       "  'from',\n",
       "  '16.37',\n",
       "  '(+/-7.26)',\n",
       "  'to',\n",
       "  '6.23',\n",
       "  '(+/-5.22)',\n",
       "  'hours',\n",
       "  '(p',\n",
       "  '<',\n",
       "  '0.001).'],\n",
       " ['long-term',\n",
       "  'exposure',\n",
       "  'to',\n",
       "  'medium-dose',\n",
       "  'glucocorticoid',\n",
       "  'therapy',\n",
       "  'associates',\n",
       "  'with',\n",
       "  'hypertension',\n",
       "  'in',\n",
       "  'patients',\n",
       "  'with',\n",
       "  'rheumatoid',\n",
       "  'arthritis.'],\n",
       " ['long-term',\n",
       "  'exposure',\n",
       "  'to',\n",
       "  'medium-dose',\n",
       "  'glucocorticoid',\n",
       "  'therapy',\n",
       "  'associates',\n",
       "  'with',\n",
       "  'hypertension',\n",
       "  'in',\n",
       "  'patients',\n",
       "  'with',\n",
       "  'rheumatoid',\n",
       "  'arthritis.'],\n",
       " ['compared',\n",
       "  'with',\n",
       "  'both',\n",
       "  'diuretics',\n",
       "  'and',\n",
       "  'contemporary',\n",
       "  'agents,',\n",
       "  'amlodipine',\n",
       "  'decreases',\n",
       "  'cardiovascular',\n",
       "  'events',\n",
       "  'to',\n",
       "  'a',\n",
       "  'similar',\n",
       "  'or',\n",
       "  'greater',\n",
       "  'extent',\n",
       "  'without',\n",
       "  'evidence',\n",
       "  'for',\n",
       "  'increased',\n",
       "  'coronary',\n",
       "  'heart',\n",
       "  'disease,',\n",
       "  'gastrointestinal',\n",
       "  'bleeding',\n",
       "  'or',\n",
       "  'cancer.'],\n",
       " ['dihydropyridine',\n",
       "  'calcium',\n",
       "  'channel',\n",
       "  'antagonists',\n",
       "  'may',\n",
       "  'exert',\n",
       "  'effects',\n",
       "  'that',\n",
       "  'protect',\n",
       "  'against',\n",
       "  'stroke',\n",
       "  'that',\n",
       "  'are',\n",
       "  'independent',\n",
       "  'of',\n",
       "  'their',\n",
       "  'blood',\n",
       "  'pressure-lowering',\n",
       "  'mechanism.'],\n",
       " ['collectively,',\n",
       "  'the',\n",
       "  'cardiovascular',\n",
       "  'benefit,',\n",
       "  'metabolic',\n",
       "  'neutrality',\n",
       "  'and',\n",
       "  'homogeneous',\n",
       "  'blood',\n",
       "  'pressure',\n",
       "  'response',\n",
       "  'illuminated',\n",
       "  'in',\n",
       "  'recent',\n",
       "  'studies,',\n",
       "  'and',\n",
       "  'reviewed',\n",
       "  'here,',\n",
       "  'represent',\n",
       "  'a',\n",
       "  'reaffirmation',\n",
       "  'of',\n",
       "  'the',\n",
       "  'benefit',\n",
       "  'of',\n",
       "  'long-acting',\n",
       "  'dihydropyridine',\n",
       "  'calcium',\n",
       "  'channel',\n",
       "  'antagonists',\n",
       "  'and',\n",
       "  'should',\n",
       "  'serve',\n",
       "  'to',\n",
       "  'help',\n",
       "  'reinforce',\n",
       "  'the',\n",
       "  'critical',\n",
       "  'importance',\n",
       "  'of',\n",
       "  'these',\n",
       "  'agents',\n",
       "  'in',\n",
       "  'the',\n",
       "  'therapeutic',\n",
       "  'armamentarium',\n",
       "  'against',\n",
       "  'cardiovascular',\n",
       "  'disease.'],\n",
       " ['compared',\n",
       "  'with',\n",
       "  'both',\n",
       "  'diuretics',\n",
       "  'and',\n",
       "  'contemporary',\n",
       "  'agents,',\n",
       "  'amlodipine',\n",
       "  'decreases',\n",
       "  'cardiovascular',\n",
       "  'events',\n",
       "  'to',\n",
       "  'a',\n",
       "  'similar',\n",
       "  'or',\n",
       "  'greater',\n",
       "  'extent',\n",
       "  'without',\n",
       "  'evidence',\n",
       "  'for',\n",
       "  'increased',\n",
       "  'coronary',\n",
       "  'heart',\n",
       "  'disease,',\n",
       "  'gastrointestinal',\n",
       "  'bleeding',\n",
       "  'or',\n",
       "  'cancer.'],\n",
       " ['compared',\n",
       "  'with',\n",
       "  'both',\n",
       "  'diuretics',\n",
       "  'and',\n",
       "  'contemporary',\n",
       "  'agents,',\n",
       "  'amlodipine',\n",
       "  'decreases',\n",
       "  'cardiovascular',\n",
       "  'events',\n",
       "  'to',\n",
       "  'a',\n",
       "  'similar',\n",
       "  'or',\n",
       "  'greater',\n",
       "  'extent',\n",
       "  'without',\n",
       "  'evidence',\n",
       "  'for',\n",
       "  'increased',\n",
       "  'coronary',\n",
       "  'heart',\n",
       "  'disease,',\n",
       "  'gastrointestinal',\n",
       "  'bleeding',\n",
       "  'or',\n",
       "  'cancer.'],\n",
       " ['compared',\n",
       "  'with',\n",
       "  'both',\n",
       "  'diuretics',\n",
       "  'and',\n",
       "  'contemporary',\n",
       "  'agents,',\n",
       "  'amlodipine',\n",
       "  'decreases',\n",
       "  'cardiovascular',\n",
       "  'events',\n",
       "  'to',\n",
       "  'a',\n",
       "  'similar',\n",
       "  'or',\n",
       "  'greater',\n",
       "  'extent',\n",
       "  'without',\n",
       "  'evidence',\n",
       "  'for',\n",
       "  'increased',\n",
       "  'coronary',\n",
       "  'heart',\n",
       "  'disease,',\n",
       "  'gastrointestinal',\n",
       "  'bleeding',\n",
       "  'or',\n",
       "  'cancer.'],\n",
       " ['dihydropyridine',\n",
       "  'calcium',\n",
       "  'channel',\n",
       "  'antagonists',\n",
       "  'have',\n",
       "  'several',\n",
       "  'noteworthy',\n",
       "  'attributes',\n",
       "  'that',\n",
       "  'merit',\n",
       "  'consideration',\n",
       "  'in',\n",
       "  'the',\n",
       "  'management',\n",
       "  'of',\n",
       "  'hypertension.'],\n",
       " ['all',\n",
       "  'three',\n",
       "  'patients',\n",
       "  'had',\n",
       "  'recurrent',\n",
       "  'admissions',\n",
       "  'for',\n",
       "  'stomal',\n",
       "  'bleeding',\n",
       "  'and',\n",
       "  'stomal',\n",
       "  'varices',\n",
       "  'secondary',\n",
       "  'to',\n",
       "  'portal',\n",
       "  'hypertension',\n",
       "  'and',\n",
       "  'were',\n",
       "  'initially',\n",
       "  'treated',\n",
       "  'with',\n",
       "  'local',\n",
       "  'measures',\n",
       "  '(pressure,',\n",
       "  'silver',\n",
       "  'nitrate,',\n",
       "  'and',\n",
       "  'suture',\n",
       "  'ligation).'],\n",
       " ['all',\n",
       "  'three',\n",
       "  'patients',\n",
       "  'had',\n",
       "  'recurrent',\n",
       "  'admissions',\n",
       "  'for',\n",
       "  'stomal',\n",
       "  'bleeding',\n",
       "  'and',\n",
       "  'stomal',\n",
       "  'varices',\n",
       "  'secondary',\n",
       "  'to',\n",
       "  'portal',\n",
       "  'hypertension',\n",
       "  'and',\n",
       "  'were',\n",
       "  'initially',\n",
       "  'treated',\n",
       "  'with',\n",
       "  'local',\n",
       "  'measures',\n",
       "  '(pressure,',\n",
       "  'silver',\n",
       "  'nitrate,',\n",
       "  'and',\n",
       "  'suture',\n",
       "  'ligation).'],\n",
       " ['at',\n",
       "  'all',\n",
       "  'doses',\n",
       "  'studied,',\n",
       "  'febuxostat',\n",
       "  'more',\n",
       "  'effectively',\n",
       "  'lowered',\n",
       "  'and',\n",
       "  'maintained',\n",
       "  'serum',\n",
       "  'urate',\n",
       "  'levels',\n",
       "  '<6.0',\n",
       "  'mg/dl',\n",
       "  'than',\n",
       "  'did',\n",
       "  'allopurinol',\n",
       "  '(300',\n",
       "  'or',\n",
       "  '100',\n",
       "  'mg)',\n",
       "  'or',\n",
       "  'placebo',\n",
       "  'in',\n",
       "  'subjects',\n",
       "  'with',\n",
       "  'hyperuricemia',\n",
       "  'and',\n",
       "  'gout,',\n",
       "  'including',\n",
       "  'those',\n",
       "  'with',\n",
       "  'mild',\n",
       "  'to',\n",
       "  'moderately',\n",
       "  'impaired',\n",
       "  'renal',\n",
       "  'function.'],\n",
       " ['at',\n",
       "  'all',\n",
       "  'doses',\n",
       "  'studied,',\n",
       "  'febuxostat',\n",
       "  'more',\n",
       "  'effectively',\n",
       "  'lowered',\n",
       "  'and',\n",
       "  'maintained',\n",
       "  'serum',\n",
       "  'urate',\n",
       "  'levels',\n",
       "  '<6.0',\n",
       "  'mg/dl',\n",
       "  'than',\n",
       "  'did',\n",
       "  'allopurinol',\n",
       "  '(300',\n",
       "  'or',\n",
       "  '100',\n",
       "  'mg)',\n",
       "  'or',\n",
       "  'placebo',\n",
       "  'in',\n",
       "  'subjects',\n",
       "  'with',\n",
       "  'hyperuricemia',\n",
       "  'and',\n",
       "  'gout,',\n",
       "  'including',\n",
       "  'those',\n",
       "  'with',\n",
       "  'mild',\n",
       "  'to',\n",
       "  'moderately',\n",
       "  'impaired',\n",
       "  'renal',\n",
       "  'function.'],\n",
       " ['a',\n",
       "  'significantly',\n",
       "  '(p',\n",
       "  '<',\n",
       "  '0.05)',\n",
       "  'higher',\n",
       "  'percentage',\n",
       "  'of',\n",
       "  'subjects',\n",
       "  'with',\n",
       "  'impaired',\n",
       "  'renal',\n",
       "  'function',\n",
       "  'treated',\n",
       "  'with',\n",
       "  'febuxostat',\n",
       "  '80',\n",
       "  'mg',\n",
       "  '(4',\n",
       "  '[44%]',\n",
       "  'of',\n",
       "  '9),',\n",
       "  '120',\n",
       "  'mg',\n",
       "  '(5',\n",
       "  '[45%]',\n",
       "  'of',\n",
       "  '11),',\n",
       "  'and',\n",
       "  '240',\n",
       "  'mg',\n",
       "  '(3',\n",
       "  '[60%]',\n",
       "  'of',\n",
       "  '5)',\n",
       "  'achieved',\n",
       "  'the',\n",
       "  'primary',\n",
       "  'end',\n",
       "  'point',\n",
       "  'compared',\n",
       "  'with',\n",
       "  'those',\n",
       "  'treated',\n",
       "  'with',\n",
       "  '100',\n",
       "  'mg',\n",
       "  'of',\n",
       "  'allopurinol',\n",
       "  '(0',\n",
       "  '[0%]',\n",
       "  'of',\n",
       "  '10).'],\n",
       " ['the',\n",
       "  'primary',\n",
       "  'reasons',\n",
       "  'for',\n",
       "  'withdrawal',\n",
       "  'were',\n",
       "  'similar',\n",
       "  'across',\n",
       "  'groups',\n",
       "  'except',\n",
       "  'for',\n",
       "  'gout',\n",
       "  'flares,',\n",
       "  'which',\n",
       "  'were',\n",
       "  'more',\n",
       "  'frequent',\n",
       "  'with',\n",
       "  'febuxostat',\n",
       "  'than',\n",
       "  'with',\n",
       "  'allopurinol.'],\n",
       " ['at',\n",
       "  'all',\n",
       "  'doses',\n",
       "  'studied,',\n",
       "  'febuxostat',\n",
       "  'more',\n",
       "  'effectively',\n",
       "  'lowered',\n",
       "  'and',\n",
       "  'maintained',\n",
       "  'serum',\n",
       "  'urate',\n",
       "  'levels',\n",
       "  '<6.0',\n",
       "  'mg/dl',\n",
       "  'than',\n",
       "  'did',\n",
       "  'allopurinol',\n",
       "  '(300',\n",
       "  'or',\n",
       "  '100',\n",
       "  'mg)',\n",
       "  'or',\n",
       "  'placebo',\n",
       "  'in',\n",
       "  'subjects',\n",
       "  'with',\n",
       "  'hyperuricemia',\n",
       "  'and',\n",
       "  'gout,',\n",
       "  'including',\n",
       "  'those',\n",
       "  'with',\n",
       "  'mild',\n",
       "  'to',\n",
       "  'moderately',\n",
       "  'impaired',\n",
       "  'renal',\n",
       "  'function.'],\n",
       " ['at',\n",
       "  'all',\n",
       "  'doses',\n",
       "  'studied,',\n",
       "  'febuxostat',\n",
       "  'more',\n",
       "  'effectively',\n",
       "  'lowered',\n",
       "  'and',\n",
       "  'maintained',\n",
       "  'serum',\n",
       "  'urate',\n",
       "  'levels',\n",
       "  '<6.0',\n",
       "  'mg/dl',\n",
       "  'than',\n",
       "  'did',\n",
       "  'allopurinol',\n",
       "  '(300',\n",
       "  'or',\n",
       "  '100',\n",
       "  'mg)',\n",
       "  'or',\n",
       "  'placebo',\n",
       "  'in',\n",
       "  'subjects',\n",
       "  'with',\n",
       "  'hyperuricemia',\n",
       "  'and',\n",
       "  'gout,',\n",
       "  'including',\n",
       "  'those',\n",
       "  'with',\n",
       "  'mild',\n",
       "  'to',\n",
       "  'moderately',\n",
       "  'impaired',\n",
       "  'renal',\n",
       "  'function.'],\n",
       " ['at',\n",
       "  'all',\n",
       "  'doses',\n",
       "  'studied,',\n",
       "  'febuxostat',\n",
       "  'more',\n",
       "  'effectively',\n",
       "  'lowered',\n",
       "  'and',\n",
       "  'maintained',\n",
       "  'serum',\n",
       "  'urate',\n",
       "  'levels',\n",
       "  '<6.0',\n",
       "  'mg/dl',\n",
       "  'than',\n",
       "  'did',\n",
       "  'allopurinol',\n",
       "  '(300',\n",
       "  'or',\n",
       "  '100',\n",
       "  'mg)',\n",
       "  'or',\n",
       "  'placebo',\n",
       "  'in',\n",
       "  'subjects',\n",
       "  'with',\n",
       "  'hyperuricemia',\n",
       "  'and',\n",
       "  'gout,',\n",
       "  'including',\n",
       "  'those',\n",
       "  'with',\n",
       "  'mild',\n",
       "  'to',\n",
       "  'moderately',\n",
       "  'impaired',\n",
       "  'renal',\n",
       "  'function.'],\n",
       " ['a',\n",
       "  'significantly',\n",
       "  '(p',\n",
       "  '<',\n",
       "  '0.05)',\n",
       "  'higher',\n",
       "  'percentage',\n",
       "  'of',\n",
       "  'subjects',\n",
       "  'with',\n",
       "  'impaired',\n",
       "  'renal',\n",
       "  'function',\n",
       "  'treated',\n",
       "  'with',\n",
       "  'febuxostat',\n",
       "  '80',\n",
       "  'mg',\n",
       "  '(4',\n",
       "  '[44%]',\n",
       "  'of',\n",
       "  '9),',\n",
       "  '120',\n",
       "  'mg',\n",
       "  '(5',\n",
       "  '[45%]',\n",
       "  'of',\n",
       "  '11),',\n",
       "  'and',\n",
       "  '240',\n",
       "  'mg',\n",
       "  '(3',\n",
       "  '[60%]',\n",
       "  'of',\n",
       "  '5)',\n",
       "  'achieved',\n",
       "  'the',\n",
       "  'primary',\n",
       "  'end',\n",
       "  'point',\n",
       "  'compared',\n",
       "  'with',\n",
       "  'those',\n",
       "  'treated',\n",
       "  'with',\n",
       "  '100',\n",
       "  'mg',\n",
       "  'of',\n",
       "  'allopurinol',\n",
       "  '(0',\n",
       "  '[0%]',\n",
       "  'of',\n",
       "  '10).'],\n",
       " ['the',\n",
       "  'primary',\n",
       "  'reasons',\n",
       "  'for',\n",
       "  'withdrawal',\n",
       "  'were',\n",
       "  'similar',\n",
       "  'across',\n",
       "  'groups',\n",
       "  'except',\n",
       "  'for',\n",
       "  'gout',\n",
       "  'flares,',\n",
       "  'which',\n",
       "  'were',\n",
       "  'more',\n",
       "  'frequent',\n",
       "  'with',\n",
       "  'febuxostat',\n",
       "  'than',\n",
       "  'with',\n",
       "  'allopurinol.'],\n",
       " ['proportions',\n",
       "  'of',\n",
       "  'subjects',\n",
       "  'experiencing',\n",
       "  'any',\n",
       "  'adverse',\n",
       "  'event',\n",
       "  'or',\n",
       "  'serious',\n",
       "  'adverse',\n",
       "  'event',\n",
       "  'were',\n",
       "  'similar',\n",
       "  'across',\n",
       "  'groups,',\n",
       "  'although',\n",
       "  'diarrhea',\n",
       "  'and',\n",
       "  'dizziness',\n",
       "  'were',\n",
       "  'more',\n",
       "  'frequent',\n",
       "  'in',\n",
       "  'the',\n",
       "  'febuxostat',\n",
       "  '240',\n",
       "  'mg',\n",
       "  'group.'],\n",
       " ['proportions',\n",
       "  'of',\n",
       "  'subjects',\n",
       "  'experiencing',\n",
       "  'any',\n",
       "  'adverse',\n",
       "  'event',\n",
       "  'or',\n",
       "  'serious',\n",
       "  'adverse',\n",
       "  'event',\n",
       "  'were',\n",
       "  'similar',\n",
       "  'across',\n",
       "  'groups,',\n",
       "  'although',\n",
       "  'diarrhea',\n",
       "  'and',\n",
       "  'dizziness',\n",
       "  'were',\n",
       "  'more',\n",
       "  'frequent',\n",
       "  'in',\n",
       "  'the',\n",
       "  'febuxostat',\n",
       "  '240',\n",
       "  'mg',\n",
       "  'group.'],\n",
       " ['the',\n",
       "  'established',\n",
       "  'teratogenicity',\n",
       "  'of',\n",
       "  'antiepileptic',\n",
       "  'drugs',\n",
       "  'raises',\n",
       "  'important',\n",
       "  'issues',\n",
       "  'in',\n",
       "  'women',\n",
       "  'of',\n",
       "  'child-bearing',\n",
       "  'age.'],\n",
       " ['while',\n",
       "  'the',\n",
       "  'association',\n",
       "  'between',\n",
       "  'neural',\n",
       "  'tube',\n",
       "  'defects',\n",
       "  'and',\n",
       "  'antiepileptic',\n",
       "  'drugs',\n",
       "  'is',\n",
       "  'well',\n",
       "  'recognised,',\n",
       "  'other',\n",
       "  'congenital',\n",
       "  'malformations',\n",
       "  'are',\n",
       "  'known',\n",
       "  'to',\n",
       "  'occur.'],\n",
       " ['while',\n",
       "  'the',\n",
       "  'association',\n",
       "  'between',\n",
       "  'neural',\n",
       "  'tube',\n",
       "  'defects',\n",
       "  'and',\n",
       "  'antiepileptic',\n",
       "  'drugs',\n",
       "  'is',\n",
       "  'well',\n",
       "  'recognised,',\n",
       "  'other',\n",
       "  'congenital',\n",
       "  'malformations',\n",
       "  'are',\n",
       "  'known',\n",
       "  'to',\n",
       "  'occur.'],\n",
       " ['data',\n",
       "  'of',\n",
       "  'our',\n",
       "  'study',\n",
       "  'revealed',\n",
       "  'an',\n",
       "  'unexpected',\n",
       "  'high',\n",
       "  'rate',\n",
       "  'of',\n",
       "  'hypogonadism',\n",
       "  'irrespective',\n",
       "  'of',\n",
       "  'cyclophosphamide',\n",
       "  'use,',\n",
       "  'and',\n",
       "  'subclinical',\n",
       "  'involvement',\n",
       "  'of',\n",
       "  'the',\n",
       "  'testes',\n",
       "  'by',\n",
       "  'the',\n",
       "  'vasculitis',\n",
       "  'itself',\n",
       "  'might',\n",
       "  'be',\n",
       "  'an',\n",
       "  'alternative',\n",
       "  'explanation.'],\n",
       " ['data',\n",
       "  'of',\n",
       "  'our',\n",
       "  'study',\n",
       "  'revealed',\n",
       "  'an',\n",
       "  'unexpected',\n",
       "  'high',\n",
       "  'rate',\n",
       "  'of',\n",
       "  'hypogonadism',\n",
       "  'irrespective',\n",
       "  'of',\n",
       "  'cyclophosphamide',\n",
       "  'use,',\n",
       "  'and',\n",
       "  'subclinical',\n",
       "  'involvement',\n",
       "  'of',\n",
       "  'the',\n",
       "  'testes',\n",
       "  'by',\n",
       "  'the',\n",
       "  'vasculitis',\n",
       "  'itself',\n",
       "  'might',\n",
       "  'be',\n",
       "  'an',\n",
       "  'alternative',\n",
       "  'explanation.'],\n",
       " ['the',\n",
       "  'patient',\n",
       "  'was',\n",
       "  'on',\n",
       "  'corticosteroids',\n",
       "  'and',\n",
       "  'azathioprine',\n",
       "  'for',\n",
       "  'autoimmune',\n",
       "  'hepatitis',\n",
       "  'at',\n",
       "  'the',\n",
       "  'time',\n",
       "  'of',\n",
       "  'her',\n",
       "  'presentation.'],\n",
       " ['pulmonary',\n",
       "  'alveolar',\n",
       "  'proteinosis:',\n",
       "  'a',\n",
       "  'rare',\n",
       "  'pulmonary',\n",
       "  'toxicity',\n",
       "  'of',\n",
       "  'sirolimus.'],\n",
       " ['pap',\n",
       "  'is',\n",
       "  'a',\n",
       "  'very',\n",
       "  'rare',\n",
       "  'complication',\n",
       "  'of',\n",
       "  'srl',\n",
       "  'therapy',\n",
       "  'with',\n",
       "  'only',\n",
       "  'a',\n",
       "  'few',\n",
       "  'cases',\n",
       "  'described.'],\n",
       " ['two',\n",
       "  'years',\n",
       "  'after',\n",
       "  'initiating',\n",
       "  'srl,',\n",
       "  'she',\n",
       "  'presented',\n",
       "  'complaints',\n",
       "  'of',\n",
       "  'progressive',\n",
       "  'dyspnoea,',\n",
       "  'nonproductive',\n",
       "  'cough,',\n",
       "  'chest',\n",
       "  'pain',\n",
       "  'and',\n",
       "  'low-grade',\n",
       "  'fever',\n",
       "  'of',\n",
       "  '1',\n",
       "  'month',\n",
       "  'duration.'],\n",
       " ['two',\n",
       "  'years',\n",
       "  'after',\n",
       "  'initiating',\n",
       "  'srl,',\n",
       "  'she',\n",
       "  'presented',\n",
       "  'complaints',\n",
       "  'of',\n",
       "  'progressive',\n",
       "  'dyspnoea,',\n",
       "  'nonproductive',\n",
       "  'cough,',\n",
       "  'chest',\n",
       "  'pain',\n",
       "  'and',\n",
       "  'low-grade',\n",
       "  'fever',\n",
       "  'of',\n",
       "  '1',\n",
       "  'month',\n",
       "  'duration.'],\n",
       " ['the',\n",
       "  'only',\n",
       "  'patient',\n",
       "  'with',\n",
       "  'leucoencephalopathy',\n",
       "  'showed',\n",
       "  'improved',\n",
       "  'neurologic',\n",
       "  'status',\n",
       "  'after',\n",
       "  'srl',\n",
       "  'conversion.'],\n",
       " ['all',\n",
       "  'patients',\n",
       "  'converted',\n",
       "  'to',\n",
       "  'srl',\n",
       "  'because',\n",
       "  'of',\n",
       "  'gi',\n",
       "  'side',\n",
       "  'effects',\n",
       "  'of',\n",
       "  'mmf',\n",
       "  'showed',\n",
       "  'improvements,',\n",
       "  'and',\n",
       "  'none',\n",
       "  'of',\n",
       "  'those',\n",
       "  'converted',\n",
       "  'because',\n",
       "  'of',\n",
       "  'hyperglycemia',\n",
       "  'experienced',\n",
       "  'improvement.'],\n",
       " ['we',\n",
       "  'concluded',\n",
       "  'that',\n",
       "  'conversion',\n",
       "  'to',\n",
       "  'srl',\n",
       "  'in',\n",
       "  'pancreas',\n",
       "  'transplantation',\n",
       "  'should',\n",
       "  'be',\n",
       "  'considered',\n",
       "  'an',\n",
       "  'important',\n",
       "  'alternative',\n",
       "  'strategy,',\n",
       "  'particularly',\n",
       "  'for',\n",
       "  'cni',\n",
       "  'nephrotoxicity',\n",
       "  'and',\n",
       "  'neurotoxicity,',\n",
       "  'and',\n",
       "  'in',\n",
       "  'cases',\n",
       "  'of',\n",
       "  'severe',\n",
       "  'diarrhea',\n",
       "  'due',\n",
       "  'to',\n",
       "  'mmf.'],\n",
       " ['the',\n",
       "  'reasons',\n",
       "  'for',\n",
       "  'conversion',\n",
       "  'were',\n",
       "  'calcineurin',\n",
       "  'inhibitors',\n",
       "  '(cni)',\n",
       "  'nephrotoxicity',\n",
       "  '(n',\n",
       "  '=',\n",
       "  '24;',\n",
       "  '73%),',\n",
       "  'severe',\n",
       "  'neurotoxicity',\n",
       "  'owing',\n",
       "  'to',\n",
       "  'cni',\n",
       "  '(n',\n",
       "  '=',\n",
       "  '1;',\n",
       "  '3%),',\n",
       "  'severe',\n",
       "  'and/or',\n",
       "  'recurrent',\n",
       "  'acute',\n",
       "  'rejection',\n",
       "  'episodes',\n",
       "  '(n',\n",
       "  '=',\n",
       "  '7;',\n",
       "  '21%),',\n",
       "  'gastrointestinal',\n",
       "  '(gi)',\n",
       "  'side',\n",
       "  'effects',\n",
       "  'of',\n",
       "  'mycophenolate',\n",
       "  'mofetil',\n",
       "  '(mmf;',\n",
       "  'n',\n",
       "  '=',\n",
       "  '5;',\n",
       "  '15%),',\n",
       "  'and',\n",
       "  'hyperglycemia',\n",
       "  '(n',\n",
       "  '=',\n",
       "  '4;',\n",
       "  '12%).'],\n",
       " ['the',\n",
       "  'reasons',\n",
       "  'for',\n",
       "  'conversion',\n",
       "  'were',\n",
       "  'calcineurin',\n",
       "  'inhibitors',\n",
       "  '(cni)',\n",
       "  'nephrotoxicity',\n",
       "  '(n',\n",
       "  '=',\n",
       "  '24;',\n",
       "  '73%),',\n",
       "  'severe',\n",
       "  'neurotoxicity',\n",
       "  'owing',\n",
       "  'to',\n",
       "  'cni',\n",
       "  '(n',\n",
       "  '=',\n",
       "  '1;',\n",
       "  '3%),',\n",
       "  'severe',\n",
       "  'and/or',\n",
       "  'recurrent',\n",
       "  'acute',\n",
       "  'rejection',\n",
       "  'episodes',\n",
       "  '(n',\n",
       "  '=',\n",
       "  '7;',\n",
       "  '21%),',\n",
       "  'gastrointestinal',\n",
       "  '(gi)',\n",
       "  'side',\n",
       "  'effects',\n",
       "  'of',\n",
       "  'mycophenolate',\n",
       "  'mofetil',\n",
       "  '(mmf;',\n",
       "  'n',\n",
       "  '=',\n",
       "  '5;',\n",
       "  '15%),',\n",
       "  'and',\n",
       "  'hyperglycemia',\n",
       "  '(n',\n",
       "  '=',\n",
       "  '4;',\n",
       "  '12%).'],\n",
       " ['moreover,',\n",
       "  'oxcarbazepine',\n",
       "  'can',\n",
       "  'be',\n",
       "  'a',\n",
       "  'valid',\n",
       "  'choice',\n",
       "  'when',\n",
       "  'long-term',\n",
       "  'therapy',\n",
       "  'is',\n",
       "  'required',\n",
       "  'because',\n",
       "  'of',\n",
       "  'the',\n",
       "  'low',\n",
       "  'interaction',\n",
       "  'with',\n",
       "  'other',\n",
       "  'drugs',\n",
       "  'and',\n",
       "  'the',\n",
       "  'low',\n",
       "  'hematological',\n",
       "  'side',\n",
       "  'effects.'],\n",
       " ['our',\n",
       "  'data',\n",
       "  'showed',\n",
       "  'that',\n",
       "  'oxcarbazepine',\n",
       "  'can',\n",
       "  'be',\n",
       "  'a',\n",
       "  'good',\n",
       "  'alternative',\n",
       "  'to',\n",
       "  'traditional',\n",
       "  'antiepileptic',\n",
       "  'agents',\n",
       "  'in',\n",
       "  'the',\n",
       "  'prevention',\n",
       "  'of',\n",
       "  'perioperative',\n",
       "  'seizures',\n",
       "  'being',\n",
       "  'efficacy,',\n",
       "  'ease',\n",
       "  'of',\n",
       "  'use',\n",
       "  '(rapid',\n",
       "  'titration',\n",
       "  'in',\n",
       "  '3',\n",
       "  'days,',\n",
       "  'not',\n",
       "  'requiring',\n",
       "  'close',\n",
       "  'plasma',\n",
       "  'concentration',\n",
       "  'monitoring)',\n",
       "  'and',\n",
       "  'good',\n",
       "  'tolerability',\n",
       "  '(no',\n",
       "  'major',\n",
       "  'side',\n",
       "  'effects',\n",
       "  'during',\n",
       "  'titration',\n",
       "  'and',\n",
       "  'during',\n",
       "  'the',\n",
       "  'first',\n",
       "  'postoperative',\n",
       "  'week)',\n",
       "  'the',\n",
       "  'key',\n",
       "  'factors.'],\n",
       " ['our',\n",
       "  'data',\n",
       "  'showed',\n",
       "  'that',\n",
       "  'oxcarbazepine',\n",
       "  'can',\n",
       "  'be',\n",
       "  'a',\n",
       "  'good',\n",
       "  'alternative',\n",
       "  'to',\n",
       "  'traditional',\n",
       "  'antiepileptic',\n",
       "  'agents',\n",
       "  'in',\n",
       "  'the',\n",
       "  'prevention',\n",
       "  'of',\n",
       "  'perioperative',\n",
       "  'seizures',\n",
       "  'being',\n",
       "  'efficacy,',\n",
       "  'ease',\n",
       "  'of',\n",
       "  'use',\n",
       "  '(rapid',\n",
       "  'titration',\n",
       "  'in',\n",
       "  '3',\n",
       "  'days,',\n",
       "  'not',\n",
       "  'requiring',\n",
       "  'close',\n",
       "  'plasma',\n",
       "  'concentration',\n",
       "  'monitoring)',\n",
       "  'and',\n",
       "  'good',\n",
       "  'tolerability',\n",
       "  '(no',\n",
       "  'major',\n",
       "  'side',\n",
       "  'effects',\n",
       "  'during',\n",
       "  'titration',\n",
       "  'and',\n",
       "  'during',\n",
       "  'the',\n",
       "  'first',\n",
       "  'postoperative',\n",
       "  'week)',\n",
       "  'the',\n",
       "  'key',\n",
       "  'factors.'],\n",
       " ['furthermore,',\n",
       "  'the',\n",
       "  'efficacy',\n",
       "  'of',\n",
       "  'the',\n",
       "  'new',\n",
       "  'generation',\n",
       "  'of',\n",
       "  'antiepileptic',\n",
       "  'agents',\n",
       "  'in',\n",
       "  'the',\n",
       "  'prophylaxis',\n",
       "  'of',\n",
       "  'perioperative',\n",
       "  'seizures',\n",
       "  'has',\n",
       "  'not',\n",
       "  'been',\n",
       "  'assessed',\n",
       "  'so',\n",
       "  'far.'],\n",
       " ['we',\n",
       "  'tested',\n",
       "  'the',\n",
       "  'hypothesis',\n",
       "  'that',\n",
       "  'oral',\n",
       "  'beclomethasone',\n",
       "  'dipropionate',\n",
       "  '(bdp)',\n",
       "  'would',\n",
       "  'control',\n",
       "  'gastrointestinal',\n",
       "  'graft-versus-host',\n",
       "  'disease',\n",
       "  '(gvhd)',\n",
       "  'in',\n",
       "  'patients',\n",
       "  'with',\n",
       "  'anorexia,',\n",
       "  'vomiting,',\n",
       "  'and',\n",
       "  'diarrhea.'],\n",
       " ['we',\n",
       "  'tested',\n",
       "  'the',\n",
       "  'hypothesis',\n",
       "  'that',\n",
       "  'oral',\n",
       "  'beclomethasone',\n",
       "  'dipropionate',\n",
       "  '(bdp)',\n",
       "  'would',\n",
       "  'control',\n",
       "  'gastrointestinal',\n",
       "  'graft-versus-host',\n",
       "  'disease',\n",
       "  '(gvhd)',\n",
       "  'in',\n",
       "  'patients',\n",
       "  'with',\n",
       "  'anorexia,',\n",
       "  'vomiting,',\n",
       "  'and',\n",
       "  'diarrhea.'],\n",
       " ['oral',\n",
       "  'bdp',\n",
       "  'prevents',\n",
       "  'relapses',\n",
       "  'of',\n",
       "  'gastrointestinal',\n",
       "  'gvhd',\n",
       "  'following',\n",
       "  'tapering',\n",
       "  'of',\n",
       "  'prednisone;',\n",
       "  'survival',\n",
       "  'is',\n",
       "  'statistically',\n",
       "  'significantly',\n",
       "  'better',\n",
       "  'among',\n",
       "  'patients',\n",
       "  'receiving',\n",
       "  'bdp.'],\n",
       " ['oral',\n",
       "  'bdp',\n",
       "  'prevents',\n",
       "  'relapses',\n",
       "  'of',\n",
       "  'gastrointestinal',\n",
       "  'gvhd',\n",
       "  'following',\n",
       "  'tapering',\n",
       "  'of',\n",
       "  'prednisone;',\n",
       "  'survival',\n",
       "  'is',\n",
       "  'statistically',\n",
       "  'significantly',\n",
       "  'better',\n",
       "  'among',\n",
       "  'patients',\n",
       "  'receiving',\n",
       "  'bdp.'],\n",
       " ['grade',\n",
       "  '3',\n",
       "  'or',\n",
       "  '4',\n",
       "  'leukopenia',\n",
       "  'and',\n",
       "  'edema',\n",
       "  'and',\n",
       "  'various',\n",
       "  'grade',\n",
       "  '1',\n",
       "  'or',\n",
       "  '2',\n",
       "  'adverse',\n",
       "  'events',\n",
       "  'were',\n",
       "  'more',\n",
       "  'frequent',\n",
       "  'in',\n",
       "  'patients',\n",
       "  'receiving',\n",
       "  'eight',\n",
       "  'tac',\n",
       "  'cycles',\n",
       "  'than',\n",
       "  'in',\n",
       "  'those',\n",
       "  'receiving',\n",
       "  'six',\n",
       "  'cycles.'],\n",
       " ['grade',\n",
       "  '3',\n",
       "  'or',\n",
       "  '4',\n",
       "  'leukopenia',\n",
       "  'and',\n",
       "  'edema',\n",
       "  'and',\n",
       "  'various',\n",
       "  'grade',\n",
       "  '1',\n",
       "  'or',\n",
       "  '2',\n",
       "  'adverse',\n",
       "  'events',\n",
       "  'were',\n",
       "  'more',\n",
       "  'frequent',\n",
       "  'in',\n",
       "  'patients',\n",
       "  'receiving',\n",
       "  'eight',\n",
       "  'tac',\n",
       "  'cycles',\n",
       "  'than',\n",
       "  'in',\n",
       "  'those',\n",
       "  'receiving',\n",
       "  'six',\n",
       "  'cycles.']]"
      ]
     },
     "execution_count": 116,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "documents"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 144,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2019-06-19 16:24:52,509 : WARNING : consider setting layer size to a multiple of 4 for greater performance\n",
      "2019-06-19 16:24:52,513 : INFO : collecting all words and their counts\n",
      "2019-06-19 16:24:52,515 : INFO : PROGRESS: at sentence #0, processed 0 words, keeping 0 word types\n",
      "2019-06-19 16:24:52,527 : INFO : collected 3704 word types from a corpus of 23456 raw words and 846 sentences\n",
      "2019-06-19 16:24:52,530 : INFO : Loading a fresh vocabulary\n",
      "2019-06-19 16:24:52,544 : INFO : effective_min_count=0 retains 3704 unique words (100% of original 3704, drops 0)\n",
      "2019-06-19 16:24:52,547 : INFO : effective_min_count=0 leaves 23456 word corpus (100% of original 23456, drops 0)\n",
      "2019-06-19 16:24:52,563 : INFO : deleting the raw counts dictionary of 3704 items\n",
      "2019-06-19 16:24:52,566 : INFO : sample=0.001 downsamples 35 most-common words\n",
      "2019-06-19 16:24:52,568 : INFO : downsampling leaves estimated 19182 word corpus (81.8% of prior 23456)\n",
      "2019-06-19 16:24:52,577 : INFO : estimated required memory for 3704 words and 50 dimensions: 3333600 bytes\n",
      "2019-06-19 16:24:52,579 : INFO : resetting layer weights\n",
      "2019-06-19 16:24:52,616 : INFO : training model with 10 workers on 3704 vocabulary and 50 features, using sg=0 hs=0 sample=0.001 negative=5 window=30\n",
      "2019-06-19 16:24:52,642 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:52,652 : INFO : worker thread finished; awaiting finish of 8 more threads\n",
      "2019-06-19 16:24:52,661 : INFO : worker thread finished; awaiting finish of 7 more threads\n",
      "2019-06-19 16:24:52,663 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:52,666 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:52,667 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:52,669 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:52,670 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:52,673 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:52,675 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:52,677 : INFO : EPOCH - 1 : training on 23456 raw words (19235 effective words) took 0.0s, 483097 effective words/s\n",
      "2019-06-19 16:24:52,699 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:52,702 : INFO : worker thread finished; awaiting finish of 8 more threads\n",
      "2019-06-19 16:24:52,704 : INFO : worker thread finished; awaiting finish of 7 more threads\n",
      "2019-06-19 16:24:52,706 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:52,707 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:52,709 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:52,710 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:52,713 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:52,721 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:52,725 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:52,726 : INFO : EPOCH - 2 : training on 23456 raw words (19168 effective words) took 0.0s, 708464 effective words/s\n",
      "2019-06-19 16:24:52,754 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:52,766 : INFO : worker thread finished; awaiting finish of 8 more threads\n",
      "2019-06-19 16:24:52,768 : INFO : worker thread finished; awaiting finish of 7 more threads\n",
      "2019-06-19 16:24:52,775 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:52,778 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:52,785 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:52,787 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:52,789 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:52,792 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:52,794 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:52,797 : INFO : EPOCH - 3 : training on 23456 raw words (19177 effective words) took 0.0s, 443871 effective words/s\n",
      "2019-06-19 16:24:52,819 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:52,821 : INFO : worker thread finished; awaiting finish of 8 more threads\n",
      "2019-06-19 16:24:52,824 : INFO : worker thread finished; awaiting finish of 7 more threads\n",
      "2019-06-19 16:24:52,825 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:52,826 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:52,828 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:52,830 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:52,834 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:52,836 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:52,837 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:52,838 : INFO : EPOCH - 4 : training on 23456 raw words (19161 effective words) took 0.0s, 1039191 effective words/s\n",
      "2019-06-19 16:24:52,853 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:52,859 : INFO : worker thread finished; awaiting finish of 8 more threads\n",
      "2019-06-19 16:24:52,867 : INFO : worker thread finished; awaiting finish of 7 more threads\n",
      "2019-06-19 16:24:52,868 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:52,873 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:52,883 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:52,886 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:52,888 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:52,890 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:52,896 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:52,899 : INFO : EPOCH - 5 : training on 23456 raw words (19163 effective words) took 0.0s, 419597 effective words/s\n",
      "2019-06-19 16:24:52,901 : INFO : training on a 117280 raw words (95904 effective words) took 0.3s, 341287 effective words/s\n",
      "2019-06-19 16:24:52,903 : WARNING : under 10 jobs per worker: consider setting a smaller `batch_words' for smoother alpha decay\n",
      "2019-06-19 16:24:52,910 : WARNING : Effective 'alpha' higher than previous training cycles\n",
      "2019-06-19 16:24:52,916 : INFO : training model with 10 workers on 3704 vocabulary and 50 features, using sg=0 hs=0 sample=0.001 negative=5 window=30\n",
      "2019-06-19 16:24:52,949 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:52,954 : INFO : worker thread finished; awaiting finish of 8 more threads\n",
      "2019-06-19 16:24:52,954 : INFO : worker thread finished; awaiting finish of 7 more threads\n",
      "2019-06-19 16:24:52,956 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:52,957 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:52,958 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:52,960 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:52,963 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:52,964 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:52,975 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:52,977 : INFO : EPOCH - 1 : training on 23456 raw words (19150 effective words) took 0.0s, 410566 effective words/s\n",
      "2019-06-19 16:24:53,002 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:53,005 : INFO : worker thread finished; awaiting finish of 8 more threads\n",
      "2019-06-19 16:24:53,008 : INFO : worker thread finished; awaiting finish of 7 more threads\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2019-06-19 16:24:53,010 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:53,012 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:53,014 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:53,017 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:53,019 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:53,020 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:53,022 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:53,024 : INFO : EPOCH - 2 : training on 23456 raw words (19170 effective words) took 0.0s, 751742 effective words/s\n",
      "2019-06-19 16:24:53,042 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:53,045 : INFO : worker thread finished; awaiting finish of 8 more threads\n",
      "2019-06-19 16:24:53,046 : INFO : worker thread finished; awaiting finish of 7 more threads\n",
      "2019-06-19 16:24:53,048 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:53,050 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:53,053 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:53,056 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:53,057 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:53,059 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:53,069 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:53,071 : INFO : EPOCH - 3 : training on 23456 raw words (19179 effective words) took 0.0s, 658567 effective words/s\n",
      "2019-06-19 16:24:53,085 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:53,090 : INFO : worker thread finished; awaiting finish of 8 more threads\n",
      "2019-06-19 16:24:53,093 : INFO : worker thread finished; awaiting finish of 7 more threads\n",
      "2019-06-19 16:24:53,094 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:53,097 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:53,098 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:53,099 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:53,102 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:53,106 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:53,111 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:53,112 : INFO : EPOCH - 4 : training on 23456 raw words (19213 effective words) took 0.0s, 723646 effective words/s\n",
      "2019-06-19 16:24:53,137 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:53,140 : INFO : worker thread finished; awaiting finish of 8 more threads\n",
      "2019-06-19 16:24:53,141 : INFO : worker thread finished; awaiting finish of 7 more threads\n",
      "2019-06-19 16:24:53,142 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:53,144 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:53,148 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:53,152 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:53,153 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:53,154 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:53,157 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:53,160 : INFO : EPOCH - 5 : training on 23456 raw words (19245 effective words) took 0.0s, 559404 effective words/s\n",
      "2019-06-19 16:24:53,175 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:53,178 : INFO : worker thread finished; awaiting finish of 8 more threads\n",
      "2019-06-19 16:24:53,182 : INFO : worker thread finished; awaiting finish of 7 more threads\n",
      "2019-06-19 16:24:53,185 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:53,189 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:53,192 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:53,195 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:53,198 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:53,203 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:53,204 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:53,205 : INFO : EPOCH - 6 : training on 23456 raw words (19191 effective words) took 0.0s, 636396 effective words/s\n",
      "2019-06-19 16:24:53,224 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:53,230 : INFO : worker thread finished; awaiting finish of 8 more threads\n",
      "2019-06-19 16:24:53,235 : INFO : worker thread finished; awaiting finish of 7 more threads\n",
      "2019-06-19 16:24:53,238 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:53,241 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:53,242 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:53,245 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:53,247 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:53,252 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:53,273 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:53,274 : INFO : EPOCH - 7 : training on 23456 raw words (19236 effective words) took 0.1s, 356749 effective words/s\n",
      "2019-06-19 16:24:53,289 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:53,293 : INFO : worker thread finished; awaiting finish of 8 more threads\n",
      "2019-06-19 16:24:53,294 : INFO : worker thread finished; awaiting finish of 7 more threads\n",
      "2019-06-19 16:24:53,296 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:53,297 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:53,301 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:53,303 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:53,304 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:53,309 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:53,320 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:53,322 : INFO : EPOCH - 8 : training on 23456 raw words (19209 effective words) took 0.0s, 560395 effective words/s\n",
      "2019-06-19 16:24:53,338 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:53,351 : INFO : worker thread finished; awaiting finish of 8 more threads\n",
      "2019-06-19 16:24:53,358 : INFO : worker thread finished; awaiting finish of 7 more threads\n",
      "2019-06-19 16:24:53,360 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:53,361 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:53,363 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:53,369 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:53,372 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:53,374 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:53,376 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:53,379 : INFO : EPOCH - 9 : training on 23456 raw words (19193 effective words) took 0.0s, 451805 effective words/s\n",
      "2019-06-19 16:24:53,401 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:53,405 : INFO : worker thread finished; awaiting finish of 8 more threads\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2019-06-19 16:24:53,406 : INFO : worker thread finished; awaiting finish of 7 more threads\n",
      "2019-06-19 16:24:53,408 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:53,409 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:53,410 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:53,410 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:53,411 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:53,413 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:53,417 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:53,420 : INFO : EPOCH - 10 : training on 23456 raw words (19208 effective words) took 0.0s, 1030815 effective words/s\n",
      "2019-06-19 16:24:53,429 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:53,438 : INFO : worker thread finished; awaiting finish of 8 more threads\n",
      "2019-06-19 16:24:53,440 : INFO : worker thread finished; awaiting finish of 7 more threads\n",
      "2019-06-19 16:24:53,446 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:53,453 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:53,457 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:53,461 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:53,464 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:53,469 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:53,473 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:53,474 : INFO : EPOCH - 11 : training on 23456 raw words (19224 effective words) took 0.0s, 425826 effective words/s\n",
      "2019-06-19 16:24:53,500 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:53,501 : INFO : worker thread finished; awaiting finish of 8 more threads\n",
      "2019-06-19 16:24:53,505 : INFO : worker thread finished; awaiting finish of 7 more threads\n",
      "2019-06-19 16:24:53,508 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:53,509 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:53,510 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:53,511 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:53,512 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:53,517 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:53,522 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:53,524 : INFO : EPOCH - 12 : training on 23456 raw words (19230 effective words) took 0.0s, 544014 effective words/s\n",
      "2019-06-19 16:24:53,553 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:53,556 : INFO : worker thread finished; awaiting finish of 8 more threads\n",
      "2019-06-19 16:24:53,561 : INFO : worker thread finished; awaiting finish of 7 more threads\n",
      "2019-06-19 16:24:53,564 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:53,567 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:53,568 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:53,572 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:53,573 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:53,574 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:53,578 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:53,580 : INFO : EPOCH - 13 : training on 23456 raw words (19211 effective words) took 0.0s, 720093 effective words/s\n",
      "2019-06-19 16:24:53,592 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:53,596 : INFO : worker thread finished; awaiting finish of 8 more threads\n",
      "2019-06-19 16:24:53,608 : INFO : worker thread finished; awaiting finish of 7 more threads\n",
      "2019-06-19 16:24:53,610 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:53,614 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:53,618 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:53,620 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:53,621 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:53,623 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:53,630 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:53,632 : INFO : EPOCH - 14 : training on 23456 raw words (19126 effective words) took 0.0s, 475723 effective words/s\n",
      "2019-06-19 16:24:53,662 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:53,664 : INFO : worker thread finished; awaiting finish of 8 more threads\n",
      "2019-06-19 16:24:53,665 : INFO : worker thread finished; awaiting finish of 7 more threads\n",
      "2019-06-19 16:24:53,669 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:53,669 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:53,670 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:53,671 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:53,673 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:53,676 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:53,678 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:53,680 : INFO : EPOCH - 15 : training on 23456 raw words (19187 effective words) took 0.0s, 629007 effective words/s\n",
      "2019-06-19 16:24:53,697 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:53,703 : INFO : worker thread finished; awaiting finish of 8 more threads\n",
      "2019-06-19 16:24:53,710 : INFO : worker thread finished; awaiting finish of 7 more threads\n",
      "2019-06-19 16:24:53,715 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:53,721 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:53,725 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:53,729 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:53,731 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:53,733 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:53,736 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:53,739 : INFO : EPOCH - 16 : training on 23456 raw words (19151 effective words) took 0.0s, 459059 effective words/s\n",
      "2019-06-19 16:24:53,761 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:53,763 : INFO : worker thread finished; awaiting finish of 8 more threads\n",
      "2019-06-19 16:24:53,765 : INFO : worker thread finished; awaiting finish of 7 more threads\n",
      "2019-06-19 16:24:53,768 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:53,771 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:53,773 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:53,774 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:53,778 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:53,783 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:53,786 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:53,791 : INFO : EPOCH - 17 : training on 23456 raw words (19166 effective words) took 0.0s, 644678 effective words/s\n",
      "2019-06-19 16:24:53,812 : INFO : worker thread finished; awaiting finish of 9 more threads\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2019-06-19 16:24:53,821 : INFO : worker thread finished; awaiting finish of 8 more threads\n",
      "2019-06-19 16:24:53,824 : INFO : worker thread finished; awaiting finish of 7 more threads\n",
      "2019-06-19 16:24:53,827 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:53,828 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:53,830 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:53,831 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:53,834 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:53,838 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:53,843 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:53,845 : INFO : EPOCH - 18 : training on 23456 raw words (19131 effective words) took 0.0s, 531913 effective words/s\n",
      "2019-06-19 16:24:53,857 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:53,858 : INFO : worker thread finished; awaiting finish of 8 more threads\n",
      "2019-06-19 16:24:53,865 : INFO : worker thread finished; awaiting finish of 7 more threads\n",
      "2019-06-19 16:24:53,871 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:53,873 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:53,873 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:53,874 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:53,877 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:53,885 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:53,892 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:53,892 : INFO : EPOCH - 19 : training on 23456 raw words (19166 effective words) took 0.0s, 542149 effective words/s\n",
      "2019-06-19 16:24:53,908 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:53,910 : INFO : worker thread finished; awaiting finish of 8 more threads\n",
      "2019-06-19 16:24:53,913 : INFO : worker thread finished; awaiting finish of 7 more threads\n",
      "2019-06-19 16:24:53,915 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:53,917 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:53,918 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:53,920 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:53,921 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:53,925 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:53,932 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:53,935 : INFO : EPOCH - 20 : training on 23456 raw words (19227 effective words) took 0.0s, 706313 effective words/s\n",
      "2019-06-19 16:24:53,950 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:53,957 : INFO : worker thread finished; awaiting finish of 8 more threads\n",
      "2019-06-19 16:24:53,958 : INFO : worker thread finished; awaiting finish of 7 more threads\n",
      "2019-06-19 16:24:53,960 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:53,960 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:53,962 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:53,964 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:53,968 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:53,970 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:53,974 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:53,976 : INFO : EPOCH - 21 : training on 23456 raw words (19147 effective words) took 0.0s, 748380 effective words/s\n",
      "2019-06-19 16:24:53,996 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:54,000 : INFO : worker thread finished; awaiting finish of 8 more threads\n",
      "2019-06-19 16:24:54,004 : INFO : worker thread finished; awaiting finish of 7 more threads\n",
      "2019-06-19 16:24:54,006 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:54,009 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:54,012 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:54,014 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:54,017 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:54,019 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:54,021 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:54,022 : INFO : EPOCH - 22 : training on 23456 raw words (19185 effective words) took 0.0s, 757519 effective words/s\n",
      "2019-06-19 16:24:54,038 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:54,042 : INFO : worker thread finished; awaiting finish of 8 more threads\n",
      "2019-06-19 16:24:54,044 : INFO : worker thread finished; awaiting finish of 7 more threads\n",
      "2019-06-19 16:24:54,046 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:54,049 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:54,050 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:54,053 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:54,057 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:54,058 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:54,060 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:54,061 : INFO : EPOCH - 23 : training on 23456 raw words (19269 effective words) took 0.0s, 600061 effective words/s\n",
      "2019-06-19 16:24:54,080 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:54,080 : INFO : worker thread finished; awaiting finish of 8 more threads\n",
      "2019-06-19 16:24:54,082 : INFO : worker thread finished; awaiting finish of 7 more threads\n",
      "2019-06-19 16:24:54,086 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:54,087 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:54,088 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:54,089 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:54,092 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:54,097 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:54,098 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:54,100 : INFO : EPOCH - 24 : training on 23456 raw words (19148 effective words) took 0.0s, 697409 effective words/s\n",
      "2019-06-19 16:24:54,120 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:54,125 : INFO : worker thread finished; awaiting finish of 8 more threads\n",
      "2019-06-19 16:24:54,126 : INFO : worker thread finished; awaiting finish of 7 more threads\n",
      "2019-06-19 16:24:54,130 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:54,132 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:54,134 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:54,137 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:54,138 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:54,141 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:54,142 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:54,144 : INFO : EPOCH - 25 : training on 23456 raw words (19204 effective words) took 0.0s, 818587 effective words/s\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2019-06-19 16:24:54,168 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:54,171 : INFO : worker thread finished; awaiting finish of 8 more threads\n",
      "2019-06-19 16:24:54,173 : INFO : worker thread finished; awaiting finish of 7 more threads\n",
      "2019-06-19 16:24:54,174 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:54,177 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:54,179 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:54,181 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:54,182 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:54,185 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:54,189 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:54,192 : INFO : EPOCH - 26 : training on 23456 raw words (19209 effective words) took 0.0s, 566451 effective words/s\n",
      "2019-06-19 16:24:54,216 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:54,220 : INFO : worker thread finished; awaiting finish of 8 more threads\n",
      "2019-06-19 16:24:54,221 : INFO : worker thread finished; awaiting finish of 7 more threads\n",
      "2019-06-19 16:24:54,222 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:54,224 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:54,227 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:54,229 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:54,231 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:54,233 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:54,239 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:54,241 : INFO : EPOCH - 27 : training on 23456 raw words (19129 effective words) took 0.0s, 754543 effective words/s\n",
      "2019-06-19 16:24:54,268 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:54,272 : INFO : worker thread finished; awaiting finish of 8 more threads\n",
      "2019-06-19 16:24:54,273 : INFO : worker thread finished; awaiting finish of 7 more threads\n",
      "2019-06-19 16:24:54,276 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:54,278 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:54,280 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:54,284 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:54,288 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:54,290 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:54,291 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:54,293 : INFO : EPOCH - 28 : training on 23456 raw words (19161 effective words) took 0.0s, 773414 effective words/s\n",
      "2019-06-19 16:24:54,326 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:54,330 : INFO : worker thread finished; awaiting finish of 8 more threads\n",
      "2019-06-19 16:24:54,332 : INFO : worker thread finished; awaiting finish of 7 more threads\n",
      "2019-06-19 16:24:54,335 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:54,338 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:54,341 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:54,344 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:54,345 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:54,348 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:54,350 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:54,352 : INFO : EPOCH - 29 : training on 23456 raw words (19121 effective words) took 0.0s, 706656 effective words/s\n",
      "2019-06-19 16:24:54,372 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:54,373 : INFO : worker thread finished; awaiting finish of 8 more threads\n",
      "2019-06-19 16:24:54,374 : INFO : worker thread finished; awaiting finish of 7 more threads\n",
      "2019-06-19 16:24:54,374 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:54,376 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:54,385 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:54,386 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:54,389 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:54,391 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:54,394 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:54,396 : INFO : EPOCH - 30 : training on 23456 raw words (19202 effective words) took 0.0s, 564941 effective words/s\n",
      "2019-06-19 16:24:54,419 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:54,421 : INFO : worker thread finished; awaiting finish of 8 more threads\n",
      "2019-06-19 16:24:54,424 : INFO : worker thread finished; awaiting finish of 7 more threads\n",
      "2019-06-19 16:24:54,425 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:54,426 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:54,428 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:54,433 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:54,436 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:54,440 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:54,445 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:54,449 : INFO : EPOCH - 31 : training on 23456 raw words (19223 effective words) took 0.0s, 493369 effective words/s\n",
      "2019-06-19 16:24:54,470 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:54,474 : INFO : worker thread finished; awaiting finish of 8 more threads\n",
      "2019-06-19 16:24:54,478 : INFO : worker thread finished; awaiting finish of 7 more threads\n",
      "2019-06-19 16:24:54,480 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:54,484 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:54,486 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:54,488 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:54,489 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:54,490 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:54,491 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:54,493 : INFO : EPOCH - 32 : training on 23456 raw words (19233 effective words) took 0.0s, 851216 effective words/s\n",
      "2019-06-19 16:24:54,505 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:54,512 : INFO : worker thread finished; awaiting finish of 8 more threads\n",
      "2019-06-19 16:24:54,520 : INFO : worker thread finished; awaiting finish of 7 more threads\n",
      "2019-06-19 16:24:54,522 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:54,525 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:54,527 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:54,529 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:54,532 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:54,536 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:54,537 : INFO : worker thread finished; awaiting finish of 0 more threads\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2019-06-19 16:24:54,537 : INFO : EPOCH - 33 : training on 23456 raw words (19238 effective words) took 0.0s, 535743 effective words/s\n",
      "2019-06-19 16:24:54,553 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:54,556 : INFO : worker thread finished; awaiting finish of 8 more threads\n",
      "2019-06-19 16:24:54,557 : INFO : worker thread finished; awaiting finish of 7 more threads\n",
      "2019-06-19 16:24:54,560 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:54,562 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:54,566 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:54,568 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:54,572 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:54,573 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:54,577 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:54,581 : INFO : EPOCH - 34 : training on 23456 raw words (19162 effective words) took 0.0s, 549251 effective words/s\n",
      "2019-06-19 16:24:54,598 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:54,604 : INFO : worker thread finished; awaiting finish of 8 more threads\n",
      "2019-06-19 16:24:54,606 : INFO : worker thread finished; awaiting finish of 7 more threads\n",
      "2019-06-19 16:24:54,609 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:54,610 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:54,612 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:54,615 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:54,619 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:54,623 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:54,625 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:54,629 : INFO : EPOCH - 35 : training on 23456 raw words (19211 effective words) took 0.0s, 623613 effective words/s\n",
      "2019-06-19 16:24:54,654 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:54,657 : INFO : worker thread finished; awaiting finish of 8 more threads\n",
      "2019-06-19 16:24:54,661 : INFO : worker thread finished; awaiting finish of 7 more threads\n",
      "2019-06-19 16:24:54,664 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:54,667 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:54,669 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:54,672 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:54,673 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:54,674 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:54,676 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:54,677 : INFO : EPOCH - 36 : training on 23456 raw words (19204 effective words) took 0.0s, 849228 effective words/s\n",
      "2019-06-19 16:24:54,693 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:54,696 : INFO : worker thread finished; awaiting finish of 8 more threads\n",
      "2019-06-19 16:24:54,696 : INFO : worker thread finished; awaiting finish of 7 more threads\n",
      "2019-06-19 16:24:54,698 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:54,700 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:54,701 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:54,702 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:54,702 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:54,707 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:54,716 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:54,717 : INFO : EPOCH - 37 : training on 23456 raw words (19170 effective words) took 0.0s, 805427 effective words/s\n",
      "2019-06-19 16:24:54,746 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:54,749 : INFO : worker thread finished; awaiting finish of 8 more threads\n",
      "2019-06-19 16:24:54,753 : INFO : worker thread finished; awaiting finish of 7 more threads\n",
      "2019-06-19 16:24:54,756 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:54,758 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:54,759 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:54,760 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:54,762 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:54,766 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:54,774 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:54,777 : INFO : EPOCH - 38 : training on 23456 raw words (19185 effective words) took 0.0s, 445998 effective words/s\n",
      "2019-06-19 16:24:54,805 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:54,807 : INFO : worker thread finished; awaiting finish of 8 more threads\n",
      "2019-06-19 16:24:54,812 : INFO : worker thread finished; awaiting finish of 7 more threads\n",
      "2019-06-19 16:24:54,813 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:54,816 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:54,817 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:54,818 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:54,819 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:54,821 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:54,826 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:54,828 : INFO : EPOCH - 39 : training on 23456 raw words (19216 effective words) took 0.0s, 558585 effective words/s\n",
      "2019-06-19 16:24:54,852 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:54,855 : INFO : worker thread finished; awaiting finish of 8 more threads\n",
      "2019-06-19 16:24:54,857 : INFO : worker thread finished; awaiting finish of 7 more threads\n",
      "2019-06-19 16:24:54,857 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:54,858 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:54,862 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:54,864 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:54,868 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:54,869 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:54,870 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:54,871 : INFO : EPOCH - 40 : training on 23456 raw words (19198 effective words) took 0.0s, 655823 effective words/s\n",
      "2019-06-19 16:24:54,892 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:54,894 : INFO : worker thread finished; awaiting finish of 8 more threads\n",
      "2019-06-19 16:24:54,896 : INFO : worker thread finished; awaiting finish of 7 more threads\n",
      "2019-06-19 16:24:54,897 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:54,902 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:54,905 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:54,906 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:54,908 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:54,909 : INFO : worker thread finished; awaiting finish of 1 more threads\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2019-06-19 16:24:54,913 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:54,916 : INFO : EPOCH - 41 : training on 23456 raw words (19185 effective words) took 0.0s, 611568 effective words/s\n",
      "2019-06-19 16:24:54,940 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:54,942 : INFO : worker thread finished; awaiting finish of 8 more threads\n",
      "2019-06-19 16:24:54,944 : INFO : worker thread finished; awaiting finish of 7 more threads\n",
      "2019-06-19 16:24:54,945 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:54,950 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:54,953 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:54,954 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:54,958 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:54,960 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:54,962 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:54,963 : INFO : EPOCH - 42 : training on 23456 raw words (19119 effective words) took 0.0s, 807121 effective words/s\n",
      "2019-06-19 16:24:54,986 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:54,989 : INFO : worker thread finished; awaiting finish of 8 more threads\n",
      "2019-06-19 16:24:54,990 : INFO : worker thread finished; awaiting finish of 7 more threads\n",
      "2019-06-19 16:24:54,994 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:54,996 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:54,998 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:55,001 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:55,003 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:55,004 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:55,009 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:55,010 : INFO : EPOCH - 43 : training on 23456 raw words (19170 effective words) took 0.0s, 781313 effective words/s\n",
      "2019-06-19 16:24:55,035 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:55,040 : INFO : worker thread finished; awaiting finish of 8 more threads\n",
      "2019-06-19 16:24:55,041 : INFO : worker thread finished; awaiting finish of 7 more threads\n",
      "2019-06-19 16:24:55,044 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:55,048 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:55,052 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:55,053 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:55,056 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:55,058 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:55,065 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:55,068 : INFO : EPOCH - 44 : training on 23456 raw words (19203 effective words) took 0.0s, 592470 effective words/s\n",
      "2019-06-19 16:24:55,084 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:55,085 : INFO : worker thread finished; awaiting finish of 8 more threads\n",
      "2019-06-19 16:24:55,087 : INFO : worker thread finished; awaiting finish of 7 more threads\n",
      "2019-06-19 16:24:55,089 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:55,091 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:55,092 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:55,094 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:55,097 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:55,101 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:55,104 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:55,105 : INFO : EPOCH - 45 : training on 23456 raw words (19225 effective words) took 0.0s, 905782 effective words/s\n",
      "2019-06-19 16:24:55,120 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:55,121 : INFO : worker thread finished; awaiting finish of 8 more threads\n",
      "2019-06-19 16:24:55,123 : INFO : worker thread finished; awaiting finish of 7 more threads\n",
      "2019-06-19 16:24:55,124 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:55,126 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:55,127 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:55,129 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:55,130 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:55,136 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:55,140 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:55,141 : INFO : EPOCH - 46 : training on 23456 raw words (19225 effective words) took 0.0s, 635295 effective words/s\n",
      "2019-06-19 16:24:55,163 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:55,168 : INFO : worker thread finished; awaiting finish of 8 more threads\n",
      "2019-06-19 16:24:55,170 : INFO : worker thread finished; awaiting finish of 7 more threads\n",
      "2019-06-19 16:24:55,171 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:55,172 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:55,174 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:55,176 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:55,176 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:55,181 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:55,187 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:55,188 : INFO : EPOCH - 47 : training on 23456 raw words (19203 effective words) took 0.0s, 778138 effective words/s\n",
      "2019-06-19 16:24:55,197 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:55,204 : INFO : worker thread finished; awaiting finish of 8 more threads\n",
      "2019-06-19 16:24:55,209 : INFO : worker thread finished; awaiting finish of 7 more threads\n",
      "2019-06-19 16:24:55,213 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:55,217 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:55,221 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:55,222 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:55,224 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:55,226 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:55,229 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:55,232 : INFO : EPOCH - 48 : training on 23456 raw words (19135 effective words) took 0.0s, 546362 effective words/s\n",
      "2019-06-19 16:24:55,251 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:55,256 : INFO : worker thread finished; awaiting finish of 8 more threads\n",
      "2019-06-19 16:24:55,257 : INFO : worker thread finished; awaiting finish of 7 more threads\n",
      "2019-06-19 16:24:55,258 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:55,260 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:55,264 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:55,269 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:55,270 : INFO : worker thread finished; awaiting finish of 2 more threads\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2019-06-19 16:24:55,272 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:55,275 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:55,278 : INFO : EPOCH - 49 : training on 23456 raw words (19154 effective words) took 0.0s, 525882 effective words/s\n",
      "2019-06-19 16:24:55,294 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:55,298 : INFO : worker thread finished; awaiting finish of 8 more threads\n",
      "2019-06-19 16:24:55,301 : INFO : worker thread finished; awaiting finish of 7 more threads\n",
      "2019-06-19 16:24:55,305 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:55,308 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:55,309 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:55,310 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:55,312 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:55,314 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:55,322 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:55,324 : INFO : EPOCH - 50 : training on 23456 raw words (19130 effective words) took 0.0s, 624321 effective words/s\n",
      "2019-06-19 16:24:55,349 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:55,354 : INFO : worker thread finished; awaiting finish of 8 more threads\n",
      "2019-06-19 16:24:55,356 : INFO : worker thread finished; awaiting finish of 7 more threads\n",
      "2019-06-19 16:24:55,357 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:55,358 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:55,364 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:55,368 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:55,370 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:55,372 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:55,373 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:55,373 : INFO : EPOCH - 51 : training on 23456 raw words (19227 effective words) took 0.0s, 721681 effective words/s\n",
      "2019-06-19 16:24:55,396 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:55,401 : INFO : worker thread finished; awaiting finish of 8 more threads\n",
      "2019-06-19 16:24:55,407 : INFO : worker thread finished; awaiting finish of 7 more threads\n",
      "2019-06-19 16:24:55,409 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:55,411 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:55,413 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:55,414 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:55,419 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:55,420 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:55,421 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:55,422 : INFO : EPOCH - 52 : training on 23456 raw words (19198 effective words) took 0.0s, 505953 effective words/s\n",
      "2019-06-19 16:24:55,439 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:55,442 : INFO : worker thread finished; awaiting finish of 8 more threads\n",
      "2019-06-19 16:24:55,444 : INFO : worker thread finished; awaiting finish of 7 more threads\n",
      "2019-06-19 16:24:55,445 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:55,447 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:55,449 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:55,453 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:55,456 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:55,460 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:55,462 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:55,465 : INFO : EPOCH - 53 : training on 23456 raw words (19190 effective words) took 0.0s, 740064 effective words/s\n",
      "2019-06-19 16:24:55,480 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:55,486 : INFO : worker thread finished; awaiting finish of 8 more threads\n",
      "2019-06-19 16:24:55,490 : INFO : worker thread finished; awaiting finish of 7 more threads\n",
      "2019-06-19 16:24:55,492 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:55,493 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:55,498 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:55,502 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:55,505 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:55,506 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:55,507 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:55,509 : INFO : EPOCH - 54 : training on 23456 raw words (19181 effective words) took 0.0s, 526722 effective words/s\n",
      "2019-06-19 16:24:55,530 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:55,536 : INFO : worker thread finished; awaiting finish of 8 more threads\n",
      "2019-06-19 16:24:55,538 : INFO : worker thread finished; awaiting finish of 7 more threads\n",
      "2019-06-19 16:24:55,539 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:55,540 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:55,541 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:55,545 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:55,546 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:55,547 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:55,551 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:55,553 : INFO : EPOCH - 55 : training on 23456 raw words (19203 effective words) took 0.0s, 835446 effective words/s\n",
      "2019-06-19 16:24:55,568 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:55,572 : INFO : worker thread finished; awaiting finish of 8 more threads\n",
      "2019-06-19 16:24:55,580 : INFO : worker thread finished; awaiting finish of 7 more threads\n",
      "2019-06-19 16:24:55,584 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:55,588 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:55,590 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:55,592 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:55,594 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:55,597 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:55,603 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:55,605 : INFO : EPOCH - 56 : training on 23456 raw words (19188 effective words) took 0.0s, 509254 effective words/s\n",
      "2019-06-19 16:24:55,620 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:55,625 : INFO : worker thread finished; awaiting finish of 8 more threads\n",
      "2019-06-19 16:24:55,628 : INFO : worker thread finished; awaiting finish of 7 more threads\n",
      "2019-06-19 16:24:55,633 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:55,636 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:55,639 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:55,640 : INFO : worker thread finished; awaiting finish of 3 more threads\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2019-06-19 16:24:55,644 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:55,648 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:55,655 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:55,656 : INFO : EPOCH - 57 : training on 23456 raw words (19194 effective words) took 0.0s, 522461 effective words/s\n",
      "2019-06-19 16:24:55,674 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:55,677 : INFO : worker thread finished; awaiting finish of 8 more threads\n",
      "2019-06-19 16:24:55,679 : INFO : worker thread finished; awaiting finish of 7 more threads\n",
      "2019-06-19 16:24:55,690 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:55,693 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:55,696 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:55,700 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:55,702 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:55,709 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:55,718 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:55,722 : INFO : EPOCH - 58 : training on 23456 raw words (19136 effective words) took 0.1s, 380997 effective words/s\n",
      "2019-06-19 16:24:55,745 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:55,750 : INFO : worker thread finished; awaiting finish of 8 more threads\n",
      "2019-06-19 16:24:55,754 : INFO : worker thread finished; awaiting finish of 7 more threads\n",
      "2019-06-19 16:24:55,756 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:55,756 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:55,758 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:55,759 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:55,761 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:55,765 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:55,785 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:55,790 : INFO : EPOCH - 59 : training on 23456 raw words (19282 effective words) took 0.0s, 427392 effective words/s\n",
      "2019-06-19 16:24:55,806 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:55,817 : INFO : worker thread finished; awaiting finish of 8 more threads\n",
      "2019-06-19 16:24:55,821 : INFO : worker thread finished; awaiting finish of 7 more threads\n",
      "2019-06-19 16:24:55,822 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:55,824 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:55,828 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:55,833 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:55,837 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:55,838 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:55,840 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:55,842 : INFO : EPOCH - 60 : training on 23456 raw words (19201 effective words) took 0.0s, 540499 effective words/s\n",
      "2019-06-19 16:24:55,865 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:55,873 : INFO : worker thread finished; awaiting finish of 8 more threads\n",
      "2019-06-19 16:24:55,877 : INFO : worker thread finished; awaiting finish of 7 more threads\n",
      "2019-06-19 16:24:55,879 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:55,884 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:55,886 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:55,887 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:55,889 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:55,890 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:55,892 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:55,893 : INFO : EPOCH - 61 : training on 23456 raw words (19216 effective words) took 0.0s, 678804 effective words/s\n",
      "2019-06-19 16:24:55,909 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:55,911 : INFO : worker thread finished; awaiting finish of 8 more threads\n",
      "2019-06-19 16:24:55,916 : INFO : worker thread finished; awaiting finish of 7 more threads\n",
      "2019-06-19 16:24:55,917 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:55,919 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:55,921 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:55,923 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:55,925 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:55,927 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:55,930 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:55,932 : INFO : EPOCH - 62 : training on 23456 raw words (19210 effective words) took 0.0s, 824078 effective words/s\n",
      "2019-06-19 16:24:55,943 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:55,950 : INFO : worker thread finished; awaiting finish of 8 more threads\n",
      "2019-06-19 16:24:55,957 : INFO : worker thread finished; awaiting finish of 7 more threads\n",
      "2019-06-19 16:24:55,960 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:55,961 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:55,964 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:55,965 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:55,967 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:55,970 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:55,974 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:55,976 : INFO : EPOCH - 63 : training on 23456 raw words (19213 effective words) took 0.0s, 572366 effective words/s\n",
      "2019-06-19 16:24:56,001 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:56,004 : INFO : worker thread finished; awaiting finish of 8 more threads\n",
      "2019-06-19 16:24:56,006 : INFO : worker thread finished; awaiting finish of 7 more threads\n",
      "2019-06-19 16:24:56,008 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:56,009 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:56,010 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:56,013 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:56,016 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:56,020 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:56,022 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:56,025 : INFO : EPOCH - 64 : training on 23456 raw words (19155 effective words) took 0.0s, 805604 effective words/s\n",
      "2019-06-19 16:24:56,045 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:56,054 : INFO : worker thread finished; awaiting finish of 8 more threads\n",
      "2019-06-19 16:24:56,058 : INFO : worker thread finished; awaiting finish of 7 more threads\n",
      "2019-06-19 16:24:56,060 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:56,061 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:56,062 : INFO : worker thread finished; awaiting finish of 4 more threads\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2019-06-19 16:24:56,065 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:56,066 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:56,073 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:56,076 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:56,079 : INFO : EPOCH - 65 : training on 23456 raw words (19197 effective words) took 0.0s, 552996 effective words/s\n",
      "2019-06-19 16:24:56,096 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:56,104 : INFO : worker thread finished; awaiting finish of 8 more threads\n",
      "2019-06-19 16:24:56,112 : INFO : worker thread finished; awaiting finish of 7 more threads\n",
      "2019-06-19 16:24:56,114 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:56,116 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:56,118 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:56,119 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:56,121 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:56,123 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:56,138 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:56,141 : INFO : EPOCH - 66 : training on 23456 raw words (19182 effective words) took 0.0s, 428643 effective words/s\n",
      "2019-06-19 16:24:56,154 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:56,157 : INFO : worker thread finished; awaiting finish of 8 more threads\n",
      "2019-06-19 16:24:56,160 : INFO : worker thread finished; awaiting finish of 7 more threads\n",
      "2019-06-19 16:24:56,162 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:56,162 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:56,164 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:56,165 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:56,166 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:56,170 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:56,174 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:56,176 : INFO : EPOCH - 67 : training on 23456 raw words (19213 effective words) took 0.0s, 743595 effective words/s\n",
      "2019-06-19 16:24:56,192 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:56,196 : INFO : worker thread finished; awaiting finish of 8 more threads\n",
      "2019-06-19 16:24:56,199 : INFO : worker thread finished; awaiting finish of 7 more threads\n",
      "2019-06-19 16:24:56,202 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:56,205 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:56,206 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:56,208 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:56,210 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:56,213 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:56,216 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:56,218 : INFO : EPOCH - 68 : training on 23456 raw words (19186 effective words) took 0.0s, 639638 effective words/s\n",
      "2019-06-19 16:24:56,232 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:56,238 : INFO : worker thread finished; awaiting finish of 8 more threads\n",
      "2019-06-19 16:24:56,240 : INFO : worker thread finished; awaiting finish of 7 more threads\n",
      "2019-06-19 16:24:56,241 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:56,244 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:56,247 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:56,251 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:56,253 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:56,256 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:56,261 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:56,264 : INFO : EPOCH - 69 : training on 23456 raw words (19171 effective words) took 0.0s, 605542 effective words/s\n",
      "2019-06-19 16:24:56,282 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:56,285 : INFO : worker thread finished; awaiting finish of 8 more threads\n",
      "2019-06-19 16:24:56,286 : INFO : worker thread finished; awaiting finish of 7 more threads\n",
      "2019-06-19 16:24:56,288 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:56,289 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:56,290 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:56,291 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:56,292 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:56,295 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:56,302 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:56,304 : INFO : EPOCH - 70 : training on 23456 raw words (19174 effective words) took 0.0s, 882317 effective words/s\n",
      "2019-06-19 16:24:56,319 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:56,322 : INFO : worker thread finished; awaiting finish of 8 more threads\n",
      "2019-06-19 16:24:56,325 : INFO : worker thread finished; awaiting finish of 7 more threads\n",
      "2019-06-19 16:24:56,327 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:56,332 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:56,334 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:56,336 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:56,338 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:56,341 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:56,342 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:56,343 : INFO : EPOCH - 71 : training on 23456 raw words (19168 effective words) took 0.0s, 765517 effective words/s\n",
      "2019-06-19 16:24:56,362 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:56,368 : INFO : worker thread finished; awaiting finish of 8 more threads\n",
      "2019-06-19 16:24:56,370 : INFO : worker thread finished; awaiting finish of 7 more threads\n",
      "2019-06-19 16:24:56,375 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:56,376 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:56,377 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:56,383 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:56,386 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:56,389 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:56,390 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:56,392 : INFO : EPOCH - 72 : training on 23456 raw words (19135 effective words) took 0.0s, 521898 effective words/s\n",
      "2019-06-19 16:24:56,409 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:56,412 : INFO : worker thread finished; awaiting finish of 8 more threads\n",
      "2019-06-19 16:24:56,414 : INFO : worker thread finished; awaiting finish of 7 more threads\n",
      "2019-06-19 16:24:56,417 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:56,419 : INFO : worker thread finished; awaiting finish of 5 more threads\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2019-06-19 16:24:56,421 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:56,422 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:56,425 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:56,428 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:56,429 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:56,430 : INFO : EPOCH - 73 : training on 23456 raw words (19108 effective words) took 0.0s, 874403 effective words/s\n",
      "2019-06-19 16:24:56,449 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:56,452 : INFO : worker thread finished; awaiting finish of 8 more threads\n",
      "2019-06-19 16:24:56,454 : INFO : worker thread finished; awaiting finish of 7 more threads\n",
      "2019-06-19 16:24:56,456 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:56,457 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:56,457 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:56,458 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:56,459 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:56,465 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:56,470 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:56,472 : INFO : EPOCH - 74 : training on 23456 raw words (19156 effective words) took 0.0s, 844027 effective words/s\n",
      "2019-06-19 16:24:56,489 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:56,491 : INFO : worker thread finished; awaiting finish of 8 more threads\n",
      "2019-06-19 16:24:56,499 : INFO : worker thread finished; awaiting finish of 7 more threads\n",
      "2019-06-19 16:24:56,505 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:56,508 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:56,509 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:56,513 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:56,514 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:56,517 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:56,523 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:56,525 : INFO : EPOCH - 75 : training on 23456 raw words (19184 effective words) took 0.0s, 532649 effective words/s\n",
      "2019-06-19 16:24:56,545 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:56,549 : INFO : worker thread finished; awaiting finish of 8 more threads\n",
      "2019-06-19 16:24:56,552 : INFO : worker thread finished; awaiting finish of 7 more threads\n",
      "2019-06-19 16:24:56,553 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:56,554 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:56,557 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:56,561 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:56,564 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:56,567 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:56,569 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:56,570 : INFO : EPOCH - 76 : training on 23456 raw words (19214 effective words) took 0.0s, 628778 effective words/s\n",
      "2019-06-19 16:24:56,593 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:56,596 : INFO : worker thread finished; awaiting finish of 8 more threads\n",
      "2019-06-19 16:24:56,608 : INFO : worker thread finished; awaiting finish of 7 more threads\n",
      "2019-06-19 16:24:56,612 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:56,616 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:56,618 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:56,620 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:56,621 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:56,623 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:56,631 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:56,636 : INFO : EPOCH - 77 : training on 23456 raw words (19105 effective words) took 0.0s, 406289 effective words/s\n",
      "2019-06-19 16:24:56,655 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:56,656 : INFO : worker thread finished; awaiting finish of 8 more threads\n",
      "2019-06-19 16:24:56,657 : INFO : worker thread finished; awaiting finish of 7 more threads\n",
      "2019-06-19 16:24:56,657 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:56,657 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:56,660 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:56,661 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:56,663 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:56,666 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:56,669 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:56,670 : INFO : EPOCH - 78 : training on 23456 raw words (19205 effective words) took 0.0s, 745601 effective words/s\n",
      "2019-06-19 16:24:56,686 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:56,688 : INFO : worker thread finished; awaiting finish of 8 more threads\n",
      "2019-06-19 16:24:56,690 : INFO : worker thread finished; awaiting finish of 7 more threads\n",
      "2019-06-19 16:24:56,693 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:56,694 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:56,703 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:56,708 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:56,709 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:56,710 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:56,713 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:56,714 : INFO : EPOCH - 79 : training on 23456 raw words (19165 effective words) took 0.0s, 689457 effective words/s\n",
      "2019-06-19 16:24:56,735 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:56,737 : INFO : worker thread finished; awaiting finish of 8 more threads\n",
      "2019-06-19 16:24:56,739 : INFO : worker thread finished; awaiting finish of 7 more threads\n",
      "2019-06-19 16:24:56,743 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:56,750 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:56,752 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:56,754 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:56,756 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:56,757 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:56,758 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:56,761 : INFO : EPOCH - 80 : training on 23456 raw words (19132 effective words) took 0.0s, 534043 effective words/s\n",
      "2019-06-19 16:24:56,784 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:56,786 : INFO : worker thread finished; awaiting finish of 8 more threads\n",
      "2019-06-19 16:24:56,787 : INFO : worker thread finished; awaiting finish of 7 more threads\n",
      "2019-06-19 16:24:56,789 : INFO : worker thread finished; awaiting finish of 6 more threads\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2019-06-19 16:24:56,791 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:56,794 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:56,796 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:56,800 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:56,802 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:56,804 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:56,808 : INFO : EPOCH - 81 : training on 23456 raw words (19135 effective words) took 0.0s, 774723 effective words/s\n",
      "2019-06-19 16:24:56,822 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:56,828 : INFO : worker thread finished; awaiting finish of 8 more threads\n",
      "2019-06-19 16:24:56,831 : INFO : worker thread finished; awaiting finish of 7 more threads\n",
      "2019-06-19 16:24:56,834 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:56,836 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:56,837 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:56,840 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:56,845 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:56,846 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:56,848 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:56,851 : INFO : EPOCH - 82 : training on 23456 raw words (19195 effective words) took 0.0s, 663544 effective words/s\n",
      "2019-06-19 16:24:56,869 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:56,872 : INFO : worker thread finished; awaiting finish of 8 more threads\n",
      "2019-06-19 16:24:56,874 : INFO : worker thread finished; awaiting finish of 7 more threads\n",
      "2019-06-19 16:24:56,876 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:56,879 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:56,880 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:56,883 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:56,885 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:56,887 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:56,890 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:56,891 : INFO : EPOCH - 83 : training on 23456 raw words (19182 effective words) took 0.0s, 848119 effective words/s\n",
      "2019-06-19 16:24:56,907 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:56,912 : INFO : worker thread finished; awaiting finish of 8 more threads\n",
      "2019-06-19 16:24:56,915 : INFO : worker thread finished; awaiting finish of 7 more threads\n",
      "2019-06-19 16:24:56,917 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:56,919 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:56,922 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:56,925 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:56,927 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:56,930 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:56,932 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:56,936 : INFO : EPOCH - 84 : training on 23456 raw words (19220 effective words) took 0.0s, 588845 effective words/s\n",
      "2019-06-19 16:24:56,950 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:56,953 : INFO : worker thread finished; awaiting finish of 8 more threads\n",
      "2019-06-19 16:24:56,955 : INFO : worker thread finished; awaiting finish of 7 more threads\n",
      "2019-06-19 16:24:56,957 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:56,958 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:56,961 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:56,964 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:56,966 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:56,968 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:56,971 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:56,972 : INFO : EPOCH - 85 : training on 23456 raw words (19186 effective words) took 0.0s, 879702 effective words/s\n",
      "2019-06-19 16:24:56,993 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:56,996 : INFO : worker thread finished; awaiting finish of 8 more threads\n",
      "2019-06-19 16:24:57,001 : INFO : worker thread finished; awaiting finish of 7 more threads\n",
      "2019-06-19 16:24:57,005 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:57,007 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:57,008 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:57,009 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:57,011 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:57,012 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:57,014 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:57,016 : INFO : EPOCH - 86 : training on 23456 raw words (19191 effective words) took 0.0s, 716261 effective words/s\n",
      "2019-06-19 16:24:57,028 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:57,032 : INFO : worker thread finished; awaiting finish of 8 more threads\n",
      "2019-06-19 16:24:57,045 : INFO : worker thread finished; awaiting finish of 7 more threads\n",
      "2019-06-19 16:24:57,047 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:57,052 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:57,053 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:57,056 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:57,057 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:57,059 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:57,072 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:57,073 : INFO : EPOCH - 87 : training on 23456 raw words (19169 effective words) took 0.0s, 423949 effective words/s\n",
      "2019-06-19 16:24:57,089 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:57,092 : INFO : worker thread finished; awaiting finish of 8 more threads\n",
      "2019-06-19 16:24:57,097 : INFO : worker thread finished; awaiting finish of 7 more threads\n",
      "2019-06-19 16:24:57,100 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:57,104 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:57,105 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:57,106 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:57,107 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:57,109 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:57,114 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:57,119 : INFO : EPOCH - 88 : training on 23456 raw words (19119 effective words) took 0.0s, 621669 effective words/s\n",
      "2019-06-19 16:24:57,144 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:57,146 : INFO : worker thread finished; awaiting finish of 8 more threads\n",
      "2019-06-19 16:24:57,150 : INFO : worker thread finished; awaiting finish of 7 more threads\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2019-06-19 16:24:57,152 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:57,154 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:57,157 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:57,159 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:57,160 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:57,163 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:57,176 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:57,178 : INFO : EPOCH - 89 : training on 23456 raw words (19158 effective words) took 0.0s, 547644 effective words/s\n",
      "2019-06-19 16:24:57,204 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:57,207 : INFO : worker thread finished; awaiting finish of 8 more threads\n",
      "2019-06-19 16:24:57,209 : INFO : worker thread finished; awaiting finish of 7 more threads\n",
      "2019-06-19 16:24:57,211 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:57,214 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:57,216 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:57,218 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:57,221 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:57,224 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:57,224 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:57,226 : INFO : EPOCH - 90 : training on 23456 raw words (19165 effective words) took 0.0s, 859665 effective words/s\n",
      "2019-06-19 16:24:57,250 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:57,253 : INFO : worker thread finished; awaiting finish of 8 more threads\n",
      "2019-06-19 16:24:57,255 : INFO : worker thread finished; awaiting finish of 7 more threads\n",
      "2019-06-19 16:24:57,256 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:57,258 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:57,258 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:57,260 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:57,261 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:57,262 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:57,264 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:57,268 : INFO : EPOCH - 91 : training on 23456 raw words (19240 effective words) took 0.0s, 640330 effective words/s\n",
      "2019-06-19 16:24:57,287 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:57,289 : INFO : worker thread finished; awaiting finish of 8 more threads\n",
      "2019-06-19 16:24:57,290 : INFO : worker thread finished; awaiting finish of 7 more threads\n",
      "2019-06-19 16:24:57,291 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:57,292 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:57,293 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:57,294 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:57,296 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:57,301 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:57,307 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:57,308 : INFO : EPOCH - 92 : training on 23456 raw words (19193 effective words) took 0.0s, 672574 effective words/s\n",
      "2019-06-19 16:24:57,331 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:57,334 : INFO : worker thread finished; awaiting finish of 8 more threads\n",
      "2019-06-19 16:24:57,336 : INFO : worker thread finished; awaiting finish of 7 more threads\n",
      "2019-06-19 16:24:57,337 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:57,338 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:57,338 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:57,340 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:57,341 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:57,344 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:57,355 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:57,357 : INFO : EPOCH - 93 : training on 23456 raw words (19197 effective words) took 0.0s, 671586 effective words/s\n",
      "2019-06-19 16:24:57,377 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:57,380 : INFO : worker thread finished; awaiting finish of 8 more threads\n",
      "2019-06-19 16:24:57,383 : INFO : worker thread finished; awaiting finish of 7 more threads\n",
      "2019-06-19 16:24:57,385 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:57,387 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:57,389 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:57,392 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:57,394 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:57,397 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:57,401 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:57,404 : INFO : EPOCH - 94 : training on 23456 raw words (19129 effective words) took 0.0s, 691861 effective words/s\n",
      "2019-06-19 16:24:57,423 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:57,425 : INFO : worker thread finished; awaiting finish of 8 more threads\n",
      "2019-06-19 16:24:57,427 : INFO : worker thread finished; awaiting finish of 7 more threads\n",
      "2019-06-19 16:24:57,429 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:57,431 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:57,433 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:57,436 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:57,443 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:57,445 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:57,447 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:57,452 : INFO : EPOCH - 95 : training on 23456 raw words (19200 effective words) took 0.0s, 620867 effective words/s\n",
      "2019-06-19 16:24:57,473 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:57,476 : INFO : worker thread finished; awaiting finish of 8 more threads\n",
      "2019-06-19 16:24:57,481 : INFO : worker thread finished; awaiting finish of 7 more threads\n",
      "2019-06-19 16:24:57,484 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:57,488 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:57,489 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:57,492 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:57,493 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:57,498 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:57,509 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:57,513 : INFO : EPOCH - 96 : training on 23456 raw words (19208 effective words) took 0.0s, 482762 effective words/s\n",
      "2019-06-19 16:24:57,530 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:57,536 : INFO : worker thread finished; awaiting finish of 8 more threads\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2019-06-19 16:24:57,541 : INFO : worker thread finished; awaiting finish of 7 more threads\n",
      "2019-06-19 16:24:57,542 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:57,544 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:57,546 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:57,548 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:57,551 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:57,553 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:57,554 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:57,556 : INFO : EPOCH - 97 : training on 23456 raw words (19159 effective words) took 0.0s, 602838 effective words/s\n",
      "2019-06-19 16:24:57,569 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:57,577 : INFO : worker thread finished; awaiting finish of 8 more threads\n",
      "2019-06-19 16:24:57,581 : INFO : worker thread finished; awaiting finish of 7 more threads\n",
      "2019-06-19 16:24:57,586 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:57,588 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:57,590 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:57,591 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:57,593 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:57,596 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:57,598 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:57,601 : INFO : EPOCH - 98 : training on 23456 raw words (19163 effective words) took 0.0s, 502294 effective words/s\n",
      "2019-06-19 16:24:57,621 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:57,624 : INFO : worker thread finished; awaiting finish of 8 more threads\n",
      "2019-06-19 16:24:57,625 : INFO : worker thread finished; awaiting finish of 7 more threads\n",
      "2019-06-19 16:24:57,625 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:57,627 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:57,629 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:57,630 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:57,635 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:57,637 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:57,638 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:57,640 : INFO : EPOCH - 99 : training on 23456 raw words (19168 effective words) took 0.0s, 992374 effective words/s\n",
      "2019-06-19 16:24:57,658 : INFO : worker thread finished; awaiting finish of 9 more threads\n",
      "2019-06-19 16:24:57,662 : INFO : worker thread finished; awaiting finish of 8 more threads\n",
      "2019-06-19 16:24:57,670 : INFO : worker thread finished; awaiting finish of 7 more threads\n",
      "2019-06-19 16:24:57,672 : INFO : worker thread finished; awaiting finish of 6 more threads\n",
      "2019-06-19 16:24:57,675 : INFO : worker thread finished; awaiting finish of 5 more threads\n",
      "2019-06-19 16:24:57,676 : INFO : worker thread finished; awaiting finish of 4 more threads\n",
      "2019-06-19 16:24:57,677 : INFO : worker thread finished; awaiting finish of 3 more threads\n",
      "2019-06-19 16:24:57,678 : INFO : worker thread finished; awaiting finish of 2 more threads\n",
      "2019-06-19 16:24:57,680 : INFO : worker thread finished; awaiting finish of 1 more threads\n",
      "2019-06-19 16:24:57,689 : INFO : worker thread finished; awaiting finish of 0 more threads\n",
      "2019-06-19 16:24:57,692 : INFO : EPOCH - 100 : training on 23456 raw words (19232 effective words) took 0.0s, 552768 effective words/s\n",
      "2019-06-19 16:24:57,695 : INFO : training on a 2345600 raw words (1918475 effective words) took 4.8s, 401744 effective words/s\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "(1918475, 2345600)"
      ]
     },
     "execution_count": 144,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "model = gensim.models.Word2Vec(\n",
    "        documents,\n",
    "        size=50,\n",
    "        window=30,\n",
    "        min_count=0,\n",
    "        workers=10)\n",
    "\n",
    "model.train(documents, total_examples=len(documents), epochs=100)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 148,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Most similar to ABCG2 [('transporter', 0.8971574306488037), ('gefitinib', 0.8629952073097229), ('extrusion', 0.8603367209434509), ('causes', 0.8382961750030518), ('away', 0.8380654454231262), ('concomitant', 0.8371683359146118), ('membrane,', 0.8368896245956421), ('doxorubicin', 0.8220955729484558), ('inhibition', 0.8169850707054138), ('egfr', 0.8140828609466553)]\n"
     ]
    }
   ],
   "source": [
    "w1 = \"ABCG2\".lower()\n",
    "\n",
    "print(\"Most similar to {0}\".format('ABCG2'), model.wv.most_similar(positive=w1))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 149,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Most similar to glaucoma [('open-angle', 0.9977099299430847), ('(poag).', 0.9970671534538269), ('loxl1', 0.6293195486068726), ('population.', 0.5295864343643188), ('investigated.', 0.5186614990234375), ('thoroughly', 0.5030410289764404), ('recently,', 0.48044827580451965), ('been', 0.4706741273403168), ('middle', 0.4550781846046448), ('cyp1a1', 0.4542720317840576)]\n"
     ]
    }
   ],
   "source": [
    "w1 = \"glaucoma\".lower()\n",
    "\n",
    "print(\"Most similar to {0}\".format('glaucoma'), model.wv.most_similar(positive=w1))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 150,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Most similar to ias [('rs42524', 0.9814943671226501), ('ethnicity.', 0.9536105394363403), ('col1a2', 0.8689796328544617), ('han', 0.8114165663719177), ('sporadic', 0.7153281569480896), ('chinese', 0.7105603218078613), ('authors', 0.6703982949256897), ('polymorphism', 0.5799390077590942), ('predicts', 0.5696506500244141), ('cyp3a5,', 0.563604474067688)]\n"
     ]
    }
   ],
   "source": [
    "w1 = \"ias\".lower()\n",
    "\n",
    "print(\"Most similar to {0}\".format(w1), model.wv.most_similar(positive=w1))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 143,
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[('open-angle', 0.941875159740448),\n",
       " ('(poag).', 0.9250666499137878),\n",
       " ('garcinia', 0.8112842440605164),\n",
       " ('primary', 0.8009686470031738),\n",
       " ('kola', 0.7902020812034607),\n",
       " ('stx2vha.', 0.7898602485656738),\n",
       " ('anti-hcv', 0.7787668108940125),\n",
       " ('intracranial', 0.7740756869316101),\n",
       " ('inactivate', 0.765733540058136),\n",
       " ('outcomes', 0.7632365822792053),\n",
       " ('instilled', 0.7628531455993652),\n",
       " ('aneurysms', 0.7626500725746155),\n",
       " ('old', 0.7582007646560669),\n",
       " ('2c9)', 0.758067786693573),\n",
       " ('occurred.', 0.7561087608337402),\n",
       " ('fluconazole.', 0.7476499080657959),\n",
       " ('1.04-1.52).', 0.746239185333252),\n",
       " ('cerebrovascular', 0.7415264248847961),\n",
       " ('disorder.', 0.7408965826034546),\n",
       " ('nut', 0.7371277809143066),\n",
       " ('pds.', 0.7356117963790894),\n",
       " ('hypertension.', 0.7261499166488647),\n",
       " ('exercise-induced', 0.7218173146247864),\n",
       " ('familial', 0.7216811180114746),\n",
       " ('(and/or', 0.7207029461860657),\n",
       " ('0.047).', 0.7203524708747864),\n",
       " ('cvcr', 0.7195112705230713),\n",
       " ('tests', 0.718197762966156),\n",
       " ('duplication.', 0.7180609703063965),\n",
       " ('six', 0.7162793874740601),\n",
       " ('pst1', 0.7150653600692749),\n",
       " ('mapping.', 0.7136626243591309),\n",
       " ('(cd).', 0.7127693891525269),\n",
       " ('investigated.', 0.7110795974731445),\n",
       " ('neurons.', 0.7110493183135986),\n",
       " ('cycles.', 0.7100599408149719),\n",
       " ('non-carriers.', 0.7097626328468323),\n",
       " ('extract', 0.7096697688102722),\n",
       " ('p=0.003).', 0.7096185088157654),\n",
       " ('rna.', 0.7080550789833069),\n",
       " ('0.036).', 0.7068217396736145),\n",
       " ('1.26,', 0.7038348913192749),\n",
       " ('withdrawal', 0.7006680965423584),\n",
       " ('olfactory', 0.6997119784355164),\n",
       " ('sensory', 0.699518620967865),\n",
       " ('non-homologous', 0.6991856098175049),\n",
       " ('1.6-4.8).', 0.6989588737487793),\n",
       " ('disorders,', 0.6980295181274414),\n",
       " ('0.017).', 0.6969116926193237),\n",
       " ('frequently', 0.6957465410232544),\n",
       " ('end', 0.6952546238899231),\n",
       " ('0.64-0.99;', 0.6944828629493713),\n",
       " ('e', 0.6933218836784363),\n",
       " ('1.22-2.54,', 0.6930149793624878),\n",
       " ('mb.', 0.6925565004348755),\n",
       " ('cyp3a4', 0.6923347115516663),\n",
       " ('overall,', 0.6918094754219055),\n",
       " ('girl', 0.6917228102684021),\n",
       " ('specimens.', 0.6908363699913025),\n",
       " ('range.', 0.6906014084815979),\n",
       " ('thoroughly', 0.6904035210609436),\n",
       " ('exacerbations', 0.6894702315330505),\n",
       " ('(p=0.028),', 0.6893291473388672),\n",
       " ('sample.', 0.6877285838127136),\n",
       " ('(p=0.0000).', 0.6875819563865662),\n",
       " ('apolipoprotein', 0.6874971389770508),\n",
       " ('manic', 0.6848588585853577),\n",
       " ('states', 0.6836956143379211),\n",
       " ('classified', 0.6832000017166138),\n",
       " ('poison', 0.6825156211853027),\n",
       " ('poag', 0.682361364364624),\n",
       " ('techniques.', 0.6795703172683716),\n",
       " ('need', 0.6793354749679565),\n",
       " ('psychosis', 0.6791712045669556),\n",
       " ('structure-activity', 0.6782728433609009),\n",
       " ('methotrexate.', 0.6777829527854919),\n",
       " ('triphosphate', 0.6773598194122314),\n",
       " ('ex1+82a>g', 0.6764879822731018),\n",
       " ('polymorphism,', 0.6756957769393921),\n",
       " ('joining', 0.6739121079444885),\n",
       " ('reduces', 0.6733028888702393),\n",
       " ('-308', 0.6732358336448669),\n",
       " ('(p=0.00006),', 0.6726595163345337),\n",
       " ('cyp1a2', 0.6722336411476135),\n",
       " ('1970', 0.6699852347373962),\n",
       " ('1.76,', 0.6697853207588196),\n",
       " ('0.0179).', 0.6697190403938293),\n",
       " ('rs3093200).', 0.6692189574241638),\n",
       " ('(mean:', 0.669062077999115),\n",
       " ('bronchoconstriction.', 0.6686797142028809),\n",
       " ('local', 0.668440580368042),\n",
       " ('hormone-induced', 0.6679073572158813),\n",
       " ('(mef)', 0.6679021716117859),\n",
       " ('events;', 0.6676385402679443),\n",
       " ('guidelines,', 0.6666772961616516),\n",
       " ('point', 0.6657727360725403),\n",
       " ('2-year-old', 0.6645543575286865),\n",
       " ('summarize', 0.6639624834060669),\n",
       " ('(apoe)', 0.6636437773704529),\n",
       " ('assessed', 0.663267195224762)]"
      ]
     },
     "execution_count": 143,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "word = 'glaucoma'\n",
    "new_sentence = word.split()\n",
    "model.wv.most_similar(positive=filter(lambda x: x in model.wv.vocab, new_sentence), topn=100)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.7.3"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
